1	PMA	PMA	B-NP	NN	O	2	NMOD
2	treatment	treatment	I-NP	NN	O	8	NMOD
3	,	,	O	,	O	8	P
4	and	and	B-CONJP	CC	O	8	NMOD
5	not	not	I-CONJP	RB	O	4	DEP
6	retinoic	retinoic	B-NP	JJ	O	8	NMOD
7	acid	acid	I-NP	NN	O	8	NMOD
8	treatment	treatment	I-NP	NN	O	13	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	U937	U937	I-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	9	PMOD
13	acts	act	B-VP	VBZ	O	0	ROOT
14	in	in	B-PP	IN	O	13	VMOD
15	inducing	induce	B-VP	VBG	O	14	PMOD
16	NF-KB	NF-KB	B-NP	NN	B-protein	17	NMOD
17	expression	expression	I-NP	NN	O	15	OBJ
18	in	in	B-PP	IN	O	15	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	nuclei	nucleus	I-NP	NNS	O	18	PMOD
21	.	.	O	.	O	13	P

1	When	When	B-ADVP	WRB	O	17	VMOD
2	U937	U937	B-NP	NN	B-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	4	SUB
4	were	be	B-VP	VBD	O	1	SBAR
5	infected	infect	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	HIV-1	HIV-1	B-NP	NN	O	6	PMOD
8	,	,	O	,	O	17	P
9	no	no	B-NP	DT	O	10	NMOD
10	induction	induction	I-NP	NN	O	14	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	NF-KB	NF-KB	B-NP	NN	B-protein	13	NMOD
13	factor	factor	I-NP	NN	I-protein	11	PMOD
14	was	be	B-VP	VBD	O	17	VMOD
15	detected	detect	I-VP	VBN	O	14	VC
16	,	,	O	,	O	17	P
17	whereas	whereas	O	IN	O	26	VMOD
18	high	high	B-NP	JJ	O	19	NMOD
19	level	level	I-NP	NN	O	23	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	progeny	progeny	B-NP	NN	O	22	NMOD
22	virions	virion	I-NP	NNS	O	20	PMOD
23	was	be	B-VP	VBD	O	17	SBAR
24	produced	produce	I-VP	VBN	O	23	VC
25	,	,	O	,	O	26	P
26	suggesting	suggest	B-VP	VBG	O	0	ROOT
27	that	that	B-SBAR	IN	O	26	VMOD
28	this	this	B-NP	DT	O	29	NMOD
29	factor	factor	I-NP	NN	O	30	SUB
30	was	be	B-VP	VBD	O	27	SBAR
31	not	not	I-VP	RB	O	30	VMOD
32	required	require	I-VP	VBN	O	30	VC
33	for	for	B-PP	IN	O	32	VMOD
34	viral	viral	B-NP	JJ	O	35	NMOD
35	replication	replication	I-NP	NN	O	33	PMOD
36	.	.	O	.	O	26	P

1	Positive	Positive	B-NP	JJ	O	4	NMOD
2	and	and	I-NP	CC	O	4	NMOD
3	negative	negative	I-NP	JJ	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	0	ROOT
5	of	of	B-PP	IN	O	4	NMOD
6	immunoglobulin	immunoglobulin	B-NP	NN	B-DNA	8	NMOD
7	gene	gene	I-NP	NN	I-DNA	8	NMOD
8	expression	expression	I-NP	NN	O	5	PMOD
9	by	by	B-PP	IN	O	4	NMOD
10	a	a	B-NP	DT	O	14	NMOD
11	novel	novel	I-NP	JJ	O	14	NMOD
12	B-cell-specific	B-cell-specific	I-NP	JJ	B-DNA	14	NMOD
13	enhancer	enhancer	I-NP	NN	I-DNA	14	NMOD
14	element	element	I-NP	NN	I-DNA	9	PMOD
15	.	.	O	.	O	4	P

1	Tandem	Tandem	B-NP	JJ	O	2	NMOD
2	copies	copy	I-NP	NNS	O	22	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	7	NMOD
5	67-bp	67-bp	I-NP	JJ	B-DNA	7	NMOD
6	MnlI-AluI	MnlI-AluI	I-NP	NN	I-DNA	7	NMOD
7	fragment	fragment	I-NP	NN	I-DNA	3	PMOD
8	,	,	O	,	O	22	P
9	when	when	B-ADVP	WRB	O	22	VMOD
10	fused	fuse	B-VP	VBN	O	9	SBAR
11	to	to	B-PP	TO	O	10	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	chloramphenicol	chloramphenicol	I-NP	NN	B-DNA	15	NMOD
14	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	15	NMOD
15	gene	gene	I-NP	NN	I-DNA	11	PMOD
16	driven	drive	B-VP	VBN	O	15	NMOD
17	by	by	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	20	NMOD
19	conalbumin	conalbumin	I-NP	NN	B-DNA	20	NMOD
20	promoter	promoter	I-NP	NN	I-DNA	17	PMOD
21	,	,	O	,	O	22	P
22	stimulated	stimulate	B-VP	VBD	O	0	ROOT
23	transcription	transcription	B-NP	NN	O	22	OBJ
24	in	in	B-PP	IN	O	23	NMOD
25	B	B	B-NP	NN	B-cell_type	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_type	24	PMOD
27	but	but	B-PP	CC	O	24	PMOD
28	not	not	B-PP	RB	O	29	PMOD
29	in	in	I-PP	IN	O	24	PMOD
30	Jurkat	Jurkat	B-NP	NN	B-cell_line	32	NMOD
31	T	T	I-NP	NN	I-cell_line	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_line	35	NMOD
33	or	or	O	CC	O	35	NMOD
34	HeLa	HeLa	B-NP	NN	B-cell_line	35	NMOD
35	cells	cell	I-NP	NNS	I-cell_line	29	PMOD
36	.	.	O	.	O	22	P

1	In	In	B-PP	IN	O	17	VMOD
2	agreement	agreement	I-PP	NN	O	1	PMOD
3	with	with	I-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	results	result	I-NP	NNS	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	gel	gel	B-NP	NN	O	9	NMOD
8	retardation	retardation	I-NP	NN	O	9	NMOD
9	assays	assay	I-NP	NNS	O	6	PMOD
10	,	,	O	,	O	17	P
11	tandem	tandem	B-NP	JJ	O	12	NMOD
12	copies	copy	I-NP	NNS	O	17	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	E6	E6	I-NP	NN	B-DNA	16	NMOD
16	motif	motif	I-NP	NN	I-DNA	13	PMOD
17	stimulated	stimulate	B-VP	VBD	O	0	ROOT
18	transcription	transcription	B-NP	NN	O	17	OBJ
19	in	in	B-PP	IN	O	18	NMOD
20	ARH77	ARH77	B-NP	NN	B-cell_line	23	NMOD
21	and	and	O	CC	O	23	NMOD
22	Raji	Raji	B-NP	NN	B-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	19	PMOD
24	but	but	B-PP	CC	O	19	PMOD
25	not	not	B-PP	RB	O	26	PMOD
26	in	in	I-PP	IN	O	19	PMOD
27	Jurkat	Jurkat	B-NP	NN	B-cell_line	29	NMOD
28	or	or	O	CC	O	29	NMOD
29	HeLa	HeLa	B-NP	NN	B-cell_line	30	NMOD
30	cells	cell	B-NP	NNS	I-cell_line	26	PMOD
31	.	.	O	.	O	17	P

1	In	In	B-PP	IN	O	26	VMOD
2	striking	striking	B-NP	JJ	O	3	NMOD
3	contrast	contrast	I-NP	NN	O	1	PMOD
4	to	to	B-PP	TO	O	3	NMOD
5	the	the	B-NP	DT	O	9	NMOD
6	mouse	mouse	I-NP	NN	B-DNA	9	NMOD
7	Ig	Ig	I-NP	NN	I-DNA	9	NMOD
8	heavy-chain	heavy-chain	I-NP	JJ	I-DNA	9	NMOD
9	enhancer	enhancer	I-NP	NN	I-DNA	4	PMOD
10	,	,	O	,	O	9	P
11	in	in	B-PP	IN	O	9	NMOD
12	which	which	B-NP	WDT	O	11	PMOD
13	the	the	B-NP	DT	O	15	NMOD
14	octamer	octamer	I-NP	NN	B-DNA	15	NMOD
15	motif	motif	I-NP	NN	I-DNA	16	SUB
16	acts	act	B-VP	VBZ	O	11	SBAR
17	as	as	B-PP	IN	O	16	VMOD
18	a	a	B-NP	DT	O	21	NMOD
19	B-cell-specific	B-cell-specific	I-NP	JJ	B-DNA	21	NMOD
20	enhancer	enhancer	I-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	17	PMOD
22	,	,	O	,	O	26	P
23	the	the	B-NP	DT	O	25	NMOD
24	human	human	I-NP	JJ	B-DNA	25	NMOD
25	enhancer	enhancer	I-NP	NN	I-DNA	26	SUB
26	contains	contain	B-VP	VBZ	O	0	ROOT
27	an	an	B-NP	DT	O	29	NMOD
28	octamerlike	octamerlike	I-NP	JJ	B-DNA	29	NMOD
29	sequence	sequence	I-NP	NN	I-DNA	26	OBJ
30	with	with	B-PP	IN	O	29	NMOD
31	one	one	B-NP	CD	O	33	NMOD
32	base	base	I-NP	NN	O	33	NMOD
33	substitution	substitution	I-NP	NN	O	30	PMOD
34	which	which	B-NP	WDT	O	29	NMOD
35	bound	bind	B-VP	VBD	O	34	SBAR
36	octamer-binding	octamer-binding	B-NP	JJ	B-protein	37	NMOD
37	proteins	protein	I-NP	NNS	I-protein	35	OBJ
38	with	with	B-PP	IN	O	37	NMOD
39	only	only	B-NP	RB	O	41	AMOD
40	very	very	I-NP	RB	O	41	AMOD
41	low	low	I-NP	JJ	O	42	NMOD
42	affinity	affinity	I-NP	NN	O	38	PMOD
43	and	and	O	CC	O	35	VMOD
44	showed	show	B-VP	VBD	O	35	VMOD
45	no	no	B-NP	DT	O	47	NMOD
46	enhancer	enhancer	I-NP	NN	O	47	NMOD
47	activity	activity	I-NP	NN	O	44	OBJ
48	of	of	B-PP	IN	O	47	NMOD
49	its	its	B-NP	PRP$	O	50	NMOD
50	own	own	I-NP	JJ	O	48	PMOD
51	.	.	O	.	O	26	P

1	Moreover	Moreover	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	simian	simian	B-NP	JJ	O	7	NMOD
4	virus	virus	I-NP	NN	O	7	NMOD
5	40	40	I-NP	CD	O	7	NMOD
6	enhancer	enhancer	I-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	blocked	block	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	MnlI-AluI	MnlI-AluI	I-NP	NN	B-DNA	13	NMOD
13	fragment	fragment	I-NP	NN	I-DNA	10	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	HeLa	HeLa	B-NP	NN	B-cell_line	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
17	but	but	B-PP	CC	O	14	PMOD
18	not	not	B-PP	RB	O	19	PMOD
19	in	in	I-PP	IN	O	14	PMOD
20	B	B	B-NP	NN	B-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
22	.	.	O	.	O	8	P

1	Thus	Thus	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	the	the	B-NP	DT	O	6	NMOD
4	novel	novel	I-NP	JJ	O	6	NMOD
5	enhancer	enhancer	I-NP	NN	B-DNA	6	NMOD
6	element	element	I-NP	NN	I-DNA	11	SUB
7	identified	identify	B-VP	VBN	O	6	NMOD
8	in	in	B-PP	IN	O	7	VMOD
9	this	this	B-NP	DT	O	10	NMOD
10	study	study	I-NP	NN	O	8	PMOD
11	is	be	B-VP	VBZ	O	0	ROOT
12	probably	probably	B-ADVP	RB	O	11	VMOD
13	a	a	B-NP	DT	O	15	NMOD
14	target	target	I-NP	NN	B-DNA	15	NMOD
15	site	site	I-NP	NN	I-DNA	11	PRD
16	for	for	B-PP	IN	O	15	NMOD
17	both	both	B-NP	CC	O	20	AMOD
18	positive	positive	I-NP	JJ	B-protein	20	AMOD
19	and	and	I-NP	CC	I-protein	20	AMOD
20	negative	negative	I-NP	JJ	I-protein	21	NMOD
21	factors	factor	I-NP	NNS	I-protein	16	PMOD
22	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	2	NMOD
2	rate	rate	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	LTR-directed	LTR-directed	B-NP	JJ	B-DNA	6	NMOD
5	gene	gene	I-NP	NN	I-DNA	6	NMOD
6	expression	expression	I-NP	NN	O	3	PMOD
7	increased	increase	B-VP	VBD	O	0	ROOT
8	in	in	B-PP	IN	O	7	VMOD
9	response	response	I-PP	NN	O	8	PMOD
10	to	to	I-PP	TO	O	8	PMOD
11	treatment	treatment	B-NP	NN	O	8	PMOD
12	with	with	B-PP	IN	O	7	VMOD
13	either	either	O	CC	O	21	NMOD
14	a	a	B-NP	DT	O	16	NMOD
15	phorbol	phorbol	I-NP	NN	O	16	NMOD
16	ester	ester	I-NP	NN	O	21	NMOD
17	or	or	O	CC	O	21	NMOD
18	tumor	tumor	B-NP	NN	B-protein	21	NMOD
19	necrosis	necrosis	I-NP	NN	I-protein	21	NMOD
20	factor	factor	I-NP	NN	I-protein	21	NMOD
21	alpha	alpha	I-NP	NN	I-protein	12	PMOD
22	if	if	B-SBAR	IN	O	7	VMOD
23	either	either	O	CC	O	31	NMOD
24	the	the	O	DT	O	31	NMOD
25	NFAT-1	NFAT-1	B-NP	NN	B-protein	31	NMOD
26	or	or	O	CC	O	31	NMOD
27	NF	NF	B-NP	NN	B-DNA	31	NMOD
28	kappa	kappa	I-NP	NN	I-DNA	31	NMOD
29	B	B	I-NP	NN	I-DNA	31	NMOD
30	binding	binding	I-NP	NN	I-DNA	31	NMOD
31	sites	site	I-NP	NNS	I-DNA	32	SUB
32	were	be	B-VP	VBD	O	22	SBAR
33	deleted	delete	I-VP	VBN	O	32	VC
34	,	,	O	,	O	7	P
35	but	but	O	CC	O	7	VMOD
36	failed	fail	B-VP	VBD	O	7	VMOD
37	to	to	I-VP	TO	O	38	VMOD
38	respond	respond	I-VP	VB	O	36	VMOD
39	to	to	B-PP	TO	O	38	VMOD
40	these	these	B-NP	DT	O	42	NMOD
41	mitogenic	mitogenic	I-NP	JJ	O	42	NMOD
42	stimuli	stimulus	I-NP	NNS	O	39	PMOD
43	if	if	B-SBAR	IN	O	38	VMOD
44	both	both	B-NP	DT	O	45	NMOD
45	sequences	sequence	I-NP	NNS	O	46	SUB
46	were	be	B-VP	VBD	O	43	SBAR
47	absent	absent	B-ADJP	JJ	O	46	PRD
48	.	.	O	.	O	7	P

1	Neither	Neither	O	CC	O	8	NMOD
2	deletion	deletion	B-NP	NN	O	8	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	NF	NF	B-NP	NN	B-protein	6	NMOD
5	kappa	kappa	I-NP	NN	I-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	3	PMOD
7	nor	nor	O	CC	O	8	NMOD
8	deletion	deletion	B-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	NFAT-1	NFAT-1	B-NP	NN	B-protein	9	PMOD
11	decreased	decrease	B-VP	VBD	O	0	ROOT
12	activation	activation	B-NP	NN	O	11	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	viral	viral	B-NP	JJ	O	15	NMOD
15	replication	replication	I-NP	NN	O	13	PMOD
16	by	by	B-PP	IN	O	12	NMOD
17	phorbol	phorbol	B-NP	NN	O	18	NMOD
18	ester	ester	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	11	P

1	Employing	Employ	B-VP	VBG	O	11	VMOD
2	the	the	B-NP	DT	O	8	NMOD
3	EBV-transformed	EBV-transformed	I-NP	JJ	B-cell_line	8	NMOD
4	human	human	I-NP	JJ	I-cell_line	8	NMOD
5	B	B	I-NP	NN	I-cell_line	8	NMOD
6	cell	cell	I-NP	NN	I-cell_line	8	NMOD
7	line	line	I-NP	NN	I-cell_line	8	NMOD
8	SKW6.4	SKW6.4	I-NP	NN	B-cell_line	1	OBJ
9	,	,	O	,	O	11	P
10	we	we	B-NP	PRP	O	11	SUB
11	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
12	that	that	B-SBAR	IN	O	11	VMOD
13	platelet-activating	platelet-activating	B-NP	JJ	B-protein	14	NMOD
14	factor	factor	I-NP	NN	I-protein	16	SUB
15	significantly	significantly	B-ADVP	RB	O	16	VMOD
16	alters	alter	B-VP	VBZ	O	12	SBAR
17	membrane	membrane	B-NP	NN	O	19	NMOD
18	phospholipid	phospholipid	I-NP	NN	O	19	NMOD
19	metabolism	metabolism	I-NP	NN	O	16	OBJ
20	indicated	indicate	B-VP	VBN	O	19	NMOD
21	by	by	B-PP	IN	O	20	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	incorporation	incorporation	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	32P	32P	B-NP	NN	O	24	PMOD
26	into	into	B-PP	IN	O	23	NMOD
27	phosphatidylcholine	phosphatidylcholine	B-NP	NN	O	33	NMOD
28	,	,	O	,	O	33	P
29	phosphatidylinositol	phosphatidylinositol	B-NP	NN	O	33	NMOD
30	,	,	O	,	O	33	P
31	and	and	O	CC	O	33	NMOD
32	phosphatidic	phosphatidic	B-NP	JJ	O	33	NMOD
33	acid	acid	I-NP	NN	O	26	PMOD
34	but	but	B-PP	CC	O	26	PMOD
35	not	not	B-ADVP	RB	O	37	PMOD
36	significantly	significantly	I-ADVP	RB	O	35	AMOD
37	into	into	B-PP	IN	O	26	PMOD
38	phosphatidylethanolamine	phosphatidylethanolamine	B-NP	NN	O	37	PMOD
39	at	at	B-PP	IN	O	23	NMOD
40	concentrations	concentration	B-NP	NNS	O	39	PMOD
41	ranging	range	B-VP	VBG	O	40	NMOD
42	from	from	B-PP	IN	O	41	VMOD
43	10	10	B-NP	CD	O	46	NMOD
44	(	(	O	(	O	46	DEP
45	-9	-9	B-NP	CD	O	46	DEP
46	)	)	O	)	O	42	PMOD
47	to	to	B-PP	TO	O	42	PMOD
48	10	10	B-NP	CD	O	47	PMOD
49	(	(	O	(	O	51	DEP
50	-6	-6	B-NP	CD	O	51	DEP
51	)	)	O	)	O	48	NMOD
52	M	M	B-NP	NN	O	47	PMOD
53	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	3	NMOD
2	inactive	inactive	I-NP	JJ	O	3	NMOD
3	precursor	precursor	I-NP	NN	O	6	NMOD
4	,	,	O	,	O	6	P
5	lyso-platelet-activating	lyso-platelet-activating	B-NP	JJ	B-protein	6	NMOD
6	factor	factor	I-NP	NN	I-protein	19	SUB
7	,	,	O	,	O	6	P
8	at	at	B-PP	IN	O	6	NMOD
9	a	a	B-NP	DT	O	10	NMOD
10	concentration	concentration	I-NP	NN	O	8	PMOD
11	as	as	B-ADJP	RB	O	12	AMOD
12	high	high	I-ADJP	JJ	O	10	NMOD
13	as	as	B-PP	IN	O	12	AMOD
14	10	10	B-NP	CD	O	18	NMOD
15	(	(	O	(	O	17	DEP
16	-7	-7	B-NP	CD	O	17	DEP
17	)	)	O	)	O	14	NMOD
18	M	M	B-NP	NN	O	13	PMOD
19	had	have	B-VP	VBD	O	0	ROOT
20	no	no	B-NP	DT	O	21	NMOD
21	effect	effect	I-NP	NN	O	19	OBJ
22	on	on	B-PP	IN	O	19	VMOD
23	any	any	B-NP	DT	O	22	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	membrane	membrane	I-NP	NN	O	27	NMOD
27	phospholipids	phospholipid	I-NP	NNS	O	24	PMOD
28	.	.	O	.	O	19	P

1	Receptor	Receptor	B-NP	NN	B-RNA	2	NMOD
2	transcripts	transcript	I-NP	NNS	I-RNA	3	SUB
3	were	be	B-VP	VBD	O	14	VMOD
4	4.6	4.6	B-NP	CD	O	3	PRD
5	kilobases	kilobas	B-NP	NNS	O	4	NMOD
6	(	(	O	(	O	8	DEP
7	kb	kb	B-NP	NN	O	8	DEP
8	)	)	O	)	O	5	NMOD
9	,	,	O	,	O	14	P
10	and	and	O	CC	O	14	VMOD
11	no	no	B-NP	DT	O	13	NMOD
12	variant	variant	I-NP	JJ	O	13	NMOD
13	sizes	size	I-NP	NNS	O	14	SUB
14	were	be	B-VP	VBD	O	0	ROOT
15	observed	observe	I-VP	VBN	O	14	VC
16	.	.	O	.	O	14	P

1	Levels	Level	B-NP	NNS	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	RNA	RNA	B-NP	NN	O	4	NMOD
4	coding	coding	I-NP	NN	O	2	PMOD
5	for	for	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	receptor	receptor	I-NP	NN	O	5	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	modulated	modulate	I-VP	VBN	O	8	VC
11	by	by	B-PP	IN	O	10	VMOD
12	exposure	exposure	B-NP	NN	O	11	PMOD
13	to	to	B-PP	TO	O	12	NMOD
14	high	high	B-NP	JJ	O	15	NMOD
15	levels	level	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	ligand	ligand	B-NP	NN	O	16	PMOD
18	.	.	O	.	O	8	P

1	Steady-state	Steady-state	B-NP	JJ	O	2	NMOD
2	levels	level	I-NP	NNS	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	1	1	B-NP	CD	B-RNA	12	NMOD
5	,	,	I-NP	,	I-RNA	12	P
6	25	25	I-NP	CD	I-RNA	12	NMOD
7	(	(	O	(	I-RNA	12	NMOD
8	OH	OH	B-NP	NN	I-RNA	12	NMOD
9	)	)	O	)	I-RNA	12	NMOD
10	2D3	2D3	B-NP	NN	I-RNA	12	NMOD
11	receptor	receptor	I-NP	NN	I-RNA	12	NMOD
12	RNA	RNA	I-NP	NN	I-RNA	3	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	not	not	I-VP	RB	O	13	VMOD
15	affected	affect	I-VP	VBN	O	13	VC
16	by	by	B-PP	IN	O	15	VMOD
17	terminal	terminal	B-NP	JJ	O	18	NMOD
18	differentiation	differentiation	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	HL-60	HL-60	B-NP	NN	B-cell_line	19	PMOD
21	toward	toward	B-PP	IN	O	18	NMOD
22	either	either	O	CC	O	25	NMOD
23	granulocytes	granulocyte	B-NP	NNS	B-cell_type	25	NMOD
24	or	or	O	CC	O	25	NMOD
25	macrophages	macrophage	B-NP	NNS	B-cell_type	21	PMOD
26	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	11	P
4	nondividing	nondividing	B-NP	JJ	B-cell_type	7	NMOD
5	peripheral	peripheral	I-NP	JJ	I-cell_type	7	NMOD
6	blood	blood	I-NP	NN	I-cell_type	7	NMOD
7	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	SUB
8	from	from	B-PP	IN	O	7	NMOD
9	normal	normal	B-NP	JJ	O	10	NMOD
10	individuals	individual	I-NP	NNS	O	8	PMOD
11	did	do	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	express	express	I-VP	VB	O	11	VC
14	1	1	B-NP	CD	B-RNA	22	NMOD
15	,	,	I-NP	,	I-RNA	22	P
16	25	25	I-NP	CD	I-RNA	22	NMOD
17	(	(	O	(	I-RNA	22	NMOD
18	OH	OH	B-NP	NN	I-RNA	22	NMOD
19	)	)	O	)	I-RNA	22	NMOD
20	2D3	2D3	B-NP	NN	I-RNA	22	NMOD
21	receptor	receptor	I-NP	NN	I-RNA	22	NMOD
22	RNA	RNA	I-NP	NN	I-RNA	13	OBJ
23	;	;	O	:	O	11	P

1	The	The	B-NP	DT	O	4	NMOD
2	Thy-1	Thy-1	I-NP	NN	B-DNA	4	NMOD
3	gene	gene	I-NP	NN	I-DNA	4	NMOD
4	promoter	promoter	I-NP	NN	I-DNA	5	SUB
5	resembles	resemble	B-VP	VBZ	O	0	ROOT
6	a	a	B-NP	DT	O	10	NMOD
7	``	``	I-NP	``	B-DNA	10	NMOD
8	housekeeping	housekeeping	I-NP	JJ	I-DNA	10	NMOD
9	``	``	I-NP	``	I-DNA	10	NMOD
10	promoter	promoter	I-NP	NN	I-DNA	5	OBJ
11	in	in	B-PP	IN	O	5	VMOD
12	that	that	B-NP	IN	O	11	PMOD
13	it	it	B-NP	PRP	O	14	SUB
14	is	be	B-VP	VBZ	O	12	SBAR
15	located	located	B-ADJP	JJ	O	14	PRD
16	within	within	B-PP	IN	O	15	AMOD
17	a	a	B-NP	DT	O	19	NMOD
18	methylation-free	methylation-free	I-NP	JJ	B-DNA	19	NMOD
19	island	island	I-NP	NN	I-DNA	16	PMOD
20	,	,	O	,	O	14	P
21	lacks	lack	B-VP	VBZ	O	14	VMOD
22	a	a	B-NP	DT	O	25	NMOD
23	canonical	canonical	I-NP	JJ	B-DNA	25	NMOD
24	TATA	TATA	I-NP	NN	I-DNA	25	NMOD
25	box	box	I-NP	NN	I-DNA	21	OBJ
26	,	,	O	,	O	14	P
27	and	and	O	CC	O	14	VMOD
28	displays	display	B-VP	VBZ	O	14	VMOD
29	heterogeneity	heterogeneity	B-NP	NN	O	28	OBJ
30	in	in	B-PP	IN	O	28	VMOD
31	the	the	B-NP	DT	O	33	NMOD
32	5'-end	5'-end	I-NP	JJ	B-RNA	33	NMOD
33	termini	terminus	I-NP	NNS	I-RNA	30	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	the	the	B-NP	DT	O	36	NMOD
36	mRNA	mRNA	I-NP	NN	B-RNA	34	PMOD
37	.	.	O	.	O	5	P

1	Using	Use	B-VP	VBG	O	6	VMOD
2	transgenic	transgenic	B-NP	JJ	O	3	NMOD
3	mice	mouse	I-NP	NNS	O	1	OBJ
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	show	show	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	this	this	B-NP	DT	O	9	NMOD
9	promoter	promoter	I-NP	NN	B-DNA	10	SUB
10	does	do	B-VP	VBZ	O	7	SBAR
11	not	not	I-VP	RB	O	10	VMOD
12	confer	confer	I-VP	VB	O	10	VC
13	any	any	B-NP	DT	O	15	NMOD
14	tissue	tissue	I-NP	NN	O	15	NMOD
15	specificity	specificity	I-NP	NN	O	12	OBJ
16	and	and	O	CC	O	10	VMOD
17	is	be	B-VP	VBZ	O	10	VMOD
18	active	active	B-ADJP	JJ	O	17	PRD
19	only	only	B-PP	RB	O	20	PMOD
20	in	in	I-PP	IN	O	17	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	position-dependent	position-dependent	I-NP	JJ	O	23	NMOD
23	manner	manner	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	6	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	genes	gene	I-NP	NNS	O	5	SUB
5	are	be	B-VP	VBP	O	0	ROOT
6	not	not	O	RB	O	5	VMOD
7	constitutively	constitutively	B-ADJP	RB	O	8	AMOD
8	active	active	I-ADJP	JJ	O	5	PRD
9	in	in	B-PP	IN	O	8	AMOD
10	B	B	B-NP	NN	B-cell_type	11	NMOD
11	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
12	,	,	O	,	O	5	P
13	suggesting	suggest	B-VP	VBG	O	5	VMOD
14	that	that	B-SBAR	IN	O	13	VMOD
15	other	other	B-NP	JJ	O	17	NMOD
16	regulatory	regulatory	I-NP	JJ	O	17	NMOD
17	mechanisms	mechanism	I-NP	NNS	O	18	SUB
18	must	must	B-VP	MD	O	14	SBAR
19	play	play	I-VP	VB	O	18	VC
20	a	a	B-NP	DT	O	21	NMOD
21	role	role	I-NP	NN	O	19	OBJ
22	in	in	B-PP	IN	O	19	VMOD
23	determining	determine	B-VP	VBG	O	22	PMOD
24	the	the	B-NP	DT	O	25	NMOD
25	patterns	pattern	I-NP	NNS	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	expression	expression	B-NP	NN	O	26	PMOD
28	.	.	O	.	O	5	P

1	No	No	B-NP	DT	O	3	NMOD
2	group	group	I-NP	NN	O	3	NMOD
3	differences	difference	I-NP	NNS	O	7	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	cortisol	cortisol	B-NP	NN	O	6	NMOD
6	levels	level	I-NP	NNS	O	4	PMOD
7	were	be	B-VP	VBD	O	0	ROOT
8	observed	observe	I-VP	VBN	O	7	VC
9	,	,	O	,	O	7	P
10	nor	nor	O	CC	O	7	VMOD
11	were	be	O	VBD	O	7	VMOD
12	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	14	NMOD
13	receptor	receptor	I-NP	NN	I-protein	14	NMOD
14	number	number	I-NP	NN	O	17	NMOD
15	and	and	O	CC	O	17	NMOD
16	cortisol	cortisol	B-NP	NN	O	17	NMOD
17	levels	level	I-NP	NNS	O	11	SUB
18	correlated	correlate	B-VP	VBD	O	11	PRD
19	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	data	datum	I-NP	NNS	O	15	SUB
4	,	,	O	,	O	3	P
5	along	along	B-ADVP	IN	O	15	VMOD
6	with	with	B-PP	IN	O	5	PMOD
7	other	other	B-NP	JJ	O	8	NMOD
8	findings	finding	I-NP	NNS	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	HPA	HPA	B-NP	JJ	O	11	NMOD
11	abnormalities	abnormality	I-NP	NNS	O	9	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	PTSD	PTSD	B-NP	NN	O	12	PMOD
14	,	,	O	,	O	15	P
15	support	support	B-VP	VBP	O	0	ROOT
16	the	the	B-NP	DT	O	17	NMOD
17	possibility	possibility	I-NP	NN	O	15	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	a	a	B-NP	DT	O	23	NMOD
20	greater	great	I-NP	JJR	O	23	NMOD
21	negative	negative	I-NP	JJ	O	23	NMOD
22	feedback	feedback	I-NP	NN	O	23	NMOD
23	sensitivity	sensitivity	I-NP	NN	O	18	PMOD
24	at	at	B-PP	IN	O	23	NMOD
25	one	one	B-NP	CD	O	28	NMOD
26	or	or	I-NP	CC	O	25	AMOD
27	more	more	I-NP	JJR	O	25	AMOD
28	levels	level	I-NP	NNS	O	24	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	32	NMOD
31	HPA	HPA	I-NP	JJ	O	32	NMOD
32	axis	axis	I-NP	NN	O	29	PMOD
33	.	.	O	.	O	15	P

1	Using	Use	B-VP	VBG	O	7	VMOD
2	recombinant	recombinant	B-NP	JJ	B-protein	4	NMOD
3	HBxAg	HBxAg	I-NP	NN	I-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	1	OBJ
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	found	find	B-VP	VBD	O	0	ROOT
8	HBxAg-specific	HBxAg-specific	B-NP	JJ	O	9	NMOD
9	stimulation	stimulation	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD
12	blood	blood	I-NP	NN	I-cell_type	14	NMOD
13	mononuclear	mononuclear	I-NP	JJ	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
15	in	in	B-PP	IN	O	7	VMOD
16	patients	patient	B-NP	NNS	O	15	PMOD
17	with	with	B-PP	IN	O	16	NMOD
18	acute	acute	B-NP	JJ	O	22	NMOD
19	hepatitis	hepatitis	I-NP	NN	O	22	NMOD
20	B	B	I-NP	NN	O	22	NMOD
21	virus	virus	I-NP	NN	O	22	NMOD
22	infection	infection	I-NP	NN	O	33	NMOD
23	(	(	O	(	O	27	DEP
24	6	6	B-NP	CD	O	27	DEP
25	of	of	B-PP	IN	O	24	NMOD
26	6	6	B-NP	CD	O	25	PMOD
27	)	)	O	)	O	22	NMOD
28	and	and	O	CC	O	33	NMOD
29	chronic	chronic	B-NP	JJ	O	33	NMOD
30	hepatitis	hepatitis	I-NP	NN	O	33	NMOD
31	B	B	I-NP	NN	O	33	NMOD
32	virus	virus	I-NP	NN	O	33	NMOD
33	infection	infection	I-NP	NN	O	17	PMOD
34	(	(	O	(	O	38	DEP
35	6	6	B-NP	CD	O	38	DEP
36	of	of	B-PP	IN	O	35	NMOD
37	17	17	B-NP	CD	O	36	PMOD
38	)	)	O	)	O	33	NMOD
39	but	but	B-PP	CC	O	15	PMOD
40	not	not	B-PP	RB	O	41	PMOD
41	in	in	I-PP	IN	O	15	PMOD
42	healthy	healthy	B-NP	JJ	O	43	NMOD
43	individuals	individual	I-NP	NNS	O	41	PMOD
44	.	.	O	.	O	7	P

1	Five	Five	B-NP	CD	O	3	NMOD
2	T-cell	T-cell	I-NP	NN	B-cell_line	3	NMOD
3	clones	clone	I-NP	NNS	I-cell_line	16	SUB
4	specific	specific	B-ADJP	JJ	O	3	NMOD
5	for	for	B-PP	IN	O	4	AMOD
6	a	a	B-NP	DT	O	8	NMOD
7	T-cell	T-cell	I-NP	NN	B-protein	8	NMOD
8	epitope	epitope	I-NP	NN	I-protein	5	PMOD
9	located	located	B-ADJP	JJ	O	5	PMOD
10	at	at	B-PP	IN	O	9	AMOD
11	the	the	B-NP	DT	O	13	NMOD
12	carboxyterminal	carboxyterminal	I-NP	JJ	B-protein	13	NMOD
13	region	region	I-NP	NN	I-protein	10	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	HBxAg	HBxAg	B-NP	NN	B-protein	14	PMOD
16	were	be	B-VP	VBD	O	0	ROOT
17	established	establish	I-VP	VBN	O	16	VC
18	and	and	O	CC	O	17	VMOD
19	found	find	B-VP	VBN	O	17	VMOD
20	to	to	I-VP	TO	O	21	VMOD
21	belong	belong	I-VP	VB	O	19	VMOD
22	to	to	B-PP	TO	O	21	VMOD
23	the	the	B-NP	DT	O	27	NMOD
24	CD2/CD4-positive	CD2/CD4-positive	I-NP	JJ	B-cell_line	26	AMOD
25	,	,	I-NP	,	I-cell_line	26	P
26	CD8-negative	CD8-negative	I-NP	JJ	I-cell_line	27	NMOD
27	subtype	subtype	I-NP	NN	I-cell_line	22	PMOD
28	.	.	O	.	O	16	P

1	Except	Except	B-PP	IN	O	17	VMOD
2	for	for	B-PP	IN	O	1	PMOD
3	a	a	B-NP	DT	O	5	NMOD
4	4-hour	4-hour	I-NP	JJ	O	5	NMOD
5	advancement	advancement	I-NP	NN	O	1	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	peak	peak	I-NP	NN	O	6	PMOD
9	,	,	O	,	O	17	P
10	a	a	B-NP	DT	O	13	NMOD
11	similar	similar	I-NP	JJ	O	13	NMOD
12	circadian	circadian	I-NP	JJ	O	13	NMOD
13	rhythm	rhythm	I-NP	NN	O	17	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	hepatic	hepatic	B-NP	JJ	B-protein	16	NMOD
16	GR	GR	I-NP	NN	I-protein	14	PMOD
17	was	be	B-VP	VBD	O	0	ROOT
18	detected	detect	I-VP	VBN	O	17	VC
19	in	in	B-PP	IN	O	18	VMOD
20	rats	rat	B-NP	NNS	O	19	PMOD
21	reared	rear	B-VP	VBN	O	20	NMOD
22	under	under	B-PP	IN	O	21	VMOD
23	a	a	B-NP	DT	O	26	NMOD
24	reversed	reverse	I-NP	VBN	O	26	NMOD
25	lighting	lighting	I-NP	NN	O	26	NMOD
26	regimen	regimen	I-NP	NN	O	22	PMOD
27	(	(	O	(	O	43	DEP
28	12D	12D	B-NP	NN	O	30	NMOD
29	:	:	O	:	O	30	P
30	12L	12L	B-NP	NN	O	42	NMOD
31	;	;	O	:	O	42	P
32	lights	light	B-NP	NNS	O	42	NMOD
33	on	on	B-PP	IN	O	32	NMOD
34	between	between	B-NP	IN	O	33	PMOD
35	18	18	I-NP	CD	O	34	AMOD
36	:	:	O	:	O	42	P
37	30	30	B-NP	CD	O	39	NMOD
38	and	and	I-NP	CC	O	39	NMOD
39	06	06	I-NP	CD	O	42	NMOD
40	:	:	O	:	O	42	P
41	30	30	B-NP	CD	O	42	NMOD
42	h	h	I-NP	NN	O	43	DEP
43	)	)	O	)	O	26	NMOD
44	.	.	O	.	O	17	P

1	In	In	B-PP	IN	O	16	VMOD
2	patients	patient	B-NP	NNS	O	1	PMOD
3	suffering	suffer	B-VP	VBG	O	2	NMOD
4	from	from	B-PP	IN	O	3	VMOD
5	Cushing	Cushing	B-NP	NN	O	7	NMOD
6	's	's	B-NP	POS	O	7	NMOD
7	syndrome	syndrome	I-NP	NN	O	4	PMOD
8	,	,	O	,	O	16	P
9	the	the	B-NP	DT	O	11	NMOD
10	circadian	circadian	I-NP	JJ	O	11	NMOD
11	rhythm	rhythm	I-NP	NN	O	16	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	plasma	plasma	B-NP	NN	O	14	NMOD
14	cortisol	cortisol	I-NP	NN	O	12	PMOD
15	either	either	O	CC	O	16	VMOD
16	disappeared	disappear	B-VP	VBD	O	0	ROOT
17	or	or	O	CC	O	16	VMOD
18	was	be	B-VP	VBD	O	16	VMOD
19	inverted	invert	I-VP	VBN	O	18	VC
20	while	while	B-SBAR	IN	O	16	VMOD
21	that	that	B-NP	DT	O	24	SUB
22	of	of	B-PP	IN	O	21	NMOD
23	GR	GR	B-NP	NN	B-protein	22	PMOD
24	did	do	B-VP	VBD	O	20	SBAR
25	not	not	I-VP	RB	O	24	VMOD
26	significantly	significantly	I-VP	RB	O	24	VMOD
27	deviate	deviate	I-VP	VB	O	24	VC
28	from	from	B-PP	IN	O	27	VMOD
29	the	the	B-NP	DT	O	31	NMOD
30	normal	normal	I-NP	JJ	O	31	NMOD
31	subjects	subject	I-NP	NNS	O	28	PMOD
32	.	.	O	.	O	16	P

1	In	In	B-PP	IN	O	31	VMOD
2	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	1	PMOD
3	activated	activate	B-VP	VBN	O	2	NMOD
4	either	either	B-PP	CC	O	5	PMOD
5	by	by	I-PP	IN	O	3	VMOD
6	PHA	PHA	B-NP	NN	B-protein	8	NMOD
7	or	or	O	CC	O	8	NMOD
8	OKT3	OKT3	B-NP	NN	B-protein	5	PMOD
9	(	(	B-PP	(	O	1	PMOD
10	but	but	I-PP	CC	O	1	PMOD
11	not	not	B-PP	RB	O	12	PMOD
12	in	in	I-PP	IN	O	1	PMOD
13	resting	rest	B-NP	VBG	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
15	)	)	O	)	O	1	PMOD
16	,	,	O	,	O	31	P
17	a	a	B-NP	DT	O	19	NMOD
18	50-kDa	50-kDa	I-NP	JJ	B-protein	19	NMOD
19	species	specie	I-NP	NNS	I-protein	31	SUB
20	cross-reacting	cross-reacte	B-VP	VBG	O	19	NMOD
21	with	with	B-PP	IN	O	20	VMOD
22	a	a	B-NP	DT	O	24	NMOD
23	monoclonal	monoclonal	I-NP	JJ	B-protein	24	NMOD
24	antibody	antibody	I-NP	NN	I-protein	21	PMOD
25	against	against	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	30	NMOD
27	intestinal	intestinal	I-NP	JJ	B-protein	30	NMOD
28	vitamin	vitamin	I-NP	NN	I-protein	30	NMOD
29	D	D	I-NP	NN	I-protein	30	NMOD
30	receptor	receptor	I-NP	NN	I-protein	25	PMOD
31	was	be	B-VP	VBD	O	0	ROOT
32	detected	detect	I-VP	VBN	O	31	VC
33	.	.	O	.	O	31	P

1	Two	Two	B-NP	CD	O	3	NMOD
2	splice	splice	I-NP	NN	O	3	NMOD
3	alternatives	alternative	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	identified	identify	I-VP	VBN	O	4	VC
6	that	that	B-NP	WDT	O	5	VMOD
7	were	be	B-VP	VBD	O	6	SBAR
8	not	not	I-VP	RB	O	7	VMOD
9	previously	previously	I-VP	RB	O	7	VMOD
10	observed	observe	I-VP	VBN	O	7	VC
11	in	in	B-PP	IN	O	10	VMOD
12	human	human	B-NP	JJ	B-protein	13	NMOD
13	TCF-1	TCF-1	I-NP	NN	I-protein	11	PMOD
14	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	been	be	I-VP	VBN	O	3	VC
5	extended	extend	I-VP	VBN	O	4	VC
6	to	to	I-VP	TO	O	7	VMOD
7	show	show	I-VP	VB	O	5	VMOD
8	that	that	B-SBAR	IN	O	7	VMOD
9	(	(	B-LST	(	O	10	DEP
10	i	i	I-LST	LS	O	22	VMOD
11	)	)	O	)	O	10	DEP
12	a	a	B-NP	DT	O	15	NMOD
13	mutant	mutant	I-NP	JJ	O	15	NMOD
14	EBV	EBV	I-NP	NN	O	15	NMOD
15	strain	strain	I-NP	NN	O	22	SUB
16	lacking	lack	B-VP	VBG	O	15	NMOD
17	the	the	B-NP	DT	O	18	NMOD
18	gene	gene	I-NP	NN	O	16	OBJ
19	encoding	encode	B-VP	VBG	O	18	NMOD
20	EBNA	EBNA	B-NP	NN	B-protein	19	OBJ
21	2	2	I-NP	CD	I-protein	20	NMOD
22	fails	fail	B-VP	VBZ	O	103	VMOD
23	to	to	I-VP	TO	O	24	VMOD
24	switch	switch	I-VP	VB	O	22	VMOD
25	from	from	B-PP	IN	O	24	VMOD
26	Wp	Wp	B-NP	NN	B-DNA	25	PMOD
27	to	to	B-PP	TO	O	25	PMOD
28	Cp	Cp	B-NP	NN	B-DNA	27	PMOD
29	usage	usage	I-NP	NN	O	25	PMOD
30	in	in	B-PP	IN	O	24	VMOD
31	primary	primary	B-NP	JJ	B-cell_type	33	NMOD
32	B	B	I-NP	NN	I-cell_type	33	NMOD
33	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	30	PMOD
34	,	,	O	,	O	24	P
35	although	although	B-SBAR	IN	O	24	VMOD
36	the	the	B-NP	DT	O	37	NMOD
37	virus	virus	I-NP	NN	O	38	SUB
38	contains	contain	B-VP	VBZ	O	35	SBAR
39	a	a	B-NP	DT	O	41	NMOD
40	functional	functional	I-NP	JJ	O	41	NMOD
41	Cp	Cp	I-NP	NN	B-DNA	38	OBJ
42	;	;	O	:	O	103	P
43	(	(	B-LST	(	O	44	DEP
44	ii	ii	I-LST	LS	O	57	VMOD
45	)	)	O	)	O	44	DEP
46	a	a	B-NP	DT	O	47	NMOD
47	region	region	I-NP	NN	O	57	SUB
48	from	from	B-PP	IN	O	47	NMOD
49	-429	-429	B-NP	CD	B-DNA	48	AMOD
50	to	to	I-NP	TO	I-DNA	48	AMOD
51	-245	-245	I-NP	CD	I-DNA	48	AMOD
52	base	base	I-NP	NN	I-DNA	53	NMOD
53	pairs	pair	I-NP	NNS	I-DNA	48	PMOD
54	upstream	upstream	B-ADJP	JJ	O	53	NMOD
55	of	of	B-PP	IN	O	54	AMOD
56	Cp	Cp	B-NP	NN	B-DNA	55	PMOD
57	is	be	B-VP	VBZ	O	103	VMOD
58	essential	essential	B-ADJP	JJ	O	57	PRD
59	for	for	B-PP	IN	O	58	AMOD
60	Cp	Cp	B-NP	NN	B-DNA	61	NMOD
61	activity	activity	I-NP	NN	O	59	PMOD
62	in	in	B-PP	IN	O	61	NMOD
63	B	B	B-NP	NN	B-cell_type	64	NMOD
64	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	62	PMOD
65	,	,	O	,	O	58	P
66	but	but	O	CC	O	58	AMOD
67	only	only	B-PP	RB	O	68	PMOD
68	in	in	I-PP	IN	O	58	AMOD
69	the	the	B-NP	DT	O	70	NMOD
70	context	context	I-NP	NN	O	68	PMOD
71	of	of	B-PP	IN	O	70	NMOD
72	upstream	upstream	B-NP	JJ	B-DNA	74	AMOD
73	and	and	I-NP	CC	I-DNA	74	AMOD
74	downstream	downstream	I-NP	JJ	I-DNA	75	NMOD
75	sequences	sequence	I-NP	NNS	I-DNA	71	PMOD
76	;	;	O	:	O	103	P
77	(	(	B-LST	(	O	78	DEP
78	iii	iii	I-LST	LS	O	82	VMOD
79	)	)	O	)	O	78	DEP
80	this	this	B-NP	DT	O	81	NMOD
81	region	region	I-NP	NN	O	82	SUB
82	contains	contain	B-VP	VBZ	O	103	VMOD
83	an	an	B-NP	DT	O	86	NMOD
84	EBNA	EBNA	I-NP	NN	B-DNA	86	NMOD
85	2-dependent	2-dependent	I-NP	JJ	I-DNA	84	AMOD
86	enhancer	enhancer	I-NP	NN	I-DNA	82	OBJ
87	;	;	O	:	O	103	P
88	and	and	O	CC	O	103	VMOD
89	(	(	B-LST	(	O	90	DEP
90	iv	iv	I-LST	LS	O	103	VMOD
91	)	)	O	)	O	90	DEP
92	DNase	DNase	B-NP	NN	B-protein	94	NMOD
93	I	I	I-NP	CD	I-protein	94	NMOD
94	protection	protection	I-NP	NN	O	103	SUB
95	employing	employ	B-VP	VBG	O	94	NMOD
96	nuclear	nuclear	B-NP	JJ	O	97	NMOD
97	extracts	extract	I-NP	NNS	O	95	OBJ
98	from	from	B-PP	IN	O	97	NMOD
99	B	B	B-NP	NN	B-cell_type	101	NMOD
100	and	and	O	CC	I-cell_type	101	NMOD
101	T	T	B-NP	NN	I-cell_type	102	NMOD
102	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	98	PMOD
103	revealed	reveal	B-VP	VBD	O	8	SBAR
104	a	a	B-NP	DT	O	106	NMOD
105	B-cell-specific	B-cell-specific	I-NP	JJ	B-DNA	106	NMOD
106	footprint	footprint	I-NP	NN	I-DNA	103	OBJ
107	in	in	B-PP	IN	O	106	NMOD
108	the	the	B-NP	DT	O	109	NMOD
109	region	region	I-NP	NN	O	107	PMOD
110	of	of	B-PP	IN	O	109	NMOD
111	the	the	B-NP	DT	O	114	NMOD
112	EBNA	EBNA	I-NP	NN	B-DNA	114	NMOD
113	2-dependent	2-dependent	I-NP	JJ	I-DNA	112	AMOD
114	enhancer	enhancer	I-NP	NN	I-DNA	110	PMOD
115	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	corticosteroid	corticosteroid	B-NP	NN	O	6	NMOD
6	resistance	resistance	I-NP	NN	O	10	SUB
7	in	in	B-PP	IN	O	6	NMOD
8	bronchial	bronchial	B-NP	JJ	O	9	NMOD
9	asthma	asthma	I-NP	NN	O	7	PMOD
10	can	can	B-VP	MD	O	4	SBAR
11	not	not	I-VP	RB	O	10	VMOD
12	be	be	I-VP	VB	O	10	VC
13	explained	explain	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	abnormalities	abnormality	B-NP	NNS	O	14	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	corticosteroid	corticosteroid	B-NP	NN	O	19	NMOD
18	receptor	receptor	I-NP	NN	O	19	NMOD
19	characteristics	characteristic	I-NP	NNS	O	16	PMOD
20	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	induction	induction	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	AP1	AP1	B-NP	NN	B-protein	3	PMOD
5	by	by	B-PP	IN	O	2	NMOD
6	okadaic	okadaic	B-NP	JJ	O	7	NMOD
7	acid	acid	I-NP	NN	O	5	PMOD
8	suggests	suggest	B-VP	VBZ	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	protein	protein	B-NP	NN	B-protein	11	NMOD
11	phosphatases	phosphatas	I-NP	NNS	I-protein	20	SUB
12	1	1	B-NP	CD	I-protein	14	NMOD
13	and	and	O	CC	I-protein	14	NMOD
14	2A	2A	B-NP	NN	I-protein	11	NMOD
15	(	(	O	(	O	19	DEP
16	PP1	PP1	B-NP	NN	B-protein	18	NMOD
17	and	and	O	CC	O	18	NMOD
18	PP2A	PP2A	B-NP	NN	B-protein	19	DEP
19	)	)	O	)	O	11	NMOD
20	may	may	B-VP	MD	O	9	SBAR
21	be	be	I-VP	VB	O	20	VC
22	involved	involve	I-VP	VBN	O	21	VC
23	in	in	B-PP	IN	O	22	VMOD
24	T	T	B-NP	NN	O	26	NMOD
25	cell	cell	I-NP	NN	O	26	NMOD
26	activation	activation	I-NP	NN	O	23	PMOD
27	as	as	B-PP	IN	O	26	NMOD
28	important	important	B-NP	JJ	O	30	NMOD
29	negative	negative	I-NP	JJ	O	30	NMOD
30	regulators	regulator	I-NP	NNS	O	27	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	35	NMOD
33	transcription	transcription	I-NP	NN	B-protein	35	NMOD
34	factor	factor	I-NP	NN	I-protein	35	NMOD
35	AP1	AP1	I-NP	NN	B-protein	31	PMOD
36	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	5	VMOD
2	each	each	B-NP	DT	O	3	NMOD
3	cohort	cohort	I-NP	JJ	O	1	PMOD
4	there	there	B-NP	EX	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	only	only	B-NP	RB	O	8	NMOD
7	one	one	I-NP	CD	O	6	AMOD
8	case	case	I-NP	NN	O	5	PRD
9	with	with	B-PP	IN	O	8	NMOD
10	a	a	B-NP	DT	O	12	NMOD
11	negative	negative	I-NP	JJ	O	12	NMOD
12	reaction	reaction	I-NP	NN	O	20	NMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	primary	primary	I-NP	JJ	O	16	NMOD
16	tumor	tumor	I-NP	NN	O	13	PMOD
17	and	and	O	CC	O	20	NMOD
18	a	a	B-NP	DT	O	20	NMOD
19	positive	positive	I-NP	JJ	O	20	NMOD
20	reaction	reaction	I-NP	NN	O	9	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	25	NMOD
23	isolated	isolate	I-NP	VBN	O	25	NMOD
24	tumor	tumor	I-NP	NN	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
26	from	from	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	pleural	pleural	I-NP	JJ	O	29	NMOD
29	effusions	effusion	I-NP	NNS	O	26	PMOD
30	.	.	O	.	O	5	P

1	Oct-2	Oct-2	B-NP	NN	B-RNA	3	NMOD
2	mRNA	mRNA	I-NP	NN	I-RNA	3	NMOD
3	levels	level	I-NP	NNS	O	10	NMOD
4	and	and	O	CC	O	10	NMOD
5	both	both	O	CC	O	10	NMOD
6	Oct-2	Oct-2	B-NP	NN	B-protein	10	NMOD
7	and	and	O	CC	O	10	NMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	10	NMOD
9	B	B	I-NP	NN	I-protein	10	NMOD
10	proteins	protein	I-NP	NNS	I-protein	14	SUB
11	in	in	B-PP	IN	O	10	NMOD
12	nuclear	nuclear	B-NP	JJ	O	13	NMOD
13	extracts	extract	I-NP	NNS	O	11	PMOD
14	were	be	B-VP	VBD	O	0	ROOT
15	not	not	I-VP	RB	O	14	VMOD
16	altered	alter	I-VP	VBN	O	14	VC
17	by	by	B-PP	IN	O	16	VMOD
18	treatment	treatment	B-NP	NN	O	17	PMOD
19	with	with	B-PP	IN	O	18	NMOD
20	TGF-beta	TGF-beta	B-NP	NN	B-protein	19	PMOD
21	.	.	O	.	O	14	P

1	In	In	B-PP	IN	O	24	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	24	P
4	levels	level	B-NP	NNS	O	24	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	transcriptional	transcriptional	I-NP	JJ	B-protein	8	NMOD
8	factor	factor	I-NP	NN	I-protein	9	NMOD
9	AP-1	AP-1	I-NP	NN	B-protein	5	PMOD
10	,	,	O	,	O	9	P
11	which	which	B-NP	WDT	O	9	NMOD
12	is	be	B-VP	VBZ	O	11	SBAR
13	not	not	I-VP	RB	O	12	VMOD
14	known	know	I-VP	VBN	O	12	VC
15	to	to	I-VP	TO	O	16	VMOD
16	be	be	I-VP	VB	O	14	VMOD
17	important	important	B-ADJP	JJ	O	16	PRD
18	in	in	B-PP	IN	O	17	AMOD
19	B	B	B-NP	NN	B-cell_type	22	NMOD
20	cell	cell	I-NP	NN	I-cell_type	22	NMOD
21	Ig	Ig	I-NP	NN	B-protein	22	NMOD
22	production	production	I-NP	NN	O	18	PMOD
23	,	,	O	,	O	9	P
24	were	be	B-VP	VBD	O	0	ROOT
25	reduced	reduce	I-VP	VBN	O	24	VC
26	by	by	B-PP	IN	O	25	VMOD
27	TGF-beta	TGF-beta	B-NP	NN	B-protein	26	PMOD
28	.	.	O	.	O	24	P

1	The	The	B-NP	DT	O	2	NMOD
2	mechanism	mechanism	I-NP	NN	O	10	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	which	which	B-NP	WDT	O	3	PMOD
5	TGF-beta	TGF-beta	B-NP	NN	B-protein	6	SUB
6	inhibits	inhibit	B-VP	VBZ	O	3	SBAR
7	Ig	Ig	B-NP	NN	B-protein	9	NMOD
8	chain	chain	I-NP	NN	I-protein	9	NMOD
9	synthesis	synthesis	I-NP	NN	O	6	OBJ
10	is	be	B-VP	VBZ	O	0	ROOT
11	unclear	unclear	B-ADJP	JJ	O	10	PRD
12	although	although	B-SBAR	IN	O	10	VMOD
13	it	it	B-NP	PRP	O	14	SUB
14	does	do	B-VP	VBZ	O	12	SBAR
15	not	not	I-VP	RB	O	14	VMOD
16	involve	involve	I-VP	VB	O	14	VC
17	inhibition	inhibition	B-NP	NN	O	16	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	binding	binding	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	NF-kappa	NF-kappa	B-NP	NN	B-protein	23	NMOD
23	B	B	I-NP	NN	I-protein	25	NMOD
24	or	or	O	CC	O	25	NMOD
25	Oct-2	Oct-2	B-NP	NN	B-protein	21	PMOD
26	to	to	B-PP	TO	O	20	NMOD
27	their	their	B-NP	PRP$	O	30	NMOD
28	respective	respective	I-NP	JJ	O	30	NMOD
29	target	target	I-NP	NN	B-DNA	30	NMOD
30	sequences	sequence	I-NP	NNS	I-DNA	26	PMOD
31	.	.	O	.	O	10	P

1	This	This	B-NP	DT	O	2	NMOD
2	study	study	I-NP	NN	O	3	SUB
3	examines	examine	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	regions	region	I-NP	NNS	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	HIV	HIV	I-NP	NN	B-DNA	9	NMOD
9	promoter	promoter	I-NP	NN	I-DNA	6	PMOD
10	required	require	B-VP	VBN	O	5	NMOD
11	for	for	B-PP	IN	O	10	VMOD
12	HHV-6	HHV-6	B-NP	NN	O	13	NMOD
13	transactivation	transactivation	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	a	a	B-NP	DT	O	17	NMOD
16	heterogeneous	heterogeneous	I-NP	JJ	O	17	NMOD
17	population	population	I-NP	NN	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	primary	primary	B-NP	JJ	B-cell_type	22	NMOD
20	human	human	I-NP	JJ	I-cell_type	22	NMOD
21	T	T	I-NP	NN	I-cell_type	22	NMOD
22	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	18	PMOD
23	with	with	B-PP	IN	O	13	NMOD
24	or	or	B-PP	CC	O	23	PMOD
25	without	without	B-PP	IN	O	23	PMOD
26	antigenic	antigenic	B-NP	JJ	O	27	NMOD
27	stimulation	stimulation	I-NP	NN	O	23	PMOD
28	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	this	this	B-NP	DT	O	8	NMOD
4	mutated	mutate	I-NP	VBN	B-DNA	8	NMOD
5	NF	NF	I-NP	NN	I-DNA	8	NMOD
6	kappa	kappa	I-NP	NN	I-DNA	8	NMOD
7	B	B	I-NP	NN	I-DNA	8	NMOD
8	promoter	promoter	I-NP	NN	I-DNA	9	SUB
9	was	be	B-VP	VBD	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	transactivated	transactivate	I-VP	VBN	O	9	VC
12	during	during	B-PP	IN	O	11	VMOD
13	HHV-6	HHV-6	B-NP	NN	O	17	NMOD
14	(	(	I-NP	(	O	17	NMOD
15	GS	GS	I-NP	NN	O	17	NMOD
16	)	)	I-NP	)	O	17	NMOD
17	infection	infection	I-NP	NN	O	12	PMOD
18	or	or	B-PP	CC	O	12	PMOD
19	after	after	B-PP	IN	O	12	PMOD
20	cotransfection	cotransfection	B-NP	NN	O	19	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	pZVB70	pZVB70	B-NP	NN	B-DNA	24	NMOD
23	or	or	I-NP	CC	O	24	NMOD
24	pZVB10	pZVB10	I-NP	NN	B-DNA	21	PMOD
25	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	3	NMOD
2	other	other	I-NP	JJ	O	3	NMOD
3	gene	gene	I-NP	NN	O	8	SUB
4	,	,	O	,	O	3	P
5	designated	designate	B-VP	VBN	O	3	NMOD
6	Rhom-3	Rhom-3	B-NP	NN	B-DNA	5	VMOD
7	,	,	O	,	O	3	P
8	is	be	B-VP	VBZ	O	0	ROOT
9	not	not	O	RB	O	8	VMOD
10	on	on	B-PP	IN	O	8	PRD
11	chromosome	chromosome	B-NP	NN	B-DNA	10	PMOD
12	11	11	I-NP	CD	I-DNA	11	NMOD
13	but	but	B-CONJP	CC	O	8	VMOD
14	also	also	I-CONJP	RB	O	13	DEP
15	retains	retain	B-VP	VBZ	O	8	VMOD
16	homology	homology	B-NP	NN	O	15	OBJ
17	to	to	B-PP	TO	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	LIM	LIM	I-NP	NN	B-protein	20	NMOD
20	domain	domain	I-NP	NN	I-protein	17	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	rhombotin	rhombotin	B-NP	NN	B-DNA	21	PMOD
23	.	.	O	.	O	8	P

1	Preincubation	Preincubation	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	cells	cell	B-NP	NNS	O	2	PMOD
4	with	with	B-PP	IN	O	1	NMOD
5	1	1	B-NP	CD	O	11	NMOD
6	,	,	I-NP	,	O	11	P
7	25-	25-	I-NP	CD	O	11	NMOD
8	(	(	O	(	O	10	DEP
9	OH	OH	B-NP	NN	O	10	DEP
10	)	)	O	)	O	7	NMOD
11	2D3	2D3	B-NP	NN	O	4	PMOD
12	had	have	B-VP	VBD	O	0	ROOT
13	no	no	B-NP	DT	O	14	NMOD
14	effect	effect	I-NP	NN	O	12	OBJ
15	on	on	B-PP	IN	O	12	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	time	time	I-NP	NN	O	18	NMOD
18	course	course	I-NP	NN	O	15	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	IL-1	IL-1	B-NP	NN	B-RNA	23	NMOD
21	beta	beta	I-NP	NN	I-RNA	23	NMOD
22	mRNA	mRNA	I-NP	NN	I-RNA	23	NMOD
23	appearance	appearance	I-NP	NN	O	19	PMOD
24	in	in	B-PP	IN	O	12	VMOD
25	response	response	I-PP	NN	O	24	PMOD
26	to	to	I-PP	TO	O	25	NMOD
27	LPS	LPS	B-NP	NN	O	26	PMOD
28	.	.	O	.	O	12	P

1	However	However	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	exposure	exposure	B-NP	NN	O	15	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	U-937	U-937	B-NP	NN	B-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
7	to	to	B-PP	TO	O	3	NMOD
8	1	1	B-NP	CD	O	14	NMOD
9	,	,	I-NP	,	O	14	P
10	25-	25-	I-NP	CD	O	14	NMOD
11	(	(	O	(	O	13	DEP
12	OH	OH	B-NP	NN	O	13	DEP
13	)	)	O	)	O	10	NMOD
14	2D3	2D3	B-NP	NN	O	7	PMOD
15	increased	increase	B-VP	VBD	O	0	ROOT
16	by	by	B-PP	IN	O	15	VMOD
17	200	200	B-NP	CD	O	18	NMOD
18	%	%	I-NP	NN	O	16	PMOD
19	the	the	B-NP	DT	O	20	NMOD
20	level	level	I-NP	NN	O	15	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	IL-1	IL-1	B-NP	NN	B-RNA	24	NMOD
23	beta	beta	I-NP	NN	I-RNA	24	NMOD
24	mRNA	mRNA	I-NP	NN	I-RNA	21	PMOD
25	detected	detect	B-VP	VBN	O	24	NMOD
26	and	and	I-VP	CC	O	15	VMOD
27	decreased	decrease	I-VP	VBN	O	15	VMOD
28	by	by	B-PP	IN	O	27	VMOD
29	three	three	B-NP	CD	O	30	NMOD
30	orders	order	I-NP	NNS	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	magnitude	magnitude	B-NP	NN	O	31	PMOD
33	the	the	B-NP	DT	O	34	NMOD
34	concentration	concentration	I-NP	NN	O	27	OBJ
35	of	of	B-PP	IN	O	34	NMOD
36	LPS	LPS	B-NP	NN	O	35	PMOD
37	required	require	B-VP	VBN	O	34	NMOD
38	to	to	I-VP	TO	O	39	VMOD
39	achieve	achieve	I-VP	VB	O	37	VMOD
40	steady	steady	B-NP	JJ	O	43	NMOD
41	state	state	I-NP	NN	O	43	NMOD
42	mRNA	mRNA	I-NP	NN	O	43	NMOD
43	levels	level	I-NP	NNS	O	39	OBJ
44	equivalent	equivalent	B-ADJP	JJ	O	43	NMOD
45	to	to	B-PP	TO	O	44	AMOD
46	those	those	B-NP	DT	O	45	PMOD
47	observed	observe	B-VP	VBN	O	46	NMOD
48	in	in	B-PP	IN	O	47	VMOD
49	U-937	U-937	B-NP	NN	B-cell_line	50	NMOD
50	cells	cell	I-NP	NNS	I-cell_line	48	PMOD
51	not	not	B-VP	RB	O	52	VMOD
52	preincubated	preincubate	I-VP	VBN	O	50	NMOD
53	with	with	B-PP	IN	O	52	VMOD
54	the	the	B-NP	DT	O	55	NMOD
55	hormone.2+o	hormone.2+o	I-NP	NN	O	53	PMOD

1	It	It	B-NP	PRP	O	2	SUB
2	has	have	B-VP	VBZ	O	0	ROOT
3	been	be	I-VP	VBN	O	2	VC
4	shown	show	I-VP	VBN	O	3	VC
5	recently	recently	B-ADVP	RB	O	4	VMOD
6	that	that	B-SBAR	IN	O	4	VMOD
7	in	in	B-PP	IN	O	28	VMOD
8	wild-type	wild-type	B-NP	JJ	B-cell_line	10	NMOD
9	CEM	CEM	I-NP	NN	I-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	7	PMOD
11	but	but	B-PP	CC	O	7	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	in	in	I-PP	IN	O	7	PMOD
14	a	a	B-NP	DT	O	25	NMOD
15	dex-resistant	dex-resistant	I-NP	JJ	O	20	AMOD
16	,	,	I-NP	,	O	20	P
17	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	20	AMOD
18	receptor	receptor	I-NP	NN	I-protein	20	AMOD
19	(	(	I-NP	(	O	20	AMOD
20	GR	GR	I-NP	NN	B-protein	25	NMOD
21	)	)	I-NP	)	O	20	AMOD
22	-defective	-defective	I-NP	JJ	O	20	AMOD
23	clone	clone	I-NP	NN	O	25	NMOD
24	ICR-27	ICR-27	I-NP	NN	B-cell_line	25	NMOD
25	TK-3	TK-3	I-NP	NN	I-cell_line	13	PMOD
26	,	,	O	,	O	28	P
27	dex	dex	B-NP	NN	O	28	SUB
28	induces	induce	B-VP	VBZ	O	6	SBAR
29	GR	GR	B-NP	NN	B-RNA	30	NMOD
30	mRNA	mRNA	I-NP	NN	I-RNA	28	OBJ
31	.	.	O	.	O	2	P

1	Lavage	Lavage	B-NP	NN	B-cell_type	2	NMOD
2	T-lymphocytes	T-lymphocyte	I-NP	NNS	I-cell_type	13	NMOD
3	from	from	B-PP	IN	O	2	NMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	with	with	B-PP	IN	O	4	NMOD
6	tuberculosis	tuberculosis	B-NP	NN	O	5	PMOD
7	or	or	B-PP	CC	O	3	PMOD
8	with	with	B-PP	IN	O	3	PMOD
9	sarcoidosis	sarcoidosis	B-NP	NN	O	8	PMOD
10	,	,	O	,	O	13	P
11	but	but	B-CONJP	CC	O	13	NMOD
12	not	not	I-CONJP	RB	O	11	DEP
13	those	those	B-NP	DT	O	19	SUB
14	from	from	B-PP	IN	O	13	NMOD
15	normal	normal	B-NP	JJ	O	17	NMOD
16	control	control	I-NP	NN	O	17	NMOD
17	subjects	subject	I-NP	NNS	O	14	PMOD
18	,	,	O	,	O	13	P
19	expressed	express	B-VP	VBD	O	0	ROOT
20	1	1	B-NP	CD	B-protein	27	NMOD
21	,	,	I-NP	,	I-protein	27	P
22	25	25	I-NP	CD	I-protein	27	NMOD
23	(	(	O	(	I-protein	27	NMOD
24	OH	OH	B-NP	NN	I-protein	27	NMOD
25	)	)	O	)	I-protein	27	NMOD
26	2D3	2D3	B-NP	NN	I-protein	27	NMOD
27	receptors	receptor	I-NP	NNS	I-protein	19	OBJ
28	as	as	B-SBAR	IN	O	35	DEP
29	demonstrated	demonstrate	B-VP	VBN	O	28	SBAR
30	by	by	B-PP	IN	O	29	VMOD
31	binding	binding	B-NP	NN	O	30	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	[	[	B-NP	(	O	34	NMOD
34	3H	3H	I-NP	NN	O	32	PMOD
35	]	]	I-NP	)	O	19	VMOD
36	1	1	I-NP	CD	O	42	NMOD
37	,	,	I-NP	,	O	42	P
38	25	25	I-NP	CD	O	42	NMOD
39	(	(	O	(	O	41	DEP
40	OH	OH	B-NP	NN	O	41	DEP
41	)	)	O	)	O	38	NMOD
42	2D3	2D3	B-NP	NN	O	19	OBJ
43	,	,	O	,	O	42	P
44	which	which	B-NP	WDT	O	42	NMOD
45	was	be	B-VP	VBD	O	44	SBAR
46	inhibited	inhibit	I-VP	VBN	O	45	VC
47	by	by	B-PP	IN	O	46	VMOD
48	the	the	B-NP	DT	O	49	NMOD
49	presence	presence	I-NP	NN	O	47	PMOD
50	of	of	B-PP	IN	O	49	NMOD
51	excess	excess	B-NP	JJ	O	59	NMOD
52	unlabeled	unlabeled	I-NP	JJ	O	59	NMOD
53	1	1	I-NP	CD	O	59	NMOD
54	,	,	I-NP	,	O	59	P
55	25	25	I-NP	CD	O	59	NMOD
56	(	(	O	(	O	58	DEP
57	OH	OH	B-NP	NN	O	58	DEP
58	)	)	O	)	O	55	NMOD
59	2D3	2D3	B-NP	NN	O	50	PMOD
60	,	,	O	,	O	47	P
61	but	but	O	CC	O	47	PMOD
62	not	not	B-PP	RB	O	63	PMOD
63	by	by	I-PP	IN	O	47	PMOD
64	the	the	B-NP	DT	O	65	NMOD
65	presence	presence	I-NP	NN	O	63	PMOD
66	of	of	B-PP	IN	O	65	NMOD
67	unlabeled	unlabeled	B-NP	JJ	O	68	NMOD
68	25	25	I-NP	CD	O	72	NMOD
69	(	(	O	(	O	71	DEP
70	OH	OH	B-NP	NN	O	71	DEP
71	)	)	O	)	O	68	NMOD
72	D3	D3	B-NP	NN	O	66	PMOD
73	(	(	O	(	O	90	DEP
74	receptor-positive	receptor-positive	B-NP	JJ	B-cell_type	75	NMOD
75	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	82	NMOD
76	:	:	O	:	O	82	P
77	sarcoidosis	sarcoidosis	B-NP	NN	O	82	NMOD
78	,	,	O	,	O	82	P
79	20	20	B-NP	CD	O	81	AMOD
80	±	±	I-NP	HYPH	O	81	AMOD
81	12	12	I-NP	CD	O	82	NMOD
82	%	%	I-NP	NN	O	84	NMOD
83	;	;	O	:	O	84	P
84	tuberculosis	tuberculosis	B-NP	NN	O	89	NMOD
85	,	,	O	,	O	89	P
86	31	31	B-NP	CD	O	89	NMOD
87	±	±	I-NP	HYPH	O	89	NMOD
88	17	17	I-NP	CD	O	89	NMOD
89	%	%	I-NP	NN	O	90	DEP
90	)	)	O	)	O	72	NMOD
91	.	.	O	.	O	19	P

1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	11	P
4	blood	blood	B-NP	NN	B-cell_type	5	NMOD
5	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	SUB
6	from	from	B-PP	IN	O	5	NMOD
7	patients	patient	B-NP	NNS	O	6	PMOD
8	with	with	B-PP	IN	O	7	NMOD
9	granulomatous	granulomatous	B-NP	JJ	O	10	NMOD
10	diseases	disease	I-NP	NNS	O	8	PMOD
11	did	do	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	express	express	I-VP	VB	O	11	VC
14	detectable	detectable	B-NP	JJ	O	22	NMOD
15	1	1	I-NP	CD	B-protein	22	NMOD
16	,	,	I-NP	,	I-protein	22	P
17	25	25	I-NP	CD	I-protein	22	NMOD
18	(	(	O	(	I-protein	22	NMOD
19	OH	OH	B-NP	NN	I-protein	22	NMOD
20	)	)	O	)	I-protein	22	NMOD
21	2D3	2D3	B-NP	NN	I-protein	22	NMOD
22	receptors	receptor	I-NP	NNS	I-protein	13	OBJ
23	.	.	O	.	O	11	P

1	Inhibition	Inhibition	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	transcription	transcription	B-NP	NN	B-protein	4	NMOD
4	factors	factor	I-NP	NNS	I-protein	2	PMOD
5	belonging	belong	B-VP	VBG	O	4	NMOD
6	to	to	B-PP	TO	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	rel/NF-kappa	rel/NF-kappa	I-NP	NN	B-protein	10	NMOD
9	B	B	I-NP	NN	I-protein	10	NMOD
10	family	family	I-NP	NN	I-protein	6	PMOD
11	by	by	B-PP	IN	O	1	NMOD
12	a	a	B-NP	DT	O	15	NMOD
13	transdominant	transdominant	I-NP	JJ	B-protein	15	NMOD
14	negative	negative	I-NP	JJ	I-protein	15	NMOD
15	mutant	mutant	I-NP	NN	I-protein	11	PMOD
16	.	.	O	.	O	1	P

1	A	A	B-NP	DT	O	2	NMOD
2	mutant	mutant	I-NP	NN	O	23	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	KBF1/p50	KBF1/p50	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	O	8	DEP
6	delta	delta	B-NP	SYM	B-protein	7	NMOD
7	SP	SP	I-NP	NN	I-protein	8	DEP
8	)	)	O	)	O	4	NMOD
9	,	,	O	,	O	2	P
10	unable	unable	B-ADJP	JJ	O	16	AMOD
11	to	to	B-VP	TO	O	12	VMOD
12	bind	bind	I-VP	VB	O	10	AMOD
13	to	to	B-PP	TO	O	12	VMOD
14	DNA	DNA	B-NP	NN	O	13	PMOD
15	but	but	O	CC	O	16	AMOD
16	able	able	B-ADJP	JJ	O	2	NMOD
17	to	to	B-VP	TO	O	18	VMOD
18	form	form	I-VP	VB	O	16	AMOD
19	homo-	homo-	B-NP	JJ	O	21	NMOD
20	or	or	O	CC	O	21	NMOD
21	heterodimers	heterodimer	B-NP	NNS	B-protein	18	OBJ
22	,	,	O	,	O	2	P
23	has	have	B-VP	VBZ	O	0	ROOT
24	been	be	I-VP	VBN	O	23	VC
25	constructed	construct	I-VP	VBN	O	24	VC
26	.	.	O	.	O	23	P

1	This	This	B-NP	DT	O	2	NMOD
2	mutant	mutant	I-NP	NN	O	4	SUB
3	also	also	B-ADVP	RB	O	4	VMOD
4	functions	function	B-VP	VBZ	O	0	ROOT
5	in	in	B-ADVP	FW	O	4	VMOD
6	vivo	vivo	I-ADVP	FW	O	5	AMOD
7	as	as	B-PP	IN	O	4	VMOD
8	a	a	B-NP	DT	O	12	NMOD
9	trans-acting	trans-acting	I-NP	JJ	B-protein	12	NMOD
10	dominant	dominant	I-NP	JJ	I-protein	12	NMOD
11	negative	negative	I-NP	JJ	I-protein	12	NMOD
12	regulator	regulator	I-NP	NN	I-protein	7	PMOD
13	:	:	O	:	O	4	P

1	An	An	O	DT	O	7	NMOD
2	iron-responsive	iron-responsive	B-NP	JJ	B-DNA	3	NMOD
3	element	element	I-NP	NN	I-DNA	7	NMOD
4	(	(	O	(	O	6	DEP
5	IRE	IRE	B-NP	NN	B-DNA	6	DEP
6	)	)	O	)	O	3	NMOD
7	motif	motif	B-NP	NN	O	8	SUB
8	has	have	B-VP	VBZ	O	0	ROOT
9	been	be	I-VP	VBN	O	8	VC
10	identified	identify	I-VP	VBN	O	9	VC
11	in	in	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	5'-untranslated	5'-untranslated	I-NP	JJ	B-DNA	14	NMOD
14	region	region	I-NP	NN	I-DNA	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	20	NMOD
17	human	human	I-NP	JJ	B-RNA	20	NMOD
18	erythroid	erythroid	I-NP	JJ	I-RNA	20	NMOD
19	ALAS	ALAS	I-NP	NN	I-RNA	20	NMOD
20	mRNA	mRNA	I-NP	NN	I-RNA	15	PMOD
21	,	,	O	,	O	8	P
22	but	but	O	CC	O	8	VMOD
23	is	be	B-VP	VBZ	O	8	VMOD
24	not	not	O	RB	O	23	VMOD
25	present	present	B-ADJP	JJ	O	23	PRD
26	in	in	B-PP	IN	O	25	AMOD
27	the	the	B-NP	DT	O	30	NMOD
28	housekeeping	housekeeping	I-NP	JJ	B-RNA	30	NMOD
29	ALAS	ALAS	I-NP	NN	I-RNA	30	NMOD
30	mRNA	mRNA	I-NP	NN	I-RNA	26	PMOD
31	.	.	O	.	O	8	P

1	A	A	B-NP	DT	O	2	NMOD
2	transcript	transcript	I-NP	NN	O	17	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	ALAS	ALAS	I-NP	NN	B-DNA	6	NMOD
6	IRE	IRE	I-NP	NN	I-DNA	3	PMOD
7	,	,	O	,	O	2	P
8	mutated	mutate	B-VP	VBN	O	2	NMOD
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	conserved	conserve	I-NP	VBN	O	12	NMOD
12	loop	loop	I-NP	NN	O	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	IRE	IRE	I-NP	NN	B-DNA	13	PMOD
16	,	,	O	,	O	2	P
17	did	do	B-VP	VBD	O	0	ROOT
18	not	not	I-VP	RB	O	17	VMOD
19	readily	readily	I-VP	RB	O	17	VMOD
20	form	form	I-VP	VB	O	17	VC
21	this	this	O	DT	O	23	NMOD
22	protein-RNA	protein-RNA	B-NP	JJ	B-protein	23	NMOD
23	complex	complex	B-NP	NN	I-protein	20	OBJ
24	.	.	O	.	O	17	P

1	Although	Although	B-SBAR	IN	O	36	VMOD
2	three	three	B-NP	CD	O	3	NMOD
3	sites	site	I-NP	NNS	O	20	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	TNF-alpha	TNF-alpha	I-NP	NN	B-DNA	7	NMOD
7	promoter	promoter	I-NP	NN	I-DNA	4	PMOD
8	(	(	O	(	O	18	DEP
9	kappa	kappa	B-NP	NN	O	16	NMOD
10	1	1	I-NP	CD	O	9	NMOD
11	,	,	O	,	O	16	P
12	kappa	kappa	B-NP	NN	O	16	NMOD
13	2	2	I-NP	CD	O	12	NMOD
14	,	,	O	,	O	16	P
15	and	and	O	CC	O	16	NMOD
16	kappa	kappa	B-NP	NN	B-DNA	18	DEP
17	3	3	I-NP	CD	I-DNA	16	NMOD
18	)	)	O	)	O	3	NMOD
19	specifically	specifically	B-ADVP	RB	O	20	VMOD
20	bind	bind	B-VP	VBP	O	1	SBAR
21	the	the	B-NP	DT	O	25	NMOD
22	transcription	transcription	I-NP	NN	B-protein	25	NMOD
23	factor	factor	I-NP	NN	I-protein	25	NMOD
24	NF-kappa	NF-kappa	I-NP	NN	B-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	20	OBJ
26	in	in	B-PP	IN	O	25	NMOD
27	lymphoid	lymphoid	B-NP	JJ	O	29	NMOD
28	nuclear	nuclear	I-NP	JJ	O	29	NMOD
29	extracts	extract	I-NP	NNS	O	26	PMOD
30	,	,	O	,	O	36	P
31	TNF-alpha	TNF-alpha	B-NP	NN	B-RNA	33	NMOD
32	mRNA	mRNA	I-NP	NN	I-RNA	33	NMOD
33	induction	induction	I-NP	NN	O	36	SUB
34	by	by	B-PP	IN	O	33	NMOD
35	PMA	PMA	B-NP	NN	O	34	PMOD
36	does	do	B-VP	VBZ	O	0	ROOT
37	not	not	I-VP	RB	O	36	VMOD
38	correlate	correlate	I-VP	VB	O	36	VC
39	with	with	B-PP	IN	O	38	VMOD
40	NF-kappa	NF-kappa	B-NP	NN	B-protein	41	NMOD
41	B	B	I-NP	NN	I-protein	43	NMOD
42	binding	binding	I-NP	NN	O	43	NMOD
43	activities	activity	I-NP	NNS	O	39	PMOD
44	displayed	display	B-VP	VBN	O	43	NMOD
45	by	by	B-PP	IN	O	44	VMOD
46	different	different	B-NP	JJ	O	51	NMOD
47	T	T	I-NP	NN	B-cell_line	51	NMOD
48	and	and	I-NP	CC	I-cell_line	51	NMOD
49	B	B	I-NP	NN	I-cell_line	51	NMOD
50	cell	cell	I-NP	NN	I-cell_line	51	NMOD
51	lines	line	I-NP	NNS	I-cell_line	45	PMOD
52	.	.	O	.	O	36	P

1	Therefore	Therefore	B-ADVP	RB	O	17	VMOD
2	,	,	O	,	O	17	P
3	TNF-alpha	TNF-alpha	B-NP	NN	B-RNA	5	NMOD
4	mRNA	mRNA	I-NP	NN	I-RNA	5	NMOD
5	induction	induction	I-NP	NN	O	17	SUB
6	by	by	B-PP	IN	O	5	NMOD
7	PMA	PMA	B-NP	NN	O	6	PMOD
8	,	,	O	,	O	17	P
9	like	like	B-PP	IN	O	17	VMOD
10	its	its	B-NP	PRP$	O	11	NMOD
11	induction	induction	I-NP	NN	O	9	PMOD
12	by	by	B-PP	IN	O	11	NMOD
13	virus	virus	B-NP	NN	O	15	NMOD
14	and	and	O	CC	O	15	NMOD
15	LPS	LPS	B-NP	NN	O	12	PMOD
16	,	,	O	,	O	17	P
17	is	be	B-VP	VBZ	O	0	ROOT
18	not	not	I-VP	RB	O	17	VMOD
19	primarily	primarily	I-VP	RB	O	17	VMOD
20	mediated	mediate	I-VP	VBN	O	17	VC
21	by	by	B-PP	IN	O	20	VMOD
22	NF-kappa	NF-kappa	B-NP	NN	B-protein	23	NMOD
23	B	B	I-NP	NN	I-protein	21	PMOD
24	,	,	O	,	O	21	P
25	but	but	B-CONJP	CC	O	21	PMOD
26	rather	rather	I-CONJP	RB	O	25	DEP
27	is	be	B-VP	VBZ	O	21	SBAR
28	mediated	mediate	I-VP	VBN	O	27	VC
29	through	through	B-PP	IN	O	28	VMOD
30	other	other	B-NP	JJ	O	31	NMOD
31	sequences	sequence	I-NP	NNS	O	34	NMOD
32	and	and	O	CC	O	34	NMOD
33	protein	protein	B-NP	NN	B-protein	34	NMOD
34	factors	factor	I-NP	NNS	I-protein	29	PMOD
35	.	.	O	.	O	17	P

1	Surprisingly	Surprisingly	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	multimers	multimer	B-NP	NNS	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	kappa	kappa	B-NP	NN	B-DNA	6	NMOD
6	1-kappa	1-kappa	I-NP	NN	I-DNA	4	PMOD
7	3	3	I-NP	CD	I-DNA	6	NMOD
8	can	can	B-VP	MD	O	0	ROOT
9	confer	confer	I-VP	VB	O	8	VC
10	PMA	PMA	B-NP	NN	O	11	NMOD
11	inducibility	inducibility	I-NP	NN	O	9	OBJ
12	on	on	B-PP	IN	O	9	VMOD
13	a	a	B-NP	DT	O	15	NMOD
14	heterologous	heterologous	I-NP	JJ	B-DNA	15	NMOD
15	promoter	promoter	I-NP	NN	I-DNA	12	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	a	a	B-NP	DT	O	26	NMOD
18	B	B	B-NP	NN	O	26	NMOD
19	(	(	O	(	O	21	DEP
20	Raji	Raji	B-NP	NN	B-cell_line	21	DEP
21	)	)	O	)	O	18	NMOD
22	,	,	O	,	O	26	P
23	but	but	B-CONJP	CC	O	26	NMOD
24	not	not	I-CONJP	RB	O	23	DEP
25	a	a	B-NP	DT	O	26	NMOD
26	T	T	B-NP	NN	B-cell_line	31	NMOD
27	(	(	O	(	I-cell_line	29	DEP
28	HUT78	HUT78	B-NP	NN	I-cell_line	29	DEP
29	)	)	O	)	I-cell_line	26	NMOD
30	cell	cell	B-NP	NN	I-cell_line	31	NMOD
31	line	line	I-NP	NN	I-cell_line	16	PMOD
32	.	.	O	.	O	8	P

1	However	However	B-ADVP	RB	O	3	VMOD
2	they	they	B-NP	PRP	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	not	not	O	RB	O	3	VMOD
5	functional	functional	B-ADJP	JJ	O	3	PRD
6	on	on	B-PP	IN	O	5	AMOD
7	a	a	B-NP	DT	O	10	NMOD
8	truncated	truncate	I-NP	VBN	O	10	NMOD
9	TNF-alpha	TNF-alpha	I-NP	NN	B-DNA	10	NMOD
10	promoter	promoter	I-NP	NN	I-DNA	6	PMOD
11	,	,	O	,	O	3	P
12	indicating	indicate	B-VP	VBG	O	3	VMOD
13	that	that	B-SBAR	IN	O	12	VMOD
14	promoter	promoter	B-NP	NN	O	15	NMOD
15	context	context	I-NP	NN	O	19	NMOD
16	and	and	O	CC	O	19	NMOD
17	cell	cell	B-NP	NN	O	19	NMOD
18	type	type	I-NP	NN	O	19	NMOD
19	specificity	specificity	I-NP	NN	O	20	SUB
20	influence	influence	B-VP	VBP	O	13	SBAR
21	the	the	B-NP	DT	O	24	NMOD
22	PMA	PMA	I-NP	NN	O	24	NMOD
23	inducible	inducible	I-NP	JJ	O	24	NMOD
24	function	function	I-NP	NN	O	20	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	these	these	B-NP	DT	O	30	NMOD
27	NF-kappa	NF-kappa	I-NP	NN	B-DNA	30	NMOD
28	B	B	I-NP	NN	I-DNA	30	NMOD
29	binding	binding	I-NP	NN	I-DNA	30	NMOD
30	sites	site	I-NP	NNS	I-DNA	25	PMOD
31	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	HB24	HB24	I-NP	NN	B-RNA	3	NMOD
3	mRNA	mRNA	I-NP	NN	I-RNA	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	absent	absent	B-ADJP	JJ	O	7	AMOD
6	or	or	O	CC	O	7	AMOD
7	present	present	B-ADJP	JJ	O	4	PRD
8	at	at	B-PP	IN	O	7	AMOD
9	low	low	B-NP	JJ	O	10	NMOD
10	levels	level	I-NP	NNS	O	8	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	normal	normal	B-NP	JJ	O	11	PMOD
13	B	B	B-NP	NN	O	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	T	T	B-NP	NN	B-cell_type	16	NMOD
16	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	12	NMOD
17	;	;	O	:	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	proband	proband	I-NP	NN	O	3	SUB
3	had	have	B-VP	VBD	O	0	ROOT
4	no	no	B-NP	DT	O	7	NMOD
5	detectable	detectable	I-NP	JJ	O	7	NMOD
6	DPD	DPD	I-NP	NN	B-protein	7	NMOD
7	activity	activity	I-NP	NN	O	3	OBJ
8	.	.	O	.	O	3	P

1	In	In	B-ADVP	FW	O	5	NMOD
2	vitro	vitro	I-ADVP	FW	O	1	AMOD
3	translated	translate	B-NP	VBN	O	1	AMOD
4	MAD-3	MAD-3	I-NP	NN	B-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	6	SUB
6	was	be	B-VP	VBD	O	0	ROOT
7	found	find	I-VP	VBN	O	6	VC
8	to	to	I-VP	TO	O	10	VMOD
9	specifically	specifically	I-VP	RB	O	10	VMOD
10	inhibit	inhibit	I-VP	VB	O	7	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	DNA-binding	DNA-binding	I-NP	JJ	O	13	NMOD
13	activity	activity	I-NP	NN	O	22	NMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	19	NMOD
16	p50/p65	p50/p65	I-NP	NN	B-protein	19	NMOD
17	NF-kappa	NF-kappa	I-NP	NN	I-protein	19	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	complex	complex	I-NP	NN	I-protein	14	PMOD
20	but	but	B-CONJP	CC	O	22	NMOD
21	not	not	I-CONJP	RB	O	20	DEP
22	that	that	B-NP	DT	O	10	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	27	NMOD
25	p50/p50	p50/p50	I-NP	NN	B-protein	27	NMOD
26	KBF1	KBF1	I-NP	NN	I-protein	27	NMOD
27	factor	factor	I-NP	NN	I-protein	23	PMOD
28	or	or	B-PP	CC	O	23	PMOD
29	of	of	B-PP	IN	O	23	PMOD
30	other	other	B-NP	JJ	O	32	NMOD
31	DNA-binding	DNA-binding	I-NP	JJ	B-protein	32	NMOD
32	proteins	protein	I-NP	NNS	I-protein	29	PMOD
33	.	.	O	.	O	6	P

1	Starting	Start	B-VP	VBG	O	48	VMOD
2	with	with	B-PP	IN	O	1	VMOD
3	a	a	B-NP	DT	O	6	NMOD
4	replication-incompetent	replication-incompetent	I-NP	JJ	O	6	NMOD
5	molecular	molecular	I-NP	JJ	O	6	NMOD
6	clone	clone	I-NP	NN	O	2	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	human	human	B-NP	JJ	O	11	NMOD
9	immunodeficiency	immunodeficiency	I-NP	NN	O	11	NMOD
10	virus	virus	I-NP	NN	O	11	NMOD
11	type	type	I-NP	NN	O	7	PMOD
12	1	1	I-NP	CD	O	11	NMOD
13	,	,	O	,	O	6	P
14	lacking	lack	B-VP	VBG	O	6	NMOD
15	all	all	B-NP	PDT	O	22	NMOD
16	the	the	I-NP	DT	O	22	NMOD
17	NF-kappa	NF-kappa	I-NP	NN	B-DNA	18	NMOD
18	B	B	I-NP	NN	I-DNA	20	NMOD
19	and	and	O	CC	I-DNA	20	NMOD
20	Sp1	Sp1	B-NP	NN	I-DNA	22	NMOD
21	binding	binding	B-NP	NN	I-DNA	22	NMOD
22	sites	site	I-NP	NNS	I-DNA	14	OBJ
23	present	present	B-ADJP	JJ	O	22	NMOD
24	in	in	B-PP	IN	O	23	AMOD
25	the	the	B-NP	DT	O	29	NMOD
26	native	native	I-NP	JJ	B-DNA	29	NMOD
27	long	long	I-NP	JJ	I-DNA	29	NMOD
28	terminal	terminal	I-NP	JJ	I-DNA	29	NMOD
29	repeat	repeat	I-NP	NN	I-DNA	24	PMOD
30	(	(	O	(	O	32	DEP
31	LTR	LTR	B-NP	NN	B-DNA	32	DEP
32	)	)	O	)	O	29	NMOD
33	,	,	O	,	O	48	P
34	proviruses	provirus	B-NP	NNS	O	48	SUB
35	containing	contain	B-VP	VBG	O	34	NMOD
36	reconstructed	reconstruct	B-NP	VBN	B-DNA	37	NMOD
37	LTRs	LTR	I-NP	NNS	I-DNA	35	OBJ
38	with	with	B-PP	IN	O	37	NMOD
39	individual	individual	B-NP	JJ	O	41	NMOD
40	or	or	O	CC	O	41	NMOD
41	combinations	combination	B-NP	NNS	O	38	PMOD
42	of	of	B-PP	IN	O	41	NMOD
43	NF-kappa	NF-kappa	B-NP	NN	B-protein	44	NMOD
44	B	B	I-NP	NN	I-protein	47	NMOD
45	and	and	O	CC	O	47	NMOD
46	Sp1	Sp1	B-NP	NN	B-DNA	47	NMOD
47	elements	element	B-NP	NNS	I-DNA	42	PMOD
48	were	be	B-VP	VBD	O	0	ROOT
49	generated	generate	I-VP	VBN	O	48	VC
50	and	and	O	CC	O	49	VMOD
51	evaluated	evaluate	B-VP	VBN	O	49	VMOD
52	for	for	B-PP	IN	O	51	VMOD
53	their	their	B-NP	PRP$	O	54	NMOD
54	capacity	capacity	I-NP	NN	O	52	PMOD
55	to	to	B-VP	TO	O	56	VMOD
56	produce	produce	I-VP	VB	O	54	NMOD
57	virus	virus	B-NP	NN	O	58	NMOD
58	progeny	progeny	I-NP	NN	O	56	OBJ
59	following	follow	B-PP	VBG	O	56	VMOD
60	transfection-cocultivation	transfection-cocultivation	B-NP	NN	O	59	PMOD
61	.	.	O	.	O	48	P

1	For	For	B-PP	IN	O	50	VMOD
2	example	example	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	50	P
4	in	in	B-PP	IN	O	50	VMOD
5	experiments	experiment	B-NP	NNS	O	4	PMOD
6	involving	involve	B-VP	VBG	O	5	NMOD
7	proviral	proviral	B-NP	JJ	O	8	NMOD
8	clones	clone	I-NP	NNS	O	6	OBJ
9	with	with	B-PP	IN	O	8	NMOD
10	LTRs	LTR	B-NP	NNS	B-DNA	9	PMOD
11	containing	contain	B-VP	VBG	O	10	NMOD
12	one	one	B-NP	CD	O	14	AMOD
13	or	or	I-NP	CC	O	14	AMOD
14	two	two	I-NP	CD	O	11	OBJ
15	NF-kappa	NF-kappa	I-NP	NN	B-DNA	17	NMOD
16	B	B	I-NP	NN	I-DNA	17	NMOD
17	elements	element	I-NP	NNS	I-DNA	14	NMOD
18	(	(	O	(	O	24	DEP
19	and	and	O	CC	O	23	NMOD
20	no	no	B-NP	DT	O	23	NMOD
21	Sp1	Sp1	I-NP	NN	B-DNA	23	NMOD
22	binding	binding	I-NP	NN	I-DNA	23	NMOD
23	sites	site	I-NP	NNS	I-DNA	24	DEP
24	)	)	O	)	O	14	NMOD
25	,	,	O	,	O	50	P
26	a	a	B-NP	DT	O	27	NMOD
27	hierarchy	hierarchy	I-NP	NN	O	50	SUB
28	of	of	B-PP	IN	O	27	NMOD
29	cellular	cellular	B-NP	JJ	O	30	NMOD
30	permissivity	permissivity	I-NP	NN	O	28	PMOD
31	to	to	B-PP	TO	O	30	NMOD
32	virus	virus	B-NP	NN	O	33	NMOD
33	replication	replication	I-NP	NN	O	31	PMOD
34	(	(	O	(	O	49	DEP
35	peripheral	peripheral	B-NP	JJ	B-cell_type	37	NMOD
36	blood	blood	I-NP	NN	I-cell_type	37	NMOD
37	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	39	SUB
38	=	=	B-VP	SYM	O	39	VMOD
39	MT4	MT4	B-NP	NN	B-cell_line	49	DEP
40	greater	great	B-ADJP	JJR	O	39	NMOD
41	than	than	B-PP	IN	O	40	AMOD
42	H9	H9	B-NP	NN	B-cell_line	41	PMOD
43	greater	great	B-ADJP	JJR	O	42	NMOD
44	than	than	B-PP	IN	O	43	AMOD
45	CEM	CEM	B-NP	NN	B-cell_line	44	PMOD
46	greater	great	B-ADJP	JJR	O	45	NMOD
47	than	than	B-PP	IN	O	46	AMOD
48	Jurkat	Jurkat	B-NP	NN	B-cell_line	47	PMOD
49	)	)	O	)	O	30	NMOD
50	was	be	B-VP	VBD	O	0	ROOT
51	observed	observe	I-VP	VBN	O	50	VC
52	.	.	O	.	O	50	P

1	However	However	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	inhibition	inhibition	B-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	HIV-1	HIV-1	B-NP	NN	O	6	NMOD
6	replication	replication	I-NP	NN	O	4	PMOD
7	appears	appear	B-VP	VBZ	O	0	ROOT
8	not	not	I-VP	RB	O	10	VMOD
9	to	to	I-VP	TO	O	10	VMOD
10	be	be	I-VP	VB	O	7	VMOD
11	directly	directly	I-VP	RB	O	10	VMOD
12	correlated	correlate	I-VP	VBN	O	10	VC
13	with	with	B-PP	IN	O	12	VMOD
14	GSH	GSH	B-NP	NN	O	15	NMOD
15	levels	level	I-NP	NNS	O	13	PMOD
16	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	2	SUB
2	studied	study	B-VP	VBD	O	0	ROOT
3	glucocorticosteroid	glucocorticosteroid	B-NP	NN	B-protein	4	NMOD
4	receptor	receptor	I-NP	NN	I-protein	2	OBJ
5	density	density	B-NP	NN	O	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	affinity	affinity	B-NP	NN	O	4	NMOD
8	on	on	B-PP	IN	O	4	NMOD
9	peripheral	peripheral	B-NP	JJ	B-cell_type	12	NMOD
10	blood	blood	I-NP	NN	I-cell_type	12	NMOD
11	mononuclear	mononuclear	I-NP	JJ	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
13	by	by	B-PP	IN	O	2	VMOD
14	the	the	B-NP	DT	O	17	NMOD
15	glucocorticosteroid	glucocorticosteroid	I-NP	NN	O	17	NMOD
16	binding	binding	I-NP	NN	O	17	NMOD
17	assay	assay	I-NP	NN	O	13	PMOD
18	in	in	B-PP	IN	O	2	VMOD
19	33	33	B-NP	CD	O	20	NMOD
20	patients	patient	I-NP	NNS	O	18	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	SLE	SLE	B-NP	NN	O	21	PMOD
23	who	who	B-NP	WP	O	20	NMOD
24	had	have	B-VP	VBD	O	23	SBAR
25	taken	take	I-VP	VBN	O	24	VC
26	no	no	B-NP	DT	O	27	NMOD
27	glucocorticosteroid	glucocorticosteroid	I-NP	NN	O	25	OBJ
28	for	for	B-PP	IN	O	25	VMOD
29	the	the	B-NP	DT	O	32	NMOD
30	previous	previous	I-NP	JJ	O	32	NMOD
31	6	6	I-NP	CD	O	32	NMOD
32	months	month	I-NP	NNS	O	28	PMOD
33	and	and	B-PP	CC	O	28	PMOD
34	in	in	B-PP	IN	O	28	PMOD
35	32	32	B-NP	CD	O	37	NMOD
36	healthy	healthy	I-NP	JJ	O	37	NMOD
37	controls	control	I-NP	NNS	O	34	PMOD
38	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	binding	binding	I-NP	NN	O	3	NMOD
3	affinity	affinity	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	not	not	O	RB	O	4	VMOD
6	different	different	B-ADJP	JJ	O	4	PRD
7	between	between	B-PP	IN	O	4	VMOD
8	patients	patient	B-NP	NNS	O	10	NMOD
9	and	and	O	CC	O	10	NMOD
10	controls	control	B-NP	NNS	O	7	PMOD
11	.	.	O	.	O	4	P

1	There	There	B-NP	EX	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	no	no	B-NP	DT	O	4	NMOD
4	correlation	correlation	I-NP	NN	O	2	PRD
5	between	between	B-PP	IN	O	4	NMOD
6	glucocorticosteroid	glucocorticosteroid	B-NP	NN	B-protein	8	NMOD
7	receptor	receptor	I-NP	NN	I-protein	8	NMOD
8	number	number	I-NP	NN	O	12	NMOD
9	and	and	O	CC	O	12	NMOD
10	SLE	SLE	B-NP	NN	O	12	NMOD
11	disease	disease	I-NP	NN	O	12	NMOD
12	activity	activity	I-NP	NN	O	5	PMOD
13	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	compared	compare	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	those	those	B-NP	DT	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	12	12	B-NP	CD	O	10	NMOD
9	menopausal	menopausal	I-NP	JJ	O	10	NMOD
10	women	woman	I-NP	NNS	O	16	NMOD
11	without	without	B-PP	IN	O	10	NMOD
12	diabetes	diabete	B-NP	NNS	O	11	PMOD
13	and	and	O	CC	O	16	NMOD
14	12	12	B-NP	CD	O	16	NMOD
15	normal	normal	I-NP	JJ	O	16	NMOD
16	women	woman	I-NP	NNS	O	7	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	childbearing	childbeare	B-VP	VBG	O	19	NMOD
19	age	age	B-NP	NN	O	17	PMOD
20	.	.	O	.	O	3	P

1	There	There	B-NP	EX	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	no	no	B-NP	DT	O	4	NMOD
4	difference	difference	I-NP	NN	O	2	PRD
5	in	in	B-PP	IN	O	4	NMOD
6	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	7	NMOD
7	receptor	receptor	I-NP	NN	I-protein	5	PMOD
8	number	number	B-NP	NN	O	10	NMOD
9	or	or	O	CC	O	10	NMOD
10	affinity	affinity	B-NP	NN	O	7	NMOD
11	between	between	B-PP	IN	O	4	NMOD
12	depressed	depressed	B-NP	JJ	O	13	NMOD
13	patients	patient	I-NP	NNS	O	18	NMOD
14	and	and	O	CC	O	18	NMOD
15	recovered	recover	B-VP	VBD	O	18	NMOD
16	or	or	O	CC	O	18	NMOD
17	control	control	B-NP	NN	O	18	NMOD
18	subjects	subject	I-NP	NNS	O	11	PMOD
19	.	.	O	.	O	2	P

1	Afternoon	Afternoon	B-NP	NN	O	5	NMOD
2	ACTH	ACTH	I-NP	NN	O	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	cortisol	cortisol	B-NP	NN	O	5	NMOD
5	concentrations	concentration	B-NP	NNS	O	6	SUB
6	did	do	B-VP	VBD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	differ	differ	I-VP	VB	O	6	VC
9	significantly	significantly	B-ADVP	RB	O	8	VMOD
10	between	between	B-PP	IN	O	8	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	three	three	I-NP	CD	O	13	NMOD
13	groups	group	I-NP	NNS	O	10	PMOD
14	.	.	O	.	O	6	P

1	No	No	B-NP	DT	O	2	NMOD
2	relationship	relationship	I-NP	NN	O	3	SUB
3	could	could	B-VP	MD	O	0	ROOT
4	be	be	I-VP	VB	O	3	VC
5	established	establish	I-VP	VBN	O	4	VC
6	between	between	B-PP	IN	O	5	VMOD
7	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	9	NMOD
8	receptor	receptor	I-NP	NN	I-protein	9	NMOD
9	binding	binding	I-NP	NN	O	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	antidepressant	antidepressant	B-NP	NN	O	12	NMOD
12	medication	medication	I-NP	NN	O	6	PMOD
13	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	support	support	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	view	view	I-NP	NN	O	18	NMOD
6	of	of	B-PP	IN	O	5	NMOD
7	an	an	B-NP	DT	O	10	NMOD
8	impaired	impaired	I-NP	JJ	O	9	AMOD
9	ligand-induced	ligand-induced	I-NP	JJ	O	10	NMOD
10	plasticity	plasticity	I-NP	NN	O	6	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	14	NMOD
13	receptor	receptor	I-NP	NN	I-protein	14	NMOD
14	regulation	regulation	I-NP	NN	O	11	PMOD
15	rather	rather	B-CONJP	RB	O	18	NMOD
16	than	than	I-CONJP	IN	O	15	DEP
17	the	the	B-NP	DT	O	18	NMOD
18	hypothesis	hypothesis	I-NP	NN	O	3	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	decreased	decrease	B-NP	VBN	O	23	NMOD
21	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	23	NMOD
22	receptor	receptor	I-NP	NN	I-protein	23	NMOD
23	numbers	number	I-NP	NNS	O	19	PMOD
24	during	during	B-PP	IN	O	18	NMOD
25	depression	depression	B-NP	NN	O	24	PMOD
26	.	.	O	.	O	3	P

1	Binding	Binding	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	drug	drug	I-NP	NN	O	2	PMOD
5	inhibits	inhibit	B-VP	VBZ	O	23	VMOD
6	isomerase	isomerase	B-NP	NN	B-protein	7	NMOD
7	activity	activity	I-NP	NN	O	5	OBJ
8	,	,	O	,	O	23	P
9	but	but	O	CC	O	23	VMOD
10	studies	study	B-NP	NNS	O	17	NMOD
11	with	with	B-PP	IN	O	10	NMOD
12	other	other	B-NP	JJ	O	15	NMOD
13	prolyl	prolyl	I-NP	JJ	O	15	NMOD
14	isomerase	isomerase	I-NP	NN	B-protein	15	NMOD
15	inhibitors	inhibitor	I-NP	NNS	O	11	PMOD
16	and	and	O	CC	O	17	NMOD
17	analysis	analysis	B-NP	NN	O	23	SUB
18	of	of	B-PP	IN	O	17	NMOD
19	cyclosporin-resistant	cyclosporin-resistant	B-NP	JJ	B-cell_line	20	NMOD
20	mutants	mutant	I-NP	NNS	I-cell_line	18	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	yeast	yeast	B-NP	NN	O	21	PMOD
23	suggest	suggest	B-VP	VBP	O	0	ROOT
24	that	that	B-SBAR	IN	O	23	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	effects	effect	I-NP	NNS	O	30	SUB
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	drug	drug	I-NP	NN	O	27	PMOD
30	result	result	B-VP	VBP	O	24	SBAR
31	from	from	B-PP	IN	O	30	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	formation	formation	I-NP	NN	O	31	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	an	an	B-NP	DT	O	37	NMOD
36	inhibitory	inhibitory	I-NP	JJ	B-protein	37	NMOD
37	complex	complex	I-NP	NN	I-protein	34	PMOD
38	between	between	B-PP	IN	O	33	NMOD
39	the	the	B-NP	DT	O	40	NMOD
40	drug	drug	I-NP	NN	O	42	NMOD
41	and	and	I-NP	CC	O	42	NMOD
42	isomerase	isomerase	I-NP	NN	B-protein	38	PMOD
43	,	,	B-PP	,	O	31	P
44	and	and	I-PP	CC	O	31	PMOD
45	not	not	B-PP	RB	O	46	PMOD
46	from	from	I-PP	IN	O	31	PMOD
47	inhibition	inhibition	B-NP	NN	O	46	PMOD
48	of	of	B-PP	IN	O	47	NMOD
49	isomerase	isomerase	B-NP	NN	B-protein	50	NMOD
50	activity	activity	I-NP	NN	O	48	PMOD
51	.	.	O	.	O	23	P

1	A	A	B-NP	DT	O	3	NMOD
2	transcription	transcription	I-NP	NN	B-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	5	NMOD
4	,	,	O	,	O	5	P
5	NF-AT	NF-AT	B-NP	NN	B-protein	16	SUB
6	,	,	O	,	O	5	P
7	which	which	B-NP	WDT	O	5	NMOD
8	is	be	B-VP	VBZ	O	7	SBAR
9	essential	essential	B-ADJP	JJ	O	8	PRD
10	for	for	B-PP	IN	O	9	AMOD
11	early	early	B-NP	JJ	B-DNA	14	NMOD
12	T-cell	T-cell	I-NP	NN	I-DNA	14	NMOD
13	gene	gene	I-NP	NN	I-DNA	14	NMOD
14	activation	activation	I-NP	NN	O	10	PMOD
15	,	,	O	,	O	5	P
16	seems	seem	B-VP	VBZ	O	0	ROOT
17	to	to	I-VP	TO	O	18	VMOD
18	be	be	I-VP	VB	O	16	VMOD
19	a	a	B-NP	DT	O	21	NMOD
20	specific	specific	I-NP	JJ	O	21	NMOD
21	target	target	I-NP	NN	O	18	PRD
22	of	of	B-PP	IN	O	21	NMOD
23	cyclosporin	cyclosporin	B-NP	NN	O	24	NMOD
24	A	A	I-NP	NN	O	26	NMOD
25	and	and	O	CC	O	26	NMOD
26	FK506	FK506	B-NP	NN	O	27	NMOD
27	action	action	B-NP	NN	O	22	PMOD
28	because	because	B-SBAR	IN	O	18	VMOD
29	transcription	transcription	B-NP	NN	O	34	SUB
30	directed	direct	B-VP	VBN	O	29	NMOD
31	by	by	B-PP	IN	O	30	VMOD
32	this	this	B-NP	DT	O	33	NMOD
33	protein	protein	I-NP	NN	O	31	PMOD
34	is	be	B-VP	VBZ	O	28	SBAR
35	blocked	block	I-VP	VBN	O	34	VC
36	in	in	B-PP	IN	O	35	VMOD
37	T	T	B-NP	NN	B-cell_type	38	NMOD
38	cells	cell	I-NP	NNS	I-cell_type	36	PMOD
39	treated	treat	B-VP	VBN	O	38	NMOD
40	with	with	B-PP	IN	O	39	VMOD
41	these	these	B-NP	DT	O	42	NMOD
42	drugs	drug	I-NP	NNS	O	40	PMOD
43	,	,	O	,	O	35	P
44	with	with	B-PP	IN	O	35	VMOD
45	little	little	B-NP	JJ	O	48	NMOD
46	or	or	I-NP	CC	O	48	NMOD
47	no	no	I-NP	DT	O	48	NMOD
48	effect	effect	I-NP	NN	O	44	PMOD
49	on	on	B-PP	IN	O	48	NMOD
50	other	other	B-NP	JJ	O	52	NMOD
51	transcription	transcription	I-NP	NN	B-protein	52	NMOD
52	factors	factor	I-NP	NNS	I-protein	49	PMOD
53	such	such	B-PP	JJ	O	54	PMOD
54	as	as	I-PP	IN	O	52	NMOD
55	AP-1	AP-1	B-NP	NN	B-protein	58	NMOD
56	and	and	O	CC	O	58	NMOD
57	NF-kappa	NF-kappa	B-NP	NN	B-protein	58	NMOD
58	B	B	I-NP	NN	I-protein	54	PMOD
59	.	.	O	.	O	16	P

1	FK506	FK506	B-NP	NN	O	4	NMOD
2	and	and	O	CC	O	4	NMOD
3	cyclosporin	cyclosporin	B-NP	NN	O	4	NMOD
4	A	A	I-NP	NN	O	5	SUB
5	block	block	B-VP	VBP	O	0	ROOT
6	translocation	translocation	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	10	NMOD
10	component	component	I-NP	NN	I-protein	7	PMOD
11	without	without	B-PP	IN	O	5	VMOD
12	affecting	affect	B-VP	VBG	O	11	PMOD
13	synthesis	synthesis	B-NP	NN	O	12	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	nuclear	nuclear	I-NP	JJ	B-protein	17	NMOD
17	subunit	subunit	I-NP	NN	I-protein	14	PMOD
18	.	.	O	.	O	5	P

1	Furthermore	Furthermore	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	activation	activation	B-NP	NN	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	PKC	PKC	B-NP	NN	B-protein	4	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	pertussis-toxin-sensitive	pertussis-toxin-sensitive	B-ADJP	JJ	O	6	PRD
8	and	and	O	CC	O	6	VMOD
9	was	be	B-VP	VBD	O	6	VMOD
10	associated	associate	I-VP	VBN	O	9	VC
11	with	with	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	detection	detection	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	an	an	B-NP	DT	O	19	NMOD
16	NF	NF	I-NP	NN	B-protein	19	NMOD
17	kappa	kappa	I-NP	NN	I-protein	19	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	protein	protein	I-NP	NN	I-protein	14	PMOD
20	in	in	B-PP	IN	O	13	NMOD
21	nuclear	nuclear	B-NP	JJ	O	22	NMOD
22	extracts	extract	I-NP	NNS	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	M-CSF-induced	M-CSF-induced	B-NP	JJ	B-cell_line	26	NMOD
25	blood	blood	I-NP	NN	I-cell_line	26	NMOD
26	monocytes	monocyte	I-NP	NNS	I-cell_line	23	PMOD
27	but	but	B-PP	CC	O	20	PMOD
28	not	not	B-PP	RB	O	29	PMOD
29	in	in	I-PP	IN	O	20	PMOD
30	monocytes	monocyte	B-NP	NNS	B-cell_type	29	PMOD
31	exposed	expose	B-VP	VBN	O	30	NMOD
32	to	to	B-PP	TO	O	31	VMOD
33	medium	medium	B-NP	NN	O	34	NMOD
34	treatment	treatment	I-NP	NN	O	32	PMOD
35	only	only	B-ADVP	RB	O	31	VMOD
36	.	.	O	.	O	6	P

1	Phorbol	Phorbol	B-NP	NN	O	2	NMOD
2	activation	activation	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	positively	positively	I-VP	RB	O	3	VMOD
5	modulated	modulate	I-VP	VBN	O	3	VC
6	by	by	B-PP	IN	O	5	VMOD
7	Ca2+	Ca2+	B-NP	NN	O	8	NMOD
8	influx	influx	I-NP	NN	O	6	PMOD
9	while	while	B-SBAR	IN	O	5	VMOD
10	TNF	TNF	B-NP	NN	B-protein	12	NMOD
11	alpha	alpha	I-NP	NN	I-protein	12	NMOD
12	activation	activation	I-NP	NN	O	13	SUB
13	was	be	B-VP	VBD	O	9	SBAR
14	not	not	O	RB	O	13	VMOD
15	.	.	O	.	O	3	P

1	TNF	TNF	B-NP	NN	B-protein	2	NMOD
2	alpha	alpha	I-NP	NN	I-protein	3	SUB
3	did	do	B-VP	VBD	O	11	VMOD
4	not	not	I-VP	RB	O	3	VMOD
5	activate	activate	I-VP	VB	O	3	VC
6	cAMP	cAMP	B-NP	NN	O	7	NMOD
7	production	production	I-NP	NN	O	5	OBJ
8	and	and	O	CC	O	11	VMOD
9	its	its	B-NP	PRP$	O	10	NMOD
10	signal	signal	I-NP	NN	O	11	SUB
11	was	be	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	modulated	modulate	I-VP	VBN	O	11	VC
14	by	by	B-PP	IN	O	13	VMOD
15	cAMP	cAMP	B-NP	NN	O	16	NMOD
16	activators	activator	I-NP	NNS	O	14	PMOD
17	.	.	O	.	O	11	P

1	Moreover	Moreover	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	cAMP	cAMP	B-NP	NN	O	4	NMOD
4	activators	activator	I-NP	NNS	O	5	SUB
5	did	do	B-VP	VBD	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	activate	activate	I-VP	VB	O	5	VC
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	7	OBJ
10	in	in	B-PP	IN	O	7	VMOD
11	Jurkat	Jurkat	B-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
13	.	.	O	.	O	5	P

1	Thus	Thus	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	TNF	TNF	B-NP	NN	B-protein	6	NMOD
4	alpha-induced	alpha-induced	I-NP	JJ	O	3	AMOD
5	NF-kappa	NF-kappa	I-NP	NN	B-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	7	NMOD
7	activation	activation	I-NP	NN	O	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	found	find	I-VP	VBN	O	8	VC
10	to	to	I-VP	TO	O	11	VMOD
11	be	be	I-VP	VB	O	9	VMOD
12	mediated	mediate	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	none	none	B-NP	NN	O	13	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	major	major	I-NP	JJ	O	19	NMOD
18	signal-mediating	signal-mediating	I-NP	JJ	B-protein	19	NMOD
19	kinases	kinase	I-NP	NNS	I-protein	15	PMOD
20	such	such	B-PP	JJ	O	21	PMOD
21	as	as	I-PP	IN	O	19	NMOD
22	protein	protein	B-NP	NN	B-protein	24	NMOD
23	kinase	kinase	I-NP	NN	I-protein	24	NMOD
24	C	C	I-NP	NN	I-protein	39	NMOD
25	(	(	O	(	O	27	DEP
26	PKC	PKC	B-NP	NN	B-protein	27	DEP
27	)	)	O	)	O	24	NMOD
28	,	,	O	,	O	39	P
29	protein	protein	B-NP	NN	B-protein	31	NMOD
30	kinase	kinase	I-NP	NN	I-protein	31	NMOD
31	A	A	I-NP	NN	I-protein	39	NMOD
32	,	,	O	,	O	39	P
33	or	or	O	CC	O	39	NMOD
34	Ca	Ca	B-NP	NN	B-protein	39	NMOD
35	(	(	O	(	I-protein	39	NMOD
36	2+	2+	B-ADJP	JJ	I-protein	39	NMOD
37	)	)	O	)	I-protein	39	NMOD
38	-regulated	-regulated	B-NP	JJ	I-protein	39	NMOD
39	kinases	kinase	I-NP	NNS	I-protein	21	PMOD
40	.	.	O	.	O	8	P

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	found	find	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	cytoplasmic	cytoplasmic	B-NP	JJ	O	7	NMOD
7	acidification	acidification	I-NP	NN	O	8	SUB
8	facilitated	facilitate	B-VP	VBD	O	5	SBAR
9	NF-kappa	NF-kappa	B-NP	NN	B-protein	11	NMOD
10	B	B	I-NP	NN	I-protein	11	NMOD
11	activation	activation	I-NP	NN	O	8	OBJ
12	by	by	B-PP	IN	O	11	NMOD
13	both	both	O	CC	O	17	NMOD
14	TNF	TNF	B-NP	NN	B-protein	15	NMOD
15	alpha	alpha	I-NP	NN	I-protein	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	PKC	PKC	B-NP	NN	B-protein	12	PMOD
18	,	,	O	,	O	8	P
19	by	by	B-PP	IN	O	8	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	mechanism	mechanism	I-NP	NN	O	19	PMOD
22	that	that	B-NP	WDT	O	21	NMOD
23	increases	increase	B-VP	VBZ	O	22	SBAR
24	NF-kappa	NF-kappa	B-NP	NN	O	28	NMOD
25	B/I	B/I	I-NP	NN	O	28	NMOD
26	kappa	kappa	I-NP	NN	O	28	NMOD
27	B	B	I-NP	NN	O	28	NMOD
28	dissociation	dissociation	I-NP	NN	O	23	OBJ
29	without	without	B-PP	IN	O	23	VMOD
30	affecting	affect	B-VP	VBG	O	29	PMOD
31	the	the	B-NP	DT	O	35	NMOD
32	NF-kappa	NF-kappa	I-NP	NN	B-protein	35	NMOD
33	B	B	I-NP	NN	I-protein	35	NMOD
34	translocation	translocation	I-NP	NN	O	35	NMOD
35	step	step	I-NP	NN	O	30	OBJ
36	.	.	O	.	O	4	P

1	Glucocorticoid	Glucocorticoid	B-NP	NN	B-protein	2	NMOD
2	receptors	receptor	I-NP	NNS	I-protein	6	SUB
3	(	(	O	(	O	5	DEP
4	GcR	GcR	B-NP	NN	B-protein	5	DEP
5	)	)	O	)	O	2	NMOD
6	were	be	B-VP	VBD	O	0	ROOT
7	determined	determine	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	a	a	B-NP	DT	O	12	NMOD
10	whole	whole	I-NP	JJ	O	12	NMOD
11	cell	cell	I-NP	NN	O	12	NMOD
12	assay	assay	I-NP	NN	O	8	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	human	human	B-NP	JJ	B-cell_type	16	NMOD
15	mononulear	mononulear	I-NP	JJ	I-cell_type	16	NMOD
16	leukocytes	leukocyte	I-NP	NNS	I-cell_type	13	PMOD
17	(	(	O	(	O	19	DEP
18	hMNL	hMNL	B-NP	NN	B-cell_type	19	DEP
19	)	)	O	)	O	16	NMOD
20	from	from	B-PP	IN	O	16	NMOD
21	control	control	B-NP	JJ	O	22	NMOD
22	subjects	subject	I-NP	NNS	O	35	NMOD
23	,	,	O	,	O	35	P
24	patients	patient	B-NP	NNS	O	35	NMOD
25	receiving	receive	B-VP	VBG	O	24	NMOD
26	glucocorticoid	glucocorticoid	B-NP	NN	O	27	NMOD
27	therapy	therapy	I-NP	NN	O	25	OBJ
28	for	for	B-PP	IN	O	27	NMOD
29	systemic	systemic	B-NP	JJ	O	30	NMOD
30	diseases	disease	I-NP	NNS	O	28	PMOD
31	and	and	O	CC	O	35	NMOD
32	Cushing	Cushing	B-NP	NN	O	33	NMOD
33	's	's	B-NP	POS	O	34	NMOD
34	disease	disease	I-NP	NN	O	35	NMOD
35	patients	patient	B-NP	NNS	O	20	PMOD
36	with	with	B-PP	IN	O	35	NMOD
37	or	or	B-PP	CC	O	36	PMOD
38	without	without	B-PP	IN	O	36	PMOD
39	ketoconazole	ketoconazole	B-NP	NN	O	40	NMOD
40	therapy	therapy	I-NP	NN	O	36	PMOD
41	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	14	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	group	group	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	14	P
5	however	however	B-ADVP	RB	O	14	VMOD
6	,	,	O	,	O	14	P
7	receptor	receptor	B-NP	NN	O	8	NMOD
8	levels	level	I-NP	NNS	O	13	NMOD
9	and	and	O	CC	O	13	NMOD
10	morning	morning	B-NP	NN	O	13	NMOD
11	plasma	plasma	I-NP	NN	O	13	NMOD
12	cortisol	cortisol	I-NP	NN	O	13	NMOD
13	values	value	I-NP	NNS	O	14	SUB
14	showed	show	B-VP	VBD	O	0	ROOT
15	a	a	B-NP	DT	O	17	NMOD
16	negative	negative	I-NP	JJ	O	17	NMOD
17	correlation	correlation	I-NP	NN	O	14	OBJ
18	,	,	O	,	O	14	P
19	indicating	indicate	B-VP	VBG	O	14	VMOD
20	a	a	B-NP	DT	O	23	NMOD
21	subtle	subtle	I-NP	JJ	O	23	NMOD
22	down-regulatory	down-regulatory	I-NP	JJ	O	23	NMOD
23	effect	effect	I-NP	NN	O	19	OBJ
24	.	.	O	.	O	14	P

1	Finally	Finally	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	did	do	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	observed	observe	I-VP	VBN	O	4	VC
7	either	either	O	CC	O	10	NMOD
8	up-regulation	up-regulation	B-NP	NN	O	10	NMOD
9	or	or	O	CC	O	10	NMOD
10	antagonism	antagonism	B-NP	NN	O	6	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	GcR	GcR	B-NP	NN	B-protein	11	PMOD
13	by	by	B-PP	IN	O	10	NMOD
14	ketoconazole	ketoconazole	B-NP	NN	O	15	NMOD
15	treatment	treatment	I-NP	NN	O	13	PMOD
16	,	,	O	,	O	6	P
17	at	at	B-PP	IN	O	6	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	time	time	I-NP	NN	O	17	PMOD
20	that	that	B-ADVP	IN	O	19	NMOD
21	cortisol	cortisol	B-NP	NN	O	22	NMOD
22	levels	level	I-NP	NNS	O	29	SUB
23	of	of	B-PP	IN	O	22	NMOD
24	patients	patient	B-NP	NNS	O	23	PMOD
25	with	with	B-PP	IN	O	24	NMOD
26	Cushing	Cushing	B-NP	NN	O	27	NMOD
27	's	's	B-NP	POS	O	28	NMOD
28	disease	disease	I-NP	NN	O	25	PMOD
29	were	be	B-VP	VBD	O	20	SBAR
30	reduced	reduce	I-VP	VBN	O	29	VC
31	.	.	O	.	O	4	P

1	This	This	B-NP	DT	O	2	SUB
2	indicates	indicate	B-VP	VBZ	O	0	ROOT
3	that	that	B-SBAR	IN	O	30	DEP
4	the	the	B-NP	DT	O	6	NMOD
5	beneficial	beneficial	I-NP	JJ	O	6	NMOD
6	effects	effect	I-NP	NNS	O	13	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	ketoconazole	ketoconazole	B-NP	NN	O	7	PMOD
9	in	in	B-PP	IN	O	6	NMOD
10	Cushing	Cushing	B-NP	NN	O	12	NMOD
11	's	's	B-NP	POS	O	12	NMOD
12	disease	disease	I-NP	NN	O	9	PMOD
13	are	be	B-VP	VBP	O	3	SBAR
14	due	due	B-PP	JJ	O	13	PRD
15	to	to	B-PP	TO	O	14	PMOD
16	adrenal	adrenal	B-NP	JJ	O	18	NMOD
17	cortisol	cortisol	I-NP	NN	O	18	NMOD
18	suppression	suppression	I-NP	NN	O	15	PMOD
19	and	and	B-PP	CC	O	15	PMOD
20	not	not	B-PP	RB	O	21	PMOD
21	to	to	I-PP	TO	O	15	PMOD
22	interaction	interaction	B-NP	NN	O	21	PMOD
23	with	with	B-PP	IN	O	22	NMOD
24	GcR	GcR	B-NP	NN	B-protein	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	target	target	B-NP	NN	B-cell_type	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_type	25	PMOD
28	,	,	O	,	O	30	P
29	and	and	O	CC	O	30	DEP
30	that	that	B-SBAR	IN	O	2	VMOD
31	the	the	B-NP	DT	O	32	NMOD
32	process	process	I-NP	NN	O	38	SUB
33	of	of	B-PP	IN	O	32	NMOD
34	GcR	GcR	B-NP	NN	B-protein	35	NMOD
35	regulation	regulation	I-NP	NN	O	33	PMOD
36	in	in	B-PP	IN	O	35	NMOD
37	hMNL	hMNL	B-NP	NN	B-cell_type	36	PMOD
38	is	be	B-VP	VBZ	O	30	SBAR
39	a	a	B-NP	DT	O	41	NMOD
40	complex	complex	I-NP	JJ	O	41	NMOD
41	phenomenon	phenomenon	I-NP	NN	O	38	PRD
42	awaiting	await	B-VP	VBG	O	41	NMOD
43	further	further	B-NP	JJ	O	44	NMOD
44	elucidation	elucidation	I-NP	NN	O	42	OBJ
45	.	.	O	.	O	2	P

1	the	the	B-NP	DT	O	2	NMOD
2	number	number	I-NP	NN	O	14	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	5	NMOD
5	receptors	receptor	I-NP	NNS	I-protein	3	PMOD
6	per	per	B-PP	IN	O	2	NMOD
7	cell	cell	B-NP	NN	O	6	PMOD
8	(	(	O	(	O	10	DEP
9	Ro	Ro	B-NP	NN	O	10	DEP
10	)	)	O	)	O	2	NMOD
11	and	and	O	CC	O	14	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	binding	binding	I-NP	NN	O	14	NMOD
14	affinity	affinity	I-NP	NN	O	20	SUB
15	(	(	O	(	O	17	DEP
16	Kd	Kd	B-NP	NN	O	17	DEP
17	)	)	O	)	O	14	NMOD
18	for	for	B-PP	IN	O	14	NMOD
19	dexamethasone	dexamethasone	B-NP	NN	O	18	PMOD
20	were	be	B-VP	VBD	O	0	ROOT
21	,	,	O	,	O	20	P
22	however	however	B-ADVP	RB	O	20	PRD
23	,	,	O	,	O	22	AMOD
24	not	not	B-ADJP	RB	O	26	AMOD
25	significantly	significantly	I-ADJP	RB	O	26	AMOD
26	different	different	I-ADJP	JJ	O	23	PRD
27	(	(	O	(	O	53	DEP
28	Ro	Ro	B-NP	NN	O	31	NMOD
29	:	:	O	:	O	31	P
30	7687	7687	B-NP	CD	O	31	NMOD
31	±	±	I-NP	NN	O	37	NMOD
32	1750	1750	B-NP	CD	O	37	NMOD
33	vs	vs	I-NP	IN	O	37	NMOD
34	7347	7347	I-NP	CD	O	37	NMOD
35	±	±	I-NP	HYPH	O	37	NMOD
36	1285	1285	I-NP	CD	O	37	NMOD
37	sites/cell	sites/cell	I-NP	NNS	O	48	NMOD
38	;	;	O	:	O	48	P
39	Kd	Kd	B-NP	NN	O	42	NMOD
40	:	:	O	:	O	42	P
41	7.7	7.7	B-NP	CD	O	42	NMOD
42	±	±	I-NP	NN	O	48	NMOD
43	2.4	2.4	B-NP	CD	O	48	NMOD
44	vs	vs	I-NP	IN	O	48	NMOD
45	7.4	7.4	I-NP	CD	O	48	NMOD
46	±	±	I-NP	HYPH	O	48	NMOD
47	1.7	1.7	I-NP	CD	O	48	NMOD
48	nM	nM	I-NP	NN	O	53	DEP
49	at	at	B-PP	IN	O	48	NMOD
50	24	24	B-NP	CD	O	52	NMOD
51	degrees	degree	I-NP	NNS	O	52	NMOD
52	C	C	I-NP	NN	O	49	PMOD
53	)	)	O	)	O	26	AMOD
54	.	.	O	.	O	20	P

1	After	After	B-PP	IN	O	17	VMOD
2	weight	weight	B-NP	NN	O	3	NMOD
3	gain	gain	I-NP	NN	O	1	PMOD
4	(	(	O	(	O	13	DEP
5	14	14	B-NP	CD	O	12	NMOD
6	±	±	I-NP	NN	O	12	NMOD
7	2	2	B-NP	CD	O	9	AMOD
8	to	to	I-NP	TO	O	9	AMOD
9	16	16	I-NP	CD	O	12	NMOD
10	±	±	I-NP	HYPH	O	12	NMOD
11	2	2	I-NP	CD	O	12	NMOD
12	kg/m2	kg/m2	I-NP	NN	O	13	DEP
13	)	)	O	)	O	3	NMOD
14	,	,	O	,	O	17	P
15	receptor	receptor	B-NP	NN	O	16	NMOD
16	numbers	number	I-NP	NNS	O	17	SUB
17	were	be	B-VP	VBD	O	0	ROOT
18	8421	8421	B-NP	CD	O	20	NMOD
19	±	±	I-NP	CC	O	20	NMOD
20	2126	2126	I-NP	CD	O	27	NMOD
21	(	(	O	(	O	23	DEP
22	pre	pre	B-NP	NN	O	23	DEP
23	)	)	O	)	O	20	NMOD
24	and	and	O	CC	O	27	NMOD
25	9011	9011	B-NP	CD	O	27	AMOD
26	±	±	I-NP	CC	O	27	AMOD
27	500	500	I-NP	CD	O	31	NMOD
28	(	(	O	(	O	30	DEP
29	post	post	B-NP	NN	O	30	DEP
30	)	)	O	)	O	27	NMOD
31	sites/cell	sites/cell	B-NP	NNS	O	17	PRD
32	,	,	O	,	O	31	P
33	which	which	B-NP	WDT	O	31	NMOD
34	are	be	B-VP	VBP	O	33	SBAR
35	not	not	O	RB	O	34	VMOD
36	significantly	significantly	B-ADJP	RB	O	37	AMOD
37	different	different	I-ADJP	JJ	O	34	PRD
38	(	(	O	(	O	43	DEP
39	P	P	B-NP	NN	O	41	SUB
40	greater	great	B-ADJP	JJR	O	41	AMOD
41	than	than	B-PP	IN	O	43	DEP
42	0.2	0.2	B-NP	CD	O	41	AMOD
43	)	)	O	)	O	37	AMOD
44	;	;	O	:	O	17	P

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT
2	Hypercortisolaemia	Hypercortisolaemia	I-NP	NN	O	3	SUB
3	does	do	B-VP	VBZ	O	17	VMOD
4	not	not	I-VP	RB	O	3	VMOD
5	down-regulate	down-regulate	I-VP	VB	O	3	VC
6	the	the	B-NP	DT	O	9	NMOD
7	lymphocyte	lymphocyte	I-NP	NN	B-protein	9	NMOD
8	glucocorticoid	glucocorticoid	I-NP	NN	I-protein	9	NMOD
9	receptors	receptor	I-NP	NNS	I-protein	5	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	anorexia	anorexia	B-NP	NN	O	12	NMOD
12	nervosa	nervosa	I-NP	NN	O	10	PMOD
13	and	and	O	CC	O	17	VMOD
14	a	a	B-NP	DT	O	16	NMOD
15	post-receptor	post-receptor	I-NP	JJ	O	16	NMOD
16	defect	defect	I-NP	NN	O	17	SUB
17	might	might	B-VP	MD	O	1	NMOD
18	be	be	I-VP	VB	O	17	VC
19	involved	involve	I-VP	VBN	O	18	VC
20	in	in	B-PP	IN	O	19	VMOD
21	peripheral	peripheral	B-NP	JJ	O	23	NMOD
22	tissue	tissue	I-NP	NN	O	23	NMOD
23	resistance	resistance	I-NP	NN	O	20	PMOD
24	to	to	B-PP	TO	O	23	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	effects	effect	I-NP	NNS	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	glucocorticoid	glucocorticoid	B-NP	NN	O	29	NMOD
29	hormones	hormone	I-NP	NNS	O	27	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	undernutrition	undernutrition	B-NP	NN	O	30	PMOD
32	.	.	O	.	O	17	P

1	Although	Although	B-SBAR	IN	O	13	VMOD
2	absent	absent	B-ADJP	JJ	O	1	SBAR
3	in	in	B-PP	IN	O	2	AMOD
4	nonexpressing	nonexpresse	B-VP	VBG	B-cell_line	7	NMOD
5	erythroleukemia	erythroleukemia	B-NP	NN	I-cell_line	7	NMOD
6	cell	cell	I-NP	NN	I-cell_line	7	NMOD
7	lines	line	I-NP	NNS	I-cell_line	3	PMOD
8	,	,	O	,	O	13	P
9	the	the	B-NP	DT	O	12	NMOD
10	DNase	DNase	I-NP	NN	B-DNA	12	NMOD
11	I	I	I-NP	CD	I-DNA	12	NMOD
12	site	site	I-NP	NN	I-DNA	13	SUB
13	is	be	B-VP	VBZ	O	0	ROOT
14	present	present	B-ADJP	JJ	O	13	PRD
15	in	in	B-PP	IN	O	14	AMOD
16	uninduced	uninduced	B-NP	JJ	B-cell_line	19	NMOD
17	myelomonocytic	myelomonocytic	I-NP	JJ	I-cell_line	19	NMOD
18	cell	cell	I-NP	NN	I-cell_line	19	NMOD
19	lines	line	I-NP	NNS	I-cell_line	15	PMOD
20	and	and	O	CC	O	13	VMOD
21	is	be	B-VP	VBZ	O	13	VMOD
22	not	not	I-VP	RB	O	21	VMOD
23	changed	change	I-VP	VBN	O	21	VC
24	after	after	B-PP	IN	O	23	VMOD
25	PMA	PMA	B-NP	NN	O	26	NMOD
26	induction	induction	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	13	P

1	This	This	B-NP	DT	O	2	NMOD
2	decrease	decrease	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	seen	see	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	patients	patient	B-NP	NNS	O	5	PMOD
7	who	who	B-NP	WP	O	6	NMOD
8	responded	respond	B-VP	VBD	O	7	SBAR
9	to	to	B-PP	TO	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	therapy	therapy	I-NP	NN	O	9	PMOD
12	as	as	B-CONJP	RB	O	5	PMOD
13	well	well	I-CONJP	RB	O	12	DEP
14	as	as	I-CONJP	IN	O	12	DEP
15	in	in	B-PP	IN	O	5	PMOD
16	those	those	B-NP	DT	O	15	PMOD
17	who	who	B-NP	WP	O	16	NMOD
18	did	do	B-VP	VBD	O	17	SBAR
19	not	not	O	RB	O	18	VMOD
20	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	paper	paper	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	B2	B2	I-NP	NN	B-protein	10	NMOD
10	factor	factor	I-NP	NN	I-protein	11	SUB
11	is	be	B-VP	VBZ	O	7	SBAR
12	expressed	express	I-VP	VBN	O	11	VC
13	in	in	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	cytosol	cytosol	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	monocytes	monocyte	B-NP	NNS	B-cell_type	19	NMOD
18	and	and	O	CC	O	19	NMOD
19	macrophages	macrophage	B-NP	NNS	B-cell_type	16	PMOD
20	as	as	B-PP	IN	O	12	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	DNA-binding	DNA-binding	I-NP	JJ	B-protein	23	NMOD
23	protein	protein	I-NP	NN	I-protein	20	PMOD
24	,	,	O	,	O	11	P
25	indicating	indicate	B-VP	VBG	O	11	VMOD
26	that	that	B-SBAR	IN	O	25	VMOD
27	it	it	B-NP	PRP	O	28	SUB
28	is	be	B-VP	VBZ	O	26	SBAR
29	not	not	I-VP	RB	O	28	VMOD
30	associated	associate	I-VP	VBN	O	28	VC
31	with	with	B-PP	IN	O	30	VMOD
32	an	an	B-NP	DT	O	33	NMOD
33	inhibitor	inhibitor	I-NP	NN	O	31	PMOD
34	(	(	O	(	O	36	DEP
35	IKB	IKB	B-NP	NN	B-protein	36	DEP
36	)	)	O	)	O	33	NMOD
37	.	.	O	.	O	6	P

1	Furthermore	Furthermore	B-ADVP	RB	O	16	VMOD
2	,	,	O	,	O	16	P
3	an	an	B-NP	DT	O	4	NMOD
4	antiserum	antiserum	I-NP	NN	O	16	SUB
5	against	against	B-PP	IN	O	4	NMOD
6	KBF1	KBF1	B-NP	NN	B-protein	5	PMOD
7	(	(	O	(	O	15	DEP
8	identical	identical	B-ADJP	JJ	O	15	DEP
9	to	to	B-PP	TO	O	8	AMOD
10	50	50	B-NP	CD	B-protein	11	AMOD
11	kDa	kDa	I-NP	NN	I-protein	14	NMOD
12	NF-kappa	NF-kappa	I-NP	NN	I-protein	14	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	protein	protein	I-NP	NN	I-protein	9	PMOD
15	)	)	O	)	O	6	NMOD
16	reacted	react	B-VP	VBD	O	0	ROOT
17	with	with	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	p50	p50	I-NP	NN	B-protein	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	NF-GM2	NF-GM2	B-NP	NN	B-protein	20	PMOD
22	,	,	O	,	O	16	P
23	indicating	indicate	B-VP	VBG	O	16	VMOD
24	that	that	B-SBAR	IN	O	23	VMOD
25	the	the	B-NP	DT	O	27	NMOD
26	NF-GM2	NF-GM2	I-NP	NN	B-protein	27	NMOD
27	polypeptide	polypeptide	I-NP	NN	I-protein	28	SUB
28	can	can	B-VP	MD	O	24	SBAR
29	not	not	I-VP	RB	O	28	VMOD
30	be	be	I-VP	VB	O	28	VC
31	immunologically	immunologically	I-VP	RB	O	30	VMOD
32	differentiated	differentiate	I-VP	VBN	O	30	VC
33	from	from	B-PP	IN	O	32	VMOD
34	the	the	B-NP	DT	O	37	NMOD
35	50	50	I-NP	CD	B-protein	36	AMOD
36	kDa	kDa	I-NP	NN	I-protein	37	NMOD
37	subunit	subunit	I-NP	NN	I-protein	33	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	NF-kappa	NF-kappa	B-NP	NN	B-protein	40	NMOD
40	B	B	I-NP	NN	I-protein	38	PMOD
41	.	.	O	.	O	16	P

1	The	The	B-NP	DT	O	3	NMOD
2	purified	purify	I-NP	VBN	O	3	NMOD
3	NF-GM2	NF-GM2	I-NP	NN	B-protein	4	SUB
4	activated	activate	B-VP	VBN	O	0	ROOT
5	in	in	B-NP	FW	O	6	AMOD
6	vitro	vitro	I-NP	FW	O	7	NMOD
7	transcription	transcription	I-NP	NN	O	4	OBJ
8	from	from	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	kappa	kappa	I-NP	NN	B-DNA	12	NMOD
11	B	B	I-NP	NN	I-DNA	12	NMOD
12	enhancer	enhancer	I-NP	NN	I-DNA	8	PMOD
13	,	,	O	,	O	4	P
14	while	while	B-SBAR	IN	O	4	VMOD
15	it	it	B-NP	PRP	O	16	SUB
16	failed	fail	B-VP	VBD	O	14	SBAR
17	to	to	I-VP	TO	O	18	VMOD
18	stimulate	stimulate	I-VP	VB	O	16	VMOD
19	transcription	transcription	B-NP	NN	O	18	OBJ
20	from	from	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	GM-CSF	GM-CSF	I-NP	NN	B-DNA	23	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	20	PMOD
24	harboring	harbor	B-VP	VBG	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	GM2	GM2	I-NP	NN	B-DNA	27	NMOD
27	sequence	sequence	I-NP	NN	I-DNA	24	OBJ
28	.	.	O	.	O	4	P

1	there	there	B-NP	EX	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	no	no	B-NP	DT	O	6	NMOD
4	apparent	apparent	I-NP	JJ	O	6	NMOD
5	seasonal	seasonal	I-NP	JJ	O	6	NMOD
6	variation	variation	I-NP	NN	O	2	PRD
7	in	in	B-PP	IN	O	6	NMOD
8	GR	GR	B-NP	NN	B-protein	7	PMOD
9	.	.	O	.	O	2	P

1	Gender	Gender	B-NP	NN	O	2	NMOD
2	difference	difference	I-NP	NN	O	8	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	number	number	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	GR	GR	B-NP	NN	B-protein	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	not	not	O	RB	O	8	VMOD
10	significant	significant	B-ADJP	JJ	O	8	PRD
11	,	,	O	,	O	8	P
12	although	although	B-SBAR	IN	O	8	VMOD
13	women	woman	B-NP	NNS	O	14	SUB
14	showed	show	B-VP	VBD	O	12	SBAR
15	slightly	slightly	B-NP	RB	O	16	AMOD
16	fewer	few	I-NP	JJR	O	17	NMOD
17	GR	GR	I-NP	NN	B-protein	14	OBJ
18	.	.	O	.	O	8	P

1	However	However	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	in	in	B-PP	IN	O	11	VMOD
4	normal	normal	B-NP	JJ	O	5	NMOD
5	subjects	subject	I-NP	NNS	O	3	PMOD
6	,	,	O	,	O	11	P
7	the	the	B-NP	DT	O	8	NMOD
8	GR	GR	I-NP	NN	B-protein	11	SUB
9	in	in	B-PP	IN	O	8	NMOD
10	MNL	MNL	B-NP	NN	B-cell_type	9	PMOD
11	did	do	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	demonstrate	demonstrate	I-VP	VB	O	11	VC
14	circadian	circadian	B-NP	JJ	O	15	NMOD
15	variation	variation	I-NP	NN	O	13	OBJ
16	,	,	O	,	O	13	P
17	in	in	B-PP	IN	O	13	VMOD
18	contrast	contrast	I-PP	NN	O	17	PMOD
19	to	to	I-PP	TO	O	17	PMOD
20	concentrations	concentration	B-NP	NNS	O	17	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	plasma	plasma	B-NP	NN	O	23	NMOD
23	cortisol	cortisol	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	11	P

1	All	All	B-NP	DT	O	2	NMOD
2	factors	factor	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	induced	induce	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	nuclei	nucleus	I-NP	NNS	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	T	T	B-NP	NN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	upon	upon	B-PP	IN	O	4	VMOD
12	activation	activation	B-NP	NN	O	11	PMOD
13	with	with	B-PP	IN	O	12	NMOD
14	mitogens	mitogen	B-NP	NNS	B-protein	13	PMOD
15	but	but	B-PP	CC	O	13	PMOD
16	not	not	B-PP	RB	O	17	PMOD
17	with	with	I-PP	IN	O	13	PMOD
18	exogenous	exogenous	B-NP	JJ	B-protein	21	NMOD
19	IL-2	IL-2	I-NP	NN	I-protein	21	NMOD
20	growth	growth	I-NP	NN	I-protein	21	NMOD
21	factor	factor	I-NP	NN	I-protein	17	PMOD
22	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	larger	large	I-NP	JJR	O	4	NMOD
3	crossreacting	crossreacte	I-NP	VBG	B-protein	4	NMOD
4	protein	protein	I-NP	NN	I-protein	5	SUB
5	exhibited	exhibit	B-VP	VBD	O	0	ROOT
6	an	an	B-NP	DT	O	8	NMOD
7	electrophoretic	electrophoretic	I-NP	JJ	O	8	NMOD
8	mobility	mobility	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	80	80	B-NP	CD	B-protein	11	NMOD
11	kDa	kDa	I-NP	NN	I-protein	9	PMOD
12	,	,	O	,	O	5	P
13	was	be	B-VP	VBD	O	5	VMOD
14	localized	localize	I-VP	VBN	O	13	VC
15	in	in	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	cell	cell	I-NP	NN	O	18	NMOD
18	cytosol	cytosol	I-NP	NN	O	15	PMOD
19	,	,	O	,	O	5	P
20	and	and	O	CC	O	5	VMOD
21	appeared	appear	B-VP	VBD	O	5	VMOD
22	to	to	I-VP	TO	O	23	VMOD
23	be	be	I-VP	VB	O	21	VMOD
24	specific	specific	B-ADJP	JJ	O	23	PRD
25	for	for	B-PP	IN	O	24	AMOD
26	activated	activate	B-NP	VBN	B-cell_type	27	NMOD
27	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	25	PMOD
28	since	since	B-SBAR	IN	O	23	VMOD
29	it	it	B-NP	PRP	O	30	SUB
30	was	be	B-VP	VBD	O	28	SBAR
31	not	not	I-VP	RB	O	30	VMOD
32	detected	detect	I-VP	VBN	O	30	VC
33	in	in	B-PP	IN	O	32	VMOD
34	several	several	B-NP	JJ	O	37	NMOD
35	other	other	I-NP	JJ	O	37	NMOD
36	human	human	I-NP	JJ	B-cell_type	37	NMOD
37	cells	cell	I-NP	NNS	I-cell_type	33	PMOD
38	including	include	B-PP	VBG	O	37	NMOD
39	monocytes	monocyte	B-NP	NNS	B-cell_type	38	PMOD
40	.	.	O	.	O	5	P

1	From	From	B-PP	IN	O	17	VMOD
2	information	information	B-NP	NN	O	1	PMOD
3	available	available	B-ADJP	JJ	O	2	NMOD
4	in	in	B-PP	IN	O	3	AMOD
5	the	the	B-NP	DT	O	6	NMOD
6	literature	literature	I-NP	NN	O	4	PMOD
7	on	on	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	substrate	substrate	I-NP	NN	O	10	NMOD
10	specificity	specificity	I-NP	NN	O	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	three	three	I-NP	CD	O	14	NMOD
14	enzymes	enzyme	I-NP	NNS	B-protein	11	PMOD
15	,	,	O	,	O	17	P
16	it	it	B-NP	PRP	O	17	SUB
17	is	be	B-VP	VBZ	O	0	ROOT
18	clear	clear	B-ADJP	JJ	O	17	PRD
19	that	that	B-SBAR	IN	O	17	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	cysteine	cysteine	I-NP	NN	O	22	SUB
22	is	be	B-VP	VBZ	O	19	SBAR
23	not	not	I-VP	RB	O	22	VMOD
24	accepted	accept	I-VP	VBN	O	22	VC
25	in	in	B-PP	IN	O	24	VMOD
26	any	any	B-NP	DT	O	25	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	39	NMOD
29	S2	S2	I-NP	NN	B-protein	39	NMOD
30	,	,	O	,	O	39	P
31	S1	S1	B-NP	NN	B-protein	39	NMOD
32	,	,	O	,	O	39	P
33	S1	S1	B-NP	NN	B-protein	39	NMOD
34	'	'	O	''	I-protein	33	NMOD
35	,	,	O	,	O	39	P
36	and	and	O	CC	O	39	NMOD
37	S2	S2	B-NP	NN	B-protein	39	NMOD
38	'	'	O	''	O	39	NMOD
39	subsites	subsite	B-NP	NNS	O	27	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	cathepsin	cathepsin	B-NP	NN	B-protein	40	PMOD
42	B	B	B-NP	NN	I-protein	44	NMOD
43	and	and	O	CC	I-protein	44	NMOD
44	L	L	B-NP	NN	I-protein	41	NMOD
45	,	,	B-PP	,	O	25	P
46	and	and	I-PP	CC	O	25	PMOD
47	not	not	B-PP	RB	O	48	PMOD
48	in	in	I-PP	IN	O	25	PMOD
49	the	the	B-NP	DT	O	52	NMOD
50	S1	S1	I-NP	NN	B-protein	52	NMOD
51	and	and	I-NP	CC	O	52	NMOD
52	S1	S1	I-NP	NN	O	54	NMOD
53	'	'	O	''	O	52	NMOD
54	subsites	subsite	B-NP	NNS	O	48	PMOD
55	of	of	B-PP	IN	O	54	NMOD
56	cathepsin	cathepsin	B-NP	NN	B-protein	57	NMOD
57	D	D	I-NP	NN	I-protein	55	PMOD
58	.	.	O	.	O	17	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	conducted	conduct	I-VP	VBN	O	2	VC
4	functional	functional	B-NP	JJ	O	5	NMOD
5	studies	study	I-NP	NNS	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	enhancer	enhancer	I-NP	NN	B-DNA	9	NMOD
9	elements	element	I-NP	NNS	I-DNA	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	human	human	B-NP	JJ	O	15	NMOD
12	T-cell	T-cell	I-NP	NN	O	15	NMOD
13	leukemia	leukemia	I-NP	NN	O	15	NMOD
14	virus	virus	I-NP	NN	O	15	NMOD
15	type	type	I-NP	NN	O	10	PMOD
16	I	I	I-NP	CD	O	15	NMOD
17	(	(	O	(	O	19	DEP
18	HTLV-I	HTLV-I	B-NP	NN	O	19	DEP
19	)	)	O	)	O	15	NMOD
20	using	use	B-VP	VBG	O	3	VMOD
21	the	the	B-NP	DT	O	24	NMOD
22	human	human	I-NP	JJ	B-cell_line	24	NMOD
23	T-cell	T-cell	I-NP	NN	I-cell_line	24	NMOD
24	lines	line	I-NP	NNS	I-cell_line	20	OBJ
25	Jurkat	Jurkat	B-NP	NN	B-cell_line	27	NMOD
26	and	and	O	CC	O	27	NMOD
27	MOLT	MOLT	B-NP	NN	B-cell_line	39	NMOD
28	4	4	I-NP	CD	I-cell_line	27	NMOD
29	,	,	O	,	O	27	P
30	which	which	B-NP	WDT	O	27	NMOD
31	are	be	B-VP	VBP	O	30	SBAR
32	negative	negative	B-ADJP	JJ	O	31	PRD
33	for	for	B-PP	IN	O	32	AMOD
34	HTLV-I	HTLV-I	B-NP	NN	O	33	PMOD
35	,	,	O	,	O	27	P
36	and	and	O	CC	O	39	NMOD
37	MT-2	MT-2	B-NP	NN	B-cell_line	39	NMOD
38	and	and	I-NP	CC	O	39	NMOD
39	TL-Mor	TL-Mor	I-NP	NN	O	24	NMOD
40	,	,	O	,	O	39	P
41	which	which	B-NP	WDT	O	39	NMOD
42	carry	carry	B-VP	VBP	O	41	SBAR
43	the	the	B-NP	DT	O	45	NMOD
44	proviral	proviral	I-NP	JJ	B-DNA	45	NMOD
45	genome	genome	I-NP	NN	I-DNA	42	OBJ
46	of	of	B-PP	IN	O	45	NMOD
47	HTLV-I	HTLV-I	B-NP	NN	O	46	PMOD
48	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	the	the	B-NP	DT	O	5	NMOD
4	C26	C26	I-NP	NN	B-DNA	5	NMOD
5	element	element	I-NP	NN	I-DNA	12	SUB
6	alone	alone	B-ADVP	RB	O	5	NMOD
7	,	,	O	,	O	12	P
8	even	even	B-ADVP	RB	O	9	AMOD
9	when	when	I-ADVP	WRB	O	12	VMOD
10	repeated	repeat	B-VP	VBN	O	9	SBAR
11	,	,	O	,	O	12	P
12	could	could	B-VP	MD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	be	be	I-VP	VB	O	12	VC
15	activated	activate	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	p40tax	p40tax	B-NP	NN	B-protein	16	PMOD
18	,	,	O	,	O	15	P
19	unlike	unlike	B-PP	IN	O	15	VMOD
20	other	other	B-NP	JJ	O	23	NMOD
21	NF-kappa	NF-kappa	I-NP	NN	B-DNA	23	NMOD
22	B-binding	B-binding	I-NP	JJ	I-DNA	21	AMOD
23	elements	element	I-NP	NNS	I-DNA	19	PMOD
24	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	2	NMOD
2	finding	finding	I-NP	NN	O	13	SUB
3	that	that	B-SBAR	IN	O	2	NMOD
4	dexamethasone	dexamethasone	B-NP	NN	O	5	SUB
5	has	have	B-VP	VBZ	O	3	SBAR
6	no	no	B-NP	DT	O	7	NMOD
7	effect	effect	I-NP	NN	O	5	OBJ
8	on	on	B-PP	IN	O	5	VMOD
9	TPA-induced	TPA-induced	B-NP	JJ	O	10	NMOD
10	activation	activation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	PKC	PKC	B-NP	NN	B-protein	11	PMOD
13	suggests	suggest	B-VP	VBZ	O	0	ROOT
14	that	that	B-SBAR	IN	O	13	VMOD
15	this	this	B-NP	DT	O	16	NMOD
16	glucocorticoid	glucocorticoid	I-NP	NN	O	17	SUB
17	inhibits	inhibit	B-VP	VBZ	O	14	SBAR
18	signals	signal	B-NP	NNS	O	17	OBJ
19	downstream	downstream	B-ADJP	JJ	O	21	AMOD
20	or	or	O	CC	O	21	AMOD
21	parallel	parallel	B-ADJP	JJ	O	18	NMOD
22	to	to	B-PP	TO	O	21	AMOD
23	this	this	B-NP	DT	O	24	NMOD
24	enzyme	enzyme	I-NP	NN	B-protein	22	PMOD
25	.	.	O	.	O	13	P

1	Nuclear	Nuclear	B-NP	JJ	O	3	NMOD
2	run-on	run-on	I-NP	JJ	O	3	NMOD
3	assays	assay	I-NP	NNS	O	4	SUB
4	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	:	:	O	:	O	5	P
7	(	(	B-LST	(	O	8	DEP
8	1	1	I-LST	LS	O	18	VMOD
9	)	)	O	)	O	8	DEP
10	induction	induction	B-NP	NN	O	18	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	c-jun	c-jun	B-NP	NN	B-DNA	14	NMOD
13	and	and	O	CC	O	14	NMOD
14	c-fos	c-fos	B-NP	NN	B-DNA	15	NMOD
15	expression	expression	B-NP	NN	O	11	PMOD
16	by	by	B-PP	IN	O	10	NMOD
17	TPA	TPA	B-NP	NN	O	16	PMOD
18	is	be	B-VP	VBZ	O	33	VMOD
19	regulated	regulate	I-VP	VBN	O	18	VC
20	by	by	B-PP	IN	O	19	VMOD
21	transcriptional	transcriptional	B-NP	JJ	O	22	NMOD
22	mechanisms	mechanism	I-NP	NNS	O	20	PMOD
23	,	,	O	,	O	33	P
24	(	(	B-LST	(	O	25	DEP
25	2	2	I-LST	LS	O	33	VMOD
26	)	)	O	)	O	25	DEP
27	TPA-induced	TPA-induced	B-NP	JJ	O	28	NMOD
28	expression	expression	I-NP	NN	O	33	SUB
29	of	of	B-PP	IN	O	28	NMOD
30	c-jun	c-jun	B-NP	NN	B-DNA	32	NMOD
31	and	and	O	CC	O	32	NMOD
32	c-fos	c-fos	B-NP	NN	B-DNA	29	PMOD
33	does	do	B-VP	VBZ	O	48	VMOD
34	not	not	I-VP	RB	O	33	VMOD
35	require	require	I-VP	VB	O	33	VC
36	protein	protein	B-NP	NN	O	37	NMOD
37	synthesis	synthesis	I-NP	NN	O	35	OBJ
38	,	,	O	,	O	33	P
39	and	and	O	CC	O	48	VMOD
40	(	(	B-LST	(	O	41	DEP
41	3	3	I-LST	LS	O	48	VMOD
42	)	)	O	)	O	41	DEP
43	TPA-induced	TPA-induced	B-NP	JJ	O	44	NMOD
44	expression	expression	I-NP	NN	O	48	SUB
45	of	of	B-PP	IN	O	44	NMOD
46	both	both	B-NP	DT	O	47	NMOD
47	genes	gene	I-NP	NNS	O	45	PMOD
48	is	be	B-VP	VBZ	O	5	SBAR
49	inhibited	inhibit	I-VP	VBN	O	48	VC
50	at	at	B-PP	IN	O	49	VMOD
51	the	the	B-NP	DT	O	53	NMOD
52	transcriptional	transcriptional	I-NP	JJ	O	53	NMOD
53	level	level	I-NP	NN	O	50	PMOD
54	by	by	B-PP	IN	O	49	VMOD
55	dexamethasone	dexamethasone	B-NP	NN	O	54	PMOD
56	.	.	O	.	O	4	P

1	Charybdotoxin-sensitive	Charybdotoxin-sensitive	B-ADJP	JJ	O	11	VMOD
2	,	,	O	,	O	11	P
3	Ca	Ca	B-NP	NN	O	10	NMOD
4	(	(	O	(	O	6	DEP
5	2+	2+	B-ADJP	JJ	O	6	DEP
6	)	)	O	)	O	3	NMOD
7	-dependent	-dependent	B-NP	JJ	O	10	NMOD
8	membrane	membrane	I-NP	NN	O	10	NMOD
9	potential	potential	I-NP	NN	O	10	NMOD
10	changes	change	I-NP	NNS	O	11	SUB
11	are	be	B-VP	VBP	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	involved	involve	I-VP	VBN	O	11	VC
14	in	in	B-PP	IN	O	13	VMOD
15	human	human	B-NP	JJ	O	19	NMOD
16	T	T	I-NP	NN	O	19	NMOD
17	or	or	I-NP	CC	O	19	NMOD
18	B	B	I-NP	NN	O	19	NMOD
19	cell	cell	I-NP	NN	O	14	PMOD
20	activation	activation	B-NP	NN	O	19	NMOD
21	and	and	O	CC	O	19	NMOD
22	proliferation	proliferation	B-NP	NN	O	19	NMOD
23	.	.	O	.	O	11	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	charybdotoxin	charybdotoxin	B-NP	NN	O	5	SUB
5	inhibits	inhibit	B-VP	VBZ	O	3	SBAR
6	the	the	B-NP	DT	O	10	NMOD
7	ligand-induced	ligand-induced	I-NP	JJ	O	10	NMOD
8	transient	transient	I-NP	JJ	O	10	NMOD
9	membrane	membrane	I-NP	NN	O	10	NMOD
10	hyperpolarization	hyperpolarization	I-NP	NN	O	5	OBJ
11	in	in	B-PP	IN	O	10	NMOD
12	B	B	B-NP	NN	B-cell_type	15	NMOD
13	and	and	O	CC	I-cell_type	15	NMOD
14	T	T	B-NP	NN	I-cell_type	15	NMOD
15	cells	cell	B-NP	NNS	I-cell_type	11	PMOD
16	in	in	B-PP	IN	O	5	VMOD
17	a	a	B-NP	DT	O	19	NMOD
18	dose-dependent	dose-dependent	I-NP	JJ	O	19	NMOD
19	fashion	fashion	I-NP	NN	O	16	PMOD
20	,	,	O	,	O	5	P
21	without	without	B-PP	IN	O	5	VMOD
22	affecting	affect	B-VP	VBG	O	21	PMOD
23	changes	change	B-NP	NNS	O	22	OBJ
24	in	in	B-PP	IN	O	23	NMOD
25	cytosolic	cytosolic	B-NP	JJ	O	26	NMOD
26	Ca2+	Ca2+	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	13	VMOD
2	,	,	O	,	O	13	P
3	blockade	blockade	B-NP	NN	O	13	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	12	NMOD
6	Ca	Ca	I-NP	NN	B-protein	12	NMOD
7	(	(	O	(	I-protein	12	NMOD
8	2+	2+	B-ADJP	JJ	I-protein	12	NMOD
9	)	)	O	)	I-protein	12	NMOD
10	-activated	-activated	B-NP	JJ	I-protein	12	NMOD
11	K+	K+	I-NP	NN	I-protein	12	NMOD
12	channel	channel	I-NP	NN	I-protein	4	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	not	not	I-VP	RB	O	13	VMOD
15	associated	associate	I-VP	VBN	O	13	VC
16	with	with	B-PP	IN	O	15	VMOD
17	changes	change	B-NP	NNS	O	16	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	cell-cycle	cell-cycle	B-NP	NN	O	21	NMOD
20	gene	gene	I-NP	NN	O	21	NMOD
21	activation	activation	I-NP	NN	O	33	NMOD
22	,	,	O	,	O	33	P
23	IL-2	IL-2	B-NP	NN	B-protein	24	NMOD
24	production	production	I-NP	NN	O	33	NMOD
25	,	,	O	,	O	33	P
26	IL-2R	IL-2R	B-NP	NN	B-protein	27	NMOD
27	expression	expression	I-NP	NN	O	33	NMOD
28	or	or	O	CC	O	33	NMOD
29	B	B	B-NP	NN	O	33	NMOD
30	and	and	O	CC	O	33	NMOD
31	T	T	B-NP	NN	O	33	NMOD
32	cell	cell	B-NP	NN	O	33	NMOD
33	mitogenesis	mitogenesis	I-NP	NN	O	18	PMOD
34	.	.	O	.	O	13	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	imply	imply	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	membrane	membrane	B-NP	NN	O	7	NMOD
6	potential	potential	I-NP	NN	O	7	NMOD
7	changes	change	I-NP	NNS	O	21	SUB
8	secondary	secondary	B-ADJP	JJ	O	7	NMOD
9	to	to	B-PP	TO	O	8	AMOD
10	the	the	B-NP	DT	O	12	NMOD
11	ligand-dependent	ligand-dependent	I-NP	JJ	O	12	NMOD
12	opening	opening	I-NP	NN	O	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	Ca	Ca	B-NP	NN	B-protein	20	NMOD
15	(	(	O	(	I-protein	20	NMOD
16	2+	2+	B-ADJP	JJ	I-protein	20	NMOD
17	)	)	O	)	I-protein	20	NMOD
18	-activated	-activated	B-NP	JJ	I-protein	20	NMOD
19	K+	K+	I-NP	NN	I-protein	20	NMOD
20	channels	channel	I-NP	NNS	I-protein	13	PMOD
21	are	be	B-VP	VBP	O	4	SBAR
22	not	not	I-VP	RB	O	21	VMOD
23	involved	involve	I-VP	VBN	O	21	VC
24	in	in	B-PP	IN	O	23	VMOD
25	B	B	B-NP	NN	B-cell_type	28	NMOD
26	and	and	O	CC	I-cell_type	28	NMOD
27	T	T	B-NP	NN	I-cell_type	28	NMOD
28	lymphocyte	lymphocyte	B-NP	NN	I-cell_type	24	PMOD
29	activation	activation	B-NP	NN	O	31	NMOD
30	and	and	O	CC	O	31	NMOD
31	mitogenesis	mitogenesis	B-NP	NN	O	28	NMOD
32	.	.	O	.	O	3	P

1	In	In	B-ADVP	FW	O	4	NMOD
2	vitro	vitro	I-ADVP	FW	O	1	AMOD
3	translated	translate	B-NP	VBN	O	1	AMOD
4	hGR	hGR	I-NP	NN	B-protein	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	capable	capable	B-ADJP	JJ	O	5	PRD
7	of	of	B-PP	IN	O	6	AMOD
8	selective	selective	B-NP	JJ	O	10	NMOD
9	DNA	DNA	I-NP	NN	O	10	NMOD
10	binding	binding	I-NP	NN	O	7	PMOD
11	even	even	B-ADVP	RB	O	12	PMOD
12	in	in	B-PP	IN	O	6	AMOD
13	the	the	B-NP	DT	O	14	NMOD
14	absence	absence	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	glucocorticoid	glucocorticoid	B-NP	NN	O	15	PMOD
17	.	.	O	.	O	5	P

1	Treatment	Treatment	B-NP	NN	O	8	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	dexamethasone	dexamethasone	B-NP	NN	O	7	NMOD
4	or	or	O	CC	O	7	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	antiglucocorticoid	antiglucocorticoid	I-NP	JJ	O	7	NMOD
7	RU486	RU486	I-NP	NN	O	2	PMOD
8	had	have	B-VP	VBD	O	0	ROOT
9	no	no	B-NP	DT	O	11	NMOD
10	additional	additional	I-NP	JJ	O	11	NMOD
11	effect	effect	I-NP	NN	O	8	OBJ
12	on	on	B-PP	IN	O	8	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	DNA-binding	DNA-binding	I-NP	JJ	O	15	NMOD
15	capacity	capacity	I-NP	NN	O	12	PMOD
16	when	when	B-ADVP	WRB	O	8	VMOD
17	receptor	receptor	B-NP	NN	O	18	NMOD
18	preparations	preparation	I-NP	NNS	O	19	SUB
19	were	be	B-VP	VBD	O	16	SBAR
20	maintained	maintain	I-VP	VBN	O	19	VC
21	at	at	B-PP	IN	O	20	VMOD
22	0	0	B-NP	CD	O	23	NMOD
23	C	C	I-NP	NN	O	21	PMOD
24	(	(	O	(	O	27	DEP
25	no	no	B-NP	DT	O	26	NMOD
26	activation	activation	I-NP	NN	O	27	DEP
27	)	)	O	)	O	23	NMOD
28	.	.	O	.	O	8	P

1	Oligonucleotides	Oligonucleotide	B-NP	NNS	O	6	SUB
2	containing	contain	B-VP	VBG	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	consensus	consensus	I-NP	NN	B-DNA	5	NMOD
5	GRE	GRE	I-NP	NN	I-DNA	2	OBJ
6	were	be	B-VP	VBD	O	20	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	most	most	I-NP	RBS	O	9	AMOD
9	efficient	efficient	I-NP	JJ	O	10	NMOD
10	competitors	competitor	I-NP	NNS	O	6	PRD
11	,	,	O	,	O	20	P
12	and	and	O	CC	O	20	VMOD
13	fragments	fragment	B-NP	NNS	O	20	SUB
14	containing	contain	B-VP	VBG	O	13	NMOD
15	regulatory	regulatory	B-NP	JJ	B-DNA	16	NMOD
16	sequences	sequence	I-NP	NNS	I-DNA	14	OBJ
17	from	from	B-PP	IN	O	16	NMOD
18	glucocorticoid-repressible	glucocorticoid-repressible	B-NP	JJ	B-DNA	19	NMOD
19	genes	gene	I-NP	NNS	I-DNA	17	PMOD
20	were	be	B-VP	VBD	O	24	VMOD
21	somewhat	somewhat	B-ADJP	RB	O	22	AMOD
22	competitive	competitive	I-ADJP	JJ	O	20	PRD
23	,	,	O	,	O	24	P
24	whereas	whereas	O	IN	O	0	ROOT
25	single	single	B-NP	JJ	O	26	AMOD
26	stranded	stranded	I-NP	JJ	O	27	NMOD
27	oligonucleotides	oligonucleotide	I-NP	NNS	O	28	SUB
28	were	be	B-VP	VBD	O	24	VMOD
29	unable	unable	B-ADJP	JJ	O	28	PRD
30	to	to	B-VP	TO	O	31	VMOD
31	compete	compete	I-VP	VB	O	29	AMOD
32	for	for	B-PP	IN	O	31	VMOD
33	mouse	mouse	B-NP	NN	B-DNA	40	NMOD
34	mammary	mammary	I-NP	JJ	I-DNA	40	NMOD
35	tumor	tumor	I-NP	NN	I-DNA	40	NMOD
36	virus-long	virus-long	I-NP	JJ	I-DNA	40	NMOD
37	terminal	terminal	I-NP	JJ	I-DNA	40	NMOD
38	repeat	repeat	I-NP	NN	I-DNA	40	NMOD
39	DNA	DNA	I-NP	NN	O	40	NMOD
40	binding	binding	I-NP	NN	O	32	PMOD
41	,	,	O	,	O	28	P
42	except	except	B-PP	IN	O	28	VMOD
43	when	when	B-ADVP	WRB	O	42	PMOD
44	competitor	competitor	B-NP	NN	O	45	SUB
45	was	be	B-VP	VBD	O	43	SBAR
46	present	present	B-ADJP	JJ	O	45	PRD
47	at	at	B-PP	IN	O	46	AMOD
48	extremely	extremely	B-NP	RB	O	49	AMOD
49	high	high	I-NP	JJ	O	50	NMOD
50	concentrations	concentration	I-NP	NNS	O	47	PMOD
51	.	.	O	.	O	24	P

1	Similarities	Similarity	B-NP	NNS	O	9	SUB
2	between	between	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	effects	effect	I-NP	NNS	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	dexamethasone	dexamethasone	B-NP	NN	O	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	RU486	RU486	B-NP	NN	O	5	PMOD
9	suggest	suggest	B-VP	VBP	O	0	ROOT
10	that	that	B-SBAR	IN	O	9	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	antiglucocorticoid	antiglucocorticoid	I-NP	JJ	O	13	NMOD
13	properties	property	I-NP	NNS	O	16	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	RU486	RU486	B-NP	NN	O	14	PMOD
16	do	do	B-VP	VBP	O	10	SBAR
17	not	not	I-VP	RB	O	16	VMOD
18	occur	occur	I-VP	VB	O	16	VC
19	at	at	B-PP	IN	O	18	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	level	level	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	specific	specific	B-NP	JJ	O	25	NMOD
24	DNA	DNA	I-NP	NN	O	25	NMOD
25	binding	binding	I-NP	NN	O	22	PMOD
26	.	.	O	.	O	9	P

1	When	When	B-ADVP	WRB	O	15	VMOD
2	cloned	clone	B-VP	VBN	O	1	SBAR
3	in	in	B-PP	IN	O	2	VMOD
4	multiple	multiple	B-NP	JJ	O	5	NMOD
5	copies	copy	I-NP	NNS	O	3	PMOD
6	this	this	B-NP	DT	O	7	NMOD
7	so-called	so-called	I-NP	JJ	O	15	SUB
8	TCEd	TCEd	I-NP	NN	B-DNA	7	NMOD
9	(	(	O	(	O	14	DEP
10	distal	distal	B-NP	JJ	B-DNA	13	NMOD
11	T	T	I-NP	NN	I-DNA	13	NMOD
12	cell	cell	I-NP	NN	I-DNA	13	NMOD
13	element	element	I-NP	NN	I-DNA	14	DEP
14	)	)	O	)	O	8	NMOD
15	acts	act	B-VP	VBZ	O	0	ROOT
16	as	as	B-PP	IN	O	15	VMOD
17	an	an	B-NP	DT	O	20	NMOD
18	inducible	inducible	I-NP	JJ	O	20	NMOD
19	proto-enhancer	proto-enhancer	I-NP	NN	B-DNA	20	NMOD
20	element	element	I-NP	NN	I-DNA	16	PMOD
21	in	in	B-PP	IN	O	15	VMOD
22	E14	E14	B-NP	NN	B-cell_line	25	NMOD
23	T	T	I-NP	NN	I-cell_line	25	NMOD
24	lymphoma	lymphoma	I-NP	NN	I-cell_line	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_line	21	PMOD
26	,	,	B-PP	,	O	21	P
27	but	but	I-PP	CC	O	21	PMOD
28	not	not	B-PP	RB	O	29	PMOD
29	in	in	I-PP	IN	O	21	PMOD
30	HeLa	HeLa	B-NP	NN	B-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	29	PMOD
32	.	.	O	.	O	15	P

1	Negative	Negative	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	13	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	human	human	B-NP	JJ	O	9	NMOD
5	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD
6	virus	virus	I-NP	NN	O	9	NMOD
7	type	type	I-NP	NN	O	9	NMOD
8	1	1	I-NP	CD	O	9	NMOD
9	expression	expression	I-NP	NN	O	3	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	monocytes	monocyte	B-NP	NNS	B-cell_type	10	PMOD
12	:	:	O	:	O	2	P
13	role	role	B-NP	NN	O	0	ROOT
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	21	NMOD
16	65-kDa	65-kDa	I-NP	JJ	B-protein	18	AMOD
17	plus	plus	I-NP	CC	O	18	AMOD
18	50-kDa	50-kDa	I-NP	JJ	B-protein	21	NMOD
19	NF-kappa	NF-kappa	I-NP	NN	I-protein	21	NMOD
20	B	B	I-NP	NN	I-protein	21	NMOD
21	dimer	dimer	I-NP	NN	I-protein	14	PMOD
22	.	.	O	.	O	13	P

1	These	These	B-NP	DT	O	2	NMOD
2	differences	difference	I-NP	NNS	O	6	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	gene	gene	B-NP	NN	O	5	NMOD
5	expression	expression	I-NP	NN	O	3	PMOD
6	have	have	B-VP	VBP	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	been	be	I-VP	VBN	O	6	VC
9	molecularly	molecularly	B-ADJP	RB	O	10	AMOD
10	defined	define	I-ADJP	VBN	O	8	PRD
11	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	10	VMOD
2	THP-1	THP-1	B-NP	NN	B-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
4	with	with	B-PP	IN	O	3	NMOD
5	restricted	restricted	B-NP	JJ	O	7	NMOD
6	HIV	HIV	I-NP	NN	O	7	NMOD
7	expression	expression	I-NP	NN	O	4	PMOD
8	,	,	O	,	O	10	P
9	there	there	B-NP	EX	O	10	SUB
10	is	be	B-VP	VBZ	O	0	ROOT
11	an	an	B-NP	DT	O	12	NMOD
12	absence	absence	I-NP	NN	O	10	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	DNA-protein	DNA-protein	B-NP	JJ	B-protein	17	NMOD
15	binding	binding	I-NP	NN	I-protein	17	NMOD
16	complex	complex	I-NP	NN	I-protein	17	NMOD
17	formation	formation	I-NP	NN	O	13	PMOD
18	with	with	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	HIV-1	HIV-1	I-NP	NN	B-DNA	21	NMOD
21	promoter-enhancer	promoter-enhancer	I-NP	NN	I-DNA	18	PMOD
22	associated	associate	B-VP	VBN	O	21	NMOD
23	with	with	B-PP	IN	O	22	VMOD
24	markedly	markedly	B-NP	RB	O	28	NMOD
25	less	less	I-NP	JJR	O	24	AMOD
26	viral	viral	I-NP	JJ	B-RNA	28	NMOD
27	RNA	RNA	I-NP	NN	I-RNA	28	NMOD
28	production	production	I-NP	NN	O	23	PMOD
29	.	.	O	.	O	10	P

1	This	This	B-NP	DT	O	2	NMOD
2	absence	absence	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	binding	binding	B-NP	NN	O	3	PMOD
5	was	be	B-VP	VBD	O	0	ROOT
6	localized	localized	B-ADJP	JJ	O	5	PRD
7	to	to	B-PP	TO	O	6	AMOD
8	the	the	B-NP	DT	O	11	NMOD
9	NF-kappa	NF-kappa	I-NP	NN	B-DNA	11	NMOD
10	B	B	I-NP	NN	I-DNA	11	NMOD
11	region	region	I-NP	NN	I-DNA	7	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	HIV-1	HIV-1	I-NP	NN	B-DNA	15	NMOD
15	enhancer	enhancer	I-NP	NN	I-DNA	12	PMOD
16	;	;	O	:	O	5	P

1	Adding	Add	B-VP	VBG	O	14	SUB
2	purified	purify	B-NP	VBN	O	5	NMOD
3	NF-kappa	NF-kappa	I-NP	NN	B-protein	5	NMOD
4	B	B	I-NP	NN	I-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	1	OBJ
6	to	to	B-PP	TO	O	1	VMOD
7	nuclear	nuclear	B-NP	JJ	O	8	NMOD
8	extracts	extract	I-NP	NNS	O	6	PMOD
9	from	from	B-PP	IN	O	8	NMOD
10	cells	cell	B-NP	NNS	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	restricted	restricted	B-NP	JJ	O	13	NMOD
13	expression	expression	I-NP	NN	O	11	PMOD
14	overcomes	overcome	B-VP	VBZ	O	0	ROOT
15	this	this	B-NP	DT	O	16	NMOD
16	lack	lack	I-NP	NN	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	binding	binding	B-NP	NN	O	17	PMOD
19	.	.	O	.	O	14	P

1	Antiserum	Antiserum	B-NP	NN	O	12	NMOD
2	specific	specific	B-ADJP	JJ	O	1	NMOD
3	for	for	B-PP	IN	O	2	AMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD
5	B	B	I-NP	NN	I-protein	7	NMOD
6	binding	binding	I-NP	NN	I-protein	7	NMOD
7	proteins	protein	I-NP	NNS	I-protein	3	PMOD
8	,	,	O	,	O	12	P
9	but	but	B-CONJP	CC	O	12	NMOD
10	not	not	I-CONJP	RB	O	9	DEP
11	c-rel-specific	c-rel-specific	B-NP	JJ	O	12	NMOD
12	antiserum	antiserum	I-NP	NN	O	14	SUB
13	,	,	O	,	O	12	P
14	disrupted	disrupt	B-VP	VBD	O	0	ROOT
15	heterodimer	heterodimer	B-NP	NN	B-protein	17	NMOD
16	complex	complex	I-NP	NN	I-protein	17	NMOD
17	formation	formation	I-NP	NN	O	14	OBJ
18	.	.	O	.	O	14	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	determined	determine	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	developmental	developmental	I-NP	JJ	O	7	NMOD
7	control	control	I-NP	NN	O	4	SBAR
8	of	of	B-PP	IN	O	7	VMOD
9	immunoglobulin	immunoglobulin	B-NP	NN	B-DNA	13	NMOD
10	kappa	kappa	I-NP	NN	I-DNA	13	NMOD
11	3	3	I-NP	CD	I-DNA	13	NMOD
12	'	'	I-NP	SYM	I-DNA	13	NMOD
13	enhancer	enhancer	I-NP	NN	I-DNA	8	PMOD
14	(	(	O	(	O	18	DEP
15	kappa	kappa	B-NP	NN	B-DNA	16	NMOD
16	E3	E3	I-NP	NN	I-DNA	18	DEP
17	'	'	O	''	I-DNA	16	NMOD
18	)	)	O	)	O	13	NMOD
19	activity	activity	B-NP	NN	O	13	NMOD
20	is	be	B-VP	VBZ	O	19	SBAR
21	the	the	B-NP	DT	O	22	NMOD
22	result	result	I-NP	NN	O	20	PRD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	combined	combined	I-NP	JJ	O	26	NMOD
26	influence	influence	I-NP	NN	O	23	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	positive-	positive-	B-NP	NN	B-DNA	30	AMOD
29	and	and	O	CC	I-DNA	30	AMOD
30	negative-acting	negative-acting	B-NP	JJ	I-DNA	31	NMOD
31	elements	element	I-NP	NNS	I-DNA	27	PMOD
32	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	a	a	B-NP	DT	O	6	NMOD
5	central	central	I-NP	JJ	O	6	NMOD
6	core	core	I-NP	NN	O	13	SUB
7	in	in	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	12	NMOD
9	kappa	kappa	I-NP	NN	B-DNA	12	NMOD
10	E3	E3	I-NP	NN	I-DNA	12	NMOD
11	'	'	I-NP	''	I-DNA	12	NMOD
12	enhancer	enhancer	I-NP	NN	I-DNA	7	PMOD
13	is	be	B-VP	VBZ	O	3	SBAR
14	active	active	B-ADJP	JJ	O	13	PRD
15	at	at	B-PP	IN	O	14	AMOD
16	the	the	B-NP	DT	O	18	NMOD
17	pre-B-cell	pre-B-cell	I-NP	JJ	O	18	NMOD
18	stage	stage	I-NP	NN	O	15	PMOD
19	but	but	O	CC	O	13	VMOD
20	is	be	B-VP	VBZ	O	13	VMOD
21	repressed	repress	I-VP	VBN	O	20	VC
22	by	by	B-PP	IN	O	21	VMOD
23	flanking	flank	B-NP	VBG	B-DNA	25	NMOD
24	negative-acting	negative-acting	I-NP	JJ	I-DNA	25	NMOD
25	elements	element	I-NP	NNS	I-DNA	22	PMOD
26	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	negative-acting	negative-acting	I-NP	JJ	B-DNA	3	NMOD
3	sequences	sequence	I-NP	NNS	I-DNA	4	SUB
4	repress	repress	B-VP	VBP	O	0	ROOT
5	enhancer	enhancer	B-NP	NN	O	6	NMOD
6	activity	activity	I-NP	NN	O	4	OBJ
7	in	in	B-PP	IN	O	4	VMOD
8	a	a	O	DT	O	12	NMOD
9	position-	position-	B-NP	NN	O	11	AMOD
10	and	and	O	CC	O	11	AMOD
11	orientation-independent	orientation-independent	B-NP	JJ	O	12	NMOD
12	manner	manner	I-NP	NN	O	7	PMOD
13	at	at	B-PP	IN	O	4	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	pre-B-cell	pre-B-cell	I-NP	JJ	O	16	NMOD
16	stage	stage	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	isolated	isolate	I-VP	VBN	O	2	VC
4	a	a	B-NP	DT	O	7	NMOD
5	human	human	I-NP	JJ	B-DNA	7	NMOD
6	cDNA	cDNA	I-NP	NN	I-DNA	7	NMOD
7	clone	clone	I-NP	NN	I-DNA	3	OBJ
8	encoding	encode	B-VP	VBG	O	7	NMOD
9	a	a	B-NP	DT	O	12	NMOD
10	zinc	zinc	I-NP	NN	B-protein	12	NMOD
11	finger	finger	I-NP	NN	I-protein	12	NMOD
12	protein	protein	I-NP	NN	I-protein	8	OBJ
13	(	(	O	(	O	15	DEP
14	NF-E1	NF-E1	B-NP	NN	B-protein	15	DEP
15	)	)	O	)	O	12	NMOD
16	that	that	B-NP	WDT	O	12	NMOD
17	binds	bind	B-VP	VBZ	O	16	SBAR
18	to	to	B-PP	TO	O	17	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	negative-acting	negative-acting	I-NP	JJ	B-DNA	21	NMOD
21	segment	segment	I-NP	NN	I-DNA	18	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	27	NMOD
24	kappa	kappa	I-NP	NN	B-DNA	27	NMOD
25	E3	E3	I-NP	NN	I-DNA	27	NMOD
26	'	'	I-NP	''	I-DNA	27	NMOD
27	enhancer	enhancer	I-NP	NN	I-DNA	22	PMOD
28	.	.	O	.	O	2	P

1	Except	Except	B-PP	IN	O	16	VMOD
2	for	for	B-PP	IN	O	1	PMOD
3	the	the	B-NP	DT	O	6	NMOD
4	conserved	conserve	I-NP	VBN	O	6	NMOD
5	zinc-finger	zinc-finger	I-NP	NN	B-protein	6	NMOD
6	domains	domain	I-NP	NNS	I-protein	1	PMOD
7	,	,	O	,	O	16	P
8	the	the	B-NP	DT	O	11	NMOD
9	amino	amino	I-NP	JJ	B-protein	11	NMOD
10	acid	acid	I-NP	NN	I-protein	11	NMOD
11	sequences	sequence	I-NP	NNS	I-protein	16	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	three	three	I-NP	CD	O	15	NMOD
15	proteins	protein	I-NP	NNS	O	12	PMOD
16	are	be	B-VP	VBP	O	0	ROOT
17	distinct	distinct	B-ADJP	JJ	O	16	PRD
18	.	.	O	.	O	16	P

1	In	In	B-PP	IN	O	0	ROOT
2	contrast	contrast	B-NP	NN	O	3	NMOD
3	mRNA	mRNA	B-NP	NN	O	7	SUB
4	representing	represent	B-VP	VBG	O	3	NMOD
5	pAT	pAT	B-NP	NN	O	6	NMOD
6	591/EGR2	591/EGR2	I-NP	NN	B-protein	4	OBJ
7	was	be	B-VP	VBD	O	1	SBAR
8	not	not	I-VP	RB	O	7	VMOD
9	expressed	express	I-VP	VBN	O	7	VC
10	in	in	B-PP	IN	O	9	VMOD
11	these	these	B-NP	DT	O	12	NMOD
12	cells	cell	I-NP	NNS	O	10	PMOD
13	.	.	O	.	O	1	P

1	cAMP-dependent	cAMP-dependent	B-NP	JJ	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	13	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	proenkephalin	proenkephalin	B-NP	NN	O	3	PMOD
5	by	by	B-PP	IN	O	2	NMOD
6	JunD	JunD	B-NP	NN	B-protein	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	JunB	JunB	B-NP	NN	B-protein	5	PMOD
9	:	:	O	:	O	2	P
10	positive	positive	B-NP	JJ	O	12	AMOD
11	and	and	I-NP	CC	O	12	AMOD
12	negative	negative	I-NP	JJ	O	13	NMOD
13	effects	effect	I-NP	NNS	O	0	ROOT
14	of	of	B-PP	IN	O	13	NMOD
15	AP-1	AP-1	B-NP	NN	B-protein	16	NMOD
16	proteins	protein	I-NP	NNS	I-protein	14	PMOD
17	.	.	O	.	O	13	P

1	As	As	B-PP	IN	O	5	VMOD
2	a	a	B-NP	DT	O	3	NMOD
3	homodimer	homodimer	I-NP	NN	O	1	PMOD
4	JunB	JunB	B-NP	NN	B-protein	5	SUB
5	is	be	B-VP	VBZ	O	21	VMOD
6	unable	unable	B-ADJP	JJ	O	5	PRD
7	to	to	B-VP	TO	O	8	VMOD
8	bind	bind	I-VP	VB	O	6	AMOD
9	the	the	B-NP	DT	O	10	NMOD
10	enhancer	enhancer	I-NP	NN	B-DNA	8	OBJ
11	;	;	O	:	O	21	P
12	however	however	O	RB	O	21	VMOD
13	in	in	B-PP	IN	O	21	VMOD
14	the	the	I-PP	DT	O	13	PMOD
15	presence	presence	I-PP	NN	O	13	PMOD
16	of	of	I-PP	IN	O	13	PMOD
17	c-Fos	c-Fos	B-NP	NN	B-protein	13	PMOD
18	,	,	O	,	O	21	P
19	high-affinity	high-affinity	B-NP	JJ	O	20	NMOD
20	binding	binding	I-NP	NN	O	21	SUB
21	is	be	B-VP	VBZ	O	0	ROOT
22	observed	observe	I-VP	VBN	O	21	VC
23	.	.	O	.	O	21	P

1	The	The	B-NP	DT	O	3	NMOD
2	resistant	resistant	I-NP	JJ	O	3	NMOD
3	patients	patient	I-NP	NNS	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	no	no	B-NP	DT	O	7	NMOD
6	significant	significant	I-NP	JJ	O	7	NMOD
7	improvements	improvement	I-NP	NNS	O	4	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	airflow	airflow	B-NP	NN	O	10	NMOD
10	limitation	limitation	I-NP	NN	O	8	PMOD
11	.	.	O	.	O	4	P

1	Phytohemagglutinin	Phytohemagglutinin	B-NP	NN	B-protein	3	AMOD
2	(	(	I-NP	(	O	3	AMOD
3	PHA	PHA	I-NP	NN	B-protein	6	NMOD
4	)	)	I-NP	)	O	3	AMOD
5	-induced	-induced	I-NP	JJ	O	3	AMOD
6	proliferation	proliferation	I-NP	NN	O	21	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	peripheral	peripheral	B-NP	JJ	B-cell_type	11	NMOD
9	blood	blood	I-NP	NN	I-cell_type	11	NMOD
10	T	T	I-NP	NN	I-cell_type	11	NMOD
11	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD
12	from	from	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	sensitive	sensitive	I-NP	JJ	O	18	NMOD
15	but	but	B-CONJP	CC	O	18	NMOD
16	not	not	I-CONJP	RB	O	15	DEP
17	the	the	B-NP	DT	O	18	NMOD
18	resistant	resistant	I-NP	JJ	O	20	NMOD
19	asthmatic	asthmatic	B-NP	JJ	O	20	NMOD
20	patients	patient	I-NP	NNS	O	12	PMOD
21	was	be	O	VBD	O	0	ROOT
22	significantly	significantly	O	RB	O	21	VMOD
23	(	(	O	(	O	28	DEP
24	p	p	B-NP	NN	O	26	SUB
25	less	less	B-ADJP	JJR	O	26	AMOD
26	than	than	B-PP	IN	O	28	DEP
27	0.01	0.01	B-NP	CD	O	26	AMOD
28	)	)	O	)	O	22	AMOD
29	inhibited	inhibit	B-VP	VBN	O	21	VC
30	by	by	B-PP	IN	O	29	VMOD
31	dexamethasone	dexamethasone	B-NP	NN	O	37	NMOD
32	(	(	O	(	O	36	DEP
33	10	10	B-NP	CD	O	36	DEP
34	(	(	O	(	O	36	DEP
35	-7	-7	B-NP	CD	O	36	DEP
36	)	)	O	)	O	31	NMOD
37	mol/L	mol/L	B-NP	NN	O	30	PMOD
38	)	)	O	)	O	37	NMOD
39	,	,	O	,	O	29	P
40	reflecting	reflect	B-VP	VBG	O	29	VMOD
41	a	a	B-NP	DT	O	42	NMOD
42	shift	shift	I-NP	NN	O	40	OBJ
43	of	of	B-PP	IN	O	42	NMOD
44	the	the	B-NP	DT	O	46	NMOD
45	dose-response	dose-response	I-NP	JJ	O	46	NMOD
46	curve	curve	I-NP	NN	O	43	PMOD
47	.	.	O	.	O	21	P

1	No	No	B-NP	DT	O	2	NMOD
2	differences	difference	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	observed	observe	I-VP	VBN	O	3	VC
5	between	between	B-PP	IN	O	4	VMOD
6	six	six	B-NP	CD	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	12	NMOD
9	sensitive	sensitive	I-NP	JJ	O	11	AMOD
10	and	and	I-NP	CC	O	11	AMOD
11	resistant	resistant	I-NP	JJ	O	12	NMOD
12	patients	patient	I-NP	NNS	O	7	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	clearance	clearance	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	plasma	plasma	B-NP	NN	O	18	NMOD
18	prednisolone	prednisolone	I-NP	NN	O	16	PMOD
19	derived	derive	B-VP	VBN	O	18	NMOD
20	from	from	B-PP	IN	O	19	VMOD
21	orally	orally	B-NP	RB	O	22	AMOD
22	administered	administer	I-NP	VBN	O	23	NMOD
23	prednisone	prednisone	I-NP	NN	O	20	PMOD
24	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	5	NMOD
2	numbers	number	I-NP	NNS	O	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	binding	binding	B-NP	NN	O	5	NMOD
5	affinities	affinity	I-NP	NNS	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	8	NMOD
8	receptors	receptor	I-NP	NNS	O	6	PMOD
9	could	could	B-VP	MD	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	account	account	I-VP	VB	O	9	VC
12	for	for	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	observed	observe	I-NP	VBN	O	15	NMOD
15	difference	difference	I-NP	NN	O	12	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	18	NMOD
18	susceptibility	susceptibility	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	these	these	B-NP	DT	O	21	NMOD
21	cells	cell	I-NP	NNS	O	19	PMOD
22	to	to	B-PP	TO	O	18	NMOD
23	functional	functional	B-NP	JJ	O	24	NMOD
24	inhibition	inhibition	I-NP	NN	O	22	PMOD
25	by	by	B-PP	IN	O	24	NMOD
26	dexamethasone	dexamethasone	B-NP	NN	O	25	PMOD
27	in	in	B-ADJP	FW	O	28	AMOD
28	vitro	vitro	I-ADJP	FW	O	24	NMOD
29	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	clinical	clinical	B-NP	JJ	O	7	NMOD
6	glucocorticoid	glucocorticoid	I-NP	NN	O	7	NMOD
7	resistance	resistance	I-NP	NN	O	11	SUB
8	in	in	B-PP	IN	O	7	NMOD
9	chronic	chronic	B-NP	JJ	O	10	NMOD
10	asthma	asthma	I-NP	NN	O	8	PMOD
11	does	do	B-VP	VBZ	O	4	SBAR
12	not	not	I-VP	RB	O	11	VMOD
13	reflect	reflect	I-VP	VB	O	11	VC
14	abnormal	abnormal	B-NP	JJ	O	16	NMOD
15	glucocorticoid	glucocorticoid	I-NP	NN	O	16	NMOD
16	clearance	clearance	I-NP	NN	O	13	OBJ
17	but	but	O	CC	O	11	VMOD
18	may	may	B-VP	MD	O	11	VMOD
19	be	be	I-VP	VB	O	18	VC
20	due	due	B-ADJP	JJ	O	24	PMOD
21	at	at	B-ADVP	IN	O	23	AMOD
22	least	least	I-ADVP	JJS	O	21	AMOD
23	partly	partly	B-ADVP	RB	O	24	PMOD
24	to	to	B-PP	TO	O	19	PRD
25	a	a	B-NP	DT	O	27	NMOD
26	relative	relative	I-NP	JJ	O	27	NMOD
27	insensitivity	insensitivity	I-NP	NN	O	24	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	T	T	B-NP	NN	B-cell_type	30	NMOD
30	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	28	PMOD
31	to	to	B-PP	TO	O	27	NMOD
32	glucocorticoids	glucocorticoid	B-NP	NNS	O	31	PMOD
33	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	lack	lack	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	sensitivity	sensitivity	B-NP	NN	O	3	PMOD
5	is	be	B-VP	VBZ	O	0	ROOT
6	unexplained	unexplained	B-ADJP	JJ	O	5	PRD
7	but	but	O	CC	O	5	VMOD
8	is	be	B-VP	VBZ	O	5	VMOD
9	not	not	O	RB	O	8	VMOD
10	attributable	attributable	B-ADJP	JJ	O	8	PRD
11	to	to	B-PP	TO	O	10	AMOD
12	abnormalities	abnormality	B-NP	NNS	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	cellular	cellular	B-NP	JJ	B-protein	16	NMOD
15	glucocorticoid	glucocorticoid	I-NP	NN	I-protein	16	NMOD
16	receptors	receptor	I-NP	NNS	I-protein	13	PMOD
17	.	.	O	.	O	5	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	these	these	B-NP	DT	O	3	NMOD
3	data	datum	I-NP	NNS	O	4	SUB
4	suggest	suggest	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	9	NMOD
7	phorbol	phorbol	I-NP	NN	O	9	NMOD
8	myristate-induced	myristate-induced	I-NP	JJ	O	7	AMOD
9	signal	signal	I-NP	NN	O	18	SUB
10	(	(	O	(	O	17	DEP
11	prolonged	prolong	B-NP	VBN	O	15	NMOD
12	protein	protein	I-NP	NN	B-protein	15	NMOD
13	kinase	kinase	I-NP	NN	I-protein	15	NMOD
14	C	C	I-NP	NN	I-protein	15	NMOD
15	activation	activation	I-NP	NN	O	17	DEP
16	?	?	O	.	O	15	P
17	)	)	O	)	O	9	NMOD
18	can	can	B-VP	MD	O	30	VMOD
19	not	not	I-VP	RB	O	18	VMOD
20	be	be	I-VP	VB	O	18	VC
21	inhibited	inhibit	I-VP	VBN	O	20	VC
22	by	by	B-PP	IN	O	21	VMOD
23	prior	prior	B-NP	JJ	O	24	NMOD
24	incubation	incubation	I-NP	NN	O	22	PMOD
25	with	with	B-PP	IN	O	24	NMOD
26	dexamethasone	dexamethasone	B-NP	NN	O	25	PMOD
27	and	and	O	CC	O	30	VMOD
28	it	it	B-NP	PRP	O	30	SUB
29	also	also	B-ADVP	RB	O	30	VMOD
30	protects	protect	B-VP	VBZ	O	5	SBAR
31	the	the	B-NP	DT	O	33	NMOD
32	induced	induce	I-NP	VBN	O	33	NMOD
33	mRNA	mRNA	I-NP	NN	B-RNA	30	OBJ
34	for	for	B-PP	IN	O	30	VMOD
35	the	the	B-NP	DT	O	37	NMOD
36	degradative	degradative	I-NP	JJ	O	37	NMOD
37	action	action	I-NP	NN	O	34	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	dexamethasone	dexamethasone	B-NP	NN	O	38	PMOD
40	.	.	O	.	O	4	P

1	Identification	Identification	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	transcriptional	transcriptional	B-NP	JJ	B-protein	5	NMOD
4	suppressor	suppressor	I-NP	NN	I-protein	5	NMOD
5	proteins	protein	I-NP	NNS	I-protein	2	PMOD
6	that	that	B-NP	WDT	O	5	NMOD
7	bind	bind	B-VP	VBP	O	6	SBAR
8	to	to	B-PP	TO	O	7	VMOD
9	the	the	B-NP	DT	O	12	NMOD
10	negative	negative	I-NP	JJ	B-DNA	12	NMOD
11	regulatory	regulatory	I-NP	JJ	I-DNA	12	NMOD
12	element	element	I-NP	NN	I-DNA	8	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	human	human	I-NP	JJ	O	18	NMOD
16	immunodeficiency	immunodeficiency	I-NP	NN	O	18	NMOD
17	virus	virus	I-NP	NN	O	18	NMOD
18	type	type	I-NP	NN	O	13	PMOD
19	1	1	I-NP	CD	O	18	NMOD
20	.	.	O	.	O	1	P

1	Two	Two	B-NP	CD	O	3	NMOD
2	different	different	I-NP	JJ	O	3	NMOD
3	proteins	protein	I-NP	NNS	O	27	SUB
4	which	which	B-NP	WDT	O	3	NMOD
5	independently	independently	B-ADVP	RB	O	6	VMOD
6	bound	bind	B-VP	VBD	O	4	SBAR
7	to	to	B-PP	TO	O	6	VMOD
8	neighboring	neighbor	B-NP	VBG	O	9	NMOD
9	sequences	sequence	I-NP	NNS	O	7	PMOD
10	within	within	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	negative	negative	I-NP	JJ	B-DNA	14	NMOD
13	regulatory	regulatory	I-NP	JJ	I-DNA	14	NMOD
14	element	element	I-NP	NN	I-DNA	10	PMOD
15	(	(	O	(	O	17	DEP
16	NRE	NRE	B-NP	NN	B-DNA	17	DEP
17	)	)	O	)	O	14	NMOD
18	of	of	B-PP	IN	O	14	NMOD
19	human	human	B-NP	JJ	O	22	NMOD
20	immunodeficiency	immunodeficiency	I-NP	NN	O	22	NMOD
21	virus	virus	I-NP	NN	O	22	NMOD
22	type	type	I-NP	NN	O	18	PMOD
23	1	1	I-NP	CD	O	22	NMOD
24	(	(	O	(	O	26	DEP
25	HIV-1	HIV-1	B-NP	NN	O	26	DEP
26	)	)	O	)	O	22	NMOD
27	were	be	B-VP	VBD	O	0	ROOT
28	detected	detect	I-VP	VBN	O	27	VC
29	in	in	B-PP	IN	O	28	VMOD
30	the	the	B-NP	DT	O	32	NMOD
31	nuclear	nuclear	I-NP	JJ	O	32	NMOD
32	extract	extract	I-NP	NN	O	29	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	a	a	B-NP	DT	O	39	NMOD
35	virus-infected	virus-infected	I-NP	JJ	B-cell_line	39	NMOD
36	human	human	I-NP	JJ	I-cell_line	39	NMOD
37	T	T	I-NP	NN	I-cell_line	39	NMOD
38	cell	cell	I-NP	NN	I-cell_line	39	NMOD
39	line	line	I-NP	NN	I-cell_line	33	PMOD
40	.	.	O	.	O	27	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	this	this	B-NP	DT	O	4	NMOD
4	factor	factor	I-NP	NN	O	5	SUB
5	did	do	B-VP	VBD	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	bind	bind	I-VP	VB	O	5	VC
8	to	to	B-PP	TO	O	7	VMOD
9	a	a	B-NP	DT	O	10	NMOD
10	typical	typical	I-NP	JJ	O	8	PMOD
11	AP-1	AP-1	I-NP	NN	B-DNA	12	NMOD
12	site	site	I-NP	NN	I-DNA	10	NMOD
13	.	.	O	.	O	5	P

1	Thus	Thus	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	each	each	B-NP	DT	O	4	NMOD
4	factor	factor	I-NP	NN	O	5	SUB
5	may	may	B-VP	MD	O	0	ROOT
6	function	function	I-VP	VB	O	5	VC
7	as	as	B-PP	IN	O	6	VMOD
8	a	a	B-NP	DT	O	11	NMOD
9	novel	novel	I-NP	JJ	O	11	NMOD
10	negative	negative	I-NP	JJ	O	11	NMOD
11	regulator	regulator	I-NP	NN	O	7	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	transcription	transcription	B-NP	NN	O	12	PMOD
14	.	.	O	.	O	5	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	shown	show	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	Z	Z	I-NP	NN	B-protein	8	NMOD
7	gene	gene	I-NP	NN	I-protein	8	NMOD
8	product	product	I-NP	NN	I-protein	25	SUB
9	,	,	O	,	O	8	P
10	which	which	B-NP	WDT	O	8	NMOD
11	binds	bind	B-VP	VBZ	O	10	SBAR
12	to	to	B-PP	TO	O	11	VMOD
13	AP-1	AP-1	B-NP	NN	B-DNA	14	NMOD
14	sites	site	I-NP	NNS	I-DNA	12	PMOD
15	as	as	B-PP	IN	O	11	VMOD
16	a	a	B-NP	DT	O	17	NMOD
17	homodimer	homodimer	I-NP	NN	B-protein	15	PMOD
18	and	and	O	CC	O	11	VMOD
19	has	have	B-VP	VBZ	O	11	VMOD
20	sequence	sequence	B-NP	NN	O	21	NMOD
21	similarity	similarity	I-NP	NN	O	19	OBJ
22	to	to	B-PP	TO	O	21	NMOD
23	c-Fos	c-Fos	B-NP	NN	B-protein	22	PMOD
24	,	,	O	,	O	8	P
25	can	can	B-VP	MD	O	4	SBAR
26	efficiently	efficiently	I-VP	RB	O	25	VMOD
27	activate	activate	I-VP	VB	O	25	VC
28	the	the	B-NP	DT	O	31	NMOD
29	EBV	EBV	I-NP	NN	B-DNA	31	NMOD
30	early	early	I-NP	JJ	I-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	33	NMOD
32	,	,	O	,	O	33	P
33	BMRF1	BMRF1	B-NP	NN	B-DNA	27	OBJ
34	,	,	O	,	O	33	P
35	in	in	B-PP	IN	O	27	VMOD
36	certain	certain	B-NP	JJ	O	38	NMOD
37	cell	cell	I-NP	NN	O	38	NMOD
38	types	type	I-NP	NNS	O	47	NMOD
39	(	(	O	(	O	44	DEP
40	i.e.	i.e.	B-NP	FW	O	43	NMOD
41	,	,	O	,	O	43	P
42	HeLa	HeLa	B-NP	NN	B-cell_line	43	NMOD
43	cells	cell	I-NP	NNS	I-cell_line	44	DEP
44	)	)	O	)	O	38	NMOD
45	but	but	B-CONJP	CC	O	47	NMOD
46	not	not	I-CONJP	RB	O	45	DEP
47	others	other	B-NP	NNS	O	35	PMOD
48	(	(	O	(	O	53	DEP
49	i.e.	i.e.	B-NP	FW	O	52	NMOD
50	,	,	O	,	O	52	P
51	Jurkat	Jurkat	B-NP	NN	B-cell_line	52	NMOD
52	cells	cell	I-NP	NNS	I-cell_line	53	DEP
53	)	)	O	)	O	47	NMOD
54	.	.	O	.	O	2	P

1	Synergistic	Synergistic	B-NP	JJ	O	2	NMOD
2	transactivation	transactivation	I-NP	NN	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	BMRF1	BMRF1	I-NP	NN	B-DNA	6	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	3	PMOD
7	by	by	B-PP	IN	O	2	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	Z/c-myb	Z/c-myb	I-NP	NN	B-protein	10	NMOD
10	combination	combination	I-NP	NN	I-protein	7	PMOD
11	appears	appear	B-VP	VBZ	O	0	ROOT
12	to	to	I-VP	TO	O	13	VMOD
13	involve	involve	I-VP	VB	O	11	VMOD
14	direct	direct	B-NP	JJ	O	15	NMOD
15	binding	binding	I-NP	NN	O	24	NMOD
16	by	by	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	Z	Z	I-NP	NN	B-protein	19	NMOD
19	protein	protein	I-NP	NN	I-protein	16	PMOD
20	but	but	B-CONJP	CC	O	24	NMOD
21	not	not	I-CONJP	RB	O	20	DEP
22	the	the	B-NP	DT	O	24	NMOD
23	c-myb	c-myb	I-NP	NN	B-protein	24	NMOD
24	protein	protein	I-NP	NN	I-protein	13	OBJ
25	.	.	O	.	O	11	P

1	A	A	B-NP	DT	O	3	NMOD
2	dimerization	dimerization	I-NP	NN	B-protein	3	NMOD
3	cofactor	cofactor	I-NP	NN	I-protein	10	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	HNF-1	HNF-1	B-NP	NN	B-protein	6	NMOD
6	alpha	alpha	I-NP	NN	I-protein	4	PMOD
7	(	(	O	(	O	9	DEP
8	DCoH	DCoH	B-NP	NN	B-protein	9	DEP
9	)	)	O	)	O	6	NMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	identified	identify	I-VP	VBN	O	10	VC
12	that	that	B-NP	WDT	O	11	VMOD
13	displayed	display	B-VP	VBD	O	12	SBAR
14	a	a	B-NP	DT	O	17	NMOD
15	restricted	restricted	I-NP	JJ	O	17	NMOD
16	tissue	tissue	I-NP	NN	O	17	NMOD
17	distribution	distribution	I-NP	NN	O	13	OBJ
18	and	and	O	CC	O	13	VMOD
19	did	do	B-VP	VBD	O	13	VMOD
20	not	not	I-VP	RB	O	19	VMOD
21	bind	bind	I-VP	VB	O	19	VC
22	to	to	B-PP	TO	O	21	VMOD
23	DNA	DNA	B-NP	NN	O	22	PMOD
24	,	,	O	,	O	13	P
25	but	but	O	CC	O	13	VMOD
26	,	,	O	,	O	13	P
27	rather	rather	B-ADVP	RB	O	13	VMOD
28	,	,	O	,	O	13	P
29	selectively	selectively	B-VP	RB	O	30	VMOD
30	stabilized	stabilize	I-VP	VBD	O	13	VMOD
31	HNF-1	HNF-1	B-NP	NN	B-protein	33	NMOD
32	alpha	alpha	I-NP	NN	I-protein	33	NMOD
33	dimers	dimer	I-NP	NNS	I-protein	30	OBJ
34	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	formation	formation	I-NP	NN	O	20	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	a	a	B-NP	DT	O	9	NMOD
5	stable	stable	I-NP	JJ	O	9	NMOD
6	tetrameric	tetrameric	I-NP	JJ	B-protein	9	NMOD
7	DCoH-HNF-1	DCoH-HNF-1	I-NP	NN	I-protein	9	NMOD
8	alpha	alpha	I-NP	NN	I-protein	9	NMOD
9	complex	complex	I-NP	NN	I-protein	3	PMOD
10	,	,	O	,	O	2	P
11	which	which	B-NP	WDT	O	2	NMOD
12	required	require	B-VP	VBD	O	11	SBAR
13	the	the	B-NP	DT	O	15	NMOD
14	dimerization	dimerization	I-NP	NN	B-protein	15	NMOD
15	domain	domain	I-NP	NN	I-protein	12	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	HNF-1	HNF-1	B-NP	NN	B-protein	18	NMOD
18	alpha	alpha	I-NP	NN	I-protein	16	PMOD
19	,	,	O	,	O	2	P
20	did	do	B-VP	VBD	O	0	ROOT
21	not	not	I-VP	RB	O	20	VMOD
22	change	change	I-VP	VB	O	20	VC
23	the	the	B-NP	DT	O	26	NMOD
24	DNA	DNA	I-NP	NN	O	26	NMOD
25	binding	binding	I-NP	NN	O	26	NMOD
26	characteristics	characteristic	I-NP	NNS	O	22	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	HNF-1	HNF-1	B-NP	NN	B-protein	29	NMOD
29	alpha	alpha	I-NP	NN	I-protein	27	PMOD
30	,	,	O	,	O	20	P
31	but	but	O	CC	O	20	VMOD
32	enhanced	enhance	B-VP	VBD	O	20	VMOD
33	its	its	B-NP	PRP$	O	35	NMOD
34	transcriptional	transcriptional	I-NP	JJ	O	35	NMOD
35	activity	activity	I-NP	NN	O	32	OBJ
36	.	.	O	.	O	20	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	DCoH	DCoH	B-NP	NN	B-protein	4	SUB
4	did	do	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	confer	confer	I-VP	VB	O	4	VC
7	transcriptional	transcriptional	B-NP	JJ	O	8	NMOD
8	activation	activation	I-NP	NN	O	6	OBJ
9	to	to	B-PP	TO	O	6	VMOD
10	the	the	B-NP	DT	O	14	NMOD
11	GAL4	GAL4	I-NP	NN	B-protein	14	NMOD
12	DNA	DNA	I-NP	NN	I-protein	14	NMOD
13	binding	binding	I-NP	NN	I-protein	14	NMOD
14	domain	domain	I-NP	NN	I-protein	9	PMOD
15	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	first	first	I-NP	JJ	O	3	PRD
6	to	to	B-VP	TO	O	7	VMOD
7	demonstrate	demonstrate	I-VP	VB	O	5	NMOD
8	membrane	membrane	B-NP	NN	B-protein	10	NMOD
9	binding	binding	I-NP	NN	I-protein	10	NMOD
10	sites	site	I-NP	NNS	I-protein	7	OBJ
11	with	with	B-PP	IN	O	10	NMOD
12	a	a	B-NP	DT	O	14	NMOD
13	high	high	I-NP	JJ	O	14	NMOD
14	affinity	affinity	I-NP	NN	O	11	PMOD
15	for	for	B-PP	IN	O	14	NMOD
16	aldosterone	aldosterone	B-NP	NN	O	15	PMOD
17	,	,	B-PP	,	O	5	P
18	but	but	I-PP	CC	O	5	NMOD
19	not	not	B-PP	RB	O	18	DEP
20	for	for	I-PP	IN	O	18	PMOD
21	cortisol	cortisol	B-NP	NN	O	20	PMOD
22	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	second	second	I-NP	JJ	O	4	NMOD
3	male	male	I-NP	JJ	O	4	NMOD
4	patient	patient	I-NP	NN	O	5	SUB
5	had	have	B-VP	VBD	O	0	ROOT
6	slight	slight	B-NP	JJ	O	7	NMOD
7	hypertension	hypertension	I-NP	NN	O	5	OBJ
8	without	without	B-PP	IN	O	7	NMOD
9	hypokalemia	hypokalemia	B-NP	NN	O	8	PMOD
10	.	.	O	.	O	5	P

1	There	There	B-NP	EX	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	normal	normal	I-NP	JJ	O	5	NMOD
5	increase	increase	I-NP	NN	O	2	PRD
6	in	in	B-PP	IN	O	5	NMOD
7	ACTH	ACTH	B-NP	NN	O	12	NMOD
8	,	,	O	,	O	12	P
9	cortisol	cortisol	B-NP	NN	O	12	NMOD
10	,	,	O	,	O	12	P
11	and	and	O	CC	O	12	NMOD
12	GH	GH	B-NP	NN	B-protein	6	PMOD
13	(	(	O	(	O	12	NMOD
14	except	except	B-PP	IN	O	5	NMOD
15	in	in	B-PP	IN	O	14	PMOD
16	one	one	B-NP	CD	O	18	NMOD
17	obese	obese	I-NP	JJ	O	18	NMOD
18	patient	patient	I-NP	NN	O	15	PMOD
19	)	)	O	)	O	5	NMOD
20	in	in	B-PP	IN	O	5	NMOD
21	response	response	I-PP	NN	O	20	PMOD
22	to	to	I-PP	TO	O	21	NMOD
23	insulin-induced	insulin-induced	B-NP	JJ	O	24	NMOD
24	hypoglycemia	hypoglycemia	I-NP	NN	O	22	PMOD
25	,	,	O	,	O	2	P
26	while	while	B-SBAR	IN	O	2	VMOD
27	cortisol	cortisol	B-NP	NN	O	28	NMOD
28	production	production	I-NP	NN	O	29	SUB
29	was	be	B-VP	VBD	O	26	SBAR
30	elevated	elevate	I-VP	VBN	O	29	VC
31	in	in	B-PP	IN	O	30	VMOD
32	three	three	B-NP	CD	O	33	NMOD
33	patients	patient	I-NP	NNS	O	31	PMOD
34	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	9	VMOD
2	the	the	B-NP	DT	O	5	NMOD
3	second	second	I-NP	JJ	O	5	NMOD
4	male	male	I-NP	JJ	O	5	NMOD
5	patient	patient	I-NP	NN	O	1	PMOD
6	,	,	O	,	O	9	P
7	no	no	B-NP	DT	O	8	NMOD
8	abnormalities	abnormality	I-NP	NNS	O	9	SUB
9	were	be	B-VP	VBD	O	0	ROOT
10	found	find	I-VP	VBN	O	9	VC
11	.	.	O	.	O	9	P

1	In	In	B-PP	IN	O	10	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	mild	mild	B-NP	JJ	O	5	NMOD
5	oxidation	oxidation	I-NP	NN	O	10	SUB
6	with	with	B-PP	IN	O	5	NMOD
7	glucose	glucose	B-NP	NN	B-protein	8	NMOD
8	oxidase	oxidase	I-NP	NN	I-protein	6	PMOD
9	selectively	selectively	B-ADVP	RB	O	10	VMOD
10	inhibits	inhibit	B-VP	VBZ	O	0	ROOT
11	p75	p75	B-NP	NN	B-protein	13	NMOD
12	and	and	O	CC	O	13	NMOD
13	p85	p85	B-NP	NN	B-protein	14	NMOD
14	binding	binding	I-NP	NN	O	10	OBJ
15	while	while	B-SBAR	IN	O	10	VMOD
16	not	not	B-VP	RB	O	17	VMOD
17	blocking	block	I-VP	VBG	O	15	SBAR
18	p50	p50	B-NP	NN	B-protein	20	NMOD
19	and	and	O	CC	O	20	NMOD
20	p55	p55	B-NP	NN	B-protein	21	NMOD
21	interactions	interaction	I-NP	NNS	O	17	OBJ
22	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	0	ROOT
2	vitro-translated	vitro-translated	B-NP	JJ	B-protein	3	NMOD
3	proteins	protein	I-NP	NNS	I-protein	1	PMOD
4	,	,	O	,	O	1	VMOD
5	truncated	truncate	B-VP	VBN	O	4	NMOD
6	downstream	downstream	B-ADVP	RB	O	5	VMOD
7	of	of	B-PP	IN	O	6	AMOD
8	the	the	B-NP	DT	O	10	NMOD
9	Rel	Rel	I-NP	NN	B-DNA	10	NMOD
10	domain	domain	I-NP	NN	I-DNA	7	PMOD
11	and	and	O	CC	O	5	VMOD
12	excluding	exclude	B-VP	VBG	O	5	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	repeats	repeat	I-NP	NNS	O	12	OBJ
15	,	,	O	,	O	5	P
16	bind	bind	B-VP	VBP	O	5	VMOD
17	kappa	kappa	B-NP	NN	B-DNA	19	NMOD
18	B	B	I-NP	NN	I-DNA	19	NMOD
19	sites	site	I-NP	NNS	I-DNA	16	OBJ
20	.	.	O	.	O	1	P

1	LDP	LDP	B-NP	NNP	O	4	SUB
2	not	not	B-CONJP	RB	O	4	VMOD
3	only	only	I-CONJP	RB	O	2	DEP
4	increases	increase	B-VP	VBZ	O	0	ROOT
5	plasma	plasma	B-NP	NN	O	7	NMOD
6	estradiol	estradiol	I-NP	NN	O	7	NMOD
7	levels	level	I-NP	NNS	O	4	OBJ
8	,	,	O	,	O	4	P
9	but	but	O	CC	O	4	VMOD
10	also	also	B-VP	RB	O	9	DEP
11	increases	increase	I-VP	VBZ	O	4	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	leucocytic	leucocytic	I-NP	JJ	O	15	NMOD
14	ER	ER	I-NP	NN	B-protein	15	NMOD
15	levels	level	I-NP	NNS	O	11	OBJ
16	.	.	O	.	O	4	P

1	This	This	B-NP	DT	O	2	NMOD
2	method	method	I-NP	NN	O	3	SUB
3	could	could	B-VP	MD	O	0	ROOT
4	be	be	I-VP	VB	O	3	VC
5	quite	quite	B-ADJP	RB	O	6	AMOD
6	useful	useful	I-ADJP	JJ	O	4	PRD
7	to	to	B-VP	TO	O	8	VMOD
8	detect	detect	I-VP	VB	O	6	AMOD
9	not	not	B-CONJP	RB	O	22	NMOD
10	only	only	I-CONJP	RB	O	9	DEP
11	CAG	CAG	B-NP	NN	B-DNA	12	NMOD
12	repeats	repeat	I-NP	NNS	I-DNA	22	NMOD
13	in	in	B-PP	IN	O	12	NMOD
14	SBMA	SBMA	B-NP	NN	O	13	PMOD
15	but	but	B-CONJP	CC	O	22	NMOD
16	also	also	I-CONJP	RB	O	15	DEP
17	other	other	B-NP	JJ	O	22	NMOD
18	polymorphic	polymorphic	I-NP	JJ	B-DNA	22	NMOD
19	dinucleotide	dinucleotide	I-NP	NN	I-DNA	21	NMOD
20	and	and	I-NP	CC	O	21	NMOD
21	trinucleotide	trinucleotide	I-NP	NN	B-DNA	22	NMOD
22	repeats	repeat	I-NP	NNS	I-DNA	8	OBJ
23	.	.	O	.	O	3	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD
6	NF-kappa	NF-kappa	I-NP	NN	I-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	8	SUB
8	is	be	B-VP	VBZ	O	4	SBAR
9	necessary	necessary	B-ADJP	JJ	O	8	PRD
10	to	to	B-VP	TO	O	11	VMOD
11	activate	activate	I-VP	VB	O	8	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	kappa	kappa	I-NP	NN	B-DNA	15	NMOD
14	B	B	I-NP	NN	I-DNA	15	NMOD
15	enhancer	enhancer	I-NP	NN	I-DNA	11	OBJ
16	,	,	O	,	O	8	P
17	while	while	B-SBAR	IN	O	8	VMOD
18	KBF1	KBF1	B-NP	NN	B-protein	21	SUB
19	by	by	B-PP	IN	O	18	NMOD
20	itself	itself	B-NP	PRP	O	19	PMOD
21	is	be	B-VP	VBZ	O	17	SBAR
22	not	not	O	RB	O	21	VMOD
23	sufficient	sufficient	B-ADJP	JJ	O	21	PRD
24	.	.	O	.	O	3	P

1	Estrogen	Estrogen	B-NP	NN	B-cell_line	20	NMOD
2	receptor	receptor	I-NP	NN	I-cell_line	20	NMOD
3	positive	positive	B-ADJP	JJ	I-cell_line	10	AMOD
4	(	(	O	(	I-cell_line	8	DEP
5	ER+	ER+	B-ADJP	JJ	I-cell_line	8	DEP
6	:	:	O	:	I-cell_line	5	P
7	MCF-7	MCF-7	B-NP	NN	I-cell_line	5	DEP
8	)	)	O	)	I-cell_line	3	AMOD
9	and	and	O	CC	I-cell_line	10	AMOD
10	negative	negative	O	JJ	I-cell_line	20	NMOD
11	(	(	O	(	I-cell_line	15	DEP
12	ER-	ER-	B-ADJP	JJ	I-cell_line	15	DEP
13	:	:	O	:	I-cell_line	12	P
14	MDA-MB-231	MDA-MB-231	B-NP	NN	I-cell_line	12	DEP
15	)	)	I-NP	)	I-cell_line	10	AMOD
16	human	human	I-NP	JJ	I-cell_line	20	NMOD
17	breast	breast	I-NP	NN	I-cell_line	20	NMOD
18	cancer	cancer	I-NP	NN	I-cell_line	20	NMOD
19	cell	cell	I-NP	NN	I-cell_line	20	NMOD
20	lines	line	I-NP	NNS	I-cell_line	21	SUB
21	were	be	B-VP	VBD	O	0	ROOT
22	utilized	utilize	I-VP	VBN	O	21	VC
23	to	to	I-VP	TO	O	24	VMOD
24	evaluate	evaluate	I-VP	VB	O	22	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	effects	effect	I-NP	NNS	O	24	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	tamoxifen	tamoxifen	B-NP	NN	O	33	NMOD
29	(	(	O	(	O	31	DEP
30	TAM	TAM	B-NP	NN	O	31	DEP
31	)	)	O	)	O	28	NMOD
32	and	and	O	CC	O	33	NMOD
33	estradiol	estradiol	B-NP	NN	O	27	PMOD
34	(	(	O	(	O	36	DEP
35	E2	E2	B-NP	NN	O	36	DEP
36	)	)	O	)	O	33	NMOD
37	on	on	B-PP	IN	O	26	NMOD
38	modulation	modulation	B-NP	NN	O	37	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	breast	breast	B-NP	NN	O	43	NMOD
41	cancer	cancer	I-NP	NN	O	43	NMOD
42	target	target	I-NP	NN	O	43	NMOD
43	susceptibility	susceptibility	I-NP	NN	O	39	PMOD
44	to	to	B-PP	TO	O	43	NMOD
45	lysis	lysis	B-NP	NN	O	44	PMOD
46	by	by	B-PP	IN	O	45	NMOD
47	lymphokine-activated	lymphokine-activated	B-NP	JJ	B-cell_type	48	NMOD
48	killer	killer	I-NP	NN	I-cell_type	52	NMOD
49	(	(	O	(	I-cell_type	51	DEP
50	LAK	LAK	B-NP	NN	I-cell_type	51	DEP
51	)	)	O	)	I-cell_type	48	NMOD
52	cells	cell	B-NP	NNS	I-cell_type	46	PMOD
53	.	.	O	.	O	21	P

1	E2-stimulated	E2-stimulated	B-NP	JJ	B-cell_line	3	NMOD
2	ER+	ER+	I-NP	JJ	I-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	more	more	B-ADJP	RBR	O	6	AMOD
6	susceptible	susceptible	I-ADJP	JJ	O	4	PRD
7	to	to	B-PP	TO	O	6	AMOD
8	lysis	lysis	B-NP	NN	O	7	PMOD
9	by	by	B-PP	IN	O	8	NMOD
10	LAK	LAK	B-NP	NN	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	than	than	B-PP	IN	O	6	AMOD
13	corresponding	correspond	B-VP	VBG	O	17	NMOD
14	TAM-treated	TAM-treated	B-NP	JJ	O	17	NMOD
15	or	or	I-NP	CC	O	14	DEP
16	control	control	I-NP	NN	B-cell_type	14	DEP
17	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
18	,	,	O	,	O	4	P
19	while	while	B-SBAR	IN	O	4	VMOD
20	treatment	treatment	B-NP	NN	O	30	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	ER-	ER-	B-NP	NN	B-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	21	PMOD
24	with	with	B-PP	IN	O	20	NMOD
25	either	either	O	CC	O	28	NMOD
26	E2	E2	B-NP	NN	B-protein	28	NMOD
27	or	or	O	CC	O	28	NMOD
28	TAM	TAM	B-NP	NN	O	24	PMOD
29	alone	alone	B-ADVP	RB	O	28	NMOD
30	did	do	B-VP	VBD	O	19	SBAR
31	not	not	I-VP	RB	O	30	VMOD
32	alter	alter	I-VP	VB	O	30	VC
33	from	from	B-PP	IN	O	32	VMOD
34	control	control	B-NP	NN	O	33	PMOD
35	their	their	B-NP	PRP$	O	36	NMOD
36	susceptibility	susceptibility	I-NP	NN	O	32	OBJ
37	to	to	B-PP	TO	O	36	NMOD
38	this	this	B-NP	DT	O	40	NMOD
39	immune-mediated	immune-mediated	I-NP	JJ	O	40	NMOD
40	lysis	lysis	I-NP	NN	O	37	PMOD
41	.	.	O	.	O	4	P

1	Deletions	Deletion	B-NP	NNS	O	7	SUB
2	upstream	upstream	B-ADVP	RB	O	1	NMOD
3	of	of	B-PP	IN	O	2	AMOD
4	the	the	B-NP	DT	O	6	NMOD
5	PRDII	PRDII	I-NP	NN	B-DNA	6	NMOD
6	element	element	I-NP	NN	I-DNA	3	PMOD
7	increased	increase	B-VP	VBD	O	0	ROOT
8	transcription	transcription	B-NP	NN	O	7	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	uninduced	uninduced	I-NP	JJ	O	12	NMOD
12	extract	extract	I-NP	NN	O	9	PMOD
13	,	,	O	,	O	7	P
14	indicating	indicate	B-VP	VBG	O	7	VMOD
15	predominantly	predominantly	B-NP	RB	O	16	AMOD
16	negative	negative	I-NP	JJ	O	17	NMOD
17	regulation	regulation	I-NP	NN	O	14	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	promoter	promoter	I-NP	NN	B-DNA	18	PMOD
21	.	.	O	.	O	7	P

1	Small	Small	B-NP	JJ	O	3	NMOD
2	apolar	apolar	I-NP	JJ	O	3	NMOD
3	substitutions	substitution	I-NP	NNS	O	11	SUB
4	(	(	O	(	O	10	DEP
5	11	11	B-NP	CD	O	6	NMOD
6	alpha-methyl	alpha-methyl	I-NP	NN	O	9	NMOD
7	,	,	O	,	O	9	P
8	11	11	B-NP	CD	O	9	NMOD
9	alpha-fluoromethyl	alpha-fluoromethyl	I-NP	NN	O	10	DEP
10	)	)	O	)	O	3	NMOD
11	did	do	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	markedly	markedly	I-VP	RB	O	11	VMOD
14	decrease	decrease	I-VP	VB	O	11	VC
15	the	the	B-NP	DT	O	16	NMOD
16	affinity	affinity	I-NP	NN	O	14	OBJ
17	for	for	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	vitamin	vitamin	I-NP	NN	B-protein	21	NMOD
20	D	D	I-NP	NN	I-protein	21	NMOD
21	receptor	receptor	I-NP	NN	I-protein	17	PMOD
22	,	,	O	,	O	11	P
23	but	but	O	CC	O	22	PMOD
24	larger	large	B-ADJP	JJR	O	37	AMOD
25	(	(	O	(	O	34	DEP
26	11	11	B-NP	CD	O	27	NMOD
27	alpha-chloromethyl	alpha-chloromethyl	I-NP	NN	O	33	NMOD
28	or	or	O	CC	O	33	NMOD
29	11	11	B-NP	CD	O	30	NMOD
30	alpha-	alpha-	I-NP	NN	O	33	NMOD
31	or	or	O	CC	O	33	NMOD
32	11	11	B-NP	CD	O	33	NMOD
33	beta-phenyl	beta-phenyl	I-NP	NN	O	34	DEP
34	)	)	O	)	O	24	AMOD
35	or	or	O	CC	O	37	AMOD
36	more	more	B-NP	RBR	O	37	AMOD
37	polar	polar	I-NP	JJ	O	38	NMOD
38	substitutions	substitution	I-NP	NNS	O	23	PRD
39	(	(	O	(	O	38	NMOD
40	11	11	B-NP	CD	O	41	NMOD
41	alpha-hydroxymethyl	alpha-hydroxymethyl	I-NP	NN	O	48	SUB
42	,	,	O	,	O	48	P
43	11	11	B-NP	CD	O	48	SUB
44	alpha-	alpha-	I-NP	NN	O	43	NMOD
45	(	(	O	(	O	47	DEP
46	2-hydroxyethyl	2-hydroxyethyl	B-NP	NN	O	47	DEP
47	]	]	O	)	O	44	NMOD
48	decreased	decrease	B-VP	VBD	O	39	SBAR
49	the	the	B-NP	DT	O	50	NMOD
50	affinity	affinity	I-NP	NN	O	48	OBJ
51	to	to	B-PP	TO	O	48	VMOD
52	less	less	B-NP	JJR	O	53	AMOD
53	than	than	I-NP	IN	O	55	NMOD
54	5	5	I-NP	CD	O	53	AMOD
55	%	%	I-NP	NN	O	51	PMOD
56	of	of	B-PP	IN	O	55	NMOD
57	that	that	B-NP	DT	O	56	PMOD
58	of	of	B-PP	IN	O	57	NMOD
59	1	1	B-NP	CD	O	62	NMOD
60	alpha	alpha	I-NP	SYM	O	62	NMOD
61	,	,	I-NP	,	O	62	P
62	25-OH	25-OH	I-NP	NN	O	64	NMOD
63	)	)	I-NP	)	O	62	NMOD
64	2D3	2D3	I-NP	NN	O	58	PMOD
65	.	.	O	.	O	23	P

1	The	The	B-NP	DT	O	2	NMOD
2	regulation	regulation	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	gene	gene	B-NP	NN	O	5	NMOD
5	expression	expression	I-NP	NN	O	3	PMOD
6	during	during	B-PP	IN	O	2	NMOD
7	lymphocyte	lymphocyte	B-NP	NN	B-cell_type	8	NMOD
8	differentiation	differentiation	I-NP	NN	O	6	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	a	a	B-NP	DT	O	12	NMOD
11	complex	complex	I-NP	JJ	O	12	NMOD
12	process	process	I-NP	NN	O	9	PRD
13	involving	involve	B-VP	VBG	O	12	NMOD
14	interactions	interaction	B-NP	NNS	O	13	OBJ
15	between	between	B-PP	IN	O	14	NMOD
16	multiple	multiple	B-NP	JJ	B-DNA	22	NMOD
17	positive	positive	I-NP	JJ	I-DNA	19	AMOD
18	and	and	I-NP	CC	I-DNA	19	AMOD
19	negative	negative	I-NP	JJ	I-DNA	22	NMOD
20	transcriptional	transcriptional	I-NP	JJ	I-DNA	22	NMOD
21	regulatory	regulatory	I-NP	JJ	I-DNA	22	NMOD
22	elements	element	I-NP	NNS	I-DNA	15	PMOD
23	.	.	O	.	O	9	P

1	This	This	B-NP	DT	O	2	NMOD
2	study	study	I-NP	NN	O	3	SUB
3	concerns	concern	B-VP	VBZ	O	0	ROOT
4	9	9	B-NP	CD	O	7	NMOD
5	iv	iv	I-NP	NN	O	7	NMOD
6	drug	drug	I-NP	NN	O	7	NMOD
7	abusers	abuser	I-NP	NNS	O	3	OBJ
8	with	with	B-PP	IN	O	3	VMOD
9	acquired	acquire	B-NP	VBN	O	11	NMOD
10	immunodeficiency	immunodeficiency	I-NP	NN	O	11	NMOD
11	syndrome	syndrome	I-NP	NN	O	8	PMOD
12	(	(	O	(	O	14	DEP
13	AIDS	AIDS	B-NP	NN	O	14	DEP
14	)	)	O	)	O	11	NMOD
15	who	who	B-NP	WP	O	3	VMOD
16	developed	develop	B-VP	VBD	O	15	SBAR
17	hypercortisolism	hypercortisolism	B-NP	NN	O	16	OBJ
18	without	without	B-PP	IN	O	16	VMOD
19	the	the	B-NP	DT	O	24	NMOD
20	clinical	clinical	I-NP	JJ	O	21	NMOD
21	signs	sign	I-NP	NNS	O	24	NMOD
22	or	or	O	CC	O	24	NMOD
23	metabolic	metabolic	B-NP	JJ	O	24	NMOD
24	consequences	consequence	I-NP	NNS	O	18	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	hypercortisolism	hypercortisolism	B-NP	NN	O	25	PMOD
27	.	.	O	.	O	3	P

1	Glucocorticoid	Glucocorticoid	B-NP	NN	B-protein	3	NMOD
2	receptor	receptor	I-NP	NN	I-protein	3	NMOD
3	density	density	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	increased	increase	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	AIDS	AIDS	B-NP	NN	O	8	NMOD
8	patients	patient	I-NP	NNS	O	6	PMOD
9	with	with	B-PP	IN	O	8	NMOD
10	an	an	B-NP	DT	O	12	NMOD
11	Addisonian	Addisonian	I-NP	JJ	O	12	NMOD
12	picture	picture	I-NP	NN	O	9	PMOD
13	(	(	O	(	O	22	DEP
14	group	group	B-NP	NN	O	21	NMOD
15	1	1	I-NP	CD	O	14	NMOD
16	;	;	O	:	O	21	P
17	16.2	16.2	B-NP	CD	O	19	AMOD
18	±	±	I-NP	CC	O	19	AMOD
19	9.4	9.4	I-NP	CD	O	21	NMOD
20	fmol/million	fmol/million	I-NP	CD	O	21	NMOD
21	cells	cell	I-NP	NNS	O	22	DEP
22	)	)	O	)	O	12	NMOD
23	compared	compare	B-VP	VBN	O	5	VMOD
24	to	to	B-PP	TO	O	23	VMOD
25	values	value	B-NP	NNS	O	24	PMOD
26	in	in	B-PP	IN	O	25	NMOD
27	12	12	B-NP	CD	O	29	NMOD
28	AIDS	AIDS	I-NP	NN	O	29	NMOD
29	patients	patient	I-NP	NNS	O	53	NMOD
30	without	without	B-PP	IN	O	29	NMOD
31	an	an	B-NP	DT	O	33	NMOD
32	Addisonian	Addisonian	I-NP	JJ	O	33	NMOD
33	picture	picture	I-NP	NN	O	30	PMOD
34	(	(	O	(	O	48	DEP
35	group	group	B-NP	NN	O	42	NMOD
36	2	2	I-NP	CD	O	35	NMOD
37	;	;	O	:	O	42	P
38	6.05	6.05	B-NP	CD	O	40	AMOD
39	±	±	I-NP	CC	O	40	AMOD
40	2.6	2.6	I-NP	CD	O	42	NMOD
41	fmol/million	fmol/million	I-NP	NN	O	42	NMOD
42	cells	cell	I-NP	NNS	O	48	DEP
43	;	;	O	:	O	48	P
44	P	P	B-NP	NN	O	46	SUB
45	less	less	B-ADJP	JJR	O	46	AMOD
46	than	than	B-PP	IN	O	48	DEP
47	0.01	0.01	B-NP	CD	O	46	AMOD
48	)	)	O	)	O	29	NMOD
49	and	and	O	CC	O	53	NMOD
50	sex-	sex-	B-NP	NN	O	53	NMOD
51	and	and	O	CC	O	53	NMOD
52	age-matched	age-matched	B-NP	JJ	O	53	NMOD
53	controls	control	I-NP	NNS	O	26	PMOD
54	(	(	O	(	O	65	DEP
55	3.15	3.15	B-NP	CD	O	57	AMOD
56	±	±	I-NP	SYM	O	57	AMOD
57	2.3	2.3	I-NP	CD	O	59	NMOD
58	fmol/million	fmol/million	I-NP	NN	O	59	NMOD
59	cells	cell	I-NP	NNS	O	65	DEP
60	;	;	O	:	O	65	P
61	P	P	B-NP	NN	O	65	DEP
62	less	less	B-ADJP	JJR	O	61	NMOD
63	than	than	B-PP	IN	O	62	AMOD
64	0.01	0.01	B-NP	CD	O	63	PMOD
65	)	)	O	)	O	53	NMOD
66	.	.	O	.	O	4	P

1	Mutations	Mutation	B-NP	NNS	O	13	SUB
2	affecting	affect	B-VP	VBG	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	5	5	I-NP	CD	B-DNA	7	NMOD
5	'	'	I-NP	SYM	I-DNA	7	NMOD
6	guanine	guanine	I-NP	NN	I-DNA	7	NMOD
7	residues	residue	I-NP	NNS	I-DNA	2	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	kappa	kappa	I-NP	NN	B-DNA	12	NMOD
11	B	B	I-NP	NN	I-DNA	12	NMOD
12	site	site	I-NP	NN	I-DNA	8	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	unable	unable	B-ADJP	JJ	O	13	PRD
15	to	to	B-VP	TO	O	16	VMOD
16	compete	compete	I-VP	VB	O	14	AMOD
17	for	for	B-PP	IN	O	16	VMOD
18	these	these	B-NP	DT	O	21	NMOD
19	NF-kappa	NF-kappa	I-NP	NN	B-protein	21	NMOD
20	B-related	B-related	I-NP	JJ	I-protein	19	AMOD
21	proteins	protein	I-NP	NNS	I-protein	17	PMOD
22	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	3	NMOD
2	AP-1	AP-1	I-NP	NN	B-DNA	3	NMOD
3	site	site	I-NP	NN	I-DNA	13	NMOD
4	at	at	B-PP	IN	O	3	NMOD
5	-150	-150	B-NP	CD	B-DNA	6	NMOD
6	bp	bp	I-NP	NN	I-DNA	4	PMOD
7	,	,	B-NP	,	O	13	P
8	but	but	I-NP	CC	O	13	NMOD
9	not	not	I-NP	RB	O	8	DEP
10	the	the	B-NP	DT	O	13	NMOD
11	NF-kappa	NF-kappa	I-NP	NN	B-DNA	13	NMOD
12	B	B	I-NP	NN	I-DNA	13	NMOD
13	site	site	I-NP	NN	I-DNA	15	SUB
14	,	,	O	,	O	13	P
15	is	be	B-VP	VBZ	O	0	ROOT
16	likely	likely	B-ADJP	JJ	O	15	PRD
17	to	to	B-VP	TO	O	18	VMOD
18	represent	represent	I-VP	VB	O	16	AMOD
19	the	the	B-NP	DT	O	21	NMOD
20	major	major	I-NP	JJ	O	21	NMOD
21	target	target	I-NP	NN	O	18	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	protein	protein	B-NP	NN	B-protein	25	NMOD
24	kinase	kinase	I-NP	NN	I-protein	25	NMOD
25	C	C	I-NP	NN	I-protein	22	PMOD
26	in	in	B-PP	IN	O	21	NMOD
27	the	the	B-NP	DT	O	30	NMOD
28	interleukin	interleukin	I-NP	NN	B-DNA	30	NMOD
29	2	2	I-NP	CD	I-DNA	30	NMOD
30	promoter	promoter	I-NP	NN	I-DNA	26	PMOD
31	.	.	O	.	O	15	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	23	DEP
4	induction	induction	B-NP	NN	O	14	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	a	a	B-NP	DT	O	7	NMOD
7	trimer	trimer	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	13	NMOD
10	NFAT	NFAT	I-NP	NN	B-DNA	12	NMOD
11	and	and	I-NP	CC	I-DNA	12	NMOD
12	Oct	Oct	I-NP	NN	I-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	8	PMOD
14	is	be	B-VP	VBZ	O	3	SBAR
15	not	not	O	RB	O	14	VMOD
16	sensitive	sensitive	B-ADJP	JJ	O	14	PRD
17	to	to	B-PP	TO	O	16	AMOD
18	phorbol	phorbol	B-NP	NN	O	20	NMOD
19	ester	ester	I-NP	NN	O	20	NMOD
20	treatment	treatment	I-NP	NN	O	17	PMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	DEP
23	that	that	B-SBAR	IN	O	2	VMOD
24	mutations	mutation	B-NP	NNS	O	30	SUB
25	in	in	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	29	NMOD
27	NF-kappa	NF-kappa	I-NP	NN	B-DNA	29	NMOD
28	B	B	I-NP	NN	I-DNA	29	NMOD
29	site	site	I-NP	NN	I-DNA	25	PMOD
30	have	have	B-VP	VBP	O	23	SBAR
31	no	no	B-NP	DT	O	32	NMOD
32	effect	effect	I-NP	NN	O	30	OBJ
33	on	on	B-PP	IN	O	30	VMOD
34	inducibility	inducibility	B-NP	NN	O	33	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	38	NMOD
37	IL-2	IL-2	I-NP	NN	B-DNA	38	NMOD
38	promoter	promoter	I-NP	NN	I-DNA	35	PMOD
39	.	.	O	.	O	2	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	AP-1	AP-1	I-NP	NN	B-DNA	7	NMOD
7	site	site	I-NP	NN	I-DNA	11	SUB
8	at	at	B-PP	IN	O	7	NMOD
9	-150	-150	B-NP	CD	B-DNA	10	NMOD
10	bp	bp	I-NP	NN	I-DNA	8	PMOD
11	represents	represent	B-VP	VBZ	O	4	SBAR
12	a	a	B-NP	DT	O	13	NMOD
13	major	major	I-NP	JJ	O	20	NMOD
14	,	,	O	,	O	15	P
15	if	if	B-CONJP	IN	O	20	NMOD
16	not	not	I-CONJP	RB	O	15	DEP
17	the	the	B-NP	DT	O	18	NMOD
18	only	only	I-NP	JJ	O	16	DEP
19	,	,	I-NP	,	O	15	P
20	site	site	I-NP	NN	O	11	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	PKC	PKC	B-NP	NN	B-protein	23	NMOD
23	responsiveness	responsiveness	I-NP	NN	O	21	PMOD
24	in	in	B-PP	IN	O	20	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	IL-2	IL-2	I-NP	NN	B-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	24	PMOD
28	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	addition	addition	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	antisense	antisense	B-NP	JJ	O	5	NMOD
5	oligonucleotides	oligonucleotide	I-NP	NNS	O	3	PMOD
6	to	to	B-PP	TO	O	2	NMOD
7	c-fos	c-fos	B-NP	NN	B-DNA	6	PMOD
8	significantly	significantly	B-ADVP	RB	O	9	VMOD
9	inhibited	inhibit	B-VP	VBD	O	25	VMOD
10	IL	IL	B-NP	NN	O	13	NMOD
11	6-induced	6-induced	I-NP	JJ	O	10	AMOD
12	IgM	IgM	I-NP	NN	B-protein	13	NMOD
13	production	production	I-NP	NN	O	9	OBJ
14	by	by	B-PP	IN	O	9	VMOD
15	SKW	SKW	B-NP	NN	B-cell_line	17	NMOD
16	6.4	6.4	I-NP	CD	I-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
18	(	(	O	(	O	23	DEP
19	p	p	B-NP	NN	O	23	DEP
20	less	less	B-ADJP	JJR	O	19	NMOD
21	than	than	B-PP	IN	O	20	AMOD
22	0.001	0.001	B-NP	CD	O	21	PMOD
23	)	)	O	)	O	9	VMOD
24	,	,	O	,	O	25	P
25	whereas	whereas	O	IN	O	0	ROOT
26	control	control	B-NP	NN	O	27	NMOD
27	oligonucleotides	oligonucleotide	I-NP	NNS	O	28	SUB
28	had	have	B-VP	VBD	O	25	VMOD
29	no	no	B-NP	DT	O	31	NMOD
30	inhibitory	inhibitory	I-NP	JJ	O	31	NMOD
31	effect	effect	I-NP	NN	O	28	OBJ
32	.	.	O	.	O	25	P

1	Gel	Gel	B-NP	NN	O	5	NMOD
2	electrophoresis	electrophoresis	I-NP	NN	O	5	NMOD
3	mobility	mobility	I-NP	NN	O	5	NMOD
4	shift	shift	I-NP	NN	O	5	NMOD
5	assays	assay	I-NP	NNS	O	9	NMOD
6	and	and	O	CC	O	9	NMOD
7	DNaseI	DNaseI	B-NP	NN	B-protein	9	NMOD
8	footprinting	footprinting	I-NP	NN	O	9	NMOD
9	assays	assay	I-NP	NNS	O	10	SUB
10	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
11	that	that	B-SBAR	IN	O	10	VMOD
12	these	these	B-NP	DT	O	15	NMOD
13	negative	negative	I-NP	JJ	B-DNA	15	NMOD
14	regulatory	regulatory	I-NP	JJ	I-DNA	15	NMOD
15	sequences	sequence	I-NP	NNS	I-DNA	16	SUB
16	are	be	B-VP	VBP	O	11	SBAR
17	recognized	recognize	I-VP	VBN	O	16	VC
18	differently	differently	B-ADVP	RB	O	17	VMOD
19	by	by	B-PP	IN	O	17	VMOD
20	proteins	protein	B-NP	NNS	O	19	PMOD
21	present	present	B-ADJP	JJ	O	20	NMOD
22	in	in	B-PP	IN	O	21	AMOD
23	nuclear	nuclear	B-NP	JJ	O	24	NMOD
24	extracts	extract	I-NP	NNS	O	22	PMOD
25	obtained	obtain	B-VP	VBN	O	24	NMOD
26	from	from	B-PP	IN	O	25	VMOD
27	HeLa	HeLa	B-NP	NN	B-cell_line	29	NMOD
28	and	and	I-NP	CC	O	29	NMOD
29	K562	K562	I-NP	NN	B-cell_line	30	NMOD
30	cells	cell	I-NP	NNS	I-cell_line	26	PMOD
31	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	suppressive	suppressive	I-NP	JJ	O	3	NMOD
3	activity	activity	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	lost	lose	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	molecules	molecule	B-NP	NNS	O	6	PMOD
8	,	,	O	,	O	5	P
9	lacking	lack	B-VP	VBG	O	5	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	sugar	sugar	I-NP	NN	O	12	NMOD
12	moiety	moiety	I-NP	NN	O	16	NMOD
13	or	or	O	CC	O	16	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	lipid	lipid	I-NP	NN	O	16	NMOD
16	moiety	moiety	I-NP	NN	O	9	OBJ
17	.	.	O	.	O	4	P

1	Furthermore	Furthermore	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	in	in	B-PP	IN	O	8	VMOD
4	time	time	B-NP	NN	O	5	NMOD
5	kinetics	kinetic	I-NP	NNS	O	3	PMOD
6	,	,	O	,	O	8	P
7	gangliosides	ganglioside	B-NP	NNS	O	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	effective	effective	B-ADJP	JJ	O	8	PRD
10	for	for	B-PP	IN	O	9	AMOD
11	up	up	B-NP	IN	O	14	NMOD
12	to	to	I-NP	TO	O	11	AMOD
13	30	30	I-NP	CD	O	11	AMOD
14	min	min	I-NP	NN	O	10	PMOD
15	after	after	B-PP	IN	O	14	NMOD
16	addition	addition	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	LPS	LPS	B-NP	NN	O	17	PMOD
19	,	,	O	,	O	8	VMOD
20	but	but	O	CC	O	19	VMOD
21	not	not	O	RB	O	20	DEP
22	thereafter	thereafter	B-ADVP	RB	O	20	DEP
23	.	.	O	.	O	8	P

1	On	On	B-PP	IN	O	11	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	other	other	I-NP	JJ	O	4	NMOD
4	hand	hand	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	11	P
6	phorbol	phorbol	B-NP	NN	O	8	NMOD
7	ester-induced	ester-induced	I-NP	JJ	O	6	AMOD
8	production	production	I-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	O2-	O2-	B-NP	NN	O	9	PMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	similar	similar	B-ADJP	JJ	O	11	PRD
13	in	in	B-PP	IN	O	12	AMOD
14	cells	cell	B-NP	NNS	O	13	PMOD
15	treated	treat	B-VP	VBN	O	14	NMOD
16	with	with	B-PP	IN	O	15	VMOD
17	and	and	B-PP	CC	O	16	PMOD
18	without	without	B-PP	IN	O	16	PMOD
19	gangliosides	ganglioside	B-NP	NNS	O	16	PMOD
20	.	.	O	.	O	11	P

1	T	T	B-NP	NN	O	4	NMOD
2	cell-specific	cell-specific	I-NP	JJ	O	1	AMOD
3	negative	negative	I-NP	JJ	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	0	ROOT
5	of	of	B-PP	IN	O	4	NMOD
6	transcription	transcription	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	human	human	I-NP	JJ	O	11	NMOD
10	cytokine	cytokine	I-NP	NN	O	11	NMOD
11	IL-4	IL-4	I-NP	NN	B-protein	7	PMOD
12	.	.	O	.	O	4	P

1	A	A	B-NP	DT	O	7	NMOD
2	novel	novel	I-NP	JJ	O	7	NMOD
3	T	T	I-NP	NN	B-DNA	7	NMOD
4	cell-specific	cell-specific	I-NP	JJ	I-DNA	3	AMOD
5	negative	negative	I-NP	JJ	I-DNA	7	NMOD
6	regulatory	regulatory	I-NP	JJ	I-DNA	7	NMOD
7	element	element	I-NP	NN	I-DNA	16	SUB
8	(	(	O	(	O	10	DEP
9	NRE	NRE	B-NP	NN	B-DNA	10	DEP
10	)	)	O	)	O	7	NMOD
11	composed	compose	B-VP	VBN	O	7	NMOD
12	of	of	B-PP	IN	O	11	VMOD
13	two	two	B-NP	CD	O	15	NMOD
14	protein-binding	protein-binding	I-NP	JJ	B-DNA	15	NMOD
15	sites	site	I-NP	NNS	I-DNA	12	PMOD
16	were	be	B-VP	VBD	O	0	ROOT
17	mapped	map	I-VP	VBN	O	16	VC
18	in	in	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	23	NMOD
20	5	5	I-NP	CD	B-DNA	23	NMOD
21	'	'	I-NP	SYM	I-DNA	23	NMOD
22	flanking	flanking	I-NP	NN	I-DNA	23	NMOD
23	region	region	I-NP	NN	I-DNA	18	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	IL-4	IL-4	I-NP	NN	B-DNA	27	NMOD
27	gene	gene	I-NP	NN	I-DNA	24	PMOD
28	:	:	O	:	O	17	P
29	-311CTCCCTTCT-303	-311CTCCCTTCT-303	B-NP	NN	O	34	NMOD
30	(	(	O	(	O	32	DEP
31	NRE-I	NRE-I	B-NP	NN	B-DNA	32	DEP
32	)	)	O	)	O	29	NMOD
33	and	and	O	CC	O	34	NMOD
34	-288CTTTTTGCTT-TGC-300	-288CTTTTTGCTT-TGC-300	B-NP	NN	O	17	OBJ
35	(	(	O	(	O	37	DEP
36	NRE-II	NRE-II	B-NP	NN	B-DNA	37	DEP
37	)	)	O	)	O	34	NMOD
38	.	.	O	.	O	16	P

1	After	After	B-PP	IN	O	14	VMOD
2	3	3	B-NP	CD	O	3	AMOD
3	h	h	I-NP	NN	O	4	NMOD
4	incubation	incubation	I-NP	NN	O	1	PMOD
5	the	the	B-NP	DT	O	8	NMOD
6	specific	specific	I-NP	JJ	O	8	NMOD
7	binding	bind	I-NP	VBG	O	8	NMOD
8	power	power	I-NP	NN	O	14	SUB
9	with	with	B-PP	IN	O	8	NMOD
10	[	[	O	(	O	12	DEP
11	3H	3H	B-NP	NN	O	12	DEP
12	]	]	I-NP	)	O	13	NMOD
13	Dex	Dex	I-NP	NN	O	9	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	decreased	decrease	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	23.3	23.3	B-NP	CD	O	28	NMOD
18	±	±	I-NP	NN	O	28	NMOD
19	10.0	10.0	B-NP	CD	O	28	NMOD
20	,	,	I-NP	,	O	28	P
21	32.2	32.2	I-NP	CD	O	23	AMOD
22	±	±	I-NP	CC	O	23	AMOD
23	13.2	13.2	I-NP	CD	O	28	NMOD
24	and	and	I-NP	CC	O	28	NMOD
25	54.3	54.3	I-NP	CD	O	28	NMOD
26	±	±	I-NP	HYPH	O	28	NMOD
27	9.2	9.2	I-NP	CD	O	28	NMOD
28	%	%	I-NP	NN	O	16	PMOD
29	(	(	O	(	O	57	DEP
30	P	P	B-NP	NN	O	40	NMOD
31	greater	great	B-ADJP	JJR	O	30	NMOD
32	than	than	B-PP	IN	O	31	AMOD
33	0.05	0.05	B-NP	CD	O	32	PMOD
34	,	,	O	,	O	40	P
35	P	P	B-NP	NN	O	40	NMOD
36	greater	great	B-ADJP	JJR	O	35	NMOD
37	than	than	B-PP	IN	O	36	AMOD
38	0.05	0.05	B-NP	CD	O	37	PMOD
39	and	and	O	CC	O	40	NMOD
40	P	P	B-NP	NN	O	57	DEP
41	less	less	B-ADJP	JJR	O	40	NMOD
42	than	than	B-PP	IN	O	41	AMOD
43	0.01	0.01	B-NP	CD	O	42	PMOD
44	as	as	B-PP	IN	O	40	NMOD
45	compared	compare	B-PP	VBN	O	44	SBAR
46	with	with	B-PP	IN	O	45	VMOD
47	the	the	B-NP	DT	O	49	NMOD
48	control	control	I-NP	NN	O	49	NMOD
49	value	value	I-NP	NN	O	46	PMOD
50	of	of	B-PP	IN	O	49	NMOD
51	100	100	B-NP	CD	O	50	PMOD
52	in	in	B-PP	IN	O	49	NMOD
53	the	the	B-NP	DT	O	52	PMOD
54	absence	absence	I-NP	NN	O	52	PMOD
55	of	of	B-PP	IN	O	52	PMOD
56	insulin	insulin	B-NP	NN	B-protein	52	PMOD
57	)	)	O	)	O	28	NMOD
58	respectively	respectively	B-ADVP	RB	O	15	VMOD
59	in	in	B-PP	IN	O	15	VMOD
60	the	the	B-NP	DT	O	61	NMOD
61	presence	presence	I-NP	NN	O	59	PMOD
62	of	of	B-PP	IN	O	61	NMOD
63	20	20	B-NP	CD	O	64	NMOD
64	mU/L	mU/L	I-NP	NN	O	62	PMOD
65	(	(	O	(	O	69	DEP
66	physiological	physiological	B-NP	JJ	O	68	NMOD
67	testing	testing	I-NP	NN	O	68	NMOD
68	concentration	concentration	I-NP	NN	O	69	DEP
69	)	)	O	)	O	64	NMOD
70	,	,	O	,	O	15	P
71	200	200	B-NP	CD	O	72	NMOD
72	mU/L	mU/L	I-NP	NN	O	87	NMOD
73	(	(	O	(	O	77	DEP
74	physiological	physiological	B-NP	JJ	O	76	NMOD
75	upper	upper	I-NP	JJ	O	76	NMOD
76	limit	limit	I-NP	NN	O	77	DEP
77	)	)	O	)	O	72	NMOD
78	and	and	O	CC	O	87	NMOD
79	2	2	B-NP	CD	O	87	NMOD
80	,	,	O	,	O	87	P
81	000	000	B-NP	CD	O	82	NMOD
82	mU/L	mU/L	I-NP	NN	O	87	NMOD
83	(	(	O	(	O	86	DEP
84	pharmacological	pharmacological	B-NP	JJ	O	85	NMOD
85	concentration	concentration	I-NP	NN	O	86	DEP
86	)	)	O	)	O	82	NMOD
87	insulin	insulin	B-NP	NN	O	15	VMOD
88	in	in	B-PP	IN	O	87	NMOD
89	the	the	B-NP	DT	O	91	NMOD
90	incubation	incubation	I-NP	NN	O	91	NMOD
91	medium	medium	I-NP	NN	O	88	PMOD
92	.	.	O	.	O	14	P

1	In	In	B-PP	IN	O	6	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	anti-AIM	anti-AIM	B-NP	NN	B-protein	5	NMOD
5	mAb	mAb	I-NP	NN	I-protein	6	SUB
6	did	do	B-VP	VBD	O	24	VMOD
7	not	not	I-VP	RB	O	6	VMOD
8	induce	induce	I-VP	VB	O	6	VC
9	any	any	B-NP	DT	O	10	NMOD
10	change	change	I-NP	NN	O	8	OBJ
11	in	in	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	binding	binding	I-NP	NN	O	14	NMOD
14	activity	activity	I-NP	NN	O	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	NF-kappa	NF-kappa	B-NP	NN	B-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	21	NMOD
18	,	,	O	,	O	21	P
19	a	a	B-NP	DT	O	21	NMOD
20	transcription	transcription	I-NP	NN	B-protein	21	NMOD
21	factor	factor	I-NP	NN	I-protein	23	NMOD
22	whose	whose	B-NP	WP$	O	23	NMOD
23	activity	activity	I-NP	NN	O	15	PMOD
24	is	be	B-VP	VBZ	O	0	ROOT
25	also	also	I-VP	RB	O	24	VMOD
26	regulated	regulate	I-VP	VBN	O	24	VC
27	by	by	B-PP	IN	O	26	VMOD
28	protein	protein	B-NP	NN	B-protein	30	NMOD
29	kinase	kinase	I-NP	NN	I-protein	30	NMOD
30	C	C	I-NP	NN	I-protein	27	PMOD
31	.	.	O	.	O	24	P

1	The	The	B-NP	DT	O	2	NMOD
2	increase	increase	I-NP	NN	O	6	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	AP-1-binding	AP-1-binding	B-NP	JJ	O	5	NMOD
5	activity	activity	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	accompanied	accompany	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	marked	marked	I-NP	JJ	O	11	NMOD
11	stimulation	stimulation	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	transcription	transcription	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	c-fos	c-fos	B-NP	NN	B-DNA	15	PMOD
17	but	but	B-CONJP	CC	O	19	NMOD
18	not	not	I-CONJP	RB	O	17	DEP
19	that	that	B-NP	DT	O	11	NMOD
20	of	of	B-PP	IN	O	19	NMOD
21	c-jun	c-jun	B-NP	NN	B-DNA	20	PMOD
22	.	.	O	.	O	6	P

1	Surprisingly	Surprisingly	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	however	however	B-ADVP	RB	O	9	VMOD
4	,	,	O	,	O	9	P
5	neither	neither	B-NP	DT	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	8	NMOD
8	proteins	protein	I-NP	NNS	O	6	PMOD
9	bound	bind	B-VP	VBD	O	0	ROOT
10	in	in	B-ADVP	FW	O	9	VMOD
11	vitro	vitro	I-ADVP	FW	O	10	AMOD
12	to	to	B-PP	TO	O	9	VMOD
13	EBS1	EBS1	B-NP	NN	B-DNA	15	NMOD
14	or	or	I-NP	CC	O	15	NMOD
15	EBS2	EBS2	I-NP	NN	B-DNA	12	PMOD
16	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	can	can	B-VP	MD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	be	be	I-VP	VB	O	3	VC
6	explained	explain	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	receptor	receptor	B-NP	NN	O	9	NMOD
9	down-regulation	down-regulation	I-NP	NN	O	7	PMOD
10	due	due	B-ADJP	JJ	O	11	PMOD
11	to	to	B-PP	TO	O	9	NMOD
12	higher	high	B-NP	JJR	O	13	NMOD
13	levels	level	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	mineralocorticoids	mineralocorticoid	B-NP	NNS	O	14	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	PIH	PIH	B-NP	NN	O	16	PMOD
18	;	;	O	:	O	3	P

1	Mean	Mean	B-NP	JJ	O	2	NMOD
2	values	value	I-NP	NNS	O	6	SUB
3	for	for	B-PP	IN	O	2	NMOD
4	plasma	plasma	B-NP	NN	O	5	NMOD
5	aldosterone	aldosterone	I-NP	NN	O	3	PMOD
6	were	be	B-VP	VBD	O	17	VMOD
7	not	not	B-ADJP	RB	O	6	VMOD
8	different	different	I-ADJP	JJ	O	6	PRD
9	between	between	B-PP	IN	O	6	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	two	two	I-NP	CD	O	12	NMOD
12	groups	group	I-NP	NNS	O	9	PMOD
13	,	,	O	,	O	17	P
14	but	but	O	CC	O	17	VMOD
15	significant	significant	B-NP	JJ	O	16	NMOD
16	differences	difference	I-NP	NNS	O	17	SUB
17	were	be	B-VP	VBD	O	0	ROOT
18	observed	observe	I-VP	VBN	O	17	VC
19	for	for	B-PP	IN	O	18	VMOD
20	MR	MR	B-NP	NN	B-protein	36	NMOD
21	(	(	O	(	O	34	DEP
22	preeclampsia	preeclampsia	B-NP	NN	O	27	NMOD
23	,	,	O	,	O	27	P
24	81	81	B-NP	CD	O	27	NMOD
25	±	±	I-NP	HYPH	O	27	NMOD
26	44	44	I-NP	CD	O	27	NMOD
27	receptors/cell	receptors/cell	I-NP	NNS	O	33	NMOD
28	;	;	O	:	O	33	P
29	controls	control	B-NP	NNS	O	33	NMOD
30	,	,	O	,	O	33	P
31	306	306	B-NP	CD	O	33	AMOD
32	±	±	I-NP	CC	O	33	AMOD
33	168	168	I-NP	CD	O	34	DEP
34	)	)	O	)	O	20	NMOD
35	and	and	O	CC	O	36	NMOD
36	SPD	SPD	B-NP	NN	O	19	PMOD
37	(	(	O	(	O	51	DEP
38	preeclampsia	preeclampsia	B-NP	NN	O	43	NMOD
39	,	,	O	,	O	43	P
40	65	65	B-NP	CD	O	43	NMOD
41	±	±	O	HYPH	O	43	NMOD
42	7	7	B-NP	CD	O	43	NMOD
43	mV	mV	I-NP	NN	O	50	NMOD
44	;	;	O	:	O	50	P
45	controls	control	B-NP	NNS	O	50	NMOD
46	,	,	O	,	O	50	P
47	12	12	B-NP	CD	O	50	NMOD
48	±	±	I-NP	HYPH	O	50	NMOD
49	5	5	I-NP	CD	O	50	NMOD
50	mV	mV	I-NP	NN	O	51	DEP
51	)	)	O	)	O	36	NMOD
52	.	.	O	.	O	17	P

1	In	In	B-PP	IN	O	14	VMOD
2	spite	spite	B-NP	NN	O	1	PMOD
3	of	of	B-PP	IN	O	2	NMOD
4	its	its	B-NP	PRP$	O	5	NMOD
5	association	association	I-NP	NN	O	3	PMOD
6	with	with	B-PP	IN	O	5	NMOD
7	p50	p50	B-NP	NN	B-protein	6	PMOD
8	in	in	B-ADVP	FW	O	5	NMOD
9	vitro	vitro	I-ADVP	FW	O	8	AMOD
10	,	,	O	,	O	14	P
11	however	however	B-ADVP	RB	O	14	VMOD
12	,	,	O	,	O	14	P
13	we	we	B-NP	PRP	O	14	SUB
14	found	find	B-VP	VBD	O	0	ROOT
15	a	a	B-NP	DT	O	19	NMOD
16	lymphoid	lymphoid	I-NP	JJ	B-protein	17	AMOD
17	cell-specific	cell-specific	I-NP	JJ	I-protein	19	NMOD
18	nuclear	nuclear	I-NP	JJ	I-protein	19	NMOD
19	factor	factor	I-NP	NN	I-protein	14	OBJ
20	in	in	B-ADVP	FW	O	14	VMOD
21	vivo	vivo	I-ADVP	FW	O	20	AMOD
22	that	that	B-NP	WDT	O	14	VMOD
23	contains	contain	B-VP	VBZ	O	22	SBAR
24	c-Rel	c-Rel	B-NP	NN	B-protein	27	NMOD
25	but	but	B-NP	CC	O	27	NMOD
26	not	not	I-NP	RB	O	25	DEP
27	p50	p50	B-NP	NN	B-protein	28	NMOD
28	epitopes	epitope	I-NP	NNS	I-protein	23	OBJ
29	;	;	O	:	O	14	P

1	Expression	Expression	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	human	human	I-NP	JJ	B-protein	5	NMOD
5	RAR-alpha	RAR-alpha	I-NP	NN	I-protein	2	PMOD
6	in	in	B-PP	IN	O	1	NMOD
7	receptor-negative	receptor-negative	B-NP	JJ	B-cell_line	8	NMOD
8	erythroblasts	erythroblast	I-NP	NNS	I-cell_line	6	PMOD
9	conferred	confer	B-VP	VBD	O	0	ROOT
10	RA-induced	RA-induced	B-NP	JJ	O	11	NMOD
11	regulation	regulation	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	differentiation	differentiation	B-NP	NN	O	12	PMOD
14	to	to	B-PP	TO	O	11	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	otherwise	otherwise	I-NP	RB	O	17	AMOD
17	unresponsive	unresponsive	I-NP	JJ	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
19	,	,	O	,	O	9	P
20	thus	thus	B-ADVP	RB	O	9	VMOD
21	showing	show	B-VP	VBG	O	9	VMOD
22	that	that	B-SBAR	IN	O	21	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	RAR-alpha	RAR-alpha	I-NP	NN	B-protein	25	SUB
25	is	be	B-VP	VBZ	O	22	SBAR
26	essential	essential	B-ADJP	JJ	O	25	PRD
27	for	for	B-PP	IN	O	26	AMOD
28	the	the	B-NP	DT	O	30	NMOD
29	RA	RA	I-NP	NN	O	30	NMOD
30	effect	effect	I-NP	NN	O	27	PMOD
31	.	.	O	.	O	9	P

1	Stability	Stability	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	c-fos	c-fos	I-NP	NN	B-DNA	6	NMOD
5	and	and	O	CC	O	6	NMOD
6	c-jun	c-jun	B-NP	NN	B-RNA	7	NMOD
7	mRNA	mRNA	I-NP	NN	I-RNA	2	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	affected	affect	I-VP	VBN	O	8	VC
11	by	by	B-PP	IN	O	10	VMOD
12	LTB4	LTB4	B-NP	NN	O	11	PMOD
13	,	,	O	,	O	10	P
14	as	as	B-SBAR	IN	O	10	VMOD
15	assessed	assess	B-VP	VBN	O	14	SBAR
16	after	after	B-PP	IN	O	15	VMOD
17	actinomycin	actinomycin	B-NP	NN	O	19	NMOD
18	D	D	I-NP	NN	O	19	NMOD
19	treatment	treatment	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	8	P

1	no	no	B-NP	DT	O	2	NMOD
2	additional	additional	I-NP	JJ	O	8	SUB
3	DNA	DNA	I-NP	NN	B-DNA	4	NMOD
4	segments	segment	I-NP	NNS	I-DNA	2	NMOD
5	with	with	B-PP	IN	O	2	NMOD
6	enhancer	enhancer	B-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	5	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	identified	identify	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	14	NMOD
12	human	human	I-NP	JJ	B-DNA	14	NMOD
13	IL-4	IL-4	I-NP	NN	I-DNA	14	NMOD
14	gene	gene	I-NP	NN	I-DNA	10	PMOD
15	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	3	NMOD
2	P	P	I-NP	NN	B-DNA	3	NMOD
3	sequence	sequence	I-NP	NN	I-DNA	4	SUB
4	does	do	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	share	share	I-VP	VB	O	4	VC
7	homology	homology	B-NP	NN	O	6	OBJ
8	with	with	B-PP	IN	O	6	VMOD
9	the	the	B-NP	DT	O	13	NMOD
10	5	5	I-NP	CD	B-DNA	12	AMOD
11	'	'	I-NP	SYM	I-DNA	12	AMOD
12	upstream	upstream	I-NP	JJ	I-DNA	13	NMOD
13	sequence	sequence	I-NP	NN	I-DNA	8	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	IL-2	IL-2	I-NP	NN	B-DNA	17	NMOD
17	gene	gene	I-NP	NN	I-DNA	14	PMOD
18	,	,	O	,	O	4	P
19	even	even	B-SBAR	RB	O	20	DEP
20	though	though	I-SBAR	IN	O	4	VMOD
21	surrounding	surround	B-VP	VBG	O	22	NMOD
22	sequences	sequence	B-NP	NNS	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	IL-4	IL-4	I-NP	NN	B-DNA	26	NMOD
26	gene	gene	I-NP	NN	I-DNA	29	NMOD
27	share	share	I-NP	NN	O	29	NMOD
28	high	high	I-NP	JJ	O	29	NMOD
29	homology	homology	I-NP	NN	O	23	PMOD
30	with	with	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	IL-2	IL-2	I-NP	NN	B-DNA	33	NMOD
33	gene	gene	I-NP	NN	I-DNA	30	PMOD
34	.	.	O	.	O	4	P

1	Glucocorticoid	Glucocorticoid	B-NP	NN	B-protein	3	NMOD
2	receptor	receptor	I-NP	NN	I-protein	3	NMOD
3	binding	binding	I-NP	NN	O	14	NMOD
4	in	in	B-PP	IN	O	3	NMOD
5	three	three	B-NP	CD	O	8	NMOD
6	different	different	I-NP	JJ	O	8	NMOD
7	cell	cell	I-NP	NN	O	8	NMOD
8	types	type	I-NP	NNS	O	4	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	major	major	B-NP	JJ	O	12	NMOD
11	depressive	depressive	I-NP	JJ	O	12	NMOD
12	disorder	disorder	I-NP	NN	O	9	PMOD
13	:	:	O	:	O	3	P
14	lack	lack	B-NP	NN	O	0	ROOT
15	of	of	B-PP	IN	O	14	NMOD
16	evidence	evidence	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	receptor	receptor	B-NP	NN	O	20	NMOD
19	binding	binding	I-NP	NN	O	20	NMOD
20	defect	defect	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	14	P

1	2	2	B-LST	LS	O	20	VMOD
2	.	.	O	.	O	1	P
3	Mononuclear	Mononuclear	B-NP	JJ	B-cell_type	4	NMOD
4	leukocytes	leukocyte	I-NP	NNS	I-cell_type	8	SUB
5	binding	bind	B-VP	VBG	O	4	NMOD
6	to	to	B-PP	TO	O	5	VMOD
7	glucocorticoid	glucocorticoid	B-NP	NN	O	6	PMOD
8	correlated	correlate	B-VP	VBD	O	20	VMOD
9	significantly	significantly	B-ADVP	RB	O	8	VMOD
10	with	with	B-PP	IN	O	8	VMOD
11	polymorphonuclear	polymorphonuclear	B-NP	JJ	B-cell_type	12	NMOD
12	leukocytes	leukocyte	I-NP	NNS	I-cell_type	10	PMOD
13	binding	bind	B-VP	VBG	O	12	NMOD
14	to	to	B-PP	TO	O	13	VMOD
15	glucocorticoid	glucocorticoid	B-NP	NN	O	14	PMOD
16	,	,	O	,	O	20	P
17	but	but	O	CC	O	20	VMOD
18	both	both	B-NP	DT	O	19	NMOD
19	determinations	determination	I-NP	NNS	O	20	SUB
20	failed	fail	B-VP	VBD	O	0	ROOT
21	to	to	I-VP	TO	O	22	VMOD
22	differentiate	differentiate	I-VP	VB	O	20	VMOD
23	major	major	B-NP	JJ	O	25	NMOD
24	depressive	depressive	I-NP	JJ	O	25	NMOD
25	disorder	disorder	I-NP	NN	O	28	NMOD
26	and	and	I-NP	CC	O	28	NMOD
27	control	control	I-NP	NN	O	28	NMOD
28	subjects	subject	I-NP	NNS	O	22	OBJ
29	.	.	O	.	O	20	P

1	3	3	B-LST	LS	O	12	VMOD
2	.	.	O	.	O	1	P
3	Initial	Initial	B-NP	JJ	O	5	AMOD
4	and	and	I-NP	CC	O	5	AMOD
5	post-dexamethasone	post-dexamethasone	I-NP	JJ	O	8	NMOD
6	in	in	I-NP	FW	O	7	AMOD
7	vitro	vitro	I-NP	FW	O	8	NMOD
8	fibroblast	fibroblast	I-NP	NN	O	12	SUB
9	binding	binding	I-NP	NN	O	8	NMOD
10	to	to	B-PP	TO	O	9	VMOD
11	glucocorticoid	glucocorticoid	B-NP	NN	O	10	PMOD
12	was	be	B-VP	VBD	O	0	ROOT
13	not	not	O	RB	O	12	VMOD
14	different	different	B-ADJP	JJ	O	12	PRD
15	between	between	B-PP	IN	O	12	VMOD
16	major	major	B-NP	JJ	O	18	NMOD
17	depressive	depressive	I-NP	JJ	O	18	NMOD
18	disorder	disorder	I-NP	NN	O	22	NMOD
19	and	and	O	CC	O	22	NMOD
20	non-depressed	non-depressed	B-NP	JJ	O	22	NMOD
21	control	control	I-NP	NN	O	22	NMOD
22	subjects	subject	I-NP	NNS	O	15	PMOD
23	.	.	O	.	O	12	P

1	Specific	Specific	B-NP	JJ	O	3	NMOD
2	nuclear	nuclear	I-NP	JJ	O	3	NMOD
3	translocation	translocation	I-NP	NN	O	9	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	[	[	O	(	B-protein	8	NMOD
6	3H	3H	B-NP	NN	I-protein	8	NMOD
7	]	]	I-NP	)	I-protein	8	NMOD
8	calcitriol/VDR	calcitriol/VDR	I-NP	NN	I-protein	4	PMOD
9	was	be	B-VP	VBD	O	0	ROOT
10	examined	examine	I-VP	VBN	O	9	VC
11	after	after	B-PP	IN	O	10	VMOD
12	exposure	exposure	B-NP	NN	O	37	NMOD
13	of	of	B-PP	IN	O	12	NMOD
14	whole	whole	B-NP	JJ	B-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
16	to	to	B-PP	TO	O	12	NMOD
17	10	10	B-NP	CD	O	21	AMOD
18	(	(	O	(	O	20	DEP
19	-9	-9	B-NP	CD	O	20	DEP
20	)	)	O	)	O	17	NMOD
21	M/l	M/l	B-NP	NN	O	22	NMOD
22	calcitriol	calcitriol	I-NP	NN	O	16	PMOD
23	in	in	B-PP	IN	O	12	NMOD
24	the	the	B-NP	DT	O	27	NMOD
25	presence	presence	I-NP	NN	O	27	NMOD
26	and	and	I-NP	CC	O	27	NMOD
27	absence	absence	I-NP	NN	O	23	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	a	a	B-NP	DT	O	31	NMOD
30	500-fold	500-fold	I-NP	JJ	O	31	NMOD
31	excess	excess	I-NP	NN	O	28	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	unlabeled	unlabeled	B-NP	JJ	O	34	NMOD
34	ligand	ligand	I-NP	NN	O	32	PMOD
35	and	and	O	CC	O	37	NMOD
36	subsequent	subsequent	B-NP	JJ	O	37	NMOD
37	isolation	isolation	I-NP	NN	O	11	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	nuclei	nucleus	B-NP	NNS	O	38	PMOD
40	.	.	O	.	O	9	P

1	Pulse	Pulse	B-NP	NN	O	2	NMOD
2	exposure	exposure	I-NP	NN	O	20	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	HL60	HL60	B-NP	NN	B-cell_line	3	PMOD
5	to	to	B-PP	TO	O	2	NMOD
6	radiolabeled	radiolabele	B-NP	VBN	O	7	NMOD
7	hormone	hormone	I-NP	NN	O	5	PMOD
8	for	for	B-PP	IN	O	2	NMOD
9	3	3	B-NP	CD	O	10	NMOD
10	h	h	I-NP	NN	O	8	PMOD
11	followed	follow	B-VP	VBN	O	2	NMOD
12	by	by	B-PP	IN	O	11	VMOD
13	culture	culture	B-NP	NN	O	12	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	medium	medium	B-NP	NN	O	14	PMOD
16	without	without	B-PP	IN	O	13	NMOD
17	serum	serum	B-NP	NN	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	calcitriol	calcitriol	I-NP	NN	O	16	PMOD
20	lead	lead	B-VP	VBP	O	0	ROOT
21	to	to	B-PP	TO	O	20	VMOD
22	nuclear	nuclear	B-NP	JJ	O	23	NMOD
23	retention	retention	I-NP	NN	O	35	NMOD
24	of	of	B-PP	IN	O	23	NMOD
25	approximately	approximately	B-NP	RB	O	28	NMOD
26	1600	1600	I-NP	CD	O	25	AMOD
27	radiolabeled	radiolabele	I-NP	VBN	O	28	NMOD
28	VDR	VDR	I-NP	NN	B-protein	24	PMOD
29	by	by	B-PP	IN	O	23	NMOD
30	8	8	B-NP	CD	O	31	NMOD
31	h	h	I-NP	NN	O	29	PMOD
32	and	and	O	CC	O	35	NMOD
33	approximately	approximately	B-NP	RB	O	35	NMOD
34	1000	1000	I-NP	CD	O	33	AMOD
35	VDR	VDR	I-NP	NN	B-protein	21	PMOD
36	by	by	B-PP	IN	O	20	VMOD
37	24	24	B-NP	CD	O	38	NMOD
38	h	h	I-NP	NN	O	36	PMOD
39	.	.	O	.	O	20	P

1	No	No	B-NP	DT	O	2	NMOD
2	difference	difference	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	VDR	VDR	B-NP	NN	B-protein	5	NMOD
5	retention	retention	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	pulse	pulse	B-NP	NN	O	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	pulse/chase-experiments	pulse/chase-experiment	I-NP	NNS	O	6	PMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	seen	see	I-VP	VBN	O	10	VC
12	in	in	B-PP	IN	O	11	VMOD
13	PBL	PBL	B-NP	NN	B-cell_type	12	PMOD
14	,	,	O	,	O	13	P
15	where	where	B-ADVP	WRB	O	13	NMOD
16	VDR	VDR	B-NP	NN	B-protein	17	NMOD
17	halflife	halflife	I-NP	NN	O	18	SUB
18	was	be	B-VP	VBD	O	15	SBAR
19	approximately	approximately	B-NP	RB	O	21	NMOD
20	30	30	I-NP	CD	O	19	AMOD
21	min	min	I-NP	NN	O	18	PRD
22	.	.	O	.	O	10	P

1	No	No	B-NP	DT	O	3	NMOD
2	specific	specific	I-NP	JJ	O	3	NMOD
3	translocation	translocation	I-NP	NN	O	8	SUB
4	into	into	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	nuclear	nuclear	I-NP	JJ	O	7	NMOD
7	compartment	compartment	I-NP	NN	O	4	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	seen	see	I-VP	VBN	O	8	VC
10	when	when	B-ADVP	WRB	O	9	VMOD
11	isolated	isolate	B-NP	VBN	O	12	NMOD
12	nuclei	nucleus	I-NP	NNS	O	13	SUB
13	were	be	B-VP	VBD	O	10	SBAR
14	incubated	incubate	I-VP	VBN	O	13	VC
15	in	in	B-PP	IN	O	14	VMOD
16	[	[	B-NP	(	O	18	DEP
17	3H	3H	I-NP	NN	O	18	DEP
18	]	]	I-NP	)	O	19	NMOD
19	calcitriol	calcitriol	I-NP	NN	O	15	PMOD
20	.	.	O	.	O	8	P

1	Radiolabeled	Radiolabele	B-NP	VBN	B-protein	3	NMOD
2	hormone/receptor	hormone/receptor	I-NP	NN	I-protein	3	NMOD
3	complexes	complex	I-NP	NNS	I-protein	26	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	nuclei	nucleus	B-NP	NNS	O	4	PMOD
6	isolated	isolate	B-VP	VBN	O	5	NMOD
7	from	from	B-PP	IN	O	6	VMOD
8	cells	cell	B-NP	NNS	O	7	PMOD
9	exposed	expose	B-VP	VBN	O	8	NMOD
10	for	for	B-PP	IN	O	9	VMOD
11	3	3	B-NP	CD	O	12	NMOD
12	h	h	I-NP	NN	O	10	PMOD
13	to	to	B-PP	TO	O	9	VMOD
14	radiolabeled	radiolabele	B-NP	VBN	O	15	NMOD
15	hormone	hormone	I-NP	NN	O	13	PMOD
16	--	--	O	:	O	9	P
17	in	in	B-PP	IN	O	9	VMOD
18	contrast	contrast	B-NP	NN	O	17	PMOD
19	to	to	B-PP	TO	O	17	PMOD
20	identical	identical	B-NP	JJ	O	21	NMOD
21	experiments	experiment	I-NP	NNS	O	17	PMOD
22	with	with	B-PP	IN	O	21	NMOD
23	intact	intact	B-NP	JJ	O	24	NMOD
24	cells	cell	I-NP	NNS	O	22	PMOD
25	--	--	O	:	O	9	P
26	did	do	B-VP	VBD	O	0	ROOT
27	not	not	I-VP	RB	O	26	VMOD
28	disappear	disappear	I-VP	VB	O	26	VC
29	from	from	B-PP	IN	O	28	VMOD
30	the	the	B-NP	DT	O	32	NMOD
31	nuclear	nuclear	I-NP	JJ	O	32	NMOD
32	compartment	compartment	I-NP	NN	O	29	PMOD
33	upon	upon	B-PP	IN	O	28	VMOD
34	incubation	incubation	B-NP	NN	O	33	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	nuclei	nucleus	B-NP	NNS	O	35	PMOD
37	with	with	B-PP	IN	O	34	NMOD
38	identical	identical	B-NP	JJ	O	39	NMOD
39	concentrations	concentration	I-NP	NNS	O	37	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	43	NMOD
42	unlabeled	unlabeled	I-NP	JJ	O	43	NMOD
43	compound	compound	I-NP	NN	O	40	PMOD
44	.	.	O	.	O	26	P

1	No	No	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	seen	see	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	ethanol	ethanol	B-NP	NN	B-cell_line	8	NMOD
7	treated	treat	I-NP	VBN	I-cell_line	6	AMOD
8	controls	control	I-NP	NNS	I-cell_line	5	PMOD
9	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	report	report	I-NP	NN	O	4	SUB
3	directly	directly	B-ADVP	RB	O	4	VMOD
4	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	OTF-2	OTF-2	B-NP	NN	B-protein	9	NMOD
7	but	but	B-NP	CC	O	9	NMOD
8	not	not	I-NP	RB	O	7	DEP
9	OTF-1	OTF-1	B-NP	NN	B-protein	10	SUB
10	regulates	regulate	B-VP	VBZ	O	5	SBAR
11	the	the	B-NP	DT	O	13	NMOD
12	DRA	DRA	I-NP	NN	B-DNA	13	NMOD
13	gene	gene	I-NP	NN	I-DNA	10	OBJ
14	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	7	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	7	P
4	OTF-1-enriched	OTF-1-enriched	B-NP	JJ	O	6	NMOD
5	protein	protein	I-NP	NN	O	6	NMOD
6	fractions	fraction	I-NP	NNS	O	7	SUB
7	did	do	B-VP	VBD	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	affect	affect	I-VP	VB	O	7	VC
10	DRA	DRA	B-NP	NN	B-DNA	12	NMOD
11	gene	gene	I-NP	NN	I-DNA	12	NMOD
12	transcription	transcription	I-NP	NN	O	9	OBJ
13	although	although	B-SBAR	IN	O	9	VMOD
14	it	it	B-NP	PRP	O	16	SUB
15	functionally	functionally	B-ADVP	RB	O	16	VMOD
16	enhanced	enhance	B-VP	VBD	O	13	SBAR
17	the	the	B-NP	DT	O	18	NMOD
18	transcription	transcription	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	another	another	B-NP	DT	O	21	NMOD
21	gene	gene	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	16	VMOD
2	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	1	PMOD
3	from	from	B-PP	IN	O	2	NMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	with	with	B-PP	IN	O	4	NMOD
6	hereditary	hereditary	B-NP	JJ	O	7	NMOD
7	hypercholesteremia	hypercholesteremia	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	homozygous	homozygous	B-NP	JJ	O	10	NMOD
10	type	type	I-NP	NN	O	8	PMOD
11	the	the	B-NP	DT	O	12	NMOD
12	number	number	I-NP	NN	O	16	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	15	NMOD
15	receptors	receptor	I-NP	NNS	I-protein	13	PMOD
16	did	do	B-VP	VBD	O	0	ROOT
17	not	not	I-VP	RB	O	16	VMOD
18	exceed	exceed	I-VP	VB	O	16	VC
19	10	10	B-NP	CD	O	20	NMOD
20	%	%	I-NP	NN	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	their	their	B-NP	PRP$	O	23	NMOD
23	content	content	I-NP	NN	O	21	PMOD
24	in	in	B-PP	IN	O	23	NMOD
25	normal	normal	B-NP	JJ	B-cell_type	26	NMOD
26	cells	cell	I-NP	NNS	I-cell_type	24	PMOD
27	.	.	O	.	O	16	P

1	Tumor	Tumor	B-NP	NN	B-protein	3	NMOD
2	necrosis	necrosis	I-NP	NN	I-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	4	SUB
4	induced	induce	B-VP	VBD	O	0	ROOT
5	slightly	slightly	B-NP	RB	O	4	VMOD
6	c-fos	c-fos	I-NP	NN	B-DNA	4	OBJ
7	and	and	O	CC	O	4	VMOD
8	had	have	B-VP	VBD	O	4	VMOD
9	almost	almost	B-NP	RB	O	11	NMOD
10	no	no	I-NP	DT	O	9	AMOD
11	effect	effect	I-NP	NN	O	8	OBJ
12	on	on	B-PP	IN	O	8	VMOD
13	c-jun	c-jun	B-NP	NN	B-DNA	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	AP1	AP1	I-NP	NN	B-protein	12	PMOD
16	.	.	O	.	O	4	P

1	Plasma	Plasma	B-NP	NN	O	7	NMOD
2	aldosterone	aldosterone	I-NP	NN	O	4	NMOD
3	and	and	O	CC	O	4	NMOD
4	cortisol	cortisol	B-NP	NN	O	1	NMOD
5	and	and	I-NP	CC	O	7	NMOD
6	lymphocyte	lymphocyte	I-NP	NN	B-cell_type	7	NMOD
7	subsets	subset	I-NP	NNS	I-cell_type	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	not	not	B-ADJP	RB	O	8	VMOD
10	different	different	I-ADJP	JJ	O	8	PRD
11	in	in	B-PP	IN	O	10	AMOD
12	the	the	B-NP	DT	O	14	NMOD
13	two	two	I-NP	CD	O	14	NMOD
14	groups	group	I-NP	NNS	O	11	PMOD
15	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	22	DEP
5	aged	aged	B-NP	JJ	O	6	NMOD
6	subjects	subject	I-NP	NNS	O	7	SUB
7	have	have	B-VP	VBP	O	4	SBAR
8	reductions	reduction	B-NP	NNS	O	7	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	corticosteroid	corticosteroid	B-NP	NN	B-protein	11	NMOD
11	receptors	receptor	I-NP	NNS	I-protein	9	PMOD
12	that	that	B-NP	WDT	O	8	NMOD
13	are	be	B-VP	VBP	O	12	SBAR
14	not	not	I-VP	RB	O	13	VMOD
15	associated	associate	I-VP	VBN	O	13	VC
16	with	with	B-PP	IN	O	15	VMOD
17	increase	increase	B-NP	NN	O	16	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	related	related	B-NP	JJ	O	20	NMOD
20	steroids	steroid	I-NP	NNS	O	18	PMOD
21	and	and	O	CC	O	22	DEP
22	that	that	B-SBAR	IN	O	3	VMOD
23	this	this	B-NP	DT	O	24	NMOD
24	situation	situation	I-NP	NN	O	26	SUB
25	probably	probably	B-ADVP	RB	O	26	VMOD
26	represents	represent	B-VP	VBZ	O	22	SBAR
27	a	a	B-NP	DT	O	28	NMOD
28	concomitant	concomitant	I-NP	NN	O	26	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	33	NMOD
31	normal	normal	I-NP	JJ	O	33	NMOD
32	aging	aging	I-NP	NN	O	33	NMOD
33	process	process	I-NP	NN	O	29	PMOD
34	.	.	O	.	O	3	P

1	T3SO4	T3SO4	B-NP	NN	O	2	SUB
2	had	have	B-VP	VBD	O	0	ROOT
3	no	no	B-NP	DT	O	5	NMOD
4	thyromimetic	thyromimetic	I-NP	JJ	O	5	NMOD
5	effect	effect	I-NP	NN	O	2	OBJ
6	on	on	B-PP	IN	O	2	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	activity	activity	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	Ca	Ca	B-NP	NN	B-protein	14	NMOD
11	(	(	O	(	I-protein	14	NMOD
12	2+	2+	O	JJ	I-protein	14	NMOD
13	)	)	O	)	I-protein	14	NMOD
14	-ATPase	-ATPase	B-NP	NN	I-protein	9	PMOD
15	in	in	B-PP	IN	O	8	NMOD
16	human	human	B-NP	JJ	O	18	NMOD
17	erythrocyte	erythrocyte	I-NP	NN	O	18	NMOD
18	membranes	membrane	I-NP	NNS	O	15	PMOD
19	at	at	B-PP	IN	O	8	NMOD
20	doses	dose	B-NP	NNS	O	19	PMOD
21	up	up	B-PP	RB	O	22	PMOD
22	to	to	B-PP	TO	O	20	NMOD
23	10	10	B-NP	CD	O	26	AMOD
24	,	,	O	,	O	26	P
25	000	000	B-NP	CD	O	26	AMOD
26	times	time	I-NP	NNS	O	30	NMOD
27	the	the	I-NP	DT	O	30	NMOD
28	maximally	maximally	I-NP	RB	O	29	AMOD
29	effective	effective	I-NP	JJ	O	30	NMOD
30	dose	dose	I-NP	NN	O	22	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	T3	T3	B-NP	NN	O	31	PMOD
33	(	(	O	(	O	37	DEP
34	10	10	B-NP	CD	O	37	DEP
35	(	(	O	(	O	37	DEP
36	-10	-10	B-NP	CD	O	37	DEP
37	)	)	O	)	O	30	NMOD
38	mol/L	mol/L	B-NP	NN	O	30	NMOD
39	)	)	O	)	O	2	VMOD
40	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	7	VMOD
2	GH4C1	GH4C1	B-NP	NN	B-cell_line	4	NMOD
3	pituitary	pituitary	I-NP	JJ	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
5	,	,	O	,	O	7	P
6	T3SO4	T3SO4	B-NP	NN	O	7	SUB
7	failed	fail	B-VP	VBD	O	0	ROOT
8	to	to	I-VP	TO	O	9	VMOD
9	displace	displace	I-VP	VB	O	7	VMOD
10	[	[	O	(	O	12	DEP
11	125I	125I	B-NP	NN	O	12	DEP
12	]	]	O	)	O	9	VMOD
13	T3	T3	B-NP	NN	O	9	VMOD
14	from	from	B-PP	IN	O	13	NMOD
15	nuclear	nuclear	B-NP	JJ	B-protein	16	NMOD
16	receptors	receptor	I-NP	NNS	I-protein	14	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	intact	intact	B-NP	JJ	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	22	NMOD
20	or	or	O	CC	O	22	NMOD
21	soluble	soluble	B-NP	JJ	O	22	NMOD
22	preparations	preparation	I-NP	NNS	O	17	PMOD
23	.	.	O	.	O	7	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	T3SO4	T3SO4	B-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	not	not	O	RB	O	4	VMOD
6	directly	directly	B-ADJP	RB	O	4	VMOD
7	thyromimetic	thyromimetic	I-ADJP	JJ	O	4	PRD
8	in	in	B-PP	IN	O	4	VMOD
9	either	either	O	CC	O	19	NMOD
10	an	an	B-NP	DT	O	14	NMOD
11	isolated	isolate	I-NP	VBN	O	14	NMOD
12	human	human	I-NP	JJ	O	14	NMOD
13	membrane	membrane	I-NP	NN	O	14	NMOD
14	system	system	I-NP	NN	O	19	NMOD
15	or	or	O	CC	O	19	NMOD
16	a	a	B-NP	DT	O	19	NMOD
17	pituitary	pituitary	I-NP	JJ	O	19	NMOD
18	cell	cell	I-NP	NN	O	19	NMOD
19	system	system	I-NP	NN	O	8	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	which	which	B-NP	WDT	O	20	PMOD
22	nuclear	nuclear	B-NP	JJ	O	24	NMOD
23	receptor	receptor	I-NP	NN	O	24	NMOD
24	occupancy	occupancy	I-NP	NN	O	25	SUB
25	correlates	correlate	B-VP	VBZ	O	20	SBAR
26	with	with	B-PP	IN	O	25	VMOD
27	GH	GH	B-NP	NN	O	28	NMOD
28	synthesis	synthesis	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	4	P

1	Propylthiouracil	Propylthiouracil	B-NP	NN	O	6	SUB
2	(	(	O	(	O	5	DEP
3	50	50	B-NP	CD	O	4	NMOD
4	mumol/L	mumol/L	I-NP	NN	O	5	DEP
5	)	)	O	)	O	1	NMOD
6	did	do	B-VP	VBD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	affect	affect	I-VP	VB	O	6	VC
9	the	the	B-NP	DT	O	10	NMOD
10	action	action	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	T3SO4	T3SO4	B-NP	NN	O	11	PMOD
13	,	,	O	,	O	8	P
14	suggesting	suggest	B-VP	VBG	O	8	VMOD
15	that	that	B-SBAR	IN	O	14	VMOD
16	deiodination	deiodination	B-NP	NN	O	17	SUB
17	was	be	B-VP	VBD	O	15	SBAR
18	not	not	O	RB	O	17	VMOD
19	important	important	B-ADJP	JJ	O	17	PRD
20	for	for	B-PP	IN	O	19	AMOD
21	this	this	B-NP	DT	O	22	NMOD
22	activity	activity	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	T3SO4	T3SO4	B-NP	NN	O	23	PMOD
25	.	.	O	.	O	6	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	appears	appear	B-VP	VBZ	O	0	ROOT
5	T3SO4	T3SO4	B-NP	NN	O	6	SUB
6	has	have	B-VP	VBZ	O	4	VMOD
7	no	no	B-NP	DT	O	10	NMOD
8	intrinsic	intrinsic	I-NP	JJ	O	10	NMOD
9	biological	biological	I-NP	JJ	O	10	NMOD
10	activity	activity	I-NP	NN	O	6	OBJ
11	,	,	O	,	O	6	P
12	but	but	O	CC	O	6	VMOD
13	,	,	O	,	O	6	P
14	under	under	B-PP	IN	O	18	VMOD
15	certain	certain	B-NP	JJ	O	16	NMOD
16	circumstances	circumstance	I-NP	NNS	O	14	PMOD
17	,	,	O	,	O	18	P
18	may	may	B-VP	MD	O	6	VMOD
19	be	be	I-VP	VB	O	18	VC
20	reactivated	reactivate	I-VP	VBN	O	19	VC
21	by	by	B-PP	IN	O	20	VMOD
22	desulfation	desulfation	B-NP	NN	O	21	PMOD
23	.	.	O	.	O	4	P

1	Although	Although	B-SBAR	IN	O	11	VMOD
2	NF-AT	NF-AT	B-NP	NN	B-protein	3	SUB
3	has	have	B-VP	VBZ	O	1	SBAR
4	not	not	I-VP	RB	O	3	VMOD
5	been	be	I-VP	VBN	O	3	VC
6	cloned	clone	I-VP	VBN	O	5	VC
7	or	or	I-VP	CC	O	6	VMOD
8	purified	purify	I-VP	VBN	O	6	VMOD
9	,	,	O	,	O	11	P
10	there	there	B-NP	EX	O	11	SUB
11	is	be	B-VP	VBZ	O	0	ROOT
12	evidence	evidence	B-NP	NN	O	11	PRD
13	that	that	B-SBAR	IN	O	12	NMOD
14	it	it	B-NP	PRP	O	15	SUB
15	is	be	B-VP	VBZ	O	13	SBAR
16	a	a	B-NP	DT	O	18	NMOD
17	major	major	I-NP	JJ	O	18	NMOD
18	target	target	I-NP	NN	O	15	PRD
19	for	for	B-PP	IN	O	18	NMOD
20	immunosuppression	immunosuppression	B-NP	NN	O	19	PMOD
21	by	by	B-PP	IN	O	20	NMOD
22	cyclosporin	cyclosporin	B-NP	NN	O	23	NMOD
23	A	A	I-NP	NN	O	28	NMOD
24	(	(	O	(	O	26	DEP
25	CsA	CsA	B-NP	NN	O	26	DEP
26	)	)	O	)	O	23	NMOD
27	and	and	O	CC	O	28	NMOD
28	FK506	FK506	B-NP	NN	O	21	PMOD
29	(	(	O	(	O	32	DEP
30	refs	ref	B-NP	NNS	O	32	DEP
31	2-7	2-7	B-NP	CD	O	30	NMOD
32	)	)	O	)	O	28	NMOD
33	.	.	O	.	O	11	P

1	Pretreatment	Pretreatment	B-NP	NN	O	4	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	2	PMOD
4	potentiates	potentiate	B-VP	VBZ	O	12	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	IFN-alpha-induced	IFN-alpha-induced	I-NP	JJ	O	7	NMOD
7	protection	protection	I-NP	NN	O	4	OBJ
8	,	,	O	,	O	12	P
9	but	but	O	CC	O	12	VMOD
10	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	12	SUB
11	alone	alone	B-ADVP	RB	O	10	NMOD
12	does	do	B-VP	VBZ	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	have	have	I-VP	VB	O	12	VC
15	any	any	B-NP	DT	O	17	NMOD
16	antiviral	antiviral	I-NP	JJ	O	17	NMOD
17	activity	activity	I-NP	NN	O	14	OBJ
18	.	.	O	.	O	12	P

1	ISG15	ISG15	B-NP	NN	B-RNA	3	NMOD
2	mRNA	mRNA	I-NP	NN	I-RNA	3	NMOD
3	accumulation	accumulation	I-NP	NN	O	7	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	U937	U937	B-NP	NN	B-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	not	not	O	RB	O	7	VMOD
9	detectable	detectable	B-ADJP	JJ	O	7	PRD
10	before	before	B-PP	IN	O	7	VMOD
11	6	6	B-NP	CD	O	12	NMOD
12	h	h	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	IFN-alpha	IFN-alpha	B-NP	NN	B-protein	15	NMOD
15	treatment	treatment	I-NP	NN	O	13	PMOD
16	,	,	O	,	O	7	P
17	peaks	peak	B-VP	VBZ	O	7	VMOD
18	at	at	B-PP	IN	O	17	VMOD
19	24	24	B-NP	CD	O	20	NMOD
20	h	h	I-NP	NN	O	18	PMOD
21	,	,	O	,	O	7	P
22	and	and	O	CC	O	7	VMOD
23	requires	require	B-VP	VBZ	O	7	VMOD
24	protein	protein	B-NP	NN	O	25	NMOD
25	synthesis	synthesis	I-NP	NN	O	23	OBJ
26	.	.	O	.	O	7	P

1	Although	Although	B-SBAR	IN	O	13	VMOD
2	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	4	SUB
3	alone	alone	B-ADVP	RB	O	2	NMOD
4	does	do	B-VP	VBZ	O	1	SBAR
5	not	not	I-VP	RB	O	4	VMOD
6	induce	induce	I-VP	VB	O	4	VC
7	ISG	ISG	B-NP	NN	B-protein	8	NMOD
8	expression	expression	I-NP	NN	O	6	OBJ
9	,	,	O	,	O	13	P
10	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	11	NMOD
11	pretreatment	pretreatment	I-NP	NN	O	13	SUB
12	markedly	markedly	B-ADVP	RB	O	13	VMOD
13	increases	increase	B-VP	VBZ	O	0	ROOT
14	and	and	I-VP	CC	O	13	VMOD
15	hastens	hasten	I-VP	VBZ	O	13	VMOD
16	ISG	ISG	B-NP	NN	B-protein	17	NMOD
17	expression	expression	I-NP	NN	O	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	transcriptional	transcriptional	B-NP	JJ	O	20	NMOD
20	induction	induction	I-NP	NN	O	13	VMOD
21	.	.	O	.	O	13	P

1	Little	Little	B-NP	JJ	O	2	NMOD
2	effect	effect	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	observed	observe	I-VP	VBN	O	3	VC
5	with	with	B-PP	IN	O	4	VMOD
6	50-kDa	50-kDa	B-NP	JJ	B-protein	7	NMOD
7	forms	form	I-NP	NNS	I-protein	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	p105	p105	B-NP	NN	B-protein	11	NMOD
10	NF-kappa	NF-kappa	I-NP	NN	B-protein	11	NMOD
11	B	B	I-NP	NN	I-protein	13	NMOD
12	or	or	O	CC	O	13	NMOD
13	rel	rel	B-NP	NN	B-protein	8	PMOD
14	,	,	O	,	O	4	P
15	in	in	B-PP	IN	O	4	VMOD
16	combination	combination	B-NP	NN	O	15	PMOD
17	with	with	B-PP	IN	O	16	NMOD
18	p65	p65	B-NP	NN	B-protein	21	NMOD
19	or	or	O	CC	O	21	NMOD
20	full-length	full-length	B-NP	JJ	B-protein	21	NMOD
21	c-rel	c-rel	I-NP	NN	I-protein	17	PMOD
22	,	,	O	,	O	21	P
23	which	which	B-NP	WDT	O	21	NMOD
24	do	do	B-VP	VBP	O	23	SBAR
25	not	not	I-VP	RB	O	24	VMOD
26	stimulate	stimulate	I-VP	VB	O	24	VC
27	the	the	B-NP	DT	O	29	NMOD
28	HIV	HIV	I-NP	NN	B-DNA	29	NMOD
29	enhancer	enhancer	I-NP	NN	I-DNA	26	OBJ
30	in	in	B-PP	IN	O	29	NMOD
31	these	these	B-NP	DT	O	32	NMOD
32	cells	cell	I-NP	NNS	O	30	PMOD
33	.	.	O	.	O	3	P

1	Activation	Activation	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	9	NMOD
4	human	human	I-NP	JJ	B-DNA	9	NMOD
5	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	9	NMOD
6	virus	virus	I-NP	NN	I-DNA	9	NMOD
7	type	type	I-NP	NN	I-DNA	9	NMOD
8	1	1	I-NP	CD	I-DNA	9	NMOD
9	enhancer	enhancer	I-NP	NN	I-DNA	2	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	not	not	O	RB	O	10	VMOD
12	dependent	dependent	B-ADJP	JJ	O	10	PRD
13	on	on	B-PP	IN	O	12	AMOD
14	NFAT-1	NFAT-1	B-NP	NN	B-protein	13	PMOD
15	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	4	NMOD
2	putative	putative	I-NP	JJ	B-DNA	4	NMOD
3	NFAT-1	NFAT-1	I-NP	NN	I-DNA	4	NMOD
4	region	region	I-NP	NN	I-DNA	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	required	require	I-VP	VBN	O	5	VC
8	for	for	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	response	response	I-NP	NN	O	8	PMOD
11	to	to	B-PP	TO	O	10	NMOD
12	anti-CD3	anti-CD3	B-NP	NN	B-protein	11	PMOD
13	or	or	B-PP	CC	O	11	PMOD
14	to	to	B-PP	TO	O	11	PMOD
15	mitogens	mitogen	B-NP	NNS	B-protein	14	PMOD
16	in	in	B-PP	IN	O	10	NMOD
17	T-cell	T-cell	B-NP	NN	B-cell_type	24	NMOD
18	,	,	O	,	O	24	P
19	B-cell	B-cell	B-NP	NN	B-cell_type	24	NMOD
20	,	,	O	,	O	24	P
21	or	or	O	CC	O	24	NMOD
22	monocyte/macrophage	monocyte/macrophage	B-NP	NN	B-cell_line	24	NMOD
23	leukemia	leukemia	I-NP	NN	I-cell_line	24	NMOD
24	lines	line	I-NP	NNS	I-cell_line	16	PMOD
25	,	,	O	,	O	5	P
26	nor	nor	O	CC	O	5	VMOD
27	is	be	O	VBZ	O	5	VMOD
28	it	it	B-NP	PRP	O	27	SUB
29	a	a	B-NP	DT	O	33	NMOD
30	cis-acting	cis-acting	I-NP	JJ	B-DNA	33	NMOD
31	negative	negative	I-NP	JJ	I-DNA	33	NMOD
32	regulatory	regulatory	I-NP	JJ	I-DNA	33	NMOD
33	element	element	I-NP	NN	I-DNA	27	PRD
34	.	.	O	.	O	5	P

1	Long	Long	B-NP	JJ	O	3	NMOD
2	term	term	I-NP	NN	O	3	NMOD
3	culture	culture	I-NP	NN	O	17	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	TPA-differentiated	TPA-differentiated	B-NP	JJ	B-cell_line	7	NMOD
6	U-937	U-937	I-NP	NN	I-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
8	in	in	B-PP	IN	O	3	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	absence	absence	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	phorbol	phorbol	B-NP	NN	O	13	NMOD
13	ester	ester	I-NP	NN	O	11	PMOD
14	for	for	B-PP	IN	O	3	NMOD
15	32-36	32-36	B-NP	CD	O	16	NMOD
16	days	day	I-NP	NNS	O	14	PMOD
17	resulted	result	B-VP	VBD	O	0	ROOT
18	in	in	B-PP	IN	O	17	VMOD
19	a	a	B-NP	DT	O	20	NMOD
20	process	process	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	retrodifferentiation	retrodifferentiation	B-NP	NN	O	21	PMOD
23	.	.	O	.	O	17	P

1	Moreover	Moreover	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	this	this	B-NP	DT	O	4	NMOD
4	site	site	I-NP	NN	O	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	occupied	occupy	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	BSAP	BSAP	B-NP	NN	B-protein	7	PMOD
9	in	in	B-ADVP	FW	O	6	VMOD
10	vivo	vivo	I-ADVP	FW	O	9	AMOD
11	in	in	B-PP	IN	O	6	VMOD
12	a	a	B-NP	DT	O	15	NMOD
13	CD19-expressing	CD19-expressing	I-NP	JJ	B-cell_line	15	NMOD
14	B-cell	B-cell	I-NP	NN	I-cell_line	15	NMOD
15	line	line	I-NP	NN	I-cell_line	11	PMOD
16	but	but	B-PP	CC	O	11	PMOD
17	not	not	B-PP	RB	O	18	PMOD
18	in	in	I-PP	IN	O	11	PMOD
19	plasma	plasma	B-NP	NN	B-cell_type	22	NMOD
20	or	or	I-NP	CC	O	22	NMOD
21	HeLa	HeLa	I-NP	NN	B-cell_line	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
23	.	.	O	.	O	5	P

1	PMA	PMA	B-NP	NN	O	2	NMOD
2	treatment	treatment	I-NP	NN	O	3	SUB
3	induced	induce	B-VP	VBD	O	0	ROOT
4	CD3	CD3	B-NP	NN	B-protein	6	NMOD
5	and	and	O	CC	I-protein	6	NMOD
6	CD25	CD25	B-NP	NN	I-protein	10	NMOD
7	(	(	O	(	I-protein	9	DEP
8	IL-2R	IL-2R	B-NP	NN	I-protein	9	DEP
9	)	)	O	)	I-protein	6	NMOD
10	receptors	receptor	B-NP	NNS	I-protein	3	OBJ
11	on	on	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	parental	parental	I-NP	JJ	O	14	NMOD
14	line	line	I-NP	NN	O	11	PMOD
15	and	and	B-PP	CC	O	3	VMOD
16	on	on	B-PP	IN	O	3	VMOD
17	other	other	B-NP	JJ	O	19	NMOD
18	ethyl-methanesulfonate-derived	ethyl-methanesulfonate-derived	I-NP	JJ	B-cell_line	19	NMOD
19	subclones	subclone	I-NP	NNS	I-cell_line	16	PMOD
20	,	,	O	,	O	16	P
21	but	but	B-PP	CC	O	16	PMOD
22	not	not	I-PP	RB	O	16	PMOD
23	on	on	B-PP	IN	O	16	PMOD
24	these	these	B-NP	DT	O	26	NMOD
25	two	two	I-NP	CD	O	26	NMOD
26	mutants	mutant	I-NP	NNS	O	23	PMOD
27	.	.	O	.	O	3	P

1	Chloramphenicol	Chloramphenicol	B-NP	NN	B-protein	3	NMOD
2	acetyl	acetyl	I-NP	NN	I-protein	3	NMOD
3	transferase	transferase	I-NP	NN	I-protein	7	NMOD
4	(	(	O	(	O	6	DEP
5	CAT	CAT	B-NP	NN	B-protein	6	DEP
6	)	)	O	)	O	3	NMOD
7	assays	assay	B-NP	NNS	O	18	SUB
8	using	use	B-VP	VBG	O	7	NMOD
9	the	the	B-NP	DT	O	17	NMOD
10	HIV-1	HIV-1	I-NP	NN	B-DNA	17	NMOD
11	(	(	O	(	I-DNA	16	AMOD
12	-139	-139	B-NP	CD	I-DNA	16	AMOD
13	)	)	O	)	I-DNA	16	AMOD
14	long	long	B-NP	JJ	I-DNA	16	AMOD
15	terminal	terminal	I-NP	JJ	I-DNA	16	AMOD
16	repeat-CAT	repeat-CAT	I-NP	NN	I-DNA	17	NMOD
17	construct	construct	I-NP	NN	I-DNA	8	OBJ
18	showed	show	B-VP	VBD	O	0	ROOT
19	no	no	B-NP	DT	O	21	NMOD
20	PMA	PMA	I-NP	NN	O	21	NMOD
21	induction	induction	I-NP	NN	O	18	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	CAT	CAT	B-NP	NN	B-protein	24	NMOD
24	activity	activity	I-NP	NN	O	22	PMOD
25	in	in	B-PP	IN	O	21	NMOD
26	these	these	B-NP	DT	O	27	NMOD
27	subclones	subclone	I-NP	NNS	O	25	PMOD
28	(	(	O	(	O	36	DEP
29	unlike	unlike	B-PP	IN	O	36	DEP
30	the	the	B-NP	DT	O	32	NMOD
31	parental	parental	I-NP	JJ	O	32	NMOD
32	line	line	I-NP	NN	O	35	NMOD
33	and	and	O	CC	O	35	NMOD
34	other	other	B-NP	JJ	O	35	NMOD
35	subclones	subclone	I-NP	NNS	O	29	PMOD
36	)	)	O	)	O	21	NMOD
37	.	.	O	.	O	18	P

1	Okadaic	Okadaic	B-NP	JJ	O	2	NMOD
2	acid	acid	I-NP	NN	O	5	NMOD
3	,	,	O	,	O	5	P
4	an	an	B-NP	DT	O	5	NMOD
5	inhibitor	inhibitor	I-NP	NN	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	phosphatases	phosphatas	B-NP	NNS	B-protein	6	PMOD
8	1	1	B-NP	CD	I-protein	10	NMOD
9	and	and	O	CC	I-protein	10	NMOD
10	2A	2A	B-NP	NN	I-protein	7	NMOD
11	,	,	O	,	O	5	P
12	did	do	B-VP	VBD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	overcome	overcome	I-VP	VB	O	12	VC
15	the	the	B-NP	DT	O	16	NMOD
16	defect	defect	I-NP	NN	O	14	OBJ
17	in	in	B-PP	IN	O	16	NMOD
18	these	these	B-NP	DT	O	19	NMOD
19	subclones	subclone	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	12	P

1	Thus	Thus	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	reduced	reduce	B-NP	VBN	O	4	NMOD
4	levels	level	I-NP	NNS	O	15	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	PKC-induced	PKC-induced	B-NP	JJ	O	9	NMOD
7	nuclear	nuclear	I-NP	JJ	O	9	NMOD
8	NF-kB	NF-kB	I-NP	NN	B-protein	9	NMOD
9	activity	activity	I-NP	NN	O	5	PMOD
10	in	in	B-PP	IN	O	4	NMOD
11	two	two	B-NP	CD	O	14	NMOD
12	T	T	I-NP	NN	O	14	NMOD
13	cell	cell	I-NP	NN	O	14	NMOD
14	subclones	subclone	I-NP	NNS	O	10	PMOD
15	did	do	B-VP	VBD	O	0	ROOT
16	not	not	I-VP	RB	O	15	VMOD
17	affect	affect	I-VP	VB	O	15	VC
18	their	their	B-NP	PRP$	O	21	NMOD
19	normal	normal	I-NP	JJ	O	21	NMOD
20	cell	cell	I-NP	NN	O	21	NMOD
21	growth	growth	I-NP	NN	O	17	OBJ
22	,	,	O	,	O	15	P
23	but	but	O	CC	O	15	VMOD
24	correlated	correlate	B-VP	VBD	O	15	VMOD
25	with	with	B-PP	IN	O	24	VMOD
26	a	a	B-NP	DT	O	28	NMOD
27	pronounced	pronounced	I-NP	JJ	O	28	NMOD
28	reduction	reduction	I-NP	NN	O	25	PMOD
29	in	in	B-PP	IN	O	28	NMOD
30	their	their	B-NP	PRP$	O	31	NMOD
31	susceptibility	susceptibility	I-NP	NN	O	29	PMOD
32	to	to	B-PP	TO	O	31	NMOD
33	HIV-1	HIV-1	B-NP	NN	O	34	NMOD
34	infection	infection	I-NP	NN	O	32	PMOD
35	.	.	O	.	O	15	P

1	Except	Except	B-PP	IN	O	14	VMOD
2	for	for	B-PP	IN	O	1	PMOD
3	PGF2	PGF2	B-NP	NN	O	4	NMOD
4	alpha	alpha	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	14	P
6	HHT	HHT	B-NP	NN	O	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	15-HETE	15-HETE	B-NP	NN	O	11	NMOD
9	no	no	B-NP	DT	O	11	NMOD
10	detectable	detectable	I-NP	JJ	O	11	NMOD
11	quantities	quantity	I-NP	NNS	O	14	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	eicosanoids	eicosanoid	B-NP	NNS	O	12	PMOD
14	were	be	B-VP	VBD	O	21	VMOD
15	found	find	I-VP	VBN	O	14	VC
16	in	in	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	non-tumor	non-tumor	I-NP	JJ	O	19	NMOD
19	material	material	I-NP	NN	O	16	PMOD
20	,	,	O	,	O	21	P
21	whereas	whereas	O	IN	O	0	ROOT
22	in	in	B-PP	IN	O	35	VMOD
23	the	the	B-NP	DT	O	26	NMOD
24	malignant	malignant	I-NP	JJ	O	26	NMOD
25	tumor	tumor	I-NP	NN	O	26	NMOD
26	material	material	I-NP	NN	O	22	PMOD
27	substantial	substantial	I-NP	JJ	O	28	NMOD
28	quantities	quantity	I-NP	NNS	O	35	SUB
29	of	of	B-PP	IN	O	28	NMOD
30	a	a	B-NP	DT	O	31	NMOD
31	number	number	I-NP	NN	O	29	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	eicosanoid	eicosanoid	B-NP	NN	O	34	NMOD
34	metabolites	metabolite	I-NP	NNS	O	32	PMOD
35	were	be	B-VP	VBD	O	21	VMOD
36	present	present	B-ADJP	JJ	O	35	PRD
37	.	.	O	.	O	21	P

1	c-myc	c-myc	B-NP	NN	B-DNA	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	correlate	correlate	I-VP	VB	O	2	VC
5	with	with	B-PP	IN	O	4	VMOD
6	c-fos	c-fos	B-NP	NN	B-DNA	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	c-jun	c-jun	B-NP	NN	B-protein	10	NMOD
9	protein	protein	I-NP	NN	O	10	NMOD
10	expression	expression	I-NP	NN	O	5	PMOD
11	.	.	O	.	O	2	P

1	Stronger	Strong	B-NP	JJR	O	4	NMOD
2	c-myc	c-myc	I-NP	NN	B-RNA	4	NMOD
3	mRNA	mRNA	I-NP	NN	I-RNA	4	NMOD
4	expression	expression	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	detected	detect	I-VP	VBN	O	5	VC
7	in	in	B-PP	IN	O	6	VMOD
8	labial	labial	B-NP	JJ	O	10	NMOD
9	salivary	salivary	I-NP	JJ	O	10	NMOD
10	glands	gland	I-NP	NNS	O	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	patients	patient	B-NP	NNS	O	11	PMOD
13	with	with	B-PP	IN	O	12	NMOD
14	longer	long	B-NP	JJR	O	16	NMOD
15	disease	disease	I-NP	NN	O	16	NMOD
16	duration	duration	I-NP	NN	O	31	NMOD
17	(	(	O	(	O	25	DEP
18	p	p	B-NP	NN	O	20	SUB
19	less	less	B-ADJP	JJR	O	20	AMOD
20	than	than	B-PP	IN	O	25	DEP
21	or	or	O	CC	O	20	AMOD
22	equal	equal	B-ADJP	JJ	O	20	AMOD
23	to	to	B-PP	TO	O	20	AMOD
24	0.002	0.002	B-NP	CD	O	20	AMOD
25	)	)	O	)	O	16	NMOD
26	and	and	O	CC	O	31	NMOD
27	more	more	B-NP	RBR	O	28	AMOD
28	intense	intense	I-NP	JJ	O	31	NMOD
29	T	T	I-NP	NN	O	31	NMOD
30	lymphocyte	lymphocyte	I-NP	NN	O	31	NMOD
31	infiltrates	infiltrate	I-NP	NNS	O	13	PMOD
32	(	(	O	(	O	37	DEP
33	p	p	B-NP	NN	O	35	SUB
34	less	less	B-ADJP	JJR	O	35	AMOD
35	than	than	B-PP	IN	O	37	DEP
36	0.05	0.05	B-NP	CD	O	35	AMOD
37	)	)	O	)	O	31	NMOD
38	although	although	B-SBAR	IN	O	6	VMOD
39	these	these	B-NP	DT	O	40	NMOD
40	patients	patient	I-NP	NNS	O	41	SUB
41	revealed	reveal	B-VP	VBD	O	38	SBAR
42	no	no	B-NP	DT	O	43	NMOD
43	hypergammaglobulinemia	hypergammaglobulinemia	I-NP	NN	O	41	OBJ
44	.	.	O	.	O	5	P

1	No	No	B-NP	DT	O	2	NMOD
2	correlation	correlation	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	observed	observe	I-VP	VBN	O	3	VC
5	between	between	B-PP	IN	O	4	VMOD
6	c-myc	c-myc	B-NP	NN	B-RNA	7	NMOD
7	mRNA	mRNA	I-NP	NN	I-RNA	10	NMOD
8	and	and	I-NP	CC	O	10	NMOD
9	B	B	I-NP	NN	O	10	NMOD
10	lymphocyte	lymphocyte	I-NP	NN	O	5	PMOD
11	monoclonicity	monoclonicity	I-NP	NN	O	13	NMOD
12	or	or	I-NP	CC	O	13	NMOD
13	lymphoma	lymphoma	I-NP	NN	O	10	NMOD
14	.	.	O	.	O	3	P

1	Transfection	Transfection	B-NP	NN	O	22	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	an	an	B-NP	DT	O	8	NMOD
4	Fc	Fc	I-NP	NN	B-cell_line	5	AMOD
5	gamma	gamma	I-NP	NN	I-cell_line	8	NMOD
6	RII-negative	RII-negative	I-NP	JJ	I-cell_line	5	AMOD
7	B-cell	B-cell	I-NP	NN	I-cell_line	8	NMOD
8	line	line	I-NP	NN	I-cell_line	2	PMOD
9	with	with	B-PP	IN	O	1	NMOD
10	complementary	complementary	B-NP	JJ	B-DNA	12	NMOD
11	DNA	DNA	I-NP	NN	I-DNA	12	NMOD
12	's	's	B-NP	POS	O	13	SUB
13	encoding	encode	B-VP	VBG	O	9	PMOD
14	the	the	B-NP	DT	O	17	NMOD
15	two	two	I-NP	CD	O	17	NMOD
16	splice	splice	I-NP	NN	O	17	NMOD
17	products	product	I-NP	NNS	O	21	NMOD
18	and	and	O	CC	O	21	NMOD
19	various	various	B-NP	JJ	O	21	NMOD
20	receptor	receptor	I-NP	NN	O	21	NMOD
21	mutants	mutant	I-NP	NNS	O	13	OBJ
22	indicated	indicate	B-VP	VBD	O	0	ROOT
23	that	that	B-SBAR	IN	O	22	VMOD
24	the	the	B-NP	DT	O	25	NMOD
25	insertion	insertion	I-NP	NN	O	26	SUB
26	was	be	B-VP	VBD	O	23	SBAR
27	responsible	responsible	B-ADJP	JJ	O	26	PRD
28	for	for	B-PP	IN	O	27	AMOD
29	preventing	prevent	B-VP	VBG	O	28	PMOD
30	both	both	O	CC	O	40	NMOD
31	Fc	Fc	B-NP	NN	O	32	AMOD
32	gamma	gamma	I-NP	NN	O	34	NMOD
33	RII-mediated	RII-mediated	I-NP	JJ	O	32	AMOD
34	endocytosis	endocytosis	I-NP	NN	O	40	NMOD
35	and	and	I-NP	CC	O	40	NMOD
36	Fc	Fc	I-NP	NN	O	37	AMOD
37	gamma	gamma	I-NP	NN	O	40	NMOD
38	RII-mediated	RII-mediated	I-NP	JJ	O	37	AMOD
39	antigen	antigen	I-NP	NN	O	40	NMOD
40	presentation	presentation	I-NP	NN	O	29	OBJ
41	.	.	O	.	O	22	P

1	The	The	B-NP	DT	O	2	NMOD
2	insertion	insertion	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	required	require	I-VP	VBN	O	3	VC
6	for	for	B-PP	IN	O	5	VMOD
7	Fc	Fc	B-NP	NN	B-protein	9	NMOD
8	gamma	gamma	I-NP	NN	I-protein	9	NMOD
9	RII	RII	I-NP	NN	I-protein	11	SUB
10	to	to	B-VP	TO	O	11	VMOD
11	modulate	modulate	I-VP	VB	O	6	PMOD
12	surface	surface	B-NP	NN	O	15	NMOD
13	immunoglobulin-triggered	immunoglobulin-triggered	I-NP	JJ	O	15	NMOD
14	B-cell	B-cell	I-NP	NN	O	15	NMOD
15	activation	activation	I-NP	NN	O	11	OBJ
16	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	6	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	the	the	B-NP	DT	O	5	NMOD
5	insertion	insertion	I-NP	NN	O	6	SUB
6	did	do	B-VP	VBD	O	0	ROOT
7	contribute	contribute	I-VP	VB	O	6	VC
8	to	to	B-PP	TO	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	formation	formation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	caps	cap	B-NP	NNS	O	11	PMOD
13	in	in	B-PP	IN	O	7	VMOD
14	response	response	B-NP	NN	O	13	PMOD
15	to	to	B-PP	TO	O	14	NMOD
16	receptor	receptor	B-NP	NN	O	17	NMOD
17	cross-linking	cross-linking	I-NP	NN	O	15	PMOD
18	,	,	O	,	O	7	P
19	consistent	consistent	B-ADJP	JJ	O	7	VMOD
20	with	with	B-PP	IN	O	19	AMOD
21	suggestions	suggestion	B-NP	NNS	O	20	PMOD
22	that	that	B-SBAR	IN	O	21	NMOD
23	the	the	B-NP	DT	O	27	NMOD
24	lymphocyte	lymphocyte	I-NP	NN	B-cell_type	27	NMOD
25	but	but	B-NP	CC	O	27	NMOD
26	not	not	I-NP	RB	O	25	DEP
27	macrophage	macrophage	B-NP	NN	O	28	NMOD
28	form	form	I-NP	NN	O	32	SUB
29	of	of	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	31	NMOD
31	receptor	receptor	I-NP	NN	O	29	PMOD
32	can	can	B-VP	MD	O	22	SBAR
33	associate	associate	I-VP	VB	O	32	VC
34	with	with	B-PP	IN	O	33	VMOD
35	the	the	B-NP	DT	O	37	NMOD
36	detergent-insoluble	detergent-insoluble	I-NP	JJ	O	37	NMOD
37	cytoskeleton	cytoskeleton	I-NP	NN	O	34	PMOD
38	.	.	O	.	O	6	P

1	While	While	B-SBAR	IN	O	12	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	expectation	expectation	I-NP	NN	O	4	SUB
4	may	may	B-VP	MD	O	1	SBAR
5	be	be	I-VP	VB	O	4	VC
6	realized	realize	I-VP	VBN	O	5	VC
7	in	in	B-PP	IN	O	6	VMOD
8	some	some	B-NP	DT	O	9	NMOD
9	cases	case	I-NP	NNS	O	7	PMOD
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	have	have	B-VP	VBP	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	found	find	I-VP	VBN	O	12	VC
15	evidence	evidence	B-NP	NN	O	14	OBJ
16	for	for	B-PP	IN	O	15	NMOD
17	it	it	B-NP	PRP	O	16	PMOD
18	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	found	find	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	6	NMOD
5	relative	relative	I-NP	JJ	O	6	NMOD
6	efficiency	efficiency	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	enhancers	enhancer	I-NP	NNS	B-DNA	7	PMOD
10	is	be	B-VP	VBZ	O	26	VMOD
11	approximately	approximately	B-NP	RB	O	13	NMOD
12	the	the	I-NP	DT	O	13	NMOD
13	same	same	I-NP	JJ	O	10	PRD
14	,	,	I-NP	,	O	10	P
15	irrespective	irrespective	I-NP	JJ	O	10	VMOD
16	of	of	B-PP	IN	O	15	AMOD
17	the	the	B-NP	DT	O	18	NMOD
18	type	type	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	promoter	promoter	B-NP	NN	B-DNA	19	PMOD
21	used	use	B-VP	VBN	O	20	NMOD
22	,	,	O	,	O	10	P
23	i.e.	i.e.	B-NP	FW	O	26	VMOD
24	,	,	O	,	O	26	P
25	there	there	B-NP	EX	O	26	SUB
26	was	be	B-VP	VBD	O	3	SBAR
27	no	no	B-NP	DT	O	29	NMOD
28	strong	strong	I-NP	JJ	O	29	NMOD
29	preference	preference	I-NP	NN	O	26	PRD
30	for	for	B-PP	IN	O	29	NMOD
31	any	any	B-NP	DT	O	34	NMOD
32	given	give	I-NP	VBN	O	34	NMOD
33	enhancer/promoter	enhancer/promoter	I-NP	NN	O	34	NMOD
34	combination	combination	I-NP	NN	O	30	PMOD
35	.	.	O	.	O	2	P

1	Notably	Notably	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	do	do	B-VP	VBP	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	see	see	I-VP	VB	O	4	VC
7	particularly	particularly	B-NP	RB	O	8	AMOD
8	strong	strong	I-NP	JJ	O	9	NMOD
9	transcription	transcription	I-NP	NN	O	6	OBJ
10	when	when	B-ADVP	WRB	O	6	VMOD
11	the	the	B-NP	DT	O	14	NMOD
12	immunoglobulin	immunoglobulin	I-NP	NN	B-DNA	14	NMOD
13	kappa	kappa	I-NP	NN	I-DNA	14	NMOD
14	enhancer	enhancer	I-NP	NN	I-DNA	23	SUB
15	(	(	O	(	O	22	DEP
16	or	or	O	CC	O	21	NMOD
17	the	the	B-NP	DT	O	21	NMOD
18	immunoglobulin	immunoglobulin	I-NP	NN	B-DNA	21	NMOD
19	heavy	heavy	I-NP	JJ	I-DNA	21	NMOD
20	chain	chain	I-NP	NN	I-DNA	21	NMOD
21	enhancer	enhancer	I-NP	NN	I-DNA	22	DEP
22	)	)	O	)	O	14	NMOD
23	is	be	B-VP	VBZ	O	10	SBAR
24	used	use	I-VP	VBN	O	23	VC
25	to	to	B-VP	TO	O	26	VMOD
26	activate	activate	I-VP	VB	O	24	VMOD
27	a	a	B-NP	DT	O	30	NMOD
28	kappa	kappa	I-NP	NN	B-DNA	30	NMOD
29	gene	gene	I-NP	NN	I-DNA	30	NMOD
30	promoter	promoter	I-NP	NN	I-DNA	26	OBJ
31	.	.	O	.	O	4	P

1	Furthermore	Furthermore	B-ADVP	RB	O	25	VMOD
2	,	,	O	,	O	25	P
3	using	use	B-VP	VBG	O	25	VMOD
4	DNA	DNA	B-NP	NN	B-DNA	5	NMOD
5	templates	template	I-NP	NNS	I-DNA	3	OBJ
6	containing	contain	B-VP	VBG	O	5	NMOD
7	two	two	B-NP	CD	O	8	NMOD
8	copies	copy	I-NP	NNS	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	PRDII	PRDII	I-NP	NN	B-DNA	12	NMOD
12	domain	domain	I-NP	NN	I-DNA	9	PMOD
13	linked	link	B-VP	VBN	O	12	NMOD
14	to	to	B-PP	TO	O	13	VMOD
15	the	the	B-NP	DT	O	19	NMOD
16	rabbit	rabbit	I-NP	NN	B-DNA	19	NMOD
17	beta	beta	I-NP	NN	I-DNA	19	NMOD
18	globin	globin	I-NP	NN	I-DNA	19	NMOD
19	gene	gene	I-NP	NN	I-DNA	14	PMOD
20	,	,	O	,	O	25	P
21	the	the	B-NP	DT	O	23	NMOD
22	purified	purify	I-NP	VBN	O	23	NMOD
23	polypeptides	polypeptide	I-NP	NNS	O	25	SUB
24	specifically	specifically	B-ADVP	RB	O	25	VMOD
25	stimulated	stimulate	B-VP	VBD	O	0	ROOT
26	NF-kappa	NF-kappa	B-NP	NN	B-protein	27	NMOD
27	B	B	I-NP	NN	I-protein	28	AMOD
28	dependent	dependent	I-NP	JJ	O	29	NMOD
29	transcription	transcription	I-NP	NN	O	25	OBJ
30	in	in	B-PP	IN	O	29	NMOD
31	an	an	B-NP	DT	O	35	NMOD
32	in	in	I-NP	FW	O	33	AMOD
33	vitro	vitro	I-NP	FW	O	35	NMOD
34	reconstitution	reconstitution	I-NP	NN	O	35	NMOD
35	assay	assay	I-NP	NN	O	30	PMOD
36	as	as	B-PP	IN	O	25	VMOD
37	heterodimers	heterodimer	B-NP	NNS	B-protein	36	PMOD
38	but	but	B-PP	CC	O	36	PMOD
39	not	not	B-PP	RB	O	40	PMOD
40	as	as	I-PP	IN	O	36	PMOD
41	p50	p50	B-NP	NN	B-protein	42	NMOD
42	homodimers	homodimer	I-NP	NNS	I-protein	40	PMOD
43	.	.	O	.	O	25	P

1	Oct2	Oct2	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	unable	unable	B-ADJP	JJ	O	3	PRD
5	to	to	B-VP	TO	O	6	VMOD
6	stimulate	stimulate	I-VP	VB	O	4	AMOD
7	a	a	B-NP	DT	O	11	NMOD
8	multimerized	multimerized	I-NP	JJ	B-DNA	11	NMOD
9	octamer	octamer	I-NP	NN	I-DNA	11	NMOD
10	enhancer	enhancer	I-NP	NN	I-DNA	11	NMOD
11	element	element	I-NP	NN	I-DNA	6	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	HeLa	HeLa	B-NP	NN	B-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	12	PMOD
15	,	,	O	,	O	3	P
16	however	however	B-ADVP	RB	O	3	VMOD
17	.	.	O	.	O	3	P

1	Moreover	Moreover	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	this	this	B-NP	DT	O	4	NMOD
4	domain	domain	I-NP	NN	O	5	SUB
5	conferred	confer	B-VP	VBD	O	0	ROOT
6	enhancing	enhancing	B-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	5	OBJ
8	when	when	B-ADVP	WRB	O	5	VMOD
9	fused	fuse	B-VP	VBN	O	8	SBAR
10	to	to	B-PP	TO	O	9	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	Oct1	Oct1	I-NP	NN	B-protein	13	NMOD
13	protein	protein	I-NP	NN	I-protein	10	PMOD
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	by	by	B-PP	IN	O	18	VMOD
17	itself	itself	B-NP	PRP	O	16	PMOD
18	was	be	B-VP	VBD	O	15	SBAR
19	unable	unable	B-ADJP	JJ	O	18	PRD
20	to	to	B-VP	TO	O	21	VMOD
21	stimulate	stimulate	I-VP	VB	O	19	AMOD
22	from	from	B-PP	IN	O	21	VMOD
23	a	a	B-NP	DT	O	25	NMOD
24	remote	remote	I-NP	JJ	O	25	NMOD
25	position	position	I-NP	NN	O	22	PMOD
26	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	3	NMOD
2	programmed	program	I-NP	VBN	O	3	NMOD
3	activation/repression	activation/repression	I-NP	NN	O	11	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	transcription	transcription	B-NP	NN	B-protein	6	NMOD
6	factors	factor	I-NP	NNS	I-protein	4	PMOD
7	in	in	B-PP	IN	O	3	NMOD
8	early	early	B-NP	JJ	O	10	NMOD
9	hematopoietic	hematopoietic	I-NP	JJ	O	10	NMOD
10	differentiation	differentiation	I-NP	NN	O	7	PMOD
11	has	have	B-VP	VBZ	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	yet	yet	I-VP	RB	O	11	VMOD
14	been	be	I-VP	VBN	O	11	VC
15	explored	explore	I-VP	VBN	O	14	VC
16	.	.	O	.	O	11	P

1	Class	Class	B-NP	NN	B-cell_line	6	NMOD
2	II	II	I-NP	CD	I-cell_line	6	NMOD
3	antigen	antigen	I-NP	NN	I-cell_line	6	NMOD
4	expressing	express	B-VP	VBG	I-cell_line	6	NMOD
5	T-cell	T-cell	B-NP	NN	I-cell_line	6	NMOD
6	lines	line	I-NP	NNS	I-cell_line	7	SUB
7	maintained	maintain	B-VP	VBD	O	0	ROOT
8	contacts	contact	B-NP	NNS	O	7	OBJ
9	identical	identical	B-ADJP	JJ	O	8	NMOD
10	to	to	B-PP	TO	O	9	AMOD
11	B-cell	B-cell	B-NP	NN	B-cell_line	12	NMOD
12	lines	line	I-NP	NNS	I-cell_line	10	PMOD
13	,	,	O	,	O	7	P
14	while	while	B-SBAR	IN	O	7	VMOD
15	class	class	B-NP	NN	B-cell_line	18	NMOD
16	II-negative	II-negative	I-NP	JJ	I-cell_line	18	NMOD
17	T-cell	T-cell	I-NP	NN	I-cell_line	18	NMOD
18	lines	line	I-NP	NNS	I-cell_line	19	SUB
19	exhibited	exhibit	B-VP	VBD	O	14	SBAR
20	no	no	B-NP	DT	O	21	NMOD
21	interactions	interaction	I-NP	NNS	O	19	OBJ
22	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	11	P
4	the	the	B-NP	DT	O	10	NMOD
5	class	class	I-NP	NN	B-cell_line	10	NMOD
6	II-positive	II-positive	I-NP	JJ	I-cell_line	5	AMOD
7	nonlymphoid	nonlymphoid	I-NP	JJ	I-cell_line	10	NMOD
8	glioblastoma	glioblastoma	I-NP	NN	I-cell_line	10	NMOD
9	cell	cell	I-NP	NN	I-cell_line	10	NMOD
10	line	line	I-NP	NN	I-cell_line	11	SUB
11	does	do	B-VP	VBZ	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	exhibit	exhibit	I-VP	VB	O	11	VC
14	interactions	interaction	B-NP	NNS	O	13	OBJ
15	at	at	B-PP	IN	O	13	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	octamer	octamer	I-NP	NN	B-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	15	PMOD
19	despite	despite	B-PP	IN	O	13	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	presence	presence	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	ubiquitous	ubiquitous	I-NP	JJ	B-protein	26	NMOD
25	OTF-1	OTF-1	I-NP	NN	I-protein	26	NMOD
26	factor	factor	I-NP	NN	I-protein	22	PMOD
27	and	and	O	CC	O	13	VMOD
28	an	an	B-NP	DT	O	31	NMOD
29	open	open	I-NP	JJ	B-DNA	31	NMOD
30	binding	bind	I-NP	VBG	I-DNA	31	NMOD
31	site	site	I-NP	NN	I-DNA	13	VMOD
32	.	.	O	.	O	11	P

1	Deletions	Deletion	B-NP	NNS	O	5	SUB
2	in	in	B-PP	IN	O	1	NMOD
3	this	this	B-NP	DT	O	4	NMOD
4	promoter	promoter	I-NP	NN	B-DNA	2	PMOD
5	indicated	indicate	B-VP	VBD	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	this	this	B-NP	DT	O	8	NMOD
8	upregulation	upregulation	I-NP	NN	O	9	SUB
9	was	be	B-VP	VBD	O	6	SBAR
10	mediated	mediate	I-VP	VBN	O	9	VC
11	through	through	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	NF-kappa	NF-kappa	I-NP	NN	B-protein	14	NMOD
14	B-	B-	I-NP	NN	I-protein	18	NMOD
15	but	but	B-NP	CC	O	18	NMOD
16	not	not	I-NP	RB	O	15	DEP
17	the	the	B-NP	DT	O	18	NMOD
18	AP-1-binding	AP-1-binding	I-NP	JJ	B-DNA	19	NMOD
19	motif	motif	I-NP	NN	I-DNA	11	PMOD
20	,	,	O	,	O	10	P
21	by	by	B-PP	IN	O	10	VMOD
22	bona	bona	B-NP	NN	B-protein	25	NMOD
23	fide	fide	I-NP	NN	I-protein	25	NMOD
24	p50/p65	p50/p65	I-NP	NN	I-protein	25	NMOD
25	heterodimers	heterodimer	I-NP	NNS	I-protein	21	PMOD
26	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	23	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	1	PMOD
4	the	the	B-NP	DT	O	8	NMOD
5	transient	transient	I-NP	JJ	O	8	NMOD
6	NF-kappa	NF-kappa	I-NP	NN	B-protein	8	NMOD
7	B	B	I-NP	NN	I-protein	8	NMOD
8	activation	activation	I-NP	NN	O	1	PMOD
9	induced	induce	B-VP	VBN	O	8	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	phorbol	phorbol	B-NP	NN	O	12	NMOD
12	ester	ester	I-NP	NN	O	10	PMOD
13	,	,	O	,	O	23	P
14	the	the	B-NP	DT	O	18	NMOD
15	permanent	permanent	I-NP	JJ	O	18	NMOD
16	NF-kappa	NF-kappa	I-NP	NN	B-protein	18	NMOD
17	B	B	I-NP	NN	I-protein	18	NMOD
18	translocation	translocation	I-NP	NN	O	23	SUB
19	induced	induce	B-VP	VBN	O	18	NMOD
20	by	by	B-PP	IN	O	19	VMOD
21	HIV	HIV	B-NP	NN	O	22	NMOD
22	infection	infection	I-NP	NN	O	20	PMOD
23	was	be	B-VP	VBD	O	0	ROOT
24	not	not	O	RB	O	23	VMOD
25	dependent	dependent	B-ADJP	JJ	O	23	PRD
26	on	on	B-PP	IN	O	25	AMOD
27	PKC	PKC	B-NP	NN	B-protein	28	NMOD
28	isoenzymes	isoenzyme	I-NP	NNS	I-protein	26	PMOD
29	alpha	alpha	I-NP	NN	I-protein	31	NMOD
30	and	and	O	CC	I-protein	31	NMOD
31	beta	beta	B-NP	NN	I-protein	28	NMOD
32	as	as	B-SBAR	IN	O	23	VMOD
33	shown	show	B-VP	VBN	O	32	SBAR
34	by	by	B-PP	IN	O	33	VMOD
35	the	the	B-NP	DT	O	36	NMOD
36	use	use	I-NP	NN	O	34	PMOD
37	of	of	B-PP	IN	O	36	NMOD
38	a	a	B-NP	DT	O	40	NMOD
39	specific	specific	I-NP	JJ	O	40	NMOD
40	inhibitor	inhibitor	I-NP	NN	O	37	PMOD
41	(	(	O	(	O	44	DEP
42	GF	GF	B-NP	NN	O	43	NMOD
43	109203X	109203X	I-NP	NN	O	44	DEP
44	)	)	O	)	O	40	NMOD
45	.	.	O	.	O	23	P

1	The	The	B-NP	DT	O	2	NMOD
2	details	detail	I-NP	NNS	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	regulatory	regulatory	I-NP	JJ	O	6	NMOD
6	mechanism	mechanism	I-NP	NN	O	3	PMOD
7	that	that	B-NP	WDT	O	6	NMOD
8	selects	select	B-VP	VBZ	O	7	SBAR
9	particular	particular	B-NP	JJ	O	10	NMOD
10	loci	locus	I-NP	NNS	O	8	OBJ
11	for	for	B-PP	IN	O	10	NMOD
12	rearrangement	rearrangement	B-NP	NN	O	11	PMOD
13	are	be	B-VP	VBP	O	0	ROOT
14	still	still	B-ADVP	RB	O	13	VMOD
15	not	not	O	RB	O	13	VMOD
16	known	know	B-VP	VBN	O	13	VC
17	.	.	O	.	O	13	P

1	It	It	B-NP	PRP	O	2	SUB
2	seems	seem	B-VP	VBZ	O	41	VMOD
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	rearrangement	rearrangement	I-NP	NN	O	16	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	TCR	TCR	I-NP	NN	B-DNA	10	NMOD
9	gamma	gamma	I-NP	NN	I-DNA	10	NMOD
10	loci	locus	I-NP	NNS	I-DNA	6	PMOD
11	in	in	B-PP	IN	O	5	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	gamma	gamma	I-NP	NN	B-cell_type	15	NMOD
14	delta	delta	I-NP	NN	I-cell_type	15	NMOD
15	lineage	lineage	I-NP	NN	I-cell_type	11	PMOD
16	may	may	B-VP	MD	O	3	SBAR
17	not	not	I-VP	RB	O	16	VMOD
18	always	always	I-VP	RB	O	16	VMOD
19	take	take	I-VP	VB	O	16	VC
20	place	place	B-NP	NN	O	19	OBJ
21	at	at	B-PP	IN	O	19	VMOD
22	a	a	B-NP	DT	O	24	NMOD
23	developmental	developmental	I-NP	JJ	O	24	NMOD
24	stage	stage	I-NP	NN	O	21	PMOD
25	strictly	strictly	B-ADJP	RB	O	26	AMOD
26	equivalent	equivalent	I-ADJP	JJ	O	24	NMOD
27	to	to	B-PP	TO	O	26	AMOD
28	the	the	B-NP	DT	O	29	NMOD
29	rearrangement	rearrangement	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	TCR	TCR	B-NP	NN	B-DNA	32	NMOD
32	beta	beta	I-NP	NN	I-DNA	30	PMOD
33	in	in	B-PP	IN	O	29	NMOD
34	the	the	B-NP	DT	O	37	NMOD
35	alpha	alpha	I-NP	NN	B-cell_type	37	NMOD
36	beta	beta	I-NP	NN	I-cell_type	37	NMOD
37	lineage	lineage	I-NP	NN	I-cell_type	33	PMOD
38	,	,	O	,	O	41	P
39	and	and	O	CC	O	41	VMOD
40	it	it	B-NP	PRP	O	41	SUB
41	is	be	B-VP	VBZ	O	0	ROOT
42	not	not	O	RB	O	41	VMOD
43	clear	clear	B-ADJP	JJ	O	41	PRD
44	just	just	B-ADVP	RB	O	45	AMOD
45	how	how	I-ADVP	WRB	O	41	VMOD
46	early	early	I-ADVP	RB	O	45	AMOD
47	the	the	B-NP	DT	O	49	NMOD
48	two	two	I-NP	CD	O	49	NMOD
49	lineages	lineage	I-NP	NNS	O	50	SUB
50	diverge	diverge	B-VP	VBP	O	45	SBAR
51	.	.	O	.	O	41	P

1	Whereas	Whereas	B-PP	IN	O	32	VMOD
2	peripheral	peripheral	B-NP	JJ	B-cell_type	4	NMOD
3	T	T	I-NP	NN	I-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	5	SUB
5	can	can	B-VP	MD	O	1	SBAR
6	undergo	undergo	I-VP	VB	O	5	VC
7	forms	form	B-NP	NNS	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	positive	positive	B-NP	JJ	O	10	NMOD
10	selection	selection	I-NP	NN	O	19	NMOD
11	(	(	O	(	O	10	NMOD
12	by	by	B-PP	IN	O	10	NMOD
13	antigen-driven	antigen-driven	B-NP	JJ	O	15	NMOD
14	clonal	clonal	I-NP	JJ	O	15	NMOD
15	expansion	expansion	I-NP	NN	O	12	PMOD
16	)	)	O	)	O	10	NMOD
17	and	and	O	CC	O	19	NMOD
18	negative	negative	B-NP	JJ	O	19	NMOD
19	selection	selection	I-NP	NN	O	8	PMOD
20	(	(	O	(	O	19	NMOD
21	by	by	B-PP	IN	O	19	NMOD
22	abortive	abortive	B-NP	JJ	O	23	NMOD
23	stimulation	stimulation	I-NP	NN	O	21	PMOD
24	leading	lead	B-VP	VBG	O	23	NMOD
25	to	to	B-PP	TO	O	24	VMOD
26	anergy	anergy	B-NP	NN	O	28	NMOD
27	or	or	I-NP	CC	O	28	NMOD
28	death	death	I-NP	NN	O	25	PMOD
29	)	)	O	)	O	19	NMOD
30	,	,	O	,	O	32	P
31	neither	neither	B-NP	DT	O	32	SUB
32	is	be	B-VP	VBZ	O	0	ROOT
33	exactly	exactly	B-NP	RB	O	35	AMOD
34	the	the	I-NP	DT	O	35	AMOD
35	same	same	I-NP	JJ	O	36	NMOD
36	phenomenon	phenomenon	I-NP	NN	O	32	PRD
37	that	that	B-NP	WDT	O	36	NMOD
38	occurs	occur	B-VP	VBZ	O	37	SBAR
39	in	in	B-PP	IN	O	38	VMOD
40	the	the	B-NP	DT	O	42	NMOD
41	thymic	thymic	I-NP	JJ	O	42	NMOD
42	cortex	cortex	I-NP	NN	O	39	PMOD
43	.	.	O	.	O	32	P

1	Negative	Negative	B-NP	JJ	O	2	NMOD
2	selection	selection	I-NP	NN	O	6	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	cortex	cortex	I-NP	NN	O	3	PMOD
6	appears	appear	B-VP	VBZ	O	26	VMOD
7	to	to	I-VP	TO	O	8	VMOD
8	be	be	I-VP	VB	O	6	VMOD
9	a	a	B-NP	DT	O	11	NMOD
10	suicidal	suicidal	I-NP	JJ	O	11	NMOD
11	inversion	inversion	I-NP	NN	O	8	PRD
12	of	of	B-PP	IN	O	11	NMOD
13	antigen	antigen	B-NP	NN	O	14	NMOD
14	responsiveness	responsiveness	I-NP	NN	O	12	PMOD
15	:	:	O	:	O	6	P
16	instead	instead	B-PP	RB	O	17	PMOD
17	of	of	I-PP	IN	O	26	VMOD
18	turning	turn	B-VP	VBG	O	17	PMOD
19	on	on	B-PP	IN	O	18	VMOD
20	IL-2	IL-2	B-NP	NN	B-protein	21	NMOD
21	expression	expression	I-NP	NN	O	18	OBJ
22	,	,	O	,	O	26	P
23	the	the	B-NP	DT	O	25	NMOD
24	activated	activate	I-NP	VBN	B-cell_type	25	NMOD
25	cell	cell	I-NP	NN	I-cell_type	26	SUB
26	destroys	destroy	B-VP	VBZ	O	0	ROOT
27	its	its	B-NP	PRP$	O	29	NMOD
28	own	own	I-NP	JJ	O	29	NMOD
29	chromatin	chromatin	I-NP	NN	B-DNA	26	OBJ
30	.	.	O	.	O	26	P

1	The	The	B-NP	DT	O	2	NMOD
2	genes	gene	I-NP	NNS	O	11	SUB
3	that	that	B-NP	WDT	O	2	NMOD
4	need	need	B-VP	VBP	O	3	SBAR
5	to	to	I-VP	TO	O	6	VMOD
6	be	be	I-VP	VB	O	4	VMOD
7	induced	induce	I-VP	VBN	O	6	VC
8	for	for	B-PP	IN	O	7	VMOD
9	this	this	B-NP	DT	O	10	NMOD
10	response	response	I-NP	NN	O	8	PMOD
11	are	be	B-VP	VBP	O	18	VMOD
12	not	not	I-VP	RB	O	11	VMOD
13	yet	yet	I-VP	RB	O	11	VMOD
14	identified	identify	I-VP	VBN	O	11	VC
15	,	,	O	,	O	18	P
16	but	but	O	CC	O	18	VMOD
17	it	it	B-NP	PRP	O	18	SUB
18	is	be	B-VP	VBZ	O	0	ROOT
19	unquestionably	unquestionably	B-ADVP	RB	O	18	VMOD
20	a	a	B-NP	DT	O	21	NMOD
21	form	form	I-NP	NN	O	18	PRD
22	of	of	B-PP	IN	O	21	NMOD
23	activation	activation	B-NP	NN	O	22	PMOD
24	.	.	O	.	O	18	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	interesting	interesting	B-ADJP	JJ	O	2	PRD
4	that	that	B-SBAR	IN	O	2	VMOD
5	in	in	B-PP	IN	O	15	VMOD
6	humans	human	B-NP	NNS	O	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	rats	rat	I-NP	NNS	O	5	PMOD
9	,	,	O	,	O	15	P
10	cortical	cortical	B-NP	JJ	B-cell_type	11	NMOD
11	thymocytes	thymocyte	I-NP	NNS	I-cell_type	15	SUB
12	undergoing	undergo	B-VP	VBG	O	11	NMOD
13	negative	negative	B-NP	JJ	O	14	NMOD
14	selection	selection	I-NP	NN	O	12	OBJ
15	can	can	B-VP	MD	O	4	SBAR
16	still	still	I-VP	RB	O	17	VMOD
17	induce	induce	I-VP	VB	O	15	VC
18	IL-2R	IL-2R	B-NP	NN	B-protein	20	NMOD
19	alpha	alpha	I-NP	NN	I-protein	20	NMOD
20	expression	expression	I-NP	NN	O	17	OBJ
21	and	and	O	CC	O	17	VMOD
22	even	even	B-VP	RB	O	23	VMOD
23	be	be	I-VP	VB	O	17	VMOD
24	rescued	rescue	I-VP	VBN	O	23	VC
25	in	in	B-ADVP	FW	O	24	VMOD
26	vitro	vitro	I-ADVP	FW	O	25	AMOD
27	,	,	O	,	O	17	P
28	if	if	B-SBAR	IN	O	17	VMOD
29	exogenous	exogenous	B-NP	JJ	O	30	NMOD
30	IL-2	IL-2	I-NP	NN	B-protein	31	SUB
31	is	be	B-VP	VBZ	O	28	SBAR
32	provided	provide	I-VP	VBN	O	31	VC
33	.	.	O	.	O	2	P

1	Perhaps	Perhaps	B-NP	RB	O	4	VMOD
2	murine	murine	I-NP	JJ	B-cell_type	3	NMOD
3	thymocytes	thymocyte	I-NP	NNS	I-cell_type	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	denied	deny	I-VP	VBN	O	4	VC
6	this	this	B-NP	DT	O	7	NMOD
7	form	form	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	rescue	rescue	B-NP	NN	O	8	PMOD
10	because	because	B-SBAR	IN	O	23	DEP
11	they	they	B-NP	PRP	O	12	SUB
12	shut	shut	B-VP	VBD	O	10	SBAR
13	off	off	B-PRT	RP	O	12	VMOD
14	IL-2R	IL-2R	B-NP	NN	B-protein	17	NMOD
15	beta	beta	I-NP	NN	I-protein	17	NMOD
16	chain	chain	I-NP	NN	I-protein	17	NMOD
17	expression	expression	I-NP	NN	O	12	OBJ
18	at	at	B-PP	IN	O	12	VMOD
19	an	an	B-NP	DT	O	21	NMOD
20	earlier	early	I-NP	JJR	O	21	NMOD
21	stage	stage	I-NP	NN	O	18	PMOD
22	or	or	O	CC	O	23	DEP
23	because	because	B-SBAR	IN	O	5	VMOD
24	they	they	B-NP	PRP	O	25	SUB
25	may	may	B-VP	MD	O	23	SBAR
26	be	be	I-VP	VB	O	25	VC
27	uncommonly	uncommonly	B-ADJP	RB	O	29	AMOD
28	Bcl-2	Bcl-2	I-ADJP	NN	B-protein	29	AMOD
29	deficient	deficient	I-ADJP	JJ	O	26	PRD
30	(	(	O	(	O	43	DEP
31	cf.	cf.	B-NP	NN	O	43	DEP
32	Sentman	Sentman	I-NP	NNP	O	38	NMOD
33	et	et	I-NP	FW	O	32	NMOD
34	al.	al.	I-NP	FW	O	32	NMOD
35	,	,	O	,	O	32	P
36	1991	1991	B-NP	CD	O	32	NMOD
37	;	;	O	:	O	38	P
38	Strasser	Strasser	B-NP	NNP	O	31	OBJ
39	et	et	I-NP	FW	O	38	NMOD
40	al.	al.	I-NP	FW	O	38	NMOD
41	,	,	O	,	O	38	P
42	1991	1991	B-NP	CD	O	38	NMOD
43	)	)	O	)	O	5	VMOD
44	.	.	O	.	O	4	P

1	Even	Even	B-ADVP	RB	O	6	VMOD
2	so	so	I-ADVP	RB	O	1	AMOD
3	,	,	O	,	O	6	P
4	medullary	medullary	B-NP	JJ	B-cell_type	5	NMOD
5	thymocytes	thymocyte	I-NP	NNS	I-cell_type	6	SUB
6	remain	remain	B-VP	VBP	O	0	ROOT
7	at	at	B-ADVP	IN	O	9	AMOD
8	least	least	I-ADVP	JJS	O	7	AMOD
9	partially	partially	B-ADJP	RB	O	6	PRD
10	susceptible	susceptible	I-ADJP	JJ	O	9	AMOD
11	to	to	B-PP	TO	O	9	AMOD
12	negative	negative	B-NP	JJ	O	13	NMOD
13	selection	selection	I-NP	NN	O	11	PMOD
14	even	even	B-SBAR	RB	O	15	DEP
15	as	as	I-SBAR	IN	O	6	VMOD
16	they	they	B-NP	PRP	O	17	SUB
17	continue	continue	B-VP	VBP	O	15	SBAR
18	to	to	I-VP	TO	O	19	VMOD
19	mature	mature	I-VP	VB	O	17	VMOD
20	.	.	O	.	O	6	P

1	CsA	CsA	B-NP	NN	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	found	find	I-VP	VBN	O	2	VC
4	not	not	O	RB	O	6	VMOD
5	to	to	B-VP	TO	O	6	VMOD
6	inhibit	inhibit	I-VP	VB	O	3	VMOD
7	lck	lck	B-NP	NN	B-DNA	9	NMOD
8	gene	gene	I-NP	NN	I-DNA	9	NMOD
9	expression	expression	I-NP	NN	O	13	NMOD
10	,	,	O	,	O	13	P
11	nor	nor	O	CC	O	13	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	activity	activity	I-NP	NN	O	6	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	lck	lck	I-NP	NN	B-protein	18	NMOD
17	gene	gene	I-NP	NN	I-protein	18	NMOD
18	product	product	I-NP	NN	I-protein	14	PMOD
19	.	.	O	.	O	2	P

1	A	A	B-NP	DT	O	3	NMOD
2	Tat-responsive	Tat-responsive	I-NP	JJ	B-DNA	3	NMOD
3	element	element	I-NP	NN	I-DNA	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	found	find	I-VP	VBN	O	4	VC
6	upstream	upstream	B-ADVP	RB	O	5	VMOD
7	within	within	B-PP	IN	O	5	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	viral	viral	I-NP	JJ	B-DNA	10	NMOD
10	promoter	promoter	I-NP	NN	I-DNA	7	PMOD
11	that	that	B-NP	IN	O	10	NMOD
12	in	in	B-PP	IN	O	16	VMOD
13	glial-derived	glial-derived	B-NP	JJ	B-cell_line	15	NMOD
14	cell	cell	I-NP	NN	I-cell_line	15	NMOD
15	lines	line	I-NP	NNS	I-cell_line	12	PMOD
16	allows	allow	B-VP	VBZ	O	11	SBAR
17	transactivation	transactivation	B-NP	NN	O	16	OBJ
18	in	in	B-PP	IN	O	16	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	absence	absence	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	TAR	TAR	B-NP	NN	B-DNA	21	PMOD
23	.	.	O	.	O	4	P

1	PMA	PMA	B-NP	NN	O	8	SUB
2	,	,	O	,	O	1	P
3	which	which	B-NP	WDT	O	1	NMOD
4	directly	directly	B-VP	RB	O	5	VMOD
5	activates	activate	I-VP	VBZ	O	3	SBAR
6	PKC	PKC	B-NP	NN	B-protein	5	OBJ
7	,	,	O	,	O	1	P
8	mimicked	mimic	B-VP	VBD	O	28	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	effect	effect	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	lectins	lectin	I-NP	NNS	B-protein	11	PMOD
14	on	on	B-PP	IN	O	10	NMOD
15	c-Fos	c-Fos	B-NP	NN	B-protein	17	NMOD
16	and	and	I-NP	CC	O	17	NMOD
17	c-Jun	c-Jun	I-NP	NN	B-protein	14	PMOD
18	,	,	O	,	O	28	P
19	but	but	O	CC	O	28	VMOD
20	elevation	elevation	B-NP	NN	O	28	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	either	either	B-NP	CC	O	27	NMOD
23	intracellular	intracellular	I-NP	JJ	O	27	NMOD
24	Ca2+	Ca2+	I-NP	NN	O	26	NMOD
25	or	or	I-NP	CC	O	26	NMOD
26	cAMP	cAMP	I-NP	NN	O	27	NMOD
27	levels	level	I-NP	NNS	O	21	PMOD
28	had	have	B-VP	VBD	O	0	ROOT
29	little	little	B-NP	JJ	O	32	NMOD
30	or	or	I-NP	CC	O	32	NMOD
31	no	no	I-NP	DT	O	32	NMOD
32	effect	effect	I-NP	NN	O	28	OBJ
33	.	.	O	.	O	28	P

1	The	The	B-NP	DT	O	2	NMOD
2	protein	protein	I-NP	NN	O	9	SUB
3	expressed	express	B-VP	VBN	O	2	NMOD
4	by	by	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	v-erb	v-erb	I-NP	NN	B-DNA	8	NMOD
7	A	A	I-NP	NN	I-DNA	8	NMOD
8	oncogene	oncogene	I-NP	NN	I-DNA	4	PMOD
9	binds	bind	B-VP	VBZ	O	0	ROOT
10	to	to	B-PP	TO	O	9	VMOD
11	DNA	DNA	B-NP	NN	O	10	PMOD
12	and	and	O	CC	O	9	VMOD
13	acts	act	B-VP	VBZ	O	9	VMOD
14	as	as	B-PP	IN	O	13	VMOD
15	a	a	B-NP	DT	O	18	NMOD
16	dominant	dominant	I-NP	JJ	O	18	NMOD
17	negative	negative	I-NP	JJ	O	18	NMOD
18	inhibitor	inhibitor	I-NP	NN	O	14	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	both	both	O	CC	O	31	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	thyroid	thyroid	I-NP	NN	B-protein	24	NMOD
23	hormone	hormone	I-NP	NN	I-protein	24	NMOD
24	receptor	receptor	I-NP	NN	I-protein	31	NMOD
25	and	and	O	CC	O	31	NMOD
26	the	the	B-NP	DT	O	31	NMOD
27	closely	closely	I-NP	RB	O	28	AMOD
28	related	related	I-NP	JJ	O	31	NMOD
29	retinoic	retinoic	I-NP	JJ	B-protein	31	NMOD
30	acid	acid	I-NP	NN	I-protein	31	NMOD
31	receptor	receptor	I-NP	NN	I-protein	19	PMOD
32	.	.	O	.	O	9	P

1	Threonine	Threonine	B-NP	NN	O	3	SUB
2	78	78	I-NP	CD	O	1	NMOD
3	lies	lie	B-VP	VBZ	O	0	ROOT
4	within	within	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	D-box	D-box	I-NP	NN	B-DNA	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	v-erb	v-erb	I-NP	NN	B-protein	11	NMOD
10	A	A	I-NP	NN	I-protein	11	NMOD
11	protein	protein	I-NP	NN	I-protein	14	NMOD
12	,	,	O	,	O	14	P
13	a	a	B-NP	DT	O	14	NMOD
14	region	region	I-NP	NN	O	7	PMOD
15	thought	think	B-VP	VBN	O	6	NMOD
16	to	to	I-VP	TO	O	17	VMOD
17	mediate	mediate	I-VP	VB	O	15	VMOD
18	receptor-receptor	receptor-receptor	B-NP	JJ	O	19	NMOD
19	dimerizations	dimerization	I-NP	NNS	O	17	OBJ
20	,	,	O	,	O	3	P
21	and	and	O	CC	O	3	VMOD
22	is	be	B-VP	VBZ	O	3	VMOD
23	not	not	O	RB	O	22	VMOD
24	in	in	B-PP	IN	O	22	PRD
25	physical	physical	B-NP	JJ	O	26	NMOD
26	proximity	proximity	I-NP	NN	O	24	PMOD
27	to	to	B-PP	TO	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	serine	serine	I-NP	NN	O	27	PMOD
30	at	at	B-PP	IN	O	29	NMOD
31	position	position	B-NP	NN	B-protein	30	PMOD
32	61	61	I-NP	CD	I-protein	31	NMOD
33	.	.	O	.	O	3	P

1	BSAP	BSAP	B-NP	NN	B-protein	2	SUB
2	has	have	B-VP	VBZ	O	0	ROOT
3	been	be	I-VP	VBN	O	2	VC
4	identified	identify	I-VP	VBN	O	3	VC
5	previously	previously	B-ADVP	RB	O	4	VMOD
6	as	as	B-PP	IN	O	4	VMOD
7	a	a	B-NP	DT	O	9	NMOD
8	transcription	transcription	I-NP	NN	B-protein	9	NMOD
9	factor	factor	I-NP	NN	I-protein	6	PMOD
10	that	that	B-NP	WDT	O	9	NMOD
11	is	be	B-VP	VBZ	O	10	SBAR
12	expressed	express	I-VP	VBN	O	11	VC
13	at	at	B-PP	IN	O	12	VMOD
14	early	early	B-NP	JJ	O	18	AMOD
15	,	,	I-NP	,	O	18	P
16	but	but	I-NP	CC	O	18	AMOD
17	not	not	I-NP	RB	O	16	DEP
18	late	late	B-ADJP	JJ	O	20	NMOD
19	,	,	O	,	O	18	P
20	stages	stage	B-NP	NNS	O	13	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	B-cell	B-cell	B-NP	NN	O	23	NMOD
23	differentiation	differentiation	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	2	P

1	All	All	B-NP	DT	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	this	this	B-NP	DT	O	4	NMOD
4	evidence	evidence	I-NP	NN	O	2	PMOD
5	indicates	indicate	B-VP	VBZ	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	transcription	transcription	I-NP	NN	B-protein	10	NMOD
9	factor	factor	I-NP	NN	I-protein	10	NMOD
10	BSAP	BSAP	I-NP	NN	B-protein	11	SUB
11	may	may	B-VP	MD	O	6	SBAR
12	not	not	I-VP	RB	O	14	VMOD
13	only	only	I-VP	RB	O	12	DEP
14	play	play	I-VP	VB	O	11	VC
15	an	an	B-NP	DT	O	17	NMOD
16	important	important	I-NP	JJ	O	17	NMOD
17	role	role	I-NP	NN	O	14	OBJ
18	in	in	B-PP	IN	O	14	VMOD
19	B-cell	B-cell	B-NP	NN	O	20	NMOD
20	differentiation	differentiation	I-NP	NN	O	18	PMOD
21	but	but	B-CONJP	CC	O	14	VMOD
22	also	also	I-CONJP	RB	O	21	DEP
23	in	in	B-PP	IN	O	14	VMOD
24	neural	neural	B-NP	JJ	O	25	NMOD
25	development	development	I-NP	NN	O	27	NMOD
26	and	and	I-NP	CC	O	27	NMOD
27	spermatogenesis	spermatogenesis	I-NP	NN	O	23	PMOD
28	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	19	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	19	P
4	no	no	B-NP	DT	O	5	NMOD
5	effect	effect	I-NP	NN	O	19	SUB
6	on	on	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	levels	level	I-NP	NNS	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	octamer	octamer	I-NP	NN	B-protein	13	NMOD
12	binding	binding	I-NP	NN	I-protein	13	NMOD
13	proteins	protein	I-NP	NNS	I-protein	17	NMOD
14	,	,	O	,	O	17	P
15	Oct-1	Oct-1	B-NP	NN	B-protein	17	NMOD
16	or	or	I-NP	CC	O	17	NMOD
17	Oct-2	Oct-2	I-NP	NN	B-protein	9	PMOD
18	,	,	O	,	O	5	P
19	were	be	B-VP	VBD	O	0	ROOT
20	found	find	I-VP	VBN	O	19	VC
21	.	.	O	.	O	19	P

1	Although	Although	B-SBAR	IN	O	15	VMOD
2	okadaic	okadaic	B-NP	JJ	O	3	NMOD
3	acid	acid	I-NP	NN	O	4	SUB
4	provides	provide	B-VP	VBZ	O	1	SBAR
5	a	a	B-NP	DT	O	8	NMOD
6	potent	potent	I-NP	JJ	O	8	NMOD
7	inductive	inductive	I-NP	JJ	O	8	NMOD
8	signal	signal	I-NP	NN	O	4	OBJ
9	for	for	B-PP	IN	O	8	NMOD
10	AP-1	AP-1	B-NP	NN	B-protein	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	9	PMOD
14	it	it	B-NP	PRP	O	15	SUB
15	did	do	B-VP	VBD	O	0	ROOT
16	not	not	I-VP	RB	O	15	VMOD
17	induce	induce	I-VP	VB	O	15	VC
18	either	either	O	CC	O	24	NMOD
19	B	B	B-NP	NN	O	21	NMOD
20	cell	cell	I-NP	NN	O	21	NMOD
21	proliferation	proliferation	I-NP	NN	O	24	NMOD
22	or	or	O	CC	O	24	NMOD
23	immunoglobulin	immunoglobulin	B-NP	NN	B-protein	24	NMOD
24	secretion	secretion	I-NP	NN	O	17	OBJ
25	.	.	O	.	O	15	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	Nef	Nef	B-NP	NN	B-protein	4	SUB
4	does	do	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	affect	affect	I-VP	VB	O	4	VC
7	the	the	B-NP	DT	O	9	NMOD
8	DNA-binding	DNA-binding	I-NP	JJ	O	9	NMOD
9	activity	activity	I-NP	NN	O	6	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	other	other	B-NP	JJ	O	13	NMOD
12	transcription	transcription	I-NP	NN	B-protein	13	NMOD
13	factors	factor	I-NP	NNS	I-protein	10	PMOD
14	implicated	implicate	B-VP	VBN	O	13	NMOD
15	in	in	B-PP	IN	O	14	VMOD
16	HIV-1	HIV-1	B-NP	NN	O	17	NMOD
17	regulation	regulation	I-NP	NN	O	15	PMOD
18	,	,	O	,	O	13	P
19	including	include	B-PP	VBG	O	13	NMOD
20	SP-1	SP-1	B-NP	NN	B-protein	27	NMOD
21	,	,	O	,	O	27	P
22	USF	USF	B-NP	NN	B-protein	27	NMOD
23	,	,	O	,	O	27	P
24	URS	URS	B-NP	NN	B-protein	27	NMOD
25	,	,	O	,	O	27	P
26	and	and	O	CC	O	27	NMOD
27	NF-AT	NF-AT	B-NP	NN	B-protein	19	PMOD
28	.	.	O	.	O	4	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	defective	defective	B-NP	JJ	O	6	NMOD
6	recruitment	recruitment	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	NF-kappa	NF-kappa	B-NP	NN	B-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	7	PMOD
10	may	may	B-VP	MD	O	4	SBAR
11	underlie	underlie	I-VP	VB	O	10	VC
12	Nef	Nef	B-NP	NN	B-protein	13	NMOD
13	's	's	B-NP	POS	O	16	NMOD
14	negative	negative	I-NP	JJ	O	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	O	16	NMOD
16	effects	effect	I-NP	NNS	O	11	OBJ
17	on	on	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	23	NMOD
19	HIV-1	HIV-1	I-NP	NN	B-DNA	23	NMOD
20	and	and	I-NP	CC	I-DNA	23	NMOD
21	interleukin	interleukin	I-NP	NN	I-DNA	23	NMOD
22	2	2	B-NP	CD	I-DNA	23	NMOD
23	promoters	promoter	I-NP	NNS	I-DNA	17	PMOD
24	.	.	O	.	O	3	P

1	Activation	Activation	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	IL-6	IL-6	I-NP	NN	B-DNA	5	NMOD
5	promoter	promoter	I-NP	NN	I-DNA	2	PMOD
6	by	by	B-PP	IN	O	1	NMOD
7	LTB4	LTB4	B-NP	NN	O	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	only	only	I-VP	RB	O	9	DEP
11	associated	associate	I-VP	VBN	O	8	VC
12	with	with	B-PP	IN	O	11	VMOD
13	accumulation	accumulation	B-NP	NN	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	respective	respective	I-NP	JJ	O	17	NMOD
17	transcripts	transcript	I-NP	NNS	O	14	PMOD
18	but	but	O	CC	O	8	VMOD
19	resulted	result	B-VP	VBD	O	8	VMOD
20	in	in	B-PP	IN	O	19	VMOD
21	synthesis	synthesis	B-NP	NN	O	20	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	functional	functional	B-NP	JJ	O	25	NMOD
24	IL-6	IL-6	I-NP	NN	B-protein	25	NMOD
25	protein	protein	I-NP	NN	I-protein	22	PMOD
26	as	as	B-ADVP	RB	O	19	VMOD
27	well	well	I-ADVP	RB	O	26	AMOD
28	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	5	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	LTB4	LTB4	B-NP	NN	B-protein	5	SUB
5	mediated	mediate	B-VP	VBD	O	0	ROOT
6	transactivation	transactivation	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	11	NMOD
9	heterologous	heterologous	I-NP	JJ	B-DNA	11	NMOD
10	promoter	promoter	I-NP	NN	I-DNA	11	NMOD
11	construct	construct	I-NP	NN	I-DNA	7	PMOD
12	containing	contain	B-VP	VBG	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	NF-chi	NF-chi	I-NP	NN	B-protein	15	NMOD
15	B	B	I-NP	NN	I-protein	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	NF-IL6	NF-IL6	I-NP	NN	B-DNA	19	NMOD
19	enhancer	enhancer	I-NP	NN	I-DNA	25	NMOD
20	,	,	O	,	O	25	P
21	but	but	B-CONJP	CC	O	25	NMOD
22	not	not	I-CONJP	RB	O	21	DEP
23	the	the	B-NP	DT	O	25	NMOD
24	AP-1	AP-1	I-NP	NN	B-DNA	25	NMOD
25	enhancer	enhancer	I-NP	NN	I-DNA	12	OBJ
26	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	3	NMOD
2	signaling	signaling	I-NP	NN	O	3	NMOD
3	events	event	I-NP	NNS	O	7	SUB
4	mediating	mediate	B-VP	VBG	O	3	NMOD
5	this	this	B-NP	DT	O	6	NMOD
6	effect	effect	I-NP	NN	O	4	OBJ
7	appeared	appear	B-VP	VBD	O	0	ROOT
8	to	to	I-VP	TO	O	9	VMOD
9	involve	involve	I-VP	VB	O	7	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	release	release	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	H2O2	H2O2	B-NP	NN	O	12	PMOD
14	,	,	O	,	O	9	P
15	since	since	B-SBAR	IN	O	9	VMOD
16	LTB4	LTB4	B-NP	NN	O	17	SUB
17	failed	fail	B-VP	VBD	O	15	SBAR
18	to	to	I-VP	TO	O	19	VMOD
19	induce	induce	I-VP	VB	O	17	VMOD
20	NF-chi	NF-chi	B-NP	NN	B-protein	21	NMOD
21	B	B	I-NP	NN	I-protein	23	NMOD
22	or	or	O	CC	O	23	NMOD
23	NF-IL6	NF-IL6	B-NP	NN	B-protein	19	OBJ
24	in	in	B-PP	IN	O	19	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	presence	presence	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	scavenger	scavenger	I-NP	NN	O	33	NMOD
30	of	of	B-PP	IN	O	29	NMOD
31	H2O2	H2O2	B-NP	NN	O	30	PMOD
32	,	,	O	,	O	33	P
33	N-acetyl-L-cysteine	N-acetyl-L-cysteine	B-NP	NN	O	27	PMOD
34	.	.	O	.	O	7	P

1	Their	Their	B-NP	PRP$	O	3	NMOD
2	action	action	I-NP	NN	O	3	NMOD
3	mechanism	mechanism	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	not	not	O	RB	O	4	VMOD
6	completely	completely	B-ADJP	RB	O	4	VMOD
7	cleared	clear	I-ADJP	VBN	O	4	VC
8	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	estrogens	estrogen	I-NP	NNS	O	3	SUB
3	participate	participate	B-VP	VBP	O	0	ROOT
4	in	in	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	regulation	regulation	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	practically	practically	B-NP	RB	O	14	NMOD
9	all	all	I-NP	PDT	O	8	AMOD
10	the	the	I-NP	DT	O	14	NMOD
11	reproductive	reproductive	I-NP	JJ	O	13	AMOD
12	and	and	I-NP	CC	O	13	AMOD
13	sexual	sexual	I-NP	JJ	O	14	NMOD
14	events	event	I-NP	NNS	O	7	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	17	NMOD
17	female	female	I-NP	NN	O	15	PMOD
18	,	,	O	,	O	3	P
19	although	although	B-SBAR	IN	O	3	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	intracellular	intracellular	I-NP	JJ	O	22	NMOD
22	actions	action	I-NP	NNS	O	28	SUB
23	by	by	B-PP	IN	O	22	NMOD
24	which	which	B-NP	WDT	O	23	PMOD
25	they	they	B-NP	PRP	O	26	SUB
26	take	take	B-VP	VBP	O	23	SBAR
27	place	place	B-NP	NN	O	26	OBJ
28	are	be	B-VP	VBP	O	36	VMOD
29	not	not	I-VP	RB	O	28	VMOD
30	well	well	I-VP	RB	O	28	VMOD
31	known	know	I-VP	VBN	O	28	VC
32	and	and	O	CC	O	36	VMOD
33	the	the	B-NP	DT	O	35	NMOD
34	proposed	propose	I-NP	VBN	O	35	NMOD
35	models	model	I-NP	NNS	O	36	SUB
36	do	do	B-VP	VBP	O	19	SBAR
37	not	not	I-VP	RB	O	36	VMOD
38	adequately	adequately	I-VP	RB	O	36	VMOD
39	satisfy	satisfy	I-VP	VB	O	36	VC
40	the	the	B-NP	DT	O	41	NMOD
41	questions	question	I-NP	NNS	O	39	OBJ
42	.	.	O	.	O	3	P

1	Currently	Currently	B-ADVP	RB	O	3	VMOD
2	it	it	B-NP	PRP	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	accepted	accept	I-VP	VBN	O	3	VC
5	the	the	B-NP	DT	O	6	NMOD
6	existence	existence	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	12	NMOD
9	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	11	AMOD
10	and/or	and/or	I-NP	CC	I-protein	11	AMOD
11	nuclear	nuclear	I-NP	JJ	I-protein	12	NMOD
12	receptor	receptor	I-NP	NN	I-protein	7	PMOD
13	,	,	O	,	O	4	P
14	without	without	B-PP	IN	O	4	VMOD
15	explaining	explain	B-VP	VBG	O	14	PMOD
16	satisfactorily	satisfactorily	B-ADVP	RB	O	15	VMOD
17	how	how	B-ADVP	WRB	O	15	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	hormones	hormone	I-NP	NNS	O	20	SUB
20	come	come	B-VP	VBP	O	17	SBAR
21	to	to	B-PP	TO	O	20	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	nucleus	nucleus	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	3	P

1	To	To	B-VP	TO	O	2	VMOD
2	determine	determine	I-VP	VB	O	25	VMOD
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	such	such	B-NP	JJ	O	7	NMOD
5	transdominant	transdominant	I-NP	JJ	B-protein	7	NMOD
6	Rev	Rev	I-NP	NN	I-protein	7	NMOD
7	proteins	protein	I-NP	NNS	I-protein	8	SUB
8	could	could	B-VP	MD	O	3	SBAR
9	provide	provide	I-VP	VB	O	8	VC
10	long-term	long-term	B-NP	JJ	O	11	NMOD
11	protection	protection	I-NP	NN	O	9	OBJ
12	against	against	B-PP	IN	O	11	NMOD
13	HIV	HIV	B-NP	NN	O	14	NMOD
14	infection	infection	I-NP	NN	O	12	PMOD
15	without	without	B-PP	IN	O	9	VMOD
16	affecting	affect	B-VP	VBG	O	15	PMOD
17	T	T	B-NP	NN	O	19	NMOD
18	cell	cell	I-NP	NN	O	19	NMOD
19	function	function	I-NP	NN	O	16	OBJ
20	,	,	O	,	O	25	P
21	T	T	B-NP	NN	B-cell_line	24	NMOD
22	leukemia	leukemia	I-NP	NN	I-cell_line	24	NMOD
23	cell	cell	I-NP	NN	I-cell_line	24	NMOD
24	lines	line	I-NP	NNS	I-cell_line	25	SUB
25	were	be	B-VP	VBD	O	0	ROOT
26	stably	stably	I-VP	RB	O	25	VMOD
27	transduced	transduce	I-VP	VBN	O	25	VC
28	with	with	B-PP	IN	O	27	VMOD
29	a	a	B-NP	DT	O	31	NMOD
30	retroviral	retroviral	I-NP	JJ	B-DNA	31	NMOD
31	vector	vector	I-NP	NN	I-DNA	28	PMOD
32	encoding	encode	B-VP	VBG	O	31	NMOD
33	a	a	B-NP	DT	O	35	NMOD
34	transdominant	transdominant	I-NP	JJ	B-protein	35	NMOD
35	mutant	mutant	I-NP	NN	I-protein	41	NMOD
36	of	of	B-PP	IN	O	35	NMOD
37	the	the	B-NP	DT	O	39	NMOD
38	Rev	Rev	I-NP	NN	B-protein	39	NMOD
39	protein	protein	I-NP	NN	I-protein	36	PMOD
40	,	,	O	,	O	41	P
41	M10	M10	B-NP	NN	B-protein	32	OBJ
42	.	.	O	.	O	25	P

1	While	While	B-SBAR	IN	O	15	VMOD
2	all	all	B-NP	PDT	O	6	NMOD
3	the	the	I-NP	DT	O	6	NMOD
4	M10-expressing	M10-expressing	I-NP	JJ	B-cell_line	6	NMOD
5	cell	cell	I-NP	NN	I-cell_line	6	NMOD
6	lines	line	I-NP	NNS	I-cell_line	7	SUB
7	remained	remain	B-VP	VBD	O	1	SBAR
8	infectable	infectable	B-ADJP	JJ	O	7	PRD
9	by	by	B-PP	IN	O	8	AMOD
10	HIV-1	HIV-1	B-NP	NN	O	9	PMOD
11	,	,	O	,	O	15	P
12	these	these	B-NP	DT	O	14	NMOD
13	same	same	I-NP	JJ	O	14	NMOD
14	cells	cell	I-NP	NNS	O	15	SUB
15	failed	fail	B-VP	VBD	O	0	ROOT
16	to	to	I-VP	TO	O	17	VMOD
17	support	support	I-VP	VB	O	15	VMOD
18	a	a	B-NP	DT	O	21	NMOD
19	productive	productive	I-NP	JJ	O	21	NMOD
20	replication	replication	I-NP	NN	O	21	NMOD
21	cycle	cycle	I-NP	NN	O	17	OBJ
22	when	when	B-ADVP	WRB	O	17	VMOD
23	infected	infect	B-VP	VBN	O	22	SBAR
24	with	with	B-PP	IN	O	23	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	cloned	clone	I-NP	VBN	O	27	NMOD
27	isolate	isolate	I-NP	NN	O	24	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	HIV-1	HIV-1	B-NP	NN	O	28	PMOD
30	.	.	O	.	O	15	P

1	Expression	Expression	B-NP	NN	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	M10	M10	B-NP	NN	B-protein	2	PMOD
4	did	do	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	affect	affect	I-VP	VB	O	4	VC
7	induction	induction	B-NP	NN	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	HIV	HIV	B-NP	NN	O	10	NMOD
10	transcription	transcription	I-NP	NN	O	8	PMOD
11	mediated	mediate	B-VP	VBN	O	7	NMOD
12	by	by	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	17	NMOD
14	kappa	kappa	I-NP	NN	B-DNA	17	NMOD
15	B	B	I-NP	NN	I-DNA	17	NMOD
16	regulatory	regulatory	I-NP	JJ	I-DNA	17	NMOD
17	element	element	I-NP	NN	I-DNA	19	NMOD
18	or	or	I-NP	CC	O	19	NMOD
19	Tat	Tat	I-NP	NN	B-protein	12	PMOD
20	.	.	O	.	O	4	P

1	Importantly	Importantly	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	constitutive	constitutive	B-NP	JJ	O	4	NMOD
4	expression	expression	I-NP	NN	O	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	Rev	Rev	B-NP	NN	B-protein	7	NMOD
7	M10	M10	I-NP	NN	I-protein	5	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	alter	alter	I-VP	VB	O	8	VC
11	the	the	B-NP	DT	O	12	NMOD
12	secretion	secretion	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	interleukin	interleukin	B-NP	NN	B-protein	13	PMOD
15	2	2	I-NP	CD	I-protein	14	NMOD
16	in	in	B-PP	IN	O	10	VMOD
17	response	response	B-NP	NN	O	16	PMOD
18	to	to	B-PP	TO	O	17	NMOD
19	mitogen	mitogen	B-NP	NN	B-protein	20	NMOD
20	stimulation	stimulation	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	EL-4	EL-4	B-NP	NN	B-cell_line	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	Jurkat	Jurkat	I-NP	NN	B-cell_line	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_line	21	PMOD
26	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	inhibition	inhibition	I-NP	NN	O	27	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	HIV	HIV	B-NP	NN	O	5	NMOD
5	infection	infection	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	cells	cell	B-NP	NNS	O	6	PMOD
8	stably	stably	B-VP	RB	O	9	VMOD
9	expressing	express	I-VP	VBG	O	7	NMOD
10	a	a	B-NP	DT	O	13	NMOD
11	transdominant	transdominant	I-NP	JJ	B-protein	13	NMOD
12	Rev	Rev	I-NP	NN	I-protein	13	NMOD
13	protein	protein	I-NP	NN	I-protein	9	OBJ
14	,	,	O	,	O	2	P
15	in	in	B-PP	IN	O	2	NMOD
16	the	the	B-NP	DT	O	17	NMOD
17	absence	absence	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	any	any	B-NP	DT	O	21	NMOD
20	deleterious	deleterious	I-NP	JJ	O	21	NMOD
21	effect	effect	I-NP	NN	O	18	PMOD
22	on	on	B-PP	IN	O	21	NMOD
23	T	T	B-NP	NN	O	25	NMOD
24	cell	cell	I-NP	NN	O	25	NMOD
25	function	function	I-NP	NN	O	22	PMOD
26	,	,	O	,	O	2	P
27	suggests	suggest	B-VP	VBZ	O	0	ROOT
28	that	that	B-SBAR	IN	O	27	VMOD
29	such	such	B-NP	PDT	O	31	NMOD
30	a	a	I-NP	DT	O	31	NMOD
31	strategy	strategy	I-NP	NN	O	32	SUB
32	could	could	B-VP	MD	O	28	SBAR
33	provide	provide	I-VP	VB	O	32	VC
34	a	a	B-NP	DT	O	36	NMOD
35	therapeutic	therapeutic	I-NP	JJ	O	36	NMOD
36	effect	effect	I-NP	NN	O	33	OBJ
37	in	in	B-PP	IN	O	36	NMOD
38	the	the	B-NP	DT	O	40	NMOD
39	T	T	I-NP	NN	B-cell_type	40	NMOD
40	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	37	PMOD
41	of	of	B-PP	IN	O	40	NMOD
42	acquired	acquire	B-NP	VBN	O	45	NMOD
43	immunodeficiency	immunodeficiency	I-NP	NN	O	45	NMOD
44	syndrome	syndrome	I-NP	NN	O	45	NMOD
45	patients	patient	I-NP	NNS	O	41	PMOD
46	.	.	O	.	O	27	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	these	these	B-NP	DT	O	4	NMOD
4	studies	study	I-NP	NNS	O	5	SUB
5	have	have	B-VP	VBP	O	29	VMOD
6	used	use	I-VP	VBN	O	5	VC
7	a	a	B-NP	DT	O	9	NMOD
8	limited	limit	I-NP	VBN	O	9	NMOD
9	number	number	I-NP	NN	O	6	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	known	known	B-NP	JJ	O	15	NMOD
12	kappa	kappa	I-NP	NN	O	15	NMOD
13	B	B	I-NP	NN	O	15	NMOD
14	DNA	DNA	I-NP	NN	O	15	NMOD
15	motifs	motif	I-NP	NNS	O	10	PMOD
16	,	,	O	,	O	29	P
17	and	and	O	CC	O	29	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	question	question	I-NP	NN	O	29	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	optimal	optimal	I-NP	JJ	B-DNA	24	NMOD
23	DNA	DNA	I-NP	NN	I-DNA	24	NMOD
24	sequences	sequence	I-NP	NNS	I-DNA	20	PMOD
25	preferred	prefer	B-VP	VBN	O	24	NMOD
26	by	by	B-PP	IN	O	25	VMOD
27	each	each	B-NP	DT	O	28	NMOD
28	homodimer	homodimer	I-NP	NN	B-protein	26	PMOD
29	has	have	B-VP	VBZ	O	0	ROOT
30	not	not	I-VP	RB	O	29	VMOD
31	been	be	I-VP	VBN	O	29	VC
32	addressed	address	I-VP	VBN	O	31	VC
33	.	.	O	.	O	29	P

1	Contrary	Contrary	B-ADVP	JJ	O	2	PMOD
2	to	to	B-PP	TO	O	7	VMOD
3	previous	previous	B-NP	JJ	O	4	NMOD
4	assumptions	assumption	I-NP	NNS	O	2	PMOD
5	,	,	O	,	O	7	P
6	we	we	B-NP	PRP	O	7	SUB
7	observed	observe	B-VP	VBD	O	0	ROOT
8	that	that	B-SBAR	IN	O	7	VMOD
9	p65	p65	B-NP	NN	B-protein	10	NMOD
10	homodimers	homodimer	I-NP	NNS	I-protein	11	SUB
11	can	can	B-VP	MD	O	8	SBAR
12	interact	interact	I-VP	VB	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	15	NMOD
15	subset	subset	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	DNA	DNA	B-NP	NN	B-DNA	18	NMOD
18	sequences	sequence	I-NP	NNS	I-DNA	16	PMOD
19	not	not	B-VP	RB	O	20	VMOD
20	recognized	recognize	I-VP	VBN	O	15	NMOD
21	by	by	B-PP	IN	O	20	VMOD
22	p50	p50	B-NP	NN	B-protein	23	NMOD
23	homodimers	homodimer	I-NP	NNS	I-protein	21	PMOD
24	.	.	O	.	O	7	P

1	Using	Use	B-VP	VBG	O	26	VMOD
2	either	either	O	CC	O	9	NMOD
3	a	a	B-NP	DT	O	9	NMOD
4	p50-	p50-	I-NP	NN	B-protein	6	AMOD
5	or	or	O	CC	O	6	AMOD
6	p65-selected	p65-selected	B-NP	JJ	B-protein	9	NMOD
7	kappa	kappa	I-NP	NN	I-protein	9	NMOD
8	B	B	I-NP	NN	I-protein	9	NMOD
9	motif	motif	I-NP	NN	I-protein	1	OBJ
10	,	,	O	,	O	9	P
11	which	which	B-NP	WDT	O	9	NMOD
12	displayed	display	B-VP	VBD	O	11	SBAR
13	differential	differential	B-NP	JJ	O	14	NMOD
14	binding	binding	I-NP	NN	O	12	OBJ
15	with	with	B-PP	IN	O	12	VMOD
16	respect	respect	B-NP	NN	O	15	PMOD
17	to	to	B-PP	TO	O	15	PMOD
18	the	the	B-NP	DT	O	20	NMOD
19	other	other	I-NP	JJ	O	20	NMOD
20	protein	protein	I-NP	NN	O	15	PMOD
21	,	,	O	,	O	9	P
22	little	little	B-NP	JJ	O	25	NMOD
23	to	to	B-PP	TO	O	22	AMOD
24	no	no	B-NP	DT	O	22	AMOD
25	binding	binding	I-NP	NN	O	26	SUB
26	was	be	B-VP	VBD	O	0	ROOT
27	observed	observe	I-VP	VBN	O	26	VC
28	with	with	B-PP	IN	O	27	VMOD
29	the	the	B-NP	DT	O	33	NMOD
30	heterodimeric	heterodimeric	I-NP	JJ	B-protein	33	NMOD
31	NF-kappa	NF-kappa	I-NP	NN	I-protein	33	NMOD
32	B	B	I-NP	NN	I-protein	33	NMOD
33	complex	complex	I-NP	NN	I-protein	28	PMOD
34	.	.	O	.	O	26	P

1	Similarly	Similarly	B-ADVP	RB	O	14	VMOD
2	,	,	O	,	O	14	P
3	in	in	B-PP	IN	O	14	VMOD
4	transfection	transfection	B-NP	NN	O	5	NMOD
5	experiments	experiment	I-NP	NNS	O	3	PMOD
6	in	in	B-PP	IN	O	5	NMOD
7	which	which	B-NP	WDT	O	6	PMOD
8	the	the	B-NP	DT	O	13	NMOD
9	selective	selective	I-NP	JJ	B-DNA	13	NMOD
10	kappa	kappa	I-NP	NN	I-DNA	13	NMOD
11	B	B	I-NP	NN	I-DNA	13	NMOD
12	binding	binding	I-NP	NN	I-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	6	PMOD
14	were	be	B-VP	VBD	O	32	VMOD
15	used	use	I-VP	VBN	O	14	VC
16	to	to	B-VP	TO	O	17	VMOD
17	drive	drive	I-VP	VB	O	15	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	expression	expression	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	a	a	B-NP	DT	O	25	NMOD
22	chloramphenicol	chloramphenicol	I-NP	NN	B-DNA	25	NMOD
23	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	25	NMOD
24	reporter	reporter	I-NP	NN	I-DNA	25	NMOD
25	construct	construct	I-NP	NN	I-DNA	20	PMOD
26	,	,	O	,	O	14	P
27	the	the	B-NP	DT	O	31	NMOD
28	p65-	p65-	I-NP	NN	B-DNA	30	AMOD
29	and	and	I-NP	CC	I-DNA	30	AMOD
30	p50-selected	p50-selected	I-NP	JJ	I-DNA	31	NMOD
31	motifs	motif	I-NP	NNS	I-DNA	32	SUB
32	were	be	B-VP	VBD	O	64	VMOD
33	activated	activate	I-VP	VBN	O	32	VC
34	only	only	B-PP	RB	O	35	PMOD
35	in	in	I-PP	IN	O	33	VMOD
36	the	the	B-NP	DT	O	35	PMOD
37	presence	presence	I-NP	NN	O	35	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	p65	p65	B-NP	NN	B-protein	41	NMOD
40	and	and	O	CC	O	41	NMOD
41	p50/65	p50/65	B-NP	NN	B-protein	58	NMOD
42	(	(	O	(	O	56	DEP
43	a	a	B-NP	DT	O	45	NMOD
44	chimeric	chimeric	I-NP	JJ	B-protein	45	NMOD
45	protein	protein	I-NP	NN	I-protein	56	DEP
46	with	with	B-PP	IN	O	45	NMOD
47	the	the	B-NP	DT	O	51	NMOD
48	p50	p50	I-NP	NN	B-protein	51	NMOD
49	DNA	DNA	I-NP	NN	I-protein	51	NMOD
50	binding	binding	I-NP	NN	I-protein	51	NMOD
51	domain	domain	I-NP	NN	I-protein	55	NMOD
52	and	and	O	CC	O	55	NMOD
53	p65	p65	B-NP	NN	B-protein	55	NMOD
54	activation	activation	I-NP	NN	I-protein	55	NMOD
55	domain	domain	I-NP	NN	I-protein	46	PMOD
56	)	)	O	)	O	41	NMOD
57	expression	expression	B-NP	NN	O	58	NMOD
58	vectors	vector	I-NP	NNS	O	38	PMOD
59	,	,	O	,	O	33	P
60	respectively	respectively	B-ADVP	RB	O	33	VMOD
61	,	,	O	,	O	64	P
62	and	and	O	CC	O	64	VMOD
63	neither	neither	B-NP	DT	O	64	SUB
64	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
65	a	a	B-NP	DT	O	67	NMOD
66	significant	significant	I-NP	JJ	O	67	NMOD
67	response	response	I-NP	NN	O	64	OBJ
68	to	to	B-PP	TO	O	67	NMOD
69	stimuli	stimulus	B-NP	NNS	O	68	PMOD
70	that	that	B-NP	WDT	O	69	NMOD
71	induce	induce	B-VP	VBP	O	70	SBAR
72	NF-kappa	NF-kappa	B-NP	NN	B-protein	74	NMOD
73	B	B	I-NP	NN	I-protein	74	NMOD
74	activity	activity	I-NP	NN	O	71	OBJ
75	.	.	O	.	O	64	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	biochemically	biochemically	I-VP	RB	O	2	VMOD
4	and	and	I-VP	CC	O	3	AMOD
5	functionally	functionally	I-VP	RB	O	3	AMOD
6	characterized	characterize	I-VP	VBD	O	2	VC
7	a	a	B-NP	DT	O	10	NMOD
8	new	new	I-NP	JJ	O	10	NMOD
9	transcription	transcription	I-NP	NN	B-protein	10	NMOD
10	factor	factor	I-NP	NN	I-protein	12	NMOD
11	,	,	O	,	O	12	P
12	NP-TCII	NP-TCII	B-NP	NN	B-protein	6	OBJ
13	,	,	O	,	O	12	P
14	which	which	B-NP	WDT	O	12	NMOD
15	is	be	B-VP	VBZ	O	14	SBAR
16	present	present	B-ADJP	JJ	O	15	PRD
17	in	in	B-PP	IN	O	16	AMOD
18	nuclei	nucleus	B-NP	NNS	O	17	PMOD
19	from	from	B-PP	IN	O	18	NMOD
20	unstimulated	unstimulated	B-NP	JJ	B-cell_line	24	NMOD
21	T	T	I-NP	NN	I-cell_line	24	NMOD
22	and	and	I-NP	CC	I-cell_line	24	NMOD
23	B	B	I-NP	NN	I-cell_line	24	NMOD
24	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	19	PMOD
25	but	but	O	CC	O	15	VMOD
26	is	be	B-VP	VBZ	O	15	VMOD
27	not	not	I-VP	RB	O	26	VMOD
28	found	find	I-VP	VBN	O	26	VC
29	in	in	B-PP	IN	O	28	VMOD
30	nonhematopoietic	nonhematopoietic	B-NP	JJ	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
32	.	.	O	.	O	2	P

1	No	No	B-NP	DT	O	3	NMOD
2	biological	biological	I-NP	JJ	O	3	NMOD
3	function	function	I-NP	NN	O	4	SUB
4	has	have	B-VP	VBZ	O	13	VMOD
5	yet	yet	I-VP	RB	O	4	VMOD
6	been	be	I-VP	VBN	O	4	VC
7	described	describe	I-VP	VBN	O	6	VC
8	for	for	B-PP	IN	O	7	VMOD
9	Bcl-3	Bcl-3	B-NP	NN	B-protein	8	PMOD
10	,	,	O	,	O	13	P
11	but	but	O	CC	O	13	VMOD
12	it	it	B-NP	PRP	O	13	SUB
13	was	be	B-VP	VBD	O	0	ROOT
14	noted	note	I-VP	VBN	O	13	VC
15	recently	recently	B-ADVP	RB	O	14	VMOD
16	that	that	B-SBAR	IN	O	14	VMOD
17	Bcl-3	Bcl-3	B-NP	NN	B-protein	18	SUB
18	interferes	interfere	B-VP	VBZ	O	16	SBAR
19	with	with	B-PP	IN	O	18	VMOD
20	DNA-binding	DNA-binding	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	p50	p50	I-NP	NN	B-protein	24	NMOD
24	subunit	subunit	I-NP	NN	I-protein	21	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	NF-kappa	NF-kappa	B-NP	NN	B-protein	27	NMOD
27	B	B	I-NP	NN	I-protein	25	PMOD
28	in	in	B-ADVP	FW	O	18	VMOD
29	vitro	vitro	I-ADVP	FW	O	28	AMOD
30	.	.	O	.	O	13	P

1	On	On	B-PP	IN	O	12	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	first	first	I-NP	JJ	O	4	NMOD
4	day	day	I-NP	NN	O	1	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	disease	disease	I-NP	NN	O	5	PMOD
8	,	,	O	,	O	12	P
9	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	11	NMOD
10	receptor	receptor	I-NP	NN	I-protein	11	NMOD
11	capacity	capacity	I-NP	NN	O	12	SUB
12	was	be	B-VP	VBD	O	22	VMOD
13	significantly	significantly	I-VP	RB	O	12	VMOD
14	decreased	decrease	I-VP	VBN	O	12	VC
15	without	without	B-PP	IN	O	14	VMOD
16	alteration	alteration	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	receptor-ligand	receptor-ligand	I-NP	JJ	O	20	NMOD
20	affinity	affinity	I-NP	NN	O	17	PMOD
21	,	,	O	,	O	22	P
22	whereas	whereas	O	IN	O	0	ROOT
23	on	on	B-PP	IN	O	33	VMOD
24	days	day	B-NP	NNS	O	23	PMOD
25	4	4	B-NP	CD	O	27	NMOD
26	and	and	I-NP	CC	O	27	NMOD
27	12	12	I-NP	CD	O	24	NMOD
28	the	the	B-NP	DT	O	29	NMOD
29	number	number	I-NP	NN	O	33	SUB
30	of	of	B-PP	IN	O	29	NMOD
31	receptor	receptor	B-NP	NN	O	32	NMOD
32	sites	site	I-NP	NNS	O	30	PMOD
33	was	be	B-VP	VBD	O	22	VMOD
34	normal	normal	B-ADJP	JJ	O	33	PRD
35	again	again	B-ADVP	RB	O	33	VMOD
36	.	.	O	.	O	22	P

1	Since	Since	B-SBAR	IN	O	17	VMOD
2	previous	previous	B-NP	JJ	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	have	have	B-VP	VBP	O	1	SBAR
5	demonstrated	demonstrate	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	c-jun	c-jun	I-NP	NN	B-DNA	9	NMOD
9	gene	gene	I-NP	NN	I-DNA	10	SUB
10	is	be	B-VP	VBZ	O	6	SBAR
11	autoinduced	autoinduce	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	Jun/AP-1	Jun/AP-1	B-NP	NN	B-protein	12	PMOD
14	,	,	O	,	O	17	P
15	we	we	B-NP	PRP	O	17	SUB
16	also	also	B-ADVP	RB	O	17	VMOD
17	studied	study	B-VP	VBD	O	0	ROOT
18	transcription	transcription	B-NP	NN	O	17	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	c-jun	c-jun	B-NP	NN	B-DNA	28	NMOD
21	promoter	promoter	I-NP	NN	I-DNA	28	NMOD
22	(	(	O	(	I-DNA	25	DEP
23	positions	position	B-NP	NNS	I-DNA	25	DEP
24	-132/+170	-132/+170	B-NP	CD	I-DNA	23	NMOD
25	)	)	O	)	I-DNA	28	NMOD
26	-reporter	-reporter	B-NP	JJ	I-DNA	28	NMOD
27	gene	gene	I-NP	NN	I-DNA	28	NMOD
28	constructs	construct	I-NP	NNS	I-DNA	19	PMOD
29	with	with	B-PP	IN	O	18	NMOD
30	and	and	I-PP	CC	O	29	PMOD
31	without	without	I-PP	IN	O	29	PMOD
32	a	a	B-NP	DT	O	35	NMOD
33	mutated	mutate	I-NP	VBN	O	35	NMOD
34	AP-1	AP-1	I-NP	NN	B-protein	35	NMOD
35	element.	element.	I-NP	NN	O	29	PMOD
36	(	(	O	(	O	42	DEP
37	ABSTRACT	ABSTRACT	B-NP	NN	O	42	DEP
38	TRUNCATED	TRUNCATED	B-VP	VBN	O	37	NMOD
39	AT	AT	B-PP	IN	O	38	VMOD
40	250	250	B-NP	CD	O	41	NMOD
41	WORDS	WORDS	I-NP	NNS	O	39	PMOD
42	)	)	O	)	O	35	NMOD

1	Similarly	Similarly	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	IL-2	IL-2	B-NP	NN	B-protein	4	SUB
4	activates	activate	B-VP	VBZ	O	0	ROOT
5	NF-kappa	NF-kappa	B-NP	NN	B-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	4	OBJ
7	in	in	B-PP	IN	O	4	VMOD
8	the	the	B-NP	DT	O	13	NMOD
9	human	human	I-NP	JJ	B-cell_line	13	NMOD
10	monocytic	monocytic	I-NP	JJ	I-cell_line	13	NMOD
11	cell	cell	I-NP	NN	I-cell_line	13	NMOD
12	line	line	I-NP	NN	I-cell_line	13	NMOD
13	U	U	I-NP	NN	I-cell_line	7	PMOD
14	937	937	I-NP	CD	I-cell_line	13	NMOD
15	,	,	B-PP	,	O	7	P
16	but	but	I-PP	CC	O	7	PMOD
17	not	not	B-PP	RB	O	18	PMOD
18	in	in	I-PP	IN	O	7	PMOD
19	resting	rest	B-NP	VBG	B-cell_type	21	NMOD
20	human	human	I-NP	JJ	I-cell_type	21	NMOD
21	T-cells	T-cell	I-NP	NNS	I-cell_type	18	PMOD
22	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	average	average	I-NP	JJ	O	3	NMOD
3	values	value	I-NP	NNS	O	7	SUB
4	from	from	B-PP	IN	O	3	NMOD
5	healthy	healthy	B-NP	JJ	O	6	NMOD
6	volunteers	volunteer	I-NP	NNS	O	4	PMOD
7	did	do	B-VP	VBD	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	differ	differ	I-VP	VB	O	7	VC
10	significantly	significantly	B-ADVP	RB	O	9	VMOD
11	from	from	B-PP	IN	O	9	VMOD
12	those	those	B-NP	DT	O	11	PMOD
13	found	find	B-VP	VBN	O	12	NMOD
14	in	in	B-PP	IN	O	13	VMOD
15	these	these	B-NP	DT	O	16	NMOD
16	children	child	I-NP	NNS	O	14	PMOD
17	,	,	O	,	O	9	P
18	though	though	B-NP	RB	O	22	DEP
19	much	much	I-NP	RB	O	20	AMOD
20	broader	broad	I-NP	JJR	O	21	NMOD
21	range	range	I-NP	NN	O	22	SUB
22	was	be	B-VP	VBD	O	9	VMOD
23	found	find	I-VP	VBN	O	22	VC
24	in	in	B-PP	IN	O	23	VMOD
25	patients	patient	B-NP	NNS	O	24	PMOD
26	.	.	O	.	O	7	P

1	OCA-B	OCA-B	B-NP	NN	B-protein	2	SUB
2	stimulates	stimulate	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	transcription	transcription	I-NP	NN	O	2	OBJ
5	from	from	B-PP	IN	O	4	NMOD
6	an	an	B-NP	DT	O	8	NMOD
7	IgH	IgH	I-NP	NN	B-DNA	8	NMOD
8	promoter	promoter	I-NP	NN	I-DNA	5	PMOD
9	in	in	B-PP	IN	O	2	VMOD
10	conjunction	conjunction	B-NP	NN	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	either	either	O	CC	O	15	NMOD
13	Oct-1	Oct-1	B-NP	NN	B-protein	15	NMOD
14	or	or	I-NP	CC	O	15	NMOD
15	Oct-2	Oct-2	I-NP	NN	B-protein	11	PMOD
16	but	but	O	CC	O	2	VMOD
17	shows	show	B-VP	VBZ	O	2	VMOD
18	no	no	B-NP	DT	O	20	NMOD
19	significant	significant	I-NP	JJ	O	20	NMOD
20	effect	effect	I-NP	NN	O	17	OBJ
21	on	on	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	octamer/Oct-dependent	octamer/Oct-dependent	I-NP	JJ	O	24	NMOD
24	transcription	transcription	I-NP	NN	O	34	NMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	31	NMOD
27	ubiquitously	ubiquitously	I-NP	RB	B-DNA	28	AMOD
28	expressed	express	I-NP	VBN	I-DNA	31	NMOD
29	histone	histone	I-NP	NN	I-DNA	31	NMOD
30	H2B	H2B	I-NP	NN	I-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	25	PMOD
32	and	and	O	CC	O	34	NMOD
33	the	the	B-NP	DT	O	34	NMOD
34	transcription	transcription	I-NP	NN	O	21	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	USF-	USF-	B-NP	NN	B-DNA	38	AMOD
37	and	and	O	CC	I-DNA	38	AMOD
38	Sp1-regulated	Sp1-regulated	B-NP	JJ	I-DNA	39	NMOD
39	promoters	promoter	I-NP	NNS	I-DNA	35	PMOD
40	.	.	O	.	O	2	P

1	Analysis	Analysis	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	4	NMOD
4	series	series	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	5'-truncations	5'-truncation	B-NP	NNS	B-DNA	5	PMOD
7	showed	show	B-VP	VBD	O	0	ROOT
8	several	several	B-NP	JJ	O	9	NMOD
9	peaks	peak	I-NP	NNS	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	basal	basal	B-NP	JJ	O	13	AMOD
12	and	and	I-NP	CC	O	13	AMOD
13	PMA	PMA	I-NP	NN	O	15	NMOD
14	induced	induce	B-VP	VBD	O	13	AMOD
15	activity	activity	B-NP	NN	O	10	PMOD
16	suggesting	suggest	B-VP	VBG	O	9	NMOD
17	the	the	B-NP	DT	O	18	NMOD
18	presence	presence	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	several	several	B-NP	JJ	O	19	PMOD
21	positive	positive	I-NP	JJ	O	20	NMOD
22	and	and	I-NP	CC	O	20	NMOD
23	negative	negative	I-NP	JJ	B-DNA	25	NMOD
24	regulatory	regulatory	I-NP	JJ	I-DNA	25	NMOD
25	elements	element	I-NP	NNS	I-DNA	20	NMOD
26	.	.	O	.	O	7	P

1	BHA	BHA	B-NP	NN	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	found	find	I-VP	VBN	O	2	VC
4	to	to	I-VP	TO	O	5	VMOD
5	suppress	suppress	I-VP	VB	O	3	VMOD
6	not	not	B-CONJP	RB	O	14	AMOD
7	only	only	I-CONJP	RB	O	6	DEP
8	PMA-	PMA-	B-NP	NN	O	10	AMOD
9	or	or	O	CC	O	10	AMOD
10	TNF-induced	TNF-induced	B-ADJP	JJ	O	14	AMOD
11	,	,	O	,	O	14	P
12	but	but	B-CONJP	CC	O	14	AMOD
13	also	also	I-CONJP	RB	O	12	DEP
14	constitutive	constitutive	B-ADJP	JJ	O	17	NMOD
15	,	,	O	,	O	14	P
16	HIV-enhancer	HIV-enhancer	B-NP	NN	B-DNA	17	NMOD
17	activity	activity	I-NP	NN	O	5	OBJ
18	concomitant	concomitant	B-ADJP	JJ	O	17	NMOD
19	to	to	B-PP	TO	O	18	AMOD
20	an	an	B-NP	DT	O	21	NMOD
21	inhibition	inhibition	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	NF-kappa	NF-kappa	B-NP	NN	B-protein	26	NMOD
24	B	B	I-NP	NN	I-protein	26	NMOD
25	binding	binding	I-NP	NN	O	26	NMOD
26	activity	activity	I-NP	NN	O	22	PMOD
27	in	in	B-PP	IN	O	21	NMOD
28	both	both	B-NP	CC	O	35	AMOD
29	lymphoblastoid	lymphoblastoid	I-NP	JJ	B-cell_line	30	AMOD
30	T	T	I-NP	NN	I-cell_line	35	AMOD
31	(	(	O	(	O	33	DEP
32	J.Jhan	J.Jhan	B-NP	NN	B-cell_line	33	DEP
33	)	)	O	)	O	30	AMOD
34	and	and	O	CC	O	35	AMOD
35	monocytic	monocytic	B-NP	JJ	B-cell_line	40	NMOD
36	(	(	O	(	I-cell_line	38	DEP
37	U937	U937	B-NP	NN	I-cell_line	38	DEP
38	)	)	O	)	I-cell_line	35	AMOD
39	cell	cell	B-NP	NN	I-cell_line	40	NMOD
40	lines	line	I-NP	NNS	I-cell_line	27	PMOD
41	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	anti-oxidative	anti-oxidative	I-NP	JJ	O	3	NMOD
3	effect	effect	I-NP	NN	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	BHA	BHA	B-NP	NN	B-protein	4	PMOD
6	was	be	B-VP	VBD	O	26	VMOD
7	accompanied	accompany	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	an	an	B-NP	DT	O	10	NMOD
10	increase	increase	I-NP	NN	O	16	NMOD
11	in	in	B-PP	IN	O	10	NMOD
12	thiol	thiol	B-NP	NN	O	11	PMOD
13	,	,	O	,	O	16	P
14	but	but	O	CC	O	16	NMOD
15	not	not	O	RB	O	14	DEP
16	glutathione	glutathione	B-NP	NN	O	18	NMOD
17	,	,	O	,	O	16	P
18	content	content	B-NP	NN	O	8	PMOD
19	in	in	B-PP	IN	O	18	NMOD
20	stimulated	stimulate	B-NP	VBN	O	22	AMOD
21	and	and	I-NP	CC	O	22	AMOD
22	unstimulated	unstimulated	I-NP	JJ	O	24	NMOD
23	T	T	I-NP	NN	O	24	NMOD
24	cell	cell	I-NP	NN	O	19	PMOD
25	,	,	O	,	O	26	P
26	whereas	whereas	O	IN	O	0	ROOT
27	TNF	TNF	B-NP	NN	B-protein	28	NMOD
28	stimulation	stimulation	I-NP	NN	O	29	NMOD
29	itself	itself	B-NP	PRP	O	31	SUB
30	barely	barely	B-VP	RB	O	31	VMOD
31	modified	modify	I-VP	VBD	O	26	VMOD
32	the	the	B-NP	DT	O	35	NMOD
33	cellular	cellular	I-NP	JJ	O	35	NMOD
34	thiol	thiol	I-NP	NN	O	35	NMOD
35	level	level	I-NP	NN	O	31	OBJ
36	.	.	O	.	O	26	P

1	Oxidative	Oxidative	B-NP	JJ	O	2	NMOD
2	stress	stress	I-NP	NN	O	18	SUB
3	obtained	obtain	B-VP	VBN	O	2	NMOD
4	by	by	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	addition	addition	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	H2O2	H2O2	B-NP	NN	O	7	PMOD
9	to	to	B-PP	TO	O	6	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	culture	culture	I-NP	NN	O	12	NMOD
12	medium	medium	I-NP	NN	O	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	J.Jhan	J.Jhan	B-NP	NN	B-cell_line	16	NMOD
15	or	or	I-NP	CC	O	16	NMOD
16	U937	U937	I-NP	NN	B-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
18	could	could	B-VP	MD	O	0	ROOT
19	not	not	O	RB	O	18	VMOD
20	by	by	B-PP	IN	O	18	VMOD
21	itself	itself	B-NP	PRP	O	20	PMOD
22	induce	induce	B-VP	VBP	O	18	VC
23	NF-kappa	NF-kappa	B-NP	NN	B-protein	24	NMOD
24	B	B	I-NP	NN	I-protein	25	NMOD
25	activation	activation	I-NP	NN	O	22	OBJ
26	.	.	O	.	O	18	P

1	These	These	B-NP	DT	O	2	NMOD
2	observations	observation	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	TNF	TNF	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	PMA	PMA	I-NP	NN	O	8	SUB
8	do	do	B-VP	VBP	O	4	SBAR
9	not	not	I-VP	RB	O	8	VMOD
10	lead	lead	I-VP	VB	O	8	VC
11	to	to	B-PP	TO	O	10	VMOD
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	activation	activation	I-NP	NN	O	11	PMOD
15	through	through	B-PP	IN	O	10	VMOD
16	induction	induction	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	changes	change	B-NP	NNS	O	17	PMOD
19	in	in	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	cell	cell	I-NP	NN	O	23	NMOD
22	redox	redox	I-NP	NN	O	23	NMOD
23	status	status	I-NP	NN	O	19	PMOD
24	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	8	VMOD
2	PHA-activated	PHA-activated	B-NP	JJ	B-cell_line	3	NMOD
3	PBL	PBL	I-NP	NN	I-cell_line	1	PMOD
4	,	,	O	,	O	8	P
5	no	no	B-NP	DT	O	7	NMOD
6	age-related	age-related	I-NP	JJ	O	7	NMOD
7	differences	difference	I-NP	NNS	O	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	observed	observe	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	c-fos	c-fos	B-NP	NN	B-DNA	16	NMOD
12	or	or	O	CC	O	16	NMOD
13	jun	jun	B-NP	NN	B-RNA	14	NMOD
14	B	B	I-NP	NN	I-RNA	16	NMOD
15	mRNA	mRNA	I-NP	NN	I-RNA	16	NMOD
16	expression	expression	I-NP	NN	O	10	PMOD
17	.	.	O	.	O	8	P

1	No	No	B-NP	DT	O	3	NMOD
2	age-related	age-related	I-NP	JJ	O	3	NMOD
3	differences	difference	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	found	find	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	expression	expression	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	either	either	B-NP	DT	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	these	these	B-NP	DT	O	14	NMOD
13	two	two	I-NP	CD	O	14	NMOD
14	proto-oncogenes	proto-oncogene	I-NP	NNS	B-DNA	11	PMOD
15	by	by	B-PP	IN	O	8	NMOD
16	anti-CD2	anti-CD2	B-NP	JJ	B-protein	19	NMOD
17	activated	activate	I-NP	VBN	I-protein	19	NMOD
18	T	T	I-NP	NN	I-protein	19	NMOD
19	cells	cell	I-NP	NNS	I-protein	15	PMOD
20	.	.	O	.	O	4	P

1	Characterization	Characterization	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	7	NMOD
4	novel	novel	I-NP	JJ	O	7	NMOD
5	T	T	I-NP	NN	B-protein	7	NMOD
6	lymphocyte	lymphocyte	I-NP	NN	I-protein	7	NMOD
7	protein	protein	I-NP	NN	I-protein	2	PMOD
8	which	which	B-NP	WDT	O	7	NMOD
9	binds	bind	B-VP	VBZ	O	8	SBAR
10	to	to	B-PP	TO	O	9	VMOD
11	a	a	B-NP	DT	O	12	NMOD
12	site	site	I-NP	NN	O	10	PMOD
13	related	related	B-ADJP	JJ	O	12	NMOD
14	to	to	B-PP	TO	O	13	AMOD
15	steroid/thyroid	steroid/thyroid	B-NP	JJ	B-DNA	19	NMOD
16	hormone	hormone	I-NP	NN	I-DNA	19	NMOD
17	receptor	receptor	I-NP	NN	I-DNA	19	NMOD
18	response	response	I-NP	NN	I-DNA	19	NMOD
19	elements	element	I-NP	NNS	I-DNA	14	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	negative	negative	I-NP	JJ	B-DNA	24	NMOD
23	regulatory	regulatory	I-NP	JJ	I-DNA	24	NMOD
24	sequence	sequence	I-NP	NN	I-DNA	20	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	32	NMOD
27	human	human	I-NP	JJ	B-DNA	32	NMOD
28	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	32	NMOD
29	virus	virus	I-NP	NN	I-DNA	32	NMOD
30	long	long	I-NP	JJ	I-DNA	32	NMOD
31	terminal	terminal	I-NP	JJ	I-DNA	32	NMOD
32	repeat	repeat	I-NP	NN	I-DNA	25	PMOD
33	.	.	O	.	O	1	P

1	Corticosteroids	Corticosteroid	B-NP	NNS	O	2	SUB
2	are	be	B-VP	VBP	O	0	ROOT
3	the	the	B-NP	DT	O	6	NMOD
4	preeminent	preeminent	I-NP	JJ	O	6	NMOD
5	antiinflammatory	antiinflammatory	I-NP	JJ	O	6	NMOD
6	agents	agent	I-NP	NNS	O	2	PRD
7	although	although	B-SBAR	IN	O	2	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	molecular	molecular	I-NP	JJ	O	10	NMOD
10	mechanisms	mechanism	I-NP	NNS	O	15	SUB
11	that	that	B-NP	WDT	O	10	NMOD
12	impart	impart	B-VP	VBP	O	11	SBAR
13	their	their	B-NP	PRP$	O	14	NMOD
14	efficacy	efficacy	I-NP	NN	O	12	OBJ
15	have	have	B-VP	VBP	O	7	SBAR
16	not	not	I-VP	RB	O	15	VMOD
17	been	be	I-VP	VBN	O	15	VC
18	defined	define	I-VP	VBN	O	17	VC
19	.	.	O	.	O	2	P

1	Moreover	Moreover	B-ADVP	RB	O	24	VMOD
2	,	,	O	,	O	24	P
3	the	the	B-NP	DT	O	7	NMOD
4	steroid	steroid	I-NP	NN	B-protein	7	NMOD
5	receptor	receptor	I-NP	NN	I-protein	7	NMOD
6	agonist	agonist	I-NP	NN	O	7	NMOD
7	cortisol	cortisol	I-NP	NN	O	18	NMOD
8	(	(	O	(	O	11	DEP
9	10	10	B-NP	CD	O	10	NMOD
10	microM	microM	I-NP	NN	O	11	DEP
11	)	)	O	)	O	7	NMOD
12	,	,	O	,	O	18	P
13	but	but	O	CC	O	18	NMOD
14	not	not	O	RB	O	13	DEP
15	its	its	B-NP	PRP$	O	18	NMOD
16	inactive	inactive	I-NP	JJ	O	18	NMOD
17	metabolite	metabolite	I-NP	NN	O	18	NMOD
18	tetrahydrocortisol	tetrahydrocortisol	I-NP	NN	O	24	SUB
19	(	(	O	(	O	22	DEP
20	10	10	B-NP	CD	O	21	NMOD
21	microM	microM	I-NP	NN	O	22	DEP
22	)	)	O	)	O	18	NMOD
23	,	,	O	,	O	18	P
24	diminished	diminish	B-VP	VBD	O	0	ROOT
25	LPS-induced	LPS-induced	B-NP	JJ	O	28	NMOD
26	endothelial	endothelial	I-NP	JJ	O	28	NMOD
27	cell	cell	I-NP	NN	O	28	NMOD
28	adhesiveness	adhesiveness	I-NP	NN	O	24	OBJ
29	.	.	O	.	O	24	P

1	As	As	B-PP	IN	O	11	VMOD
2	in	in	B-PP	IN	O	1	PMOD
3	the	the	B-NP	DT	O	5	NMOD
4	adhesion	adhesion	I-NP	NN	O	5	NMOD
5	studies	study	I-NP	NNS	O	2	PMOD
6	,	,	O	,	O	11	P
7	cortisol	cortisol	B-NP	NN	O	10	NMOD
8	but	but	B-NP	CC	O	10	NMOD
9	not	not	I-NP	RB	O	8	DEP
10	tetrahydrocortisol	tetrahydrocortisol	B-NP	NN	O	11	SUB
11	inhibited	inhibit	B-VP	VBD	O	0	ROOT
12	expression	expression	B-NP	NN	O	11	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	ELAM-1	ELAM-1	B-NP	NN	B-protein	16	NMOD
15	and	and	O	CC	O	16	NMOD
16	ICAM-1	ICAM-1	B-NP	NN	B-protein	31	NMOD
17	(	(	O	(	O	31	NMOD
18	both	both	O	CC	O	31	NMOD
19	P	P	B-NP	NN	B-protein	21	NMOD
20	&	&	I-NP	CC	I-protein	21	NMOD
21	lt	lt	I-NP	NN	I-protein	31	NMOD
22	;	;	O	:	O	31	P
23	0.005	0.005	B-NP	CD	O	31	NMOD
24	,	,	O	,	O	31	P
25	n	n	B-NP	NN	O	29	SUB
26	=	=	B-VP	JJ	O	29	VMOD
27	3	3	B-NP	CD	O	29	NMOD
28	or	or	I-NP	CC	O	29	NMOD
29	4	4	I-NP	CD	O	31	NMOD
30	)	)	O	)	O	31	NMOD
31	9	9	B-NP	CD	O	13	PMOD
32	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	10	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	sodium	sodium	B-NP	NN	O	5	NMOD
5	salicylate	salicylate	I-NP	NN	O	10	SUB
6	(	(	O	(	O	9	DEP
7	1	1	B-NP	CD	O	8	NMOD
8	mM	mM	I-NP	NN	O	9	DEP
9	)	)	O	)	O	5	NMOD
10	inhibited	inhibit	B-VP	VBD	O	0	ROOT
11	neither	neither	O	CC	O	10	VMOD
12	adhesion	adhesion	B-NP	NN	O	14	NMOD
13	nor	nor	I-NP	CC	O	14	NMOD
14	expression	expression	I-NP	NN	O	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	these	these	B-NP	DT	O	18	NMOD
17	adhesion	adhesion	I-NP	NN	B-protein	18	NMOD
18	molecules	molecule	I-NP	NNS	I-protein	15	PMOD
19	.	.	O	.	O	10	P

1	REVs	REV	B-NP	NNS	O	2	SUB
2	do	do	B-VP	VBP	O	30	VMOD
3	not	not	I-VP	RB	O	2	VMOD
4	encode	encode	I-VP	VB	O	2	VC
5	a	a	B-NP	DT	O	6	NMOD
6	transactivator	transactivator	I-NP	NN	B-protein	4	OBJ
7	targeted	target	B-VP	VBN	O	6	NMOD
8	to	to	B-PP	TO	O	7	VMOD
9	the	the	B-NP	DT	O	11	NMOD
10	viral	viral	I-NP	JJ	B-DNA	11	NMOD
11	LTR	LTR	I-NP	NN	I-DNA	8	PMOD
12	,	,	O	,	O	30	P
13	and	and	O	CC	O	30	VMOD
14	cells	cell	B-NP	NNS	O	30	SUB
15	infected	infect	B-VP	VBN	O	14	NMOD
16	with	with	B-PP	IN	O	15	VMOD
17	Marek	Marek	B-NP	NNP	O	18	NMOD
18	's	's	B-NP	POS	O	20	NMOD
19	disease	disease	I-NP	NN	O	20	NMOD
20	virus	virus	I-NP	NN	O	23	NMOD
21	,	,	O	,	O	23	P
22	a	a	B-NP	DT	O	23	NMOD
23	herpesvirus	herpesvirus	I-NP	NN	O	16	PMOD
24	with	with	B-PP	IN	O	23	NMOD
25	an	an	B-NP	DT	O	28	NMOD
26	overlapping	overlap	I-NP	VBG	O	28	NMOD
27	host	host	I-NP	NN	O	28	NMOD
28	range	range	I-NP	NN	O	24	PMOD
29	,	,	O	,	O	14	P
30	do	do	B-VP	VBP	O	0	ROOT
31	not	not	I-VP	RB	O	30	VMOD
32	express	express	I-VP	VB	O	30	VC
33	factors	factor	B-NP	NNS	O	32	OBJ
34	that	that	B-NP	WDT	O	33	NMOD
35	preferentially	preferentially	B-ADVP	RB	O	36	VMOD
36	enhance	enhance	B-VP	VBP	O	34	SBAR
37	expression	expression	B-NP	NN	O	36	OBJ
38	from	from	B-PP	IN	O	37	NMOD
39	REV	REV	B-NP	NN	O	44	NMOD
40	or	or	O	CC	O	44	NMOD
41	avian	avian	B-NP	JJ	B-DNA	44	NMOD
42	sarcoma/leukemia	sarcoma/leukemia	I-NP	NN	I-DNA	44	NMOD
43	virus	virus	I-NP	NN	I-DNA	44	NMOD
44	LTRs	LTR	I-NP	NNS	I-DNA	38	PMOD
45	.	.	O	.	O	30	P

1	No	No	B-NP	DT	O	3	NMOD
2	positive	positive	I-NP	JJ	O	3	NMOD
3	effect	effect	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	duplicated	duplicate	I-NP	VBN	O	7	NMOD
7	CTG-motif	CTG-motif	I-NP	NN	B-DNA	4	PMOD
8	could	could	B-VP	MD	O	0	ROOT
9	be	be	I-VP	VB	O	8	VC
10	detected	detect	I-VP	VBN	O	9	VC
11	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	mechanism	mechanism	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	HS2	HS2	B-NP	NN	B-DNA	6	NMOD
5	enhancer	enhancer	I-NP	NN	I-DNA	6	NMOD
6	function	function	I-NP	NN	O	3	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	known	know	I-VP	VBN	O	7	VC
10	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	16	VMOD
2	nonerythroid	nonerythroid	B-NP	JJ	B-cell_line	4	NMOD
3	HL-60	HL-60	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
5	in	in	B-PP	IN	O	4	NMOD
6	which	which	B-NP	WDT	O	5	PMOD
7	the	the	B-NP	DT	O	9	NMOD
8	HS2	HS2	I-NP	NN	B-DNA	9	NMOD
9	enhancer	enhancer	I-NP	NN	I-DNA	10	SUB
10	is	be	B-VP	VBZ	O	5	SBAR
11	inactive	inactive	B-NP	JJ	O	10	PRD
12	,	,	I-NP	,	O	16	P
13	long	long	I-NP	JJ	B-RNA	15	NMOD
14	enhancer	enhancer	I-NP	NN	I-RNA	15	NMOD
15	transcripts	transcript	I-NP	NNS	I-RNA	16	SUB
16	are	be	B-VP	VBP	O	0	ROOT
17	not	not	O	RB	O	16	VMOD
18	detectable	detectable	B-ADJP	JJ	O	16	PRD
19	.	.	O	.	O	16	P

1	In	In	B-PP	IN	O	7	VMOD
2	THP-1	THP-1	B-NP	NN	B-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
4	,	,	O	,	O	7	P
5	TPA	TPA	B-NP	NN	O	7	SUB
6	also	also	B-ADVP	RB	O	7	VMOD
7	induced	induce	B-VP	VBD	O	0	ROOT
8	a	a	B-NP	DT	O	15	NMOD
9	new	new	I-NP	JJ	O	11	AMOD
10	,	,	I-NP	,	O	11	P
11	faster-migrating	faster-migrating	I-NP	JJ	B-protein	15	NMOD
12	NF	NF	I-NP	NN	I-protein	15	NMOD
13	kappa	kappa	I-NP	NN	I-protein	15	NMOD
14	B	B	I-NP	NN	I-protein	15	NMOD
15	species	specie	I-NP	NNS	I-protein	7	OBJ
16	not	not	B-VP	RB	O	17	VMOD
17	induced	induce	I-VP	VBN	O	15	NMOD
18	in	in	B-PP	IN	O	17	VMOD
19	monocytes	monocyte	B-NP	NNS	B-cell_type	18	PMOD
20	.	.	O	.	O	7	P

1	Protein	Protein	B-NP	NN	B-protein	5	NMOD
2	kinase	kinase	I-NP	NN	I-protein	5	NMOD
3	C	C	I-NP	NN	I-protein	5	NMOD
4	inhibitor	inhibitor	I-NP	NN	O	5	NMOD
5	staurosporine	staurosporine	I-NP	NN	O	14	NMOD
6	,	,	O	,	O	14	P
7	but	but	O	CC	O	14	NMOD
8	not	not	O	RB	O	7	DEP
9	cyclic	cyclic	B-NP	JJ	O	10	AMOD
10	nucleotide-dependent	nucleotide-dependent	I-NP	JJ	O	14	NMOD
11	protein	protein	I-NP	NN	O	14	NMOD
12	kinase	kinase	I-NP	NN	O	14	NMOD
13	inhibitor	inhibitor	I-NP	NN	O	14	NMOD
14	HA-1004	HA-1004	I-NP	NN	O	18	SUB
15	,	,	O	,	O	14	P
16	also	also	B-ADVP	RB	O	18	VMOD
17	dramatically	dramatically	B-ADVP	RB	O	18	VMOD
18	reduced	reduce	B-VP	VBD	O	0	ROOT
19	constitutive	constitutive	B-NP	JJ	O	20	NMOD
20	levels	level	I-NP	NNS	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	nuclear	nuclear	B-NP	JJ	B-protein	25	NMOD
23	NF	NF	I-NP	NN	I-protein	25	NMOD
24	kappa	kappa	I-NP	NN	I-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	21	PMOD
26	.	.	O	.	O	18	P

1	In	In	B-PP	IN	O	9	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	9	P
4	antisense	antisense	B-NP	JJ	O	5	NMOD
5	inhibition	inhibition	I-NP	NN	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	Tax	Tax	B-NP	NN	B-protein	8	NMOD
8	itself	itself	B-NP	PRP	O	6	PMOD
9	had	have	B-VP	VBD	O	0	ROOT
10	no	no	B-NP	DT	O	12	NMOD
11	apparent	apparent	I-NP	JJ	O	12	NMOD
12	effect	effect	I-NP	NN	O	9	OBJ
13	on	on	B-PP	IN	O	9	VMOD
14	cell	cell	B-NP	NN	O	15	NMOD
15	growth	growth	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	9	P

1	Proliferation	Proliferation	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	2	PMOD
5	was	be	B-VP	VBD	O	0	ROOT
6	induced	induce	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	immobilized	immobilize	B-NP	VBN	O	9	NMOD
9	anti-CD3	anti-CD3	I-NP	JJ	B-protein	7	PMOD
10	monoclonal	monoclonal	I-NP	JJ	I-protein	11	NMOD
11	antibody	antibody	I-NP	NN	I-protein	9	NMOD
12	(	(	O	(	O	14	DEP
13	mAb	mAb	B-NP	NN	B-protein	14	DEP
14	)	)	O	)	O	11	NMOD
15	in	in	B-PP	IN	O	6	VMOD
16	the	the	B-NP	DT	O	19	NMOD
17	presence	presence	I-NP	NN	O	19	NMOD
18	or	or	I-NP	CC	O	19	NMOD
19	absence	absence	I-NP	NN	O	15	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	an	an	B-NP	DT	O	24	NMOD
22	additional	additional	I-NP	JJ	O	24	NMOD
23	costimulatory	costimulatory	I-NP	JJ	O	24	NMOD
24	signal	signal	I-NP	NN	O	20	PMOD
25	delivered	deliver	B-VP	VBN	O	24	NMOD
26	by	by	B-PP	IN	O	25	VMOD
27	anti-CD28	anti-CD28	B-NP	JJ	B-protein	28	NMOD
28	mAb	mAb	I-NP	NN	I-protein	26	PMOD
29	.	.	O	.	O	5	P

1	Synergistic	Synergistic	B-NP	JJ	O	2	NMOD
2	suppression	suppression	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	T-cell	T-cell	B-NP	NN	O	5	NMOD
5	proliferation	proliferation	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	observed	observe	I-VP	VBN	O	6	VC
8	when	when	B-ADVP	WRB	O	7	VMOD
9	various	various	B-NP	JJ	O	10	NMOD
10	concentrations	concentration	I-NP	NNS	O	20	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	DEX	DEX	B-NP	NN	O	14	NMOD
13	and	and	I-NP	CC	O	14	NMOD
14	PGE2	PGE2	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	20	P
16	but	but	O	CC	O	20	NMOD
17	not	not	O	RB	O	16	DEP
18	DEX	DEX	B-NP	NN	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	ISO	ISO	I-NP	NN	O	22	SUB
21	,	,	O	,	O	20	P
22	were	be	B-VP	VBD	O	8	SBAR
23	added	add	I-VP	VBN	O	22	VC
24	to	to	B-PP	TO	O	23	VMOD
25	cultures	culture	B-NP	NNS	O	24	PMOD
26	.	.	O	.	O	6	P

1	This	This	B-NP	DT	O	3	NMOD
2	synergistic	synergistic	I-NP	JJ	O	3	NMOD
3	suppression	suppression	I-NP	NN	O	4	SUB
4	could	could	B-VP	MD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	be	be	I-VP	VB	O	4	VC
7	explained	explain	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	an	an	B-NP	DT	O	10	NMOD
10	increase	increase	I-NP	NN	O	8	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	cAMP	cAMP	B-NP	NN	O	13	NMOD
13	accumulation	accumulation	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	13	NMOD
15	T	T	B-NP	NN	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
17	stimulated	stimulate	B-VP	VBN	O	16	NMOD
18	with	with	B-PP	IN	O	17	VMOD
19	DEX	DEX	B-NP	NN	O	21	NMOD
20	and	and	I-NP	CC	O	21	NMOD
21	PGE2	PGE2	I-NP	NN	O	18	PMOD
22	.	.	O	.	O	4	P

1	Targeted	Target	B-NP	VBN	O	2	NMOD
2	degradation	degradation	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	c-Fos	c-Fos	B-NP	NN	B-protein	8	NMOD
5	,	,	B-NP	,	O	8	P
6	but	but	I-NP	CC	O	8	NMOD
7	not	not	I-NP	RB	O	6	DEP
8	v-Fos	v-Fos	B-NP	NN	B-protein	3	PMOD
9	,	,	O	,	O	2	P
10	by	by	B-PP	IN	O	2	NMOD
11	a	a	B-NP	DT	O	13	NMOD
12	phosphorylation-dependent	phosphorylation-dependent	I-NP	JJ	B-protein	13	NMOD
13	signal	signal	I-NP	NN	I-protein	10	PMOD
14	on	on	B-PP	IN	O	13	NMOD
15	c-Jun	c-Jun	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	2	P

1	c-Jun	c-Jun	B-NP	NN	B-protein	2	NMOD
2	protein	protein	I-NP	NN	O	8	SUB
3	isolated	isolate	B-VP	VBN	O	2	NMOD
4	from	from	B-PP	IN	O	3	VMOD
5	phorbol	phorbol	B-NP	NN	B-cell_line	7	NMOD
6	ester-induced	ester-induced	I-NP	JJ	I-cell_line	5	AMOD
7	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	target	target	I-VP	VB	O	8	VC
11	c-Fos	c-Fos	B-NP	NN	B-protein	10	OBJ
12	for	for	B-PP	IN	O	10	VMOD
13	degradation	degradation	B-NP	NN	O	12	PMOD
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	suggests	suggest	B-VP	VBZ	O	15	SBAR
17	that	that	B-SBAR	IN	O	16	VMOD
18	c-Fos	c-Fos	B-NP	NN	B-protein	19	SUB
19	is	be	B-VP	VBZ	O	17	SBAR
20	transiently	transiently	I-VP	RB	O	19	VMOD
21	stabilized	stabilize	I-VP	VBN	O	19	VC
22	after	after	B-PP	IN	O	21	VMOD
23	stimulation	stimulation	B-NP	NN	O	22	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	cell	cell	B-NP	NN	O	26	NMOD
26	growth	growth	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	8	P

1	v-Fos	v-Fos	B-NP	NN	B-protein	2	NMOD
2	protein	protein	I-NP	NN	I-protein	6	NMOD
3	,	,	O	,	O	6	P
4	the	the	B-NP	DT	O	6	NMOD
5	retroviral	retroviral	I-NP	JJ	O	6	NMOD
6	counterpart	counterpart	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	c-Fos	c-Fos	B-NP	NN	B-protein	7	PMOD
9	,	,	O	,	O	6	P
10	was	be	B-VP	VBD	O	0	ROOT
11	not	not	O	RB	O	10	VMOD
12	susceptible	susceptible	B-ADJP	JJ	O	10	PRD
13	to	to	B-PP	TO	O	12	AMOD
14	degradation	degradation	B-NP	NN	O	13	PMOD
15	targeted	target	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	c-Jun	c-Jun	B-NP	NN	B-protein	16	PMOD
18	.	.	O	.	O	10	P

1	No	No	B-NP	DT	O	3	NMOD
2	unifying	unifying	I-NP	JJ	O	3	NMOD
3	hypothesis	hypothesis	I-NP	NN	O	4	SUB
4	has	have	B-VP	VBZ	O	0	ROOT
5	yet	yet	I-VP	RB	O	4	VMOD
6	emerged	emerge	I-VP	VBN	O	4	VC
7	explaining	explain	I-VP	VBG	O	6	VMOD
8	this	this	B-NP	DT	O	9	NMOD
9	collection	collection	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	data	datum	B-NP	NNS	O	10	PMOD
12	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	9	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	9	P
4	monocytes	monocyte	B-NP	NNS	B-cell_type	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	IFN-U937	IFN-U937	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	8	NMOD
8	both	both	O	DT	O	9	SUB
9	responded	respond	B-VP	VBD	O	0	ROOT
10	to	to	B-PP	TO	O	9	VMOD
11	red	red	B-NP	JJ	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
13	sensitized	sensitize	B-VP	VBN	O	12	NMOD
14	with	with	B-PP	IN	O	13	VMOD
15	antibodies	antibody	B-NP	NNS	B-protein	14	PMOD
16	against	against	B-PP	IN	O	15	NMOD
17	a	a	B-NP	DT	O	18	NMOD
18	variety	variety	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	specificities	specificity	B-NP	NNS	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	assumed	assume	B-VP	VBN	O	26	AMOD
23	(	(	O	(	O	26	AMOD
24	although	although	B-SBAR	IN	O	26	AMOD
25	not	not	O	RB	O	26	AMOD
26	documented	document	B-VP	VBN	O	29	NMOD
27	)	)	O	)	O	26	AMOD
28	clinical	clinical	B-NP	JJ	O	29	NMOD
29	significance	significance	I-NP	NN	O	21	PMOD
30	for	for	B-PP	IN	O	29	NMOD
31	blood	blood	B-NP	NN	O	33	NMOD
32	transfusion	transfusion	I-NP	NN	O	33	NMOD
33	recipients	recipient	I-NP	NNS	O	30	PMOD
34	.	.	O	.	O	9	P

1	In	In	B-PP	IN	O	8	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	monocytes	monocyte	B-NP	NNS	B-cell_type	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	IFN-U937	IFN-U937	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	8	SUB
8	responded	respond	B-VP	VBD	O	0	ROOT
9	only	only	B-ADVP	RB	O	8	VMOD
10	weakly	weakly	I-ADVP	RB	O	9	AMOD
11	to	to	B-PP	TO	O	8	VMOD
12	red	red	B-NP	JJ	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
14	sensitized	sensitize	B-VP	VBN	O	13	NMOD
15	with	with	B-PP	IN	O	14	VMOD
16	either	either	O	CC	O	15	PMOD
17	anti-D	anti-D	B-ADJP	JJ	B-protein	15	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	sera	serum	B-NP	NNS	O	18	PMOD
20	from	from	B-PP	IN	O	19	NMOD
21	mothers	mother	B-NP	NNS	O	20	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	babies	baby	B-NP	NNS	O	22	PMOD
24	unaffected	unaffected	B-ADJP	JJ	O	23	NMOD
25	by	by	B-PP	IN	O	24	VMOD
26	HDN	HDN	B-NP	NN	O	25	PMOD
27	,	,	O	,	O	15	P
28	or	or	O	CC	O	15	PMOD
29	with	with	B-PP	IN	O	15	PMOD
30	antisera	antiserum	B-NP	NNS	O	29	PMOD
31	containing	contain	B-VP	VBG	O	30	NMOD
32	high	high	B-NP	JJ	B-protein	34	NMOD
33	titre	titre	I-NP	NN	I-protein	34	NMOD
34	antibodies	antibody	I-NP	NNS	I-protein	31	OBJ
35	with	with	B-PP	IN	O	34	NMOD
36	specificities	specificity	B-NP	NNS	O	35	PMOD
37	not	not	B-VP	RB	O	39	VMOD
38	normally	normally	I-VP	RB	O	39	VMOD
39	associated	associate	I-VP	VBN	O	36	NMOD
40	with	with	B-PP	IN	O	39	VMOD
41	significantly	significantly	B-NP	RB	O	42	AMOD
42	reduced	reduce	I-NP	VBN	O	45	NMOD
43	red	red	I-NP	JJ	B-cell_type	45	NMOD
44	cell	cell	I-NP	NN	I-cell_type	45	NMOD
45	survival	survival	I-NP	NN	O	40	PMOD
46	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	second	second	I-NP	JJ	O	6	SUB
3	(	(	O	(	O	5	DEP
4	-365/-264	-365/-264	B-NP	CD	O	5	DEP
5	)	)	O	)	O	2	NMOD
6	binds	bind	B-VP	VBZ	O	0	ROOT
7	to	to	B-PP	TO	O	6	VMOD
8	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD
9	factors	factor	I-NP	NNS	I-protein	7	PMOD
10	,	,	O	,	O	9	P
11	which	which	B-NP	WDT	O	9	NMOD
12	appear	appear	B-VP	VBP	O	11	SBAR
13	to	to	I-VP	TO	O	14	VMOD
14	be	be	I-VP	VB	O	12	VMOD
15	different	different	B-ADJP	JJ	O	14	PRD
16	in	in	B-PP	IN	O	14	VMOD
17	basophils	basophil	B-NP	NNS	B-cell_type	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	T	T	B-NP	NN	B-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
21	,	,	O	,	O	6	P
22	and	and	O	CC	O	6	VMOD
23	acts	act	B-VP	VBZ	O	6	VMOD
24	as	as	B-PP	IN	O	23	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	negative	negative	I-NP	JJ	B-DNA	27	NMOD
27	element	element	I-NP	NN	I-DNA	24	PMOD
28	in	in	B-PP	IN	O	23	VMOD
29	basophils	basophil	B-NP	NNS	B-cell_type	28	PMOD
30	and	and	B-PP	CC	O	23	VMOD
31	as	as	B-PP	IN	O	23	VMOD
32	a	a	B-NP	DT	O	34	NMOD
33	positive	positive	I-NP	JJ	O	34	NMOD
34	one	one	I-NP	NN	O	31	PMOD
35	in	in	B-PP	IN	O	34	NMOD
36	T	T	B-NP	NN	B-cell_type	37	NMOD
37	cells	cell	I-NP	NNS	I-cell_type	35	PMOD
38	.	.	O	.	O	6	P

1	Thus	Thus	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	this	this	B-NP	DT	O	5	NMOD
4	Alu	Alu	I-NP	NN	B-DNA	5	NMOD
5	repeat	repeat	I-NP	NN	I-DNA	15	SUB
6	(	(	O	(	O	14	DEP
7	90	90	B-NP	CD	O	8	NMOD
8	%	%	I-NP	NN	O	9	AMOD
9	identical	identical	B-ADJP	JJ	O	14	DEP
10	to	to	B-PP	TO	O	9	AMOD
11	Alu	Alu	B-NP	NN	B-DNA	13	NMOD
12	consensus	consensus	I-NP	NN	I-DNA	13	NMOD
13	sequences	sequence	I-NP	NNS	I-DNA	10	PMOD
14	)	)	O	)	O	5	NMOD
15	has	have	B-VP	VBZ	O	0	ROOT
16	evolved	evolve	I-VP	VBN	O	15	VC
17	to	to	B-VP	TO	O	18	VMOD
18	become	become	I-VP	VB	O	16	VMOD
19	both	both	O	CC	O	24	NMOD
20	a	a	B-NP	DT	O	24	NMOD
21	positive	positive	I-NP	JJ	O	23	AMOD
22	and	and	I-NP	CC	O	23	AMOD
23	negative	negative	I-NP	JJ	O	24	NMOD
24	regulator	regulator	I-NP	NN	O	18	PRD
25	.	.	O	.	O	15	P

1	Sodium	Sodium	B-NP	NN	O	5	NMOD
2	dodecyl	dodecyl	I-NP	NN	O	5	NMOD
3	sulfate-polyacrylamide	sulfate-polyacrylamide	I-NP	NN	O	5	NMOD
4	gel	gel	I-NP	NN	O	5	NMOD
5	electrophoresis	electrophoresis	I-NP	NN	O	6	SUB
6	showed	show	B-VP	VBD	O	0	ROOT
7	significant	significant	B-NP	JJ	O	9	NMOD
8	aldosterone	aldosterone	I-NP	NN	O	9	NMOD
9	binding	binding	I-NP	NN	O	6	OBJ
10	at	at	B-PP	IN	O	6	VMOD
11	a	a	B-NP	DT	O	13	NMOD
12	molecular	molecular	I-NP	JJ	O	13	NMOD
13	weight	weight	I-NP	NN	O	10	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	approximately	approximately	B-NP	RB	O	17	NMOD
16	50000	50000	I-NP	CD	O	15	AMOD
17	Dalton	Dalton	I-NP	NN	O	14	PMOD
18	which	which	B-NP	WDT	O	6	VMOD
19	was	be	B-VP	VBD	O	18	SBAR
20	absent	absent	B-ADJP	JJ	O	19	PRD
21	with	with	B-PP	IN	O	20	AMOD
22	1	1	B-NP	CD	O	25	NMOD
23	microM	microM	I-NP	NN	O	25	NMOD
24	cold	cold	I-NP	JJ	O	25	NMOD
25	aldosterone	aldosterone	I-NP	NN	O	29	NMOD
26	,	,	B-NP	,	O	29	P
27	but	but	I-NP	CC	O	29	NMOD
28	not	not	I-NP	RB	O	27	DEP
29	cortisol	cortisol	B-NP	NN	O	21	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	33	NMOD
32	binding	bind	I-NP	VBG	O	33	NMOD
33	media	medium	I-NP	NNS	O	30	PMOD
34	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	presence	presence	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	sulfhydryl	sulfhydryl	I-NP	NN	O	7	NMOD
6	agent	agent	I-NP	NN	O	7	NMOD
7	dithiothreitol	dithiothreitol	I-NP	NN	O	3	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	affect	affect	I-VP	VB	O	8	VC
11	results	result	B-NP	NNS	O	10	OBJ
12	suggesting	suggest	B-VP	VBG	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	absence	absence	I-NP	NN	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	disulfide	disulfide	B-NP	NN	B-protein	17	NMOD
17	bridges	bridge	I-NP	NNS	I-protein	15	PMOD
18	in	in	B-PP	IN	O	14	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	steroid	steroid	I-NP	NN	B-protein	22	NMOD
21	binding	binding	I-NP	NN	I-protein	22	NMOD
22	domain	domain	I-NP	NN	I-protein	18	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	receptor	receptor	I-NP	NN	O	23	PMOD
26	.	.	O	.	O	8	P

1	IL-4	IL-4	B-NP	NN	B-protein	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	affect	affect	I-VP	VB	O	2	VC
5	the	the	B-NP	DT	O	6	NMOD
6	stability	stability	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	12	NMOD
9	c-fos	c-fos	I-NP	NN	B-RNA	11	NMOD
10	and	and	O	CC	I-RNA	11	NMOD
11	c-jun	c-jun	B-NP	NN	I-RNA	12	NMOD
12	transcripts	transcript	I-NP	NNS	I-RNA	7	PMOD
13	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	ras-transformed	ras-transformed	I-NP	JJ	B-cell_line	3	NMOD
3	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	4	SUB
4	displayed	display	B-VP	VBD	O	23	VMOD
5	a	a	B-NP	DT	O	8	NMOD
6	fully	fully	I-NP	RB	O	7	AMOD
7	functional	functional	I-NP	JJ	O	8	NMOD
8	IL-2r	IL-2r	I-NP	NN	B-protein	4	OBJ
9	,	,	O	,	O	4	P
10	as	as	B-SBAR	IN	O	4	VMOD
11	assessed	assess	B-VP	VBN	O	10	SBAR
12	by	by	B-PP	IN	O	11	VMOD
13	c-fos	c-fos	B-NP	NN	B-DNA	14	NMOD
14	induction	induction	I-NP	NN	O	12	PMOD
15	following	follow	B-PP	VBG	O	14	NMOD
16	treatment	treatment	B-NP	NN	O	15	PMOD
17	with	with	B-PP	IN	O	16	NMOD
18	IL-2	IL-2	B-NP	NN	B-protein	17	PMOD
19	;	;	O	:	O	23	P
20	nevertheless	nevertheless	B-ADVP	RB	O	23	VMOD
21	,	,	O	,	O	23	P
22	they	they	B-NP	PRP	O	23	SUB
23	were	be	B-VP	VBD	O	0	ROOT
24	not	not	O	RB	O	23	VMOD
25	growth	growth	B-NP	NN	O	23	PRD
26	stimulated	stimulate	B-VP	VBN	O	25	NMOD
27	by	by	B-PP	IN	O	26	VMOD
28	this	this	B-NP	DT	O	29	NMOD
29	lymphokine	lymphokine	I-NP	NN	B-protein	27	PMOD
30	.	.	O	.	O	23	P

1	Somewhat	Somewhat	B-ADVP	RB	O	8	VMOD
2	unexpectedly	unexpectedly	I-ADVP	RB	O	1	AMOD
3	,	,	O	,	O	8	P
4	the	the	B-NP	DT	O	7	NMOD
5	constitutive	constitutive	I-NP	JJ	O	7	NMOD
6	p21ras	p21ras	I-NP	NN	B-protein	7	NMOD
7	activity	activity	I-NP	NN	O	8	SUB
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	cause	cause	I-VP	VB	O	8	VC
11	an	an	B-NP	DT	O	14	NMOD
12	increased	increase	I-NP	VBN	O	14	NMOD
13	DNA	DNA	I-NP	NN	O	14	NMOD
14	binding	binding	I-NP	NN	O	10	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	transcription	transcription	B-NP	NN	B-protein	17	NMOD
17	factors	factor	I-NP	NNS	I-protein	27	NMOD
18	PEA1	PEA1	B-NP	NN	B-protein	27	NMOD
19	(	(	O	(	O	21	DEP
20	AP1	AP1	B-NP	NN	B-protein	21	DEP
21	)	)	O	)	O	18	NMOD
22	,	,	O	,	O	27	P
23	PEA3	PEA3	B-NP	NN	B-protein	27	NMOD
24	,	,	O	,	O	27	P
25	Oct-2	Oct-2	B-NP	NN	B-protein	27	NMOD
26	or	or	I-NP	CC	O	27	NMOD
27	NF-kB	NF-kB	I-NP	NN	B-protein	15	PMOD
28	.	.	O	.	O	8	P

1	We	We	B-NP	PRP	O	2	SUB
2	can	can	B-VP	MD	O	0	ROOT
3	now	now	I-VP	RB	O	2	VMOD
4	study	study	I-VP	VB	O	2	VC
5	regulatory	regulatory	B-NP	JJ	B-DNA	6	NMOD
6	regions	region	I-NP	NNS	I-DNA	9	NMOD
7	and	and	O	CC	O	9	NMOD
8	functional	functional	B-NP	JJ	O	9	NMOD
9	domains	domain	I-NP	NNS	O	4	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	12	NMOD
12	protein	protein	I-NP	NN	O	10	PMOD
13	in	in	B-PP	IN	O	9	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	context	context	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	a	a	B-NP	DT	O	20	NMOD
18	true	true	I-NP	JJ	O	20	NMOD
19	erythroid	erythroid	I-NP	JJ	O	20	NMOD
20	environment	environment	I-NP	NN	O	16	PMOD
21	,	,	O	,	O	4	P
22	experiments	experiment	B-NP	NNS	O	4	VMOD
23	that	that	B-NP	WDT	O	22	NMOD
24	have	have	B-VP	VBP	O	23	SBAR
25	not	not	I-VP	RB	O	24	VMOD
26	been	be	I-VP	VBN	O	24	VC
27	possible	possible	B-ADJP	JJ	O	26	PRD
28	heretofore	heretofore	B-ADVP	RB	O	26	VMOD
29	.	.	O	.	O	2	P

1	If	If	B-SBAR	IN	O	8	VMOD
2	they	they	B-NP	PRP	O	3	SUB
3	can	can	B-VP	MD	O	1	SBAR
4	not	not	O	RB	O	3	VMOD
5	,	,	O	,	O	8	P
6	chimeric	chimeric	B-NP	JJ	B-protein	7	NMOD
7	proteins	protein	I-NP	NNS	I-protein	8	SUB
8	can	can	B-VP	MD	O	0	ROOT
9	be	be	I-VP	VB	O	8	VC
10	tested	test	I-VP	VBN	O	9	VC
11	to	to	B-VP	TO	O	12	VMOD
12	identify	identify	I-VP	VB	O	10	VMOD
13	which	which	B-NP	WDT	O	12	VMOD
14	amino	amino	I-NP	NN	O	13	NMOD
15	acids	acid	I-NP	NNS	O	13	NMOD
16	distinguish	distinguish	B-VP	VBP	O	13	SBAR
17	the	the	B-NP	DT	O	20	NMOD
18	different	different	I-NP	JJ	O	20	NMOD
19	family	family	I-NP	NN	O	20	NMOD
20	members	member	I-NP	NNS	O	16	OBJ
21	.	.	O	.	O	8	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	isolated	isolate	I-VP	VBN	O	2	VC
4	cDNA	cDNA	B-NP	NN	B-DNA	5	NMOD
5	clones	clone	I-NP	NNS	I-DNA	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	myeloid	myeloid	B-NP	JJ	B-DNA	10	NMOD
8	differentiation	differentiation	I-NP	NN	I-DNA	10	NMOD
9	primary	primary	I-NP	JJ	I-DNA	10	NMOD
10	response	response	I-NP	NN	I-DNA	14	NMOD
11	(	(	O	(	I-DNA	13	DEP
12	MyD	MyD	B-NP	NN	I-DNA	13	DEP
13	)	)	O	)	I-DNA	10	NMOD
14	genes	gene	B-NP	NNS	I-DNA	6	PMOD
15	,	,	O	,	O	5	P
16	activated	activate	B-VP	VBN	O	5	NMOD
17	in	in	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	absence	absence	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	de	de	B-NP	FW	O	22	AMOD
22	novo	novo	I-NP	FW	O	24	NMOD
23	protein	protein	I-NP	NN	O	24	NMOD
24	synthesis	synthesis	I-NP	NN	O	20	PMOD
25	following	follow	B-PP	VBG	O	16	VMOD
26	induction	induction	B-NP	NN	O	25	PMOD
27	for	for	B-PP	IN	O	26	NMOD
28	differentiation	differentiation	B-NP	NN	O	27	PMOD
29	along	along	B-PP	IN	O	28	NMOD
30	either	either	O	CC	O	35	NMOD
31	the	the	B-NP	DT	O	35	NMOD
32	macrophage	macrophage	I-NP	NN	B-cell_type	35	NMOD
33	or	or	I-NP	CC	O	35	NMOD
34	granulocyte	granulocyte	I-NP	NN	B-cell_type	35	NMOD
35	lineage	lineage	I-NP	NN	I-cell_type	29	PMOD
36	in	in	B-PP	IN	O	35	NMOD
37	human	human	B-NP	JJ	B-cell_line	41	NMOD
38	myeloblastic	myeloblastic	I-NP	JJ	I-cell_line	41	NMOD
39	leukemia	leukemia	I-NP	NN	I-cell_line	41	NMOD
40	HL-60	HL-60	I-NP	NN	I-cell_line	41	NMOD
41	cells	cell	I-NP	NNS	I-cell_line	36	PMOD
42	.	.	O	.	O	2	P

1	HL-60	HL-60	B-NP	NN	B-cell_line	2	NMOD
2	cells	cell	I-NP	NNS	I-cell_line	11	SUB
3	constitutively	constitutively	B-VP	RB	O	4	VMOD
4	expressing	express	I-VP	VBG	O	2	NMOD
5	an	an	B-NP	DT	O	7	NMOD
6	Egr-1	Egr-1	I-NP	NN	B-DNA	7	NMOD
7	transgene	transgene	I-NP	NN	I-DNA	4	OBJ
8	(	(	O	(	O	10	DEP
9	HL-60Egr-1	HL-60Egr-1	B-NP	NN	B-DNA	10	DEP
10	)	)	O	)	O	7	NMOD
11	could	could	B-VP	MD	O	0	ROOT
12	be	be	I-VP	VB	O	11	VC
13	induced	induce	I-VP	VBN	O	12	VC
14	for	for	B-PP	IN	O	13	VMOD
15	macrophage	macrophage	B-NP	NN	B-cell_type	19	NMOD
16	,	,	B-NP	,	O	19	P
17	but	but	I-NP	CC	O	19	NMOD
18	not	not	I-NP	RB	O	17	DEP
19	granulocyte	granulocyte	B-NP	NN	B-cell_type	21	NMOD
20	,	,	O	,	O	19	P
21	differentiation	differentiation	B-NP	NN	O	14	PMOD
22	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	3	NMOD
2	trans-activation	trans-activation	I-NP	NN	B-protein	3	NMOD
3	domain	domain	I-NP	NN	I-protein	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	E2	E2	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	Tax	Tax	I-NP	NN	B-protein	4	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	interchangeable	interchangeable	B-ADJP	JJ	O	8	PRD
10	although	although	B-SBAR	IN	O	8	VMOD
11	they	they	B-NP	PRP	O	12	SUB
12	have	have	B-VP	VBP	O	10	SBAR
13	no	no	B-NP	DT	O	16	NMOD
14	obvious	obvious	I-NP	JJ	O	16	NMOD
15	sequence	sequence	I-NP	NN	O	16	NMOD
16	homology	homology	I-NP	NN	O	12	OBJ
17	between	between	B-PP	IN	O	16	NMOD
18	them	them	B-NP	PRP	O	17	PMOD
19	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	3	NMOD
2	viral	viral	I-NP	JJ	B-protein	3	NMOD
3	trans-activators	trans-activator	I-NP	NNS	I-protein	4	SUB
4	appear	appear	B-VP	VBP	O	0	ROOT
5	to	to	I-VP	TO	O	6	VMOD
6	target	target	I-VP	VB	O	4	VMOD
7	specific	specific	B-NP	JJ	O	10	NMOD
8	DNA	DNA	I-NP	NN	B-protein	10	NMOD
9	binding	binding	I-NP	NN	I-protein	10	NMOD
10	protein	protein	I-NP	NN	I-protein	6	OBJ
11	such	such	B-PP	JJ	O	12	PMOD
12	as	as	I-PP	IN	O	10	NMOD
13	NF-kB	NF-kB	B-NP	NN	B-protein	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	Sp1	Sp1	I-NP	NN	B-protein	12	PMOD
16	to	to	B-PP	TO	O	6	VMOD
17	cis-acting	cis-acting	B-NP	JJ	B-DNA	19	NMOD
18	DNA	DNA	I-NP	NN	I-DNA	19	NMOD
19	site	site	I-NP	NN	I-DNA	16	PMOD
20	and	and	O	CC	O	6	VMOD
21	promote	promote	B-VP	VB	O	6	VMOD
22	lymphokine	lymphokine	B-NP	NN	B-DNA	24	NMOD
23	gene	gene	I-NP	NN	I-DNA	24	NMOD
24	expression	expression	I-NP	NN	O	21	OBJ
25	without	without	B-PP	IN	O	21	VMOD
26	TCR-mediated	TCR-mediated	B-NP	JJ	O	27	NMOD
27	stimulation	stimulation	I-NP	NN	O	25	PMOD
28	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	10	VMOD
2	immature	immature	B-NP	JJ	B-cell_type	4	NMOD
3	hematopoietic	hematopoietic	I-NP	JJ	I-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	1	PMOD
5	,	,	O	,	O	10	P
6	tal-1	tal-1	B-NP	NN	B-DNA	9	NMOD
7	and	and	I-NP	CC	I-DNA	9	NMOD
8	GATA-1	GATA-1	I-NP	NN	I-DNA	9	NMOD
9	genes	gene	I-NP	NNS	I-DNA	10	SUB
10	are	be	B-VP	VBP	O	0	ROOT
11	coexpressed	coexpresse	I-VP	VBN	O	10	VC
12	in	in	B-PP	IN	O	11	VMOD
13	committed	commit	B-NP	VBN	B-cell_type	15	NMOD
14	progenitors	progenitor	I-NP	NNS	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
16	(	(	O	(	O	21	DEP
17	CD34+/CD38	CD34+/CD38	B-NP	NN	B-cell_line	21	DEP
18	(	(	O	(	I-cell_line	20	DEP
19	2+	2+	B-ADJP	JJ	I-cell_line	20	DEP
20	)	)	O	)	I-cell_line	17	NMOD
21	)	)	O	)	O	15	NMOD
22	,	,	O	,	O	11	P
23	whereas	whereas	O	IN	O	11	VMOD
24	they	they	B-NP	PRP	O	25	SUB
25	are	be	B-VP	VBP	O	23	SBAR
26	not	not	O	RB	O	25	VMOD
27	detectable	detectable	B-ADJP	JJ	O	25	PRD
28	in	in	B-PP	IN	O	25	VMOD
29	the	the	B-NP	DT	O	32	NMOD
30	most	most	I-NP	RBS	O	31	AMOD
31	primitive	primitive	I-NP	JJ	B-cell_type	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_type	28	PMOD
33	(	(	O	(	O	39	DEP
34	CD34	CD34	B-NP	NN	B-protein	38	NMOD
35	(	(	O	(	I-protein	38	NMOD
36	2+	2+	O	JJ	I-protein	38	NMOD
37	)	)	O	)	I-protein	38	NMOD
38	/CD38-	/CD38-	B-NP	NN	I-protein	39	DEP
39	)	)	O	)	O	32	NMOD
40	.	.	O	.	O	10	P

1	Transactivation	Transactivation	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	PTHrP	PTHrP	B-NP	NN	B-protein	2	PMOD
4	by	by	B-PP	IN	O	1	NMOD
5	Tax	Tax	B-NP	NN	B-protein	4	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	seen	see	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	T	T	B-NP	NN	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	but	but	B-PP	CC	O	8	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	in	in	I-PP	IN	O	8	PMOD
14	B-cell	B-cell	B-NP	NN	B-cell_line	15	NMOD
15	lines	line	I-NP	NNS	I-cell_line	17	NMOD
16	or	or	O	CC	O	17	NMOD
17	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	13	PMOD
18	.	.	O	.	O	6	P

1	A	A	B-NP	DT	O	6	NMOD
2	carboxy	carboxy	I-NP	NN	B-DNA	6	NMOD
3	terminal	terminal	I-NP	JJ	I-DNA	6	NMOD
4	Tax	Tax	I-NP	NN	I-DNA	6	NMOD
5	deletion	deletion	I-NP	NN	I-DNA	6	NMOD
6	mutant	mutant	I-NP	NN	I-DNA	7	SUB
7	was	be	B-VP	VBD	O	0	ROOT
8	deficient	deficient	B-ADJP	JJ	O	7	PRD
9	in	in	B-PP	IN	O	7	VMOD
10	transactivation	transactivation	B-NP	NN	O	25	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	both	both	O	CC	O	18	NMOD
13	the	the	B-NP	DT	O	18	NMOD
14	PTHrP	PTHrP	I-NP	NN	B-DNA	17	NMOD
15	and	and	I-NP	CC	I-DNA	17	NMOD
16	IL2R	IL2R	I-NP	NN	I-DNA	17	NMOD
17	alpha	alpha	I-NP	NN	I-DNA	18	NMOD
18	promoters	promoter	I-NP	NNS	I-DNA	11	PMOD
19	but	but	B-NP	CC	O	22	NMOD
20	not	not	I-NP	RB	O	19	DEP
21	the	the	B-NP	DT	O	22	NMOD
22	HTLV-I	HTLV-I	I-NP	NN	B-DNA	25	NMOD
23	long	long	I-NP	JJ	I-DNA	25	NMOD
24	terminal	terminal	I-NP	JJ	I-DNA	25	NMOD
25	repeat	repeat	I-NP	NN	I-DNA	9	PMOD
26	(	(	O	(	O	28	DEP
27	LTR	LTR	B-NP	NN	B-DNA	28	DEP
28	)	)	O	)	O	25	NMOD
29	.	.	O	.	O	7	P

1	Exogenous	Exogenous	B-NP	JJ	O	2	NMOD
2	provision	provision	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NFkB	NFkB	B-NP	NN	B-protein	3	PMOD
5	rescued	rescue	B-VP	VBD	O	0	ROOT
6	IL2R	IL2R	B-NP	NN	B-protein	8	NMOD
7	alpha	alpha	I-NP	NN	I-protein	8	NMOD
8	expression	expression	I-NP	NN	O	13	NMOD
9	but	but	B-NP	CC	O	13	NMOD
10	not	not	I-NP	RB	O	9	DEP
11	the	the	B-NP	DT	O	13	NMOD
12	PTHrP	PTHrP	I-NP	NN	B-DNA	13	NMOD
13	promoter	promoter	I-NP	NN	I-DNA	5	OBJ
14	.	.	O	.	O	5	P

1	This	This	B-NP	DT	O	2	NMOD
2	region	region	I-NP	NN	O	3	SUB
3	binds	bind	B-VP	VBZ	O	0	ROOT
4	an	an	B-NP	DT	O	8	NMOD
5	inducible	inducible	I-NP	JJ	O	7	AMOD
6	,	,	I-NP	,	O	7	P
7	T-cell-specific	T-cell-specific	I-NP	JJ	B-protein	8	NMOD
8	factor	factor	I-NP	NN	I-protein	3	OBJ
9	over	over	B-PP	IN	O	3	VMOD
10	its	its	B-NP	PRP$	O	13	NMOD
11	5	5	I-NP	CD	B-DNA	13	NMOD
12	'	'	I-NP	SYM	I-DNA	13	NMOD
13	end	end	I-NP	NN	I-DNA	16	NMOD
14	,	,	O	,	O	16	P
15	a	a	B-NP	DT	O	16	NMOD
16	site	site	I-NP	NN	O	9	PMOD
17	that	that	B-NP	WDT	O	16	NMOD
18	is	be	B-VP	VBZ	O	17	SBAR
19	necessary	necessary	B-ADJP	JJ	O	18	PRD
20	for	for	B-PP	IN	O	19	AMOD
21	the	the	B-NP	DT	O	22	NMOD
22	expression	expression	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	IL-3	IL-3	B-NP	NN	B-protein	23	PMOD
25	in	in	B-PP	IN	O	22	NMOD
26	the	the	B-NP	DT	O	27	NMOD
27	absence	absence	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	other	other	B-NP	JJ	O	31	NMOD
30	upstream	upstream	I-NP	JJ	B-DNA	31	NMOD
31	elements	element	I-NP	NNS	I-DNA	28	PMOD
32	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	17	VMOD
2	,	,	O	,	O	17	P
3	and	and	O	CC	O	17	VMOD
4	despite	despite	B-PP	IN	O	17	VMOD
5	a	a	B-NP	DT	O	6	NMOD
6	lack	lack	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	sequence	sequence	B-NP	NN	O	9	NMOD
9	homology	homology	I-NP	NN	O	7	PMOD
10	,	,	O	,	O	17	P
11	the	the	B-NP	DT	O	12	NMOD
12	promoters	promoter	I-NP	NNS	B-DNA	17	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	IL-3	IL-3	B-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	IL-2	IL-2	I-NP	NN	B-protein	13	PMOD
17	share	share	B-VP	VBP	O	0	ROOT
18	an	an	B-NP	DT	O	20	NMOD
19	organizational	organizational	I-NP	JJ	O	20	NMOD
20	pattern	pattern	I-NP	NN	O	17	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	regulatory	regulatory	B-NP	JJ	B-DNA	23	NMOD
23	elements	element	I-NP	NNS	I-DNA	21	PMOD
24	that	that	B-NP	WDT	O	20	NMOD
25	is	be	B-VP	VBZ	O	24	SBAR
26	likely	likely	B-ADJP	JJ	O	25	PRD
27	to	to	B-VP	TO	O	28	VMOD
28	be	be	I-VP	VB	O	26	AMOD
29	important	important	B-ADJP	JJ	O	28	PRD
30	for	for	B-PP	IN	O	28	VMOD
31	the	the	B-NP	DT	O	33	NMOD
32	T-cell-specific	T-cell-specific	I-NP	JJ	O	33	NMOD
33	expression	expression	I-NP	NN	O	30	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	these	these	B-NP	DT	O	36	NMOD
36	genes	gene	I-NP	NNS	O	34	PMOD
37	.	.	O	.	O	17	P

1	In	In	B-PP	IN	O	8	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	6	NMOD
5	B	B	I-NP	NN	I-protein	6	NMOD
6	p50	p50	I-NP	NN	I-protein	8	SUB
7	alone	alone	B-ADVP	RB	O	6	NMOD
8	fails	fail	B-VP	VBZ	O	0	ROOT
9	to	to	I-VP	TO	O	10	VMOD
10	stimulate	stimulate	I-VP	VB	O	8	VMOD
11	kappa	kappa	B-NP	NN	O	13	NMOD
12	B-directed	B-directed	I-NP	JJ	O	11	AMOD
13	transcription	transcription	I-NP	NN	O	10	OBJ
14	,	,	O	,	O	8	P
15	and	and	O	CC	O	8	VMOD
16	based	base	B-VP	VBN	O	23	VMOD
17	on	on	B-PP	IN	O	16	PMOD
18	prior	prior	B-NP	JJ	O	21	NMOD
19	in	in	I-NP	FW	O	20	AMOD
20	vitro	vitro	I-NP	FW	O	21	NMOD
21	studies	study	I-NP	NNS	O	17	PMOD
22	,	,	O	,	O	23	P
23	is	be	B-VP	VBZ	O	8	VMOD
24	not	not	I-VP	RB	O	23	VMOD
25	directly	directly	I-VP	RB	O	23	VMOD
26	regulated	regulate	I-VP	VBN	O	23	VC
27	by	by	B-PP	IN	O	26	VMOD
28	I	I	B-NP	NN	B-protein	30	NMOD
29	kappa	kappa	I-NP	NN	I-protein	30	NMOD
30	B	B	I-NP	NN	I-protein	27	PMOD
31	.	.	O	.	O	8	P

1	However	However	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	no	no	B-NP	DT	O	4	NMOD
4	loss	loss	I-NP	NN	O	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	DNA	DNA	B-NP	NN	O	8	NMOD
7	binding	binding	I-NP	NN	O	8	NMOD
8	activity	activity	I-NP	NN	O	5	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	observed	observe	I-VP	VBN	O	9	VC
11	,	,	O	,	O	10	P
12	presumably	presumably	B-VP	RB	O	13	VMOD
13	reflecting	reflect	I-VP	VBG	O	10	VMOD
14	the	the	B-NP	DT	O	17	NMOD
15	unique	unique	I-NP	JJ	O	17	NMOD
16	C-terminal	C-terminal	I-NP	JJ	B-protein	17	NMOD
17	domain	domain	I-NP	NN	I-protein	13	OBJ
18	that	that	B-NP	WDT	O	17	NMOD
19	is	be	B-VP	VBZ	O	18	SBAR
20	distinct	distinct	B-ADJP	JJ	O	19	PRD
21	from	from	B-PP	IN	O	20	AMOD
22	that	that	B-NP	DT	O	21	PMOD
23	present	present	B-ADJP	JJ	O	22	NMOD
24	in	in	B-PP	IN	O	23	AMOD
25	NF-kappa	NF-kappa	B-NP	NN	B-protein	27	NMOD
26	B	B	I-NP	NN	I-protein	27	NMOD
27	p65	p65	I-NP	NN	I-protein	24	PMOD
28	.	.	O	.	O	9	P

1	Using	Use	B-VP	VBG	O	6	VMOD
2	flow	flow	B-NP	NN	O	3	NMOD
3	cytometry	cytometry	I-NP	NN	O	1	OBJ
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	detected	detect	B-VP	VBD	O	0	ROOT
7	surrogate	surrogate	B-NP	JJ	B-protein	9	NMOD
8	TG	TG	I-NP	NN	I-protein	9	NMOD
9	receptors	receptor	I-NP	NNS	I-protein	6	OBJ
10	on	on	B-PP	IN	O	6	VMOD
11	non-T	non-T	O	JJ	O	10	PMOD
12	(	(	O	(	O	11	AMOD
13	but	but	B-PP	CC	O	12	PMOD
14	not	not	I-PP	RB	O	13	DEP
15	on	on	B-PP	IN	O	13	PMOD
16	T	T	B-NP	NN	O	15	PMOD
17	)	)	I-NP	)	O	18	NMOD
18	cells	cell	I-NP	NNS	O	15	PMOD
19	from	from	B-PP	IN	O	18	NMOD
20	11	11	B-NP	CD	O	21	AMOD
21	of	of	B-PP	IN	O	23	NMOD
22	11	11	B-NP	CD	O	21	AMOD
23	individuals	individual	I-NP	NNS	O	19	PMOD
24	studied	study	B-VP	VBN	O	23	NMOD
25	(	(	O	(	O	33	DEP
26	5	5	B-NP	CD	O	28	NMOD
27	Hashimoto	Hashimoto	I-NP	NN	O	28	NMOD
28	patients	patient	I-NP	NNS	O	32	NMOD
29	and	and	O	CC	O	32	NMOD
30	6	6	B-NP	CD	O	32	NMOD
31	control	control	I-NP	NN	O	32	NMOD
32	donors	donor	I-NP	NNS	O	33	DEP
33	)	)	O	)	O	23	NMOD
34	.	.	O	.	O	6	P

1	This	This	B-NP	DT	O	3	NMOD
2	low	low	I-NP	JJ	O	3	NMOD
3	frequency	frequency	I-NP	NN	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	response	response	B-NP	NN	O	4	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	no	no	B-NP	DT	O	8	AMOD
8	different	different	I-NP	JJ	O	6	PRD
9	from	from	B-PP	IN	O	8	AMOD
10	that	that	B-NP	DT	O	9	PMOD
11	previously	previously	B-NP	RB	O	12	VMOD
12	detected	detect	I-NP	VBN	O	10	NMOD
13	using	use	I-NP	VBG	O	12	VMOD
14	cultures	culture	B-NP	NNS	O	13	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	T	T	B-NP	NN	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	21	NMOD
18	and	and	O	CC	O	21	NMOD
19	autologous	autologous	B-NP	JJ	B-cell_type	21	NMOD
20	dendritic	dendritic	I-NP	JJ	I-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
22	.	.	O	.	O	6	P

1	Therefore	Therefore	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	the	the	B-NP	DT	O	5	NMOD
4	successful	successful	I-NP	JJ	O	5	NMOD
5	generation	generation	I-NP	NN	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	surrogate	surrogate	B-NP	JJ	B-protein	8	NMOD
8	receptors	receptor	I-NP	NNS	I-protein	6	PMOD
9	on	on	B-PP	IN	O	5	NMOD
10	non-T	non-T	B-NP	JJ	B-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
12	is	be	B-VP	VBZ	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	associated	associate	I-VP	VBN	O	12	VC
15	with	with	B-PP	IN	O	14	VMOD
16	more	more	B-NP	RBR	O	17	AMOD
17	efficient	efficient	I-NP	JJ	O	19	NMOD
18	TG	TG	I-NP	NN	O	19	NMOD
19	presentation	presentation	I-NP	NN	O	15	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	T	T	B-NP	NN	B-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
23	.	.	O	.	O	12	P

1	Furthermore	Furthermore	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	the	the	B-NP	DT	O	4	NMOD
4	significance	significance	I-NP	NN	O	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	present	present	I-NP	JJ	O	8	NMOD
8	study	study	I-NP	NN	O	5	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	that	that	B-SBAR	IN	O	9	PRD
11	the	the	B-NP	DT	O	13	NMOD
12	T	T	I-NP	NN	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	15	NMOD
14	,	,	B-NP	,	O	15	P
15	not	not	I-NP	RB	O	20	SUB
16	the	the	B-NP	DT	O	18	NMOD
17	antigen-presenting	antigen-presenting	I-NP	JJ	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	NMOD
19	,	,	O	,	O	15	P
20	are	be	B-VP	VBP	O	10	SBAR
21	likely	likely	B-ADJP	JJ	O	20	PRD
22	to	to	B-VP	TO	O	23	VMOD
23	be	be	I-VP	VB	O	21	AMOD
24	the	the	B-NP	DT	O	26	NMOD
25	limiting	limit	I-NP	VBG	O	26	NMOD
26	element	element	I-NP	NN	O	23	PRD
27	in	in	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	32	NMOD
29	T	T	I-NP	NN	O	32	NMOD
30	cell	cell	I-NP	NN	O	32	NMOD
31	proliferative	proliferative	I-NP	JJ	O	32	NMOD
32	response	response	I-NP	NN	O	27	PMOD
33	to	to	B-PP	TO	O	32	NMOD
34	TG	TG	B-NP	NN	B-protein	38	NMOD
35	and	and	O	CC	O	38	NMOD
36	other	other	B-NP	JJ	O	38	NMOD
37	thyroid	thyroid	I-NP	JJ	B-protein	38	NMOD
38	autoantigens	autoantigen	I-NP	NNS	I-protein	33	PMOD
39	.	.	O	.	O	9	P

1	To	To	B-VP	TO	O	2	VMOD
2	identify	identify	I-VP	VB	O	14	VMOD
3	an	an	B-NP	DT	O	7	NMOD
4	EBNA2	EBNA2	I-NP	NN	B-DNA	7	NMOD
5	dependent	dependent	I-NP	JJ	I-DNA	4	AMOD
6	cis-acting	cis-acting	I-NP	JJ	I-DNA	7	NMOD
7	element	element	I-NP	NN	I-DNA	2	OBJ
8	,	,	O	,	O	14	P
9	various	various	B-NP	JJ	O	13	NMOD
10	TP1	TP1	I-NP	NN	B-DNA	13	NMOD
11	promoter-reporter	promoter-reporter	I-NP	NN	I-DNA	13	NMOD
12	gene	gene	I-NP	NN	I-DNA	13	NMOD
13	constructs	construct	I-NP	NNS	I-DNA	14	SUB
14	were	be	B-VP	VBD	O	0	ROOT
15	transfected	transfecte	I-VP	VBN	O	14	VC
16	in	in	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	20	NMOD
18	absence	absence	I-NP	NN	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	presence	presence	I-NP	NN	O	16	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	an	an	B-NP	DT	O	25	NMOD
23	EBNA2	EBNA2	I-NP	NN	B-DNA	25	NMOD
24	expression	expression	I-NP	NN	I-DNA	25	NMOD
25	vector	vector	I-NP	NN	I-DNA	21	PMOD
26	into	into	B-PP	IN	O	15	VMOD
27	the	the	B-NP	DT	O	31	NMOD
28	established	established	I-NP	JJ	O	31	NMOD
29	B-cell	B-cell	I-NP	NN	B-cell_line	31	NMOD
30	line	line	I-NP	NN	I-cell_line	31	NMOD
31	BL41-P3HR1	BL41-P3HR1	I-NP	NN	I-cell_line	26	PMOD
32	.	.	O	.	O	14	P

1	Two	Two	B-NP	CD	O	4	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	these	these	B-NP	DT	O	2	PMOD
4	were	be	B-VP	VBD	O	13	VMOD
5	not	not	O	RB	O	4	VMOD
6	cell	cell	B-NP	NN	O	7	NMOD
7	type	type	I-NP	NN	O	8	AMOD
8	specific	specific	B-ADJP	JJ	O	4	PRD
9	,	,	O	,	O	13	P
10	but	but	O	CC	O	13	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	third	third	I-NP	JJ	O	13	SUB
13	was	be	B-VP	VBD	O	0	ROOT
14	detected	detect	I-VP	VBN	O	13	VC
15	only	only	B-ADVP	RB	O	16	PMOD
16	in	in	B-PP	IN	O	14	VMOD
17	EBNA2	EBNA2	B-NP	NN	B-protein	20	NMOD
18	positive	positive	I-NP	JJ	O	17	AMOD
19	cell	cell	I-NP	NN	O	20	NMOD
20	extracts	extract	I-NP	NNS	O	16	PMOD
21	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	7	VMOD
2	cotransfection	cotransfection	B-NP	NN	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	7	P
5	oncogenic	oncogenic	B-NP	JJ	O	6	NMOD
6	rats	rat	I-NP	NNS	O	7	SUB
7	obviated	obviate	B-VP	VBD	O	0	ROOT
8	the	the	B-NP	DT	O	9	NMOD
9	need	need	I-NP	NN	O	7	OBJ
10	for	for	B-PP	IN	O	9	NMOD
11	PKC	PKC	B-NP	NN	B-protein	12	NMOD
12	stimulation	stimulation	I-NP	NN	O	10	PMOD
13	but	but	O	CC	O	7	VMOD
14	did	do	B-VP	VBD	O	7	VMOD
15	not	not	I-VP	RB	O	14	VMOD
16	replace	replace	I-VP	VB	O	14	VC
17	either	either	O	CC	O	22	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	calcium	calcium	I-NP	NN	O	20	NMOD
20	signal	signal	I-NP	NN	O	22	NMOD
21	or	or	I-NP	CC	O	22	NMOD
22	interleukin-1	interleukin-1	I-NP	NN	B-protein	16	OBJ
23	.	.	O	.	O	7	P

1	Overexpression	Overexpression	B-NP	NN	O	12	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	cJun	cJun	B-NP	NN	B-protein	5	NMOD
4	or	or	I-NP	CC	O	5	NMOD
5	JunD	JunD	I-NP	NN	B-protein	9	NMOD
6	,	,	O	,	O	9	P
7	but	but	O	CC	O	9	NMOD
8	not	not	O	RB	O	7	DEP
9	JunB	JunB	B-NP	NN	B-protein	2	PMOD
10	,	,	O	,	O	1	P
11	also	also	B-ADVP	RB	O	12	VMOD
12	eliminates	eliminate	B-VP	VBZ	O	0	ROOT
13	the	the	B-NP	DT	O	14	NMOD
14	requirement	requirement	I-NP	NN	O	12	OBJ
15	for	for	B-PP	IN	O	14	NMOD
16	PMA	PMA	B-NP	NN	O	15	PMOD
17	,	,	O	,	O	12	P
18	indicating	indicate	B-VP	VBG	O	12	VMOD
19	that	that	B-SBAR	IN	O	18	VMOD
20	many	many	B-NP	JJ	O	23	AMOD
21	but	but	I-NP	CC	O	23	AMOD
22	not	not	I-NP	RB	O	23	AMOD
23	all	all	I-NP	DT	O	27	NMOD
24	Jun-	Jun-	I-NP	NN	B-protein	26	AMOD
25	and	and	I-NP	CC	I-protein	26	AMOD
26	Fos-related	Fos-related	I-NP	JJ	I-protein	27	NMOD
27	proteins	protein	I-NP	NNS	I-protein	29	SUB
28	functionally	functionally	B-ADVP	RB	O	29	VMOD
29	activate	activate	B-VP	VBP	O	19	SBAR
30	NF-AT-dependent	NF-AT-dependent	B-NP	JJ	O	31	NMOD
31	transcription	transcription	I-NP	NN	O	29	OBJ
32	in	in	B-PP	IN	O	29	VMOD
33	the	the	B-NP	DT	O	34	NMOD
34	presence	presence	I-NP	NN	O	32	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	38	NMOD
37	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	38	NMOD
38	component	component	I-NP	NN	I-protein	35	PMOD
39	.	.	O	.	O	12	P

1	Fos	Fos	B-NP	NN	B-protein	2	NMOD
2	proteins	protein	I-NP	NNS	I-protein	3	SUB
3	are	be	B-VP	VBP	O	18	VMOD
4	not	not	I-VP	RB	O	3	VMOD
5	needed	need	I-VP	VBN	O	3	VC
6	for	for	B-PP	IN	O	5	VMOD
7	this	this	B-NP	DT	O	8	NMOD
8	reconstitution	reconstitution	I-NP	NN	O	6	PMOD
9	,	,	O	,	O	18	P
10	and	and	O	CC	O	18	VMOD
11	although	although	B-SBAR	IN	O	18	VMOD
12	JunB	JunB	B-NP	NN	B-protein	13	SUB
13	is	be	B-VP	VBZ	O	11	SBAR
14	not	not	O	RB	O	13	VMOD
15	functional	functional	B-ADJP	JJ	O	13	PRD
16	,	,	O	,	O	18	P
17	it	it	B-NP	PRP	O	18	SUB
18	can	can	B-VP	MD	O	0	ROOT
19	participate	participate	I-VP	VB	O	18	VC
20	in	in	B-PP	IN	O	19	VMOD
21	the	the	B-NP	DT	O	25	NMOD
22	NF-AT	NF-AT	I-NP	NN	B-protein	25	NMOD
23	DNA	DNA	I-NP	NN	I-protein	25	NMOD
24	binding	binding	I-NP	NN	I-protein	25	NMOD
25	complex	complex	I-NP	NN	I-protein	20	PMOD
26	.	.	O	.	O	18	P

1	These	These	B-NP	DT	O	3	NMOD
2	inhibitory	inhibitory	I-NP	JJ	O	3	NMOD
3	effects	effect	I-NP	NNS	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	c-Rel	c-Rel	B-NP	NN	B-protein	4	PMOD
6	correlate	correlate	B-VP	VBP	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	its	its	B-NP	PRP$	O	10	NMOD
9	DNA-binding	DNA-binding	I-NP	JJ	O	10	NMOD
10	activity	activity	I-NP	NN	O	7	PMOD
11	but	but	B-PP	CC	O	7	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	with	with	I-PP	IN	O	7	PMOD
14	its	its	B-NP	PRP$	O	15	NMOD
15	ability	ability	I-NP	NN	O	13	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	heterodimerize	heterodimerize	I-VP	VB	O	15	NMOD
18	with	with	B-PP	IN	O	17	VMOD
19	p50	p50	B-NP	NN	B-protein	18	PMOD
20	,	,	O	,	O	6	P
21	suggesting	suggest	B-VP	VBG	O	6	VMOD
22	that	that	B-SBAR	IN	O	21	VMOD
23	c-Rel	c-Rel	B-NP	NN	B-protein	24	NMOD
24	inhibition	inhibition	I-NP	NN	O	25	SUB
25	involves	involve	B-VP	VBZ	O	22	SBAR
26	competition	competition	B-NP	NN	O	25	OBJ
27	with	with	B-PP	IN	O	26	NMOD
28	p50/p65	p50/p65	B-NP	NN	B-protein	27	PMOD
29	for	for	B-PP	IN	O	26	NMOD
30	occupancy	occupancy	B-NP	NN	O	29	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	36	NMOD
33	kappa	kappa	I-NP	NN	B-DNA	36	NMOD
34	B	B	I-NP	NN	I-DNA	36	NMOD
35	enhancer	enhancer	I-NP	NN	I-DNA	36	NMOD
36	element	element	I-NP	NN	I-DNA	31	PMOD
37	.	.	O	.	O	6	P

1	To	To	B-VP	TO	O	3	VMOD
2	further	further	I-VP	RB	O	3	VMOD
3	evaluate	evaluate	I-VP	VB	O	24	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	role	role	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	X	X	B-NP	NN	B-protein	10	NMOD
8	box	box	I-NP	NN	I-protein	10	NMOD
9	DNA-binding	DNA-binding	I-NP	JJ	I-protein	10	NMOD
10	proteins	protein	I-NP	NNS	I-protein	6	PMOD
11	in	in	B-PP	IN	O	5	NMOD
12	class	class	B-NP	NN	B-DNA	15	NMOD
13	II	II	I-NP	CD	I-DNA	15	NMOD
14	gene	gene	I-NP	NN	I-DNA	15	NMOD
15	expression	expression	I-NP	NN	O	11	PMOD
16	,	,	O	,	O	24	P
17	the	the	B-NP	DT	O	18	NMOD
18	role	role	I-NP	NN	O	24	SUB
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	X	X	I-NP	NN	B-DNA	23	NMOD
22	box	box	I-NP	NN	I-DNA	23	NMOD
23	region	region	I-NP	NN	I-DNA	19	PMOD
24	was	be	B-VP	VBD	O	0	ROOT
25	examined	examine	I-VP	VBN	O	24	VC
26	in	in	B-PP	IN	O	25	VMOD
27	both	both	O	CC	O	31	AMOD
28	class	class	B-NP	NN	B-cell_line	31	AMOD
29	II-positive	II-positive	I-NP	JJ	I-cell_line	28	AMOD
30	and	and	I-NP	CC	O	31	AMOD
31	-negative	-negative	I-NP	JJ	B-cell_type	33	NMOD
32	lymphoid	lymphoid	I-NP	JJ	I-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
34	.	.	O	.	O	24	P

1	In	In	B-PP	IN	O	34	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	2	NMOD
4	the	the	B-NP	DT	O	9	NMOD
5	wild-type	wild-type	I-NP	JJ	B-cell_line	9	NMOD
6	B	B	I-NP	NN	I-cell_line	9	NMOD
7	cell	cell	I-NP	NN	I-cell_line	9	NMOD
8	line	line	I-NP	NN	I-cell_line	9	NMOD
9	Raji	Raji	I-NP	NN	I-cell_line	3	PMOD
10	,	,	O	,	O	34	P
11	two	two	B-NP	CD	O	17	NMOD
12	class	class	I-NP	NN	B-cell_line	17	NMOD
13	II	II	I-NP	CD	I-cell_line	12	AMOD
14	transcriptional	transcriptional	I-NP	JJ	I-cell_line	12	AMOD
15	mutant	mutant	I-NP	JJ	I-cell_line	17	NMOD
16	cell	cell	I-NP	NN	I-cell_line	17	NMOD
17	lines	line	I-NP	NNS	I-cell_line	32	NMOD
18	,	,	O	,	O	32	P
19	SJO	SJO	B-NP	NN	B-cell_line	21	NMOD
20	and	and	I-NP	CC	O	21	NMOD
21	RJ2.2.5	RJ2.2.5	I-NP	NN	B-cell_line	32	NMOD
22	,	,	O	,	O	32	P
23	and	and	O	CC	O	32	NMOD
24	Jurkat	Jurkat	B-NP	NN	B-cell_line	32	NMOD
25	,	,	O	,	O	32	P
26	a	a	B-NP	DT	O	32	NMOD
27	class	class	I-NP	NN	B-cell_line	32	NMOD
28	II	II	I-NP	CD	I-cell_line	32	NMOD
29	negative	negative	I-NP	JJ	I-cell_line	32	NMOD
30	T	T	I-NP	NN	I-cell_line	32	NMOD
31	cell	cell	I-NP	NN	I-cell_line	32	NMOD
32	line	line	I-NP	NN	I-cell_line	34	SUB
33	,	,	O	,	O	32	P
34	were	be	B-VP	VBD	O	0	ROOT
35	examined	examine	I-VP	VBN	O	34	VC
36	.	.	O	.	O	34	P

1	In	In	B-PP	IN	O	16	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	1	PMOD
4	wild-type	wild-type	B-NP	JJ	B-cell_line	6	NMOD
5	B	B	I-NP	NN	I-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
7	,	,	O	,	O	16	P
8	neither	neither	B-NP	DT	O	16	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	15	NMOD
11	class	class	I-NP	NN	B-cell_line	15	NMOD
12	II	II	I-NP	CD	I-cell_line	15	NMOD
13	mutant	mutant	I-NP	JJ	I-cell_line	15	NMOD
14	cell	cell	I-NP	NN	I-cell_line	15	NMOD
15	lines	line	I-NP	NNS	I-cell_line	9	PMOD
16	could	could	B-VP	MD	O	0	ROOT
17	use	use	I-VP	VB	O	16	VC
18	the	the	B-NP	DT	O	21	NMOD
19	X	X	I-NP	NN	B-DNA	21	NMOD
20	box	box	I-NP	NN	I-DNA	21	NMOD
21	region	region	I-NP	NN	I-DNA	17	OBJ
22	to	to	B-VP	TO	O	23	VMOD
23	direct	direct	I-VP	VB	O	17	VMOD
24	the	the	B-NP	DT	O	25	NMOD
25	expression	expression	I-NP	NN	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	a	a	B-NP	DT	O	31	NMOD
28	transiently	transiently	I-NP	RB	O	29	AMOD
29	transfected	transfecte	I-NP	VBN	O	31	NMOD
30	reporter	reporter	I-NP	NN	B-DNA	31	NMOD
31	gene	gene	I-NP	NN	I-DNA	26	PMOD
32	,	,	O	,	O	17	P
33	indicating	indicate	B-VP	VBG	O	17	VMOD
34	that	that	B-SBAR	IN	O	33	VMOD
35	the	the	B-NP	DT	O	39	NMOD
36	X	X	I-NP	NN	O	39	NMOD
37	box-dependent	box-dependent	I-NP	JJ	O	36	AMOD
38	transcriptional	transcriptional	I-NP	JJ	O	39	NMOD
39	pathway	pathway	I-NP	NN	O	40	SUB
40	is	be	B-VP	VBZ	O	34	SBAR
41	defective	defective	B-ADJP	JJ	O	40	PRD
42	in	in	B-PP	IN	O	40	VMOD
43	these	these	B-NP	DT	O	44	NMOD
44	cells	cell	I-NP	NNS	O	42	PMOD
45	.	.	O	.	O	16	P

1	The	The	B-NP	DT	O	3	NMOD
2	binding	binding	I-NP	NN	O	3	NMOD
3	activity	activity	I-NP	NN	O	11	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	10	NMOD
6	X1	X1	I-NP	NN	B-protein	10	NMOD
7	box	box	I-NP	NN	I-protein	10	NMOD
8	DNA-binding	DNA-binding	I-NP	JJ	I-protein	10	NMOD
9	protein	protein	I-NP	NN	I-protein	10	NMOD
10	RFX	RFX	I-NP	NN	B-protein	4	PMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	examined	examine	I-VP	VBN	O	11	VC
13	and	and	O	CC	O	12	VMOD
14	found	find	B-VP	VBN	O	12	VMOD
15	to	to	I-VP	TO	O	16	VMOD
16	be	be	I-VP	VB	O	14	VMOD
17	present	present	B-ADJP	JJ	O	16	PRD
18	in	in	B-PP	IN	O	17	AMOD
19	wild-type	wild-type	B-NP	JJ	B-cell_line	21	NMOD
20	B	B	I-NP	NN	I-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	25	NMOD
22	and	and	O	CC	O	25	NMOD
23	the	the	B-NP	DT	O	25	NMOD
24	mutant	mutant	I-NP	JJ	O	25	NMOD
25	RJ2.2.5	RJ2.2.5	I-NP	NN	B-cell_line	18	PMOD
26	but	but	O	CC	O	11	VMOD
27	was	be	B-VP	VBD	O	11	VMOD
28	absent	absent	B-ADJP	JJ	O	27	PRD
29	in	in	B-PP	IN	O	28	AMOD
30	SJO	SJO	B-NP	NN	B-cell_line	32	NMOD
31	and	and	I-NP	CC	O	32	NMOD
32	Jurkat	Jurkat	I-NP	NN	B-cell_line	29	PMOD
33	.	.	O	.	O	11	P

1	A	A	B-NP	DT	O	3	NMOD
2	similar	similar	I-NP	JJ	O	3	NMOD
3	comparison	comparison	I-NP	NN	O	11	SUB
4	with	with	B-PP	IN	O	3	NMOD
5	protease-treated	protease-treated	B-NP	JJ	O	6	NMOD
6	extracts	extract	I-NP	NNS	O	4	PMOD
7	prepared	prepare	B-VP	VBN	O	6	NMOD
8	from	from	B-PP	IN	O	7	VMOD
9	Jurkat	Jurkat	B-NP	NN	B-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	8	PMOD
11	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
12	the	the	B-NP	DT	O	13	NMOD
13	presence	presence	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	band	band	I-NP	NN	O	18	NMOD
17	1pk	1pk	I-NP	NN	O	18	NMOD
18	activity	activity	I-NP	NN	O	14	PMOD
19	despite	despite	B-PP	IN	O	11	VMOD
20	an	an	B-NP	DT	O	21	NMOD
21	absence	absence	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	26	NMOD
24	native	native	I-NP	JJ	O	26	NMOD
25	RFX	RFX	I-NP	NN	B-protein	26	NMOD
26	activity	activity	I-NP	NN	O	22	PMOD
27	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	11	P
4	protease	protease	B-NP	NN	B-protein	5	NMOD
5	treatment	treatment	I-NP	NN	O	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	analysis	analysis	B-NP	NN	O	11	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	SJO	SJO	B-NP	NN	O	10	NMOD
10	extracts	extract	I-NP	NNS	O	8	PMOD
11	showed	show	B-VP	VBD	O	0	ROOT
12	no	no	B-NP	DT	O	14	NMOD
13	detectable	detectable	I-NP	JJ	O	14	NMOD
14	levels	level	I-NP	NNS	O	11	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	band	band	I-NP	NN	O	19	NMOD
18	1pk	1pk	I-NP	NN	O	19	NMOD
19	activity	activity	I-NP	NN	O	15	PMOD
20	.	.	O	.	O	11	P

1	Three	Three	B-NP	CD	O	2	NMOD
2	mutants	mutant	I-NP	NNS	O	14	SUB
3	(	(	O	(	O	13	DEP
4	-201/-184	-201/-184	B-NP	CD	O	5	NMOD
5	NXS	NXS	O	NN|NNS	O	12	NMOD
6	,	,	O	,	O	12	P
7	-165/-148	-165/-148	B-NP	CD	O	8	NMOD
8	NXS	NXS	B-ADJP	NN|NNS	O	12	NMOD
9	,	,	O	,	O	12	P
10	and	and	O	CC	O	12	NMOD
11	-147/-130	-147/-130	B-NP	CD	O	12	NMOD
12	NXS	NXS	I-NP	NN	O	13	DEP
13	)	)	O	)	O	2	NMOD
14	had	have	B-VP	VBD	O	49	VMOD
15	effects	effect	B-NP	NNS	O	14	OBJ
16	on	on	B-PP	IN	O	14	VMOD
17	viral	viral	B-NP	JJ	O	18	NMOD
18	replication	replication	I-NP	NN	O	16	PMOD
19	that	that	B-NP	WDT	O	18	NMOD
20	were	be	B-VP	VBD	O	19	SBAR
21	much	much	B-ADJP	RB	O	20	PRD
22	more	more	I-ADJP	RBR	O	21	AMOD
23	severe	severe	I-ADJP	JJ	O	21	AMOD
24	than	than	B-PP	IN	O	21	AMOD
25	the	the	B-NP	DT	O	26	NMOD
26	effects	effect	I-NP	NNS	O	24	PMOD
27	predicted	predict	B-VP	VBN	O	26	NMOD
28	from	from	B-PP	IN	O	27	VMOD
29	their	their	B-NP	PRP$	O	30	NMOD
30	performance	performance	I-NP	NN	O	28	PMOD
31	in	in	B-PP	IN	O	30	NMOD
32	transfection	transfection	B-NP	NN	O	33	NMOD
33	analyses	analysis	I-NP	NNS	O	31	PMOD
34	,	,	O	,	O	49	P
35	and	and	O	CC	O	37	NMOD
36	the	the	B-NP	DT	O	37	NMOD
37	effects	effect	I-NP	NNS	O	49	SUB
38	of	of	B-PP	IN	O	37	NMOD
39	two	two	B-NP	CD	O	41	NMOD
40	LS	LS	I-NP	NN	O	41	NMOD
41	mutations	mutation	I-NP	NNS	O	38	PMOD
42	(	(	O	(	O	48	DEP
43	-201/-184	-201/-184	B-NP	CD	O	44	NMOD
44	NXS	NXS	O	NN|NNS	O	47	NMOD
45	and	and	O	CC	O	47	NMOD
46	-183/-166	-183/-166	B-NP	CD	O	47	NMOD
47	NXS	NXS	I-NP	NN	O	48	DEP
48	)	)	O	)	O	41	NMOD
49	were	be	B-VP	VBD	O	0	ROOT
50	not	not	I-VP	RB	O	49	VMOD
51	predicted	predict	I-VP	VBN	O	49	VC
52	by	by	B-PP	IN	O	51	VMOD
53	their	their	B-NP	PRP$	O	54	NMOD
54	effects	effect	I-NP	NNS	O	52	PMOD
55	in	in	B-PP	IN	O	54	NMOD
56	transfection	transfection	B-NP	NN	O	55	PMOD
57	.	.	O	.	O	49	P

1	In	In	B-PP	IN	O	10	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	cell	cell	I-NP	NN	O	4	NMOD
4	types	type	I-NP	NNS	O	1	PMOD
5	tested	test	B-VP	VBN	O	4	NMOD
6	,	,	O	,	O	10	P
7	the	the	B-NP	DT	O	9	NMOD
8	LS	LS	I-NP	NN	O	9	NMOD
9	mutations	mutation	I-NP	NNS	O	10	SUB
10	indicated	indicate	B-VP	VBD	O	0	ROOT
11	an	an	B-NP	DT	O	13	NMOD
12	apparent	apparent	I-NP	JJ	O	13	NMOD
13	requirement	requirement	I-NP	NN	O	10	OBJ
14	not	not	B-CONJP	RB	O	13	NMOD
15	only	only	I-CONJP	RB	O	14	DEP
16	for	for	B-PP	IN	O	14	PMOD
17	the	the	B-NP	DT	O	23	NMOD
18	intact	intact	I-NP	JJ	O	23	NMOD
19	NF-kappa	NF-kappa	I-NP	NN	B-protein	20	NMOD
20	B	B	I-NP	NN	I-protein	22	AMOD
21	and	and	O	CC	O	22	AMOD
22	SP1-binding	SP1-binding	B-NP	JJ	B-DNA	23	NMOD
23	sites	site	I-NP	NNS	I-DNA	16	PMOD
24	but	but	B-CONJP	CC	O	14	PMOD
25	also	also	I-CONJP	RB	O	24	DEP
26	for	for	B-PP	IN	O	14	PMOD
27	several	several	B-NP	JJ	O	28	NMOD
28	regions	region	I-NP	NNS	O	26	PMOD
29	between	between	B-PP	IN	O	28	NMOD
30	-201	-201	B-NP	CD	B-DNA	32	NMOD
31	and	and	I-NP	CC	I-DNA	32	NMOD
32	-130	-130	I-NP	CD	I-DNA	29	PMOD
33	not	not	B-VP	RB	O	35	VMOD
34	previously	previously	I-VP	RB	O	35	VMOD
35	associated	associate	I-VP	VBN	O	28	NMOD
36	with	with	B-PP	IN	O	35	VMOD
37	viral	viral	B-NP	JJ	O	38	NMOD
38	infectivity	infectivity	I-NP	NN	O	36	PMOD
39	.	.	O	.	O	10	P

1	When	When	B-ADVP	WRB	O	29	VMOD
2	ligated	ligate	B-VP	VBN	O	1	SBAR
3	to	to	B-PP	TO	O	2	VMOD
4	the	the	B-NP	DT	O	9	NMOD
5	proIL-1	proIL-1	I-NP	NN	B-DNA	9	NMOD
6	beta	beta	I-NP	NN	I-DNA	9	NMOD
7	cap	cap	I-NP	NN	I-DNA	9	NMOD
8	site-proximal	site-proximal	I-NP	JJ	I-DNA	7	AMOD
9	region	region	I-NP	NN	I-DNA	3	PMOD
10	(	(	O	(	O	9	NMOD
11	located	located	B-ADJP	JJ	O	9	NMOD
12	between	between	B-PP	IN	O	11	AMOD
13	-131	-131	B-NP	CD	B-DNA	15	NMOD
14	to	to	B-PP	TO	I-DNA	15	NMOD
15	+12	+12	B-NP	CD	I-DNA	12	PMOD
16	)	)	O	)	O	9	NMOD
17	,	,	O	,	O	29	P
18	both	both	O	CC	O	28	NMOD
19	the	the	B-NP	DT	O	21	NMOD
20	proIL-1	proIL-1	I-NP	NN	B-protein	21	NMOD
21	beta	beta	I-NP	NN	I-protein	28	NMOD
22	and	and	O	CC	O	28	NMOD
23	the	the	B-NP	DT	O	28	NMOD
24	simian	simian	I-NP	JJ	B-DNA	28	NMOD
25	virus	virus	I-NP	NN	I-DNA	28	NMOD
26	40	40	I-NP	CD	I-DNA	28	NMOD
27	enhancer	enhancer	I-NP	NN	I-DNA	28	NMOD
28	elements	element	I-NP	NNS	I-DNA	29	SUB
29	functioned	function	B-VP	VBD	O	0	ROOT
30	more	more	B-ADVP	RBR	O	31	AMOD
31	efficiently	efficiently	I-ADVP	RB	O	29	VMOD
32	in	in	B-PP	IN	O	29	VMOD
33	monocytes	monocyte	B-NP	NNS	B-cell_type	32	PMOD
34	than	than	B-PP	IN	O	29	VMOD
35	in	in	B-PP	IN	O	34	PMOD
36	HeLa	HeLa	B-NP	NN	B-cell_line	37	NMOD
37	cells	cell	I-NP	NNS	I-cell_line	35	PMOD
38	,	,	O	,	O	37	P
39	which	which	B-NP	WDT	O	37	NMOD
40	are	be	B-VP	VBP	O	39	SBAR
41	not	not	O	RB	O	40	VMOD
42	normally	normally	B-ADJP	RB	O	40	VMOD
43	competent	competent	I-ADJP	JJ	O	40	PRD
44	for	for	B-PP	IN	O	43	AMOD
45	IL-1	IL-1	B-NP	NN	B-protein	46	NMOD
46	beta	beta	I-NP	NN	I-protein	47	NMOD
47	expression	expression	I-NP	NN	O	44	PMOD
48	.	.	O	.	O	29	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	2	NMOD
4	T	T	B-NP	NN	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
6	,	,	O	,	O	12	P
7	in	in	B-PP	IN	O	12	VMOD
8	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	7	PMOD
9	PILOT	PILOT	I-NP	NN	B-protein	11	NMOD
10	gene	gene	I-NP	NN	O	11	NMOD
11	expression	expression	I-NP	NN	O	12	SUB
12	requires	require	B-VP	VBZ	O	0	ROOT
13	only	only	B-NP	RB	O	15	NMOD
14	one	one	I-NP	CD	O	13	AMOD
15	signal	signal	I-NP	NN	O	12	OBJ
16	(	(	O	(	O	18	DEP
17	PMA	PMA	B-NP	NN	O	18	DEP
18	)	)	O	)	O	15	NMOD
19	and	and	O	CC	O	12	VMOD
20	is	be	B-VP	VBZ	O	12	VMOD
21	not	not	I-VP	RB	O	20	VMOD
22	affected	affect	I-VP	VBN	O	20	VC
23	by	by	B-PP	IN	O	22	VMOD
24	CyA	CyA	B-NP	NN	O	23	PMOD
25	.	.	O	.	O	12	P

1	This	This	B-NP	DT	O	2	NMOD
2	observation	observation	I-NP	NN	O	4	SUB
3	directly	directly	B-ADVP	RB	O	4	VMOD
4	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	existence	existence	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	a	a	B-NP	DT	O	12	NMOD
9	Ca2+	Ca2+	I-NP	NN	B-DNA	12	NMOD
10	signal-dependent	signal-dependent	I-NP	JJ	I-DNA	9	AMOD
11	regulatory	regulatory	I-NP	JJ	I-DNA	12	NMOD
12	element	element	I-NP	NN	I-DNA	7	PMOD
13	obligatory	obligatory	B-ADJP	JJ	O	12	NMOD
14	for	for	B-PP	IN	O	13	AMOD
15	expression	expression	B-NP	NN	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	some	some	B-NP	DT	O	18	NMOD
18	genes	gene	I-NP	NNS	O	16	PMOD
19	in	in	B-PP	IN	O	15	NMOD
20	T	T	B-NP	NN	B-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
22	but	but	B-PP	CC	O	19	PMOD
23	not	not	B-PP	RB	O	24	PMOD
24	in	in	I-PP	IN	O	19	PMOD
25	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	24	PMOD
26	.	.	O	.	O	4	P

1	Control	Control	B-NP	NN	O	2	NMOD
2	peptides	peptide	I-NP	NNS	O	12	SUB
3	corresponding	correspond	B-VP	VBG	O	2	NMOD
4	to	to	B-PP	TO	O	3	VMOD
5	the	the	B-NP	DT	O	11	NMOD
6	normal	normal	I-NP	JJ	O	7	NMOD
7	pml	pml	I-NP	NN	O	10	NMOD
8	and	and	I-NP	CC	O	10	NMOD
9	RAR	RAR	I-NP	NN	B-protein	10	NMOD
10	alpha	alpha	I-NP	NN	I-protein	11	NMOD
11	proteins	protein	I-NP	NNS	I-protein	4	PMOD
12	were	be	B-VP	VBD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	recognized	recognize	I-VP	VBN	O	12	VC
15	.	.	O	.	O	12	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	concluded	conclude	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	10	NMOD
6	bcr1	bcr1	I-NP	NN	B-protein	10	NMOD
7	type-pml/RAR	type-pml/RAR	I-NP	NN	I-protein	10	NMOD
8	alpha	alpha	I-NP	NN	I-protein	10	NMOD
9	fusion	fusion	I-NP	NN	I-protein	10	NMOD
10	protein	protein	I-NP	NN	I-protein	13	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	APL	APL	B-NP	NN	B-protein	11	PMOD
13	contains	contain	B-VP	VBZ	O	4	SBAR
14	an	an	B-NP	DT	O	16	NMOD
15	antigenic	antigenic	I-NP	JJ	O	16	NMOD
16	site	site	I-NP	NN	O	13	OBJ
17	,	,	O	,	O	13	P
18	absent	absent	B-ADJP	JJ	O	13	VMOD
19	from	from	B-PP	IN	O	18	AMOD
20	the	the	B-NP	DT	O	23	NMOD
21	normal	normal	I-NP	JJ	O	23	NMOD
22	parent	parent	I-NP	NN	O	23	NMOD
23	molecules	molecule	I-NP	NNS	O	19	PMOD
24	and	and	O	CC	O	13	VMOD
25	recognized	recognize	B-VP	VBN	O	13	VMOD
26	by	by	B-PP	IN	O	25	VMOD
27	human	human	B-NP	JJ	B-cell_type	29	NMOD
28	CD4+	CD4+	I-NP	JJ	I-cell_type	29	NMOD
29	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	26	PMOD
30	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	12	VMOD
2	gel-shift	gel-shift	B-NP	JJ	O	3	NMOD
3	assays	assay	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	12	P
5	the	the	B-NP	DT	O	7	NMOD
6	-1280	-1280	I-NP	CD	B-DNA	7	NMOD
7	element	element	I-NP	NN	I-DNA	11	NMOD
8	and	and	O	CC	O	11	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	c-fos	c-fos	I-NP	NN	B-DNA	11	NMOD
11	SRE	SRE	I-NP	NN	I-DNA	12	SUB
12	cross-competed	cross-compete	B-VP	VBD	O	14	VMOD
13	,	,	O	,	O	14	P
14	whereas	whereas	O	IN	O	0	ROOT
15	their	their	B-NP	PRP$	O	19	NMOD
16	functional	functional	I-NP	JJ	O	19	NMOD
17	and	and	I-NP	CC	O	19	NMOD
18	binding	binding	I-NP	NN	B-DNA	19	NMOD
19	mutants	mutant	I-NP	NNS	I-DNA	20	SUB
20	did	do	B-VP	VBD	O	14	VMOD
21	not	not	O	RB	O	20	VMOD
22	.	.	O	.	O	14	P

1	Methylation	Methylation	B-NP	NN	O	3	NMOD
2	interference	interference	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	-65	-65	I-NP	CD	B-DNA	7	NMOD
7	region	region	I-NP	NN	I-DNA	4	PMOD
8	identified	identify	B-VP	VBD	O	36	VMOD
9	a	a	B-NP	DT	O	10	NMOD
10	pattern	pattern	I-NP	NN	O	30	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	contacts	contact	B-NP	NNS	O	11	PMOD
13	with	with	B-PP	IN	O	12	NMOD
14	nuclear	nuclear	B-NP	JJ	B-protein	15	NMOD
15	factors	factor	I-NP	NNS	I-protein	13	PMOD
16	resembling	resemble	B-VP	VBG	O	10	NMOD
17	that	that	B-SBAR	IN	O	16	OBJ
18	for	for	B-PP	IN	O	17	NMOD
19	NF-Y	NF-Y	B-NP	NN	B-protein	18	PMOD
20	,	,	O	,	O	30	P
21	and	and	O	CC	O	24	NMOD
22	an	an	B-NP	DT	O	24	NMOD
23	NF-Y-binding	NF-Y-binding	I-NP	JJ	B-DNA	24	NMOD
24	site	site	I-NP	NN	I-DNA	30	NMOD
25	and	and	O	CC	O	30	NMOD
26	the	the	B-NP	DT	O	30	NMOD
27	proximal	proximal	I-NP	JJ	B-DNA	30	NMOD
28	TSP	TSP	I-NP	NN	I-DNA	30	NMOD
29	1	1	I-NP	CD	I-DNA	30	NMOD
30	element	element	I-NP	NN	I-DNA	8	OBJ
31	cross-competed	cross-compete	B-VP	VBD	O	30	NMOD
32	in	in	B-PP	IN	O	31	VMOD
33	gel-shift	gel-shift	B-NP	JJ	O	34	NMOD
34	assays	assay	I-NP	NNS	O	32	PMOD
35	,	,	O	,	O	36	P
36	whereas	whereas	O	IN	O	0	ROOT
37	their	their	B-NP	PRP$	O	39	NMOD
38	binding	bind	I-NP	VBG	B-DNA	39	NMOD
39	mutants	mutant	I-NP	NNS	I-DNA	40	SUB
40	did	do	B-VP	VBD	O	36	VMOD
41	not	not	O	RB	O	40	VMOD
42	.	.	O	.	O	36	P

1	Hemin	Hemin	B-NP	NN	B-protein	2	NMOD
2	induction	induction	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	K562	K562	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	3	PMOD
6	does	do	B-VP	VBZ	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	facilitate	facilitate	I-VP	VB	O	6	VC
9	the	the	B-NP	DT	O	10	NMOD
10	binding	binding	I-NP	NN	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	NF-E2	NF-E2	B-NP	NN	B-protein	11	PMOD
13	to	to	B-PP	TO	O	10	NMOD
14	its	its	B-NP	PRP$	O	16	NMOD
15	recognition	recognition	I-NP	NN	O	16	NMOD
16	site	site	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	6	P

1	No	No	B-NP	DT	O	3	NMOD
2	such	such	I-NP	JJ	O	3	NMOD
3	increase	increase	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	observed	observe	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	control	control	B-NP	NN	O	9	NMOD
8	U937	U937	I-NP	NN	B-cell_line	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
10	.	.	O	.	O	4	P

1	Although	Although	B-SBAR	IN	O	19	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	-20	-20	I-NP	CD	B-DNA	6	NMOD
4	GATA	GATA	I-NP	NN	I-DNA	6	NMOD
5	binding	binding	I-NP	NN	I-DNA	6	NMOD
6	site	site	I-NP	NN	I-DNA	10	SUB
7	(	(	O	(	O	9	DEP
8	AGATAA	AGATAA	B-NP	NN	O	9	DEP
9	)	)	O	)	O	6	NMOD
10	is	be	B-VP	VBZ	O	1	SBAR
11	also	also	B-ADVP	RB	O	10	VMOD
12	a	a	B-NP	DT	O	16	NMOD
13	potential	potential	I-NP	JJ	O	16	NMOD
14	TFIID	TFIID	I-NP	NN	B-DNA	16	NMOD
15	binding	binding	I-NP	NN	I-DNA	16	NMOD
16	site	site	I-NP	NN	I-DNA	10	PRD
17	,	,	O	,	O	19	P
18	it	it	B-NP	PRP	O	19	SUB
19	does	do	B-VP	VBZ	O	0	ROOT
20	not	not	I-VP	RB	O	19	VMOD
21	bind	bind	I-VP	VB	O	19	VC
22	TFIID	TFIID	B-NP	NN	B-protein	21	OBJ
23	.	.	O	.	O	19	P

1	Proliferation	Proliferation	B-NP	NN	O	5	SUB
2	to	to	B-PP	TO	O	1	NMOD
3	tetanus	tetanus	B-NP	NN	O	4	NMOD
4	toxoid	toxoid	I-NP	NN	O	2	PMOD
5	did	do	B-VP	VBD	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	differ	differ	I-VP	VB	O	5	VC
8	significantly	significantly	B-ADVP	RB	O	7	VMOD
9	between	between	B-PP	IN	O	7	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	groups	group	I-NP	NNS	O	9	PMOD
12	.	.	O	.	O	5	P

1	Responses	Response	B-NP	NNS	O	4	SUB
2	to	to	B-PP	TO	O	1	NMOD
3	jun-B	jun-B	B-NP	NN	B-protein	2	PMOD
4	were	be	B-VP	VBD	O	0	ROOT
5	not	not	O	RB	O	4	VMOD
6	related	related	B-ADJP	JJ	O	4	PRD
7	to	to	B-PP	TO	O	6	AMOD
8	age	age	B-NP	NN	O	16	NMOD
9	,	,	O	,	O	16	P
10	sex	sex	B-NP	NN	O	16	NMOD
11	,	,	O	,	O	16	P
12	or	or	O	CC	O	16	NMOD
13	human	human	B-NP	JJ	B-protein	16	NMOD
14	leukocyte	leukocyte	I-NP	NN	I-protein	16	NMOD
15	antigen	antigen	I-NP	NN	I-protein	16	NMOD
16	status	status	I-NP	NN	O	7	PMOD
17	.	.	O	.	O	4	P

1	Site-directed	Site-directed	B-NP	JJ	O	2	NMOD
2	mutagenesis	mutagenesis	I-NP	NN	O	4	SUB
3	further	further	B-ADVP	RBR	O	4	VMOD
4	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	8	NMOD
7	enhancer	enhancer	I-NP	NN	B-DNA	8	NMOD
8	function	function	I-NP	NN	O	18	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	one	one	B-NP	CD	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	two	two	I-NP	CD	O	15	NMOD
14	NF-E2/AP1	NF-E2/AP1	I-NP	NN	B-DNA	15	NMOD
15	motifs	motif	I-NP	NNS	I-DNA	11	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	HS-40	HS-40	B-NP	NN	B-DNA	16	PMOD
18	is	be	B-VP	VBZ	O	5	SBAR
19	mediated	mediate	I-VP	VBN	O	18	VC
20	through	through	B-PP	IN	O	19	VMOD
21	its	its	B-NP	PRP$	O	22	NMOD
22	binding	binding	I-NP	NN	O	20	PMOD
23	to	to	B-PP	TO	O	22	NMOD
24	NF-E2	NF-E2	B-NP	NN	B-protein	29	NMOD
25	but	but	B-NP	CC	O	29	NMOD
26	not	not	I-NP	RB	O	25	DEP
27	AP1	AP1	B-NP	NN	B-protein	29	NMOD
28	transcription	transcription	I-NP	NN	I-protein	29	NMOD
29	factor	factor	I-NP	NN	I-protein	23	PMOD
30	.	.	O	.	O	4	P

1	All	All	B-NP	DT	O	3	NMOD
2	sequence	sequence	I-NP	NN	B-DNA	3	NMOD
3	motifs	motif	I-NP	NNS	I-DNA	18	SUB
4	within	within	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	functional	functional	I-NP	JJ	O	7	NMOD
7	core	core	I-NP	NN	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	HS-40	HS-40	B-NP	NN	B-DNA	8	PMOD
10	,	,	O	,	O	3	P
11	as	as	B-SBAR	IN	O	3	NMOD
12	mapped	map	B-VP	VBN	O	11	SBAR
13	by	by	B-PP	IN	O	12	VMOD
14	transient	transient	B-NP	JJ	O	16	NMOD
15	expression	expression	I-NP	NN	O	16	NMOD
16	analysis	analysis	I-NP	NN	O	13	PMOD
17	,	,	O	,	O	3	P
18	appeared	appear	B-VP	VBD	O	0	ROOT
19	to	to	I-VP	TO	O	20	VMOD
20	bind	bind	I-VP	VB	O	18	VMOD
21	a	a	B-NP	DT	O	25	NMOD
22	nuclear	nuclear	I-NP	JJ	B-protein	25	NMOD
23	factor	factor	I-NP	NN	I-protein	25	NMOD
24	(	(	I-NP	(	O	25	NMOD
25	s	s	I-NP	NNS	O	20	OBJ
26	)	)	O	)	O	25	NMOD
27	in	in	B-PP	IN	O	25	NMOD
28	living	live	B-VP	VBG	O	30	NMOD
29	K562	K562	B-NP	NN	B-cell_line	30	NMOD
30	cells	cell	I-NP	NNS	I-cell_line	27	PMOD
31	but	but	B-PP	CC	O	27	PMOD
32	not	not	B-PP	RB	O	33	PMOD
33	in	in	I-PP	IN	O	27	PMOD
34	nonerythroid	nonerythroid	B-NP	JJ	B-cell_type	35	NMOD
35	cells	cell	I-NP	NNS	I-cell_type	33	PMOD
36	.	.	O	.	O	18	P

1	This	This	B-NP	DT	O	2	NMOD
2	activation	activation	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	observed	observe	I-VP	VBN	O	3	VC
6	in	in	B-PP	IN	O	5	VMOD
7	undifferentiated	undifferentiated	B-NP	JJ	B-cell_line	10	NMOD
8	embryocarcinoma	embryocarcinoma	I-NP	NN	I-cell_line	10	NMOD
9	F9	F9	I-NP	NN	I-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
11	.	.	O	.	O	3	P

1	Using	Use	B-VP	VBG	O	9	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	DNA	DNA	I-NP	NN	O	6	NMOD
4	affinity	affinity	I-NP	NN	O	6	NMOD
5	precipitation	precipitation	I-NP	NN	O	6	NMOD
6	assay	assay	I-NP	NN	O	1	OBJ
7	,	,	O	,	O	9	P
8	we	we	B-NP	PRP	O	9	SUB
9	observed	observe	B-VP	VBD	O	0	ROOT
10	that	that	B-SBAR	IN	O	9	VMOD
11	Tax1	Tax1	B-NP	NN	B-protein	12	SUB
12	is	be	B-VP	VBZ	O	22	VMOD
13	able	able	B-ADJP	JJ	O	12	PRD
14	to	to	B-VP	TO	O	16	VMOD
15	efficiently	efficiently	I-VP	RB	O	16	VMOD
16	induce	induce	I-VP	VB	O	13	AMOD
17	the	the	B-NP	DT	O	18	NMOD
18	binding	binding	I-NP	NN	O	16	OBJ
19	of	of	B-PP	IN	O	18	NMOD
20	Rel	Rel	B-NP	NN	B-protein	19	PMOD
21	,	,	O	,	O	22	P
22	whereas	whereas	O	IN	O	10	SBAR
23	PMA	PMA	B-NP	NN	O	24	SUB
24	is	be	B-VP	VBZ	O	22	VMOD
25	not	not	O	RB	O	24	VMOD
26	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	4	NMOD
2	Rel/NF-kappa	Rel/NF-kappa	I-NP	NN	B-protein	4	NMOD
3	B	B	I-NP	NN	I-protein	4	NMOD
4	family	family	I-NP	NN	I-protein	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	transcription	transcription	B-NP	NN	B-protein	7	NMOD
7	factors	factor	I-NP	NNS	I-protein	5	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	composed	compose	I-VP	VBN	O	8	VC
10	of	of	B-PP	IN	O	9	VMOD
11	two	two	B-NP	CD	O	13	NMOD
12	distinct	distinct	I-NP	JJ	O	13	NMOD
13	subgroups	subgroup	I-NP	NNS	O	35	NMOD
14	,	,	O	,	O	35	P
15	proteins	protein	B-NP	NNS	O	35	NMOD
16	that	that	B-NP	WDT	O	15	NMOD
17	undergo	undergo	B-VP	VBP	O	16	SBAR
18	proteolytic	proteolytic	B-NP	JJ	O	19	NMOD
19	processing	processing	I-NP	NN	O	17	OBJ
20	and	and	O	CC	O	17	VMOD
21	contain	contain	B-VP	VBP	O	17	VMOD
22	SWI6/ankyrin	SWI6/ankyrin	B-NP	NN	B-protein	23	NMOD
23	repeats	repeat	I-NP	NNS	I-protein	21	OBJ
24	in	in	B-PP	IN	O	21	VMOD
25	their	their	B-NP	PRP$	O	27	NMOD
26	carboxyl	carboxyl	I-NP	NN	B-protein	27	NMOD
27	termini	terminus	I-NP	NNS	I-protein	24	PMOD
28	(	(	O	(	O	32	DEP
29	p105	p105	B-NP	NN	B-protein	31	NMOD
30	,	,	I-NP	,	O	31	P
31	p98	p98	I-NP	NN	B-protein	32	DEP
32	)	)	O	)	O	15	NMOD
33	,	,	O	,	O	35	P
34	and	and	O	CC	O	35	NMOD
35	those	those	B-NP	DT	O	10	PMOD
36	without	without	B-PP	IN	O	35	NMOD
37	such	such	B-NP	JJ	O	38	NMOD
38	repeats	repeat	I-NP	NNS	O	36	PMOD
39	that	that	B-NP	WDT	O	38	NMOD
40	do	do	B-VP	VBP	O	39	SBAR
41	not	not	I-VP	RB	O	40	VMOD
42	require	require	I-VP	VB	O	40	VC
43	processing	processing	B-NP	NN	O	42	OBJ
44	(	(	O	(	O	53	DEP
45	p65	p65	B-NP	NN	B-protein	52	NMOD
46	,	,	O	,	O	52	P
47	c-Rel	c-Rel	B-NP	NN	B-protein	52	NMOD
48	,	,	O	,	O	52	P
49	RelB	RelB	B-NP	NN	B-protein	52	NMOD
50	,	,	O	,	O	52	P
51	and	and	O	CC	O	52	NMOD
52	Dorsal	Dorsal	B-NP	NN	B-protein	53	DEP
53	)	)	O	)	O	38	NMOD
54	.	.	O	.	O	8	P

1	These	These	B-NP	DT	O	2	NMOD
2	observations	observation	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	second	second	I-NP	JJ	O	6	NMOD
6	pathway	pathway	I-NP	NN	O	3	OBJ
7	leading	lead	B-VP	VBG	O	6	NMOD
8	to	to	B-PP	TO	O	7	VMOD
9	NF-kappa	NF-kappa	B-NP	NN	B-protein	11	NMOD
10	B	B	I-NP	NN	I-protein	11	NMOD
11	induction	induction	I-NP	NN	O	8	PMOD
12	,	,	O	,	O	6	P
13	in	in	B-PP	IN	O	6	NMOD
14	which	which	B-NP	WDT	O	13	PMOD
15	processing	processing	B-NP	NN	O	21	NMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	18	NMOD
18	precursors	precursor	I-NP	NNS	O	16	PMOD
19	rather	rather	B-CONJP	RB	O	21	NMOD
20	than	than	I-CONJP	IN	O	19	DEP
21	phosphorylation	phosphorylation	B-NP	NN	O	26	SUB
22	of	of	B-PP	IN	O	21	NMOD
23	I	I	B-NP	NN	B-protein	25	NMOD
24	kappa	kappa	I-NP	NN	I-protein	25	NMOD
25	B	B	I-NP	NN	I-protein	22	PMOD
26	plays	play	B-VP	VBZ	O	13	SBAR
27	a	a	B-NP	DT	O	29	NMOD
28	major	major	I-NP	JJ	O	29	NMOD
29	role	role	I-NP	NN	O	26	OBJ
30	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	1	PMOD
4	MEL	MEL	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
6	,	,	O	,	O	11	P
7	however	however	B-ADVP	RB	O	11	VMOD
8	,	,	O	,	O	11	P
9	K562	K562	B-NP	NN	B-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	11	SUB
11	acquired	acquire	B-VP	VBD	O	0	ROOT
12	a	a	B-NP	DT	O	14	NMOD
13	macrophage-like	macrophage-like	I-NP	JJ	O	14	NMOD
14	morphology	morphology	I-NP	NN	O	11	OBJ
15	and	and	O	CC	O	11	VMOD
16	exhibited	exhibit	B-VP	VBD	O	11	VMOD
17	a	a	B-NP	DT	O	19	NMOD
18	complete	complete	I-NP	JJ	O	19	NMOD
19	failure	failure	I-NP	NN	O	16	OBJ
20	to	to	B-VP	TO	O	21	VMOD
21	generate	generate	I-VP	VB	O	19	NMOD
22	benzidine-positive	benzidine-positive	B-NP	JJ	B-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	21	OBJ
24	.	.	O	.	O	11	P

1	No	No	B-NP	DT	O	2	NMOD
2	upregulation	upregulation	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	megakaryocyte	megakaryocyte	B-NP	NN	B-cell_type	7	NMOD
5	or	or	O	CC	O	7	NMOD
6	lymphoid	lymphoid	B-NP	JJ	B-protein	7	NMOD
7	markers	marker	I-NP	NNS	I-protein	3	PMOD
8	occurred	occur	B-VP	VBD	O	0	ROOT
9	.	.	O	.	O	8	P

1	In	In	B-ADVP	FW	O	6	VMOD
2	vivo	vivo	I-ADVP	FW	O	1	AMOD
3	the	the	B-NP	DT	O	5	NMOD
4	Sp1	Sp1	I-NP	NN	B-DNA	5	NMOD
5	site	site	I-NP	NN	I-DNA	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	bound	bind	I-VP	VBN	O	6	VC
8	only	only	B-ADVP	RB	O	9	PMOD
9	in	in	B-PP	IN	O	7	VMOD
10	myeloid	myeloid	B-NP	JJ	B-cell_line	14	NMOD
11	(	(	O	(	I-cell_line	14	NMOD
12	U937	U937	B-NP	NN	I-cell_line	14	NMOD
13	)	)	I-NP	)	I-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	9	PMOD
15	,	,	B-PP	,	O	9	P
16	not	not	I-PP	RB	O	17	PMOD
17	in	in	B-PP	IN	O	9	PMOD
18	cervical	cervical	B-NP	JJ	B-cell_line	23	NMOD
19	carcinoma	carcinoma	I-NP	NN	I-cell_line	23	NMOD
20	(	(	O	(	I-cell_line	22	DEP
21	HeLa	HeLa	B-NP	NN	I-cell_line	22	DEP
22	)	)	O	)	I-cell_line	19	NMOD
23	cells	cell	B-NP	NNS	I-cell_line	17	PMOD
24	.	.	O	.	O	6	P

1	PBL	PBL	B-NP	NN	B-cell_type	3	SUB
2	constitutively	constitutively	B-ADVP	RB	O	3	VMOD
3	express	express	B-VP	VBP	O	13	VMOD
4	c-jun	c-jun	B-NP	NN	B-protein	5	NMOD
5	transcripts	transcript	I-NP	NNS	I-protein	3	OBJ
6	,	,	O	,	O	13	P
7	and	and	O	CC	O	13	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	level	level	I-NP	NN	O	13	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	c-jun	c-jun	B-NP	NN	B-RNA	12	NMOD
12	mRNA	mRNA	I-NP	NN	I-RNA	10	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	not	not	I-VP	RB	O	13	VMOD
15	altered	alter	I-VP	VBN	O	13	VC
16	by	by	B-PP	IN	O	15	VMOD
17	PHA	PHA	B-NP	NN	B-protein	18	NMOD
18	activation	activation	I-NP	NN	O	16	PMOD
19	in	in	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	absence	absence	I-NP	NN	O	23	NMOD
22	or	or	I-NP	CC	O	23	NMOD
23	presence	presence	I-NP	NN	O	19	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	EC	EC	B-NP	NN	B-cell_type	24	PMOD
26	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	6	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	6	P
4	c-fos	c-fos	B-NP	NN	B-RNA	5	NMOD
5	mRNA	mRNA	I-NP	NN	I-RNA	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	absent	absent	B-ADJP	JJ	O	6	PRD
8	from	from	B-PP	IN	O	7	AMOD
9	resting	rest	B-NP	VBG	B-cell_type	11	NMOD
10	T	T	I-NP	NN	I-cell_type	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
12	and	and	O	CC	O	6	VMOD
13	is	be	B-VP	VBZ	O	6	VMOD
14	induced	induce	I-VP	VBN	O	13	VC
15	on	on	B-PP	IN	O	14	VMOD
16	PHA	PHA	B-NP	NN	B-protein	17	NMOD
17	activation	activation	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	6	P

1	EC	EC	B-NP	NN	B-cell_type	3	SUB
2	alone	alone	B-ADVP	RB	O	1	NMOD
3	do	do	B-VP	VBP	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	induce	induce	I-VP	VB	O	3	VC
6	c-fos	c-fos	B-NP	NN	B-RNA	7	NMOD
7	mRNA	mRNA	I-NP	NN	I-RNA	5	OBJ
8	but	but	O	CC	O	3	VMOD
9	augment	augment	B-VP	VBP	O	3	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	level	level	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	c-fos	c-fos	B-NP	NN	B-RNA	14	NMOD
14	mRNA	mRNA	I-NP	NN	I-RNA	12	PMOD
15	in	in	B-PP	IN	O	11	NMOD
16	PHA-activated	PHA-activated	B-NP	JJ	B-cell_type	18	NMOD
17	T	T	I-NP	NN	I-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
19	by	by	B-PP	IN	O	9	VMOD
20	3-	3-	B-NP	CD	O	19	PMOD
21	to	to	B-PP	TO	O	20	NMOD
22	10-fold	10-fold	B-NP	RB	O	20	NMOD
23	.	.	O	.	O	3	P

1	Gel-shift	Gel-shift	B-NP	JJ	O	2	NMOD
2	analysis	analysis	I-NP	NN	O	3	SUB
3	reveals	reveal	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	constitutive	constitutive	I-NP	JJ	O	6	NMOD
6	presence	presence	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD
9	factors	factor	I-NP	NNS	I-protein	7	PMOD
10	in	in	B-PP	IN	O	6	NMOD
11	resting	rest	B-VP	VBG	B-cell_type	12	NMOD
12	PBL	PBL	B-NP	NN	I-cell_type	10	PMOD
13	that	that	B-NP	WDT	O	25	DEP
14	bind	bind	B-VP	VBP	O	13	SBAR
15	to	to	B-PP	TO	O	14	VMOD
16	the	the	B-NP	DT	O	19	NMOD
17	proximal	proximal	I-NP	JJ	B-DNA	19	NMOD
18	AP-1	AP-1	I-NP	NN	I-DNA	19	NMOD
19	site	site	I-NP	NN	I-DNA	15	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	IL-2	IL-2	I-NP	NN	B-DNA	23	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	20	PMOD
24	and	and	O	CC	O	25	DEP
25	that	that	B-NP	WDT	O	6	NMOD
26	contain	contain	B-VP	VBP	O	25	SBAR
27	immunoreactive	immunoreactive	B-NP	JJ	O	32	NMOD
28	c-Jun	c-Jun	I-NP	NN	B-protein	32	NMOD
29	but	but	B-NP	CC	O	32	NMOD
30	not	not	I-NP	RB	O	29	DEP
31	c-Fos	c-Fos	B-NP	NN	B-protein	32	NMOD
32	protein	protein	I-NP	NN	I-protein	26	OBJ
33	.	.	O	.	O	3	P

1	Levels	Level	B-NP	NNS	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	other	other	B-NP	JJ	O	5	NMOD
4	nuclear	nuclear	I-NP	JJ	B-protein	5	NMOD
5	factors	factor	I-NP	NNS	I-protein	2	PMOD
6	involved	involve	B-VP	VBN	O	5	NMOD
7	in	in	B-PP	IN	O	6	VMOD
8	IL-2	IL-2	B-NP	NN	B-protein	9	NMOD
9	regulation	regulation	I-NP	NN	O	7	PMOD
10	were	be	B-VP	VBD	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	altered	alter	I-VP	VBN	O	10	VC
13	by	by	B-PP	IN	O	12	VMOD
14	EC	EC	B-NP	NN	B-cell_type	13	PMOD
15	,	,	O	,	O	12	P
16	although	although	B-SBAR	IN	O	12	VMOD
17	NFAT-DNA	NFAT-DNA	B-NP	NN	B-protein	18	NMOD
18	complexes	complex	I-NP	NNS	I-protein	19	SUB
19	migrated	migrate	B-VP	VBD	O	16	SBAR
20	at	at	B-PP	IN	O	19	VMOD
21	a	a	B-NP	DT	O	24	NMOD
22	slightly	slightly	I-NP	RB	O	23	AMOD
23	different	different	I-NP	JJ	O	24	NMOD
24	mobility	mobility	I-NP	NN	O	20	PMOD
25	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	composition	composition	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-AT	NF-AT	B-NP	NN	B-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	3	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	still	still	B-ADVP	RB	O	6	VMOD
8	not	not	O	RB	O	6	VMOD
9	fully	fully	B-ADJP	RB	O	8	AMOD
10	elucidated	elucidate	I-ADJP	VBN	O	6	VC
11	.	.	O	.	O	6	P

1	There	There	B-NP	EX	O	2	SUB
2	was	be	B-VP	VBD	O	24	VMOD
3	no	no	B-NP	DT	O	5	NMOD
4	detectable	detectable	I-NP	JJ	O	5	NMOD
5	binding	binding	I-NP	NN	O	2	PRD
6	of	of	B-PP	IN	O	5	NMOD
7	in	in	B-ADVP	FW	O	11	NMOD
8	vitro	vitro	I-ADVP	FW	O	7	AMOD
9	translated	translate	B-NP	VBN	O	7	AMOD
10	Jun/Fos	Jun/Fos	I-NP	NN	B-protein	11	NMOD
11	heterodimer	heterodimer	I-NP	NN	I-protein	6	PMOD
12	(	(	O	(	O	14	DEP
13	AP-1	AP-1	B-NP	NN	B-protein	14	DEP
14	)	)	O	)	O	11	NMOD
15	to	to	B-PP	TO	O	5	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	NF-AT	NF-AT	I-NP	NN	B-DNA	18	NMOD
18	sequence	sequence	I-NP	NN	I-DNA	15	PMOD
19	,	,	O	,	O	24	P
20	and	and	O	CC	O	24	VMOD
21	the	the	B-NP	DT	O	23	NMOD
22	NF-AT	NF-AT	I-NP	NN	B-DNA	23	NMOD
23	sequence	sequence	I-NP	NN	I-DNA	24	SUB
24	was	be	B-VP	VBD	O	0	ROOT
25	unable	unable	B-ADJP	JJ	O	24	PRD
26	to	to	B-VP	TO	O	27	VMOD
27	inhibit	inhibit	I-VP	VB	O	25	AMOD
28	the	the	B-NP	DT	O	29	NMOD
29	binding	binding	I-NP	NN	O	27	OBJ
30	of	of	B-PP	IN	O	29	NMOD
31	Jun/Fos	Jun/Fos	B-NP	NN	B-protein	30	PMOD
32	to	to	B-PP	TO	O	29	NMOD
33	the	the	B-NP	DT	O	35	NMOD
34	AP-1	AP-1	I-NP	NN	B-DNA	35	NMOD
35	sequence	sequence	I-NP	NN	I-DNA	32	PMOD
36	.	.	O	.	O	24	P

1	In	In	B-PP	IN	O	10	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	U-937	U-937	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	10	SUB
6	induced	induce	B-VP	VBN	O	5	NMOD
7	by	by	B-PP	IN	O	6	VMOD
8	RA	RA	B-NP	NN	O	7	PMOD
9	strongly	strongly	B-ADVP	RB	O	10	VMOD
10	increased	increase	B-VP	VBD	O	19	VMOD
11	their	their	B-NP	PRP$	O	12	NMOD
12	expression	expression	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	CD23	CD23	B-NP	NN	B-RNA	15	NMOD
15	mRNA	mRNA	I-NP	NN	I-RNA	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	protein	protein	B-NP	NN	O	13	PMOD
18	,	,	O	,	O	19	P
19	whereas	whereas	O	IN	O	0	ROOT
20	they	they	B-NP	PRP	O	22	SUB
21	completely	completely	B-ADVP	RB	O	22	VMOD
22	lacked	lack	B-VP	VBD	O	19	VMOD
23	detectable	detectable	B-NP	JJ	O	26	NMOD
24	CD14	CD14	I-NP	NN	O	26	NMOD
25	cell	cell	I-NP	NN	O	26	NMOD
26	surface	surface	I-NP	NN	O	29	NMOD
27	or	or	O	CC	O	29	NMOD
28	mRNA	mRNA	B-NP	NN	O	29	NMOD
29	expression	expression	I-NP	NN	O	22	OBJ
30	.	.	O	.	O	19	P

1	No	No	B-NP	DT	O	3	NMOD
2	lytic	lytic	I-NP	JJ	O	3	NMOD
3	effect	effect	I-NP	NN	O	8	SUB
4	on	on	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	reporter	reporter	I-NP	NN	O	7	NMOD
7	cells	cell	I-NP	NNS	O	4	PMOD
8	could	could	B-VP	MD	O	0	ROOT
9	be	be	I-VP	VB	O	8	VC
10	measured	measure	I-VP	VBN	O	9	VC
11	,	,	O	,	O	10	P
12	neither	neither	B-PP	CC	O	10	VMOD
13	by	by	B-PP	IN	O	12	PMOD
14	cocultivation	cocultivation	B-NP	NN	O	13	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	activator	activator	B-NP	NN	B-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	15	PMOD
18	nor	nor	B-PP	CC	O	12	PMOD
19	by	by	B-PP	IN	O	12	PMOD
20	coincubation	coincubation	B-NP	NN	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	BZLF	BZLF	B-NP	NN	B-protein	25	NMOD
23	1-containing	1-containing	I-NP	JJ	O	22	AMOD
24	cell	cell	I-NP	NN	O	25	NMOD
25	lysates	lysate	I-NP	NNS	O	21	PMOD
26	.	.	O	.	O	8	P

1	Negative	Negative	B-NP	JJ	O	3	NMOD
2	transcriptional	transcriptional	I-NP	JJ	O	3	NMOD
3	regulation	regulation	I-NP	NN	O	0	ROOT
4	of	of	B-PP	IN	O	3	NMOD
5	human	human	B-NP	JJ	B-DNA	11	NMOD
6	interleukin	interleukin	I-NP	NN	I-DNA	11	NMOD
7	2	2	I-NP	CD	I-DNA	6	NMOD
8	(	(	O	(	I-DNA	10	DEP
9	IL-2	IL-2	B-NP	NN	I-DNA	10	DEP
10	)	)	O	)	I-DNA	7	NMOD
11	gene	gene	B-NP	NN	I-DNA	4	PMOD
12	by	by	B-PP	IN	O	3	NMOD
13	glucocorticoids	glucocorticoid	B-NP	NNS	O	12	PMOD
14	through	through	B-PP	IN	O	3	NMOD
15	interference	interference	B-NP	NN	O	14	PMOD
16	with	with	B-PP	IN	O	15	NMOD
17	nuclear	nuclear	B-NP	JJ	B-protein	19	NMOD
18	transcription	transcription	I-NP	NN	I-protein	19	NMOD
19	factors	factor	I-NP	NNS	I-protein	16	PMOD
20	AP-1	AP-1	B-NP	NN	B-protein	22	NMOD
21	and	and	O	CC	O	22	NMOD
22	NF-AT	NF-AT	B-NP	NN	B-protein	19	NMOD
23	.	.	O	.	O	3	P

1	Both	Both	O	CC	O	4	NMOD
2	Dex	Dex	B-NP	NN	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	CsA	CsA	I-NP	NN	O	5	SUB
5	inhibited	inhibit	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	7	NMOD
7	binding	binding	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	transcription	transcription	B-NP	NN	B-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	8	PMOD
11	AP-1	AP-1	B-NP	NN	B-protein	13	NMOD
12	and	and	O	CC	O	13	NMOD
13	NF-AT	NF-AT	B-NP	NN	B-protein	10	NMOD
14	,	,	B-PP	,	O	8	P
15	but	but	I-PP	CC	O	8	PMOD
16	not	not	B-PP	RB	O	17	PMOD
17	of	of	I-PP	IN	O	8	PMOD
18	NF-kB	NF-kB	B-NP	NN	B-protein	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	OCT-1/OAF	OCT-1/OAF	I-NP	NN	B-protein	17	PMOD
21	,	,	O	,	O	5	P
22	to	to	B-PP	TO	O	5	VMOD
23	their	their	B-NP	PRP$	O	25	NMOD
24	corresponding	correspond	I-NP	VBG	O	25	NMOD
25	sites	site	I-NP	NNS	O	22	PMOD
26	on	on	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	30	NMOD
28	IL-2	IL-2	I-NP	NN	B-DNA	30	NMOD
29	gene	gene	I-NP	NN	I-DNA	30	NMOD
30	promoter	promoter	I-NP	NN	I-DNA	26	PMOD
31	.	.	O	.	O	5	P

1	Dex	Dex	B-NP	NN	O	2	SUB
2	inhibited	inhibit	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	IL-2	IL-2	I-NP	NN	B-DNA	5	NMOD
5	promoter	promoter	I-NP	NN	I-DNA	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	AP-1	AP-1	I-NP	NN	B-protein	15	NMOD
9	,	,	O	,	O	15	P
10	but	but	B-CONJP	CC	O	15	NMOD
11	not	not	I-CONJP	RB	O	10	DEP
12	the	the	B-NP	DT	O	15	NMOD
13	NF-AT	NF-AT	I-NP	NN	B-protein	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	NF-kB	NF-kB	I-NP	NN	B-DNA	16	NMOD
16	plasmids	plasmid	I-NP	NNS	I-DNA	2	OBJ
17	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	5	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	CsA	CsA	B-NP	NN	O	5	SUB
5	inhibited	inhibit	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	8	NMOD
7	IL-2	IL-2	I-NP	NN	B-DNA	8	NMOD
8	promoter	promoter	I-NP	NN	I-DNA	11	NMOD
9	and	and	O	CC	O	11	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	NF-AT	NF-AT	I-NP	NN	B-protein	18	NMOD
12	,	,	O	,	O	18	P
13	but	but	B-CONJP	CC	O	18	NMOD
14	not	not	I-CONJP	RB	O	13	DEP
15	the	the	B-NP	DT	O	18	NMOD
16	AP-1	AP-1	I-NP	NN	B-protein	18	NMOD
17	and	and	I-NP	CC	O	18	NMOD
18	NF-kB	NF-kB	I-NP	NN	B-DNA	19	NMOD
19	plasmids	plasmid	I-NP	NNS	I-DNA	5	OBJ
20	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	expression	expression	I-NP	NN	O	25	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	hGATA-3	hGATA-3	B-NP	NN	B-protein	9	NMOD
5	,	,	O	,	O	9	P
6	a	a	B-NP	DT	O	9	NMOD
7	T	T	I-NP	NN	B-protein	9	NMOD
8	cell-specific	cell-specific	I-NP	JJ	I-protein	7	AMOD
9	factor	factor	I-NP	NN	I-protein	3	PMOD
10	known	know	B-VP	VBN	O	9	NMOD
11	to	to	I-VP	TO	O	12	VMOD
12	be	be	I-VP	VB	O	10	VMOD
13	involved	involve	I-VP	VBN	O	12	VC
14	in	in	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	regulation	regulation	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	transcription	transcription	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	TcR	TcR	B-NP	NN	B-DNA	23	NMOD
22	delta	delta	I-NP	NN	I-DNA	23	NMOD
23	locus	locus	I-NP	NN	I-DNA	20	PMOD
24	,	,	O	,	O	2	P
25	was	be	B-VP	VBD	O	0	ROOT
26	analyzed	analyze	I-VP	VBN	O	25	VC
27	by	by	B-PP	IN	O	26	VMOD
28	Northern	Northern	B-NP	NN	O	29	NMOD
29	blot	blot	I-NP	NN	O	27	PMOD
30	,	,	O	,	O	26	P
31	in	in	B-PP	IN	O	26	VMOD
32	cultured	culture	B-NP	VBN	B-cell_line	35	NMOD
33	NK	NK	I-NP	NN	I-cell_line	35	NMOD
34	cell	cell	I-NP	NN	I-cell_line	35	NMOD
35	population	population	I-NP	NN	I-cell_line	31	PMOD
36	and	and	O	CC	O	37	NMOD
37	clones	clone	B-NP	NNS	O	35	NMOD
38	(	(	O	(	O	46	DEP
39	but	but	B-PP	CC	O	46	DEP
40	not	not	B-PP	RB	O	41	PMOD
41	in	in	I-PP	IN	O	46	DEP
42	freshly	freshly	B-NP	RB	O	43	AMOD
43	derived	derive	I-NP	VBN	O	45	NMOD
44	cell	cell	I-NP	NN	O	45	NMOD
45	populations	population	I-NP	NNS	O	41	PMOD
46	)	)	O	)	O	35	NMOD
47	.	.	O	.	O	25	P

1	Finally	Finally	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	no	no	B-NP	DT	O	4	NMOD
4	transcription	transcription	I-NP	NN	O	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	RAG-1	RAG-1	I-NP	NN	B-DNA	8	NMOD
8	gene	gene	I-NP	NN	I-DNA	5	PMOD
9	could	could	B-VP	MD	O	0	ROOT
10	be	be	I-VP	VB	O	9	VC
11	detected	detect	I-VP	VBN	O	10	VC
12	in	in	B-PP	IN	O	11	VMOD
13	all	all	B-NP	DT	O	18	NMOD
14	NK	NK	I-NP	NN	B-cell_line	16	NMOD
15	cell	cell	I-NP	NN	I-cell_line	16	NMOD
16	lines	line	I-NP	NNS	I-cell_line	18	NMOD
17	or	or	O	CC	O	18	NMOD
18	clones	clone	B-NP	NNS	O	12	PMOD
19	analyzed	analyze	B-VP	VBN	O	18	NMOD
20	.	.	O	.	O	9	P

1	To	To	B-VP	TO	O	2	VMOD
2	determine	determine	I-VP	VB	O	23	VMOD
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	Nef	Nef	B-NP	NN	B-protein	5	SUB
5	affects	affect	B-VP	VBZ	O	3	SBAR
6	the	the	B-NP	DT	O	7	NMOD
7	binding	binding	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	cellular	cellular	B-NP	JJ	B-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	8	PMOD
11	implicated	implicate	B-VP	VBN	O	7	NMOD
12	in	in	B-PP	IN	O	11	VMOD
13	HIV-1	HIV-1	B-NP	NN	O	14	NMOD
14	regulation	regulation	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	23	P
16	32P-labeled	32P-labeled	B-NP	JJ	O	17	NMOD
17	oligonucleotides	oligonucleotide	I-NP	NNS	O	23	SUB
18	corresponding	correspond	B-VP	VBG	O	17	NMOD
19	to	to	B-PP	TO	O	18	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	binding	bind	I-NP	VBG	B-DNA	22	NMOD
22	sites	site	I-NP	NNS	I-DNA	19	PMOD
23	were	be	B-VP	VBD	O	0	ROOT
24	incubated	incubate	I-VP	VBN	O	23	VC
25	with	with	B-PP	IN	O	24	VMOD
26	nuclear	nuclear	B-NP	JJ	O	27	NMOD
27	extracts	extract	I-NP	NNS	O	25	PMOD
28	prepared	prepare	B-VP	VBN	O	27	NMOD
29	from	from	B-PP	IN	O	28	VMOD
30	Nef-expressing	Nef-expressing	B-NP	JJ	B-cell_line	32	NMOD
31	T-cell	T-cell	I-NP	NN	I-cell_line	32	NMOD
32	lines	line	I-NP	NNS	I-cell_line	29	PMOD
33	that	that	B-NP	WDT	O	32	NMOD
34	were	be	B-VP	VBD	O	33	SBAR
35	not	not	I-VP	RB	O	34	VMOD
36	stimulated	stimulate	I-VP	VBN	O	34	VC
37	or	or	O	CC	O	34	VMOD
38	were	be	B-VP	VBD	O	34	VMOD
39	stimulated	stimulate	I-VP	VBN	O	38	VC
40	with	with	B-PP	IN	O	39	VMOD
41	T-cell	T-cell	B-NP	NN	B-protein	42	NMOD
42	mitogens	mitogen	I-NP	NNS	I-protein	40	PMOD
43	.	.	O	.	O	23	P

1	Mitogen-mediated	Mitogen-mediated	B-NP	JJ	O	3	NMOD
2	transcriptional	transcriptional	I-NP	JJ	O	3	NMOD
3	activation	activation	I-NP	NN	O	11	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	CAT	CAT	I-NP	NN	B-DNA	7	NMOD
7	gene	gene	I-NP	NN	I-DNA	4	PMOD
8	in	in	B-PP	IN	O	3	NMOD
9	this	this	B-NP	DT	O	10	NMOD
10	construct	construct	I-NP	NN	O	8	PMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	inhibited	inhibit	I-VP	VBN	O	11	VC
13	in	in	B-PP	IN	O	12	VMOD
14	Nef-expressing	Nef-expressing	B-NP	JJ	B-cell_line	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
16	but	but	B-PP	CC	O	13	PMOD
17	not	not	B-PP	RB	O	18	PMOD
18	in	in	I-PP	IN	O	13	PMOD
19	control	control	B-NP	NN	B-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	18	PMOD
21	.	.	O	.	O	11	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	can	can	B-VP	MD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	be	be	I-VP	VB	O	3	VC
6	explained	explain	I-VP	VBN	O	5	VC
7	by	by	B-PP	IN	O	6	VMOD
8	receptor	receptor	B-NP	NN	O	9	NMOD
9	down-regulation	down-regulation	I-NP	NN	O	7	PMOD
10	due	due	B-ADJP	JJ	O	11	PMOD
11	to	to	B-PP	TO	O	9	NMOD
12	higher	high	B-NP	JJR	O	13	NMOD
13	level	level	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	mineralocorticoids	mineralocorticoid	B-NP	NNS	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	zona	zona	I-NP	NN	O	19	NMOD
19	glomerulosa	glomerulosa	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	hypertension	hypertension	B-NP	NN	O	9	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	preeclamptic	preeclamptic	B-NP	JJ	O	8	NMOD
8	women	woman	I-NP	NNS	O	6	PMOD
9	can	can	B-VP	MD	O	4	SBAR
10	be	be	I-VP	VB	O	9	VC
11	treated	treat	I-VP	VBN	O	10	VC
12	by	by	B-PP	IN	O	11	VMOD
13	Urapidil	Urapidil	B-NP	NN	O	12	PMOD
14	without	without	B-PP	IN	O	11	VMOD
15	side	side	B-NP	JJ	O	16	NMOD
16	effects	effect	I-NP	NNS	O	18	NMOD
17	or	or	O	CC	O	18	NMOD
18	reflex-tachycardia	reflex-tachycardia	B-NP	NN	O	14	PMOD
19	.	.	O	.	O	3	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	19	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	extrarenal	extrarenal	B-NP	JJ	B-cell_type	6	AMOD
5	,	,	I-NP	,	I-cell_type	6	P
6	non-epithelial	non-epithelial	I-NP	JJ	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
8	such	such	B-PP	JJ	O	9	PMOD
9	as	as	I-PP	IN	O	7	NMOD
10	smooth	smooth	B-NP	JJ	B-cell_type	12	NMOD
11	muscle	muscle	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	18	NMOD
13	and	and	O	CC	O	18	NMOD
14	more	more	B-ADVP	RBR	O	15	AMOD
15	recently	recently	I-ADVP	RB	O	18	NMOD
16	circulating	circulate	B-VP	VBG	B-cell_type	18	NMOD
17	human	human	B-NP	JJ	I-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
19	have	have	B-VP	VBP	O	0	ROOT
20	provided	provide	I-VP	VBN	O	19	VC
21	increasing	increase	B-NP	VBG	O	22	NMOD
22	evidence	evidence	I-NP	NN	O	20	OBJ
23	that	that	B-SBAR	IN	O	22	NMOD
24	aldosterone	aldosterone	B-NP	NN	O	25	SUB
25	produces	produce	B-VP	VBZ	O	23	SBAR
26	not	not	B-CONJP	RB	O	37	NMOD
27	only	only	I-CONJP	RB	O	26	DEP
28	classical	classical	B-NP	JJ	O	30	NMOD
29	genomic	genomic	I-NP	JJ	O	30	NMOD
30	effects	effect	I-NP	NNS	O	37	NMOD
31	,	,	O	,	O	37	P
32	but	but	B-CONJP	CC	O	37	NMOD
33	also	also	I-CONJP	RB	O	32	DEP
34	rapid	rapid	B-NP	JJ	O	36	AMOD
35	,	,	I-NP	,	O	36	P
36	non-genomic	non-genomic	I-NP	JJ	O	37	NMOD
37	effects	effect	I-NP	NNS	O	25	OBJ
38	on	on	B-PP	IN	O	37	NMOD
39	transmembrane	transmembrane	B-NP	NN	O	41	NMOD
40	electrolyte	electrolyte	I-NP	NN	O	41	NMOD
41	movements	movement	I-NP	NNS	O	38	PMOD
42	.	.	O	.	O	19	P

1	Such	Such	B-NP	JJ	O	2	NMOD
2	changes	change	I-NP	NNS	O	4	SUB
3	clearly	clearly	B-ADVP	RB	O	4	VMOD
4	can	can	B-VP	MD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	be	be	I-VP	VB	O	4	VC
7	explained	explain	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	genomic	genomic	B-NP	JJ	O	10	NMOD
10	mechanisms	mechanism	I-NP	NNS	O	8	PMOD
11	,	,	O	,	O	10	P
12	which	which	B-NP	WDT	O	10	NMOD
13	are	be	B-VP	VBP	O	12	SBAR
14	responsible	responsible	B-ADJP	JJ	O	13	PRD
15	for	for	B-PP	IN	O	14	AMOD
16	later	later	B-NP	JJ	O	17	NMOD
17	effects	effect	I-NP	NNS	O	15	PMOD
18	than	than	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	23	NMOD
20	membrane	membrane	I-NP	NN	O	21	AMOD
21	related	related	I-NP	JJ	O	23	NMOD
22	rapid	rapid	I-NP	JJ	O	23	NMOD
23	responses	response	I-NP	NNS	O	18	PMOD
24	.	.	O	.	O	4	P

1	IFN-MCP	IFN-MCP	B-NP	NN	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	inhibited	inhibit	I-VP	VBN	O	2	VC
5	by	by	B-PP	IN	O	4	VMOD
6	infection	infection	B-NP	NN	O	5	PMOD
7	with	with	B-PP	IN	O	6	NMOD
8	dl343	dl343	B-NP	NN	O	7	PMOD
9	,	,	O	,	O	4	P
10	despite	despite	B-PP	IN	O	4	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	production	production	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	large	large	B-NP	JJ	O	15	NMOD
15	amounts	amount	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	both	both	O	CC	O	30	NMOD
18	early	early	B-ADVP	JJ	O	30	NMOD
19	(	(	O	(	O	23	DEP
20	E1B	E1B	B-NP	NN	B-protein	22	NMOD
21	,	,	O	,	O	22	P
22	p55	p55	B-NP	NN	B-protein	23	DEP
23	)	)	O	)	O	18	NMOD
24	and	and	O	CC	O	30	NMOD
25	late	late	B-NP	JJ	O	30	NMOD
26	(	(	I-NP	(	O	28	DEP
27	hexon	hexon	I-NP	NN	O	28	DEP
28	)	)	O	)	O	25	NMOD
29	Ad	Ad	B-NP	NN	B-protein	30	NMOD
30	proteins	protein	I-NP	NNS	I-protein	16	PMOD
31	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	11	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	1	PMOD
4	E1A-negative	E1A-negative	B-NP	JJ	B-cell_line	6	AMOD
5	,	,	I-NP	,	I-cell_line	6	P
6	parental	parental	I-NP	JJ	I-cell_line	8	NMOD
7	cell	cell	I-NP	NN	I-cell_line	8	NMOD
8	lines	line	I-NP	NNS	I-cell_line	1	PMOD
9	,	,	O	,	O	11	P
10	IFN-MCP	IFN-MCP	B-NP	NN	O	11	SUB
11	was	be	B-VP	VBD	O	0	ROOT
12	blocked	block	I-VP	VBN	O	11	VC
13	in	in	B-PP	IN	O	12	VMOD
14	Ad5	Ad5	B-NP	NN	O	20	NMOD
15	E1A-transfected	E1A-transfected	I-NP	JJ	O	14	AMOD
16	epithelial	epithelial	I-NP	JJ	O	18	AMOD
17	and	and	I-NP	CC	O	18	AMOD
18	fibroblastic	fibroblastic	I-NP	JJ	B-cell_line	20	NMOD
19	cell	cell	I-NP	NN	I-cell_line	20	NMOD
20	lines	line	I-NP	NNS	I-cell_line	13	PMOD
21	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	21	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	type	type	I-NP	NN	B-protein	7	NMOD
6	I	I	I-NP	CD	I-protein	7	NMOD
7	receptor	receptor	I-NP	NN	I-protein	3	PMOD
8	,	,	O	,	O	21	P
9	the	the	B-NP	DT	O	12	NMOD
10	type	type	I-NP	NN	B-protein	12	NMOD
11	II	II	I-NP	CD	I-protein	12	NMOD
12	IL-1R	IL-1R	I-NP	NN	I-protein	13	SUB
13	has	have	B-VP	VBZ	O	21	VMOD
14	a	a	B-NP	DT	O	17	NMOD
15	small	small	I-NP	JJ	O	17	NMOD
16	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	17	NMOD
17	tail	tail	I-NP	NN	I-protein	13	OBJ
18	,	,	O	,	O	21	P
19	and	and	O	CC	O	21	VMOD
20	it	it	B-NP	PRP	O	21	SUB
21	is	be	B-VP	VBZ	O	0	ROOT
22	not	not	O	RB	O	21	VMOD
23	clear	clear	B-ADJP	JJ	O	21	PRD
24	whether	whether	B-SBAR	IN	O	21	VMOD
25	this	this	B-NP	DT	O	26	NMOD
26	receptor	receptor	I-NP	NN	O	27	SUB
27	is	be	B-VP	VBZ	O	24	SBAR
28	a	a	B-NP	DT	O	29	NMOD
29	signal-transducing	signal-transducing	I-NP	JJ	B-protein	33	NMOD
30	or	or	O	CC	O	33	NMOD
31	a	a	B-NP	DT	O	33	NMOD
32	regulatory	regulatory	I-NP	JJ	B-protein	33	NMOD
33	molecule	molecule	I-NP	NN	I-protein	27	PRD
34	.	.	O	.	O	21	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	report	report	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	type	type	I-NP	NN	B-protein	8	NMOD
7	II	II	I-NP	CD	I-protein	8	NMOD
8	IL-1R	IL-1R	I-NP	NN	I-protein	9	SUB
9	does	do	B-VP	VBZ	O	4	SBAR
10	not	not	I-VP	RB	O	9	VMOD
11	mediate	mediate	I-VP	VB	O	9	VC
12	gene	gene	B-NP	NN	O	13	NMOD
13	activation	activation	I-NP	NN	O	11	OBJ
14	in	in	B-PP	IN	O	13	NMOD
15	Jurkat	Jurkat	B-NP	NN	B-cell_line	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
17	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	precise	precise	I-NP	JJ	O	4	NMOD
3	molecular	molecular	I-NP	JJ	O	4	NMOD
4	abnormalities	abnormality	I-NP	NNS	O	10	SUB
5	that	that	B-NP	WDT	O	4	NMOD
6	cause	cause	B-VP	VBP	O	5	SBAR
7	primary	primary	B-NP	JJ	O	9	NMOD
8	cortisol	cortisol	I-NP	NN	O	9	NMOD
9	resistance	resistance	I-NP	NN	O	6	OBJ
10	have	have	B-VP	VBP	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	been	be	I-VP	VBN	O	10	VC
13	completely	completely	B-ADJP	RB	O	14	VMOD
14	described	describe	I-ADJP	VBN	O	12	VC
15	.	.	O	.	O	10	P

1	Cells	Cell	B-NP	NNS	O	5	SUB
2	from	from	B-PP	IN	O	1	NMOD
3	TNFRp55-/-mutant	TNFRp55-/-mutant	B-NP	JJ	O	4	NMOD
4	mice	mouse	I-NP	NNS	O	2	PMOD
5	lack	lack	B-VP	VBP	O	0	ROOT
6	expression	expression	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	TNFRp55	TNFRp55	B-NP	NN	B-protein	7	PMOD
9	but	but	O	CC	O	5	VMOD
10	display	display	B-VP	VBP	O	5	VMOD
11	normal	normal	B-NP	JJ	O	12	NMOD
12	numbers	number	I-NP	NNS	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	high	high	B-NP	JJ	B-protein	17	NMOD
15	affinity	affinity	I-NP	NN	I-protein	17	NMOD
16	TNFRp75	TNFRp75	I-NP	NN	I-protein	17	NMOD
17	molecules	molecule	I-NP	NNS	I-protein	13	PMOD
18	.	.	O	.	O	5	P

1	Thymocyte	Thymocyte	B-NP	NN	B-cell_type	2	NMOD
2	development	development	I-NP	NN	O	5	NMOD
3	and	and	O	CC	O	5	NMOD
4	lymphocyte	lymphocyte	B-NP	NN	B-cell_type	5	NMOD
5	populations	population	I-NP	NNS	I-cell_type	6	SUB
6	are	be	B-VP	VBP	O	17	VMOD
7	unaltered	unaltered	B-ADJP	JJ	O	6	PRD
8	,	,	O	,	O	17	P
9	and	and	O	CC	O	17	VMOD
10	clonal	clonal	B-NP	JJ	O	11	NMOD
11	deletion	deletion	I-NP	NN	O	17	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	potentially	potentially	B-NP	RB	O	14	AMOD
14	self-reactive	self-reactive	I-NP	JJ	B-cell_type	16	NMOD
15	T	T	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
17	is	be	B-VP	VBZ	O	0	ROOT
18	not	not	O	RB	O	17	VMOD
19	impaired	impaired	B-ADJP	JJ	O	17	PRD
20	.	.	O	.	O	17	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	TNF	TNF	B-NP	NN	B-protein	4	NMOD
4	signaling	signaling	I-NP	NN	O	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	largely	largely	I-VP	RB	O	5	VMOD
7	abolished	abolish	I-VP	VBN	O	5	VC
8	,	,	O	,	O	7	P
9	as	as	B-SBAR	IN	O	7	VMOD
10	judged	judge	B-VP	VBN	O	9	SBAR
11	by	by	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	failure	failure	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	TNF	TNF	B-NP	NN	B-protein	14	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	induce	induce	I-VP	VB	O	13	NMOD
18	NF-kappa	NF-kappa	B-NP	NN	B-protein	19	NMOD
19	B	B	I-NP	NN	I-protein	17	OBJ
20	in	in	B-PP	IN	O	17	VMOD
21	T	T	B-NP	NN	B-cell_type	22	NMOD
22	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	20	PMOD
23	from	from	B-PP	IN	O	22	NMOD
24	TNFRp55-deficient	TNFRp55-deficient	B-NP	JJ	O	25	NMOD
25	mice	mouse	I-NP	NNS	O	23	PMOD
26	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	cDNA	cDNA	I-NP	NN	B-DNA	3	SUB
3	hybridized	hybridize	B-VP	VBD	O	15	VMOD
4	to	to	B-PP	TO	O	3	VMOD
5	multiple	multiple	B-NP	JJ	O	6	NMOD
6	transcripts	transcript	I-NP	NNS	O	4	PMOD
7	in	in	B-PP	IN	O	3	VMOD
8	pre-B	pre-B	B-NP	NN	B-cell_line	11	NMOD
9	and	and	O	CC	I-cell_line	11	NMOD
10	B-cell	B-cell	B-NP	NN	I-cell_line	11	NMOD
11	lines	line	I-NP	NNS	I-cell_line	7	PMOD
12	,	,	O	,	O	15	P
13	but	but	O	CC	O	15	VMOD
14	transcripts	transcript	B-NP	NNS	O	15	SUB
15	were	be	B-VP	VBD	O	0	ROOT
16	not	not	I-VP	RB	O	15	VMOD
17	detected	detect	I-VP	VBN	O	15	VC
18	at	at	B-PP	IN	O	17	VMOD
19	significant	significant	B-NP	JJ	O	20	NMOD
20	levels	level	I-NP	NNS	O	18	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	plasmacytoma	plasmacytoma	B-NP	NN	B-cell_line	29	NMOD
23	,	,	O	,	O	22	P
24	T-cell	T-cell	B-NP	NN	B-cell_type	22	DEP
25	,	,	O	,	O	22	P
26	and	and	O	CC	O	22	DEP
27	nonlymphoid	nonlymphoid	B-NP	JJ	B-cell_line	22	DEP
28	cell	cell	I-NP	NN	I-cell_line	29	NMOD
29	lines	line	I-NP	NNS	I-cell_line	21	PMOD
30	.	.	O	.	O	15	P

1	Analysis	Analysis	B-NP	NN	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	DNA	DNA	B-NP	NN	O	4	NMOD
4	binding	binding	I-NP	NN	O	2	PMOD
5	by	by	B-PP	IN	O	4	NMOD
6	deletion	deletion	B-NP	NN	O	7	NMOD
7	mutants	mutant	I-NP	NNS	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	EBF	EBF	B-NP	NN	B-protein	8	PMOD
10	identified	identify	B-VP	VBD	O	0	ROOT
11	an	an	B-NP	DT	O	15	NMOD
12	amino-terminal	amino-terminal	I-NP	JJ	B-protein	15	NMOD
13	cysteine-rich	cysteine-rich	I-NP	JJ	I-protein	15	NMOD
14	DNA-binding	DNA-binding	I-NP	JJ	I-protein	15	NMOD
15	domain	domain	I-NP	NN	I-protein	10	OBJ
16	lacking	lack	B-VP	VBG	O	15	NMOD
17	obvious	obvious	B-NP	JJ	O	19	NMOD
18	sequence	sequence	I-NP	NN	O	19	NMOD
19	similarity	similarity	I-NP	NN	O	16	OBJ
20	to	to	B-PP	TO	O	19	NMOD
21	known	know	B-NP	VBN	O	23	NMOD
22	transcription	transcription	I-NP	NN	B-protein	23	NMOD
23	factors	factor	I-NP	NNS	I-protein	20	PMOD
24	.	.	O	.	O	10	P

1	However	However	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	the	the	B-NP	DT	O	5	NMOD
4	molecular	molecular	I-NP	JJ	O	5	NMOD
5	basis	basis	I-NP	NN	O	15	SUB
6	for	for	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	commitment	commitment	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	progenitors	progenitor	B-NP	NNS	B-cell_type	9	PMOD
11	to	to	B-PP	TO	O	8	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	eosinophil	eosinophil	I-NP	NN	B-cell_type	14	NMOD
14	lineage	lineage	I-NP	NN	I-cell_type	11	PMOD
15	has	have	B-VP	VBZ	O	0	ROOT
16	not	not	I-VP	RB	O	15	VMOD
17	been	be	I-VP	VBN	O	15	VC
18	determined	determine	I-VP	VBN	O	17	VC
19	.	.	O	.	O	15	P

1	Elf-1	Elf-1	B-NP	NN	B-protein	2	SUB
2	binds	bind	B-VP	VBZ	O	0	ROOT
3	exclusively	exclusively	B-ADVP	RB	O	2	VMOD
4	to	to	B-PP	TO	O	2	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	underphosphorylated	underphosphorylated	I-NP	JJ	O	7	NMOD
7	form	form	I-NP	NN	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	Rb	Rb	B-NP	NN	B-protein	8	PMOD
10	and	and	O	CC	O	2	VMOD
11	fails	fail	B-VP	VBZ	O	2	VMOD
12	to	to	I-VP	TO	O	13	VMOD
13	bind	bind	I-VP	VB	O	11	VMOD
14	to	to	B-PP	TO	O	13	VMOD
15	Rb	Rb	B-NP	NN	B-protein	16	NMOD
16	mutants	mutant	I-NP	NNS	I-protein	14	PMOD
17	derived	derive	B-VP	VBN	O	16	NMOD
18	from	from	B-PP	IN	O	17	VMOD
19	patients	patient	B-NP	NNS	O	18	PMOD
20	with	with	B-PP	IN	O	19	NMOD
21	retinoblastoma	retinoblastoma	B-NP	NN	O	20	PMOD
22	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	9	NMOD
2	potent	potent	I-NP	JJ	O	9	NMOD
3	interleukin	interleukin	I-NP	NN	B-protein	9	NMOD
4	2	2	I-NP	CD	I-protein	9	NMOD
5	(	(	O	(	O	7	DEP
6	IL-2	IL-2	B-NP	NN	B-protein	7	DEP
7	)	)	O	)	O	4	NMOD
8	-dependent	-dependent	B-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	10	SUB
10	does	do	B-VP	VBZ	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	require	require	I-VP	VB	O	10	VC
13	monocytes	monocyte	B-NP	NNS	B-cell_type	16	NMOD
14	or	or	O	CC	O	16	NMOD
15	accessory	accessory	B-NP	JJ	B-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	12	OBJ
17	.	.	O	.	O	10	P

1	TSH-R	TSH-R	B-NP	NN	B-protein	3	NMOD
2	expression	expression	I-NP	NN	O	3	NMOD
3	levels	level	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	variable	variable	B-ADJP	JJ	O	4	PRD
6	,	,	O	,	O	4	P
7	but	but	O	CC	O	4	VMOD
8	displayed	display	B-VP	VBD	O	4	VMOD
9	a	a	B-NP	DT	O	11	NMOD
10	close	close	I-NP	JJ	O	11	NMOD
11	correlation	correlation	I-NP	NN	O	47	NMOD
12	to	to	B-PP	TO	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	expression	expression	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	thyroid	thyroid	B-NP	NN	B-protein	17	NMOD
17	peroxidase	peroxidase	I-NP	NN	I-protein	15	PMOD
18	(	(	O	(	O	28	DEP
19	r	r	B-NP	NN	O	21	SUB
20	=	=	B-VP	SYM	O	21	VMOD
21	0.703	0.703	B-NP	CD	O	27	NMOD
22	;	;	O	:	O	27	P
23	P	P	B-NP	NN	B-protein	25	NMOD
24	&	&	I-NP	CC	I-protein	25	NMOD
25	lt	lt	I-NP	NN	I-protein	27	NMOD
26	;	;	O	:	O	27	P
27	0.05	0.05	B-NP	CD	O	28	DEP
28	)	)	O	)	O	11	NMOD
29	,	,	O	,	O	47	P
30	thyroglobulin	thyroglobulin	B-NP	NN	B-protein	47	NMOD
31	(	(	O	(	O	41	DEP
32	r	r	B-NP	NN	O	34	SUB
33	=	=	B-VP	SYM	O	34	VMOD
34	0.817	0.817	B-NP	CD	O	40	VMOD
35	;	;	O	:	O	40	P
36	P	P	B-NP	NN	B-protein	38	NMOD
37	&	&	I-NP	CC	I-protein	38	NMOD
38	lt	lt	I-NP	NN	I-protein	40	NMOD
39	;	;	O	:	O	40	P
40	0.01	0.01	B-NP	CD	O	41	DEP
41	)	)	O	)	O	30	NMOD
42	,	,	O	,	O	47	P
43	and	and	O	CC	O	47	NMOD
44	the	the	B-NP	DT	O	47	NMOD
45	nuclear	nuclear	I-NP	JJ	B-DNA	47	NMOD
46	oncogene	oncogene	I-NP	NN	I-DNA	47	NMOD
47	c-fos	c-fos	I-NP	NN	I-DNA	62	NMOD
48	(	(	O	(	O	58	DEP
49	r	r	B-NP	NN	O	51	SUB
50	=	=	B-VP	SYM	O	51	VMOD
51	0.935	0.935	B-NP	CD	O	57	VMOD
52	;	;	O	:	O	57	P
53	P	P	B-NP	NN	B-protein	55	NMOD
54	&	&	I-NP	CC	I-protein	55	NMOD
55	lt	lt	I-NP	NN	I-protein	57	NMOD
56	;	;	O	:	O	57	P
57	0.001	0.001	B-NP	CD	O	58	DEP
58	)	)	O	)	O	47	NMOD
59	,	,	O	,	O	62	P
60	but	but	O	CC	O	62	NMOD
61	not	not	O	RB	O	60	DEP
62	c-myc	c-myc	B-NP	NN	B-DNA	8	OBJ
63	.	.	O	.	O	4	P

1	Overall	Overall	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	TSH-R	TSH-R	B-NP	NN	B-protein	5	NMOD
4	transcript	transcript	I-NP	NN	O	5	NMOD
5	levels	level	I-NP	NNS	O	6	SUB
6	were	be	B-VP	VBD	O	0	ROOT
7	low	low	B-ADJP	JJ	O	9	AMOD
8	or	or	I-ADJP	CC	O	9	AMOD
9	absent	absent	I-ADJP	JJ	O	6	PRD
10	in	in	B-PP	IN	O	6	VMOD
11	those	those	B-NP	DT	O	12	NMOD
12	thyroids	thyroid	I-NP	NNS	O	10	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	which	which	B-NP	WDT	O	13	PMOD
15	expression	expression	B-NP	NN	O	31	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	21	NMOD
18	major	major	I-NP	JJ	B-protein	21	NMOD
19	histocompatibility	histocompatibility	I-NP	NN	I-protein	21	NMOD
20	complex	complex	I-NP	NN	I-protein	21	NMOD
21	class	class	I-NP	NN	I-protein	16	PMOD
22	I	I	B-NP	CD	I-protein	24	NMOD
23	or	or	I-NP	CC	I-protein	24	NMOD
24	II	II	I-NP	CD	I-protein	21	NMOD
25	(	(	O	(	O	30	DEP
26	MHC	MHC	B-NP	NN	B-protein	30	DEP
27	I	I	B-NP	CD	I-protein	29	NMOD
28	or	or	I-NP	CC	I-protein	29	NMOD
29	II	II	I-NP	CD	I-protein	26	NMOD
30	)	)	O	)	O	21	NMOD
31	was	be	B-VP	VBD	O	13	SBAR
32	high	high	B-ADJP	JJ	O	31	PRD
33	,	,	O	,	O	6	P
34	thus	thus	B-ADVP	RB	O	35	VMOD
35	establishing	establish	B-VP	VBG	O	6	VMOD
36	an	an	B-NP	DT	O	38	NMOD
37	inverse	inverse	I-NP	JJ	O	38	NMOD
38	relation	relation	I-NP	NN	O	35	OBJ
39	(	(	O	(	O	65	DEP
40	MHC	MHC	B-NP	NN	B-protein	41	NMOD
41	I	I	I-NP	NN	I-protein	64	NMOD
42	,	,	O	,	O	64	P
43	r	r	B-NP	NN	O	45	SUB
44	=	=	B-VP	SYM	O	45	VMOD
45	-0.791	-0.791	B-NP	CD	O	64	NMOD
46	;	;	O	:	O	64	P
47	P	P	B-NP	NN	B-protein	49	NMOD
48	&	&	I-NP	CC	I-protein	49	NMOD
49	lt	lt	I-NP	NN	I-protein	64	SUB
50	;	;	O	:	O	64	P
51	0.01	0.01	B-NP	CD	O	64	NMOD
52	;	;	O	:	O	64	P
53	MHC	MHC	B-NP	NN	B-protein	64	VMOD
54	II	II	I-NP	CD	I-protein	53	DEP
55	,	,	O	,	O	64	P
56	r	r	B-NP	NN	O	58	SUB
57	=	=	B-VP	SYM	O	58	VMOD
58	-0.784	-0.784	B-NP	CD	O	64	NMOD
59	;	;	O	:	O	64	P
60	P	P	B-NP	NN	B-protein	62	NMOD
61	&	&	I-NP	CC	I-protein	62	NMOD
62	lt	lt	I-NP	NN	I-protein	64	SUB
63	;	;	O	:	O	64	P
64	0.01	0.01	B-NP	CD	O	65	DEP
65	)	)	O	)	O	6	VMOD
66	.	.	O	.	O	6	P

1	Thus	Thus	B-NP	RB	O	3	VMOD
2	p59fyn	p59fyn	I-NP	NN	B-protein	3	SUB
3	could	could	B-VP	MD	O	0	ROOT
4	replace	replace	I-VP	VB	O	3	VC
5	the	the	B-NP	DT	O	7	NMOD
6	calcium	calcium	I-NP	NN	O	7	NMOD
7	ionophore	ionophore	I-NP	NN	O	10	NMOD
8	but	but	B-NP	CC	O	10	NMOD
9	not	not	I-NP	RB	O	8	DEP
10	activation	activation	B-NP	NN	O	4	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	protein	protein	B-NP	NN	B-protein	14	NMOD
13	kinase	kinase	I-NP	NN	I-protein	14	NMOD
14	C	C	I-NP	NN	I-protein	11	PMOD
15	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	presence	presence	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	c-fos	c-fos	B-NP	NN	B-DNA	3	PMOD
5	had	have	B-VP	VBD	O	0	ROOT
6	a	a	B-NP	DT	O	8	NMOD
7	negative	negative	I-NP	JJ	O	8	NMOD
8	influence	influence	I-NP	NN	O	5	OBJ
9	on	on	B-PP	IN	O	5	VMOD
10	GR	GR	B-NP	NN	B-protein	11	NMOD
11	function	function	I-NP	NN	O	9	PMOD
12	and	and	O	CC	O	5	VMOD
13	correlated	correlate	B-VP	VBD	O	5	VMOD
14	with	with	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	20	NMOD
16	cell-specific	cell-specific	I-NP	JJ	O	19	AMOD
17	synergistic	synergistic	I-NP	JJ	O	19	AMOD
18	or	or	I-NP	CC	O	19	AMOD
19	antagonistic	antagonistic	I-NP	JJ	O	20	NMOD
20	activity	activity	I-NP	NN	O	14	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	Jun	Jun	B-NP	NN	B-protein	21	PMOD
23	with	with	B-PP	IN	O	13	VMOD
24	respect	respect	B-NP	NN	O	23	PMOD
25	to	to	B-PP	TO	O	24	NMOD
26	GR	GR	B-NP	NN	B-protein	25	PMOD
27	;	;	O	:	O	5	P

1	high	high	B-NP	JJ	O	3	NMOD
2	basal	basal	I-NP	JJ	O	3	NMOD
3	expression	expression	I-NP	NN	O	14	NMOD
4	of	of	B-PP	IN	O	3	NMOD
5	c-fos	c-fos	B-NP	NN	B-DNA	4	PMOD
6	as	as	B-CONJP	RB	O	14	NMOD
7	well	well	I-CONJP	RB	O	6	DEP
8	as	as	I-CONJP	IN	O	6	DEP
9	AP-1	AP-1	B-NP	NN	B-protein	11	NMOD
10	DNA	DNA	I-NP	NN	O	11	NMOD
11	binding	binding	I-NP	NN	O	14	NMOD
12	and	and	O	CC	O	14	NMOD
13	transcriptional	transcriptional	B-NP	JJ	O	14	NMOD
14	activity	activity	I-NP	NN	O	15	SUB
15	were	be	B-VP	VBD	O	0	ROOT
16	observed	observe	I-VP	VBN	O	15	VC
17	in	in	B-PP	IN	O	16	VMOD
18	HeLa	HeLa	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	,	,	B-PP	,	O	17	P
21	but	but	I-PP	CC	O	17	PMOD
22	not	not	B-PP	RB	O	23	PMOD
23	in	in	I-PP	IN	O	17	PMOD
24	T	T	B-NP	NN	B-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	23	PMOD
26	.	.	O	.	O	15	P

1	These	These	B-NP	DT	O	3	NMOD
2	phenotypic	phenotypic	I-NP	JJ	O	3	NMOD
3	effects	effect	I-NP	NNS	O	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	specifically	specifically	B-ADJP	RB	O	4	VMOD
6	attributable	attributable	I-ADJP	JJ	O	4	PRD
7	to	to	B-PP	TO	O	6	AMOD
8	the	the	B-NP	DT	O	9	NMOD
9	action	action	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	ectopically	ectopically	B-NP	RB	O	12	AMOD
12	expressed	express	I-NP	VBN	O	13	NMOD
13	GATA-2/ER	GATA-2/ER	I-NP	NN	B-protein	10	PMOD
14	because	because	B-SBAR	IN	O	25	DEP
15	erythroblasts	erythroblast	B-NP	NNS	B-cell_type	19	SUB
16	expressing	express	B-VP	VBG	O	15	NMOD
17	exogenous	exogenous	B-NP	JJ	O	18	NMOD
18	GATA-2	GATA-2	I-NP	NN	B-protein	16	OBJ
19	are	be	B-VP	VBP	O	14	SBAR
20	constitutively	constitutively	I-VP	RB	O	21	VMOD
21	arrested	arrest	I-VP	VBN	O	19	VC
22	in	in	B-PP	IN	O	21	VMOD
23	differentiation	differentiation	B-NP	NN	O	22	PMOD
24	and	and	O	CC	O	25	DEP
25	because	because	B-SBAR	IN	O	4	VMOD
26	erythroid	erythroid	B-NP	JJ	B-cell_type	27	NMOD
27	progenitors	progenitor	I-NP	NNS	I-cell_type	33	SUB
28	expressing	express	B-VP	VBG	O	27	NMOD
29	either	either	O	CC	O	32	NMOD
30	Gal/ER	Gal/ER	B-NP	NN	B-protein	32	NMOD
31	or	or	I-NP	CC	O	32	NMOD
32	GATA-3/ER	GATA-3/ER	I-NP	NN	B-protein	28	OBJ
33	do	do	B-VP	VBP	O	25	SBAR
34	not	not	I-VP	RB	O	33	VMOD
35	display	display	I-VP	VB	O	33	VC
36	a	a	B-NP	DT	O	38	NMOD
37	hormone-responsive	hormone-responsive	I-NP	JJ	O	38	NMOD
38	block	block	I-NP	NN	O	35	OBJ
39	in	in	B-PP	IN	O	35	VMOD
40	differentiation	differentiation	B-NP	NN	O	39	PMOD
41	.	.	O	.	O	4	P

1	By	By	B-PP	IN	O	5	VMOD
2	comparison	comparison	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	there	there	B-NP	EX	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	no	no	B-NP	DT	O	7	NMOD
7	modification	modification	I-NP	NN	O	5	PRD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	expression	expression	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	CD4	CD4	B-NP	NN	B-protein	13	NMOD
13	antigen	antigen	I-NP	NN	I-protein	11	PMOD
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	is	be	B-VP	VBZ	O	15	SBAR
17	expressed	express	I-VP	VBN	O	16	VC
18	at	at	B-PP	IN	O	17	VMOD
19	high	high	B-NP	JJ	O	20	NMOD
20	levels	level	I-NP	NNS	O	18	PMOD
21	in	in	B-PP	IN	O	17	VMOD
22	these	these	B-NP	DT	O	23	NMOD
23	cells	cell	I-NP	NNS	O	21	PMOD
24	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	5	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	there	there	B-NP	EX	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	no	no	B-NP	DT	O	7	NMOD
7	regulation	regulation	I-NP	NN	O	5	PRD
8	by	by	B-PP	IN	O	7	NMOD
9	glucocorticoids	glucocorticoid	B-NP	NNS	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	either	either	O	CC	O	16	NMOD
12	the	the	B-NP	DT	O	16	NMOD
13	CD8	CD8	I-NP	NN	B-protein	15	NMOD
14	or	or	I-NP	CC	O	15	NMOD
15	CD4	CD4	I-NP	NN	B-protein	16	NMOD
16	antigens	antigen	I-NP	NNS	I-protein	10	PMOD
17	in	in	B-PP	IN	O	7	NMOD
18	the	the	B-NP	DT	O	22	NMOD
19	leukemic	leukemic	I-NP	JJ	B-cell_line	22	NMOD
20	clone	clone	I-NP	NN	I-cell_line	22	NMOD
21	CEM	CEM	I-NP	NN	I-cell_line	22	NMOD
22	C1	C1	I-NP	NN	I-cell_line	17	PMOD
23	.	.	O	.	O	5	P

1	Furthermore	Furthermore	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	no	no	B-NP	DT	O	4	NMOD
4	modification	modification	I-NP	NN	O	15	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	suppressor	suppressor	I-NP	NN	O	8	NMOD
8	function	function	I-NP	NN	O	5	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	CEM	CEM	B-NP	NN	B-cell_line	12	NMOD
11	C1	C1	I-NP	NN	I-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	9	PMOD
13	by	by	B-PP	IN	O	4	NMOD
14	dexamethasone	dexamethasone	B-NP	NN	O	13	PMOD
15	was	be	B-VP	VBD	O	0	ROOT
16	observed	observe	I-VP	VBN	O	15	VC
17	.	.	O	.	O	15	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	multidrug-resistant	multidrug-resistant	B-NP	JJ	B-cell_line	7	NMOD
6	HL-60	HL-60	I-NP	NN	I-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	12	SUB
8	,	,	O	,	O	7	P
9	designated	designate	B-VP	VBN	O	7	NMOD
10	HL-60/vinc	HL-60/vinc	B-NP	NN	B-cell_line	9	VMOD
11	,	,	O	,	O	7	P
12	fail	fail	B-VP	VBP	O	4	SBAR
13	to	to	I-VP	TO	O	14	VMOD
14	respond	respond	I-VP	VB	O	12	VMOD
15	to	to	B-PP	TO	O	14	VMOD
16	TPA	TPA	B-NP	NN	O	15	PMOD
17	with	with	B-PP	IN	O	14	VMOD
18	an	an	B-NP	DT	O	19	NMOD
19	increase	increase	I-NP	NN	O	17	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	c-jun	c-jun	B-NP	NN	B-RNA	22	NMOD
22	transcripts	transcript	I-NP	NNS	I-RNA	26	NMOD
23	or	or	O	CC	O	26	NMOD
24	other	other	B-NP	JJ	O	26	NMOD
25	phenotypic	phenotypic	I-NP	JJ	O	26	NMOD
26	characteristics	characteristic	I-NP	NNS	O	20	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	monocytic	monocytic	B-NP	JJ	O	29	NMOD
29	differentiation	differentiation	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	finding	finding	I-NP	NN	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	NMOD
4	HL-60/vinc/R	HL-60/vinc/R	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	6	SUB
6	respond	respond	B-VP	VBP	O	3	SBAR
7	to	to	B-PP	TO	O	6	VMOD
8	TPA	TPA	B-NP	NN	O	7	PMOD
9	with	with	B-PP	IN	O	6	VMOD
10	induction	induction	B-NP	NN	O	9	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	a	a	B-NP	DT	O	14	NMOD
13	monocytic	monocytic	I-NP	JJ	O	14	NMOD
14	phenotype	phenotype	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	21	P
16	but	but	O	CC	O	19	NMOD
17	not	not	O	RB	O	16	DEP
18	c-jun	c-jun	B-NP	NN	B-DNA	19	NMOD
19	expression	expression	I-NP	NN	O	21	SUB
20	,	,	O	,	O	19	P
21	suggests	suggest	B-VP	VBZ	O	3	SBAR
22	that	that	B-SBAR	IN	O	21	VMOD
23	c-jun	c-jun	B-NP	NN	B-DNA	24	NMOD
24	induction	induction	I-NP	NN	O	25	SUB
25	is	be	B-VP	VBZ	O	22	SBAR
26	not	not	O	RB	O	25	VMOD
27	obligatory	obligatory	B-ADJP	JJ	O	25	PRD
28	for	for	B-PP	IN	O	27	AMOD
29	monocytic	monocytic	B-NP	JJ	O	30	NMOD
30	differentiation	differentiation	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	2	P

1	Activity	Activity	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	mitogen-activated	mitogen-activated	I-NP	JJ	B-protein	7	NMOD
5	protein	protein	I-NP	NN	I-protein	7	NMOD
6	kinase	kinase	I-NP	NN	I-protein	7	NMOD
7	family	family	I-NP	NN	I-protein	2	PMOD
8	with	with	B-PP	IN	O	1	NMOD
9	associated	associate	B-NP	VBN	O	10	NMOD
10	phosphorylation	phosphorylation	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	c-Jun	c-Jun	B-NP	NN	B-protein	13	NMOD
13	Y-peptide	Y-peptide	I-NP	NN	I-protein	11	PMOD
14	was	be	B-VP	VBD	O	0	ROOT
15	markedly	markedly	I-VP	RB	O	14	VMOD
16	diminished	diminish	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	TPA-treated	TPA-treated	B-NP	JJ	B-cell_line	20	NMOD
19	HL-60/vinc	HL-60/vinc	I-NP	NN	I-cell_line	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
21	,	,	B-PP	,	O	17	P
22	but	but	I-PP	CC	O	17	PMOD
23	not	not	B-PP	RB	O	24	PMOD
24	in	in	I-PP	IN	O	17	PMOD
25	response	response	B-NP	NN	O	24	PMOD
26	to	to	B-PP	TO	O	25	NMOD
27	okadaic	okadaic	B-NP	JJ	O	28	NMOD
28	acid	acid	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	14	P

1	Further	Far	B-NP	JJR	O	2	NMOD
2	examination	examination	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	5	NMOD
5	system	system	I-NP	NN	O	3	PMOD
6	has	have	B-VP	VBZ	O	0	ROOT
7	shown	show	I-VP	VBN	O	6	VC
8	that	that	B-SBAR	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	inhibition	inhibition	I-NP	NN	O	19	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	HSV-1	HSV-1	B-NP	NN	O	13	NMOD
13	replication	replication	I-NP	NN	O	11	PMOD
14	by	by	B-PP	IN	O	10	NMOD
15	the	the	B-NP	DT	O	18	NMOD
16	antiviral	antiviral	I-NP	JJ	O	18	NMOD
17	drug	drug	I-NP	NN	O	18	NMOD
18	acyclovir	acyclovir	I-NP	NN	O	14	PMOD
19	does	do	B-VP	VBZ	O	8	SBAR
20	not	not	I-VP	RB	O	19	VMOD
21	inhibit	inhibit	I-VP	VB	O	19	VC
22	HSV-1-mediated	HSV-1-mediated	B-NP	JJ	O	23	NMOD
23	induction	induction	I-NP	NN	O	21	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	HIV-1	HIV-1	B-NP	NN	O	26	NMOD
26	provirus	provirus	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	12	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	transient-transfection	transient-transfection	I-NP	JJ|NN	O	4	NMOD
4	assay	assay	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	12	P
6	ICP0	ICP0	B-NP	NN	B-protein	10	NMOD
7	,	,	O	,	O	10	P
8	but	but	O	CC	O	10	NMOD
9	not	not	O	RB	O	8	DEP
10	ICP4	ICP4	B-NP	NN	B-protein	12	SUB
11	,	,	O	,	O	10	P
12	activated	activate	B-VP	VBD	O	25	VMOD
13	the	the	B-NP	DT	O	19	NMOD
14	HIV-1	HIV-1	I-NP	NN	B-DNA	19	NMOD
15	long	long	I-NP	JJ	I-DNA	19	NMOD
16	terminal	terminal	I-NP	JJ	I-DNA	19	NMOD
17	repeat	repeat	I-NP	NN	I-DNA	19	NMOD
18	promoter	promoter	I-NP	NN	I-DNA	19	NMOD
19	region	region	I-NP	NN	I-DNA	12	OBJ
20	and	and	O	CC	O	25	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	effect	effect	I-NP	NN	O	25	SUB
23	of	of	B-PP	IN	O	22	NMOD
24	ICP0	ICP0	B-NP	NN	B-protein	23	PMOD
25	was	be	B-VP	VBD	O	0	ROOT
26	greatly	greatly	I-VP	RB	O	25	VMOD
27	enhanced	enhance	I-VP	VBN	O	25	VC
28	in	in	B-PP	IN	O	27	VMOD
29	the	the	B-NP	DT	O	30	NMOD
30	presence	presence	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	36	NMOD
33	NF-kappa	NF-kappa	I-NP	NN	B-protein	36	NMOD
34	B	B	I-NP	NN	I-protein	36	NMOD
35	binding	binding	I-NP	NN	I-protein	36	NMOD
36	proteins	protein	I-NP	NNS	I-protein	31	PMOD
37	,	,	O	,	O	27	P
38	suggesting	suggest	B-VP	VBG	O	27	VMOD
39	that	that	B-SBAR	IN	O	61	NMOD
40	induction	induction	B-NP	NN	O	45	SUB
41	of	of	B-PP	IN	O	40	NMOD
42	the	the	B-NP	DT	O	44	NMOD
43	HIV-1	HIV-1	I-NP	NN	O	44	NMOD
44	provirus	provirus	I-NP	NN	O	41	PMOD
45	involves	involve	B-VP	VBZ	O	39	SBAR
46	cooperation	cooperation	B-NP	NN	O	45	OBJ
47	between	between	B-PP	IN	O	46	NMOD
48	the	the	B-NP	DT	O	51	NMOD
49	HSV-1-activated	HSV-1-activated	I-NP	JJ	B-protein	51	NMOD
50	cellular	cellular	I-NP	JJ	I-protein	51	NMOD
51	factor	factor	I-NP	NN	I-protein	54	NMOD
52	,	,	O	,	O	54	P
53	NF-kappa	NF-kappa	B-NP	NN	B-protein	54	NMOD
54	B	B	I-NP	NN	I-protein	47	PMOD
55	,	,	O	,	O	39	P
56	and	and	O	CC	O	61	NMOD
57	the	the	B-NP	DT	O	59	NMOD
58	virus-encoded	virus-encoded	I-NP	JJ	B-protein	59	NMOD
59	transactivator	transactivator	I-NP	NN	I-protein	61	NMOD
60	,	,	O	,	O	61	P
61	ICP0	ICP0	B-NP	NN	B-protein	38	OBJ
62	.	.	O	.	O	25	P

1	4	4	B-NP	CD	O	2	NMOD
2	patients	patient	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	receiving	receive	I-VP	VBG	O	3	VC
5	dopamine	dopamine	B-NP	NN	O	4	OBJ
6	,	,	O	,	O	5	P
7	which	which	B-NP	WDT	O	5	NMOD
8	did	do	B-VP	VBD	O	7	SBAR
9	not	not	I-VP	RB	O	8	VMOD
10	affect	affect	I-VP	VB	O	8	VC
11	the	the	B-NP	DT	O	13	NMOD
12	GR	GR	I-NP	NN	B-protein	13	NMOD
13	count	count	I-NP	NN	O	10	OBJ
14	.	.	O	.	O	3	P

1	Despite	Despite	B-PP	IN	O	17	VMOD
2	a	a	B-NP	DT	O	4	NMOD
3	wide	wide	I-NP	JJ	O	4	NMOD
4	range	range	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	17	P
6	the	the	B-NP	DT	O	11	NMOD
7	mean	mean	I-NP	JJ	O	11	NMOD
8	GR	GR	I-NP	NN	B-protein	11	NMOD
9	count	count	I-NP	NN	O	11	NMOD
10	and	and	O	CC	O	11	NMOD
11	affinity	affinity	B-NP	NN	O	17	SUB
12	in	in	B-PP	IN	O	11	NMOD
13	MNC	MNC	B-NP	NN	B-cell_type	12	PMOD
14	from	from	B-PP	IN	O	13	NMOD
15	septic	septic	B-NP	JJ	O	16	NMOD
16	patients	patient	I-NP	NNS	O	14	PMOD
17	did	do	B-VP	VBD	O	0	ROOT
18	not	not	I-VP	RB	O	17	VMOD
19	differ	differ	I-VP	VB	O	17	VC
20	from	from	B-PP	IN	O	19	VMOD
21	those	those	B-NP	DT	O	20	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	normal	normal	B-NP	JJ	O	24	NMOD
24	controls	control	I-NP	NNS	O	22	PMOD
25	,	,	O	,	O	19	P
26	suggesting	suggest	B-VP	VBG	O	19	VMOD
27	that	that	B-SBAR	IN	O	26	VMOD
28	glucocorticoids	glucocorticoid	B-NP	NNS	O	29	SUB
29	could	could	B-VP	MD	O	27	SBAR
30	still	still	I-VP	RB	O	31	VMOD
31	be	be	I-VP	VB	O	29	VC
32	effective	effective	B-ADJP	JJ	O	31	PRD
33	in	in	B-PP	IN	O	31	VMOD
34	the	the	B-NP	DT	O	37	NMOD
35	hemodynamic	hemodynamic	I-NP	JJ	O	37	NMOD
36	compensatory	compensatory	I-NP	JJ	O	37	NMOD
37	phase	phase	I-NP	NN	O	33	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	sepsis	sepsis	B-NP	NN	O	38	PMOD
40	.	.	O	.	O	17	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	compared	compare	I-VP	VBN	O	3	VC
5	to	to	B-PP	TO	O	4	VMOD
6	those	those	B-NP	DT	O	5	PMOD
7	obtained	obtain	B-VP	VBN	O	6	NMOD
8	with	with	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	19	NMOD
10	parental	parental	I-NP	JJ	B-cell_line	19	NMOD
11	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	I-cell_line	19	NMOD
12	colony-stimulating	colony-stimulating	I-NP	JJ	I-cell_line	19	NMOD
13	factor	factor	I-NP	NN	I-cell_line	19	NMOD
14	(	(	O	(	I-cell_line	19	NMOD
15	GM-CSF	GM-CSF	B-NP	NN	I-cell_line	19	NMOD
16	)	)	O	)	I-cell_line	19	NMOD
17	-dependent	-dependent	B-NP	JJ	I-cell_line	19	NMOD
18	cell	cell	I-NP	NN	I-cell_line	19	NMOD
19	line	line	I-NP	NN	I-cell_line	21	NMOD
20	,	,	O	,	O	21	P
21	UT-7	UT-7	B-NP	NN	B-cell_line	8	PMOD
22	,	,	O	,	O	21	P
23	which	which	B-NP	WDT	O	21	NMOD
24	has	have	B-VP	VBZ	O	23	SBAR
25	a	a	B-NP	DT	O	28	NMOD
26	predominantly	predominantly	I-NP	RB	O	27	AMOD
27	megakaryoblastic	megakaryoblastic	I-NP	JJ	O	28	NMOD
28	phenotype	phenotype	I-NP	NN	O	24	OBJ
29	and	and	O	CC	O	24	VMOD
30	is	be	B-VP	VBZ	O	24	VMOD
31	unable	unable	B-ADJP	JJ	O	30	PRD
32	to	to	B-VP	TO	O	33	VMOD
33	proliferate	proliferate	I-VP	VB	O	31	AMOD
34	continuously	continuously	B-ADVP	RB	O	33	VMOD
35	in	in	B-PP	IN	O	33	VMOD
36	the	the	I-PP	DT	O	37	NMOD
37	presence	presence	I-PP	NN	O	35	PMOD
38	of	of	I-PP	IN	O	37	NMOD
39	Epo	Epo	B-NP	NN	B-protein	38	PMOD
40	.	.	O	.	O	3	P

1	By	By	B-PP	IN	O	7	VMOD
2	Northern	Northern	B-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	7	P
5	UT-7	UT-7	B-NP	NN	B-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	7	SUB
7	expressed	express	B-VP	VBD	O	0	ROOT
8	detectable	detectable	B-NP	JJ	O	9	NMOD
9	levels	level	I-NP	NNS	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	beta-	beta-	B-NP	NN	B-protein	13	NMOD
12	and	and	I-NP	CC	I-protein	13	NMOD
13	gamma-globin	gamma-globin	I-NP	NN	I-protein	16	NMOD
14	but	but	B-NP	CC	O	16	NMOD
15	not	not	I-NP	RB	O	14	DEP
16	alpha-globin	alpha-globin	B-NP	NN	B-protein	10	PMOD
17	.	.	O	.	O	7	P

1	Globin	Globin	B-NP	NN	B-protein	2	NMOD
2	chains	chain	I-NP	NNS	I-protein	10	SUB
3	(	(	O	(	O	9	DEP
4	alpha	alpha	B-NP	NN	O	8	NMOD
5	,	,	O	,	O	8	P
6	beta	beta	B-NP	NN	O	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	gamma	gamma	B-NP	NN	O	9	DEP
9	)	)	O	)	O	2	NMOD
10	were	be	B-VP	VBD	O	0	ROOT
11	clearly	clearly	B-ADVP	RB	O	10	VMOD
12	detectable	detectable	B-ADJP	JJ	O	10	PRD
13	by	by	B-PP	IN	O	12	AMOD
14	affinity	affinity	B-NP	NN	O	15	NMOD
15	chromatography	chromatography	I-NP	NN	O	13	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	UT-7	UT-7	B-NP	NN	B-protein	18	NMOD
18	Epo	Epo	I-NP	NN	I-protein	16	PMOD
19	but	but	B-PP	CC	O	16	PMOD
20	not	not	B-PP	RB	O	21	PMOD
21	in	in	I-PP	IN	O	16	PMOD
22	UT-7	UT-7	B-NP	NN	B-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	21	PMOD
24	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	2	NMOD
2	levels	level	I-NP	NNS	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	GATA-1	GATA-1	B-NP	NN	B-protein	9	NMOD
5	,	,	O	,	O	9	P
6	Epo-R	Epo-R	B-NP	NN	B-protein	9	NMOD
7	and	and	O	CC	O	9	NMOD
8	globin	globin	B-NP	NN	B-RNA	9	NMOD
9	mRNA	mRNA	I-NP	NN	I-RNA	3	PMOD
10	expressed	express	B-VP	VBN	O	9	NMOD
11	were	be	B-VP	VBD	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	affected	affect	I-VP	VBN	O	11	VC
14	by	by	B-PP	IN	O	13	VMOD
15	a	a	B-NP	DT	O	17	NMOD
16	24-hour	24-hour	I-NP	JJ	O	17	NMOD
17	incubation	incubation	I-NP	NN	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	either	either	B-NP	DT	O	21	NMOD
20	cell	cell	I-NP	NN	O	21	NMOD
21	line	line	I-NP	NN	O	18	PMOD
22	with	with	B-PP	IN	O	17	NMOD
23	Epo	Epo	B-NP	NN	B-protein	27	NMOD
24	,	,	O	,	O	27	P
25	GM-CSF	GM-CSF	B-NP	NN	B-protein	27	NMOD
26	or	or	O	CC	O	27	NMOD
27	interleukin-3	interleukin-3	B-NP	NN	B-protein	22	PMOD
28	(	(	O	(	O	30	DEP
29	IL-3	IL-3	B-NP	NN	B-protein	30	DEP
30	)	)	O	)	O	27	NMOD
31	.	.	O	.	O	38	P
32	(	(	O	(	O	38	DEP
33	ABSTRACT	ABSTRACT	B-NP	NN	O	38	DEP
34	TRUNCATED	TRUNCATED	B-VP	VBN	O	33	NMOD
35	AT	AT	B-PP	IN	O	34	VMOD
36	400	400	B-NP	CD	O	37	NMOD
37	WORDS	WORDS	I-NP	NNS	O	35	PMOD
38	)	)	O	)	O	11	VMOD

1	Human	Human	B-NP	JJ	B-cell_type	4	NMOD
2	peripheral	peripheral	I-NP	JJ	I-cell_type	4	NMOD
3	blood	blood	I-NP	NN	I-cell_type	4	NMOD
4	monocytes	monocyte	I-NP	NNS	I-cell_type	9	SUB
5	(	(	O	(	O	7	DEP
6	Mo	Mo	B-NP	NN	B-cell_type	7	DEP
7	)	)	O	)	O	4	NMOD
8	constitutively	constitutively	B-ADVP	RB	O	9	VMOD
9	display	display	B-VP	VBP	O	18	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	beta-chain	beta-chain	I-NP	NN	B-protein	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	receptor	receptor	I-NP	NN	O	12	PMOD
15	for	for	B-PP	IN	O	14	NMOD
16	IL-2	IL-2	B-NP	NN	B-protein	15	PMOD
17	,	,	O	,	O	18	P
18	whereas	whereas	O	IN	O	0	ROOT
19	expression	expression	B-NP	NN	O	24	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	IL-2R	IL-2R	I-NP	NN	B-protein	23	NMOD
23	alpha-chain	alpha-chain	I-NP	NN	I-protein	20	PMOD
24	is	be	B-VP	VBZ	O	18	VMOD
25	not	not	O	RB	O	24	VMOD
26	constitutive	constitutive	B-ADJP	JJ	O	28	AMOD
27	but	but	I-ADJP	CC	O	28	AMOD
28	inducible	inducible	I-ADJP	JJ	O	24	PRD
29	with	with	B-PP	IN	O	28	AMOD
30	IL-2	IL-2	B-NP	NN	B-protein	29	PMOD
31	.	.	O	.	O	18	P

1	The	The	B-NP	DT	O	5	NMOD
2	B	B	I-NP	NN	B-protein	5	NMOD
3	cell	cell	I-NP	NN	I-protein	5	NMOD
4	NFAT	NFAT	I-NP	NN	I-protein	5	NMOD
5	complex	complex	I-NP	NN	I-protein	9	SUB
6	,	,	O	,	O	9	P
7	however	however	B-ADVP	RB	O	9	VMOD
8	,	,	O	,	O	9	P
9	was	be	B-VP	VBD	O	0	ROOT
10	not	not	O	RB	O	9	VMOD
11	functional	functional	B-ADJP	JJ	O	9	PRD
12	,	,	O	,	O	9	P
13	since	since	B-SBAR	IN	O	9	VMOD
14	it	it	B-NP	PRP	O	15	SUB
15	failed	fail	B-VP	VBD	O	13	SBAR
16	to	to	I-VP	TO	O	17	VMOD
17	activate	activate	I-VP	VB	O	15	VMOD
18	transcription	transcription	B-NP	NN	O	17	OBJ
19	from	from	B-PP	IN	O	17	VMOD
20	an	an	B-NP	DT	O	27	NMOD
21	NFAT-driven	NFAT-driven	I-NP	JJ	B-DNA	27	NMOD
22	chloramphenicol	chloramphenicol	I-NP	NN	I-DNA	23	NMOD
23	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	27	NMOD
24	(	(	O	(	I-DNA	26	DEP
25	CAT	CAT	B-NP	NN	I-DNA	26	DEP
26	)	)	O	)	I-DNA	23	NMOD
27	construct	construct	B-NP	NN	I-DNA	19	PMOD
28	.	.	O	.	O	9	P

1	Purified	Purify	B-NP	VBN	O	6	NMOD
2	recombinant	recombinant	I-NP	JJ	O	6	NMOD
3	Jun	Jun	I-NP	NN	B-protein	6	NMOD
4	and	and	I-NP	CC	I-protein	6	NMOD
5	Fos	Fos	I-NP	NN	I-protein	6	NMOD
6	proteins	protein	I-NP	NNS	I-protein	7	SUB
7	failed	fail	B-VP	VBD	O	0	ROOT
8	to	to	I-VP	TO	O	9	VMOD
9	bind	bind	I-VP	VB	O	7	VMOD
10	directly	directly	B-ADVP	RB	O	9	VMOD
11	to	to	B-PP	TO	O	9	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	NFAT	NFAT	I-NP	NN	B-DNA	14	NMOD
14	motif	motif	I-NP	NN	I-DNA	11	PMOD
15	.	.	O	.	O	7	P

1	However	However	B-ADVP	RB	O	21	VMOD
2	,	,	O	,	O	21	P
3	when	when	B-ADVP	WRB	O	21	VMOD
4	combined	combine	B-VP	VBN	O	3	SBAR
5	with	with	B-PP	IN	O	4	VMOD
6	unstimulated	unstimulated	B-NP	JJ	O	11	NMOD
7	B	B	I-NP	NN	O	11	NMOD
8	or	or	O	CC	O	11	NMOD
9	T	T	B-NP	NN	O	11	NMOD
10	cell	cell	I-NP	NN	O	11	NMOD
11	extracts	extract	I-NP	NNS	O	5	PMOD
12	,	,	O	,	O	21	P
13	full-length	full-length	B-ADJP	JJ	O	17	AMOD
14	,	,	O	,	O	17	P
15	but	but	O	CC	O	17	AMOD
16	not	not	B-VP	RB	O	17	AMOD
17	truncated	truncate	I-VP	VBN	O	20	NMOD
18	,	,	O	,	O	17	P
19	Jun/Fos	Jun/Fos	B-NP	NN	B-protein	20	NMOD
20	heterodimers	heterodimer	I-NP	NNS	I-protein	21	SUB
21	were	be	B-VP	VBD	O	0	ROOT
22	able	able	B-ADJP	JJ	O	21	PRD
23	to	to	B-VP	TO	O	24	VMOD
24	form	form	I-VP	VB	O	22	AMOD
25	an	an	B-NP	DT	O	27	NMOD
26	NFAT	NFAT	I-NP	NN	B-protein	27	NMOD
27	complex	complex	I-NP	NN	I-protein	24	OBJ
28	,	,	O	,	O	21	P
29	indicating	indicate	B-VP	VBG	O	21	VMOD
30	the	the	B-NP	DT	O	31	NMOD
31	presence	presence	I-NP	NN	O	29	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	a	a	B-NP	DT	O	39	NMOD
34	constitutively	constitutively	I-NP	RB	B-protein	35	AMOD
35	expressed	express	I-NP	VBN	I-protein	39	NMOD
36	nuclear	nuclear	I-NP	JJ	I-protein	39	NMOD
37	factor	factor	I-NP	NN	I-protein	39	NMOD
38	(	(	I-NP	(	O	39	NMOD
39	s	s	I-NP	NNS	O	32	PMOD
40	)	)	O	)	O	39	NMOD
41	in	in	B-PP	IN	O	31	NMOD
42	B	B	B-NP	NN	B-cell_type	45	NMOD
43	and	and	O	CC	I-cell_type	45	NMOD
44	T	T	B-NP	NN	I-cell_type	45	NMOD
45	cells	cell	B-NP	NNS	I-cell_type	41	PMOD
46	necessary	necessary	B-ADJP	JJ	O	45	NMOD
47	for	for	B-PP	IN	O	46	AMOD
48	the	the	B-NP	DT	O	49	NMOD
49	formation	formation	I-NP	NN	O	47	PMOD
50	of	of	B-PP	IN	O	49	NMOD
51	the	the	B-NP	DT	O	53	NMOD
52	NFAT	NFAT	I-NP	NN	B-protein	53	NMOD
53	complex	complex	I-NP	NN	I-protein	50	PMOD
54	in	in	B-PP	IN	O	49	NMOD
55	both	both	B-NP	DT	O	57	NMOD
56	cell	cell	I-NP	NN	O	57	NMOD
57	types	type	I-NP	NNS	O	54	PMOD
58	.	.	O	.	O	21	P

1	An	An	B-NP	DT	O	3	NMOD
2	NFAT	NFAT	I-NP	NN	B-protein	3	NMOD
3	oligonucleotide	oligonucleotide	I-NP	NN	O	16	SUB
4	carrying	carry	B-VP	VBG	O	3	NMOD
5	mutations	mutation	B-NP	NNS	O	4	OBJ
6	in	in	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	11	NMOD
8	5	5	I-NP	CD	B-DNA	10	AMOD
9	'	'	I-NP	SYM	I-DNA	10	AMOD
10	purine-rich	purine-rich	I-NP	JJ	I-DNA	11	NMOD
11	part	part	I-NP	NN	I-DNA	6	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	NFAT	NFAT	I-NP	NN	B-DNA	15	NMOD
15	sequence	sequence	I-NP	NN	I-DNA	12	PMOD
16	failed	fail	B-VP	VBD	O	0	ROOT
17	to	to	I-VP	TO	O	18	VMOD
18	form	form	I-VP	VB	O	16	VMOD
19	a	a	B-NP	DT	O	20	NMOD
20	complex	complex	I-NP	NN	O	18	OBJ
21	and	and	O	CC	O	18	VMOD
22	to	to	B-VP	TO	O	23	VMOD
23	compete	compete	I-VP	VB	O	18	VMOD
24	with	with	B-PP	IN	O	23	VMOD
25	the	the	B-NP	DT	O	28	NMOD
26	wild	wild	I-NP	JJ	B-DNA	28	NMOD
27	type	type	I-NP	NN	I-DNA	28	NMOD
28	motif	motif	I-NP	NN	I-DNA	24	PMOD
29	for	for	B-PP	IN	O	28	NMOD
30	NFAT	NFAT	B-NP	NN	B-protein	32	NMOD
31	complex	complex	I-NP	NN	I-protein	32	NMOD
32	formation	formation	I-NP	NN	O	29	PMOD
33	in	in	B-PP	IN	O	18	VMOD
34	both	both	O	CC	O	38	NMOD
35	T	T	B-NP	NN	B-cell_type	38	NMOD
36	and	and	I-NP	CC	I-cell_type	38	NMOD
37	B	B	I-NP	NN	I-cell_type	38	NMOD
38	cells	cell	I-NP	NNS	I-cell_type	33	PMOD
39	.	.	O	.	O	16	P

1	Thus	Thus	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	positive	positive	B-NP	JJ	O	4	NMOD
4	autoregulation	autoregulation	I-NP	NN	O	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	neither	neither	O	CC	O	12	NMOD
7	a	a	B-NP	DT	O	8	NMOD
8	consequence	consequence	I-NP	NN	O	12	NMOD
9	nor	nor	O	CC	O	12	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	sole	sole	I-NP	JJ	O	12	NMOD
12	cause	cause	I-NP	NN	O	5	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	growth	growth	B-NP	NN	O	15	NMOD
15	arrest	arrest	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	degree	degree	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	negative	negative	B-NP	JJ	O	5	NMOD
5	autoregulation	autoregulation	I-NP	NN	O	11	NMOD
6	in	in	B-PP	IN	O	5	NMOD
7	IM-9	IM-9	B-NP	NN	B-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	6	PMOD
9	and	and	O	CC	O	11	NMOD
10	positive	positive	B-NP	JJ	O	11	NMOD
11	autoregulation	autoregulation	I-NP	NN	O	3	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	6TG1.1	6TG1.1	B-NP	NN	B-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	12	PMOD
15	was	be	B-VP	VBD	O	0	ROOT
16	unaffected	unaffected	B-ADJP	JJ	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	inhibition	inhibition	B-NP	NN	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	protein	protein	B-NP	NN	O	21	NMOD
21	synthesis	synthesis	I-NP	NN	O	19	PMOD
22	with	with	B-PP	IN	O	21	NMOD
23	cycloheximide	cycloheximide	B-NP	NN	O	22	PMOD
24	.	.	O	.	O	15	P

1	In	In	B-PP	IN	O	13	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	13	P
4	p65	p65	B-NP	NN	B-protein	5	NMOD
5	delta	delta	I-NP	NN	I-protein	11	NMOD
6	,	,	O	,	O	11	P
7	a	a	B-NP	DT	O	11	NMOD
8	naturally	naturally	I-NP	RB	O	9	AMOD
9	occurring	occur	I-NP	VBG	O	11	NMOD
10	splice	splice	I-NP	NN	O	11	NMOD
11	variant	variant	I-NP	NN	O	13	SUB
12	,	,	O	,	O	11	P
13	fails	fail	B-VP	VBZ	O	0	ROOT
14	to	to	I-VP	TO	O	16	VMOD
15	markedly	markedly	I-VP	RB	O	16	VMOD
16	augment	augment	I-VP	VB	O	13	VMOD
17	I	I	B-NP	NN	B-protein	21	NMOD
18	kappa	kappa	I-NP	NN	I-protein	21	NMOD
19	B	B	I-NP	NN	I-protein	21	NMOD
20	protein	protein	I-NP	NN	O	21	NMOD
21	levels	level	I-NP	NNS	O	16	OBJ
22	.	.	O	.	O	13	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	X	X	B-NP	NN	B-protein	4	SUB
4	failed	fail	B-VP	VBD	O	0	ROOT
5	to	to	I-VP	TO	O	6	VMOD
6	react	react	I-VP	VB	O	4	VMOD
7	with	with	B-PP	IN	O	6	VMOD
8	a	a	B-NP	DT	O	9	NMOD
9	variety	variety	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	antibodies	antibody	B-NP	NNS	B-protein	10	PMOD
12	against	against	B-PP	IN	O	11	NMOD
13	Rb	Rb	B-NP	NN	B-protein	15	NMOD
14	or	or	I-NP	CC	O	15	NMOD
15	p107	p107	I-NP	NN	B-protein	12	PMOD
16	,	,	O	,	O	4	P
17	implicating	implicate	B-VP	VBG	O	4	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	involvement	involvement	I-NP	NN	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	an	an	B-NP	DT	O	23	NMOD
22	E1A-binding	E1A-binding	I-NP	JJ	B-protein	23	NMOD
23	protein	protein	I-NP	NN	I-protein	20	PMOD
24	other	other	B-ADJP	JJ	O	25	PMOD
25	than	than	B-PP	IN	O	23	NMOD
26	Rb	Rb	B-NP	NN	B-protein	28	NMOD
27	or	or	I-NP	CC	O	28	NMOD
28	p107	p107	I-NP	NN	B-protein	25	PMOD
29	.	.	O	.	O	4	P

1	UV	UV	B-NP	NN	O	3	NMOD
2	cross-linking	cross-linking	I-NP	JJ	O	3	NMOD
3	experiments	experiment	I-NP	NNS	O	4	SUB
4	suggested	suggest	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	a	a	B-NP	DT	O	10	NMOD
7	distinct	distinct	I-NP	JJ	O	10	NMOD
8	E2F	E2F	I-NP	NN	B-protein	10	NMOD
9	DNA-binding	DNA-binding	I-NP	JJ	O	10	NMOD
10	protein	protein	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	5	SBAR
12	uniquely	uniquely	I-VP	RB	O	11	VMOD
13	associated	associate	I-VP	VBN	O	11	VC
14	with	with	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	S-phase	S-phase	I-NP	NN	B-protein	18	NMOD
17	p107	p107	I-NP	NN	I-protein	18	NMOD
18	complex	complex	I-NP	NN	I-protein	14	PMOD
19	and	and	O	CC	O	11	VMOD
20	is	be	B-VP	VBZ	O	11	VMOD
21	not	not	I-VP	RB	O	20	VMOD
22	associated	associate	I-VP	VBN	O	20	VC
23	with	with	B-PP	IN	O	22	VMOD
24	Rb	Rb	B-NP	NN	B-protein	23	PMOD
25	.	.	O	.	O	4	P

1	Occurrence	Occurrence	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	a	a	B-NP	DT	O	4	NMOD
4	silencer	silencer	I-NP	NN	B-DNA	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	interleukin-2	interleukin-2	I-NP	NN	B-DNA	8	NMOD
8	gene	gene	I-NP	NN	I-DNA	5	PMOD
9	in	in	B-PP	IN	O	1	NMOD
10	naive	naive	B-ADJP	JJ	O	9	PMOD
11	but	but	B-PP	CC	O	9	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	in	in	I-PP	IN	O	9	PMOD
14	memory	memory	B-NP	NN	B-cell_type	13	PMOD
15	resting	rest	I-NP	VBG	I-cell_type	14	NMOD
16	T	T	I-NP	NN	I-cell_type	18	NMOD
17	helper	helper	I-NP	NN	I-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
19	.	.	O	.	O	1	P

1	By	By	B-PP	IN	O	38	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	38	P
4	memory	memory	B-NP	NN	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	31	NMOD
6	,	,	O	,	O	31	P
7	either	either	O	CC	O	31	NMOD
8	in	in	B-ADVP	FW	O	13	NMOD
9	vitro	vitro	I-ADVP	FW	B-cell_line	8	AMOD
10	activated	activate	B-NP	VBN	I-cell_line	8	AMOD
11	helper	helper	I-NP	NN	I-cell_line	13	NMOD
12	T	T	I-NP	NN	I-cell_line	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_line	31	NMOD
14	reverting	revert	B-VP	VBG	O	13	NMOD
15	to	to	B-PP	TO	O	14	VMOD
16	a	a	B-NP	DT	O	18	NMOD
17	resting	resting	I-NP	JJ	O	18	NMOD
18	state	state	I-NP	NN	O	15	PMOD
19	,	,	O	,	O	31	P
20	or	or	O	CC	O	26	NMOD
21	CD4+	CD4+	O	JJ	B-cell_line	26	NMOD
22	T	T	B-NP	NN	I-cell_line	26	NMOD
23	(	(	O	(	I-cell_line	26	NMOD
24	memory	memory	B-NP	NN	I-cell_line	26	NMOD
25	)	)	O	)	I-cell_line	26	NMOD
26	clones	clone	B-NP	NNS	I-cell_line	31	NMOD
27	,	,	O	,	O	31	P
28	or	or	O	CC	O	31	NMOD
29	CD4+CD45RO+	CD4+CD45RO+	B-NP	JJ	B-cell_line	31	NMOD
30	T	T	I-NP	NN	I-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	38	SUB
32	isolated	isolate	B-VP	VBN	O	31	NMOD
33	ex	ex	B-ADVP	FW	O	32	VMOD
34	vivo	vivo	I-ADVP	FW	O	33	AMOD
35	,	,	O	,	O	31	P
36	no	no	B-VP	RB	O	38	VMOD
37	longer	longer	I-VP	RB	O	36	AMOD
38	have	have	I-VP	VB	O	0	ROOT
39	a	a	B-NP	DT	O	40	NMOD
40	silencer	silencer	I-NP	NN	B-DNA	38	OBJ
41	.	.	O	.	O	38	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	previously	previously	I-VP	RB	O	2	VMOD
4	shown	show	I-VP	VBN	O	2	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	minimally	minimally	B-NP	RB	B-cell_line	7	AMOD
7	oxidized	oxidize	I-NP	VBN	I-cell_line	8	NMOD
8	LDL	LDL	I-NP	NN	I-cell_line	12	SUB
9	(	(	O	(	I-cell_line	11	DEP
10	MM-LDL	MM-LDL	B-NP	NN	I-cell_line	11	DEP
11	)	)	O	)	I-cell_line	8	NMOD
12	activated	activate	B-VP	VBD	I-cell_line	5	SBAR
13	endothelial	endothelial	B-NP	JJ	I-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	12	OBJ
15	to	to	B-VP	TO	O	16	VMOD
16	increase	increase	I-VP	VB	O	12	VMOD
17	their	their	B-NP	PRP$	O	18	NMOD
18	interaction	interaction	I-NP	NN	O	16	OBJ
19	with	with	B-PP	IN	O	18	NMOD
20	monocytes	monocyte	B-NP	NNS	B-cell_type	23	NMOD
21	but	but	B-NP	CC	O	23	NMOD
22	not	not	I-NP	RB	O	21	DEP
23	neutrophils	neutrophil	B-NP	NNS	B-cell_type	19	PMOD
24	,	,	O	,	O	12	P
25	inducing	induce	B-VP	VBG	O	12	VMOD
26	monocyte	monocyte	B-NP	NN	O	29	NMOD
27	but	but	B-NP	CC	O	29	NMOD
28	not	not	I-NP	RB	O	27	DEP
29	neutrophil	neutrophil	B-NP	NN	B-cell_type	32	NMOD
30	binding	binding	I-NP	NN	O	32	NMOD
31	and	and	O	CC	O	32	NMOD
32	synthesis	synthesis	B-NP	NN	O	25	OBJ
33	of	of	B-PP	IN	O	32	NMOD
34	monocyte	monocyte	B-NP	NN	B-protein	36	NMOD
35	chemotactic	chemotactic	I-NP	JJ	I-protein	36	NMOD
36	protein-1	protein-1	I-NP	NN	I-protein	40	NMOD
37	and	and	O	CC	O	40	NMOD
38	monocyte	monocyte	B-NP	NN	B-protein	40	NMOD
39	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	40	NMOD
40	factor	factor	I-NP	NN	I-protein	33	PMOD
41	(	(	O	(	O	43	DEP
42	M-CSF	M-CSF	B-NP	NN	B-protein	43	DEP
43	)	)	O	)	O	40	NMOD
44	.	.	O	.	O	2	P

1	Both	Both	O	CC	O	2	NMOD
2	induction	induction	B-NP	NN	O	8	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	monocyte	monocyte	B-NP	NN	O	5	NMOD
5	binding	binding	I-NP	NN	O	3	PMOD
6	and	and	O	CC	O	8	NMOD
7	mRNA	mRNA	B-NP	NN	O	8	NMOD
8	levels	level	I-NP	NNS	O	13	SUB
9	for	for	B-PP	IN	O	8	NMOD
10	M-CSF	M-CSF	B-NP	NN	B-protein	9	PMOD
11	by	by	B-PP	IN	O	8	NMOD
12	MM-LDL	MM-LDL	B-NP	NN	B-protein	11	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	not	not	I-VP	RB	O	13	VMOD
15	inhibited	inhibit	I-VP	VBN	O	13	VC
16	in	in	B-PP	IN	O	15	VMOD
17	protein	protein	B-NP	NN	O	18	AMOD
18	kinase	kinase	I-NP	NN	O	21	NMOD
19	C-depleted	C-depleted	I-NP	JJ	O	18	AMOD
20	endothelial	endothelial	I-NP	JJ	B-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
22	.	.	O	.	O	13	P

1	Although	Although	B-SBAR	IN	O	20	VMOD
2	endothelial	endothelial	B-NP	JJ	B-RNA	10	NMOD
3	leukocyte	leukocyte	I-NP	NN	I-RNA	9	NMOD
4	adhesion	adhesion	I-NP	NN	I-RNA	9	NMOD
5	molecule	molecule	I-NP	NN	I-RNA	9	NMOD
6	(	(	O	(	I-RNA	9	NMOD
7	ELAM	ELAM	B-NP	NN	I-RNA	9	NMOD
8	)	)	O	)	I-RNA	9	NMOD
9	mRNA	mRNA	B-NP	NN	I-RNA	10	NMOD
10	synthesis	synthesis	I-NP	NN	O	11	SUB
11	can	can	B-VP	MD	O	1	SBAR
12	be	be	I-VP	VB	O	11	VC
13	regulated	regulate	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	NF	NF	B-NP	NN	B-protein	17	NMOD
16	kappa	kappa	I-NP	NN	I-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	14	PMOD
18	,	,	O	,	O	20	P
19	ELAM	ELAM	B-NP	NN	B-protein	20	SUB
20	was	be	B-VP	VBD	O	26	VMOD
21	not	not	I-VP	RB	O	20	VMOD
22	expressed	express	I-VP	VBN	O	20	VC
23	and	and	O	CC	O	26	VMOD
24	ELAM	ELAM	B-NP	NN	B-RNA	25	NMOD
25	mRNA	mRNA	I-NP	NN	I-RNA	26	SUB
26	was	be	B-VP	VBD	O	0	ROOT
27	only	only	B-ADJP	RB	O	26	PRD
28	slightly	slightly	I-ADJP	RB	O	27	AMOD
29	elevated	elevated	I-ADJP	JJ	O	27	AMOD
30	in	in	B-PP	IN	O	26	VMOD
31	response	response	B-NP	NN	O	30	PMOD
32	to	to	B-PP	TO	O	31	NMOD
33	MM-LDL	MM-LDL	B-NP	NN	B-protein	32	PMOD
34	.	.	O	.	O	26	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	7	NMOD
4	p65	p65	I-NP	NN	B-protein	7	NMOD
5	antisense	antisense	I-NP	JJ	O	7	NMOD
6	phosphorothioate	phosphorothioate	I-NP	NN	O	7	NMOD
7	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	NN	O	8	SUB
8	had	have	B-VP	VBD	O	0	ROOT
9	no	no	B-NP	DT	O	11	NMOD
10	significant	significant	I-NP	JJ	O	11	NMOD
11	effect	effect	I-NP	NN	O	8	OBJ
12	on	on	B-PP	IN	O	8	VMOD
13	the	the	B-NP	DT	O	14	NMOD
14	production	production	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	reactive	reactive	B-NP	JJ	O	18	NMOD
17	oxygen	oxygen	I-NP	NN	O	18	NMOD
18	intermediates	intermediate	I-NP	NNS	O	15	PMOD
19	or	or	B-PP	CC	O	12	PMOD
20	on	on	B-PP	IN	O	12	PMOD
21	phagocytosis	phagocytosis	B-NP	NN	O	20	PMOD
22	by	by	B-PP	IN	O	21	NMOD
23	these	these	B-NP	DT	O	24	NMOD
24	cells	cell	I-NP	NNS	O	22	PMOD
25	.	.	O	.	O	8	P

1	Remarkably	Remarkably	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	observed	observe	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	these	these	B-NP	DT	O	7	NMOD
7	samples	sample	I-NP	NNS	O	8	SUB
8	displayed	display	B-VP	VBD	O	5	SBAR
9	a	a	B-NP	DT	O	11	NMOD
10	persistent	persistent	I-NP	JJ	O	11	NMOD
11	expression	expression	I-NP	NN	O	8	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	c-fos	c-fos	I-NP	NN	B-DNA	15	NMOD
15	protooncogene	protooncogene	I-NP	NN	I-DNA	12	PMOD
16	,	,	O	,	O	11	P
17	associated	associate	B-VP	VBN	O	11	NMOD
18	to	to	B-PP	TO	O	17	VMOD
19	an	an	B-NP	DT	O	23	NMOD
20	increased	increase	I-NP	VBN	O	23	NMOD
21	AP-1	AP-1	I-NP	NN	B-protein	23	NMOD
22	DNA-binding	DNA-binding	I-NP	JJ	O	23	NMOD
23	activity	activity	I-NP	NN	O	18	PMOD
24	,	,	O	,	O	8	P
25	whereas	whereas	O	IN	O	8	VMOD
26	no	no	B-NP	DT	O	27	NMOD
27	variations	variation	I-NP	NNS	O	32	SUB
28	of	of	B-PP	IN	O	27	NMOD
29	CREB	CREB	B-NP	NN	B-protein	31	NMOD
30	or	or	I-NP	CC	O	31	NMOD
31	NF-kB	NF-kB	I-NP	NN	B-protein	28	PMOD
32	were	be	B-VP	VBD	O	25	SBAR
33	detected	detect	I-VP	VBN	O	32	VC
34	.	.	O	.	O	4	P

1	Neither	Neither	O	CC	O	4	NMOD
2	Bt2cAMP	Bt2cAMP	B-NP	NN	O	4	NMOD
3	nor	nor	O	CC	O	4	NMOD
4	PMA	PMA	B-NP	NN	O	6	SUB
5	individually	individually	B-ADVP	RB	O	6	VMOD
6	mediated	mediate	B-VP	VBD	O	0	ROOT
7	these	these	B-NP	DT	O	9	NMOD
8	sustained	sustained	I-NP	JJ	O	9	NMOD
9	effects	effect	I-NP	NNS	O	6	OBJ
10	,	,	O	,	O	9	P
11	which	which	B-NP	WDT	O	9	NMOD
12	therefore	therefore	B-ADVP	RB	O	13	VMOD
13	appear	appear	B-VP	VBP	O	11	SBAR
14	as	as	B-PP	IN	O	13	VMOD
15	a	a	B-NP	DT	O	16	NMOD
16	consequence	consequence	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	interplay	interplay	I-NP	NN	O	17	PMOD
20	between	between	B-PP	IN	O	19	NMOD
21	both	both	B-NP	DT	O	23	NMOD
22	metabolic	metabolic	I-NP	JJ	O	23	NMOD
23	stimuli	stimulus	I-NP	NNS	O	20	PMOD
24	.	.	O	.	O	6	P

1	On	On	B-PP	IN	O	16	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	contrary	contrary	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	16	P
5	other	other	B-NP	JJ	O	7	NMOD
6	steroid	steroid	I-NP	NN	O	7	NMOD
7	hormones	hormone	I-NP	NNS	O	16	SUB
8	such	such	B-PP	JJ	O	9	PMOD
9	as	as	I-PP	IN	O	7	NMOD
10	Tx	Tx	B-NP	NN	O	15	NMOD
11	,	,	O	,	O	15	P
12	progesterone	progesterone	B-NP	NN	O	15	NMOD
13	,	,	O	,	O	15	P
14	and	and	O	CC	O	15	NMOD
15	testosterone	testosterone	B-NP	NN	O	9	PMOD
16	had	have	B-VP	VBD	O	0	ROOT
17	no	no	B-NP	DT	O	18	NMOD
18	effect	effect	I-NP	NN	O	16	OBJ
19	.	.	O	.	O	16	P

1	RESULTS	RESULTS	B-NP	NNS	O	16	VMOD
2	:	:	O	:	O	1	P
3	In	In	B-PP	IN	O	16	VMOD
4	the	the	B-NP	DT	O	7	NMOD
5	OM-10.1	OM-10.1	I-NP	NN	O	7	NMOD
6	promyelocytic	promyelocytic	I-NP	JJ	O	7	NMOD
7	model	model	I-NP	NN	O	3	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	chronic	chronic	B-NP	JJ	O	10	NMOD
10	infection	infection	I-NP	NN	O	8	PMOD
11	,	,	O	,	O	16	P
12	TNF-alpha-induced	TNF-alpha-induced	B-NP	JJ	O	14	NMOD
13	HIV-1	HIV-1	I-NP	NN	O	14	NMOD
14	expression	expression	I-NP	NN	O	16	SUB
15	also	also	B-ADVP	RB	O	16	VMOD
16	resulted	result	B-VP	VBD	O	0	ROOT
17	in	in	B-PP	IN	O	16	VMOD
18	a	a	B-NP	DT	O	20	NMOD
19	substantial	substantial	I-NP	JJ	O	20	NMOD
20	increase	increase	I-NP	NN	O	17	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	75	75	B-NP	CD	B-protein	25	NMOD
23	kd	kd	I-NP	NN	I-protein	25	NMOD
24	TNF	TNF	I-NP	NN	I-protein	25	NMOD
25	receptor	receptor	I-NP	NN	I-protein	29	NMOD
26	(	(	O	(	O	28	DEP
27	TR75	TR75	B-NP	NN	B-protein	28	DEP
28	)	)	O	)	O	25	NMOD
29	expression	expression	B-NP	NN	O	21	PMOD
30	although	although	B-SBAR	IN	O	16	VMOD
31	55	55	B-NP	CD	B-protein	34	NMOD
32	kD	kD	I-NP	NN	I-protein	34	NMOD
33	TNF	TNF	I-NP	NN	I-protein	34	NMOD
34	receptor	receptor	I-NP	NN	I-protein	38	NMOD
35	(	(	O	(	O	37	DEP
36	TR55	TR55	B-NP	NN	B-protein	37	DEP
37	)	)	O	)	O	34	NMOD
38	levels	level	B-NP	NNS	O	39	SUB
39	were	be	B-VP	VBD	O	30	SBAR
40	not	not	I-VP	RB	O	39	VMOD
41	dramatically	dramatically	I-VP	RB	O	39	VMOD
42	altered	alter	I-VP	VBN	O	39	VC
43	.	.	O	.	O	16	P

1	Antibody	Antibody	B-NP	NN	O	2	NMOD
2	cross-linking	cross-linking	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	TR55	TR55	B-NP	NN	B-protein	3	PMOD
5	,	,	O	,	O	2	P
6	in	in	B-PP	IN	O	2	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	absence	absence	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	exogenous	exogenous	B-NP	JJ	O	11	NMOD
11	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	9	PMOD
12	,	,	O	,	O	2	P
13	induced	induce	B-VP	VBD	O	0	ROOT
14	maximal	maximal	B-NP	JJ	O	16	NMOD
15	HIV-1	HIV-1	I-NP	NN	O	16	NMOD
16	expression	expression	I-NP	NN	O	28	NMOD
17	,	,	O	,	O	28	P
18	an	an	B-NP	DT	O	19	NMOD
19	up-modulation	up-modulation	I-NP	NN	O	28	NMOD
20	of	of	B-PP	IN	O	19	NMOD
21	surface	surface	B-NP	NN	O	22	NMOD
22	TR75	TR75	I-NP	NN	B-protein	20	PMOD
23	,	,	O	,	O	28	P
24	and	and	O	CC	O	28	NMOD
25	nuclear	nuclear	B-NP	JJ	O	28	NMOD
26	NF-kappa	NF-kappa	I-NP	NN	B-protein	28	NMOD
27	B	B	I-NP	NN	I-protein	28	NMOD
28	activity	activity	I-NP	NN	O	13	OBJ
29	in	in	B-PP	IN	O	28	NMOD
30	OM-10.1	OM-10.1	B-NP	NN	B-cell_line	31	NMOD
31	cultures	culture	I-NP	NNS	I-cell_line	29	PMOD
32	.	.	O	.	O	13	P

1	They	They	B-NP	PRP	O	2	SUB
2	do	do	B-VP	VBP	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	directly	directly	I-VP	RB	O	2	VMOD
5	intercept	intercept	I-VP	VB	O	2	VC
6	intracellular	intracellular	B-NP	JJ	B-protein	8	NMOD
7	signalling	signalling	I-NP	NN	I-protein	8	NMOD
8	molecules	molecule	I-NP	NNS	I-protein	5	OBJ
9	.	.	O	.	O	2	P

1	So	So	B-ADVP	RB	O	5	VMOD
2	far	far	I-ADVP	RB	O	1	AMOD
3	,	,	O	,	O	5	P
4	there	there	B-NP	EX	O	5	SUB
5	are	be	B-VP	VBP	O	0	ROOT
6	no	no	B-NP	DT	O	9	NMOD
7	drugs	drug	I-NP	NNS	O	9	NMOD
8	or	or	I-NP	CC	O	9	NMOD
9	therapy	therapy	I-NP	NN	O	5	PRD
10	available	available	B-ADJP	JJ	O	9	NMOD
11	that	that	B-NP	WDT	O	9	NMOD
12	can	can	B-VP	MD	O	11	SBAR
13	provide	provide	I-VP	VB	O	12	VC
14	protection	protection	B-NP	NN	O	13	OBJ
15	against	against	B-PP	IN	O	14	NMOD
16	HIV-1	HIV-1	B-NP	NN	O	18	NMOD
17	latency	latency	I-NP	NN	O	18	NMOD
18	reactivation	reactivation	I-NP	NN	O	15	PMOD
19	.	.	O	.	O	5	P

1	Nuclei	Nucleus	B-NP	NNS	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	2	PMOD
4	from	from	B-PP	IN	O	3	NMOD
5	FDC	FDC	B-NP	NN	B-cell_type	6	NMOD
6	clusters	cluster	I-NP	NNS	O	4	PMOD
7	were	be	B-VP	VBD	O	0	ROOT
8	negative	negative	B-ADJP	JJ	O	7	PRD
9	.	.	O	.	O	7	P

1	p65	p65	B-NP	NN	B-protein	2	SUB
2	was	be	B-VP	VBD	O	10	VMOD
3	detected	detect	I-VP	VBN	O	2	VC
4	in	in	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	cytoplasm	cytoplasm	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	FDC	FDC	B-NP	NN	B-cell_type	7	PMOD
9	,	,	O	,	O	10	P
10	whereas	whereas	O	IN	O	0	ROOT
11	nuclei	nucleus	B-NP	NNS	O	12	SUB
12	were	be	B-VP	VBD	O	10	VMOD
13	negative	negative	B-ADJP	JJ	O	12	PRD
14	.	.	O	.	O	10	P

1	c-Rel	c-Rel	B-NP	NN	B-protein	2	NMOD
2	protein	protein	I-NP	NN	I-protein	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	detected	detect	I-VP	VBN	O	3	VC
5	only	only	B-ADVP	RB	O	6	PMOD
6	in	in	B-PP	IN	O	4	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	cytoplasm	cytoplasm	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	9	PMOD
11	and	and	B-PP	CC	O	6	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	in	in	I-PP	IN	O	6	PMOD
14	the	the	B-NP	DT	O	15	NMOD
15	nucleus	nucleus	I-NP	NN	O	13	PMOD
16	and	and	I-NP	CC	O	3	VMOD
17	cytoplasm	cytoplasm	I-NP	NN	O	3	VMOD
18	of	of	B-PP	IN	O	17	NMOD
19	FDC	FDC	B-NP	NN	B-cell_type	18	PMOD
20	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	hypothesis	hypothesis	I-NP	NN	O	6	SUB
3	to	to	B-VP	TO	O	4	VMOD
4	be	be	I-VP	VB	O	2	NMOD
5	tested	test	I-VP	VBN	O	4	VC
6	was	be	B-VP	VBD	O	0	ROOT
7	whether	whether	B-SBAR	IN	O	6	PRD
8	or	or	O	CC	O	7	DEP
9	not	not	O	RB	O	7	DEP
10	humans	human	B-NP	NNS	O	11	SUB
11	exhibit	exhibit	B-VP	VBP	O	7	SBAR
12	a	a	B-NP	DT	O	14	NMOD
13	similar	similar	I-NP	JJ	O	14	NMOD
14	susceptibility	susceptibility	I-NP	NN	O	11	OBJ
15	to	to	B-PP	TO	O	14	NMOD
16	PCDDs/PCDFs	PCDDs/PCDF	B-NP	NNS	O	15	PMOD
17	with	with	B-PP	IN	O	11	VMOD
18	respect	respect	B-NP	NN	O	17	PMOD
19	to	to	B-PP	TO	O	17	PMOD
20	the	the	B-NP	DT	O	22	NMOD
21	surface	surface	I-NP	NN	B-protein	22	NMOD
22	receptors	receptor	I-NP	NNS	I-protein	17	PMOD
23	found	find	B-VP	VBN	O	22	NMOD
24	previously	previously	B-ADVP	RB	O	23	VMOD
25	to	to	B-VP	TO	O	26	VMOD
26	respond	respond	I-VP	VB	O	23	VMOD
27	to	to	B-PP	TO	O	26	VMOD
28	small	small	B-NP	JJ	O	29	NMOD
29	doses	dose	I-NP	NNS	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	2	2	B-NP	CD	O	30	PMOD
32	,	,	I-NP	,	O	37	P
33	3	3	I-NP	CD	O	37	NMOD
34	,	,	I-NP	,	O	37	P
35	7	7	I-NP	CD	O	37	NMOD
36	,	,	O	,	O	37	P
37	8-tetrachlorodibenzo-p-dioxin	8-tetrachlorodibenzo-p-dioxin	B-NP	NN	O	31	NMOD
38	(	(	O	(	O	40	DEP
39	TCDD	TCDD	B-NP	NN	O	40	DEP
40	)	)	O	)	O	37	NMOD
41	in	in	B-PP	IN	O	37	NMOD
42	Callithrix	Callithrix	B-NP	FW	O	43	NMOD
43	jacchus	jacchus	I-NP	FW	O	41	PMOD
44	.	.	O	.	O	6	P

1	There	There	B-NP	EX	O	2	SUB
2	were	be	B-VP	VBD	O	0	ROOT
3	two	two	B-NP	CD	O	5	NMOD
4	main	main	I-NP	JJ	O	5	NMOD
5	goals	goal	I-NP	NNS	O	2	PRD
6	:	:	O	:	O	5	P
7	(	(	B-LST	(	O	8	DEP
8	1	1	I-LST	LS	O	11	VMOD
9	)	)	O	)	O	8	DEP
10	to	to	B-VP	TO	O	11	VMOD
11	evaluate	evaluate	I-VP	VB	O	57	VMOD
12	whether	whether	B-SBAR	IN	O	11	VMOD
13	workers	worker	B-NP	NNS	O	32	SUB
14	with	with	B-PP	IN	O	13	NMOD
15	a	a	B-NP	DT	O	19	NMOD
16	moderately	moderately	I-NP	RB	O	17	AMOD
17	increased	increase	I-NP	VBN	O	19	NMOD
18	PCDD/PCDF-body	PCDD/PCDF-body	I-NP	NN	O	19	NMOD
19	burden	burden	I-NP	NN	O	14	PMOD
20	[	[	O	(	O	31	DEP
21	25-140	25-140	B-NP	CD	O	23	NMOD
22	ppt	ppt	I-NP	NN	O	21	AMOD
23	TCDD	TCDD	I-NP	NN	O	27	NMOD
24	or	or	O	CC	O	27	NMOD
25	104-522	104-522	B-NP	CD	O	27	NMOD
26	ppt	ppt	I-NP	NN	O	25	AMOD
27	I-TE	I-TE	I-NP	NN	O	31	DEP
28	in	in	B-PP	IN	O	27	NMOD
29	blood	blood	B-NP	NN	O	30	NMOD
30	fat	fat	I-NP	NN	O	28	PMOD
31	]	]	O	)	O	19	NMOD
32	exhibit	exhibit	B-VP	VBP	O	12	SBAR
33	changes	change	B-NP	NNS	O	32	OBJ
34	in	in	B-PP	IN	O	33	NMOD
35	the	the	B-NP	DT	O	37	NMOD
36	surface	surface	I-NP	NN	B-protein	37	NMOD
37	receptors	receptor	I-NP	NNS	I-protein	34	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	white	white	B-NP	JJ	B-cell_type	41	NMOD
40	blood	blood	I-NP	NN	I-cell_type	41	NMOD
41	cells	cell	I-NP	NNS	I-cell_type	38	PMOD
42	,	,	O	,	O	32	P
43	as	as	B-SBAR	IN	O	32	VMOD
44	observed	observe	B-VP	VBN	O	43	SBAR
45	in	in	B-PP	IN	O	44	VMOD
46	previous	previous	B-NP	JJ	O	47	NMOD
47	studies	study	I-NP	NNS	O	45	PMOD
48	in	in	B-PP	IN	O	47	NMOD
49	non-human	non-human	B-NP	JJ	O	50	NMOD
50	primates	primate	I-NP	NNS	O	48	PMOD
51	,	,	O	,	O	57	P
52	and	and	O	CC	O	57	VMOD
53	(	(	B-LST	(	O	54	DEP
54	2	2	I-LST	LS	O	57	VMOD
55	)	)	O	)	O	54	DEP
56	to	to	B-VP	TO	O	57	VMOD
57	clarify	clarify	I-VP	VB	O	5	NMOD
58	whether	whether	B-SBAR	IN	O	57	VMOD
59	persons	person	B-NP	NNS	O	88	SUB
60	at	at	B-PP	IN	O	59	NMOD
61	the	the	B-NP	DT	O	63	NMOD
62	upper	upper	I-NP	JJ	O	63	NMOD
63	range	range	I-NP	NN	O	60	PMOD
64	[	[	O	(	O	75	DEP
65	10-23	10-23	B-NP	CD	O	67	NMOD
66	ppt	ppt	I-NP	NN	O	65	AMOD
67	TCDD	TCDD	I-NP	NN	O	71	NMOD
68	or	or	O	CC	O	71	NMOD
69	30-90	30-90	B-NP	CD	O	71	NMOD
70	ppt	ppt	I-NP	NN	O	69	AMOD
71	I-TE	I-TE	I-NP	NN	O	75	DEP
72	in	in	B-PP	IN	O	71	NMOD
73	blood	blood	B-NP	NN	O	74	NMOD
74	fat	fat	I-NP	NN	O	72	PMOD
75	]	]	O	)	O	63	NMOD
76	of	of	B-PP	IN	O	63	NMOD
77	the	the	B-NP	DT	O	81	NMOD
78	body	body	I-NP	NN	O	81	NMOD
79	burden	burden	I-NP	NN	O	81	NMOD
80	reference	reference	I-NP	NN	O	81	NMOD
81	values	value	I-NP	NNS	O	76	PMOD
82	of	of	B-PP	IN	O	81	NMOD
83	a	a	O	DT	O	87	NMOD
84	not	not	O	RB	O	87	NMOD
85	particularly	particularly	B-NP	RB	O	84	AMOD
86	exposed	expose	I-NP	VBN	O	84	AMOD
87	population	population	I-NP	NN	O	82	PMOD
88	show	show	B-VP	VBP	O	58	SBAR
89	detectable	detectable	B-NP	JJ	O	90	NMOD
90	deviations	deviation	I-NP	NNS	O	88	OBJ
91	in	in	B-PP	IN	O	88	VMOD
92	these	these	B-NP	DT	O	94	NMOD
93	immunological	immunological	I-NP	JJ	O	94	NMOD
94	variables	variable	I-NP	NNS	O	91	PMOD
95	,	,	O	,	O	88	P
96	when	when	B-ADVP	WRB	O	88	VMOD
97	compared	compare	B-PP	VBN	O	96	SBAR
98	with	with	B-PP	IN	O	97	VMOD
99	persons	person	B-NP	NNS	O	98	PMOD
100	at	at	B-PP	IN	O	99	NMOD
101	the	the	B-NP	DT	O	105	NMOD
102	lower	low	I-NP	JJR	O	104	AMOD
103	and	and	I-NP	CC	O	104	AMOD
104	medium	medium	I-NP	NN	O	105	NMOD
105	range	range	I-NP	NN	O	100	PMOD
106	[	[	I-NP	(	O	114	DEP
107	1-3	1-3	I-NP	NN	O	109	NMOD
108	ppt	ppt	I-NP	NN	O	107	AMOD
109	TCDD	TCDD	I-NP	NN	O	113	NMOD
110	or	or	O	CC	O	113	NMOD
111	9-29	9-29	B-NP	CD	O	113	NMOD
112	ppt	ppt	I-NP	NN	O	111	AMOD
113	I-TE	I-TE	I-NP	NN	O	114	DEP
114	]	]	O	)	O	105	NMOD
115	of	of	B-PP	IN	O	105	NMOD
116	these	these	B-NP	DT	O	120	NMOD
117	body	body	I-NP	NN	O	120	NMOD
118	burden	burden	I-NP	NN	O	120	NMOD
119	reference	reference	I-NP	NN	O	120	NMOD
120	values	value	I-NP	NNS	O	115	PMOD
121	.	.	O	.	O	2	P

1	None	None	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	alterations	alteration	I-NP	NNS	O	2	PMOD
5	observed	observe	B-VP	VBN	O	4	NMOD
6	are	be	B-VP	VBP	O	0	ROOT
7	of	of	B-PP	IN	O	6	PRD
8	medical	medical	B-NP	JJ	O	9	NMOD
9	relevance	relevance	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	6	P

1	Altogether	Altogether	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	the	the	B-NP	DT	O	4	NMOD
4	data	datum	I-NP	NNS	O	5	SUB
5	do	do	B-VP	VBP	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	provide	provide	I-VP	VB	O	5	VC
8	any	any	B-NP	DT	O	9	NMOD
9	evidence	evidence	I-NP	NN	O	7	OBJ
10	to	to	B-VP	TO	O	11	VMOD
11	support	support	I-VP	VB	O	9	NMOD
12	an	an	B-NP	DT	O	13	NMOD
13	assumption	assumption	I-NP	NN	O	11	OBJ
14	that	that	B-SBAR	IN	O	13	NMOD
15	moderately	moderately	B-NP	RB	O	16	AMOD
16	increased	increase	I-NP	VBN	O	18	NMOD
17	body	body	I-NP	NN	O	18	NMOD
18	burdens	burden	I-NP	NNS	O	23	SUB
19	of	of	B-PP	IN	O	18	NMOD
20	PCDDs/PCDFs	PCDDs/PCDF	B-NP	NNS	O	19	PMOD
21	in	in	B-PP	IN	O	18	NMOD
22	adults	adult	B-NP	NNS	O	21	PMOD
23	induce	induce	B-VP	VBP	O	14	SBAR
24	decreases	decrease	B-NP	NNS	O	23	OBJ
25	in	in	B-PP	IN	O	24	NMOD
26	the	the	B-NP	DT	O	28	NMOD
27	cellular	cellular	I-NP	JJ	O	28	NMOD
28	components	component	I-NP	NNS	O	25	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	33	NMOD
31	human	human	I-NP	JJ	O	33	NMOD
32	immune	immune	I-NP	JJ	O	33	NMOD
33	system	system	I-NP	NN	O	29	PMOD
34	.	.	O	.	O	5	P

1	Tax	Tax	B-NP	NN	B-protein	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	transfected	transfecte	I-VP	VBN	O	2	VC
4	into	into	B-PP	IN	O	3	VMOD
5	HTLV-I-negative	HTLV-I-negative	B-NP	JJ	B-cell_line	8	NMOD
6	human	human	I-NP	JJ	I-cell_line	8	NMOD
7	T-cell	T-cell	I-NP	NN	I-cell_line	8	NMOD
8	lines	line	I-NP	NNS	I-cell_line	4	PMOD
9	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	0	ROOT
2	JM	JM	B-NP	NN	B-cell_line	4	NMOD
3	T	T	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
5	,	,	O	,	O	1	VMOD
6	tax	tax	B-NP	NN	B-protein	9	SUB
7	induced	induce	B-VP	VBD	O	9	VMOD
8	LT-293	LT-293	B-NP	NN	B-DNA	9	NMOD
9	activity	activity	I-NP	NN	O	5	NMOD
10	by	by	B-PP	IN	O	9	NMOD
11	two-	two-	B-NP	CD	O	13	NMOD
12	to	to	B-PP	TO	O	13	NMOD
13	four-fold	four-fold	B-NP	RB	O	10	PMOD
14	,	,	O	,	O	9	P
15	though	though	B-SBAR	IN	O	9	NMOD
16	there	there	B-NP	EX	O	17	SUB
17	was	be	B-VP	VBD	O	15	SBAR
18	no	no	B-NP	DT	O	19	NMOD
19	induction	induction	I-NP	NN	O	17	PRD
20	of	of	B-PP	IN	O	19	NMOD
21	M1-CAT	M1-CAT	B-NP	NN	B-protein	20	PMOD
22	.	.	O	.	O	9	P

1	Increased	Increase	B-NP	VBN	O	5	NMOD
2	natural	natural	I-NP	JJ	O	5	NMOD
3	killer	killer	I-NP	NN	O	5	NMOD
4	cell	cell	I-NP	NN	O	5	NMOD
5	activity	activity	I-NP	NN	O	6	SUB
6	correlates	correlate	B-VP	VBZ	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	low	low	B-NP	JJ	O	10	AMOD
9	or	or	I-NP	CC	O	10	AMOD
10	negative	negative	I-NP	JJ	O	11	NMOD
11	expression	expression	I-NP	NN	O	7	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	HER-2/neu	HER-2/neu	I-NP	NN	B-DNA	15	NMOD
15	oncogene	oncogene	I-NP	NN	I-DNA	12	PMOD
16	in	in	B-PP	IN	O	11	NMOD
17	patients	patient	B-NP	NNS	O	16	PMOD
18	with	with	B-PP	IN	O	17	NMOD
19	breast	breast	B-NP	NN	O	20	NMOD
20	cancer	cancer	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	6	P

1	Within	Within	B-PP	IN	O	10	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	group	group	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	patients	patient	B-NP	NNS	O	4	PMOD
6	,	,	O	,	O	10	P
7	NK	NK	B-NP	NN	B-cell_type	9	NMOD
8	cell	cell	I-NP	NN	I-cell_type	9	NMOD
9	activity	activity	I-NP	NN	O	10	SUB
10	was	be	B-VP	VBD	O	0	ROOT
11	significantly	significantly	B-ADJP	RB	O	12	AMOD
12	lower	low	I-ADJP	JJR	O	10	PRD
13	(	(	O	(	O	18	DEP
14	45.6	45.6	B-NP	CD	O	16	AMOD
15	±	±	O	SYM	O	16	AMOD
16	16.1	16.1	B-NP	CD	O	17	NMOD
17	%	%	I-NP	NN	O	18	DEP
18	)	)	O	)	O	12	AMOD
19	compared	compare	B-PP	VBN	O	10	VMOD
20	with	with	B-PP	IN	O	19	PMOD
21	the	the	B-NP	DT	O	22	NMOD
22	group	group	I-NP	NN	O	20	PMOD
23	with	with	B-PP	IN	O	22	NMOD
24	no	no	B-NP	DT	O	26	NMOD
25	HER-2/neu	HER-2/neu	I-NP	NN	B-protein	26	NMOD
26	overexpression	overexpression	I-NP	NN	O	23	PMOD
27	(	(	O	(	O	32	DEP
28	57.3	57.3	B-NP	CD	O	30	AMOD
29	±	±	O	SYM	O	30	AMOD
30	11.0	11.0	B-NP	CD	O	31	NMOD
31	%	%	I-NP	NN	O	32	DEP
32	)	)	O	)	O	22	NMOD
33	.	.	O	.	O	10	P

1	NK	NK	B-NP	NN	B-cell_type	3	NMOD
2	cell	cell	I-NP	NN	I-cell_type	3	NMOD
3	activity	activity	I-NP	NN	O	4	SUB
4	did	do	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	increase	increase	I-VP	VB	O	4	VC
7	in	in	B-PP	IN	O	6	VMOD
8	patients	patient	B-NP	NNS	O	7	PMOD
9	with	with	B-PP	IN	O	8	NMOD
10	HER-2/neu	HER-2/neu	B-NP	NN	B-protein	11	NMOD
11	overexpression	overexpression	I-NP	NN	O	9	PMOD
12	.	.	O	.	O	4	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	there	there	B-NP	EX	O	4	SUB
4	was	be	B-VP	VBD	O	29	VMOD
5	a	a	B-NP	DT	O	8	NMOD
6	statistically	statistically	I-NP	RB	O	7	AMOD
7	significant	significant	I-NP	JJ	O	8	NMOD
8	correlation	correlation	I-NP	NN	O	4	PRD
9	of	of	B-PP	IN	O	8	NMOD
10	cytolytic	cytolytic	B-NP	JJ	B-cell_type	13	NMOD
11	effector	effector	I-NP	NN	I-cell_type	13	NMOD
12	cell	cell	I-NP	NN	I-cell_type	13	NMOD
13	function	function	I-NP	NN	O	9	PMOD
14	with	with	B-PP	IN	O	8	NMOD
15	HER-2/neu	HER-2/neu	B-NP	NN	B-protein	16	NMOD
16	expression	expression	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	tumor	tumor	I-NP	NN	O	17	PMOD
20	(	(	O	(	O	24	DEP
21	P	P	B-NP	NN	O	23	SUB
22	=	=	B-VP	SYM	O	23	VMOD
23	0.003	0.003	B-NP	CD	O	24	DEP
24	)	)	O	)	O	16	NMOD
25	,	,	O	,	O	29	P
26	and	and	O	CC	O	29	VMOD
27	HER-2/neu	HER-2/neu	B-NP	NN	B-protein	28	NMOD
28	overexpression	overexpression	I-NP	NN	O	29	SUB
29	correlated	correlate	B-VP	VBD	O	0	ROOT
30	with	with	B-PP	IN	O	29	VMOD
31	a	a	B-NP	DT	O	35	NMOD
32	negative	negative	I-NP	JJ	O	35	NMOD
33	estrogen	estrogen	I-NP	NN	B-protein	35	NMOD
34	receptor	receptor	I-NP	NN	I-protein	35	NMOD
35	status	status	I-NP	NN	O	30	PMOD
36	(	(	O	(	O	40	DEP
37	P	P	B-NP	NN	O	39	SUB
38	=	=	B-VP	SYM	O	39	VMOD
39	0.005	0.005	B-NP	CD	O	40	DEP
40	)	)	O	)	O	35	NMOD
41	.	.	O	.	O	29	P

1	This	This	B-NP	DT	O	2	NMOD
2	effect	effect	I-NP	NN	O	3	SUB
3	required	require	B-VP	VBD	O	0	ROOT
4	surface	surface	B-NP	NN	O	5	NMOD
5	expression	expression	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	CD45	CD45	I-NP	NN	B-protein	9	NMOD
9	PTPase	PTPase	I-NP	NN	I-protein	6	PMOD
10	and	and	O	CC	O	3	VMOD
11	was	be	B-VP	VBD	O	3	VMOD
12	not	not	I-VP	RB	O	11	VMOD
13	observed	observe	I-VP	VBN	O	11	VC
14	in	in	B-PP	IN	O	13	VMOD
15	CD45-deficient	CD45-deficient	B-NP	JJ	B-cell_line	16	NMOD
16	variants	variant	I-NP	NNS	I-cell_line	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	Jurkat	Jurkat	B-NP	NN	B-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	17	PMOD
20	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	13	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	CD45-negative	CD45-negative	I-NP	JJ	B-cell_line	4	NMOD
4	variant	variant	I-NP	NN	I-cell_line	1	PMOD
5	,	,	O	,	O	13	P
6	the	the	B-NP	DT	O	7	NMOD
7	effect	effect	I-NP	NN	O	13	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	pervanadate	pervanadate	B-NP	NN	O	8	PMOD
10	on	on	B-PP	IN	O	7	NMOD
11	tyrosine	tyrosine	B-NP	NN	O	12	NMOD
12	phosphorylation	phosphorylation	I-NP	NN	O	10	PMOD
13	was	be	B-VP	VBD	O	20	VMOD
14	globally	globally	I-VP	RB	O	13	VMOD
15	decreased	decrease	I-VP	VBN	O	13	VC
16	and	and	O	CC	O	20	VMOD
17	some	some	B-NP	DT	O	19	NMOD
18	phosphorylated	phosphorylate	I-NP	VBN	O	19	NMOD
19	substrates	substrate	I-NP	NNS	O	20	SUB
20	were	be	B-VP	VBD	O	0	ROOT
21	specifically	specifically	B-ADJP	RB	O	20	VMOD
22	missing	missing	I-ADJP	JJ	O	20	PRD
23	.	.	O	.	O	20	P

1	We	We	B-NP	PRP	O	3	SUB
2	thus	thus	B-ADVP	RB	O	3	VMOD
3	conclude	conclude	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	PTPases	PTPas	B-NP	NNS	B-protein	6	SUB
6	play	play	B-VP	VBP	O	4	SBAR
7	a	a	B-NP	DT	O	9	NMOD
8	crucial	crucial	I-NP	JJ	O	9	NMOD
9	role	role	I-NP	NN	O	6	OBJ
10	in	in	B-PP	IN	O	6	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	negative	negative	I-NP	JJ	O	13	NMOD
13	regulation	regulation	I-NP	NN	O	10	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	signal	signal	B-NP	NN	O	16	NMOD
16	transduction	transduction	I-NP	NN	O	14	PMOD
17	culminating	culminate	B-VP	VBG	O	16	NMOD
18	in	in	B-PP	IN	O	17	VMOD
19	T-lymphocyte	T-lymphocyte	B-NP	NN	B-cell_type	20	NMOD
20	activation	activation	I-NP	NN	O	18	PMOD
21	.	.	O	.	O	3	P

1	Patients	Patient	B-NP	NNS	O	2	SUB
2	were	be	B-VP	VBD	O	0	ROOT
3	classified	classify	I-VP	VBN	O	2	VC
4	as	as	B-PP	IN	O	3	VMOD
5	steroid	steroid	B-NP	NN	O	4	PMOD
6	sensitive	sensitive	B-ADJP	JJ	O	5	AMOD
7	(	(	O	(	O	9	DEP
8	SS	SS	B-NP	NN	O	9	DEP
9	)	)	O	)	O	5	AMOD
10	if	if	B-SBAR	IN	O	3	VMOD
11	their	their	B-NP	PRP$	O	13	NMOD
12	morning	morning	I-NP	NN	O	13	NMOD
13	FEV1	FEV1	I-NP	NN	O	14	SUB
14	increased	increase	B-VP	VBD	O	10	SBAR
15	&	&	B-NP	CC	O	14	VMOD
16	gt	gt	I-NP	NN	O	19	NMOD
17	;	;	O	:	O	19	P
18	30	30	B-NP	CD	O	19	NMOD
19	%	%	I-NP	NN	O	15	PMOD
20	after	after	B-PP	IN	O	19	NMOD
21	a	a	B-NP	DT	O	23	NMOD
22	1-wk	1-wk	I-NP	JJ	O	23	NMOD
23	course	course	I-NP	NN	O	20	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	oral	oral	B-NP	JJ	O	26	NMOD
26	prednisone	prednisone	I-NP	NN	O	28	NMOD
27	20	20	I-NP	CD	O	28	NMOD
28	mg	mg	I-NP	NN	O	24	PMOD
29	twice	twice	B-ADVP	RB	O	28	NMOD
30	daily	daily	I-ADVP	RB	O	29	AMOD
31	and	and	O	CC	O	32	NMOD
32	steroid	steroid	B-NP	NN	O	19	DEP
33	resistant	resistant	B-ADJP	JJ	O	32	AMOD
34	(	(	O	(	O	36	DEP
35	SR	SR	B-NP	NN	O	36	DEP
36	)	)	O	)	O	32	AMOD
37	if	if	B-SBAR	IN	O	32	NMOD
38	they	they	B-NP	PRP	O	39	SUB
39	failed	fail	B-VP	VBD	O	37	SBAR
40	to	to	I-VP	TO	O	41	VMOD
41	increase	increase	I-VP	VB	O	39	VMOD
42	&	&	I-VP	CC	O	41	VMOD
43	gt	gt	I-VP	VB	O	41	VMOD
44	;	;	O	:	O	41	P
45	15	15	B-NP	CD	O	46	NMOD
46	%	%	I-NP	NN	O	41	VMOD
47	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	5	NMOD
2	other	other	I-NP	JJ	O	5	NMOD
3	two	two	I-NP	CD	O	5	NMOD
4	SR	SR	I-NP	JJ	O	5	NMOD
5	patients	patient	I-NP	NNS	O	6	SUB
6	had	have	B-VP	VBD	O	0	ROOT
7	an	an	B-NP	DT	O	11	NMOD
8	abnormally	abnormally	I-NP	RB	O	9	AMOD
9	low	low	I-NP	JJ	O	11	NMOD
10	GR	GR	I-NP	NN	B-protein	11	NMOD
11	number	number	I-NP	NN	O	6	OBJ
12	with	with	B-PP	IN	O	11	NMOD
13	normal	normal	B-NP	JJ	O	15	NMOD
14	binding	binding	I-NP	NN	O	15	NMOD
15	affinity	affinity	I-NP	NN	O	12	PMOD
16	that	that	B-NP	WDT	O	15	NMOD
17	was	be	B-VP	VBD	O	16	SBAR
18	not	not	I-VP	RB	O	17	VMOD
19	limited	limit	I-VP	VBN	O	17	VC
20	to	to	B-PP	TO	O	19	VMOD
21	T	T	B-NP	NN	B-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
23	.	.	O	.	O	6	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	GR	GR	B-NP	NN	B-protein	4	NMOD
4	number	number	I-NP	NN	O	5	SUB
5	failed	fail	B-VP	VBD	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	normalize	normalize	I-VP	VB	O	5	VMOD
8	after	after	B-PP	IN	O	7	VMOD
9	incubation	incubation	B-NP	NN	O	8	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	media	medium	B-NP	NNS	O	16	NMOD
12	alone	alone	B-ADVP	RB	O	11	NMOD
13	or	or	O	CC	O	16	NMOD
14	IL-2	IL-2	B-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	IL-4	IL-4	I-NP	NN	B-protein	10	PMOD
17	.	.	O	.	O	5	P

1	Rhabdomyosarcomas	Rhabdomyosarcoma	B-NP	NNS	O	2	SUB
2	do	do	B-VP	VBP	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	contain	contain	I-VP	VB	O	2	VC
5	mutations	mutation	B-NP	NNS	O	4	OBJ
6	in	in	B-PP	IN	O	4	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	DNA	DNA	I-NP	NN	B-protein	10	NMOD
9	binding	binding	I-NP	NN	I-protein	10	NMOD
10	domains	domain	I-NP	NNS	I-protein	6	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	myogenic	myogenic	B-NP	JJ	B-protein	14	NMOD
13	transcription	transcription	I-NP	NN	I-protein	14	NMOD
14	factors	factor	I-NP	NNS	I-protein	11	PMOD
15	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	their	their	B-NP	PRP$	O	5	NMOD
4	specific	specific	I-NP	JJ	O	5	NMOD
5	function	function	I-NP	NN	O	9	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	8	NMOD
8	processes	process	I-NP	NNS	O	6	PMOD
9	has	have	B-VP	VBZ	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	been	be	I-VP	VBN	O	9	VC
12	clearly	clearly	I-VP	RB	O	11	VMOD
13	defined	define	I-VP	VBN	O	11	VC
14	.	.	O	.	O	9	P

1	Additionally	Additionally	B-ADVP	RB	O	14	VMOD
2	,	,	O	,	O	14	P
3	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	4	NMOD
4	activity	activity	I-NP	NN	O	13	NMOD
5	but	but	B-NP	CC	O	13	NMOD
6	not	not	I-NP	RB	O	5	DEP
7	IL-1	IL-1	B-NP	NN	B-protein	13	NMOD
8	,	,	O	,	O	13	P
9	IL-2	IL-2	B-NP	NN	B-protein	13	NMOD
10	,	,	O	,	O	13	P
11	or	or	O	CC	O	13	NMOD
12	IL-4	IL-4	B-NP	NN	B-protein	13	NMOD
13	activity	activity	I-NP	NN	O	14	SUB
14	was	be	B-VP	VBD	O	0	ROOT
15	present	present	B-ADJP	JJ	O	14	PRD
16	in	in	B-PP	IN	O	15	AMOD
17	culture	culture	B-NP	NN	O	18	NMOD
18	supernatants	supernatant	I-NP	NNS	O	16	PMOD
19	72	72	B-NP	CD	O	20	NMOD
20	h	h	I-NP	NN	O	21	PMOD
21	after	after	B-PP	IN	O	14	VMOD
22	R24	R24	B-NP	NN	B-protein	23	NMOD
23	stimulation	stimulation	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	14	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	R24	R24	B-NP	NN	B-protein	4	NMOD
4	treatment	treatment	I-NP	NN	O	5	SUB
5	resulted	result	B-VP	VBD	O	0	ROOT
6	in	in	B-PP	IN	O	5	VMOD
7	translocation	translocation	B-NP	NN	O	30	NMOD
8	of	of	B-PP	IN	O	7	NMOD
9	c-rel	c-rel	B-NP	NN	B-protein	20	NMOD
10	,	,	O	,	O	20	P
11	but	but	O	CC	O	20	NMOD
12	little	little	B-NP	JJ	O	14	AMOD
13	or	or	I-NP	CC	O	14	AMOD
14	no	no	I-NP	DT	O	17	NMOD
15	NF	NF	I-NP	NN	B-protein	17	NMOD
16	kappa	kappa	I-NP	NN	I-protein	17	NMOD
17	B	B	I-NP	NN	I-protein	20	NMOD
18	p50	p50	I-NP	NN	I-protein	20	NMOD
19	or	or	O	CC	O	20	NMOD
20	p65	p65	B-NP	NN	B-protein	8	PMOD
21	,	,	O	,	O	20	P
22	from	from	B-PP	IN	O	20	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	cytoplasm	cytoplasm	I-NP	NN	O	22	PMOD
25	to	to	B-PP	TO	O	7	NMOD
26	the	the	B-NP	DT	O	27	NMOD
27	nucleus	nucleus	I-NP	NN	O	25	PMOD
28	and	and	O	CC	O	30	NMOD
29	an	an	B-NP	DT	O	30	NMOD
30	increase	increase	I-NP	NN	O	6	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	NF	NF	B-NP	NN	B-protein	36	NMOD
33	kappa	kappa	I-NP	NN	I-protein	36	NMOD
34	B	B	I-NP	NN	I-protein	36	NMOD
35	binding	binding	I-NP	NN	I-protein	36	NMOD
36	complexes	complex	I-NP	NNS	I-protein	31	PMOD
37	containing	contain	B-VP	VBG	O	36	NMOD
38	c-rel	c-rel	B-NP	NN	B-protein	40	NMOD
39	and	and	I-NP	CC	O	40	NMOD
40	p50	p50	I-NP	NN	B-protein	37	OBJ
41	.	.	O	.	O	5	P

1	Additionally	Additionally	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	herbimycin	herbimycin	B-NP	NN	O	4	NMOD
4	A	A	I-NP	NN	O	9	NMOD
5	,	,	O	,	O	9	P
6	a	a	B-NP	DT	O	9	NMOD
7	tyrosine	tyrosine	I-NP	NN	B-protein	9	NMOD
8	kinase	kinase	I-NP	NN	I-protein	9	NMOD
9	inhibitor	inhibitor	I-NP	NN	O	11	SUB
10	,	,	O	,	O	9	P
11	blocked	block	B-VP	VBD	O	0	ROOT
12	the	the	B-NP	DT	O	14	NMOD
13	R24-stimulated	R24-stimulated	I-NP	JJ	O	14	NMOD
14	increase	increase	I-NP	NN	O	11	OBJ
15	in	in	B-PP	IN	O	14	NMOD
16	proliferation	proliferation	B-NP	NN	O	19	NMOD
17	but	but	B-NP	CC	O	19	NMOD
18	not	not	I-NP	RB	O	17	DEP
19	cytotoxicity	cytotoxicity	B-VP	NN	O	15	PMOD
20	at	at	B-PP	IN	O	11	VMOD
21	concentrations	concentration	B-NP	NNS	O	20	PMOD
22	consistent	consistent	B-ADJP	JJ	O	21	NMOD
23	with	with	B-PP	IN	O	22	AMOD
24	specificity	specificity	B-NP	NN	O	23	PMOD
25	for	for	B-PP	IN	O	24	NMOD
26	tyrosine	tyrosine	B-NP	NN	B-protein	27	NMOD
27	kinases	kinase	I-NP	NNS	I-protein	25	PMOD
28	.	.	O	.	O	11	P

1	Overexpression	Overexpression	B-NP	NN	O	16	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	full-length	full-length	B-NP	JJ	O	2	PMOD
4	SCL	SCL	I-NP	NN	B-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	3	NMOD
6	in	in	B-PP	IN	O	1	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	lymphoid	lymphoid	I-NP	JJ	B-cell_line	10	NMOD
9	cell	cell	I-NP	NN	I-cell_line	10	NMOD
10	lines	line	I-NP	NNS	I-cell_line	14	NMOD
11	,	,	O	,	O	14	P
12	SupT1	SupT1	B-NP	NN	O	14	NMOD
13	and	and	I-NP	CC	O	14	NMOD
14	Raji	Raji	I-NP	NN	B-cell_line	6	PMOD
15	,	,	O	,	O	14	P
16	did	do	B-VP	VBD	O	23	VMOD
17	not	not	I-VP	RB	O	16	VMOD
18	alter	alter	I-VP	VB	O	16	VC
19	cell	cell	B-NP	NN	O	20	NMOD
20	phenotype	phenotype	I-NP	NN	O	18	OBJ
21	and	and	O	CC	O	23	VMOD
22	there	there	B-NP	EX	O	23	SUB
23	was	be	B-VP	VBD	O	0	ROOT
24	no	no	B-NP	DT	O	25	NMOD
25	evidence	evidence	I-NP	NN	O	23	PRD
26	for	for	B-PP	IN	O	25	NMOD
27	autoregulation	autoregulation	B-NP	NN	O	26	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	SCL	SCL	B-NP	NN	B-protein	30	NMOD
30	transcription	transcription	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	23	P

1	The	The	B-NP	DT	O	3	NMOD
2	GM-CSF	GM-CSF	I-NP	NN	B-DNA	3	NMOD
3	gene	gene	I-NP	NN	I-DNA	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	expressed	express	I-VP	VBN	O	4	VC
7	in	in	B-PP	IN	O	6	VMOD
8	resting	rest	B-NP	VBG	B-cell_type	12	NMOD
9	peripheral	peripheral	I-NP	JJ	I-cell_type	12	NMOD
10	blood	blood	I-NP	NN	I-cell_type	12	NMOD
11	T	T	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
13	but	but	O	CC	O	4	VMOD
14	is	be	B-VP	VBZ	O	4	VMOD
15	rapidly	rapidly	I-VP	RB	O	14	VMOD
16	induced	induce	I-VP	VBN	O	14	VC
17	at	at	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	20	NMOD
19	transcriptional	transcriptional	I-NP	JJ	O	20	NMOD
20	level	level	I-NP	NN	O	17	PMOD
21	following	follow	B-PP	VBG	O	16	VMOD
22	activation	activation	B-NP	NN	O	21	PMOD
23	through	through	B-PP	IN	O	16	VMOD
24	the	the	B-NP	DT	O	28	NMOD
25	cell	cell	I-NP	NN	B-protein	28	NMOD
26	surface	surface	I-NP	NN	I-protein	28	NMOD
27	T-cell	T-cell	I-NP	NN	I-protein	28	NMOD
28	receptor	receptor	I-NP	NN	I-protein	23	PMOD
29	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	5	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	we	we	B-NP	PRP	O	5	SUB
5	identify	identify	B-VP	VBP	O	0	ROOT
6	a	a	B-NP	DT	O	11	NMOD
7	major	major	I-NP	JJ	O	11	NMOD
8	PB1	PB1	I-NP	NN	B-protein	11	NMOD
9	nuclear	nuclear	I-NP	JJ	I-protein	11	NMOD
10	protein-binding	protein-binding	I-NP	JJ	I-protein	11	NMOD
11	complex	complex	I-NP	NN	I-protein	5	OBJ
12	that	that	B-NP	WDT	O	11	NMOD
13	is	be	B-VP	VBZ	O	12	SBAR
14	not	not	O	RB	O	13	VMOD
15	present	present	B-ADJP	JJ	O	13	PRD
16	in	in	B-PP	IN	O	15	AMOD
17	resting	rest	B-NP	VBG	B-cell_type	21	NMOD
18	peripheral	peripheral	I-NP	JJ	I-cell_type	21	NMOD
19	blood	blood	I-NP	NN	I-cell_type	21	NMOD
20	T	T	I-NP	NN	I-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
22	but	but	O	CC	O	13	VMOD
23	is	be	B-VP	VBZ	O	13	VMOD
24	rapidly	rapidly	I-VP	RB	O	25	VMOD
25	induced	induce	I-VP	VBN	O	23	VC
26	following	follow	B-PP	VBG	O	25	VMOD
27	T-cell	T-cell	B-NP	NN	O	28	NMOD
28	activation	activation	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	5	P

1	HTLV-I	HTLV-I	B-NP	NN	O	2	SUB
2	encodes	encode	B-VP	VBZ	O	0	ROOT
3	an	an	B-NP	DT	O	6	NMOD
4	essential	essential	I-NP	JJ	O	6	NMOD
5	40-kDa	40-kDa	I-NP	JJ	B-protein	6	NMOD
6	protein	protein	I-NP	NN	I-protein	2	OBJ
7	termed	term	B-VP	VBN	O	6	NMOD
8	Tax	Tax	B-NP	NN	B-protein	7	VMOD
9	that	that	B-NP	WDT	O	6	NMOD
10	not	not	B-CONJP	RB	O	12	VMOD
11	only	only	I-CONJP	RB	O	10	DEP
12	transactivates	transactivate	B-VP	VBZ	O	9	SBAR
13	the	the	B-NP	DT	O	16	NMOD
14	long	long	I-NP	JJ	B-DNA	16	NMOD
15	terminal	terminal	I-NP	JJ	I-DNA	16	NMOD
16	repeat	repeat	I-NP	NN	I-DNA	12	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	this	this	B-NP	DT	O	19	NMOD
19	retrovirus	retrovirus	I-NP	NN	O	17	PMOD
20	but	but	O	CC	O	12	VMOD
21	also	also	B-VP	RB	O	20	DEP
22	induces	induce	I-VP	VBZ	O	12	VMOD
23	an	an	B-NP	DT	O	24	NMOD
24	array	array	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	cellular	cellular	B-NP	JJ	B-DNA	27	NMOD
27	genes	gene	I-NP	NNS	I-DNA	25	PMOD
28	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	17	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	17	P
4	a	a	B-NP	DT	O	5	NMOD
5	mutant	mutant	I-NP	NN	O	17	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	Tax	Tax	B-NP	NN	B-protein	6	PMOD
8	that	that	B-NP	WDT	O	5	NMOD
9	selectively	selectively	B-ADVP	RB	O	10	VMOD
10	fails	fail	B-VP	VBZ	O	8	SBAR
11	to	to	I-VP	TO	O	12	VMOD
12	activate	activate	I-VP	VB	O	10	VMOD
13	nuclear	nuclear	B-NP	JJ	O	16	NMOD
14	NF-kappa	NF-kappa	I-NP	NN	B-protein	16	NMOD
15	B	B	I-NP	NN	I-protein	16	NMOD
16	expression	expression	I-NP	NN	O	12	OBJ
17	does	do	B-VP	VBZ	O	0	ROOT
18	not	not	I-VP	RB	O	17	VMOD
19	associate	associate	I-VP	VB	O	17	VC
20	with	with	B-PP	IN	O	19	VMOD
21	p100	p100	B-NP	NN	B-protein	20	PMOD
22	.	.	O	.	O	17	P

1	The	The	B-NP	DT	O	4	NMOD
2	BZLF1	BZLF1	I-NP	NN	B-DNA	4	NMOD
3	gene	gene	I-NP	NN	I-DNA	4	NMOD
4	promoter	promoter	I-NP	NN	I-DNA	8	SUB
5	(	(	O	(	O	7	DEP
6	Zp	Zp	B-NP	NN	B-DNA	7	DEP
7	)	)	O	)	O	4	NMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	activated	activate	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	crosslinking	crosslinking	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	cell	cell	B-NP	NN	B-protein	15	NMOD
14	surface	surface	I-NP	NN	I-protein	15	NMOD
15	immunoglobulin	immunoglobulin	I-NP	NN	I-protein	12	PMOD
16	(	(	O	(	O	18	DEP
17	Ig	Ig	B-NP	NN	B-protein	18	DEP
18	)	)	O	)	O	15	NMOD
19	with	with	B-PP	IN	O	15	NMOD
20	anti-Ig	anti-Ig	B-NP	JJ	B-protein	21	NMOD
21	antibody	antibody	I-NP	NN	I-protein	19	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	B	B	B-NP	NN	B-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	22	PMOD
25	,	,	O	,	O	9	P
26	even	even	B-ADVP	RB	O	27	PMOD
27	in	in	B-PP	IN	O	9	VMOD
28	the	the	B-NP	DT	O	27	PMOD
29	absence	absence	I-NP	NN	O	27	PMOD
30	of	of	B-PP	IN	O	27	PMOD
31	other	other	B-NP	JJ	O	27	PMOD
32	viral	viral	I-NP	JJ	B-DNA	33	NMOD
33	genes	gene	I-NP	NNS	I-DNA	31	NMOD
34	.	.	O	.	O	8	P

1	This	This	B-NP	DT	O	2	NMOD
2	shift	shift	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	apparently	apparently	I-VP	RB	O	3	VMOD
5	not	not	I-VP	RB	O	3	VMOD
6	caused	cause	I-VP	VBN	O	3	VC
7	by	by	B-PP	IN	O	6	VMOD
8	a	a	B-NP	DT	O	10	NMOD
9	recruitment	recruitment	I-NP	NN	O	10	NMOD
10	phenomenon	phenomenon	I-NP	NN	O	7	PMOD
11	,	,	O	,	O	6	P
12	because	because	B-SBAR	IN	O	6	VMOD
13	in	in	B-PP	IN	O	22	VMOD
14	FCS+	FCS+	B-NP	JJ	B-cell_line	15	NMOD
15	culture	culture	I-NP	NN	I-cell_line	13	PMOD
16	,	,	O	,	O	22	P
17	the	the	B-NP	DT	O	19	NMOD
18	total	total	I-NP	JJ	O	19	NMOD
19	number	number	I-NP	NN	O	22	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	colonies	colony	B-NP	NNS	O	20	PMOD
22	is	be	B-VP	VBZ	O	12	SBAR
23	not	not	I-VP	RB	O	22	VMOD
24	significantly	significantly	I-VP	RB	O	22	VMOD
25	modified	modify	I-VP	VBN	O	22	VC
26	by	by	B-PP	IN	O	25	VMOD
27	RA	RA	B-NP	NN	O	28	NMOD
28	addition	addition	I-NP	NN	O	26	PMOD
29	.	.	O	.	O	3	P

1	Studies	Study	B-NP	NNS	O	13	SUB
2	on	on	B-PP	IN	O	1	NMOD
3	RA	RA	B-NP	NN	O	7	NMOD
4	time-response	time-response	I-NP	JJ	O	7	NMOD
5	or	or	I-NP	CC	O	4	DEP
6	pulse	pulse	I-NP	NN	O	4	DEP
7	treatment	treatment	I-NP	NN	O	2	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	semisolid	semisolid	B-NP	JJ	O	11	AMOD
10	or	or	I-NP	CC	O	11	AMOD
11	liquid	liquid	I-NP	JJ	O	12	NMOD
12	culture	culture	I-NP	NN	O	8	PMOD
13	show	show	B-VP	VBP	O	0	ROOT
14	that	that	B-SBAR	IN	O	13	VMOD
15	early	early	B-NP	JJ	O	17	NMOD
16	RA	RA	I-NP	NN	O	17	NMOD
17	addition	addition	I-NP	NN	O	18	SUB
18	is	be	B-VP	VBZ	O	14	SBAR
19	most	most	B-ADJP	RBS	O	20	AMOD
20	effective	effective	I-ADJP	JJ	O	18	PRD
21	,	,	O	,	O	13	P
22	thus	thus	B-ADVP	RB	O	23	VMOD
23	indicating	indicate	B-VP	VBG	O	13	VMOD
24	that	that	B-SBAR	IN	O	23	VMOD
25	early	early	B-NP	JJ	O	28	AMOD
26	but	but	I-NP	CC	O	28	AMOD
27	not	not	I-NP	RB	O	28	AMOD
28	late	late	B-NP	JJ	O	29	NMOD
29	HPC	HPC	I-NP	NN	B-cell_type	30	SUB
30	are	be	B-VP	VBP	O	24	SBAR
31	sensitive	sensitive	B-ADJP	JJ	O	30	PRD
32	to	to	B-PP	TO	O	31	AMOD
33	its	its	B-NP	PRP$	O	34	NMOD
34	action	action	I-NP	NN	O	32	PMOD
35	.	.	O	.	O	13	P

1	We	We	B-NP	PRP	O	2	SUB
2	measured	measure	B-VP	VBD	O	0	ROOT
3	effects	effect	B-NP	NNS	O	2	OBJ
4	on	on	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	HIV-1	HIV-1	I-NP	NN	B-DNA	7	NMOD
7	LTR	LTR	I-NP	NN	I-DNA	4	PMOD
8	in	in	B-PP	IN	O	3	NMOD
9	T	T	B-NP	NN	B-cell_line	11	NMOD
10	cell	cell	I-NP	NN	I-cell_line	11	NMOD
11	lines	line	I-NP	NNS	I-cell_line	8	PMOD
12	that	that	B-NP	WDT	O	11	NMOD
13	were	be	B-VP	VBD	O	12	SBAR
14	stimulated	stimulate	I-VP	VBN	O	13	VC
15	with	with	B-PP	IN	O	14	VMOD
16	antibodies	antibody	B-NP	NNS	B-protein	15	PMOD
17	against	against	B-PP	IN	O	16	NMOD
18	CD45	CD45	B-NP	NN	B-protein	17	PMOD
19	and	and	B-PP	CC	O	15	PMOD
20	in	in	B-PP	IN	O	15	PMOD
21	those	those	B-NP	DT	O	20	PMOD
22	that	that	B-NP	WDT	O	21	NMOD
23	lacked	lack	B-VP	VBD	O	22	SBAR
24	the	the	B-NP	DT	O	25	NMOD
25	expression	expression	I-NP	NN	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	CD45	CD45	B-NP	NN	B-protein	26	PMOD
28	on	on	B-PP	IN	O	25	NMOD
29	their	their	B-NP	PRP$	O	30	NMOD
30	surfaces	surface	I-NP	NNS	O	28	PMOD
31	.	.	O	.	O	2	P

1	First	First	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	anti-CD45	anti-CD45	B-NP	JJ	B-protein	4	NMOD
4	antibodies	antibody	I-NP	NNS	I-protein	5	SUB
5	did	do	B-VP	VBD	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	affect	affect	I-VP	VB	O	5	VC
8	basal	basal	B-ADJP	JJ	O	7	OBJ
9	but	but	O	CC	O	5	VMOD
10	decreased	decrease	B-VP	VBD	O	5	VMOD
11	activated	activate	I-VP	VBN	O	10	OBJ
12	levels	level	B-NP	NNS	O	5	VMOD
13	of	of	B-PP	IN	O	12	NMOD
14	expression	expression	B-NP	NN	O	13	PMOD
15	from	from	B-PP	IN	O	14	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	HIV-1	HIV-1	I-NP	NN	B-DNA	18	NMOD
18	LTR	LTR	I-NP	NN	I-DNA	15	PMOD
19	.	.	O	.	O	5	P

1	Second	Second	B-ADVP	RB	O	17	VMOD
2	,	,	O	,	O	17	P
3	T	T	B-NP	NN	B-cell_type	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_type	17	SUB
5	,	,	O	,	O	4	P
6	which	which	B-NP	WDT	O	4	NMOD
7	lack	lack	B-VP	VBP	O	6	SBAR
8	CD45	CD45	B-NP	NN	B-protein	7	OBJ
9	and	and	O	CC	O	7	VMOD
10	can	can	B-VP	MD	O	7	VMOD
11	not	not	I-VP	RB	O	10	VMOD
12	signal	signal	I-VP	VB	O	10	VC
13	via	via	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	TCR	TCR	I-NP	NN	B-protein	13	PMOD
16	,	,	O	,	O	4	P
17	supported	support	B-VP	VBD	O	0	ROOT
18	higher	high	B-NP	JJR	O	19	NMOD
19	levels	level	I-NP	NNS	O	17	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	viral	viral	B-NP	JJ	O	22	NMOD
22	replication	replication	I-NP	NN	O	25	NMOD
23	and	and	I-NP	CC	O	25	NMOD
24	gene	gene	I-NP	NN	O	25	NMOD
25	expression	expression	I-NP	NN	O	20	PMOD
26	.	.	O	.	O	17	P

1	Egr-1	Egr-1	B-NP	NN	B-RNA	3	NMOD
2	mRNA	mRNA	I-NP	NN	I-RNA	3	NMOD
3	expression	expression	I-NP	NN	O	9	SUB
4	induced	induce	B-VP	VBN	O	3	NMOD
5	by	by	B-PP	IN	O	4	VMOD
6	sIgM-	sIgM-	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	sIgD-crosslinking	sIgD-crosslinking	I-NP	NN	O	5	PMOD
9	was	be	B-VP	VBD	O	0	ROOT
10	inhibited	inhibit	I-VP	VBN	O	9	VC
11	by	by	B-PP	IN	O	10	VMOD
12	H7	H7	B-NP	NN	B-protein	16	NMOD
13	,	,	I-NP	,	O	16	P
14	erbstatin	erbstatin	I-NP	NN	O	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	genistein	genistein	I-NP	NN	O	11	PMOD
17	,	,	B-PP	,	O	11	P
18	but	but	I-PP	CC	O	11	PMOD
19	not	not	B-PP	RB	O	20	PMOD
20	by	by	I-PP	IN	O	11	PMOD
21	HA1004	HA1004	B-NP	NN	O	20	PMOD
22	.	.	O	.	O	9	P

1	Phorbol	Phorbol	B-NP	NN	O	3	NMOD
2	myristate	myristate	I-NP	NN	O	3	NMOD
3	acetate	acetate	I-NP	NN	O	4	SUB
4	induced	induce	B-VP	VBD	O	14	VMOD
5	Egr-1	Egr-1	B-NP	NN	B-RNA	7	NMOD
6	mRNA	mRNA	I-NP	NN	I-RNA	7	NMOD
7	expression	expression	I-NP	NN	O	4	OBJ
8	but	but	O	CC	O	14	VMOD
9	forskolin	forskolin	B-NP	NN	O	13	NMOD
10	and	and	O	CC	O	13	NMOD
11	dibutyryl	dibutyryl	B-NP	NN	O	13	NMOD
12	cyclic	cyclic	I-NP	JJ	O	13	NMOD
13	AMP	AMP	I-NP	NN	O	14	SUB
14	did	do	B-VP	VBD	O	0	ROOT
15	not	not	O	RB	O	14	VMOD
16	.	.	O	.	O	14	P

1	Cyclosporin	Cyclosporin	B-NP	NN	O	2	NMOD
2	A	A	I-NP	NN	O	7	NMOD
3	(	(	O	(	O	5	DEP
4	CsA	CsA	B-NP	NN	O	5	DEP
5	)	)	O	)	O	2	NMOD
6	and	and	O	CC	O	7	NMOD
7	FK506	FK506	B-NP	NN	O	8	SUB
8	rescued	rescue	B-VP	VBD	O	0	ROOT
9	B104	B104	B-NP	NN	B-cell_line	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_line	8	OBJ
11	from	from	B-PP	IN	O	8	VMOD
12	death	death	B-NP	NN	O	11	PMOD
13	induced	induce	B-VP	VBN	O	12	NMOD
14	by	by	B-PP	IN	O	13	VMOD
15	anti-IgM	anti-IgM	B-NP	JJ	B-protein	16	NMOD
16	Ab	Ab	I-NP	NN	I-protein	14	PMOD
17	,	,	O	,	O	8	P
18	but	but	O	CC	O	8	VMOD
19	did	do	B-VP	VBD	O	8	VMOD
20	not	not	I-VP	RB	O	19	VMOD
21	affect	affect	I-VP	VB	O	19	VC
22	the	the	B-NP	DT	O	23	NMOD
23	expression	expression	I-NP	NN	O	21	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	Egr-1	Egr-1	B-NP	NN	B-protein	27	NMOD
26	and	and	O	CC	O	27	NMOD
27	c-fos	c-fos	B-NP	NN	B-RNA	28	NMOD
28	mRNA	mRNA	B-NP	NN	I-RNA	24	PMOD
29	,	,	O	,	O	8	P
30	showing	show	B-VP	VBG	O	8	VMOD
31	that	that	B-SBAR	IN	O	30	VMOD
32	CsA	CsA	B-NP	NN	O	34	NMOD
33	and	and	I-NP	CC	O	34	NMOD
34	FK506	FK506	I-NP	NN	O	35	SUB
35	affect	affect	B-VP	VBP	O	31	SBAR
36	signal	signal	B-NP	NN	O	37	NMOD
37	transducers	transducer	I-NP	NNS	O	35	OBJ
38	differently	differently	B-ADVP	RB	O	35	VMOD
39	from	from	B-PP	IN	O	35	VMOD
40	or	or	O	CC	O	39	DEP
41	downstream	downstream	B-ADVP	RB	O	39	DEP
42	to	to	B-PP	TO	O	41	AMOD
43	these	these	B-NP	DT	O	44	NMOD
44	molecules	molecule	I-NP	NNS	O	39	PMOD
45	.	.	O	.	O	8	P

1	By	By	B-PP	IN	O	10	VMOD
2	using	use	B-VP	VBG	O	1	PMOD
3	the	the	B-NP	DT	O	7	NMOD
4	protein	protein	I-NP	NN	O	7	NMOD
5	synthesis	synthesis	I-NP	NN	O	7	NMOD
6	inhibitor	inhibitor	I-NP	NN	O	7	NMOD
7	cycloheximide	cycloheximide	I-NP	NN	O	2	OBJ
8	,	,	O	,	O	10	P
9	it	it	B-NP	PRP	O	10	SUB
10	was	be	B-VP	VBD	O	0	ROOT
11	shown	show	I-VP	VBN	O	10	VC
12	that	that	B-SBAR	IN	O	11	VMOD
13	G	G	B-NP	NN	O	20	NMOD
14	(	(	O	(	O	16	DEP
15	Anh	Anh	B-NP	NN	O	16	DEP
16	)	)	O	)	O	13	NMOD
17	MTetra-induced	MTetra-induced	B-NP	JJ	O	20	NMOD
18	IL-6	IL-6	I-NP	NN	B-RNA	20	NMOD
19	mRNA	mRNA	I-NP	NN	I-RNA	20	NMOD
20	expression	expression	I-NP	NN	O	21	SUB
21	depends	depend	B-VP	VBZ	O	12	SBAR
22	on	on	B-PP	IN	O	21	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	synthesis	synthesis	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	new	new	B-NP	JJ	O	27	NMOD
27	protein	protein	I-NP	NN	O	25	PMOD
28	,	,	O	,	O	21	P
29	whereas	whereas	O	IN	O	21	VMOD
30	G	G	B-NP	NN	O	38	NMOD
31	(	(	O	(	O	33	DEP
32	Anh	Anh	B-NP	NN	O	33	DEP
33	)	)	O	)	O	30	NMOD
34	MTetra-induced	MTetra-induced	B-NP	JJ	O	38	NMOD
35	IL-1	IL-1	I-NP	NN	B-RNA	38	NMOD
36	beta	beta	I-NP	NN	I-RNA	38	NMOD
37	mRNA	mRNA	I-NP	NN	I-RNA	38	NMOD
38	accumulation	accumulation	I-NP	NN	O	39	SUB
39	does	do	B-VP	VBZ	O	29	SBAR
40	not	not	O	RB	O	39	VMOD
41	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	4	NMOD
2	IRF-2	IRF-2	I-NP	NN	B-DNA	4	NMOD
3	promoter	promoter	I-NP	NN	I-DNA	4	NMOD
4	region	region	I-NP	NN	I-DNA	5	SUB
5	contains	contain	B-VP	VBZ	O	0	ROOT
6	a	a	B-NP	DT	O	8	NMOD
7	CpG	CpG	I-NP	NN	B-DNA	8	NMOD
8	island	island	I-NP	NN	I-DNA	5	OBJ
9	,	,	O	,	O	8	P
10	with	with	B-PP	IN	O	8	NMOD
11	several	several	B-NP	JJ	O	13	NMOD
12	GC	GC	I-NP	NN	B-DNA	13	NMOD
13	boxes	box	I-NP	NNS	I-DNA	24	NMOD
14	,	,	O	,	O	24	P
15	a	a	B-NP	DT	O	19	NMOD
16	putative	putative	I-NP	JJ	O	19	NMOD
17	NF-kappa	NF-kappa	I-NP	NN	B-DNA	19	NMOD
18	B-binding	B-binding	I-NP	JJ	I-DNA	19	NMOD
19	site	site	I-NP	NN	I-DNA	24	NMOD
20	,	,	O	,	O	24	P
21	and	and	O	CC	O	24	NMOD
22	a	a	B-NP	DT	O	24	NMOD
23	CAAT	CAAT	I-NP	NN	B-DNA	24	NMOD
24	box	box	I-NP	NN	I-DNA	10	PMOD
25	,	,	O	,	O	29	P
26	but	but	O	CC	O	29	NMOD
27	no	no	B-NP	DT	O	29	NMOD
28	TATA	TATA	I-NP	NN	B-DNA	29	NMOD
29	box	box	I-NP	NN	I-DNA	5	VMOD
30	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	interferon	interferon	B-NP	NN	B-protein	7	NMOD
6	regulatory	regulatory	I-NP	JJ	I-protein	7	NMOD
7	factor	factor	I-NP	NN	I-protein	11	SUB
8	1	1	I-NP	CD	I-protein	7	NMOD
9	not	not	B-CONJP	RB	O	11	VMOD
10	only	only	I-CONJP	RB	O	9	DEP
11	triggers	trigger	B-VP	VBZ	O	4	SBAR
12	the	the	B-NP	DT	O	13	NMOD
13	activation	activation	I-NP	NN	O	11	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	19	NMOD
16	interferon	interferon	I-NP	NN	B-protein	19	NMOD
17	signal	signal	I-NP	NN	O	19	NMOD
18	transduction	transduction	I-NP	NN	O	19	NMOD
19	pathway	pathway	I-NP	NN	O	14	PMOD
20	,	,	O	,	O	11	P
21	but	but	O	CC	O	11	VMOD
22	also	also	B-ADVP	RB	O	21	DEP
23	may	may	B-VP	MD	O	11	VMOD
24	play	play	I-VP	VB	O	23	VC
25	a	a	B-NP	DT	O	26	NMOD
26	role	role	I-NP	NN	O	24	OBJ
27	in	in	B-PP	IN	O	24	VMOD
28	limiting	limit	B-VP	VBG	O	27	PMOD
29	the	the	B-NP	DT	O	30	NMOD
30	duration	duration	I-NP	NN	O	28	OBJ
31	of	of	B-PP	IN	O	30	NMOD
32	this	this	B-NP	DT	O	33	NMOD
33	response	response	I-NP	NN	O	31	PMOD
34	by	by	B-PP	IN	O	28	VMOD
35	activating	activate	B-VP	VBG	O	34	PMOD
36	the	the	B-NP	DT	O	37	NMOD
37	transcription	transcription	I-NP	NN	O	35	OBJ
38	of	of	B-PP	IN	O	37	NMOD
39	IRF-2	IRF-2	B-NP	NN	B-protein	38	PMOD
40	.	.	O	.	O	3	P

1	G-CSF	G-CSF	B-NP	NN	B-protein	2	NMOD
2	receptors	receptor	I-NP	NNS	I-protein	3	SUB
3	lack	lack	B-VP	VBP	O	14	VMOD
4	intrinsic	intrinsic	B-NP	JJ	O	7	NMOD
5	tyrosine	tyrosine	I-NP	NN	B-protein	7	NMOD
6	kinase	kinase	I-NP	NN	I-protein	7	NMOD
7	activity	activity	I-NP	NN	O	3	OBJ
8	,	,	O	,	O	14	P
9	but	but	O	CC	O	14	VMOD
10	activation	activation	B-NP	NN	O	14	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	receptor	receptor	I-NP	NN	O	11	PMOD
14	results	result	B-VP	VBZ	O	0	ROOT
15	in	in	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	rapid	rapid	I-NP	JJ	O	18	NMOD
18	induction	induction	I-NP	NN	O	15	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	tyrosine	tyrosine	B-NP	NN	B-protein	22	NMOD
21	kinase	kinase	I-NP	NN	I-protein	22	NMOD
22	activity	activity	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	2	NMOD
2	induction	induction	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	tyrosine	tyrosine	B-NP	NN	O	5	NMOD
5	phosphorylation	phosphorylation	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	p80c-rel	p80c-rel	B-NP	NN	B-protein	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	unique	unique	B-ADJP	JJ	O	8	PRD
10	to	to	B-PP	TO	O	9	AMOD
11	G-CSF	G-CSF	B-NP	NN	B-protein	10	PMOD
12	in	in	B-PP	IN	O	13	DEP
13	that	that	B-NP	DT	O	8	VMOD
14	granulocyte-macrophage	granulocyte-macrophage	I-NP	JJ	B-protein	17	NMOD
15	colony	colony	I-NP	NN	I-protein	17	NMOD
16	stimulating	stimulating	I-NP	NN	I-protein	17	NMOD
17	factor	factor	I-NP	NN	I-protein	26	SUB
18	which	which	B-NP	WDT	O	17	NMOD
19	also	also	B-ADVP	RB	O	20	VMOD
20	stimulates	stimulate	B-VP	VBZ	O	18	SBAR
21	neutrophils	neutrophil	B-NP	NNS	B-cell_type	20	OBJ
22	and	and	O	CC	O	20	VMOD
23	induces	induce	B-VP	VBZ	O	20	VMOD
24	tyrosine	tyrosine	B-NP	NN	O	25	NMOD
25	phosphorylation	phosphorylation	I-NP	NN	O	23	OBJ
26	does	do	B-VP	VBZ	O	13	SBAR
27	not	not	I-VP	RB	O	26	VMOD
28	result	result	I-VP	VB	O	26	VC
29	in	in	B-PP	IN	O	28	VMOD
30	tyrosine	tyrosine	B-NP	NN	O	31	NMOD
31	phosphorylation	phosphorylation	I-NP	NN	O	29	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	p80c-rel	p80c-rel	B-NP	NN	B-protein	32	PMOD
34	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	consequences	consequence	I-NP	NNS	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	p80c-rel	p80c-rel	B-NP	NN	B-protein	6	NMOD
5	tyrosine	tyrosine	I-NP	NN	O	6	NMOD
6	phosphorylation	phosphorylation	I-NP	NN	O	3	PMOD
7	are	be	B-VP	VBP	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	yet	yet	I-VP	RB	O	7	VMOD
10	known	know	I-VP	VBN	O	7	VC
11	;	;	O	:	O	7	P

1	Subsequent	Subsequent	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	revealed	reveal	I-VP	VBN	O	3	VC
5	that	that	B-SBAR	IN	O	4	VMOD
6	(	(	B-LST	(	O	7	DEP
7	i	i	I-LST	LS	O	11	VMOD
8	)	)	O	)	O	7	DEP
9	cytoplasmic	cytoplasmic	B-NP	JJ	B-protein	10	NMOD
10	RelA	RelA	I-NP	NN	I-protein	11	SUB
11	is	be	B-VP	VBZ	O	5	SBAR
12	stably	stably	I-VP	RB	O	13	VMOD
13	associated	associate	I-VP	VBN	O	11	VC
14	not	not	B-CONJP	RB	O	13	VMOD
15	only	only	I-CONJP	RB	O	14	DEP
16	with	with	B-PP	IN	O	14	PMOD
17	I	I	B-NP	NN	B-protein	20	NMOD
18	kappa	kappa	I-NP	NN	I-protein	20	NMOD
19	B	B	I-NP	NN	I-protein	20	NMOD
20	alpha	alpha	I-NP	NN	I-protein	16	PMOD
21	but	but	B-CONJP	CC	O	14	PMOD
22	also	also	I-CONJP	RB	O	21	DEP
23	with	with	B-PP	IN	O	14	PMOD
24	other	other	B-NP	JJ	O	27	NMOD
25	ankyrin	ankyrin	I-NP	NN	B-protein	27	NMOD
26	motif-rich	motif-rich	I-NP	JJ	I-protein	27	NMOD
27	proteins	protein	I-NP	NNS	I-protein	23	PMOD
28	including	include	B-PP	VBG	O	27	NMOD
29	the	the	B-NP	DT	O	30	NMOD
30	products	product	I-NP	NNS	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	34	NMOD
33	NF-kappa	NF-kappa	I-NP	NN	B-protein	34	NMOD
34	B2	B2	I-NP	NN	I-protein	40	NMOD
35	(	(	O	(	O	37	DEP
36	p100	p100	B-NP	NN	B-protein	37	DEP
37	)	)	O	)	O	34	NMOD
38	and	and	O	CC	O	40	NMOD
39	NF-kappa	NF-kappa	B-NP	NN	B-protein	40	NMOD
40	B1	B1	I-NP	NN	I-protein	44	NMOD
41	(	(	O	(	O	43	DEP
42	p105	p105	B-NP	NN	O	43	DEP
43	)	)	O	)	O	40	NMOD
44	genes	gene	B-NP	NNS	O	31	PMOD
45	;	;	O	:	O	94	P
46	(	(	B-LST	(	O	47	DEP
47	ii	ii	I-LST	LS	O	60	VMOD
48	)	)	O	)	O	47	DEP
49	in	in	B-PP	IN	O	60	VMOD
50	contrast	contrast	B-NP	NN	O	49	PMOD
51	to	to	B-PP	TO	O	49	PMOD
52	RelA-I	RelA-I	B-NP	NN	B-protein	55	NMOD
53	kappa	kappa	I-NP	NN	I-protein	55	NMOD
54	B	B	I-NP	NN	I-protein	55	NMOD
55	alpha	alpha	I-NP	NN	I-protein	49	PMOD
56	,	,	O	,	O	60	P
57	RelA-p100	RelA-p100	B-NP	NN	B-protein	59	NMOD
58	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	59	NMOD
59	complexes	complex	I-NP	NNS	I-protein	60	SUB
60	are	be	B-VP	VBP	O	94	VMOD
61	not	not	I-VP	RB	O	60	VMOD
62	dissociated	dissociate	I-VP	VBN	O	60	VC
63	following	follow	B-PP	VBG	O	62	VMOD
64	tumor	tumor	B-NP	NN	B-protein	68	NMOD
65	necrosis	necrosis	I-NP	NN	I-protein	68	NMOD
66	factor	factor	I-NP	NN	I-protein	68	NMOD
67	alpha	alpha	I-NP	NN	I-protein	68	NMOD
68	activation	activation	I-NP	NN	O	63	PMOD
69	;	;	O	:	O	94	P
70	(	(	B-LST	(	O	71	DEP
71	iii	iii	I-LST	LS	O	74	VMOD
72	)	)	O	)	O	71	DEP
73	p100	p100	B-NP	NN	B-protein	74	SUB
74	functions	function	B-VP	VBZ	O	94	VMOD
75	as	as	B-PP	IN	O	74	VMOD
76	a	a	B-NP	DT	O	78	NMOD
77	potent	potent	I-NP	JJ	O	78	NMOD
78	inhibitor	inhibitor	I-NP	NN	O	75	PMOD
79	of	of	B-PP	IN	O	78	NMOD
80	RelA-mediated	RelA-mediated	B-NP	JJ	O	81	NMOD
81	transcription	transcription	I-NP	NN	O	79	PMOD
82	in	in	B-ADVP	FW	O	81	NMOD
83	vivo	vivo	I-ADVP	FW	O	82	AMOD
84	;	;	O	:	O	94	P
85	(	(	B-LST	(	O	86	DEP
86	iv	iv	I-LST	LS	O	94	VMOD
87	)	)	O	)	O	86	DEP
88	the	the	B-NP	DT	O	89	NMOD
89	interaction	interaction	I-NP	NN	O	94	SUB
90	of	of	B-PP	IN	O	89	NMOD
91	RelA	RelA	B-NP	NN	B-protein	93	NMOD
92	and	and	I-NP	CC	O	93	NMOD
93	p100	p100	I-NP	NN	B-protein	90	PMOD
94	involves	involve	B-VP	VBZ	O	11	VMOD
95	the	the	B-NP	DT	O	99	NMOD
96	conserved	conserve	I-NP	VBN	B-protein	99	NMOD
97	Rel	Rel	I-NP	NN	I-protein	99	NMOD
98	homology	homology	I-NP	NN	I-protein	99	NMOD
99	domain	domain	I-NP	NN	I-protein	108	NMOD
100	of	of	B-PP	IN	O	99	NMOD
101	both	both	B-NP	DT	O	102	NMOD
102	proteins	protein	B-NP	NNS	O	100	PMOD
103	but	but	B-NP	CC	O	108	NMOD
104	not	not	I-NP	RB	O	103	DEP
105	the	the	B-NP	DT	O	108	NMOD
106	nuclear	nuclear	I-NP	JJ	B-protein	108	NMOD
107	localization	localization	I-NP	NN	I-protein	108	NMOD
108	signal	signal	I-NP	NN	I-protein	94	OBJ
109	of	of	B-PP	IN	O	108	NMOD
110	RelA	RelA	B-NP	NN	B-protein	109	PMOD
111	,	,	O	,	O	108	P
112	which	which	B-NP	WDT	O	108	NMOD
113	is	be	B-VP	VBZ	O	112	SBAR
114	required	require	I-VP	VBN	O	113	VC
115	for	for	B-PP	IN	O	114	VMOD
116	I	I	B-NP	NN	B-protein	120	NMOD
117	kappa	kappa	I-NP	NN	I-protein	120	NMOD
118	B	B	I-NP	NN	I-protein	120	NMOD
119	alpha	alpha	I-NP	NN	I-protein	120	NMOD
120	binding	binding	I-NP	NN	O	115	PMOD
121	;	;	O	:	O	130	P
122	(	(	B-LST	(	O	123	DEP
123	v	v	I-LST	LS	O	130	VMOD
124	)	)	O	)	O	123	DEP
125	p100	p100	B-NP	NN	B-protein	126	NMOD
126	inhibition	inhibition	I-NP	NN	O	130	SUB
127	of	of	B-PP	IN	O	126	NMOD
128	RelA	RelA	B-NP	NN	B-protein	129	NMOD
129	function	function	I-NP	NN	O	127	PMOD
130	requires	require	B-VP	VBZ	O	94	VMOD
131	the	the	B-NP	DT	O	135	NMOD
132	C-terminal	C-terminal	I-NP	JJ	B-protein	135	NMOD
133	ankyrin	ankyrin	I-NP	NN	I-protein	135	NMOD
134	motif	motif	I-NP	NN	I-protein	135	NMOD
135	domain	domain	I-NP	NN	I-protein	130	OBJ
136	,	,	O	,	O	135	P
137	which	which	B-NP	WDT	O	135	NMOD
138	mediates	mediate	B-VP	VBZ	O	137	SBAR
139	cytoplasmic	cytoplasmic	B-NP	JJ	O	140	NMOD
140	retention	retention	I-NP	NN	O	138	OBJ
141	of	of	B-PP	IN	O	140	NMOD
142	RelA	RelA	B-NP	NN	B-protein	141	PMOD
143	;	;	O	:	O	130	VMOD
144	and	and	O	CC	O	146	DEP
145	(	(	B-LST	(	O	146	DEP
146	vi	vi	I-LST	LS	O	143	NMOD
147	)	)	O	)	O	146	DEP
148	as	as	B-SBAR	IN	O	146	DEP
149	observed	observe	B-VP	VBN	O	148	SBAR
150	with	with	B-PP	IN	O	149	VMOD
151	I	I	B-NP	NN	B-protein	154	NMOD
152	kappa	kappa	I-NP	NN	I-protein	154	NMOD
153	B	B	I-NP	NN	I-protein	154	NMOD
154	alpha	alpha	I-NP	NN	I-protein	158	SUB
155	,	,	O	,	O	158	P
156	nuclear	nuclear	B-NP	JJ	O	157	NMOD
157	RelA	RelA	I-NP	NN	B-protein	158	SUB
158	stimulates	stimulate	B-VP	VBZ	O	150	SBAR
159	p100	p100	B-NP	NN	B-RNA	163	NMOD
160	mRNA	mRNA	I-NP	NN	I-RNA	163	NMOD
161	and	and	O	CC	O	163	NMOD
162	protein	protein	B-NP	NN	O	163	NMOD
163	expression	expression	I-NP	NN	O	158	OBJ
164	.	.	O	.	O	146	P

1	Because	Because	B-SBAR	IN	O	8	VMOD
2	erythrocytes	erythrocyte	B-NP	NNS	B-cell_type	3	SUB
3	are	be	B-VP	VBP	O	1	SBAR
4	anucleated	anucleate	I-VP	VBN	O	3	VC
5	,	,	O	,	O	8	P
6	these	these	B-NP	DT	O	7	NMOD
7	results	result	I-NP	NNS	O	8	SUB
8	are	be	B-VP	VBP	O	0	ROOT
9	discussed	discuss	I-VP	VBN	O	8	VC
10	as	as	B-PP	IN	O	9	VMOD
11	evidence	evidence	B-NP	NN	O	10	PMOD
12	for	for	B-PP	IN	O	11	NMOD
13	biochemical	biochemical	B-NP	JJ	O	14	NMOD
14	changes	change	I-NP	NNS	O	12	PMOD
15	by	by	B-PP	IN	O	14	NMOD
16	TCDD	TCDD	B-NP	NN	O	15	PMOD
17	without	without	B-PP	IN	O	14	NMOD
18	requiring	require	B-VP	VBG	O	17	PMOD
19	the	the	B-NP	DT	O	20	NMOD
20	activation	activation	I-NP	NN	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	gene	gene	B-NP	NN	B-protein	23	NMOD
23	products	product	I-NP	NNS	I-protein	21	PMOD
24	.	.	O	.	O	8	P

1	Northern	Northern	B-NP	NN	O	3	NMOD
2	blot	blot	I-NP	NN	O	3	NMOD
3	analyses	analysis	I-NP	NNS	O	10	SUB
4	performed	perform	B-VP	VBN	O	3	NMOD
5	on	on	B-PP	IN	O	4	VMOD
6	rat	rat	B-NP	NN	O	8	NMOD
7	and	and	O	CC	O	8	NMOD
8	mouse	mouse	B-NP	NN	O	9	NMOD
9	tissues	tissue	I-NP	NNS	O	5	PMOD
10	have	have	B-VP	VBP	O	28	VMOD
11	detected	detect	I-VP	VBN	O	10	VC
12	ubiquitously	ubiquitously	B-NP	RB	B-RNA	13	AMOD
13	expressed	express	I-NP	VBN	I-RNA	15	NMOD
14	Pan	Pan	I-NP	NN	I-RNA	15	NMOD
15	transcripts	transcript	I-NP	NNS	I-RNA	11	OBJ
16	,	,	O	,	O	28	P
17	but	but	O	CC	O	28	VMOD
18	the	the	B-NP	DT	O	24	NMOD
19	abundance	abundance	I-NP	NN	O	24	NMOD
20	,	,	O	,	O	24	P
21	distribution	distribution	B-NP	NN	O	24	NMOD
22	,	,	O	,	O	24	P
23	and	and	O	CC	O	24	NMOD
24	form	form	B-NP	NN	O	28	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	Pan	Pan	B-NP	NN	B-protein	27	NMOD
27	proteins	protein	I-NP	NNS	I-protein	25	PMOD
28	have	have	B-VP	VBP	O	0	ROOT
29	not	not	I-VP	RB	O	28	VMOD
30	been	be	I-VP	VBN	O	28	VC
31	clearly	clearly	I-VP	RB	O	30	VMOD
32	defined	define	I-VP	VBN	O	30	VC
33	.	.	O	.	O	28	P

1	IEF-1	IEF-1	B-NP	NN	B-protein	7	NMOD
2	,	,	O	,	O	7	P
3	a	a	B-NP	DT	O	7	NMOD
4	pancreatic	pancreatic	I-NP	JJ	B-protein	5	AMOD
5	beta-cell	beta-cell	I-NP	NN	I-protein	7	NMOD
6	type-specific	type-specific	I-NP	JJ	I-protein	5	AMOD
7	complex	complex	I-NP	NN	I-protein	14	SUB
8	believed	believe	B-VP	VBN	O	7	NMOD
9	to	to	I-VP	TO	O	10	VMOD
10	regulate	regulate	I-VP	VB	O	8	VMOD
11	insulin	insulin	B-NP	NN	B-protein	12	NMOD
12	expression	expression	I-NP	NN	O	10	OBJ
13	,	,	O	,	O	7	P
14	is	be	B-VP	VBZ	O	0	ROOT
15	demonstrated	demonstrate	I-VP	VBN	O	14	VC
16	to	to	I-VP	TO	O	17	VMOD
17	consist	consist	I-VP	VB	O	15	VMOD
18	of	of	B-PP	IN	O	17	VMOD
19	at	at	B-NP	IN	O	23	NMOD
20	least	least	I-NP	JJS	O	19	AMOD
21	two	two	I-NP	CD	O	19	AMOD
22	distinct	distinct	I-NP	JJ	O	23	NMOD
23	species	specie	I-NP	NNS	O	18	PMOD
24	,	,	O	,	O	23	P
25	one	one	B-NP	CD	O	26	NMOD
26	of	of	B-PP	IN	O	23	NMOD
27	which	which	B-NP	WDT	O	26	PMOD
28	does	do	B-VP	VBZ	O	26	SBAR
29	not	not	I-VP	RB	O	28	VMOD
30	contain	contain	I-VP	VB	O	28	VC
31	Pan	Pan	B-NP	NN	B-protein	32	NMOD
32	molecules	molecule	I-NP	NNS	I-protein	30	OBJ
33	.	.	O	.	O	14	P

1	Interferon	Interferon	B-NP	NN	B-protein	2	NMOD
2	alpha	alpha	I-NP	NN	I-protein	4	SUB
3	selectively	selectively	B-ADVP	RB	O	4	VMOD
4	affects	affect	B-VP	VBZ	O	0	ROOT
5	expression	expression	B-NP	NN	O	4	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	13	NMOD
8	human	human	I-NP	JJ	B-protein	13	NMOD
9	myeloid	myeloid	I-NP	JJ	I-protein	13	NMOD
10	cell	cell	I-NP	NN	I-protein	13	NMOD
11	nuclear	nuclear	I-NP	JJ	I-protein	13	NMOD
12	differentiation	differentiation	I-NP	NN	I-protein	13	NMOD
13	antigen	antigen	I-NP	NN	I-protein	6	PMOD
14	in	in	B-PP	IN	O	5	NMOD
15	late	late	B-NP	JJ	B-cell_type	17	NMOD
16	stage	stage	I-NP	NN	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
18	in	in	B-PP	IN	O	5	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	monocytic	monocytic	I-NP	JJ	O	25	NMOD
21	but	but	B-CONJP	CC	O	25	NMOD
22	not	not	I-CONJP	RB	O	21	DEP
23	the	the	B-NP	DT	O	25	NMOD
24	granulocytic	granulocytic	I-NP	JJ	B-cell_type	25	NMOD
25	lineage	lineage	I-NP	NN	I-cell_type	18	PMOD
26	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	effects	effect	I-NP	NNS	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	phorbol	phorbol	B-NP	NN	O	5	NMOD
5	ester	ester	I-NP	NN	O	3	PMOD
6	on	on	B-PP	IN	O	2	NMOD
7	MNDA	MNDA	B-NP	NN	B-RNA	8	NMOD
8	mRNA	mRNA	I-NP	NN	I-RNA	6	PMOD
9	appeared	appear	B-VP	VBD	O	0	ROOT
10	to	to	I-VP	TO	O	11	VMOD
11	be	be	I-VP	VB	O	9	VMOD
12	associated	associate	I-VP	VBN	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	induced	induce	B-NP	VBN	O	15	NMOD
15	differentiation	differentiation	I-NP	NN	O	13	PMOD
16	since	since	B-PP	IN	O	9	VMOD
17	inhibiting	inhibit	B-VP	VBG	O	20	SUB
18	cell	cell	B-NP	NN	O	19	NMOD
19	proliferation	proliferation	I-NP	NN	O	17	OBJ
20	did	do	B-VP	VBD	O	36	VMOD
21	not	not	I-VP	RB	O	20	VMOD
22	alter	alter	I-VP	VB	O	20	VC
23	the	the	B-NP	DT	O	24	NMOD
24	level	level	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	MNDA	MNDA	B-NP	NN	B-RNA	27	NMOD
27	mRNA	mRNA	I-NP	NN	I-RNA	25	PMOD
28	and	and	O	CC	O	36	VMOD
29	cell	cell	B-NP	NN	O	31	NMOD
30	cycle	cycle	I-NP	NN	O	31	NMOD
31	variation	variation	I-NP	NN	O	36	SUB
32	in	in	B-PP	IN	O	31	NMOD
33	MNDA	MNDA	B-NP	NN	B-RNA	35	NMOD
34	mRNA	mRNA	I-NP	NN	I-RNA	35	NMOD
35	levels	level	I-NP	NNS	O	32	PMOD
36	were	be	B-VP	VBD	O	16	SBAR
37	not	not	I-VP	RB	O	36	VMOD
38	observed	observe	I-VP	VBN	O	36	VC
39	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	4	NMOD
2	constitutively	constitutively	I-NP	RB	O	3	AMOD
3	active	active	I-NP	JJ	O	4	NMOD
4	type	type	I-NP	NN	O	19	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	9	NMOD
7	CN	CN	I-NP	NN	B-protein	9	NMOD
8	A	A	I-NP	NN	I-protein	9	NMOD
9	subunit	subunit	I-NP	NN	I-protein	5	PMOD
10	,	,	O	,	O	9	P
11	which	which	B-NP	WDT	O	9	NMOD
12	lacks	lack	B-VP	VBZ	O	11	SBAR
13	the	the	B-NP	DT	O	17	NMOD
14	auto-inhibitory	auto-inhibitory	I-NP	JJ	O	16	AMOD
15	and	and	I-NP	CC	O	16	AMOD
16	calmodulin-binding	calmodulin-binding	I-NP	JJ	B-protein	17	NMOD
17	domains	domain	I-NP	NNS	I-protein	12	OBJ
18	,	,	O	,	O	4	P
19	acts	act	B-VP	VBZ	O	0	ROOT
20	in	in	B-PP	IN	O	19	VMOD
21	synergy	synergy	B-NP	NN	O	20	PMOD
22	with	with	B-PP	IN	O	21	NMOD
23	PMA	PMA	B-NP	NN	O	22	PMOD
24	to	to	B-VP	TO	O	25	VMOD
25	activate	activate	I-VP	VB	O	19	VMOD
26	transcription	transcription	B-NP	NN	O	25	OBJ
27	from	from	B-PP	IN	O	25	VMOD
28	the	the	B-NP	DT	O	30	NMOD
29	GM-CSF	GM-CSF	I-NP	NN	B-DNA	30	NMOD
30	promoter	promoter	I-NP	NN	I-DNA	27	PMOD
31	.	.	O	.	O	19	P

1	Functional	Functional	B-NP	JJ	O	2	NMOD
2	studies	study	I-NP	NNS	O	19	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	extra-renal	extra-renal	B-NP	JJ	B-cell_type	6	AMOD
5	,	,	I-NP	,	I-cell_type	6	P
6	nonepithelial	nonepithelial	I-NP	JJ	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
8	such	such	B-PP	JJ	O	9	PMOD
9	as	as	I-PP	IN	O	7	NMOD
10	smooth	smooth	B-NP	JJ	B-cell_type	12	NMOD
11	muscle	muscle	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	18	NMOD
13	and	and	O	CC	O	18	NMOD
14	more	more	B-ADVP	RBR	O	15	AMOD
15	recently	recently	I-ADVP	RB	O	18	NMOD
16	circulating	circulate	B-VP	VBG	B-cell_type	18	NMOD
17	human	human	B-NP	JJ	I-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
19	have	have	B-VP	VBP	O	0	ROOT
20	provided	provide	I-VP	VBN	O	19	VC
21	increasing	increase	B-NP	VBG	O	22	NMOD
22	evidence	evidence	I-NP	NN	O	20	OBJ
23	that	that	B-SBAR	IN	O	22	NMOD
24	aldosterone	aldosterone	B-NP	NN	O	25	SUB
25	produces	produce	B-VP	VBZ	O	23	SBAR
26	not	not	B-CONJP	RB	O	36	NMOD
27	only	only	I-CONJP	RB	O	26	DEP
28	classical	classical	B-NP	JJ	O	30	NMOD
29	genomic	genomic	I-NP	JJ	O	30	NMOD
30	effects	effect	I-NP	NNS	O	36	NMOD
31	,	,	O	,	O	36	P
32	but	but	B-CONJP	CC	O	36	NMOD
33	also	also	I-CONJP	RB	O	32	DEP
34	rapid	rapid	B-NP	JJ	O	36	NMOD
35	non-genomic	non-genomic	I-NP	JJ	O	36	NMOD
36	effects	effect	I-NP	NNS	O	25	OBJ
37	on	on	B-PP	IN	O	36	NMOD
38	transmembrane	transmembrane	B-NP	NN	O	40	NMOD
39	electrolyte	electrolyte	I-NP	NN	O	40	NMOD
40	movements	movement	I-NP	NNS	O	37	PMOD
41	.	.	O	.	O	19	P

1	Such	Such	B-NP	JJ	O	2	NMOD
2	changes	change	I-NP	NNS	O	4	SUB
3	clearly	clearly	B-ADVP	RB	O	4	VMOD
4	can	can	B-VP	MD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	be	be	I-VP	VB	O	4	VC
7	explained	explain	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	genomic	genomic	B-NP	JJ	O	10	NMOD
10	mechanisms	mechanism	I-NP	NNS	O	8	PMOD
11	,	,	O	,	O	10	P
12	which	which	B-NP	WDT	O	10	NMOD
13	are	be	B-VP	VBP	O	12	SBAR
14	responsible	responsible	B-ADJP	JJ	O	13	PRD
15	for	for	B-PP	IN	O	14	AMOD
16	later	later	B-NP	JJ	O	17	NMOD
17	effects	effect	I-NP	NNS	O	15	PMOD
18	than	than	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	membrane-related	membrane-related	I-NP	JJ	O	22	NMOD
21	rapid	rapid	I-NP	JJ	O	22	NMOD
22	responses	response	I-NP	NNS	O	18	PMOD
23	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	25	VMOD
2	T	T	B-NP	NN	B-cell_type	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_type	1	PMOD
4	stimulated	stimulate	B-VP	VBN	O	3	NMOD
5	with	with	B-PP	IN	O	4	VMOD
6	purified	purify	B-NP	VBN	O	7	NMOD
7	phytohemagglutinin	phytohemagglutinin	I-NP	NN	B-protein	15	NMOD
8	(	(	O	(	O	10	DEP
9	PHA-p	PHA-p	B-NP	NN	B-protein	10	DEP
10	)	)	O	)	O	7	NMOD
11	and	and	O	CC	O	15	NMOD
12	4	4	B-NP	CD	O	15	NMOD
13	beta-phorbol	beta-phorbol	I-NP	NN	O	15	NMOD
14	12-myristate	12-myristate	I-NP	NN	O	15	NMOD
15	13-acetate	13-acetate	I-NP	NN	O	5	PMOD
16	(	(	O	(	O	18	DEP
17	PMA	PMA	B-NP	NN	O	18	DEP
18	)	)	O	)	O	15	NMOD
19	addition	addition	B-NP	NN	O	25	SUB
20	of	of	B-PP	IN	O	19	NMOD
21	DM	DM	B-NP	NN	O	20	PMOD
22	to	to	B-PP	TO	O	19	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	cultures	culture	I-NP	NNS	O	22	PMOD
25	resulted	result	B-VP	VBD	O	0	ROOT
26	in	in	B-PP	IN	O	25	VMOD
27	a	a	B-NP	DT	O	30	NMOD
28	60	60	I-NP	CD	O	30	NMOD
29	%	%	I-NP	NN	O	30	NMOD
30	reduction	reduction	I-NP	NN	O	38	NMOD
31	in	in	B-PP	IN	O	30	NMOD
32	IL-2R	IL-2R	B-NP	NN	B-protein	33	NMOD
33	alpha	alpha	I-NP	NN	I-protein	31	PMOD
34	and	and	O	CC	O	38	NMOD
35	a	a	B-NP	DT	O	38	NMOD
36	30	30	I-NP	CD	O	38	NMOD
37	%	%	I-NP	NN	O	38	NMOD
38	reduction	reduction	I-NP	NN	O	26	PMOD
39	in	in	B-PP	IN	O	38	NMOD
40	IL-2R	IL-2R	B-NP	NN	B-protein	43	NMOD
41	beta	beta	I-NP	NN	I-protein	43	NMOD
42	membrane	membrane	I-NP	NN	O	43	NMOD
43	expression	expression	I-NP	NN	O	39	PMOD
44	compared	compare	B-VP	VBN	O	38	NMOD
45	to	to	B-PP	TO	O	44	VMOD
46	T	T	B-NP	NN	B-cell_type	47	NMOD
47	cells	cell	I-NP	NNS	I-cell_type	45	PMOD
48	cultured	culture	B-VP	VBN	O	47	NMOD
49	in	in	B-PP	IN	O	48	VMOD
50	the	the	B-NP	DT	O	51	NMOD
51	absence	absence	I-NP	NN	O	49	PMOD
52	of	of	B-PP	IN	O	51	NMOD
53	DM	DM	B-NP	NN	O	52	PMOD
54	(	(	O	(	O	60	DEP
55	p	p	B-NP	NN	O	57	NMOD
56	&	&	I-NP	CC	O	57	NMOD
57	lt	lt	I-NP	NN	O	59	SUB
58	;	;	O	:	O	59	P
59	0.01	0.01	B-NP	CD	O	60	DEP
60	)	)	O	)	O	48	VMOD
61	.	.	O	.	O	25	P

1	The	The	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	10	10	B-NP	CD	O	9	AMOD
6	(	(	O	(	O	8	DEP
7	-6	-6	B-NP	CD	O	8	DEP
8	)	)	O	)	O	5	NMOD
9	M	M	B-NP	NN	O	10	NMOD
10	DM	DM	I-NP	NN	O	11	SUB
11	increased	increase	B-VP	VBD	O	4	SBAR
12	T	T	B-NP	NN	O	17	NMOD
13	cell	cell	I-NP	NN	O	17	NMOD
14	p50	p50	I-NP	NN	O	17	NMOD
15	NF-kappa	NF-kappa	I-NP	NN	B-RNA	17	NMOD
16	B	B	I-NP	NN	I-RNA	17	NMOD
17	mRNA	mRNA	I-NP	NN	I-RNA	18	NMOD
18	levels	level	I-NP	NNS	O	11	OBJ
19	by	by	B-PP	IN	O	11	VMOD
20	four-fold	four-fold	B-VP	RB	O	19	PMOD
21	compared	compare	I-VP	VBN	O	11	VMOD
22	to	to	B-PP	TO	O	21	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	levels	level	I-NP	NNS	O	22	PMOD
25	obtained	obtain	B-VP	VBN	O	24	NMOD
26	in	in	B-PP	IN	O	25	VMOD
27	the	the	B-NP	DT	O	28	NMOD
28	absence	absence	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	DM	DM	B-NP	NN	O	29	PMOD
31	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	13	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	investigation	investigation	I-NP	NN	O	1	PMOD
4	an	an	B-NP	DT	O	12	NMOD
5	enhanced	enhance	I-NP	VBN	O	7	AMOD
6	and	and	I-NP	CC	O	7	AMOD
7	prolonged	prolong	I-NP	VBN	O	12	NMOD
8	IL-2	IL-2	I-NP	NN	B-protein	11	NMOD
9	and	and	I-NP	CC	O	11	NMOD
10	IL-2	IL-2	I-NP	NN	B-RNA	11	NMOD
11	mRNA	mRNA	I-NP	NN	I-RNA	12	NMOD
12	response	response	I-NP	NN	O	13	SUB
13	was	be	B-VP	VBD	O	0	ROOT
14	also	also	I-VP	RB	O	13	VMOD
15	detected	detect	I-VP	VBN	O	13	VC
16	in	in	B-PP	IN	O	15	VMOD
17	both	both	O	CC	O	18	AMOD
18	stimulated	stimulate	B-VP	VBN	O	27	NMOD
19	(	(	O	(	O	18	AMOD
20	T	T	B-NP	NN	B-protein	22	NMOD
21	cell	cell	I-NP	NN	I-protein	22	NMOD
22	mitogens	mitogen	I-NP	NNS	I-protein	24	NMOD
23	or	or	I-NP	CC	O	24	NMOD
24	alloantigens	alloantigen	I-NP	NNS	B-protein	27	NMOD
25	)	)	O	)	O	27	NMOD
26	murine	murine	B-NP	JJ	B-cell_type	27	NMOD
27	splenocytes	splenocyte	I-NP	NNS	I-cell_type	16	PMOD
28	and	and	B-PP	CC	O	16	PMOD
29	in	in	B-PP	IN	O	16	PMOD
30	the	the	B-NP	DT	O	36	NMOD
31	stimulated	stimulate	I-NP	VBN	O	36	NMOD
32	murine	murine	I-NP	JJ	B-cell_line	36	NMOD
33	T	T	I-NP	NN	I-cell_line	36	NMOD
34	cell	cell	I-NP	NN	I-cell_line	36	NMOD
35	line	line	I-NP	NN	I-cell_line	36	NMOD
36	EL-4	EL-4	I-NP	NN	I-cell_line	29	PMOD
37	in	in	B-PP	IN	O	15	VMOD
38	the	the	B-NP	DT	O	39	NMOD
39	presence	presence	I-NP	NN	O	37	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	ciprofloxacin	ciprofloxacin	B-NP	NN	O	40	PMOD
42	(	(	O	(	O	45	DEP
43	5-80	5-80	B-NP	CD	O	44	NMOD
44	micrograms/ml	micrograms/ml	I-NP	NNS	O	45	DEP
45	)	)	O	)	O	41	NMOD
46	as	as	B-SBAR	IN	O	13	VMOD
47	compared	compare	B-VP	VBN	O	46	SBAR
48	to	to	B-PP	TO	O	47	VMOD
49	control	control	B-NP	NN	B-cell_type	50	NMOD
50	cells	cell	I-NP	NNS	I-cell_type	48	PMOD
51	without	without	B-PP	IN	O	50	NMOD
52	antibiotics	antibiotic	B-NP	NNS	O	51	PMOD
53	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	9	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	9	P
4	EL-4	EL-4	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	9	SUB
6	incubated	incubate	B-VP	VBN	O	5	NMOD
7	with	with	B-PP	IN	O	6	VMOD
8	ciprofloxacin	ciprofloxacin	B-NP	NN	O	7	PMOD
9	showed	show	B-VP	VBD	O	0	ROOT
10	an	an	B-NP	DT	O	12	NMOD
11	early	early	I-NP	JJ	O	12	NMOD
12	peak	peak	I-NP	NN	O	21	NMOD
13	and	and	O	CC	O	21	NMOD
14	more	more	B-NP	RBR	O	15	AMOD
15	activated	activate	I-NP	VBN	O	21	NMOD
16	nuclear	nuclear	B-NP	JJ	B-protein	21	NMOD
17	factor	factor	I-NP	NN	I-protein	21	NMOD
18	of	of	B-PP	IN	I-protein	21	NMOD
19	activated	activate	B-NP	VBN	I-protein	21	NMOD
20	T	T	I-NP	NN	I-protein	21	NMOD
21	cells	cell	I-NP	NNS	I-protein	9	OBJ
22	(	(	O	(	O	24	DEP
23	NFAT-1	NFAT-1	B-NP	NN	B-protein	24	DEP
24	)	)	O	)	O	21	NMOD
25	as	as	B-SBAR	IN	O	9	VMOD
26	compared	compare	B-VP	VBN	O	25	SBAR
27	to	to	B-PP	TO	O	26	VMOD
28	control	control	B-NP	NN	B-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	27	PMOD
30	without	without	B-PP	IN	O	29	NMOD
31	antibiotics	antibiotic	B-NP	NNS	O	30	PMOD
32	.	.	O	.	O	9	P

1	Cipro	Cipro	B-NP	NN	O	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	affect	affect	I-VP	VB	O	2	VC
5	the	the	B-NP	DT	O	8	NMOD
6	nuclear	nuclear	I-NP	JJ	B-protein	8	NMOD
7	transcription	transcription	I-NP	NN	I-protein	8	NMOD
8	factors	factor	I-NP	NNS	I-protein	4	OBJ
9	AP-1	AP-1	B-NP	NN	B-protein	11	NMOD
10	or	or	O	CC	O	11	NMOD
11	NFIL-2A	NFIL-2A	B-NP	NN	B-protein	8	NMOD
12	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	sequence	sequence	I-NP	NN	O	15	SUB
3	between	between	B-PP	IN	O	2	NMOD
4	-1.7	-1.7	B-NP	CD	O	6	AMOD
5	and	and	I-NP	CC	O	6	AMOD
6	-0.2	-0.2	I-NP	CD	O	7	NMOD
7	kb	kb	I-NP	NN	O	3	PMOD
8	linked	link	B-VP	VBN	O	7	NMOD
9	to	to	B-PP	TO	O	8	VMOD
10	a	a	B-NP	DT	O	14	NMOD
11	heterologous	heterologous	I-NP	JJ	B-DNA	14	NMOD
12	thymidine	thymidine	I-NP	NN	I-DNA	14	NMOD
13	kinase	kinase	I-NP	NN	I-DNA	14	NMOD
14	promoter	promoter	I-NP	NN	I-DNA	9	PMOD
15	failed	fail	B-VP	VBD	O	0	ROOT
16	to	to	I-VP	TO	O	17	VMOD
17	respond	respond	I-VP	VB	O	15	VMOD
18	to	to	B-PP	TO	O	17	VMOD
19	PRL	PRL	B-NP	NN	B-protein	20	NMOD
20	stimulation	stimulation	I-NP	NN	O	18	PMOD
21	,	,	O	,	O	15	P
22	suggesting	suggest	B-VP	VBG	O	15	VMOD
23	that	that	B-SBAR	IN	O	22	VMOD
24	the	the	B-NP	DT	O	25	NMOD
25	activity	activity	I-NP	NN	O	31	SUB
26	of	of	B-PP	IN	O	25	NMOD
27	upstream	upstream	B-NP	JJ	B-DNA	30	NMOD
28	PRL	PRL	I-NP	NN	I-DNA	30	NMOD
29	response	response	I-NP	NN	I-DNA	30	NMOD
30	elements	element	I-NP	NNS	I-DNA	26	PMOD
31	may	may	B-VP	MD	O	23	SBAR
32	require	require	I-VP	VB	O	31	VC
33	an	an	B-NP	DT	O	34	NMOD
34	interaction	interaction	I-NP	NN	O	32	OBJ
35	with	with	B-PP	IN	O	34	NMOD
36	promoter-proximal	promoter-proximal	B-NP	JJ	B-DNA	37	NMOD
37	elements	element	I-NP	NNS	I-DNA	35	PMOD
38	.	.	O	.	O	15	P

1	Analysis	Analysis	B-NP	NN	O	8	SUB
2	at	at	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	phenotype	phenotype	I-NP	NN	O	7	NMOD
5	and	and	I-NP	CC	O	4	DEP
6	genetic	genetic	I-NP	JJ	O	4	DEP
7	level	level	I-NP	NN	O	2	PMOD
8	showed	show	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	lack	lack	B-NP	NN	O	14	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	CD5	CD5	B-NP	NN	B-protein	13	NMOD
13	expression	expression	I-NP	NN	O	11	PMOD
14	was	be	B-VP	VBD	O	9	SBAR
15	due	due	B-ADJP	JJ	O	14	PRD
16	neither	neither	B-PP	CC	O	15	PMOD
17	to	to	B-PP	TO	O	16	PMOD
18	segregation	segregation	B-NP	NN	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	human	human	B-NP	JJ	B-DNA	21	NMOD
21	autosome	autosome	I-NP	NN	I-DNA	19	PMOD
22	11	11	I-NP	CD	I-DNA	21	NMOD
23	,	,	O	,	O	21	P
24	on	on	B-PP	IN	O	21	NMOD
25	which	which	B-NP	WDT	O	24	PMOD
26	the	the	B-NP	DT	O	28	NMOD
27	CD5	CD5	I-NP	NN	B-DNA	28	NMOD
28	gene	gene	I-NP	NN	I-DNA	29	SUB
29	has	have	B-VP	VBZ	O	24	SBAR
30	been	be	I-VP	VBN	O	29	VC
31	mapped	map	I-VP	VBN	O	30	VC
32	,	,	B-PP	,	O	21	P
33	nor	nor	I-PP	CC	O	16	PMOD
34	to	to	B-PP	TO	O	16	PMOD
35	deletion	deletion	B-NP	NN	O	34	PMOD
36	of	of	B-PP	IN	O	35	NMOD
37	the	the	B-NP	DT	O	40	NMOD
38	CD5	CD5	I-NP	NN	B-DNA	40	NMOD
39	structural	structural	I-NP	JJ	I-DNA	40	NMOD
40	gene	gene	I-NP	NN	I-DNA	36	PMOD
41	.	.	O	.	O	8	P

1	Furthermore	Furthermore	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	loss	loss	B-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	CD5	CD5	B-NP	NN	B-protein	7	NMOD
6	surface	surface	I-NP	NN	O	7	NMOD
7	expression	expression	I-NP	NN	O	4	PMOD
8	correlated	correlate	B-VP	VBD	O	0	ROOT
9	with	with	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	absence	absence	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	specific	specific	B-NP	JJ	O	14	NMOD
14	mRNA	mRNA	I-NP	NN	B-RNA	12	PMOD
15	.	.	O	.	O	8	P

1	Breast	Breast	B-NP	NN	O	3	NMOD
2	tissue	tissue	I-NP	NN	O	3	NMOD
3	biomarkers	biomarker	I-NP	NNS	O	19	SUB
4	which	which	B-NP	WDT	O	3	NMOD
5	accurately	accurately	B-ADVP	RB	O	6	VMOD
6	predict	predict	B-VP	VBP	O	4	SBAR
7	breast	breast	B-NP	NN	O	9	NMOD
8	cancer	cancer	I-NP	NN	O	9	NMOD
9	development	development	I-NP	NN	O	6	OBJ
10	within	within	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	14	NMOD
12	10	10	I-NP	CD	O	13	AMOD
13	year	year	I-NP	NN	O	14	NMOD
14	period	period	I-NP	NN	O	10	PMOD
15	in	in	B-PP	IN	O	9	NMOD
16	high	high	B-NP	JJ	O	18	NMOD
17	risk	risk	I-NP	NN	O	18	NMOD
18	women	woman	I-NP	NNS	O	15	PMOD
19	are	be	B-VP	VBP	O	0	ROOT
20	needed	need	I-VP	VBN	O	19	VMOD
21	but	but	O	CC	O	20	DEP
22	currently	currently	B-ADVP	RB	O	20	PRD
23	not	not	O	RB	O	22	AMOD
24	available	available	B-ADJP	JJ	O	22	AMOD
25	.	.	O	.	O	19	P

1	Low	Low	B-NP	JJ	O	3	NMOD
2	risk	risk	I-NP	NN	O	3	NMOD
3	women	woman	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	those	those	B-NP	DT	O	4	PRD
6	without	without	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	13	NMOD
8	or	or	I-NP	CC	O	13	NMOD
9	other	other	I-NP	JJ	O	13	NMOD
10	major	major	I-NP	JJ	B-protein	13	NMOD
11	identifiable	identifiable	I-NP	JJ	I-protein	13	NMOD
12	risk	risk	I-NP	NN	I-protein	13	NMOD
13	factors	factor	I-NP	NNS	I-protein	6	PMOD
14	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	difference	difference	I-NP	NN	O	15	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	prevalence	prevalence	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	ER	ER	B-NP	NN	B-protein	8	NMOD
8	overexpression	overexpression	I-NP	NN	O	6	PMOD
9	between	between	B-PP	IN	O	2	NMOD
10	high	high	B-NP	JJ	O	12	AMOD
11	and	and	I-NP	CC	O	12	AMOD
12	low	low	I-NP	JJ	O	14	NMOD
13	risk	risk	I-NP	NN	O	14	NMOD
14	groups	group	I-NP	NNS	O	9	PMOD
15	was	be	B-VP	VBD	O	0	ROOT
16	not	not	O	RB	O	15	VMOD
17	statistically	statistically	B-ADJP	RB	O	15	VMOD
18	significant	significant	I-ADJP	JJ	O	15	PRD
19	(	(	O	(	O	23	DEP
20	p	p	B-NP	NN	O	22	SUB
21	=	=	B-VP	SYM	O	22	VMOD
22	0.095	0.095	B-NP	CD	O	23	DEP
23	)	)	O	)	O	15	VMOD
24	.	.	O	.	O	15	P

1	No	No	B-NP	DT	O	2	NMOD
2	difference	difference	I-NP	NN	O	7	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	plasma	plasma	B-NP	NN	O	6	NMOD
5	cortisol	cortisol	I-NP	NN	O	6	NMOD
6	level	level	I-NP	NN	O	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	found	find	I-VP	VBN	O	7	VC
9	between	between	B-PP	IN	O	8	VMOD
10	asthmatics	asthmatic	B-NP	NNS	O	13	NMOD
11	and	and	O	CC	O	13	NMOD
12	healthy	healthy	B-NP	JJ	O	13	NMOD
13	subjects	subject	I-NP	NNS	O	9	PMOD
14	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	there	there	B-NP	EX	O	6	SUB
6	is	be	B-VP	VBZ	O	27	VMOD
7	no	no	B-NP	DT	O	11	NMOD
8	primary	primary	I-NP	JJ	O	10	AMOD
9	and	and	I-NP	CC	O	10	AMOD
10	general	general	I-NP	JJ	O	11	NMOD
11	impairment	impairment	I-NP	NN	O	6	PRD
12	of	of	B-PP	IN	O	11	NMOD
13	glucocorticoid	glucocorticoid	B-NP	NN	O	14	NMOD
14	metabolism	metabolism	I-NP	NN	O	12	PMOD
15	in	in	B-PP	IN	O	6	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	asthmatics	asthmatic	I-NP	NNS	O	15	PMOD
18	,	,	O	,	O	27	P
19	but	but	O	CC	O	27	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	number	number	I-NP	NN	O	27	SUB
22	of	of	B-PP	IN	O	21	NMOD
23	GCR	GCR	B-NP	NN	B-protein	22	PMOD
24	in	in	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	asthmatics	asthmatic	I-NP	NNS	O	24	PMOD
27	is	be	B-VP	VBZ	O	4	SBAR
28	lower	low	B-ADJP	JJR	O	27	PRD
29	than	than	B-PP	IN	O	28	AMOD
30	that	that	B-NP	DT	O	29	PMOD
31	in	in	B-PP	IN	O	30	NMOD
32	healthy	healthy	B-NP	JJ	O	33	NMOD
33	controls	control	I-NP	NNS	O	31	PMOD
34	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	3	NMOD
2	atrophy	atrophy	I-NP	NN	O	3	NMOD
3	induction	induction	I-NP	NN	O	4	SUB
4	does	do	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	involve	involve	I-VP	VB	O	4	VC
7	apoptotic	apoptotic	B-NP	JJ	O	8	NMOD
8	mechanisms	mechanism	I-NP	NNS	O	6	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	thymocytes	thymocyte	B-NP	NNS	B-cell_type	9	PMOD
11	affected	affect	B-VP	VBN	O	10	NMOD
12	by	by	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	bcl-2	bcl-2	I-NP	NN	B-DNA	15	NMOD
15	proto-oncogene	proto-oncogene	I-NP	NN	I-DNA	12	PMOD
16	.	.	O	.	O	4	P

1	TCDD	TCDD	B-NP	NN	O	2	SUB
2	mediates	mediate	B-VP	VBZ	O	0	ROOT
3	atrophy	atrophy	B-NP	NN	O	4	NMOD
4	induction	induction	I-NP	NN	O	2	OBJ
5	through	through	B-PP	IN	O	2	VMOD
6	its	its	B-NP	PRP$	O	8	NMOD
7	specific	specific	I-NP	JJ	O	8	NMOD
8	receptor	receptor	I-NP	NN	O	5	PMOD
9	(	(	O	(	O	12	DEP
10	the	the	B-NP	DT	O	11	NMOD
11	AhR	AhR	I-NP	NN	B-protein	12	DEP
12	)	)	O	)	O	8	NMOD
13	and	and	O	CC	O	5	PMOD
14	not	not	B-PP	RB	O	15	PMOD
15	through	through	I-PP	IN	O	5	PMOD
16	effects	effect	B-NP	NNS	O	15	PMOD
17	on	on	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	estrogen	estrogen	I-NP	NN	B-protein	20	NMOD
20	receptor	receptor	I-NP	NN	I-protein	17	PMOD
21	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	observed	observe	B-VP	VBD	O	0	ROOT
3	no	no	B-NP	DT	O	4	NMOD
4	change	change	I-NP	NN	O	2	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	membrane	membrane	B-NP	NN	O	8	NMOD
7	structural	structural	I-NP	JJ	O	8	NMOD
8	order	order	I-NP	NN	O	5	PMOD
9	with	with	B-PP	IN	O	4	NMOD
10	RU	RU	B-NP	NN	O	9	PMOD
11	486	486	I-NP	CD	O	10	NMOD
12	up	up	B-PP	IN	O	4	NMOD
13	to	to	B-PP	TO	O	12	PMOD
14	a	a	B-NP	DT	O	15	NMOD
15	concentration	concentration	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	10	10	B-NP	CD	O	21	NMOD
18	(	(	O	(	O	20	DEP
19	-4	-4	B-NP	CD	O	20	DEP
20	)	)	O	)	O	17	NMOD
21	M	M	B-NP	NN	O	16	PMOD
22	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	mechanism	mechanism	I-NP	NN	O	9	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	which	which	B-NP	WDT	O	3	PMOD
5	NF-ATc	NF-ATc	B-NP	NN	B-protein	6	SUB
6	enters	enter	B-VP	VBZ	O	3	SBAR
7	the	the	B-NP	DT	O	8	NMOD
8	nucleus	nucleus	I-NP	NN	O	6	OBJ
9	is	be	B-VP	VBZ	O	21	VMOD
10	unknown	unknown	B-ADJP	JJ	O	9	PRD
11	,	,	O	,	O	21	P
12	and	and	O	CC	O	21	VMOD
13	although	although	B-SBAR	IN	O	21	VMOD
14	it	it	B-NP	PRP	O	15	SUB
15	appears	appear	B-VP	VBZ	O	13	SBAR
16	to	to	I-VP	TO	O	17	VMOD
17	require	require	I-VP	VB	O	15	VMOD
18	calcineurin	calcineurin	B-NP	NN	B-protein	17	OBJ
19	,	,	O	,	O	21	P
20	NF-ATc	NF-ATc	B-NP	NN	B-protein	21	SUB
21	has	have	B-VP	VBZ	O	0	ROOT
22	not	not	I-VP	RB	O	21	VMOD
23	yet	yet	I-VP	RB	O	21	VMOD
24	been	be	I-VP	VBN	O	21	VC
25	shown	show	I-VP	VBN	O	24	VC
26	to	to	I-VP	TO	O	27	VMOD
27	be	be	I-VP	VB	O	25	VMOD
28	an	an	B-NP	DT	O	31	NMOD
29	in	in	I-NP	FW	O	30	AMOD
30	vivo	vivo	I-NP	FW	O	31	NMOD
31	substrate	substrate	I-NP	NN	O	27	PRD
32	of	of	B-PP	IN	O	31	NMOD
33	calcineurin	calcineurin	B-NP	NN	B-protein	32	PMOD
34	.	.	O	.	O	21	P

1	Although	Although	B-SBAR	IN	O	8	VMOD
2	NF-ATp	NF-ATp	B-NP	NN	B-protein	3	SUB
3	copurifies	copurify	B-VP	VBZ	O	1	SBAR
4	with	with	B-PP	IN	O	3	VMOD
5	NF-ATc	NF-ATc	B-NP	NN	B-protein	4	PMOD
6	,	,	O	,	O	8	P
7	there	there	B-NP	EX	O	8	SUB
8	is	be	B-VP	VBZ	O	0	ROOT
9	as	as	B-ADVP	RB	O	8	VMOD
10	yet	yet	I-ADVP	RB	O	9	AMOD
11	no	no	B-NP	DT	O	12	NMOD
12	understanding	understanding	I-NP	NN	O	8	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	how	how	B-ADVP	WRB	O	13	PMOD
15	NF-ATp	NF-ATp	B-NP	NN	B-protein	16	SUB
16	is	be	B-VP	VBZ	O	14	SBAR
17	functioning	function	I-VP	VBG	O	16	VC
18	in	in	B-ADVP	FW	O	17	VMOD
19	vivo	vivo	I-ADVP	FW	O	18	AMOD
20	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	3	NMOD
2	T3-	T3-	I-NP	NN	O	3	NMOD
3	group	group	I-NP	NN	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	no	no	B-NP	DT	O	6	NMOD
6	change	change	I-NP	NN	O	4	OBJ
7	in	in	B-PP	IN	O	6	NMOD
8	MBC	MBC	B-NP	NN	O	7	PMOD
9	over	over	B-PP	IN	O	6	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	study	study	I-NP	NN	O	9	PMOD
12	.	.	O	.	O	4	P

1	Although	Although	B-SBAR	IN	O	43	VMOD
2	no	no	B-NP	DT	O	3	NMOD
3	proof	proof	I-NP	NN	O	5	SUB
4	yet	yet	B-ADVP	RB	O	5	VMOD
5	exists	exist	B-VP	VBZ	O	1	SBAR
6	of	of	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	8	NMOD
8	role	role	I-NP	NN	O	6	PMOD
9	for	for	B-PP	IN	O	8	NMOD
10	these	these	B-NP	DT	O	11	NMOD
11	lesions	lesion	I-NP	NNS	O	9	PMOD
12	in	in	B-PP	IN	O	8	NMOD
13	DLCL	DLCL	B-NP	NN	O	14	NMOD
14	pathogenesis	pathogenesis	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	43	P
16	the	the	B-NP	DT	O	17	NMOD
17	feature	feature	I-NP	NN	O	35	NMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	BCL-6	BCL-6	I-NP	NN	B-protein	22	NMOD
21	gene	gene	I-NP	NN	I-protein	22	NMOD
22	product	product	I-NP	NN	I-protein	18	PMOD
23	,	,	O	,	O	35	P
24	its	its	B-NP	PRP$	O	26	NMOD
25	specific	specific	I-NP	JJ	O	26	NMOD
26	pattern	pattern	I-NP	NN	O	35	NMOD
27	of	of	B-PP	IN	O	26	NMOD
28	expression	expression	B-NP	NN	O	27	PMOD
29	in	in	B-PP	IN	O	28	NMOD
30	B	B	B-NP	NN	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
32	,	,	O	,	O	35	P
33	and	and	O	CC	O	35	NMOD
34	the	the	B-NP	DT	O	35	NMOD
35	clustering	clustering	I-NP	NN	O	43	SUB
36	of	of	B-PP	IN	O	35	NMOD
37	lesions	lesion	B-NP	NNS	O	36	PMOD
38	disrupting	disrupt	B-VP	VBG	O	35	NMOD
39	its	its	B-NP	PRP$	O	41	NMOD
40	regulatory	regulatory	I-NP	JJ	B-protein	41	NMOD
41	domain	domain	I-NP	NN	I-protein	38	OBJ
42	strongly	strongly	B-ADVP	RB	O	43	VMOD
43	suggest	suggest	B-VP	VBP	O	0	ROOT
44	that	that	B-SBAR	IN	O	43	VMOD
45	deregulation	deregulation	B-NP	NN	O	49	SUB
46	of	of	B-PP	IN	O	45	NMOD
47	BCL-6	BCL-6	B-NP	NN	B-protein	48	NMOD
48	expression	expression	I-NP	NN	O	46	PMOD
49	may	may	B-VP	MD	O	44	SBAR
50	contribute	contribute	I-VP	VB	O	49	VC
51	to	to	B-PP	TO	O	50	VMOD
52	DLCL	DLCL	B-NP	NN	O	53	NMOD
53	development	development	I-NP	NN	O	51	PMOD
54	.	.	O	.	O	43	P

1	A	A	B-NP	DT	O	4	NMOD
2	more	more	I-NP	RBR	O	3	AMOD
3	precise	precise	I-NP	JJ	O	4	NMOD
4	definition	definition	I-NP	NN	O	16	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	role	role	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	BCL-6	BCL-6	B-NP	NN	B-protein	8	PMOD
10	in	in	B-PP	IN	O	7	NMOD
11	normal	normal	B-NP	JJ	O	13	AMOD
12	and	and	I-NP	CC	O	13	AMOD
13	neoplastic	neoplastic	I-NP	JJ	O	15	NMOD
14	B-cell	B-cell	I-NP	NN	O	15	NMOD
15	development	development	I-NP	NN	O	10	PMOD
16	is	be	B-VP	VBZ	O	0	ROOT
17	the	the	B-NP	DT	O	18	NMOD
18	goal	goal	I-NP	NN	O	16	PRD
19	of	of	B-PP	IN	O	18	NMOD
20	ongoing	ongoing	B-NP	JJ	O	21	NMOD
21	study	study	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	transgenic	transgenic	B-NP	JJ	O	24	NMOD
24	mice	mouse	I-NP	NNS	O	22	PMOD
25	engineered	engineer	B-VP	VBN	O	24	NMOD
26	either	either	O	CC	O	28	VMOD
27	to	to	B-VP	TO	O	28	VMOD
28	express	express	I-VP	VB	O	25	VMOD
29	BCL-6	BCL-6	B-NP	NN	B-protein	28	OBJ
30	under	under	B-PP	IN	O	28	VMOD
31	heterologous	heterologous	B-NP	JJ	B-DNA	32	NMOD
32	promoters	promoter	I-NP	NNS	I-DNA	30	PMOD
33	or	or	O	CC	O	28	VMOD
34	lacking	lack	B-VP	VBG	O	28	VMOD
35	BCL-6	BCL-6	B-NP	NN	B-protein	36	NMOD
36	function	function	I-NP	NN	O	34	OBJ
37	due	due	B-ADJP	JJ	O	38	PMOD
38	to	to	B-PP	TO	O	34	VMOD
39	targeted	target	B-NP	VBN	O	40	NMOD
40	deletions	deletion	I-NP	NNS	O	38	PMOD
41	.	.	O	.	O	16	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	report	report	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	present	present	B-VP	VBP	O	0	ROOT
7	data	datum	B-NP	NNS	O	6	OBJ
8	demonstrating	demonstrate	B-VP	VBG	O	7	NMOD
9	that	that	B-SBAR	IN	O	8	VMOD
10	HIV	HIV	B-NP	NN	B-DNA	12	NMOD
11	LTR	LTR	I-NP	NN	I-DNA	12	NMOD
12	activation	activation	I-NP	NN	O	13	SUB
13	is	be	B-VP	VBZ	O	9	SBAR
14	not	not	O	RB	O	13	VMOD
15	a	a	B-NP	DT	O	17	NMOD
16	general	general	I-NP	JJ	O	17	NMOD
17	consequence	consequence	I-NP	NN	O	13	PRD
18	of	of	B-PP	IN	O	17	NMOD
19	cellular	cellular	B-NP	JJ	B-DNA	21	NMOD
20	DNA	DNA	I-NP	NN	I-DNA	21	NMOD
21	damage	damage	I-NP	NN	O	18	PMOD
22	,	,	O	,	O	26	P
23	but	but	O	CC	O	26	NMOD
24	rather	rather	B-ADVP	RB	O	23	DEP
25	a	a	B-NP	DT	O	26	NMOD
26	process	process	I-NP	NN	O	13	PRD
27	unique	unique	B-ADJP	JJ	O	26	NMOD
28	to	to	B-PP	TO	O	27	AMOD
29	specific	specific	B-NP	JJ	O	31	NMOD
30	genotoxic	genotoxic	I-NP	JJ	O	31	NMOD
31	stimuli	stimulus	I-NP	NNS	O	28	PMOD
32	,	,	O	,	O	34	P
33	and	and	O	CC	O	34	DEP
34	that	that	B-SBAR	IN	O	26	NMOD
35	it	it	B-NP	PRP	O	36	SUB
36	does	do	B-VP	VBZ	O	34	SBAR
37	not	not	I-VP	RB	O	36	VMOD
38	necessarily	necessarily	I-VP	RB	O	36	VMOD
39	depend	depend	I-VP	VB	O	36	VC
40	on	on	B-PP	IN	O	39	VMOD
41	activation	activation	B-NP	NN	O	40	PMOD
42	of	of	B-PP	IN	O	41	NMOD
43	NF-kappa	NF-kappa	B-NP	NN	B-protein	44	NMOD
44	B	B	I-NP	NN	I-protein	42	PMOD
45	.	.	O	.	O	6	P

1	p60	p60	B-NP	NN	B-protein	2	NMOD
2	phosphorylation	phosphorylation	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	time	time	B-NP	NN	O	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	PMA	PMA	B-NP	NN	O	7	NMOD
7	dose	dose	I-NP	NN	O	8	AMOD
8	dependent	dependent	B-ADJP	JJ	O	3	PRD
9	,	,	O	,	O	3	P
10	and	and	O	CC	O	3	VMOD
11	was	be	B-VP	VBD	O	3	VMOD
12	induced	induce	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	cell-permeable	cell-permeable	B-NP	JJ	O	15	NMOD
15	diacylglycerol	diacylglycerol	I-NP	NN	O	13	PMOD
16	,	,	O	,	O	11	VMOD
17	but	but	O	CC	O	16	PMOD
18	not	not	O	RB	O	17	DEP
19	by	by	B-PP	IN	O	17	PMOD
20	inactive	inactive	B-NP	JJ	O	22	NMOD
21	phorbol	phorbol	I-NP	NN	O	22	NMOD
22	esters	ester	I-NP	NNS	O	19	PMOD
23	.	.	O	.	O	3	P

1	To	To	B-VP	TO	O	2	VMOD
2	investigate	investigate	I-VP	VB	O	25	VMOD
3	the	the	B-NP	DT	O	5	NMOD
4	molecular	molecular	I-NP	JJ	O	5	NMOD
5	mechanism	mechanism	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	inhibitory	inhibitory	I-NP	JJ	O	9	NMOD
9	effect	effect	I-NP	NN	O	6	PMOD
10	on	on	B-PP	IN	O	9	NMOD
11	transcriptional	transcriptional	B-NP	JJ	O	14	NMOD
12	or	or	I-NP	CC	O	14	NMOD
13	post-transcriptional	post-transcriptional	I-NP	JJ	O	14	NMOD
14	regulation	regulation	I-NP	NN	O	10	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	IL-6	IL-6	B-NP	NN	B-DNA	18	NMOD
17	gene	gene	I-NP	NN	I-DNA	18	NMOD
18	expression	expression	I-NP	NN	O	15	PMOD
19	by	by	B-PP	IN	O	9	NMOD
20	IL-4	IL-4	B-NP	NN	B-protein	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	IL-10	IL-10	I-NP	NN	B-protein	19	PMOD
23	,	,	O	,	O	25	P
24	we	we	B-NP	PRP	O	25	SUB
25	studied	study	B-VP	VBD	O	0	ROOT
26	IL-6	IL-6	B-NP	NN	B-protein	27	NMOD
27	production	production	I-NP	NN	O	49	NMOD
28	,	,	O	,	O	49	P
29	expression	expression	B-NP	NN	O	30	NMOD
30	level	level	I-NP	NN	O	49	NMOD
31	of	of	B-PP	IN	O	30	NMOD
32	IL-6	IL-6	B-NP	NN	B-RNA	33	NMOD
33	mRNA	mRNA	I-NP	NN	I-RNA	31	PMOD
34	,	,	O	,	O	49	P
35	IL-6	IL-6	B-NP	NN	B-DNA	37	NMOD
36	promoter	promoter	I-NP	NN	I-DNA	37	NMOD
37	activity	activity	I-NP	NN	O	49	NMOD
38	,	,	O	,	O	49	P
39	transcriptional	transcriptional	B-NP	JJ	O	40	NMOD
40	activity	activity	I-NP	NN	O	49	NMOD
41	of	of	B-PP	IN	O	40	NMOD
42	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	44	NMOD
43	and	and	I-NP	CC	O	44	NMOD
44	NF-IL-6	NF-IL-6	I-NP	NN	B-protein	41	PMOD
45	,	,	O	,	O	49	P
46	and	and	O	CC	O	49	NMOD
47	IL-6	IL-6	B-NP	NN	B-RNA	49	NMOD
48	mRNA	mRNA	I-NP	NN	I-RNA	49	NMOD
49	stability	stability	I-NP	NN	O	25	OBJ
50	in	in	B-PP	IN	O	49	NMOD
51	human	human	B-NP	JJ	B-cell_line	54	NMOD
52	monocytic	monocytic	I-NP	JJ	I-cell_line	54	NMOD
53	cell	cell	I-NP	NN	I-cell_line	54	NMOD
54	lines	line	I-NP	NNS	I-cell_line	58	NMOD
55	,	,	O	,	O	58	P
56	THP-1	THP-1	B-NP	NN	B-cell_line	58	NMOD
57	and	and	I-NP	CC	O	58	NMOD
58	U937	U937	I-NP	NN	B-cell_line	50	PMOD
59	,	,	O	,	O	58	P
60	stimulated	stimulate	B-VP	VBN	O	58	NMOD
61	by	by	B-PP	IN	O	60	VMOD
62	PMA	PMA	B-NP	NN	O	64	NMOD
63	and	and	O	CC	O	64	NMOD
64	LPS	LPS	B-NP	NN	O	61	PMOD
65	in	in	B-PP	IN	O	60	VMOD
66	the	the	B-NP	DT	O	67	NMOD
67	absence	absence	I-NP	NN	O	70	NMOD
68	or	or	O	CC	O	70	NMOD
69	the	the	B-NP	DT	O	70	NMOD
70	presence	presence	I-NP	NN	O	65	PMOD
71	of	of	B-PP	IN	O	70	NMOD
72	IL-4	IL-4	B-NP	NN	B-protein	74	NMOD
73	or	or	I-NP	CC	O	74	NMOD
74	IL-10	IL-10	I-NP	NN	B-protein	71	PMOD
75	.	.	O	.	O	25	P

1	In	In	B-PP	IN	O	28	VMOD
2	chloramphenicol	chloramphenicol	B-NP	NN	B-protein	4	NMOD
3	acetyltransferase	acetyltransferase	I-NP	NN	I-protein	4	NMOD
4	assays	assay	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	28	P
6	utilizing	utilize	B-VP	VBG	O	28	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	transient	transient	I-NP	JJ	O	9	NMOD
9	transfection	transfection	I-NP	NN	O	6	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	15	NMOD
12	chloramphenicol	chloramphenicol	I-NP	NN	B-DNA	15	NMOD
13	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	15	NMOD
14	reporter	reporter	I-NP	NN	I-DNA	15	NMOD
15	plasmid	plasmid	I-NP	NN	I-DNA	22	NMOD
16	containing	contain	B-VP	VBG	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	IL-6	IL-6	I-NP	NN	B-DNA	20	NMOD
19	gene	gene	I-NP	NN	I-DNA	20	NMOD
20	promoter	promoter	I-NP	NN	I-DNA	16	OBJ
21	,	,	O	,	O	22	P
22	IL-4	IL-4	B-NP	NN	B-protein	10	PMOD
23	,	,	O	,	O	28	P
24	but	but	O	CC	O	26	NMOD
25	not	not	O	RB	O	24	DEP
26	IL-10	IL-10	B-NP	NN	B-protein	28	SUB
27	,	,	O	,	O	26	P
28	suppressed	suppress	B-VP	VBD	O	0	ROOT
29	the	the	B-NP	DT	O	31	NMOD
30	transcriptional	transcriptional	I-NP	JJ	O	31	NMOD
31	activity	activity	I-NP	NN	O	28	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	36	NMOD
34	IL-6	IL-6	I-NP	NN	B-DNA	36	NMOD
35	gene	gene	I-NP	NN	I-DNA	36	NMOD
36	promoter	promoter	I-NP	NN	I-DNA	32	PMOD
37	stimulated	stimulate	B-VP	VBN	O	36	NMOD
38	by	by	B-PP	IN	O	37	VMOD
39	PMA	PMA	B-NP	NN	O	41	NMOD
40	and	and	O	CC	O	41	NMOD
41	LPS	LPS	B-NP	NN	O	38	PMOD
42	.	.	O	.	O	28	P

1	Electrophoretic	Electrophoretic	B-NP	JJ	O	4	NMOD
2	mobility	mobility	I-NP	NN	O	4	NMOD
3	shift	shift	I-NP	NN	O	4	NMOD
4	assays	assay	I-NP	NNS	O	5	SUB
5	showed	show	B-VP	VBD	O	0	ROOT
6	that	that	B-SBAR	IN	O	19	DEP
7	IL-4	IL-4	B-NP	NN	B-protein	11	NMOD
8	,	,	B-NP	,	O	11	P
9	but	but	I-NP	CC	O	11	NMOD
10	not	not	I-NP	RB	O	9	DEP
11	IL-10	IL-10	B-NP	NN	B-protein	13	SUB
12	,	,	O	,	O	11	P
13	inhibited	inhibit	B-VP	VBD	O	6	SBAR
14	nuclear	nuclear	B-NP	JJ	O	16	NMOD
15	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	16	NMOD
16	activity	activity	I-NP	NN	O	13	OBJ
17	,	,	O	,	O	19	P
18	and	and	O	CC	O	19	DEP
19	that	that	B-SBAR	IN	O	5	VMOD
20	IL-4	IL-4	B-NP	NN	B-protein	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	IL-10	IL-10	I-NP	NN	B-protein	23	SUB
23	did	do	B-VP	VBD	O	19	SBAR
24	not	not	I-VP	RB	O	23	VMOD
25	affect	affect	I-VP	VB	O	23	VC
26	NF-IL-6	NF-IL-6	B-NP	NN	B-protein	27	NMOD
27	activity	activity	I-NP	NN	O	25	OBJ
28	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	IL-4	IL-4	B-NP	NN	B-protein	6	SUB
6	may	may	B-VP	MD	O	4	SBAR
7	inhibit	inhibit	I-VP	VB	O	6	VC
8	the	the	B-NP	DT	O	9	NMOD
9	transcription	transcription	I-NP	NN	O	7	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	IL-6	IL-6	I-NP	NN	B-DNA	13	NMOD
13	gene	gene	I-NP	NN	I-DNA	10	PMOD
14	by	by	B-PP	IN	O	7	VMOD
15	affecting	affect	B-VP	VBG	O	14	PMOD
16	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	18	NMOD
17	binding	binding	I-NP	NN	O	18	NMOD
18	activity	activity	I-NP	NN	O	15	OBJ
19	,	,	O	,	O	7	P
20	while	while	B-SBAR	IN	O	7	VMOD
21	IL-10	IL-10	B-NP	NN	B-protein	22	SUB
22	may	may	B-VP	MD	O	20	SBAR
23	inhibit	inhibit	I-VP	VB	O	22	VC
24	the	the	B-NP	DT	O	27	NMOD
25	IL-6	IL-6	I-NP	NN	B-RNA	27	NMOD
26	mRNA	mRNA	I-NP	NN	I-RNA	27	NMOD
27	levels	level	I-NP	NNS	O	23	OBJ
28	post-transcriptionally	post-transcriptionally	B-ADVP	RB	O	23	VMOD
29	,	,	O	,	O	23	P
30	without	without	B-PP	IN	O	23	VMOD
31	suppressing	suppress	B-VP	VBG	O	30	PMOD
32	promoter	promoter	B-NP	NN	O	33	NMOD
33	activity	activity	I-NP	NN	O	31	OBJ
34	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	5	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	IL-13	IL-13	B-NP	NN	B-protein	5	SUB
5	phosphorylated	phosphorylated	I-NP	JJ	O	0	ROOT
6	insulin	insulin	I-NP	NN	B-protein	8	NMOD
7	response	response	I-NP	NN	I-protein	8	NMOD
8	substrate-1	substrate-1	I-NP	NN	I-protein	16	NMOD
9	,	,	O	,	O	16	P
10	IL-4R	IL-4R	B-NP	NN	B-protein	11	NMOD
11	p140	p140	I-NP	NN	I-protein	16	NMOD
12	,	,	O	,	O	16	P
13	JAK1	JAK1	B-NP	NN	B-protein	16	NMOD
14	,	,	O	,	O	16	P
15	and	and	O	CC	O	16	NMOD
16	Tyk2	Tyk2	B-NP	NN	B-protein	21	NMOD
17	,	,	O	,	O	21	P
18	but	but	O	CC	O	21	NMOD
19	not	not	O	RB	O	18	DEP
20	JAK3	JAK3	B-NP	NN	B-protein	21	NMOD
21	kinase	kinase	I-NP	NN	I-protein	5	OBJ
22	.	.	O	.	O	5	P

1	IL-4	IL-4	B-NP	NN	B-protein	3	SUB
2	also	also	B-ADVP	RB	O	3	VMOD
3	stimulated	stimulate	B-VP	VBD	O	0	ROOT
4	all	all	B-NP	DT	O	8	NMOD
5	three	three	I-NP	CD	O	4	AMOD
6	kinases	kinase	I-NP	NNS	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	substrates	substrate	I-NP	NNS	O	17	SUB
9	,	,	O	,	O	17	P
10	but	but	O	CC	O	17	VMOD
11	unlike	unlike	B-PP	IN	O	17	VMOD
12	in	in	B-PP	IN	O	11	PMOD
13	immune	immune	B-NP	JJ	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
15	,	,	O	,	O	17	P
16	IL-4	IL-4	B-NP	NN	B-protein	17	SUB
17	did	do	B-VP	VBD	O	3	VMOD
18	not	not	I-VP	RB	O	17	VMOD
19	involve	involve	I-VP	VB	O	17	VC
20	JAK3	JAK3	B-NP	NN	B-protein	21	NMOD
21	activation	activation	I-NP	NN	O	19	OBJ
22	for	for	B-PP	IN	O	21	NMOD
23	its	its	B-NP	PRP$	O	24	NMOD
24	signaling	signaling	I-NP	NN	O	22	PMOD
25	in	in	B-PP	IN	O	24	NMOD
26	colon	colon	B-NP	NN	B-cell_line	29	NMOD
27	cancer	cancer	I-NP	NN	I-cell_line	29	NMOD
28	cell	cell	I-NP	NN	I-cell_line	29	NMOD
29	lines	line	I-NP	NNS	I-cell_line	25	PMOD
30	.	.	O	.	O	3	P

1	Both	Both	O	CC	O	4	NMOD
2	IL-13	IL-13	B-NP	NN	B-protein	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	IL-4	IL-4	I-NP	NN	B-protein	5	SUB
5	induced	induce	B-VP	VBD	O	0	ROOT
6	phosphorylation	phosphorylation	B-NP	NN	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	IL-4	IL-4	B-NP	NN	B-protein	9	NMOD
9	STAT	STAT	I-NP	NN	I-protein	20	NMOD
10	(	(	O	(	O	12	DEP
11	STAT6	STAT6	B-NP	NN	B-protein	12	DEP
12	)	)	O	)	O	9	NMOD
13	but	but	B-NP	CC	O	20	NMOD
14	not	not	I-NP	RB	O	13	DEP
15	STAT1	STAT1	B-NP	NN	B-protein	20	NMOD
16	,	,	O	,	O	20	P
17	STAT3	STAT3	B-NP	NN	B-protein	20	NMOD
18	,	,	O	,	O	20	P
19	or	or	O	CC	O	20	NMOD
20	STAT5	STAT5	B-NP	NN	B-protein	7	PMOD
21	.	.	O	.	O	5	P

1	125I-IL-13	125I-IL-13	B-NP	NN	B-protein	2	SUB
2	did	do	B-VP	VBD	O	14	VMOD
3	not	not	I-VP	RB	O	2	VMOD
4	bind	bind	I-VP	VB	O	2	VC
5	to	to	B-PP	TO	O	4	VMOD
6	colon	colon	B-NP	NN	B-cell_line	9	NMOD
7	cancer	cancer	I-NP	NN	I-cell_line	9	NMOD
8	cell	cell	I-NP	NN	I-cell_line	9	NMOD
9	lines	line	I-NP	NNS	I-cell_line	5	PMOD
10	,	,	O	,	O	14	P
11	but	but	O	CC	O	14	VMOD
12	unlabeled	unlabeled	B-NP	JJ	O	13	NMOD
13	IL-13	IL-13	I-NP	NN	B-protein	14	SUB
14	competed	compete	B-VP	VBD	O	0	ROOT
15	for	for	B-PP	IN	O	14	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	binding	binding	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	125I-IL-4	125I-IL-4	B-NP	NN	B-protein	18	PMOD
20	.	.	O	.	O	14	P

1	IL-10	IL-10	B-NP	NN	B-protein	2	SUB
2	inhibited	inhibit	B-VP	VBD	O	0	ROOT
3	translocation	translocation	B-NP	NN	O	2	OBJ
4	of	of	B-PP	IN	O	3	NMOD
5	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	4	PMOD
6	in	in	B-PP	IN	O	2	VMOD
7	response	response	I-PP	NN	O	6	PMOD
8	to	to	I-PP	TO	O	7	NMOD
9	LPS	LPS	B-NP	NN	O	14	NMOD
10	but	but	B-NP	CC	O	14	NMOD
11	not	not	I-NP	RB	O	10	DEP
12	the	the	B-NP	DT	O	14	NMOD
13	fungal	fungal	I-NP	JJ	O	14	NMOD
14	stimuli	stimulus	I-NP	NNS	O	8	PMOD
15	.	.	O	.	O	2	P

1	Inactive	Inactive	B-NP	JJ	O	2	NMOD
2	calcineurin	calcineurin	I-NP	NN	B-protein	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	unable	unable	B-ADJP	JJ	O	3	PRD
5	to	to	B-VP	TO	O	6	VMOD
6	activate	activate	I-VP	VB	O	4	AMOD
7	the	the	B-NP	DT	O	13	NMOD
8	nuclear	nuclear	I-NP	JJ	B-protein	13	NMOD
9	factor	factor	I-NP	NN	I-protein	13	NMOD
10	of	of	B-PP	IN	I-protein	13	NMOD
11	activated	activate	B-NP	VBN	I-protein	13	NMOD
12	T	T	I-NP	NN	I-protein	13	NMOD
13	cells	cell	I-NP	NNS	I-protein	6	OBJ
14	(	(	O	(	O	16	DEP
15	NFAT	NFAT	B-NP	NN	B-protein	16	DEP
16	)	)	O	)	O	13	NMOD
17	,	,	O	,	O	3	P
18	a	a	B-NP	DT	O	20	NMOD
19	transcription	transcription	I-NP	NN	B-protein	20	NMOD
20	factor	factor	I-NP	NN	I-protein	3	VMOD
21	required	require	B-VP	VBN	O	20	NMOD
22	for	for	B-PP	IN	O	21	VMOD
23	expression	expression	B-NP	NN	O	22	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	31	NMOD
26	interleukin	interleukin	I-NP	NN	B-DNA	31	NMOD
27	2	2	I-NP	CD	I-DNA	31	NMOD
28	(	(	O	(	I-DNA	31	NMOD
29	IL-2	IL-2	B-NP	NN	I-DNA	31	NMOD
30	)	)	O	)	I-DNA	31	NMOD
31	gene	gene	B-NP	NN	I-DNA	24	PMOD
32	.	.	O	.	O	3	P

1	however	however	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	alterations	alteration	B-NP	NNS	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	NF	NF	B-NP	NN	B-protein	7	NMOD
6	kappa	kappa	I-NP	NN	I-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	4	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	correlate	correlate	I-VP	VB	O	8	VC
11	with	with	B-PP	IN	O	10	VMOD
12	changes	change	B-NP	NNS	O	11	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	IL-2	IL-2	B-NP	NN	B-protein	15	NMOD
15	expression	expression	I-NP	NN	O	13	PMOD
16	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	work	work	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	show	show	B-VP	VBP	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	human	human	B-NP	JJ	B-cell_type	12	NMOD
9	peripheral	peripheral	I-NP	JJ	I-cell_type	12	NMOD
10	blood	blood	I-NP	NN	I-cell_type	12	NMOD
11	T	T	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	23	SUB
13	that	that	B-NP	WDT	O	12	NMOD
14	are	be	B-VP	VBP	O	13	SBAR
15	stimulated	stimulate	I-VP	VBN	O	14	VC
16	through	through	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	TCR	TCR	I-NP	NN	B-protein	16	PMOD
19	and	and	O	CC	O	15	VMOD
20	expanded	expand	B-VP	VBN	O	15	VMOD
21	with	with	B-PP	IN	O	20	VMOD
22	IL-2	IL-2	B-NP	NN	B-protein	21	PMOD
23	are	be	B-VP	VBP	O	7	SBAR
24	unresponsive	unresponsive	B-ADJP	JJ	O	23	PRD
25	to	to	B-PP	TO	O	24	AMOD
26	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	25	PMOD
27	,	,	O	,	O	23	P
28	as	as	B-SBAR	IN	O	23	VMOD
29	determined	determine	B-VP	VBN	O	28	SBAR
30	by	by	B-PP	IN	O	29	VMOD
31	a	a	B-NP	DT	O	32	NMOD
32	lack	lack	I-NP	NN	O	41	NMOD
33	of	of	B-PP	IN	O	32	NMOD
34	activation	activation	B-NP	NN	O	33	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	jak	jak	B-NP	NN	B-protein	37	NMOD
37	kinases	kinase	I-NP	NNS	I-protein	35	PMOD
38	and	and	O	CC	O	41	NMOD
39	the	the	B-NP	DT	O	41	NMOD
40	transcription	transcription	I-NP	NN	B-protein	41	NMOD
41	factor	factor	I-NP	NN	I-protein	52	NMOD
42	,	,	O	,	O	52	P
43	STAT1	STAT1	B-NP	NN	B-protein	52	NMOD
44	(	(	O	(	O	46	DEP
45	alpha	alpha	B-NP	NN	O	46	DEP
46	)	)	O	)	O	43	NMOD
47	,	,	O	,	O	52	P
48	a	a	B-NP	DT	O	50	NMOD
49	signal	signal	I-NP	NN	O	50	NMOD
50	transducer	transducer	I-NP	NN	O	52	NMOD
51	and	and	I-NP	CC	O	52	NMOD
52	activator	activator	I-NP	NN	O	30	PMOD
53	of	of	B-PP	IN	O	52	NMOD
54	transcription	transcription	B-NP	NN	O	53	PMOD
55	.	.	O	.	O	6	P

1	This	This	B-NP	DT	O	2	NMOD
2	nonresponsiveness	nonresponsiveness	I-NP	NN	O	3	SUB
3	occurs	occur	B-VP	VBZ	O	0	ROOT
4	because	because	B-PP	IN	O	3	VMOD
5	of	of	I-PP	IN	O	4	PMOD
6	a	a	B-NP	DT	O	7	NMOD
7	lack	lack	I-NP	NN	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	expression	expression	B-NP	NN	O	8	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	12	NMOD
12	beta-chain	beta-chain	I-NP	NN	B-protein	10	PMOD
13	(	(	O	(	O	16	DEP
14	accessory	accessory	B-NP	JJ	O	15	NMOD
15	factor	factor	I-NP	NN	O	16	DEP
16	)	)	O	)	O	12	NMOD
17	of	of	B-PP	IN	O	12	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	IFN-gamma	IFN-gamma	I-NP	NN	B-protein	20	NMOD
20	receptor	receptor	I-NP	NN	I-protein	17	PMOD
21	,	,	O	,	O	3	P
22	while	while	B-SBAR	IN	O	3	VMOD
23	at	at	B-PP	IN	O	22	DEP
24	the	the	B-NP	DT	O	26	VMOD
25	same	same	I-NP	JJ	O	26	VMOD
26	time	time	I-NP	NN	O	23	PMOD
27	maintaining	maintain	B-VP	VBG	O	26	NMOD
28	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	31	NMOD
29	receptor	receptor	I-NP	NN	I-protein	31	NMOD
30	alpha-chain	alpha-chain	I-NP	NN	I-protein	31	NMOD
31	expression	expression	I-NP	NN	O	27	OBJ
32	.	.	O	.	O	3	P

1	When	When	B-ADVP	WRB	O	10	VMOD
2	expressed	express	B-VP	VBN	O	1	SBAR
3	in	in	B-PP	IN	O	2	VMOD
4	COS	COS	B-NP	NN	B-cell_line	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_line	3	PMOD
6	,	,	O	,	O	10	P
7	however	however	B-ADVP	RB	O	10	VMOD
8	,	,	O	,	O	10	P
9	NFAT1	NFAT1	B-NP	NN	B-protein	10	SUB
10	is	be	B-VP	VBZ	O	17	VMOD
11	capable	capable	B-ADJP	JJ	O	10	PRD
12	of	of	B-PP	IN	O	11	AMOD
13	transactivation	transactivation	B-NP	NN	O	12	PMOD
14	,	,	O	,	O	17	P
15	but	but	O	CC	O	17	VMOD
16	it	it	B-NP	PRP	O	17	SUB
17	is	be	B-VP	VBZ	O	0	ROOT
18	not	not	I-VP	RB	O	17	VMOD
19	regulated	regulate	I-VP	VBN	O	17	VC
20	correctly	correctly	B-ADVP	RB	O	19	VMOD
21	:	:	O	:	O	17	P

1	its	its	B-NP	PRP$	O	3	NMOD
2	subcellular	subcellular	I-NP	JJ	O	3	NMOD
3	localization	localization	I-NP	NN	O	6	NMOD
4	and	and	O	CC	O	6	NMOD
5	transcriptional	transcriptional	B-NP	JJ	O	6	NMOD
6	function	function	I-NP	NN	O	7	SUB
7	are	be	B-VP	VBP	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	affected	affect	I-VP	VBN	O	7	VC
10	by	by	B-PP	IN	O	9	VMOD
11	stimulation	stimulation	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	COS	COS	I-NP	NN	B-cell_line	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_line	12	PMOD
16	with	with	B-PP	IN	O	11	NMOD
17	ionomycin	ionomycin	B-NP	NN	O	21	NMOD
18	and	and	O	CC	O	21	NMOD
19	phorbol	phorbol	B-NP	NN	O	21	NMOD
20	12-myristate	12-myristate	I-NP	NN	O	21	NMOD
21	13-acetate	13-acetate	I-NP	NN	O	16	PMOD
22	.	.	O	.	O	7	P

1	Thus	Thus	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	signaling	signaling	B-NP	NN	O	7	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	NK3.3	NK3.3	B-NP	NN	B-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	not	not	O	RB	O	7	VMOD
9	always	always	B-ADVP	RB	O	7	VMOD
10	identical	identical	B-ADJP	JJ	O	7	PRD
11	with	with	B-PP	IN	O	10	AMOD
12	that	that	B-NP	DT	O	11	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	primary	primary	B-NP	JJ	B-cell_type	16	NMOD
15	NK	NK	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
17	.	.	O	.	O	7	P

1	STAT1	STAT1	B-NP	NN	B-protein	3	NMOD
2	alpha	alpha	I-NP	NN	I-protein	3	NMOD
3	activation	activation	I-NP	NN	O	6	SUB
4	by	by	B-PP	IN	O	3	NMOD
5	IL-12	IL-12	B-NP	NN	B-protein	4	PMOD
6	correlated	correlate	B-VP	VBD	O	0	ROOT
7	with	with	B-PP	IN	O	6	VMOD
8	increased	increase	B-NP	VBN	O	9	NMOD
9	phosphorylation	phosphorylation	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	serine	serine	B-NP	NN	O	15	NMOD
12	,	,	B-NP	,	O	15	P
13	but	but	I-NP	CC	O	15	NMOD
14	not	not	I-NP	RB	O	13	DEP
15	tyrosine	tyrosine	B-NP	NN	O	10	PMOD
16	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	present	present	I-NP	JJ	O	3	NMOD
3	results	result	I-NP	NNS	O	4	SUB
4	show	show	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	Jurkat	Jurkat	B-NP	NN	B-cell_line	8	NMOD
7	T	T	I-NP	NN	I-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	16	SUB
9	acutely	acutely	B-VP	RB	O	10	VMOD
10	exposed	expose	I-VP	VBN	O	8	NMOD
11	to	to	B-PP	TO	O	10	VMOD
12	micromolar	micromolar	B-NP	JJ	O	13	NMOD
13	concentrations	concentration	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	H2O2	H2O2	B-NP	NN	O	14	PMOD
16	exhibit	exhibit	B-VP	VBP	O	5	SBAR
17	substantial	substantial	B-NP	JJ	O	18	NMOD
18	increases	increase	I-NP	NNS	O	25	NMOD
19	in	in	B-PP	IN	O	18	NMOD
20	AP-1	AP-1	B-NP	NN	B-protein	22	NMOD
21	binding	binding	I-NP	NN	O	22	NMOD
22	activity	activity	I-NP	NN	O	19	PMOD
23	and	and	O	CC	O	25	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	expression	expression	I-NP	NN	O	16	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	c-jun	c-jun	B-NP	NN	B-DNA	30	NMOD
28	but	but	B-NP	CC	O	30	NMOD
29	not	not	I-NP	RB	O	28	DEP
30	c-fos	c-fos	B-NP	NN	B-RNA	31	NMOD
31	mRNA	mRNA	B-NP	NN	I-RNA	26	PMOD
32	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	preferential	preferential	I-NP	JJ	O	3	NMOD
3	induction	induction	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	c-jun	c-jun	B-NP	NN	B-DNA	4	PMOD
6	by	by	B-PP	IN	O	3	NMOD
7	H2O2	H2O2	B-NP	NN	O	6	PMOD
8	did	do	B-VP	VBD	O	21	VMOD
9	not	not	I-VP	RB	O	8	VMOD
10	represent	represent	I-VP	VB	O	8	VC
11	redox	redox	B-NP	NN	O	12	NMOD
12	stabilization	stabilization	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	mRNA	mRNA	B-NP	NN	B-RNA	15	NMOD
15	transcripts	transcript	I-NP	NNS	I-RNA	13	PMOD
16	,	,	O	,	O	21	P
17	and	and	O	CC	O	21	VMOD
18	oxidative	oxidative	B-NP	JJ	O	19	NMOD
19	signals	signal	I-NP	NNS	O	21	SUB
20	closely	closely	B-ADVP	RB	O	21	VMOD
21	resembled	resemble	B-VP	VBD	O	0	ROOT
22	PHA/PMA	PHA/PMA	B-NP	NN	O	23	NMOD
23	stimulation	stimulation	I-NP	NN	O	21	OBJ
24	by	by	B-PP	IN	O	21	VMOD
25	effectively	effectively	B-VP	RB	O	26	VMOD
26	transactivating	transactivate	I-VP	VBG	O	24	PMOD
27	the	the	B-NP	DT	O	31	NMOD
28	full	full	I-NP	JJ	B-DNA	31	NMOD
29	length	length	I-NP	NN	I-DNA	31	NMOD
30	c-jun	c-jun	I-NP	NN	I-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	26	OBJ
32	via	via	B-PP	IN	O	26	VMOD
33	the	the	B-NP	DT	O	44	NMOD
34	proximal	proximal	I-NP	JJ	B-DNA	44	NMOD
35	jun1	jun1	I-NP	NN	I-DNA	44	NMOD
36	tumor	tumor	I-NP	NN	I-DNA	38	NMOD
37	promoter-responsive	promoter-responsive	I-NP	JJ	I-DNA	36	AMOD
38	element	element	I-NP	NN	I-DNA	40	AMOD
39	(	(	I-NP	(	O	40	AMOD
40	TRE	TRE	I-NP	NN	B-DNA	44	NMOD
41	)	)	I-NP	)	O	40	AMOD
42	-like	-like	I-NP	JJ	O	40	AMOD
43	promoter	promoter	I-NP	NN	O	44	NMOD
44	element	element	I-NP	NN	O	32	PMOD
45	.	.	O	.	O	21	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	PHA/PMA	PHA/PMA	B-NP	NN	O	7	NMOD
4	but	but	B-CONJP	CC	O	7	NMOD
5	not	not	I-CONJP	RB	O	4	DEP
6	oxidative	oxidative	B-NP	JJ	O	7	NMOD
7	signals	signal	I-NP	NNS	O	8	SUB
8	induced	induce	B-VP	VBD	O	0	ROOT
9	the	the	B-NP	DT	O	11	NMOD
10	coordinate	coordinate	I-NP	JJ	O	11	NMOD
11	activation	activation	I-NP	NN	O	8	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	reporter	reporter	B-NP	NN	B-DNA	14	NMOD
14	constructs	construct	I-NP	NNS	I-DNA	12	PMOD
15	containing	contain	B-VP	VBG	O	14	NMOD
16	the	the	B-NP	DT	O	17	NMOD
17	AP-1-TRE	AP-1-TRE	I-NP	NN	B-DNA	24	NMOD
18	,	,	O	,	O	24	P
19	NF-AT	NF-AT	B-NP	NN	B-protein	24	NMOD
20	,	,	O	,	O	24	P
21	and	and	O	CC	O	24	NMOD
22	IL-2	IL-2	B-NP	NN	B-DNA	24	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	24	NMOD
24	regions	region	I-NP	NNS	I-DNA	15	OBJ
25	along	along	B-PP	IN	O	8	VMOD
26	with	with	B-PP	IN	O	25	PMOD
27	IL-2	IL-2	B-NP	NN	B-RNA	29	NMOD
28	mRNA	mRNA	I-NP	NN	I-RNA	29	NMOD
29	expression	expression	I-NP	NN	O	26	PMOD
30	.	.	O	.	O	8	P

1	Gel	Gel	B-NP	NN	O	3	NMOD
2	shift	shift	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	4	SUB
4	revealed	reveal	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	oxidative	oxidative	B-NP	JJ	O	7	NMOD
7	suppression	suppression	I-NP	NN	O	10	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	NF-AT	NF-AT	B-NP	NN	B-protein	8	PMOD
10	represented	represent	B-VP	VBD	O	5	SBAR
11	inhibition	inhibition	B-NP	NN	O	10	OBJ
12	in	in	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	15	NMOD
14	early	early	I-NP	JJ	O	15	NMOD
15	generation	generation	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	NFAT	NFAT	B-NP	NN	B-protein	18	NMOD
18	complexes	complex	I-NP	NNS	I-protein	16	PMOD
19	rather	rather	B-PP	RB	O	22	NMOD
20	than	than	I-PP	IN	O	19	DEP
21	the	the	B-NP	DT	O	22	NMOD
22	binding	binding	I-NP	NN	O	10	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	preformed	preformed	B-NP	JJ	O	26	NMOD
25	NF-AT	NF-AT	I-NP	NN	B-protein	26	NMOD
26	complexes	complex	I-NP	NNS	I-protein	23	PMOD
27	.	.	O	.	O	4	P

1	As	As	B-SBAR	IN	O	12	VMOD
2	glucocorticoids	glucocorticoid	B-NP	NNS	O	3	SUB
3	regulate	regulate	B-VP	VBP	O	1	SBAR
4	interferon-alpha	interferon-alpha	B-NP	NN	B-protein	9	NMOD
5	(	(	O	(	O	8	DEP
6	IFN	IFN	B-NP	NN	B-protein	7	NMOD
7	alpha	alpha	I-NP	NN	I-protein	8	DEP
8	)	)	O	)	O	4	NMOD
9	production	production	B-NP	NN	O	3	OBJ
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	hypothesized	hypothesize	B-VP	VBD	O	0	ROOT
13	that	that	B-SBAR	IN	O	12	VMOD
14	IFN	IFN	B-NP	NN	B-protein	15	NMOD
15	alpha	alpha	I-NP	NN	I-protein	18	NMOD
16	,	,	O	,	O	18	P
17	a	a	B-NP	DT	O	18	NMOD
18	cytokine	cytokine	I-NP	NN	B-protein	26	SUB
19	produced	produce	B-VP	VBN	O	18	NMOD
20	predominantly	predominantly	B-ADVP	RB	O	21	PMOD
21	by	by	B-PP	IN	O	19	VMOD
22	monocytes	monocyte	B-NP	NNS	B-cell_type	21	PMOD
23	in	in	B-PP	IN	O	19	VMOD
24	AIDS	AIDS	B-NP	NN	O	23	PMOD
25	,	,	O	,	O	18	P
26	should	should	B-VP	MD	O	13	SBAR
27	be	be	I-VP	VB	O	26	VC
28	increased	increase	I-VP	VBN	O	27	VC
29	in	in	B-PP	IN	O	28	VMOD
30	cortisol-resistant	cortisol-resistant	B-NP	JJ	O	31	NMOD
31	AIDS	AIDS	I-NP	NN	O	29	PMOD
32	,	,	O	,	O	12	P
33	attributing	attribute	B-VP	VBG	O	12	VMOD
34	the	the	B-NP	DT	O	35	NMOD
35	lack	lack	I-NP	NN	O	33	OBJ
36	of	of	B-PP	IN	O	35	NMOD
37	cortisol	cortisol	B-NP	NN	O	38	NMOD
38	inhibition	inhibition	I-NP	NN	O	36	PMOD
39	to	to	B-PP	TO	O	38	NMOD
40	IFN	IFN	B-NP	NN	B-protein	42	NMOD
41	alpha	alpha	I-NP	NN	I-protein	42	NMOD
42	production	production	I-NP	NN	O	39	PMOD
43	.	.	O	.	O	12	P

1	Therefore	Therefore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	examined	examine	B-VP	VBD	O	0	ROOT
5	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	7	NMOD
6	receptor	receptor	I-NP	NN	I-protein	7	NMOD
7	characteristics	characteristic	I-NP	NNS	O	4	OBJ
8	on	on	B-PP	IN	O	7	NMOD
9	monocytes	monocyte	B-NP	NNS	B-cell_type	8	PMOD
10	by	by	B-PP	IN	O	4	VMOD
11	[	[	B-NP	(	O	13	DEP
12	3H	3H	I-NP	NN	O	13	DEP
13	]	]	I-NP	)	O	15	NMOD
14	dexamethasone	dexamethasone	I-NP	NN	O	15	NMOD
15	binding	binding	I-NP	NN	O	24	NMOD
16	and	and	O	CC	O	24	NMOD
17	measured	measure	B-NP	VBN	O	24	NMOD
18	IFN	IFN	I-NP	NN	B-protein	19	NMOD
19	alpha	alpha	I-NP	NN	I-protein	24	NMOD
20	,	,	O	,	O	24	P
21	cortisol	cortisol	B-NP	NN	O	24	NMOD
22	,	,	O	,	O	24	P
23	and	and	O	CC	O	24	NMOD
24	ACTH	ACTH	B-NP	NN	O	10	PMOD
25	in	in	B-PP	IN	O	24	NMOD
26	AIDS	AIDS	B-NP	NN	O	27	NMOD
27	patients	patient	I-NP	NNS	O	25	PMOD
28	with	with	B-PP	IN	O	27	NMOD
29	(	(	O	(	O	31	DEP
30	AIDS-GR	AIDS-GR	B-NP	NN	O	31	DEP
31	)	)	O	)	O	27	NMOD
32	or	or	O	CC	O	10	PMOD
33	without	without	B-PP	IN	O	10	PMOD
34	glucocorticoid	glucocorticoid	B-NP	NN	O	35	NMOD
35	resistance	resistance	I-NP	NN	O	40	NMOD
36	(	(	O	(	O	38	DEP
37	AIDS-C	AIDS-C	B-NP	NN	O	38	DEP
38	)	)	O	)	O	35	NMOD
39	and	and	O	CC	O	40	NMOD
40	controls	control	B-NP	NNS	O	33	PMOD
41	(	(	O	(	O	43	DEP
42	C	C	B-NP	NN	O	43	DEP
43	)	)	O	)	O	40	NMOD
44	.	.	O	.	O	4	P

1	By	By	B-PP	IN	O	5	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	glucocorticoids	glucocorticoid	B-NP	NNS	O	5	SUB
5	failed	fail	B-VP	VBD	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	inhibit	inhibit	I-VP	VB	O	5	VMOD
8	IFNalpha	IFNalpha	B-NP	NN	B-protein	9	NMOD
9	production	production	I-NP	NN	O	7	OBJ
10	from	from	B-PP	IN	O	9	NMOD
11	AIDS-GR	AIDS-GR	B-NP	NN	B-cell_type	12	NMOD
12	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD
13	(	(	O	(	O	7	VMOD
14	approximately	approximately	B-NP	RB	O	16	NMOD
15	20	20	I-NP	CD	O	14	AMOD
16	%	%	I-NP	NN	O	17	NMOD
17	inhibition	inhibition	I-NP	NN	O	7	VMOD
18	)	)	O	)	O	7	VMOD
19	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	10	VMOD
2	conclusion	conclusion	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	elevated	elevated	B-NP	JJ	O	7	NMOD
5	IFN	IFN	I-NP	NN	B-protein	7	NMOD
6	alpha	alpha	I-NP	NN	I-protein	7	NMOD
7	levels	level	I-NP	NNS	O	10	SUB
8	in	in	B-PP	IN	O	7	NMOD
9	AIDS-GR	AIDS-GR	B-NP	NN	O	8	PMOD
10	may	may	B-VP	MD	O	0	ROOT
11	be	be	I-VP	VB	O	10	VC
12	due	due	B-ADVP	JJ	O	13	PMOD
13	to	to	B-PP	TO	O	11	PRD
14	the	the	B-NP	DT	O	15	NMOD
15	lack	lack	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	inhibitory	inhibitory	B-NP	JJ	O	18	NMOD
18	effect	effect	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	cortisol	cortisol	B-NP	NN	O	19	PMOD
21	on	on	B-PP	IN	O	18	NMOD
22	IFN	IFN	B-NP	NN	B-protein	24	NMOD
23	alpha	alpha	I-NP	NN	I-protein	24	NMOD
24	production	production	I-NP	NN	O	21	PMOD
25	due	due	B-PP	IN	O	15	NMOD
26	to	to	B-PP	TO	O	25	PMOD
27	cortisol	cortisol	B-NP	NN	O	28	NMOD
28	resistance	resistance	I-NP	NN	O	25	PMOD
29	in	in	B-PP	IN	O	28	NMOD
30	monocytes	monocyte	B-NP	NNS	B-cell_type	29	PMOD
31	.	.	O	.	O	10	P

1	This	This	B-NP	DT	O	2	NMOD
2	activity	activity	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	further	further	B-ADJP	RBR	O	5	AMOD
5	inducible	inducible	I-ADJP	JJ	O	3	PRD
6	in	in	B-PP	IN	O	5	AMOD
7	activated	activate	B-NP	VBN	B-cell_type	9	NMOD
8	T	T	I-NP	NN	I-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
10	,	,	B-PP	,	O	5	P
11	but	but	I-PP	CC	O	5	PMOD
12	not	not	B-PP	RB	O	11	DEP
13	in	in	I-PP	IN	O	5	AMOD
14	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	13	PMOD
15	.	.	O	.	O	3	P

1	Together	Together	B-ADVP	RB	O	4	VMOD
2	these	these	B-NP	DT	O	3	NMOD
3	results	result	I-NP	NNS	O	4	SUB
4	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	T	T	B-NP	NN	O	8	NMOD
7	cell	cell	I-NP	NN	O	8	NMOD
8	expression	expression	I-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	IL-3	IL-3	B-NP	NN	B-protein	9	PMOD
11	is	be	B-VP	VBZ	O	5	SBAR
12	not	not	I-VP	RB	O	11	VMOD
13	specified	specify	I-VP	VBN	O	11	VC
14	by	by	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	activity	activity	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	a	a	B-NP	DT	O	21	NMOD
19	single	single	I-NP	JJ	O	21	NMOD
20	tissue-specific	tissue-specific	I-NP	JJ	B-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	17	PMOD
22	,	,	O	,	O	11	P
23	but	but	O	CC	O	11	VMOD
24	instead	instead	B-VP	RB	O	11	VMOD
25	involves	involve	I-VP	VBZ	O	11	VMOD
26	multiple	multiple	B-NP	JJ	O	28	NMOD
27	interacting	interact	I-NP	VBG	B-DNA	28	NMOD
28	elements	element	I-NP	NNS	I-DNA	25	OBJ
29	that	that	B-NP	WDT	O	28	NMOD
30	provide	provide	B-VP	VBP	O	29	SBAR
31	both	both	O	CC	O	34	NMOD
32	specific	specific	B-NP	JJ	O	34	NMOD
33	positive	positive	I-NP	JJ	O	34	NMOD
34	regulation	regulation	I-NP	NN	O	30	OBJ
35	in	in	B-PP	IN	O	34	NMOD
36	T	T	B-NP	NN	B-cell_type	37	NMOD
37	cells	cell	I-NP	NNS	I-cell_type	41	NMOD
38	and	and	O	CC	O	41	NMOD
39	specific	specific	B-NP	JJ	O	41	NMOD
40	negative	negative	I-NP	JJ	O	41	NMOD
41	regulation	regulation	I-NP	NN	O	35	PMOD
42	in	in	B-PP	IN	O	41	NMOD
43	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	42	PMOD
44	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	molecular	molecular	I-NP	JJ	O	3	NMOD
3	background	background	I-NP	NN	O	14	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	6	NMOD
6	defects	defect	I-NP	NNS	O	4	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	immune	immune	I-NP	JJ	O	10	NMOD
10	reactivity	reactivity	I-NP	NN	O	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	human	human	B-NP	JJ	O	13	NMOD
13	neonates	neonate	I-NP	NNS	O	11	PMOD
14	has	have	B-VP	VBZ	O	0	ROOT
15	not	not	I-VP	RB	O	14	VMOD
16	been	be	I-VP	VBN	O	14	VC
17	fully	fully	B-ADJP	RB	O	16	VMOD
18	elucidated	elucidate	I-ADJP	VBN	O	16	VC
19	.	.	O	.	O	14	P

1	However	However	B-ADVP	RB	O	14	VMOD
2	,	,	O	,	O	14	P
3	the	the	B-NP	DT	O	5	NMOD
4	molecular	molecular	I-NP	JJ	O	5	NMOD
5	mechanisms	mechanism	I-NP	NNS	O	14	SUB
6	involved	involve	B-VP	VBN	O	5	NMOD
7	in	in	B-PP	IN	O	6	VMOD
8	ATRA-dependent	ATRA-dependent	B-NP	JJ	O	10	NMOD
9	growth	growth	I-NP	NN	O	10	NMOD
10	inhibition	inhibition	I-NP	NN	O	7	PMOD
11	and	and	O	CC	O	13	NMOD
12	cellular	cellular	B-NP	JJ	O	13	NMOD
13	differentiation	differentiation	I-NP	NN	O	10	NMOD
14	are	be	B-VP	VBP	O	0	ROOT
15	not	not	O	RB	O	14	VMOD
16	presently	presently	B-VP	RB	O	14	VMOD
17	understood	understand	I-VP	VBN	O	14	VC
18	.	.	O	.	O	14	P

1	ATRA	ATRA	B-NP	NN	O	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	activate	activate	I-VP	VB	O	2	VC
5	nuclear	nuclear	B-NP	JJ	B-protein	8	NMOD
6	factor	factor	I-NP	NN	I-protein	8	NMOD
7	kappa	kappa	I-NP	NN	I-protein	8	NMOD
8	B	B	I-NP	NN	I-protein	4	OBJ
9	or	or	O	CC	O	11	NMOD
10	signal	signal	B-NP	NN	O	11	NMOD
11	transducer	transducer	I-NP	NN	O	8	NMOD
12	and	and	O	CC	O	11	NMOD
13	activator	activator	B-NP	NN	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	transcription	transcription	B-NP	NN	O	20	NMOD
16	(	(	O	(	O	18	DEP
17	STAT	STAT	B-NP	NN	B-protein	18	DEP
18	)	)	O	)	O	15	NMOD
19	activation	activation	B-NP	NN	O	20	NMOD
20	pathways	pathway	I-NP	NNS	O	14	PMOD
21	,	,	O	,	O	13	P
22	suggesting	suggest	B-VP	VBG	O	13	NMOD
23	that	that	B-SBAR	IN	O	22	VMOD
24	an	an	B-NP	DT	O	26	NMOD
25	alternate	alternate	I-NP	JJ	O	26	NMOD
26	mechanism	mechanism	I-NP	NN	O	27	SUB
27	is	be	B-VP	VBZ	O	23	SBAR
28	involved	involve	I-VP	VBN	O	27	VC
29	in	in	B-PP	IN	O	28	VMOD
30	IRF-1	IRF-1	B-NP	NN	B-DNA	32	NMOD
31	gene	gene	I-NP	NN	I-DNA	32	NMOD
32	activation	activation	I-NP	NN	O	29	PMOD
33	.	.	O	.	O	2	P

1	Finally	Finally	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	recombinant	recombinant	B-NP	JJ	O	4	NMOD
4	GHF-1	GHF-1	I-NP	NN	B-protein	5	SUB
5	interacted	interact	B-VP	VBD	O	0	ROOT
6	directly	directly	B-ADVP	RB	O	5	VMOD
7	with	with	B-PP	IN	O	5	VMOD
8	c-Jun	c-Jun	B-NP	NN	B-protein	11	NMOD
9	but	but	B-NP	CC	O	11	NMOD
10	not	not	I-NP	RB	O	9	DEP
11	c-Fos	c-Fos	B-NP	NN	B-protein	12	NMOD
12	proteins	protein	I-NP	NNS	I-protein	7	PMOD
13	.	.	O	.	O	5	P

1	NFAT1	NFAT1	B-NP	NN	B-protein	2	VMOD
2	possesses	possess	B-VP	VBZ	O	0	ROOT
3	two	two	B-NP	CD	O	5	NMOD
4	transactivation	transactivation	I-NP	NN	B-protein	5	NMOD
5	domains	domain	I-NP	NNS	I-protein	2	OBJ
6	whose	whose	B-NP	WP$	O	7	NMOD
7	sequences	sequence	I-NP	NNS	O	5	NMOD
8	are	be	B-VP	VBP	O	7	SBAR
9	not	not	I-VP	RB	O	8	VMOD
10	conserved	conserve	I-VP	VBN	O	8	VC
11	in	in	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	other	other	I-NP	JJ	O	15	NMOD
14	NFAT-family	NFAT-family	I-NP	NN	B-protein	15	NMOD
15	proteins	protein	I-NP	NNS	I-protein	11	PMOD
16	,	,	O	,	O	2	P
17	and	and	O	CC	O	21	NMOD
18	a	a	B-NP	DT	O	21	NMOD
19	conserved	conserve	I-NP	VBN	O	21	NMOD
20	DNA-binding	DNA-binding	I-NP	JJ	B-protein	21	NMOD
21	domain	domain	I-NP	NN	I-protein	16	OBJ
22	that	that	B-NP	WDT	O	21	NMOD
23	mediates	mediate	B-VP	VBZ	O	22	SBAR
24	the	the	B-NP	DT	O	25	NMOD
25	recruitment	recruitment	I-NP	NN	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	cooperating	cooperate	B-VP	VBG	O	30	NMOD
28	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD
29	transcription	transcription	I-NP	NN	I-protein	30	NMOD
30	factors	factor	I-NP	NNS	I-protein	26	PMOD
31	even	even	B-ADVP	RB	O	32	AMOD
32	when	when	B-ADVP	WRB	O	21	NMOD
33	it	it	B-NP	PRP	O	34	SUB
34	is	be	B-VP	VBZ	O	32	SBAR
35	expressed	express	I-VP	VBN	O	34	VC
36	in	in	B-PP	IN	O	35	VMOD
37	the	the	B-NP	DT	O	38	NMOD
38	absence	absence	I-NP	NN	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	other	other	B-NP	JJ	O	41	NMOD
41	regions	region	I-NP	NNS	O	39	PMOD
42	of	of	B-PP	IN	O	41	NMOD
43	the	the	B-NP	DT	O	44	NMOD
44	protein	protein	I-NP	NN	O	42	PMOD
45	.	.	O	.	O	2	P

1	PU.1	PU.1	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	completely	completely	B-ADJP	RB	O	4	AMOD
4	absent	absent	I-ADJP	JJ	O	2	PRD
5	from	from	B-PP	IN	O	4	AMOD
6	peripheral	peripheral	B-NP	JJ	B-cell_type	8	NMOD
7	T	T	I-NP	NN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	13	NMOD
9	and	and	O	CC	O	13	NMOD
10	most	most	B-NP	JJS	O	13	NMOD
11	T	T	I-NP	NN	B-cell_line	13	NMOD
12	cell	cell	I-NP	NN	I-cell_line	13	NMOD
13	lines	line	I-NP	NNS	I-cell_line	5	PMOD
14	based	base	B-PP	VBN	O	2	VMOD
15	on	on	B-PP	IN	O	14	PMOD
16	sensitive	sensitive	B-NP	JJ	O	18	NMOD
17	RT-PCR	RT-PCR	I-NP	NN	O	18	NMOD
18	assays	assay	I-NP	NNS	O	15	PMOD
19	.	.	O	.	O	2	P

1	Gel-retardation	Gel-retardation	B-NP	NN	O	2	NMOD
2	experiments	experiment	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Spi-B	Spi-B	B-NP	NN	B-protein	6	SUB
6	can	can	B-VP	MD	O	4	SBAR
7	bind	bind	I-VP	VB	O	6	VC
8	to	to	B-PP	TO	O	7	VMOD
9	all	all	B-NP	DT	O	13	NMOD
10	putative	putative	I-NP	JJ	B-DNA	13	NMOD
11	PU.1	PU.1	I-NP	NN	I-DNA	13	NMOD
12	binding	binding	I-NP	NN	I-DNA	13	NMOD
13	sites	site	I-NP	NNS	I-DNA	8	PMOD
14	,	,	O	,	O	3	P
15	but	but	O	CC	O	3	VMOD
16	do	do	B-VP	VBP	O	3	VMOD
17	not	not	I-VP	RB	O	16	VMOD
18	reveal	reveal	I-VP	VB	O	16	VC
19	any	any	B-NP	DT	O	23	NMOD
20	preferred	preferred	I-NP	JJ	O	23	NMOD
21	Spi-B	Spi-B	I-NP	NN	B-DNA	23	NMOD
22	binding	binding	I-NP	NN	I-DNA	23	NMOD
23	site	site	I-NP	NN	I-DNA	18	OBJ
24	.	.	O	.	O	3	P

1	A	A	B-NP	DT	O	5	NMOD
2	4-	4-	I-NP	CD	O	4	AMOD
3	or	or	O	CC	O	4	AMOD
4	10-bp	10-bp	B-NP	JJ	O	5	NMOD
5	insertion	insertion	I-NP	NN	O	10	SUB
6	between	between	B-PP	IN	O	5	NMOD
7	muE3	muE3	B-NP	NN	B-DNA	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	muB	muB	I-NP	NN	B-DNA	6	PMOD
10	inactivated	inactivate	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	13	NMOD
12	mu	mu	I-NP	NN	B-DNA	13	NMOD
13	enhancer	enhancer	I-NP	NN	I-DNA	10	OBJ
14	in	in	B-PP	IN	O	10	VMOD
15	S194	S194	B-NP	NN	B-cell_line	17	NMOD
16	plasma	plasma	I-NP	NN	I-cell_line	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_line	14	PMOD
18	but	but	O	CC	O	10	VMOD
19	did	do	B-VP	VBD	O	10	VMOD
20	not	not	I-VP	RB	O	19	VMOD
21	affect	affect	I-VP	VB	O	19	VC
22	in	in	B-NP	FW	O	23	AMOD
23	vitro	vitro	I-NP	FW	O	24	NMOD
24	binding	binding	I-NP	NN	O	21	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	Ets-1	Ets-1	B-NP	NN	B-protein	34	NMOD
27	,	,	O	,	O	34	P
28	PU.1	PU.1	B-NP	NN	B-protein	34	NMOD
29	,	,	O	,	O	34	P
30	or	or	O	CC	O	34	NMOD
31	the	the	B-NP	DT	O	34	NMOD
32	muE3-binding	muE3-binding	I-NP	JJ	B-protein	34	NMOD
33	protein	protein	I-NP	NN	I-protein	34	NMOD
34	TFE3	TFE3	I-NP	NN	B-protein	25	PMOD
35	,	,	O	,	O	21	P
36	alone	alone	B-ADVP	RB	O	21	VMOD
37	or	or	O	CC	O	36	DEP
38	in	in	B-PP	IN	O	36	DEP
39	pairwise	pairwise	B-NP	JJ	O	40	NMOD
40	combinations	combination	I-NP	NNS	O	38	PMOD
41	.	.	O	.	O	10	P

1	Circular	Circular	B-NP	JJ	O	2	NMOD
2	permutation	permutation	I-NP	NN	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	phasing	phasing	I-NP	NN	O	5	NMOD
5	analyses	analysis	I-NP	NNS	O	6	SUB
6	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
7	that	that	B-SBAR	IN	O	6	VMOD
8	PU.1	PU.1	B-NP	NN	B-protein	9	NMOD
9	binding	binding	I-NP	NN	O	14	NMOD
10	but	but	B-NP	CC	O	14	NMOD
11	not	not	I-NP	RB	O	10	DEP
12	TFE3	TFE3	B-NP	NN	B-protein	14	NMOD
13	or	or	O	CC	O	14	NMOD
14	Ets-1	Ets-1	B-NP	NN	B-protein	15	SUB
15	bends	bend	B-VP	VBZ	O	7	SBAR
16	mu	mu	B-NP	NN	B-DNA	18	NMOD
17	enhancer	enhancer	I-NP	NN	I-DNA	18	NMOD
18	DNA	DNA	I-NP	NN	I-DNA	15	OBJ
19	toward	toward	B-PP	IN	O	15	VMOD
20	the	the	B-NP	DT	O	22	NMOD
21	major	major	I-NP	JJ	O	22	NMOD
22	groove	groove	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	6	P

1	Ectopic	Ectopic	B-NP	JJ	O	2	NMOD
2	expression	expression	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	9	NMOD
5	dominant	dominant	I-NP	JJ	O	9	NMOD
6	negative	negative	I-NP	JJ	O	9	NMOD
7	C/EBP	C/EBP	I-NP	NN	B-protein	9	NMOD
8	protein	protein	I-NP	NN	I-protein	9	NMOD
9	LIP	LIP	I-NP	NN	I-protein	3	PMOD
10	inhibited	inhibit	B-VP	VBD	O	0	ROOT
11	HIV-1	HIV-1	B-NP	NN	B-RNA	12	NMOD
12	mRNA	mRNA	I-NP	NN	I-RNA	15	NMOD
13	and	and	O	CC	O	15	NMOD
14	virus	virus	B-NP	NN	O	15	NMOD
15	production	production	I-NP	NN	O	10	OBJ
16	in	in	B-PP	IN	O	15	NMOD
17	activated	activate	B-NP	VBN	B-cell_line	19	NMOD
18	U1	U1	I-NP	NN	I-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	16	PMOD
20	,	,	O	,	O	10	P
21	demonstrating	demonstrate	B-VP	VBG	O	10	VMOD
22	that	that	B-SBAR	IN	O	21	VMOD
23	C/EBP	C/EBP	B-NP	NN	B-protein	24	NMOD
24	proteins	protein	I-NP	NNS	I-protein	25	SUB
25	are	be	B-VP	VBP	O	22	SBAR
26	required	require	I-VP	VBN	O	25	VC
27	for	for	B-PP	IN	O	26	VMOD
28	provirus	provirus	B-NP	NN	O	29	NMOD
29	induction	induction	I-NP	NN	O	27	PMOD
30	.	.	O	.	O	10	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	report	report	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	human	human	B-NP	JJ	B-cell_type	7	NMOD
6	leukaemia	leukaemia	I-NP	NN	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	18	SUB
8	carrying	carry	B-VP	VBG	O	7	NMOD
9	the	the	B-NP	DT	O	8	OBJ
10	translocation	translocation	I-NP	NN	B-DNA	9	NMOD
11	t	t	I-NP	NN	I-DNA	10	NMOD
12	(	(	O	(	I-DNA	16	DEP
13	17	17	B-NP	CD	I-DNA	15	NMOD
14	;	;	O	:	I-DNA	15	P
15	19	19	B-NP	CD	I-DNA	16	DEP
16	)	)	O	)	I-DNA	11	NMOD
17	rapidly	rapidly	B-ADVP	RB	O	18	VMOD
18	died	die	B-VP	VBD	O	4	SBAR
19	by	by	B-PP	IN	O	18	VMOD
20	apoptosis	apoptosis	B-NP	NN	O	19	PMOD
21	when	when	B-ADVP	WRB	O	18	VMOD
22	programmed	program	B-VP	VBN	O	21	SBAR
23	to	to	B-VP	TO	O	24	VMOD
24	express	express	I-VP	VB	O	22	VMOD
25	a	a	B-NP	DT	O	27	NMOD
26	dominant-negative	dominant-negative	I-NP	JJ	B-protein	27	NMOD
27	suppressor	suppressor	I-NP	NN	I-protein	24	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	32	NMOD
30	fusion	fusion	I-NP	NN	B-protein	32	NMOD
31	protein	protein	I-NP	NN	I-protein	32	NMOD
32	E2A-HLF	E2A-HLF	I-NP	NN	B-protein	28	PMOD
33	,	,	O	,	O	18	P
34	indicating	indicate	B-VP	VBG	O	18	VMOD
35	that	that	B-SBAR	IN	O	34	VMOD
36	the	the	B-NP	DT	O	38	NMOD
37	chimaeric	chimaeric	I-NP	JJ	B-protein	38	NMOD
38	oncoprotein	oncoprotein	I-NP	NN	I-protein	40	SUB
39	probably	probably	B-ADVP	RB	O	40	VMOD
40	affects	affect	B-VP	VBZ	O	35	SBAR
41	cell	cell	B-NP	NN	O	42	NMOD
42	survival	survival	I-NP	NN	O	46	NMOD
43	rather	rather	B-CONJP	RB	O	46	NMOD
44	than	than	I-CONJP	IN	O	43	DEP
45	cell	cell	B-NP	NN	O	46	NMOD
46	growth	growth	I-NP	NN	O	40	OBJ
47	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	2	SUB
2	questioned	question	B-VP	VBD	O	0	ROOT
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	or	or	O	CC	O	3	DEP
5	not	not	O	RB	O	3	DEP
6	IL-10	IL-10	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	IL-4	IL-4	I-NP	NN	B-protein	9	SUB
9	affected	affect	B-VP	VBD	O	3	SBAR
10	the	the	B-NP	DT	O	11	NMOD
11	expression	expression	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	transcription	transcription	B-NP	NN	B-protein	14	NMOD
14	factors	factor	I-NP	NNS	I-protein	30	NMOD
15	that	that	B-NP	WDT	O	14	NMOD
16	are	be	B-VP	VBP	O	15	SBAR
17	known	know	I-VP	VBN	O	16	VC
18	to	to	I-VP	TO	O	19	VMOD
19	be	be	I-VP	VB	O	17	VMOD
20	involved	involve	I-VP	VBN	O	19	VC
21	in	in	B-PP	IN	O	20	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	control	control	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	IL-6	IL-6	I-NP	NN	B-protein	28	NMOD
27	transcription	transcription	I-NP	NN	O	28	NMOD
28	rate	rate	I-NP	NN	O	24	PMOD
29	,	,	O	,	O	30	P
30	namely	namely	B-ADVP	RB	O	12	PMOD
31	activator	activator	B-NP	NN	B-protein	32	NMOD
32	protein-1	protein-1	I-NP	NN	I-protein	48	NMOD
33	(	(	O	(	O	35	DEP
34	AP-1	AP-1	B-NP	NN	B-protein	35	DEP
35	)	)	O	)	O	32	NMOD
36	,	,	O	,	O	48	P
37	nuclear	nuclear	B-NP	JJ	B-protein	39	NMOD
38	factor	factor	I-NP	NN	I-protein	39	NMOD
39	IL-6	IL-6	I-NP	NN	B-protein	48	NMOD
40	(	(	O	(	O	42	DEP
41	NF-IL6	NF-IL6	B-NP	NN	B-protein	42	DEP
42	)	)	O	)	O	39	NMOD
43	,	,	O	,	O	48	P
44	and	and	O	CC	O	48	NMOD
45	nuclear	nuclear	B-NP	JJ	B-protein	48	NMOD
46	factor	factor	I-NP	NN	I-protein	48	NMOD
47	kappa	kappa	I-NP	NN	I-protein	48	NMOD
48	B	B	I-NP	NN	I-protein	30	NMOD
49	(	(	O	(	O	51	DEP
50	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	51	DEP
51	)	)	O	)	O	48	NMOD
52	.	.	O	.	O	2	P

1	Binding	Binding	B-NP	NN	O	2	NMOD
2	activity	activity	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-IL6	NF-IL6	B-NP	NN	B-protein	3	PMOD
5	was	be	B-VP	VBD	O	11	VMOD
6	also	also	I-VP	RB	O	5	VMOD
7	strongly	strongly	I-VP	RB	O	8	VMOD
8	inhibited	inhibit	I-VP	VBN	O	5	VC
9	by	by	B-PP	IN	O	8	VMOD
10	IL-4	IL-4	B-NP	NN	B-protein	9	PMOD
11	whereas	whereas	B-PP	IN	O	0	ROOT
12	IL-10	IL-10	B-NP	NN	B-protein	13	SUB
13	showed	show	B-VP	VBD	O	11	VMOD
14	no	no	B-NP	DT	O	15	NMOD
15	effect	effect	I-NP	NN	O	13	OBJ
16	.	.	O	.	O	11	P

1	NF-IL6	NF-IL6	B-NP	NN	B-RNA	3	NMOD
2	mRNA	mRNA	I-NP	NN	I-RNA	3	NMOD
3	levels	level	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	affected	affect	I-VP	VBN	O	4	VC
7	by	by	B-PP	IN	O	6	VMOD
8	IL-10	IL-10	B-NP	NN	B-protein	10	NMOD
9	or	or	I-NP	CC	O	10	NMOD
10	IL-4	IL-4	I-NP	NN	B-protein	7	PMOD
11	,	,	O	,	O	6	P
12	suggesting	suggest	B-VP	VBG	O	6	VMOD
13	that	that	B-SBAR	IN	O	12	VMOD
14	IL-4	IL-4	B-NP	NN	B-protein	15	SUB
15	affects	affect	B-VP	VBZ	O	13	SBAR
16	binding	binding	B-NP	NN	O	17	NMOD
17	activity	activity	I-NP	NN	O	15	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	preexisting	preexist	B-VP	VBG	O	20	NMOD
20	NF-IL6	NF-IL6	B-NP	NN	B-protein	18	PMOD
21	.	.	O	.	O	4	P

1	Neither	Neither	O	CC	O	4	NMOD
2	IL-10	IL-10	B-NP	NN	B-protein	4	NMOD
3	nor	nor	I-NP	CC	O	4	NMOD
4	IL-4	IL-4	I-NP	NN	B-protein	5	SUB
5	inhibited	inhibit	B-VP	VBD	O	0	ROOT
6	LPS-induced	LPS-induced	B-NP	JJ	O	10	NMOD
7	NF-kappa	NF-kappa	I-NP	NN	B-protein	10	NMOD
8	B	B	I-NP	NN	I-protein	10	NMOD
9	binding	binding	I-NP	NN	O	10	NMOD
10	activity	activity	I-NP	NN	O	5	OBJ
11	.	.	O	.	O	5	P

1	In	In	B-PP	IN	O	18	VMOD
2	agreement	agreement	I-PP	NN	O	1	PMOD
3	with	with	I-PP	IN	O	1	PMOD
4	this	this	B-NP	DT	O	5	NMOD
5	finding	finding	I-NP	NN	O	1	PMOD
6	,	,	O	,	O	18	P
7	Northern	Northern	B-NP	NN	O	8	NMOD
8	experiments	experiment	I-NP	NNS	O	18	SUB
9	where	where	B-ADVP	WRB	O	8	NMOD
10	p65	p65	B-NP	NN	B-protein	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	p105	p105	B-NP	NN	O	14	NMOD
13	mRNA	mRNA	I-NP	NN	O	14	NMOD
14	levels	level	I-NP	NNS	O	15	SUB
15	were	be	B-VP	VBD	O	9	SBAR
16	determined	determine	I-VP	VBN	O	15	VC
17	,	,	O	,	O	18	P
18	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
19	that	that	B-SBAR	IN	O	18	VMOD
20	expression	expression	B-NP	NN	O	30	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	these	these	B-NP	DT	O	23	NMOD
23	components	component	I-NP	NNS	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	29	NMOD
26	NF-kappa	NF-kappa	I-NP	NN	B-protein	29	NMOD
27	B	B	I-NP	NN	I-protein	29	NMOD
28	transcription	transcription	I-NP	NN	I-protein	29	NMOD
29	factor	factor	I-NP	NN	I-protein	24	PMOD
30	were	be	B-VP	VBD	O	19	SBAR
31	not	not	I-VP	RB	O	30	VMOD
32	affected	affect	I-VP	VBN	O	30	VC
33	by	by	B-PP	IN	O	32	VMOD
34	IL-10	IL-10	B-NP	NN	B-protein	36	NMOD
35	or	or	I-NP	CC	O	36	NMOD
36	IL-4	IL-4	I-NP	NN	B-protein	33	PMOD
37	.	.	O	.	O	18	P

1	Furthermore	Furthermore	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	neither	neither	O	CC	O	6	NMOD
4	IL-10	IL-10	B-NP	NN	B-protein	6	NMOD
5	nor	nor	I-NP	CC	O	6	NMOD
6	IL-4	IL-4	I-NP	NN	B-protein	7	SUB
7	showed	show	B-VP	VBD	O	0	ROOT
8	any	any	B-NP	DT	O	9	NMOD
9	effect	effect	I-NP	NN	O	7	OBJ
10	on	on	B-PP	IN	O	9	NMOD
11	I-kappa	I-kappa	B-NP	NN	B-RNA	14	NMOD
12	B	B	I-NP	NN	I-RNA	14	NMOD
13	mRNA	mRNA	I-NP	NN	I-RNA	14	NMOD
14	expression	expression	I-NP	NN	O	10	PMOD
15	as	as	B-SBAR	IN	O	7	VMOD
16	determined	determine	B-VP	VBN	O	15	SBAR
17	by	by	B-PP	IN	O	16	VMOD
18	Northern	Northern	B-NP	NN	O	19	NMOD
19	experiments	experiment	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	7	P

1	cAMP	cAMP	B-NP	NN	O	2	SUB
2	inhibited	inhibit	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	induction	induction	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	expression	expression	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	IL-2	IL-2	B-NP	NN	B-protein	10	NMOD
9	receptor	receptor	I-NP	NN	I-protein	10	NMOD
10	components	component	I-NP	NNS	I-protein	7	PMOD
11	,	,	O	,	O	2	P
12	but	but	O	CC	O	2	VMOD
13	did	do	B-VP	VBD	O	2	VMOD
14	not	not	I-VP	RB	O	13	VMOD
15	inhibit	inhibit	I-VP	VB	O	13	VC
16	IL-4	IL-4	B-NP	NN	B-protein	18	NMOD
17	receptor	receptor	I-NP	NN	I-protein	18	NMOD
18	alpha-chain	alpha-chain	I-NP	NN	I-protein	21	NMOD
19	and	and	O	CC	O	21	NMOD
20	CD69	CD69	B-NP	NN	B-protein	21	NMOD
21	expression	expression	I-NP	NN	O	24	NMOD
22	or	or	O	CC	O	24	NMOD
23	the	the	B-NP	DT	O	24	NMOD
24	induction	induction	I-NP	NN	O	15	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	activator	activator	B-NP	NN	B-protein	30	NMOD
27	protein	protein	I-NP	NN	I-protein	30	NMOD
28	1	1	I-NP	CD	I-protein	30	NMOD
29	transcription	transcription	I-NP	NN	I-protein	30	NMOD
30	factors	factor	I-NP	NNS	I-protein	25	PMOD
31	.	.	O	.	O	2	P

1	Deletion	Deletion	B-NP	NN	O	15	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	glucocorticoid	glucocorticoid	I-NP	NN	B-DNA	6	NMOD
5	response	response	I-NP	NN	I-DNA	6	NMOD
6	elements	element	I-NP	NNS	I-DNA	2	PMOD
7	located	located	B-ADJP	JJ	O	6	NMOD
8	at	at	B-PP	IN	O	7	AMOD
9	ca.	ca.	B-NP	FW	B-DNA	10	NMOD
10	bp	bp	I-NP	NN	I-DNA	12	AMOD
11	-850	-850	I-NP	CD	I-DNA	10	NMOD
12	upstream	upstream	B-ADVP	RB	O	8	PMOD
13	of	of	B-PP	IN	O	12	AMOD
14	Cp	Cp	B-NP	NN	B-DNA	13	PMOD
15	did	do	B-VP	VBD	O	0	ROOT
16	not	not	I-VP	RB	O	15	VMOD
17	result	result	I-VP	VB	O	15	VC
18	in	in	B-PP	IN	O	17	VMOD
19	a	a	B-NP	DT	O	21	NMOD
20	significant	significant	I-NP	JJ	O	21	NMOD
21	loss	loss	I-NP	NN	O	18	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	activity	activity	B-NP	NN	O	22	PMOD
24	.	.	O	.	O	15	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	neither	neither	O	CC	O	11	NMOD
5	E	E	B-NP	NN	B-DNA	11	NMOD
6	(	(	O	(	I-DNA	8	DEP
7	gre	gre	B-NP	NN	I-DNA	8	DEP
8	)	)	O	)	I-DNA	5	NMOD
9	nor	nor	O	CC	O	10	NMOD
10	EA/S	EA/S	B-NP	NN	B-DNA	11	NMOD
11	motifs	motif	I-NP	NNS	I-DNA	12	SUB
12	contributed	contribute	B-VP	VBD	O	0	ROOT
13	pronouncedly	pronouncedly	B-ADVP	RB	O	12	VMOD
14	to	to	B-PP	TO	O	12	VMOD
15	Akv	Akv	B-NP	NN	O	17	NMOD
16	MLV	MLV	I-NP	NN	O	17	NMOD
17	transcription	transcription	I-NP	NN	O	14	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	NIH	NIH	B-NP	NN	B-cell_line	21	NMOD
20	3T3	3T3	I-NP	NN	I-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
22	lacking	lack	B-VP	VBG	O	21	NMOD
23	DNA-binding	DNA-binding	B-NP	JJ	O	29	NMOD
24	ALF1	ALF1	I-NP	NN	B-protein	26	NMOD
25	or	or	I-NP	CC	O	26	NMOD
26	HEB	HEB	I-NP	NN	B-protein	28	NMOD
27	and	and	I-NP	CC	O	28	NMOD
28	E2A	E2A	I-NP	NN	B-protein	29	NMOD
29	proteins	protein	I-NP	NNS	I-protein	22	OBJ
30	.	.	O	.	O	12	P

1	Moreover	Moreover	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	ectopic	ectopic	B-NP	JJ	B-protein	4	NMOD
4	Id1	Id1	I-NP	NN	I-protein	5	SUB
5	repressed	repress	B-VP	VBD	O	0	ROOT
6	E	E	B-NP	NN	B-DNA	8	NMOD
7	(	(	O	(	I-DNA	8	NMOD
8	gre	gre	B-NP	NN	I-DNA	15	NMOD
9	)	)	O	)	I-DNA	8	NMOD
10	-directed	-directed	B-ADJP	JJ	O	15	NMOD
11	but	but	B-CONJP	CC	O	15	NMOD
12	not	not	I-CONJP	RB	O	11	DEP
13	EA/S-directed	EA/S-directed	B-NP	JJ	O	15	NMOD
14	MLV	MLV	I-NP	NN	O	15	NMOD
15	transcription	transcription	I-NP	NN	O	5	OBJ
16	in	in	B-PP	IN	O	15	NMOD
17	lymphoid	lymphoid	B-NP	JJ	B-cell_line	19	NMOD
18	cell	cell	I-NP	NN	I-cell_line	19	NMOD
19	lines	line	I-NP	NNS	I-cell_line	16	PMOD
20	.	.	O	.	O	5	P

1	Expression	Expression	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	dominant	dominant	B-NP	JJ	B-protein	5	NMOD
4	negative	negative	I-NP	JJ	I-protein	5	NMOD
5	MAPKK-1	MAPKK-1	I-NP	NN	I-protein	2	PMOD
6	prevents	prevent	B-VP	VBZ	O	0	ROOT
7	NFAT	NFAT	B-NP	NN	B-protein	8	NMOD
8	induction	induction	I-NP	NN	O	6	OBJ
9	.	.	O	.	O	6	P

1	Constitutively	Constitutively	B-NP	RB	O	2	AMOD
2	active	active	I-NP	JJ	O	3	NMOD
3	MAPKK-1	MAPKK-1	I-NP	NN	B-protein	5	SUB
4	fully	fully	B-VP	RB	O	5	VMOD
5	activates	activate	I-VP	VBZ	O	0	ROOT
6	ERK-2	ERK-2	B-NP	NN	B-protein	11	NMOD
7	and	and	O	CC	O	11	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	transcription	transcription	I-NP	NN	B-protein	11	NMOD
10	factor	factor	I-NP	NN	I-protein	11	NMOD
11	Elk-1	Elk-1	I-NP	NN	B-protein	5	OBJ
12	,	,	O	,	O	5	P
13	but	but	O	CC	O	5	VMOD
14	does	do	B-VP	VBZ	O	5	VMOD
15	not	not	I-VP	RB	O	14	VMOD
16	substitute	substitute	I-VP	VB	O	14	VC
17	for	for	B-PP	IN	O	16	VMOD
18	activated	activate	B-NP	VBN	O	19	NMOD
19	p21ras	p21ras	I-NP	NN	B-protein	17	PMOD
20	and	and	O	CC	O	16	VMOD
21	synergize	synergize	B-VP	VB	O	16	VMOD
22	with	with	B-PP	IN	O	21	VMOD
23	calcium/calcineurin	calcium/calcineurin	B-NP	NN	O	24	NMOD
24	signals	signal	I-NP	NNS	O	22	PMOD
25	to	to	B-VP	TO	O	26	VMOD
26	induce	induce	I-VP	VB	O	21	VMOD
27	NFAT	NFAT	B-NP	NN	B-protein	26	OBJ
28	.	.	O	.	O	5	P

1	Expression	Expression	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	dominant	dominant	B-NP	JJ	O	6	NMOD
4	negative	negative	I-NP	JJ	O	6	NMOD
5	N17Rac	N17Rac	I-NP	NN	O	6	NMOD
6	alsoprevents	alsoprevent	I-NP	NNS	O	9	NMOD
7	TCR	TCR	I-NP	NN	B-protein	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	p21ras	p21ras	I-NP	NN	B-protein	10	NMOD
10	activation	activation	I-NP	NN	O	2	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	NFAT	NFAT	B-NP	NN	B-protein	11	PMOD
13	,	,	O	,	O	1	P
14	but	but	O	CC	O	1	NMOD
15	without	without	B-PP	IN	O	14	PMOD
16	interfering	interfere	B-VP	VBG	O	15	PMOD
17	with	with	B-PP	IN	O	16	VMOD
18	the	the	B-NP	DT	O	20	NMOD
19	ERK-2	ERK-2	I-NP	NN	B-protein	20	NMOD
20	pathway	pathway	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	1	P

1	Activated	Activate	B-NP	VBN	O	2	NMOD
2	Rac-1	Rac-1	I-NP	NN	B-protein	3	SUB
3	could	could	B-VP	MD	O	0	ROOT
4	mimic	mimic	I-VP	VB	O	3	VC
5	activated	activate	B-NP	VBN	O	6	NMOD
6	p21ras	p21ras	I-NP	NN	B-protein	4	OBJ
7	to	to	B-VP	TO	O	8	VMOD
8	induce	induce	I-VP	VB	O	4	VMOD
9	AP-1	AP-1	B-NP	NN	B-protein	8	OBJ
10	but	but	O	CC	O	8	VMOD
11	not	not	O	RB	O	13	VMOD
12	to	to	B-VP	TO	O	13	VMOD
13	induce	induce	I-VP	VB	O	8	VMOD
14	NFAT	NFAT	B-NP	NN	B-protein	13	OBJ
15	.	.	O	.	O	3	P

1	Moreover	Moreover	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	the	the	B-NP	DT	O	4	NMOD
4	combination	combination	I-NP	NN	O	10	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	activated	activate	B-NP	VBN	O	9	NMOD
7	MAPKK-1	MAPKK-1	I-NP	NN	B-protein	9	NMOD
8	and	and	I-NP	CC	O	9	NMOD
9	Rac-1	Rac-1	I-NP	NN	B-protein	5	PMOD
10	could	could	B-VP	MD	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	substitute	substitute	I-VP	VB	O	10	VC
13	for	for	B-PP	IN	O	12	VMOD
14	activated	activate	B-NP	VBN	O	15	NMOD
15	p21ras	p21ras	I-NP	NN	B-protein	13	PMOD
16	and	and	O	CC	O	12	VMOD
17	synergize	synergize	B-VP	VB	O	12	VMOD
18	with	with	B-PP	IN	O	17	VMOD
19	calcium	calcium	B-NP	NN	O	20	NMOD
20	signals	signal	I-NP	NNS	O	18	PMOD
21	to	to	B-VP	TO	O	22	VMOD
22	induce	induce	I-VP	VB	O	17	VMOD
23	NFAT	NFAT	B-NP	NN	B-protein	22	OBJ
24	.	.	O	.	O	10	P

1	Protein-tyrosine	Protein-tyrosine	B-NP	NN	B-protein	3	NMOD
2	kinase	kinase	I-NP	NN	I-protein	3	NMOD
3	activation	activation	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	20	NMOD
5	required	require	I-VP	VBN	O	4	VC
6	for	for	B-PP	IN	O	5	VMOD
7	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	8	NMOD
8	induction	induction	I-NP	NN	O	14	NMOD
9	of	of	B-PP	IN	O	8	NMOD
10	interleukin	interleukin	B-NP	NN	B-protein	11	NMOD
11	1beta	1beta	I-NP	NN	I-protein	9	PMOD
12	and	and	O	CC	O	14	NMOD
13	NFkappaB	NFkappaB	B-NP	NN	B-protein	14	NMOD
14	activation	activation	I-NP	NN	O	6	PMOD
15	,	,	O	,	O	20	P
16	but	but	O	CC	O	20	NMOD
17	not	not	O	RB	O	16	DEP
18	NFkappaB	NFkappaB	B-NP	NN	B-protein	20	NMOD
19	nuclear	nuclear	I-NP	JJ	O	20	NMOD
20	translocation	translocation	I-NP	NN	O	0	ROOT
21	.	.	O	.	O	20	P

1	Since	Since	B-SBAR	IN	O	20	VMOD
2	recent	recent	B-NP	JJ	O	3	NMOD
3	studies	study	I-NP	NNS	O	4	SUB
4	have	have	B-VP	VBP	O	1	SBAR
5	shown	show	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	lipopolysaccharide-induced	lipopolysaccharide-induced	B-NP	JJ	O	10	NMOD
8	tyrosine	tyrosine	I-NP	NN	B-protein	10	NMOD
9	kinase	kinase	I-NP	NN	I-protein	10	NMOD
10	activation	activation	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	6	SBAR
12	not	not	I-VP	RB	O	11	VMOD
13	required	require	I-VP	VBN	O	11	VC
14	for	for	B-PP	IN	O	13	VMOD
15	NFkappaB	NFkappaB	B-NP	NN	B-protein	17	NMOD
16	nuclear	nuclear	I-NP	JJ	O	17	NMOD
17	translocation	translocation	I-NP	NN	O	14	PMOD
18	,	,	O	,	O	20	P
19	we	we	B-NP	PRP	O	20	SUB
20	sought	seek	B-VP	VBD	O	0	ROOT
21	to	to	I-VP	TO	O	22	VMOD
22	determine	determine	I-VP	VB	O	20	VMOD
23	whether	whether	B-SBAR	IN	O	22	VMOD
24	NFkappaB	NFkappaB	B-NP	NN	B-protein	23	SBAR
25	translocated	translocate	B-VP	VBN	O	24	NMOD
26	in	in	B-PP	IN	O	25	VMOD
27	the	the	B-NP	DT	O	26	PMOD
28	absence	absence	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	26	PMOD
30	tyrosine	tyrosine	B-NP	NN	B-protein	32	NMOD
31	kinase	kinase	I-NP	NN	I-protein	32	NMOD
32	activity	activity	I-NP	NN	O	33	SUB
33	was	be	B-VP	VBD	O	26	SBAR
34	active	active	B-ADJP	JJ	O	33	PRD
35	in	in	B-PP	IN	O	33	VMOD
36	stimulating	stimulate	B-VP	VBG	O	35	PMOD
37	transcription	transcription	B-NP	NN	O	36	OBJ
38	.	.	O	.	O	20	P

1	Tyrosine	Tyrosine	B-NP	NN	B-protein	2	NMOD
2	kinases	kinase	I-NP	NNS	I-protein	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	required	require	I-VP	VBN	O	3	VC
6	for	for	B-PP	IN	O	5	VMOD
7	lipopolysaccharide-mediated	lipopolysaccharide-mediated	B-NP	JJ	O	9	NMOD
8	nuclear	nuclear	I-NP	JJ	O	9	NMOD
9	translocation	translocation	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	NFkappaB	NFkappaB	B-NP	NN	B-protein	10	PMOD
12	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	18	VMOD
2	,	,	O	,	O	18	P
3	in	in	B-PP	IN	O	18	VMOD
4	the	the	B-NP	DT	O	3	PMOD
5	absence	absence	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	3	PMOD
7	tyrosine	tyrosine	B-NP	NN	B-protein	9	NMOD
8	kinase	kinase	I-NP	NN	I-protein	9	NMOD
9	activity	activity	I-NP	NN	O	3	PMOD
10	,	,	O	,	O	18	P
11	the	the	B-NP	DT	O	12	NMOD
12	ability	ability	I-NP	NN	O	18	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	NFkappaB	NFkappaB	B-NP	NN	B-protein	13	PMOD
15	to	to	B-VP	TO	O	16	VMOD
16	stimulate	stimulate	I-VP	VB	O	12	NMOD
17	transcription	transcription	B-NP	NN	O	16	OBJ
18	is	be	B-VP	VBZ	O	0	ROOT
19	impaired	impaired	B-ADJP	JJ	O	18	PRD
20	.	.	O	.	O	18	P

1	in	in	B-PP	IN	O	11	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	absence	absence	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	tyrosine	tyrosine	B-NP	NN	B-protein	7	NMOD
6	kinase	kinase	I-NP	NN	I-protein	7	NMOD
7	activity	activity	I-NP	NN	O	4	PMOD
8	,	,	O	,	O	11	P
9	AP-1-dependent	AP-1-dependent	B-NP	JJ	O	10	NMOD
10	transcription	transcription	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	0	ROOT
12	enhanced	enhance	I-VP	VBN	O	11	VC
13	.	.	O	.	O	11	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	,	,	O	,	O	4	P
6	while	while	B-SBAR	IN	O	20	VMOD
7	lipopolysaccharide-induced	lipopolysaccharide-induced	B-NP	JJ	O	8	NMOD
8	expression	expression	I-NP	NN	O	12	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	inflammatory	inflammatory	B-NP	JJ	B-protein	11	NMOD
11	mediators	mediator	I-NP	NNS	I-protein	9	PMOD
12	requires	require	B-VP	VBZ	O	6	SBAR
13	tyrosine	tyrosine	B-NP	NN	B-protein	15	NMOD
14	kinase	kinase	I-NP	NN	I-protein	15	NMOD
15	activity	activity	I-NP	NN	O	12	OBJ
16	,	,	O	,	O	20	P
17	tyrosine	tyrosine	B-NP	NN	B-protein	19	NMOD
18	kinase	kinase	I-NP	NN	I-protein	19	NMOD
19	activity	activity	I-NP	NN	O	20	SUB
20	is	be	B-VP	VBZ	O	4	SBAR
21	not	not	O	RB	O	20	VMOD
22	obligatory	obligatory	B-ADJP	JJ	O	20	PRD
23	for	for	B-PP	IN	O	22	AMOD
24	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	26	NMOD
25	signal	signal	I-NP	NN	O	26	NMOD
26	transduction	transduction	I-NP	NN	O	23	PMOD
27	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	5	NMOD
2	primary	primary	I-NP	JJ	O	4	AMOD
3	and	and	I-NP	CC	O	4	AMOD
4	recurrent	recurrent	I-NP	JJ	O	5	NMOD
5	tumors	tumor	I-NP	NNS	O	9	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	Group	Group	B-NP	NN	O	8	NMOD
8	A	A	I-NP	NN	O	6	PMOD
9	did	do	B-VP	VBD	O	23	VMOD
10	not	not	I-VP	RB	O	9	VMOD
11	show	show	I-VP	VB	O	9	VC
12	structural	structural	B-NP	JJ	O	13	NMOD
13	alterations	alteration	I-NP	NNS	O	11	OBJ
14	in	in	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	21	NMOD
16	p16	p16	I-NP	NN	B-protein	20	NMOD
17	,	,	I-NP	,	O	20	P
18	p15	p15	I-NP	NN	B-protein	20	NMOD
19	or	or	I-NP	CC	O	20	NMOD
20	CDK4	CDK4	I-NP	NN	B-DNA	21	NMOD
21	genes	gene	I-NP	NNS	I-DNA	14	PMOD
22	,	,	O	,	O	23	P
23	whereas	whereas	O	IN	O	0	ROOT
24	homozygous	homozygous	B-NP	JJ	O	25	NMOD
25	codeletion	codeletion	I-NP	NN	O	30	SUB
26	of	of	B-PP	IN	O	25	NMOD
27	p16	p16	B-NP	NN	B-protein	29	NMOD
28	and	and	I-NP	CC	O	29	NMOD
29	p15	p15	I-NP	NN	B-protein	26	PMOD
30	was	be	B-VP	VBD	O	23	VMOD
31	observed	observe	I-VP	VBN	O	30	VC
32	in	in	B-PP	IN	O	31	VMOD
33	both	both	B-NP	CC	O	36	AMOD
34	primary	primary	I-NP	JJ	O	36	AMOD
35	and	and	I-NP	CC	O	36	AMOD
36	recurrent	recurrent	I-NP	JJ	O	37	NMOD
37	tumors	tumor	I-NP	NNS	O	32	PMOD
38	in	in	B-PP	IN	O	37	NMOD
39	Group	Group	B-NP	NN	O	40	NMOD
40	B	B	I-NP	NN	O	38	PMOD
41	.	.	O	.	O	23	P

1	The	The	B-NP	DT	O	2	NMOD
2	extent	extent	I-NP	NN	O	20	SUB
3	to	to	B-PP	TO	O	2	NMOD
4	which	which	B-NP	WDT	O	3	PMOD
5	peptides	peptide	B-NP	NNS	O	15	SUB
6	containing	contain	B-VP	VBG	O	5	NMOD
7	chemically	chemically	B-ADVP	RB	O	14	NMOD
8	and	and	I-ADVP	CC	O	7	AMOD
9	post-translationally	post-translationally	I-ADVP	RB	O	7	AMOD
10	modified	modify	B-VP	VBN	O	7	AMOD
11	amino	amino	B-NP	JJ	B-protein	14	NMOD
12	acid	acid	I-NP	NN	I-protein	14	NMOD
13	side	side	I-NP	NN	I-protein	14	NMOD
14	chains	chain	I-NP	NNS	I-protein	6	OBJ
15	are	be	B-VP	VBP	O	3	SBAR
16	recognized	recognize	I-VP	VBN	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	primed	prim	B-NP	VBN	B-cell_line	19	NMOD
19	CTL	CTL	I-NP	NN	I-cell_line	17	PMOD
20	has	have	B-VP	VBZ	O	0	ROOT
21	not	not	I-VP	RB	O	20	VMOD
22	been	be	I-VP	VBN	O	20	VC
23	clearly	clearly	I-VP	RB	O	22	VMOD
24	defined	define	I-VP	VBN	O	22	VC
25	.	.	O	.	O	20	P

1	Similarly	Similarly	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	CTL	CTL	B-NP	NN	B-cell_type	9	SUB
4	raised	raise	B-VP	VBN	O	3	NMOD
5	against	against	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	8	NMOD
7	parent	parent	I-NP	NN	O	8	NMOD
8	peptide	peptide	I-NP	NN	O	5	PMOD
9	did	do	B-VP	VBD	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	recognize	recognize	I-VP	VB	O	9	VC
12	the	the	B-NP	DT	O	14	NMOD
13	succinimide	succinimide	I-NP	NN	O	14	NMOD
14	derivative	derivative	I-NP	NN	O	11	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	this	this	B-NP	DT	O	17	NMOD
17	peptide	peptide	I-NP	NN	O	15	PMOD
18	.	.	O	.	O	9	P

1	Although	Although	B-SBAR	IN	O	24	VMOD
2	NGFI-B/nur77	NGFI-B/nur77	B-NP	NN	B-protein	3	SUB
3	is	be	B-VP	VBZ	O	1	SBAR
4	essential	essential	B-ADJP	JJ	O	3	PRD
5	for	for	B-PP	IN	O	4	AMOD
6	TCR-mediated	TCR-mediated	B-NP	JJ	O	7	NMOD
7	apoptosis	apoptosis	I-NP	NN	O	5	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	T-cell	T-cell	B-NP	NN	B-cell_line	10	NMOD
10	hybridomas	hybridoma	I-NP	NNS	I-cell_line	8	PMOD
11	,	,	O	,	O	24	P
12	the	the	B-NP	DT	O	13	NMOD
13	reports	report	I-NP	NNS	O	24	SUB
14	on	on	B-PP	IN	O	13	NMOD
15	nur77	nur77	B-NP	NN	O	17	NMOD
16	knock-out	knock-out	I-NP	JJ	O	17	NMOD
17	mice	mouse	I-NP	NNS	O	23	NMOD
18	and	and	O	CC	O	23	NMOD
19	nur77	nur77	B-NP	NN	O	23	NMOD
20	dominant	dominant	I-NP	JJ	O	23	NMOD
21	negative	negative	I-NP	JJ	O	23	NMOD
22	transgenic	transgenic	I-NP	JJ	O	23	NMOD
23	mice	mouse	I-NP	NNS	O	14	PMOD
24	suggest	suggest	B-VP	VBP	O	0	ROOT
25	that	that	B-SBAR	IN	O	24	VMOD
26	there	there	B-NP	EX	O	27	SUB
27	is	be	B-VP	VBZ	O	25	SBAR
28	a	a	B-NP	DT	O	30	NMOD
29	functional	functional	I-NP	JJ	O	30	NMOD
30	redundancy	redundancy	I-NP	NN	O	27	PRD
31	among	among	B-PP	IN	O	27	VMOD
32	NGFI-B/nur77	NGFI-B/nur77	B-NP	NN	B-protein	33	NMOD
33	family	family	I-NP	NN	I-protein	31	PMOD
34	.	.	O	.	O	24	P

1	Assuming	Assume	B-VP	VBG	O	13	VMOD
2	that	that	B-SBAR	IN	O	1	PMOD
3	9-cis-retinoic	9-cis-retinoic	B-NP	JJ	O	4	NMOD
4	acid	acid	I-NP	NN	O	8	SUB
5	(	(	O	(	O	7	DEP
6	9-cis-RA	9-cis-RA	B-NP	NN	O	7	DEP
7	)	)	O	)	O	4	NMOD
8	inhibits	inhibit	B-VP	VBZ	O	2	SBAR
9	TCR-mediated	TCR-mediated	B-NP	JJ	O	10	NMOD
10	apoptosis	apoptosis	I-NP	NN	O	8	OBJ
11	,	,	O	,	O	13	P
12	nur77	nur77	B-NP	NN	B-protein	13	SUB
13	may	may	B-VP	MD	O	0	ROOT
14	cause	cause	I-VP	VB	O	13	VC
15	apoptosis	apoptosis	B-NP	NN	O	14	OBJ
16	by	by	B-PP	IN	O	14	VMOD
17	monomer	monomer	B-NP	NN	O	16	PMOD
18	in	in	B-PP	IN	O	14	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	absence	absence	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	9-cis-RA	9-cis-RA	B-NP	NN	O	21	PMOD
23	and	and	O	CC	O	13	VMOD
24	may	may	B-VP	MD	O	13	VMOD
25	inhibit	inhibit	I-VP	VB	O	24	VC
26	apoptosis	apoptosis	B-NP	NN	O	25	OBJ
27	by	by	B-PP	IN	O	25	VMOD
28	heterodimer	heterodimer	B-NP	NN	B-protein	27	PMOD
29	with	with	B-PP	IN	O	27	PMOD
30	RXR	RXR	B-NP	NN	B-protein	29	PMOD
31	in	in	B-PP	IN	O	25	VMOD
32	the	the	I-PP	DT	O	33	NMOD
33	presence	presence	I-PP	NN	O	31	PMOD
34	of	of	I-PP	IN	O	33	NMOD
35	9-cis-RA	9-cis-RA	B-NP	NN	O	34	PMOD
36	.	.	O	.	O	13	P

1	Importantly	Importantly	B-ADVP	RB	O	36	VMOD
2	,	,	O	,	O	36	P
3	two	two	B-NP	CD	O	6	NMOD
4	previously	previously	I-NP	RB	O	5	AMOD
5	characterized	characterize	I-NP	VBN	O	6	NMOD
6	mutants	mutant	I-NP	NNS	O	36	SUB
7	with	with	B-PP	IN	O	6	NMOD
8	point	point	B-NP	NN	O	9	NMOD
9	mutations	mutation	I-NP	NNS	O	7	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	Tax	Tax	B-NP	NN	B-protein	20	NMOD
12	,	,	O	,	O	20	P
13	M32	M32	B-NP	NN	B-protein	20	NMOD
14	(	(	O	(	O	18	DEP
15	Y196A	Y196A	B-NP	NN	O	17	NMOD
16	,	,	O	,	O	17	P
17	K197S	K197S	B-NP	NN	B-cell_line	18	DEP
18	)	)	O	)	O	13	NMOD
19	and	and	O	CC	O	20	NMOD
20	M41	M41	B-NP	NN	B-protein	10	PMOD
21	(	(	O	(	O	25	DEP
22	H287A	H287A	B-NP	NN	O	24	NMOD
23	,	,	O	,	O	24	P
24	P288S	P288S	B-NP	NN	B-protein	25	DEP
25	)	)	O	)	O	20	NMOD
26	,	,	O	,	O	20	P
27	which	which	B-NP	WDT	O	20	NMOD
28	were	be	B-VP	VBD	O	27	SBAR
29	shown	show	I-VP	VBN	O	28	VC
30	to	to	I-VP	TO	O	31	VMOD
31	be	be	I-VP	VB	O	29	VMOD
32	defective	defective	B-ADJP	JJ	O	31	PRD
33	in	in	B-PP	IN	O	31	VMOD
34	Tax-activated	Tax-activated	B-NP	JJ	O	35	NMOD
35	transcription	transcription	I-NP	NN	O	33	PMOD
36	were	be	B-VP	VBD	O	0	ROOT
37	unable	unable	B-ADJP	JJ	O	36	PRD
38	to	to	B-VP	TO	O	39	VMOD
39	interact	interact	I-VP	VB	O	37	AMOD
40	with	with	B-PP	IN	O	39	VMOD
41	TFIIA	TFIIA	B-NP	NN	B-protein	40	PMOD
42	in	in	B-PP	IN	O	39	VMOD
43	this	this	B-NP	DT	O	44	NMOD
44	assay	assay	I-NP	NN	O	42	PMOD
45	.	.	O	.	O	36	P

1	We	We	B-NP	PRP	O	3	SUB
2	now	now	B-ADVP	RB	O	3	VMOD
3	report	report	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	vaccination	vaccination	B-NP	NN	O	32	SUB
6	with	with	B-PP	IN	O	5	NMOD
7	a	a	B-NP	DT	O	9	NMOD
8	CTL	CTL	I-NP	NN	B-protein	9	NMOD
9	epitope	epitope	I-NP	NN	I-protein	6	PMOD
10	derived	derive	B-VP	VBN	O	9	NMOD
11	from	from	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	17	NMOD
13	human	human	I-NP	JJ	B-DNA	17	NMOD
14	adenovirus	adenovirus	I-NP	NN	I-DNA	17	NMOD
15	type	type	I-NP	NN	I-DNA	17	NMOD
16	5	5	I-NP	CD	I-DNA	17	NMOD
17	E1A-region	E1A-region	I-NP	NN	I-DNA	11	PMOD
18	(	(	O	(	O	20	DEP
19	Ad5E1A234-243	Ad5E1A234-243	B-NP	NN	B-DNA	20	DEP
20	)	)	O	)	O	17	NMOD
21	,	,	O	,	O	9	P
22	which	which	B-NP	WDT	O	9	NMOD
23	can	can	B-VP	MD	O	22	SBAR
24	serve	serve	I-VP	VB	O	23	VC
25	as	as	B-PP	IN	O	24	VMOD
26	a	a	B-NP	DT	O	27	NMOD
27	target	target	I-NP	NN	O	25	PMOD
28	for	for	B-PP	IN	O	27	NMOD
29	tumor-eradicating	tumor-eradicating	B-NP	JJ	B-cell_type	30	NMOD
30	CTL	CTL	I-NP	NN	I-cell_type	28	PMOD
31	,	,	O	,	O	5	P
32	enhances	enhance	B-VP	VBZ	O	4	SBAR
33	rather	rather	B-CONJP	RB	O	32	VMOD
34	than	than	I-CONJP	IN	O	33	DEP
35	inhibits	inhibit	B-VP	VBZ	O	32	VMOD
36	the	the	B-NP	DT	O	37	NMOD
37	growth	growth	I-NP	NN	O	32	VMOD
38	of	of	B-PP	IN	O	37	NMOD
39	Ad5E1A-expressing	Ad5E1A-expressing	B-NP	JJ	O	40	NMOD
40	tumors	tumor	I-NP	NNS	O	38	PMOD
41	.	.	O	.	O	3	P

1	Ad5E1A-specific	Ad5E1A-specific	B-NP	JJ	O	3	NMOD
2	CTL	CTL	I-NP	NN	O	3	NMOD
3	activity	activity	I-NP	NN	O	4	SUB
4	could	could	B-VP	MD	O	0	ROOT
5	no	no	I-VP	RB	O	4	VMOD
6	longer	longer	I-VP	RB	O	5	AMOD
7	be	be	I-VP	VB	O	4	VC
8	isolated	isolate	I-VP	VBN	O	7	VC
9	from	from	B-PP	IN	O	8	VMOD
10	mice	mouse	B-NP	NNS	O	9	PMOD
11	after	after	B-PP	IN	O	8	VMOD
12	injection	injection	B-NP	NN	O	11	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	Ad5E1A-peptide	Ad5E1A-peptide	B-NP	NN	O	13	PMOD
15	,	,	O	,	O	8	P
16	indicating	indicate	B-VP	VBG	O	8	VMOD
17	that	that	B-SBAR	IN	O	16	VMOD
18	tolerization	tolerization	B-NP	NN	O	23	SUB
19	of	of	B-PP	IN	O	18	NMOD
20	Ad5E1A-specific	Ad5E1A-specific	B-NP	JJ	O	22	NMOD
21	CTL	CTL	I-NP	NN	O	22	NMOD
22	activity	activity	I-NP	NN	O	19	PMOD
23	causes	cause	B-VP	VBZ	O	17	SBAR
24	the	the	B-NP	DT	O	27	NMOD
25	enhanced	enhance	I-NP	VBN	O	27	NMOD
26	tumor	tumor	I-NP	NN	O	27	NMOD
27	outgrowth	outgrowth	I-NP	NN	O	23	OBJ
28	.	.	O	.	O	4	P

1	This	This	B-NP	DT	O	2	SUB
2	yields	yield	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	fusion	fusion	I-NP	NN	B-RNA	5	NMOD
5	transcript	transcript	I-NP	NN	I-RNA	11	NMOD
6	,	,	O	,	O	11	P
7	PML/RARalpha	PML/RARalpha	B-NP	NN	B-protein	11	NMOD
8	,	,	O	,	O	11	P
9	a	a	B-NP	DT	O	11	NMOD
10	transcription	transcription	I-NP	NN	B-protein	11	NMOD
11	factor	factor	I-NP	NN	I-protein	2	OBJ
12	with	with	B-PP	IN	O	11	NMOD
13	reported	report	B-NP	VBN	O	16	NMOD
14	dominant	dominant	I-NP	JJ	O	16	NMOD
15	negative	negative	I-NP	JJ	O	16	NMOD
16	functions	function	I-NP	NNS	O	12	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	17	PMOD
19	absence	absence	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	17	PMOD
21	hormone	hormone	B-NP	NN	O	17	PMOD
22	.	.	O	.	O	2	P

1	Basal	Basal	B-NP	JJ	O	8	NMOD
2	total	total	I-NP	JJ	O	8	NMOD
3	white	white	I-NP	JJ	O	5	NMOD
4	blood	blood	I-NP	NN	O	5	NMOD
5	cell	cell	I-NP	NN	O	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	granulocyte	granulocyte	I-NP	NN	O	8	NMOD
8	counts	count	I-NP	NNS	O	9	SUB
9	did	do	B-VP	VBD	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	appreciably	appreciably	I-VP	RB	O	9	VMOD
12	differ	differ	I-VP	VBP	O	9	VC
13	between	between	B-PP	IN	O	12	VMOD
14	PML/RARalpha	PML/RARalpha	B-NP	NN	B-protein	18	NMOD
15	transgenic	transgenic	I-NP	JJ	O	14	AMOD
16	and	and	I-NP	CC	O	14	DEP
17	control	control	I-NP	NN	O	14	DEP
18	mice	mouse	I-NP	NNS	O	13	PMOD
19	.	.	O	.	O	9	P

1	Granulocyte/macrophage	Granulocyte/macrophage	B-NP	JJ	B-protein	3	NMOD
2	colony-stimulating	colony-stimulating	I-NP	JJ	I-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	7	NMOD
4	and	and	I-NP	CC	O	7	NMOD
5	kit	kit	I-NP	NN	O	7	NMOD
6	ligand	ligand	I-NP	NN	O	7	NMOD
7	cotreatment	cotreatment	I-NP	NN	O	8	SUB
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	overcome	overcome	I-VP	VB	O	8	VC
11	this	this	B-NP	DT	O	12	NMOD
12	inhibition	inhibition	I-NP	NN	O	10	OBJ
13	.	.	O	.	O	8	P

1	Anergic	Anergic	B-NP	JJ	B-cell_line	4	NMOD
2	CD4+	CD4+	I-NP	JJ	I-cell_line	4	NMOD
3	Th	Th	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	5	SUB
5	do	do	B-VP	VBP	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	produce	produce	I-VP	VB	O	5	VC
8	IL-2	IL-2	B-NP	NN	B-protein	7	OBJ
9	when	when	B-ADVP	WRB	O	7	VMOD
10	challenged	challenge	B-VP	VBN	O	9	SBAR
11	with	with	B-PP	IN	O	10	VMOD
12	Ag-pulsed	Ag-pulsed	B-NP	JJ	B-cell_line	14	NMOD
13	accessory	accessory	I-NP	JJ	I-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	11	PMOD
15	because	because	B-PP	IN	O	10	VMOD
16	of	of	I-PP	IN	O	15	PMOD
17	a	a	B-NP	DT	O	19	NMOD
18	transcriptional	transcriptional	I-NP	JJ	O	19	NMOD
19	defect	defect	I-NP	NN	O	15	PMOD
20	.	.	O	.	O	5	P

1	However	However	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	the	the	B-NP	DT	O	5	NMOD
4	reduced	reduce	I-NP	VBN	O	5	NMOD
5	expression	expression	I-NP	NN	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	these	these	B-NP	DT	O	8	NMOD
8	proteins	protein	I-NP	NNS	O	6	PMOD
9	was	be	B-VP	VBD	O	0	ROOT
10	not	not	O	RB	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	result	result	I-NP	NN	O	9	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	17	NMOD
15	global	global	I-NP	JJ	O	17	NMOD
16	TCR/CD3-signaling	TCR/CD3-signaling	I-NP	JJ	O	17	NMOD
17	defect	defect	I-NP	NN	O	13	PMOD
18	because	because	B-SBAR	IN	O	9	VMOD
19	CD3	CD3	B-NP	NN	B-protein	20	NMOD
20	cross-linking	cross-linking	I-NP	NN	O	21	SUB
21	induced	induce	B-VP	VBD	O	18	SBAR
22	an	an	B-NP	DT	O	24	NMOD
23	equivalent	equivalent	I-NP	JJ	O	24	NMOD
24	increase	increase	I-NP	NN	O	43	NMOD
25	in	in	B-PP	IN	O	24	NMOD
26	intracellular-free	intracellular-free	B-NP	JJ	O	28	NMOD
27	calcium	calcium	I-NP	NN	O	28	NMOD
28	ions	ion	I-NP	NNS	O	25	PMOD
29	,	,	O	,	O	43	P
30	as	as	B-CONJP	RB	O	43	NMOD
31	well	well	I-CONJP	RB	O	30	DEP
32	as	as	I-CONJP	IN	O	30	DEP
33	NFATp	NFATp	B-NP	NN	B-protein	34	NMOD
34	dephosphorylation	dephosphorylation	I-NP	NN	O	43	NMOD
35	,	,	O	,	O	43	P
36	translocation	translocation	B-NP	NN	O	43	NMOD
37	to	to	B-PP	TO	O	36	NMOD
38	the	the	B-NP	DT	O	39	NMOD
39	nucleus	nucleus	I-NP	NN	O	37	PMOD
40	,	,	O	,	O	43	P
41	and	and	O	CC	O	43	NMOD
42	DNA	DNA	B-NP	NN	O	43	NMOD
43	binding	binding	I-NP	NN	O	21	OBJ
44	in	in	B-PP	IN	O	43	NMOD
45	both	both	B-NP	CC	O	48	AMOD
46	normal	normal	I-NP	JJ	O	48	AMOD
47	and	and	I-NP	CC	O	48	AMOD
48	anergic	anergic	I-NP	JJ	B-cell_line	50	NMOD
49	T	T	I-NP	NN	I-cell_line	50	NMOD
50	cells	cell	I-NP	NNS	I-cell_line	44	PMOD
51	.	.	O	.	O	9	P

1	Elevated	Elevated	B-NP	JJ	O	2	NMOD
2	cAMP	cAMP	I-NP	NN	O	3	SUB
3	did	do	B-VP	VBD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	prevent	prevent	I-VP	VB	O	3	VC
6	nuclear	nuclear	B-NP	JJ	O	7	NMOD
7	translocation	translocation	I-NP	NN	O	5	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	p50/p65	p50/p65	B-NP	NN	B-protein	12	NMOD
10	and	and	I-NP	CC	O	12	NMOD
11	c-Rel/p65	c-Rel/p65	I-NP	NN	B-protein	12	NMOD
12	heterodimers	heterodimer	I-NP	NNS	I-protein	8	PMOD
13	,	,	O	,	O	5	P
14	decrease	decrease	B-VP	VB	O	5	VMOD
15	nuclear	nuclear	B-NP	JJ	O	16	NMOD
16	translocation	translocation	I-NP	NN	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	p65	p65	B-NP	NN	B-protein	17	PMOD
19	,	,	O	,	O	5	P
20	or	or	O	CC	O	5	VMOD
21	significantly	significantly	B-VP	RB	O	22	VMOD
22	modify	modify	I-VP	VB	O	5	VMOD
23	TNFalpha-induced	TNFalpha-induced	B-NP	JJ	O	24	NMOD
24	phosphorylation	phosphorylation	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	p65	p65	B-NP	NN	B-protein	25	PMOD
27	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	NFATc.beta	NFATc.beta	B-NP	NN	B-protein	5	SUB
4	neither	neither	O	CC	O	5	VMOD
5	bound	bind	B-VP	VBD	O	0	ROOT
6	to	to	B-PP	TO	O	5	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	kappa3	kappa3	I-NP	NN	B-DNA	9	NMOD
9	element	element	I-NP	NN	I-DNA	6	PMOD
10	(	(	O	(	O	14	DEP
11	an	an	B-NP	DT	O	13	NMOD
12	NFAT-binding	NFAT-binding	I-NP	JJ	B-DNA	13	NMOD
13	site	site	I-NP	NN	I-DNA	14	DEP
14	)	)	O	)	O	9	NMOD
15	in	in	B-PP	IN	O	9	NMOD
16	the	the	B-NP	DT	O	20	NMOD
17	tumor	tumor	I-NP	NN	B-DNA	20	NMOD
18	necrosis	necrosis	I-NP	NN	I-DNA	20	NMOD
19	factor-alpha	factor-alpha	I-NP	NN	I-DNA	20	NMOD
20	promoter	promoter	I-NP	NN	I-DNA	15	PMOD
21	nor	nor	O	CC	O	5	VMOD
22	activated	activate	B-VP	VBD	O	5	VMOD
23	the	the	B-NP	DT	O	27	NMOD
24	tumor	tumor	I-NP	NN	B-DNA	27	NMOD
25	necrosis	necrosis	I-NP	NN	I-DNA	27	NMOD
26	factor-alpha	factor-alpha	I-NP	NN	I-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	22	OBJ
28	in	in	B-PP	IN	O	5	VMOD
29	cotransfection	cotransfection	B-NP	NN	O	30	NMOD
30	assays	assay	I-NP	NNS	O	28	PMOD
31	.	.	O	.	O	5	P

1	By	By	B-PP	IN	O	19	VMOD
2	using	use	B-VP	VBG	O	1	PMOD
3	70Z/3-derived	70Z/3-derived	B-NP	JJ	B-cell_line	5	NMOD
4	pre-B-cell	pre-B-cell	I-NP	NN	I-cell_line	5	NMOD
5	lines	line	I-NP	NNS	I-cell_line	2	OBJ
6	either	either	O	CC	O	7	VMOD
7	lacking	lack	B-VP	VBG	O	5	NMOD
8	or	or	I-VP	CC	O	7	VMOD
9	expressing	express	I-VP	VBG	O	7	VMOD
10	human	human	B-NP	JJ	B-protein	11	NMOD
11	CD14	CD14	I-NP	NN	I-protein	7	VMOD
12	(	(	O	(	O	16	DEP
13	the	the	B-NP	DT	O	15	NMOD
14	LPS	LPS	I-NP	NN	B-protein	15	NMOD
15	receptor	receptor	I-NP	NN	I-protein	16	DEP
16	)	)	O	)	O	11	NMOD
17	,	,	O	,	O	19	P
18	it	it	B-NP	PRP	O	19	SUB
19	was	be	B-VP	VBD	O	0	ROOT
20	observed	observe	I-VP	VBN	O	19	VC
21	that	that	B-SBAR	IN	O	20	VMOD
22	expression	expression	B-NP	NN	O	26	SUB
23	of	of	B-PP	IN	O	22	NMOD
24	human	human	B-NP	JJ	B-protein	25	NMOD
25	CD14	CD14	I-NP	NN	I-protein	23	PMOD
26	imparted	impart	B-VP	VBD	O	21	SBAR
27	responsiveness	responsiveness	B-NP	NN	O	26	OBJ
28	to	to	B-PP	TO	O	27	NMOD
29	LPS	LPS	B-NP	NN	O	28	PMOD
30	but	but	B-PP	CC	O	28	PMOD
31	not	not	B-PP	RB	O	32	PMOD
32	to	to	I-PP	TO	O	28	PMOD
33	OspA	OspA	B-NP	NN	B-protein	36	NMOD
34	or	or	O	CC	O	36	NMOD
35	spirochetal	spirochetal	B-NP	JJ	B-protein	36	NMOD
36	lipopeptides	lipopeptide	I-NP	NNS	I-protein	32	PMOD
37	(	(	O	(	O	50	DEP
38	assessed	assess	B-VP	VBN	O	50	DEP
39	by	by	B-PP	IN	O	38	VMOD
40	induction	induction	B-NP	NN	O	45	NMOD
41	of	of	B-PP	IN	O	40	NMOD
42	NF-kappa	NF-kappa	B-NP	NN	B-protein	43	NMOD
43	B	B	I-NP	NN	I-protein	41	PMOD
44	and	and	O	CC	O	45	NMOD
45	expression	expression	B-NP	NN	O	39	PMOD
46	of	of	B-PP	IN	O	45	NMOD
47	surface	surface	B-NP	NN	B-protein	49	NMOD
48	immunoglobulin	immunoglobulin	I-NP	NN	I-protein	49	NMOD
49	M	M	I-NP	NN	I-protein	46	PMOD
50	)	)	O	)	O	26	VMOD
51	.	.	O	.	O	19	P

1	A	A	B-NP	DT	O	3	NMOD
2	dramatic	dramatic	I-NP	JJ	O	3	NMOD
3	increase	increase	I-NP	NN	O	27	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	intracellular	intracellular	I-NP	JJ	O	7	NMOD
7	levels	level	I-NP	NNS	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	10	NMOD
10	subunits	subunit	I-NP	NNS	I-protein	14	NMOD
11	c-Rel	c-Rel	I-NP	NN	B-protein	14	NMOD
12	and	and	I-NP	CC	O	14	NMOD
13	NF-kappaB2	NF-kappaB2	I-NP	NN	B-protein	14	NMOD
14	p100	p100	I-NP	NN	I-protein	18	NMOD
15	and	and	O	CC	O	18	NMOD
16	a	a	B-NP	DT	O	18	NMOD
17	moderate	moderate	I-NP	JJ	O	18	NMOD
18	increase	increase	I-NP	NN	O	8	PMOD
19	in	in	B-PP	IN	O	18	NMOD
20	NF-kappaB2	NF-kappaB2	B-NP	NN	B-protein	21	NMOD
21	p52	p52	I-NP	NN	I-protein	25	NMOD
22	and	and	O	CC	O	25	NMOD
23	RelA	RelA	B-NP	NN	B-protein	25	NMOD
24	(	(	O	(	I-protein	25	NMOD
25	p65	p65	B-NP	NN	I-protein	19	PMOD
26	)	)	O	)	I-protein	25	NMOD
27	were	be	B-VP	VBD	O	0	ROOT
28	detected	detect	I-VP	VBN	O	27	VC
29	in	in	B-PP	IN	O	28	VMOD
30	HIV-1-infected	HIV-1-infected	B-NP	JJ	B-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	29	PMOD
32	,	,	O	,	O	27	P
33	whereas	whereas	O	IN	O	27	VMOD
34	NF-kappaB1	NF-kappaB1	B-NP	NN	B-protein	36	NMOD
35	p105/p50	p105/p50	I-NP	NN	I-protein	36	NMOD
36	levels	level	I-NP	NNS	O	37	SUB
37	were	be	B-VP	VBD	O	33	SBAR
38	not	not	I-VP	RB	O	37	VMOD
39	altered	alter	I-VP	VBN	O	37	VC
40	relative	relative	B-ADVP	JJ	O	41	PMOD
41	to	to	B-PP	TO	O	39	VMOD
42	the	the	B-NP	DT	O	43	NMOD
43	levels	level	I-NP	NNS	O	41	PMOD
44	in	in	B-PP	IN	O	43	NMOD
45	uninfected	uninfected	B-NP	JJ	B-cell_type	46	NMOD
46	cells	cell	I-NP	NNS	I-cell_type	44	PMOD
47	.	.	O	.	O	27	P

1	Reverse	Reverse	B-NP	JJ	O	3	NMOD
2	transcription-PCR	transcription-PCR	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	all	all	B-NP	DT	O	10	NMOD
7	seven	seven	I-NP	CD	O	6	AMOD
8	EBV-positive	EBV-positive	I-NP	JJ	O	10	NMOD
9	tumour	tumour	I-NP	NN	O	10	NMOD
10	tissues	tissue	I-NP	NNS	O	12	SUB
11	constitutively	constitutively	B-ADVP	RB	O	12	VMOD
12	expressed	express	B-VP	VBD	O	5	SBAR
13	EBV	EBV	B-NP	NN	B-RNA	15	NMOD
14	nuclear	nuclear	I-NP	JJ	I-RNA	15	NMOD
15	antigen	antigen	I-NP	NN	I-RNA	20	NMOD
16	(	(	O	(	I-RNA	18	DEP
17	EBNA	EBNA	B-NP	NN	I-RNA	18	DEP
18	)	)	O	)	I-RNA	15	NMOD
19	1	1	B-NP	CD	I-RNA	20	NMOD
20	mRNA	mRNA	I-NP	NN	I-RNA	25	NMOD
21	,	,	B-NP	,	O	25	P
22	but	but	I-NP	CC	O	25	NMOD
23	not	not	I-NP	RB	O	22	DEP
24	EBNA2	EBNA2	B-VP	NN	B-RNA	25	NMOD
25	mRNA	mRNA	B-NP	NN	I-RNA	12	OBJ
26	.	.	O	.	O	4	P

1	by	by	B-PP	IN	O	8	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	both	both	O	CC	O	7	NMOD
5	Cp	Cp	B-NP	NN	B-DNA	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	Wp	Wp	B-NP	NN	B-DNA	8	SUB
8	were	be	B-VP	VBD	O	0	ROOT
9	silent	silent	B-ADJP	JJ	O	8	PRD
10	,	,	O	,	O	8	P
11	thus	thus	B-ADVP	RB	O	12	VMOD
12	resulting	result	B-VP	VBG	O	8	VMOD
13	in	in	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	lack	lack	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	EBNA2	EBNA2	B-NP	NN	B-RNA	18	NMOD
18	mRNA	mRNA	I-NP	NN	I-RNA	16	PMOD
19	.	.	O	.	O	8	P

1	however	however	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	neither	neither	O	CC	O	6	NMOD
4	LMP1	LMP1	B-NP	NN	B-protein	6	NMOD
5	nor	nor	O	CC	O	6	NMOD
6	LMP2B	LMP2B	B-NP	NN	B-RNA	7	NMOD
7	mRNA	mRNA	I-NP	NN	I-RNA	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	detected	detect	I-VP	VBN	O	8	VC
10	in	in	B-PP	IN	O	9	VMOD
11	any	any	B-NP	DT	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	tumours	tumour	I-NP	NNS	O	12	PMOD
15	tested	test	B-VP	VBN	O	14	NMOD
16	.	.	O	.	O	8	P

1	BZLF1	BZLF1	B-NP	NN	B-RNA	2	NMOD
2	mRNA	mRNA	I-NP	NN	I-RNA	9	NMOD
3	and	and	O	CC	O	9	NMOD
4	the	the	B-NP	DT	O	5	NMOD
5	product	product	I-NP	NN	O	9	NMOD
6	,	,	O	,	O	9	P
7	an	an	B-NP	DT	O	9	NMOD
8	immediate-early	immediate-early	I-NP	JJ	B-DNA	9	NMOD
9	gene	gene	I-NP	NN	I-DNA	14	SUB
10	for	for	B-PP	IN	O	9	NMOD
11	EBV	EBV	B-NP	NN	O	12	NMOD
12	replication	replication	I-NP	NN	O	10	PMOD
13	,	,	O	,	O	9	P
14	was	be	B-VP	VBD	O	0	ROOT
15	not	not	I-VP	RB	O	14	VMOD
16	expressed	express	I-VP	VBN	O	14	VC
17	in	in	B-PP	IN	O	16	VMOD
18	any	any	B-NP	DT	O	17	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	them	them	B-NP	PRP	O	19	PMOD
21	,	,	O	,	O	16	P
22	thereby	thereby	B-ADVP	RB	O	23	VMOD
23	suggesting	suggest	B-VP	VBG	O	16	VMOD
24	that	that	B-SBAR	IN	O	23	VMOD
25	the	the	B-NP	DT	O	27	NMOD
26	tumour	tumour	I-NP	NN	B-cell_type	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_type	28	SUB
28	carried	carry	B-VP	VBD	O	24	SBAR
29	EBV	EBV	B-NP	NN	B-DNA	30	NMOD
30	genomes	genome	I-NP	NNS	I-DNA	28	OBJ
31	in	in	B-PP	IN	O	28	VMOD
32	a	a	B-NP	DT	O	35	NMOD
33	tightly	tightly	I-NP	RB	O	34	AMOD
34	latent	latent	I-NP	JJ	O	35	NMOD
35	form	form	I-NP	NN	O	31	PMOD
36	.	.	O	.	O	14	P

1	An	An	B-NP	DT	O	3	NMOD
2	amino-terminal	amino-terminal	I-NP	JJ	B-protein	3	NMOD
3	fragment	fragment	I-NP	NN	I-protein	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	OCA-B	OCA-B	B-NP	NN	B-protein	4	PMOD
6	binds	bind	B-VP	VBZ	O	0	ROOT
7	the	the	B-NP	DT	O	9	NMOD
8	octamer	octamer	I-NP	NN	B-DNA	9	NMOD
9	site	site	I-NP	NN	I-DNA	6	OBJ
10	in	in	B-PP	IN	O	6	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	absence	absence	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	a	a	B-NP	DT	O	16	NMOD
15	POU	POU	I-NP	NN	B-DNA	16	NMOD
16	domain	domain	I-NP	NN	I-DNA	13	PMOD
17	with	with	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	same	same	I-NP	JJ	O	21	NMOD
20	sequence	sequence	I-NP	NN	O	21	NMOD
21	specificity	specificity	I-NP	NN	O	17	PMOD
22	.	.	O	.	O	6	P

1	Southern	Southern	B-NP	NN	O	3	NMOD
2	blot	blot	I-NP	NN	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	rearrangement	rearrangement	B-NP	NN	O	4	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	BCL6	BCL6	B-NP	NN	B-protein	13	NMOD
8	,	,	O	,	O	13	P
9	JH	JH	B-NP	NN	B-protein	13	NMOD
10	,	,	O	,	O	13	P
11	and	and	O	CC	O	13	NMOD
12	TCR	TCR	B-NP	NN	B-protein	13	NMOD
13	beta	beta	I-NP	NN	I-protein	6	PMOD
14	but	but	B-PP	CC	O	6	PMOD
15	not	not	B-PP	RB	O	16	PMOD
16	of	of	I-PP	IN	O	6	PMOD
17	TCR	TCR	B-NP	NN	B-protein	18	NMOD
18	delta	delta	I-NP	NN	I-protein	16	PMOD
19	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	a	a	B-NP	DT	O	7	NMOD
5	cysteine	cysteine	I-NP	NN	O	7	NMOD
6	protease	protease	I-NP	NN	O	7	NMOD
7	inhibitor	inhibitor	I-NP	NN	O	12	SUB
8	that	that	B-NP	WDT	O	7	NMOD
9	also	also	B-ADVP	RB	O	10	VMOD
10	blocks	block	B-VP	VBZ	O	8	SBAR
11	apoptosis	apoptosis	B-NP	NN	O	10	OBJ
12	had	have	B-VP	VBD	O	0	ROOT
13	no	no	B-NP	DT	O	15	NMOD
14	substantial	substantial	I-NP	JJ	O	15	NMOD
15	affect	affect	I-NP	NN	O	12	OBJ
16	upon	upon	B-PP	IN	O	12	VMOD
17	cytokine	cytokine	B-NP	NN	B-protein	18	NMOD
18	production	production	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	8	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	ligand	ligand	B-NP	NN	O	5	NMOD
5	activation	activation	I-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	c-Kit	c-Kit	B-NP	NN	B-protein	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	unable	unable	B-ADJP	JJ	O	8	PRD
10	to	to	B-VP	TO	O	11	VMOD
11	induce	induce	I-VP	VB	O	9	AMOD
12	any	any	B-NP	DT	O	11	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	these	these	B-NP	DT	O	15	NMOD
15	effects	effect	I-NP	NNS	O	13	PMOD
16	in	in	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	19	NMOD
18	same	same	I-NP	JJ	O	19	NMOD
19	cells	cell	I-NP	NNS	O	16	PMOD
20	.	.	O	.	O	8	P

1	Activation	Activation	B-NP	NN	O	6	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	5	NMOD
4	erythropoietin	erythropoietin	I-NP	NN	B-protein	5	NMOD
5	receptor	receptor	I-NP	NN	I-protein	2	PMOD
6	caused	cause	B-VP	VBD	O	0	ROOT
7	specific	specific	B-NP	JJ	O	8	NMOD
8	DNA-binding	DNA-binding	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	Stat	Stat	B-NP	NN	B-protein	11	NMOD
11	5b	5b	I-NP	NN	I-protein	9	PMOD
12	,	,	O	,	O	6	P
13	but	but	O	CC	O	6	VMOD
14	failed	fail	B-VP	VBD	O	6	VMOD
15	to	to	I-VP	TO	O	16	VMOD
16	induce	induce	I-VP	VB	O	14	VMOD
17	reporter	reporter	B-NP	NN	B-DNA	19	NMOD
18	gene	gene	I-NP	NN	I-DNA	19	NMOD
19	transcription	transcription	I-NP	NN	O	16	OBJ
20	.	.	O	.	O	6	P

1	IL13	IL13	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	unable	unable	B-ADJP	JJ	O	2	PRD
4	to	to	B-VP	TO	O	5	VMOD
5	activate	activate	I-VP	VB	O	3	AMOD
6	JAK1	JAK1	B-NP	NN	B-protein	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	JAK3	JAK3	I-NP	NN	B-protein	5	OBJ
9	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	Id	Id	I-NP	NN	B-protein	3	NMOD
3	family	family	I-NP	NN	I-protein	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	helix-loop-helix	helix-loop-helix	B-NP	JJ	B-protein	6	NMOD
6	proteins	protein	I-NP	NNS	I-protein	4	PMOD
7	function	function	B-VP	VBP	O	0	ROOT
8	as	as	B-SBAR	IN	O	7	VMOD
9	negative	negative	B-NP	JJ	O	10	NMOD
10	regulators	regulator	I-NP	NNS	O	17	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	DNA	DNA	B-NP	NN	O	13	NMOD
13	binding	binding	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	17	P
15	basic	basic	B-NP	JJ	B-protein	17	NMOD
16	helix-loop-helix	helix-loop-helix	I-NP	JJ	I-protein	17	NMOD
17	proteins	protein	I-NP	NNS	I-protein	8	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	regulation	regulation	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	cell	cell	B-NP	NN	O	21	PMOD
23	growth	growth	B-NP	NN	O	25	NMOD
24	and	and	O	CC	O	25	NMOD
25	differentiation	differentiation	B-NP	NN	O	22	NMOD
26	.	.	O	.	O	7	P

1	Multifactor	Multifactor	B-NP	NN	O	4	NMOD
2	cis-dominant	cis-dominant	I-NP	JJ	O	4	NMOD
3	negative	negative	I-NP	JJ	O	4	NMOD
4	regulation	regulation	I-NP	NN	O	0	ROOT
5	of	of	B-PP	IN	O	4	NMOD
6	IL-2	IL-2	B-NP	NN	B-DNA	8	NMOD
7	gene	gene	I-NP	NN	I-DNA	8	NMOD
8	expression	expression	I-NP	NN	O	5	PMOD
9	in	in	B-PP	IN	O	4	NMOD
10	anergized	anergize	B-NP	VBN	B-cell_type	12	NMOD
11	T	T	I-NP	NN	I-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	9	PMOD
13	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	molecular	molecular	I-NP	JJ	O	3	NMOD
3	mechanism	mechanism	I-NP	NN	O	13	SUB
4	underlying	underlie	B-VP	VBG	O	3	NMOD
5	IL-2	IL-2	B-NP	NN	B-protein	7	NMOD
6	transcriptional	transcriptional	I-NP	JJ	O	7	NMOD
7	blockade	blockade	I-NP	NN	O	4	OBJ
8	in	in	B-PP	IN	O	7	NMOD
9	anergic	anergic	B-NP	JJ	B-cell_line	12	NMOD
10	T	T	I-NP	NN	I-cell_line	12	NMOD
11	cell	cell	I-NP	NN	I-cell_line	12	NMOD
12	clones	clone	I-NP	NNS	I-cell_line	8	PMOD
13	is	be	B-VP	VBZ	O	0	ROOT
14	not	not	I-VP	RB	O	13	VMOD
15	fully	fully	I-VP	RB	O	13	VMOD
16	understood	understand	I-VP	VBN	O	13	VC
17	.	.	O	.	O	13	P

1	To	To	B-VP	TO	O	2	VMOD
2	examine	examine	I-VP	VB	O	12	VMOD
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	an	an	B-NP	DT	O	8	NMOD
5	active	active	I-NP	JJ	O	8	NMOD
6	negative	negative	I-NP	JJ	O	8	NMOD
7	regulatory	regulatory	I-NP	JJ	O	8	NMOD
8	process	process	I-NP	NN	O	9	SUB
9	occurs	occur	B-VP	VBZ	O	3	SBAR
10	,	,	O	,	O	12	P
11	we	we	B-NP	PRP	O	12	SUB
12	created	create	B-VP	VBD	O	0	ROOT
13	a	a	B-NP	DT	O	15	NMOD
14	reporter	reporter	I-NP	NN	B-DNA	15	NMOD
15	construct	construct	I-NP	NN	I-DNA	12	OBJ
16	containing	contain	B-VP	VBG	O	15	NMOD
17	as	as	B-PP	IN	O	16	VMOD
18	an	an	B-NP	DT	O	19	NMOD
19	enhancer	enhancer	I-NP	NN	O	17	PMOD
20	four	four	B-NP	CD	O	21	NMOD
21	copies	copy	I-NP	NNS	O	28	NMOD
22	of	of	B-PP	IN	O	21	NMOD
23	the	the	B-NP	DT	O	25	NMOD
24	NF-AT	NF-AT	I-NP	NN	B-DNA	25	NMOD
25	site	site	I-NP	NN	I-DNA	22	PMOD
26	and	and	O	CC	O	28	NMOD
27	one	one	B-NP	CD	O	28	NMOD
28	copy	copy	I-NP	NN	O	16	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	the	the	B-NP	DT	O	32	NMOD
31	octamer	octamer	I-NP	NN	B-DNA	32	NMOD
32	site	site	I-NP	NN	I-DNA	29	PMOD
33	(	(	O	(	O	36	DEP
34	4X	4X	B-NP	NN	B-DNA	35	NMOD
35	NF-AT-Oct	NF-AT-Oct	I-NP	NN	I-DNA	36	DEP
36	)	)	O	)	O	32	NMOD
37	.	.	O	.	O	12	P

1	Addition	Addition	B-NP	NN	O	13	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	-176	-176	I-NP	CD	B-DNA	6	NMOD
5	to	to	I-NP	TO	I-DNA	6	NMOD
6	-96	-96	I-NP	CD	I-DNA	7	NMOD
7	sequence	sequence	I-NP	NN	I-DNA	2	PMOD
8	to	to	B-PP	TO	O	1	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	4X	4X	I-NP	NN	B-DNA	12	NMOD
11	NF-AT-Oct	NF-AT-Oct	I-NP	NN	I-DNA	12	NMOD
12	construct	construct	I-NP	NN	I-DNA	8	PMOD
13	did	do	B-VP	VBD	O	32	VMOD
14	not	not	I-VP	RB	O	13	VMOD
15	impart	impart	I-VP	VB	O	13	VC
16	the	the	B-NP	DT	O	17	NMOD
17	ability	ability	I-NP	NN	O	15	OBJ
18	to	to	B-VP	TO	O	19	VMOD
19	be	be	I-VP	VB	O	17	NMOD
20	affected	affect	I-VP	VBN	O	19	VC
21	by	by	B-PP	IN	O	20	VMOD
22	anergy	anergy	B-NP	NN	O	21	PMOD
23	,	,	O	,	O	32	P
24	but	but	O	CC	O	32	VMOD
25	addition	addition	B-NP	NN	O	32	SUB
26	of	of	B-PP	IN	O	25	NMOD
27	the	the	B-NP	DT	O	31	NMOD
28	-236	-236	I-NP	CD	B-DNA	30	NMOD
29	to	to	I-NP	TO	I-DNA	30	NMOD
30	-96	-96	I-NP	CD	I-DNA	31	NMOD
31	sequence	sequence	I-NP	NN	I-DNA	26	PMOD
32	did	do	B-VP	VBD	O	0	ROOT
33	,	,	O	,	O	32	P
34	demonstrating	demonstrate	B-VP	VBG	O	32	VMOD
35	that	that	B-SBAR	IN	O	43	DEP
36	anergy	anergy	B-NP	NN	O	37	SUB
37	is	be	B-VP	VBZ	O	35	SBAR
38	an	an	B-NP	DT	O	41	NMOD
39	active	active	I-NP	JJ	O	41	NMOD
40	inhibitory	inhibitory	I-NP	JJ	O	41	NMOD
41	process	process	I-NP	NN	O	37	PRD
42	and	and	O	CC	O	43	DEP
43	that	that	B-SBAR	IN	O	34	VMOD
44	more	more	B-NP	JJR	O	59	SUB
45	than	than	B-PP	IN	O	44	NMOD
46	the	the	B-NP	DT	O	47	NMOD
47	presence	presence	I-NP	NN	O	45	PMOD
48	of	of	B-PP	IN	O	47	NMOD
49	the	the	B-NP	DT	O	53	NMOD
50	-150	-150	I-NP	CD	B-DNA	53	NMOD
51	AP-1	AP-1	I-NP	NN	I-DNA	53	NMOD
52	binding	binding	I-NP	NN	I-DNA	53	NMOD
53	site	site	I-NP	NN	I-DNA	48	PMOD
54	(	(	O	(	O	58	DEP
55	-152	-152	B-NP	CD	B-DNA	57	NMOD
56	to	to	O	TO	I-DNA	57	NMOD
57	-147	-147	B-NP	CD	I-DNA	58	DEP
58	)	)	O	)	O	53	NMOD
59	is	be	B-VP	VBZ	O	43	SBAR
60	required	require	I-VP	VBN	O	59	VC
61	to	to	I-VP	TO	O	62	VMOD
62	mediate	mediate	I-VP	VB	O	60	VMOD
63	the	the	B-NP	DT	O	64	NMOD
64	effect	effect	I-NP	NN	O	62	OBJ
65	.	.	O	.	O	32	P

1	Because	Because	B-SBAR	IN	O	12	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	-180	-180	I-NP	CD	B-DNA	4	NMOD
4	site	site	I-NP	NN	I-DNA	5	SUB
5	is	be	B-VP	VBZ	O	1	SBAR
6	not	not	I-VP	RB	O	5	VMOD
7	required	require	I-VP	VBN	O	5	VC
8	for	for	B-PP	IN	O	7	VMOD
9	trans-activation	trans-activation	B-NP	NN	O	8	PMOD
10	,	,	O	,	O	12	P
11	it	it	B-NP	PRP	O	12	SUB
12	was	be	B-VP	VBD	O	0	ROOT
13	possible	possible	B-ADJP	JJ	O	12	PRD
14	to	to	B-VP	TO	O	15	VMOD
15	confirm	confirm	I-VP	VB	O	12	VMOD
16	by	by	B-PP	IN	O	15	VMOD
17	mutation	mutation	B-NP	NN	O	16	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	23	NMOD
20	normal	normal	I-NP	JJ	O	23	NMOD
21	mouse	mouse	I-NP	NN	B-DNA	23	NMOD
22	IL-2	IL-2	I-NP	NN	I-DNA	23	NMOD
23	enhancer	enhancer	I-NP	NN	I-DNA	18	PMOD
24	that	that	B-SBAR	IN	O	17	NMOD
25	this	this	B-NP	DT	O	26	NMOD
26	site	site	I-NP	NN	O	27	SUB
27	is	be	B-VP	VBZ	O	24	SBAR
28	absolutely	absolutely	B-ADJP	RB	O	29	AMOD
29	essential	essential	I-ADJP	JJ	O	27	PRD
30	for	for	B-PP	IN	O	29	AMOD
31	anergy	anergy	B-NP	NN	O	32	NMOD
32	induction	induction	I-NP	NN	O	30	PMOD
33	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	simplest	simple	I-NP	JJS	O	3	NMOD
3	model	model	I-NP	NN	O	8	SUB
4	to	to	B-VP	TO	O	5	VMOD
5	explain	explain	I-VP	VB	O	3	NMOD
6	these	these	B-NP	DT	O	7	NMOD
7	results	result	I-NP	NNS	O	5	OBJ
8	is	be	B-VP	VBZ	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	PRD
10	anergy	anergy	B-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	9	SBAR
12	mediated	mediate	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	15	NMOD
15	complex	complex	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	multiple	multiple	B-NP	JJ	O	19	NMOD
18	transcription	transcription	I-NP	NN	B-protein	19	NMOD
19	factors	factor	I-NP	NNS	I-protein	16	PMOD
20	that	that	B-NP	WDT	O	19	NMOD
21	exert	exert	B-VP	VBP	O	20	SBAR
22	a	a	B-NP	DT	O	27	NMOD
23	cis-acting	cis-acting	I-NP	JJ	O	27	NMOD
24	dominant	dominant	I-NP	JJ	O	27	NMOD
25	negative	negative	I-NP	JJ	O	27	NMOD
26	regulatory	regulatory	I-NP	JJ	O	27	NMOD
27	effect	effect	I-NP	NN	O	21	OBJ
28	on	on	B-PP	IN	O	21	VMOD
29	the	the	B-NP	DT	O	30	NMOD
30	trans-activation	trans-activation	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	the	the	B-NP	DT	O	34	NMOD
33	IL-2	IL-2	I-NP	NN	B-DNA	34	NMOD
34	gene	gene	I-NP	NN	I-DNA	31	PMOD
35	.	.	O	.	O	8	P

1	Stepwise	Stepwise	B-NP	JJ	O	2	NMOD
2	deletions	deletion	I-NP	NNS	O	8	SUB
3	into	into	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	proximal	proximal	I-NP	JJ	B-DNA	6	NMOD
6	promoter	promoter	I-NP	NN	I-DNA	3	PMOD
7	also	also	B-ADVP	RB	O	8	VMOD
8	revealed	reveal	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	the	the	B-NP	DT	O	12	NMOD
11	CBF	CBF	I-NP	NN	B-DNA	12	NMOD
12	site	site	I-NP	NN	I-DNA	18	NMOD
13	,	,	O	,	O	18	P
14	but	but	B-CONJP	CC	O	18	NMOD
15	not	not	I-CONJP	RB	O	14	DEP
16	the	the	B-NP	DT	O	18	NMOD
17	YY-1	YY-1	I-NP	NN	B-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	20	SUB
19	,	,	O	,	O	18	P
20	was	be	B-VP	VBD	O	9	SBAR
21	required	require	I-VP	VBN	O	20	VC
22	for	for	B-PP	IN	O	21	VMOD
23	efficient	efficient	B-NP	JJ	O	24	NMOD
24	induction	induction	I-NP	NN	O	22	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	transcriptional	transcriptional	B-NP	JJ	O	27	NMOD
27	activation	activation	I-NP	NN	O	25	PMOD
28	.	.	O	.	O	8	P

1	This	This	B-NP	DT	O	2	NMOD
2	abnormality	abnormality	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	seen	see	I-VP	VBN	O	3	VC
6	in	in	B-PP	IN	O	5	VMOD
7	resting	rest	B-NP	VBG	B-cell_type	9	NMOD
8	T	T	I-NP	NN	I-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	12	NMOD
10	nor	nor	O	CC	O	12	NMOD
11	T	T	B-NP	NN	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	6	PMOD
13	from	from	B-PP	IN	O	12	NMOD
14	patients	patient	B-NP	NNS	O	13	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	systemic	systemic	B-NP	JJ	O	18	NMOD
17	lupus	lupus	I-NP	NN	O	18	NMOD
18	erythematosus	erythematosus	I-NP	NN	O	15	PMOD
19	,	,	O	,	O	5	P
20	rheumatoid	rheumatoid	B-NP	JJ	O	21	NMOD
21	arthritis	arthritis	I-NP	NN	O	27	NMOD
22	(	(	O	(	O	24	DEP
23	RA	RA	B-NP	NN	O	24	DEP
24	)	)	O	)	O	21	NMOD
25	,	,	O	,	O	27	P
26	or	or	O	CC	O	27	NMOD
27	SS	SS	B-NP	NN	O	5	VMOD
28	accompanied	accompany	B-VP	VBN	O	27	NMOD
29	by	by	B-PP	IN	O	28	VMOD
30	RA	RA	B-NP	NN	O	29	PMOD
31	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	7	VMOD
2	both	both	B-NP	DT	O	4	NMOD
3	childrens	children	I-NP	NNS	O	4	NMOD
4	'	'	B-NP	POS	O	6	NMOD
5	T	T	I-NP	NN	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	7	SUB
7	were	be	B-VP	VBD	O	0	ROOT
8	unable	unable	B-ADJP	JJ	O	7	PRD
9	to	to	B-VP	TO	O	10	VMOD
10	produce	produce	I-VP	VB	O	8	AMOD
11	the	the	B-NP	DT	O	12	NMOD
12	cytokines	cytokine	I-NP	NNS	B-protein	10	OBJ
13	IL-2	IL-2	I-NP	NN	B-protein	24	NMOD
14	,	,	O	,	O	24	P
15	interferon-gamma	interferon-gamma	B-NP	NN	B-protein	24	NMOD
16	(	(	O	(	O	18	DEP
17	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	18	DEP
18	)	)	O	)	O	15	NMOD
19	,	,	O	,	O	24	P
20	IL-4	IL-4	B-NP	NN	B-protein	24	NMOD
21	and	and	O	CC	O	24	NMOD
22	tumor	tumor	B-NP	NN	B-protein	24	NMOD
23	necrosis	necrosis	I-NP	NN	I-protein	24	NMOD
24	factor-alpha	factor-alpha	I-NP	NN	I-protein	12	NMOD
25	(	(	O	(	O	27	DEP
26	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	27	DEP
27	)	)	O	)	O	24	NMOD
28	.	.	O	.	O	7	P

1	This	This	B-NP	DT	O	5	NMOD
2	multiple	multiple	I-NP	JJ	O	5	NMOD
3	cytokine	cytokine	I-NP	NN	B-protein	5	NMOD
4	production	production	I-NP	NN	O	5	NMOD
5	deficiency	deficiency	I-NP	NN	O	6	SUB
6	could	could	B-VP	MD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	be	be	I-VP	VB	O	6	VC
9	restored	restore	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	IL-2	IL-2	B-NP	NN	B-protein	14	NMOD
12	or	or	O	CC	O	14	NMOD
13	co-stimulatory	co-stimulatory	B-NP	JJ	O	14	NMOD
14	signals	signal	I-NP	NNS	O	10	PMOD
15	provided	provide	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	antigen-presenting	antigen-presenting	B-NP	JJ	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
19	(	(	O	(	O	21	DEP
20	APC	APC	B-NP	NN	B-cell_type	21	DEP
21	)	)	O	)	O	18	NMOD
22	.	.	O	.	O	6	P

1	Moreover	Moreover	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	mRNA	mRNA	B-NP	NN	B-RNA	8	SUB
4	for	for	B-PP	IN	O	3	NMOD
5	IL-2	IL-2	B-NP	NN	B-protein	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	IFN-gamma	IFN-gamma	I-NP	NN	B-protein	4	PMOD
8	could	could	B-VP	MD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	be	be	I-VP	VB	O	8	VC
11	detected	detect	I-VP	VBN	O	10	VC
12	.	.	O	.	O	8	P

1	To	To	B-VP	TO	O	2	VMOD
2	determine	determine	I-VP	VB	O	34	VMOD
3	whether	whether	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	6	NMOD
5	functional	functional	I-NP	JJ	O	6	NMOD
6	defect	defect	I-NP	NN	O	13	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	10	NMOD
9	patients	patient	I-NP	NNS	O	10	NMOD
10	'	'	B-NP	POS	O	12	NMOD
11	T	T	I-NP	NN	B-cell_type	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
13	was	be	B-VP	VBD	O	3	SBAR
14	due	due	B-ADJP	JJ	O	15	PMOD
15	to	to	B-PP	TO	O	13	PRD
16	the	the	B-NP	DT	O	20	NMOD
17	absence	absence	I-NP	NN	O	20	NMOD
18	or	or	O	CC	O	20	NMOD
19	abnormal	abnormal	B-NP	JJ	O	20	NMOD
20	binding	binding	I-NP	NN	O	15	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	transcription	transcription	B-NP	NN	B-protein	23	NMOD
23	factors	factor	I-NP	NNS	I-protein	21	PMOD
24	involved	involve	B-VP	VBN	O	23	NMOD
25	in	in	B-PP	IN	O	24	VMOD
26	cytokine	cytokine	B-NP	NN	B-DNA	28	NMOD
27	gene	gene	I-NP	NN	I-DNA	28	NMOD
28	expression	expression	I-NP	NN	O	25	PMOD
29	,	,	O	,	O	34	P
30	electrophoretic	electrophoretic	B-NP	JJ	O	33	NMOD
31	mobility	mobility	I-NP	NN	O	33	NMOD
32	shift	shift	I-NP	NN	O	33	NMOD
33	assays	assay	I-NP	NNS	O	34	SUB
34	were	be	B-VP	VBD	O	0	ROOT
35	used	use	I-VP	VBN	O	34	VC
36	to	to	B-VP	TO	O	37	VMOD
37	examine	examine	I-VP	VB	O	35	VMOD
38	the	the	B-NP	DT	O	40	NMOD
39	DNA	DNA	I-NP	NN	O	40	NMOD
40	binding	binding	I-NP	NN	O	37	OBJ
41	of	of	B-PP	IN	O	40	NMOD
42	AP-1	AP-1	B-NP	NN	B-protein	59	NMOD
43	,	,	O	,	O	59	P
44	Oct	Oct	B-NP	NN	B-protein	59	NMOD
45	,	,	O	,	O	59	P
46	CREB	CREB	B-NP	NN	B-protein	59	NMOD
47	,	,	O	,	O	59	P
48	SP1	SP1	B-NP	NN	B-protein	59	NMOD
49	,	,	O	,	O	59	P
50	NF-kappa	NF-kappa	B-NP	NN	B-protein	51	NMOD
51	B	B	I-NP	NN	I-protein	59	NMOD
52	and	and	O	CC	O	59	NMOD
53	the	the	B-NP	DT	O	59	NMOD
54	nuclear	nuclear	I-NP	JJ	B-protein	59	NMOD
55	factor	factor	I-NP	NN	I-protein	59	NMOD
56	of	of	B-PP	IN	I-protein	59	NMOD
57	activated	activate	B-NP	VBN	I-protein	59	NMOD
58	T	T	I-NP	NN	I-protein	59	NMOD
59	cells	cell	I-NP	NNS	I-protein	41	PMOD
60	(	(	O	(	O	62	DEP
61	NF-AT	NF-AT	B-NP	NN	B-protein	62	DEP
62	)	)	O	)	O	59	NMOD
63	to	to	B-PP	TO	O	40	NMOD
64	their	their	B-NP	PRP$	O	67	NMOD
65	respective	respective	I-NP	JJ	O	67	NMOD
66	response	response	I-NP	NN	O	67	NMOD
67	elements	element	I-NP	NNS	O	63	PMOD
68	in	in	B-PP	IN	O	67	NMOD
69	the	the	B-NP	DT	O	70	NMOD
70	promoter	promoter	I-NP	NN	B-DNA	68	PMOD
71	of	of	B-PP	IN	O	70	NMOD
72	the	the	B-NP	DT	O	74	NMOD
73	IL-2	IL-2	I-NP	NN	B-DNA	74	NMOD
74	gene	gene	I-NP	NN	I-DNA	71	PMOD
75	.	.	O	.	O	34	P

1	Mature	Mature	B-NP	JJ	B-cell_type	3	NMOD
2	human	human	I-NP	JJ	I-cell_type	3	NMOD
3	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	unique	unique	B-NP	JJ	O	6	NMOD
6	targets	target	I-NP	NNS	O	4	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	1	1	B-NP	CD	O	12	NMOD
9	alpha	alpha	B-NP	SYM	O	12	NMOD
10	,	,	O	,	O	12	P
11	25-dihydroxyvitamin	25-dihydroxyvitamin	B-NP	NN	O	12	NMOD
12	D3	D3	I-NP	NN	O	7	PMOD
13	(	(	O	(	O	22	DEP
14	1	1	B-NP	CD	O	21	NMOD
15	alpha	alpha	O	SYM	O	21	NMOD
16	,	,	O	,	O	21	P
17	25	25	B-NP	CD	O	21	NMOD
18	(	(	O	(	O	20	DEP
19	OH	OH	B-NP	NN	O	20	DEP
20	)	)	O	)	O	17	NMOD
21	2D3	2D3	B-NP	NN	O	22	DEP
22	)	)	O	)	O	12	NMOD
23	in	in	B-PP	IN	O	4	VMOD
24	that	that	B-NP	IN	O	23	PMOD
25	vitamin	vitamin	B-NP	NN	B-protein	27	NMOD
26	D	D	I-NP	NN	I-protein	27	NMOD
27	receptors	receptor	I-NP	NNS	I-protein	31	SUB
28	(	(	O	(	O	30	DEP
29	VDR	VDR	B-NP	NN	B-protein	30	DEP
30	)	)	O	)	O	27	NMOD
31	are	be	B-VP	VBP	O	41	VMOD
32	not	not	I-VP	RB	O	31	VMOD
33	constitutively	constitutively	I-VP	RB	O	31	VMOD
34	expressed	express	I-VP	VBN	O	31	VC
35	,	,	O	,	O	41	P
36	and	and	O	CC	O	41	VMOD
37	specific	specific	B-NP	JJ	O	40	NMOD
38	cellular	cellular	I-NP	JJ	O	40	NMOD
39	activation	activation	I-NP	NN	O	40	NMOD
40	signals	signal	I-NP	NNS	O	41	SUB
41	are	be	B-VP	VBP	O	24	SBAR
42	required	require	I-VP	VBN	O	41	VC
43	for	for	B-PP	IN	O	42	VMOD
44	both	both	O	CC	O	46	NMOD
45	the	the	B-NP	DT	O	46	NMOD
46	up-regulation	up-regulation	I-NP	NN	O	50	NMOD
47	of	of	B-PP	IN	O	46	NMOD
48	VDR	VDR	B-NP	NN	B-protein	47	PMOD
49	and	and	I-NP	CC	O	50	NMOD
50	establishment	establishment	I-NP	NN	O	43	PMOD
51	of	of	B-PP	IN	O	50	NMOD
52	reactivity	reactivity	B-NP	NN	O	51	PMOD
53	to	to	B-PP	TO	O	52	NMOD
54	the	the	B-NP	DT	O	56	NMOD
55	lipophilic	lipophilic	I-NP	JJ	O	56	NMOD
56	ligand	ligand	I-NP	NN	O	53	PMOD
57	.	.	O	.	O	4	P

1	Treatment	Treatment	B-NP	NN	O	20	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	B	B	B-NP	NN	B-cell_type	4	NMOD
4	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	cytokine	cytokine	I-NP	NN	B-protein	8	NMOD
8	IL-4	IL-4	I-NP	NN	B-protein	5	PMOD
9	(	(	O	(	O	11	DEP
10	IL-4	IL-4	B-NP	NN	B-protein	11	DEP
11	)	)	O	)	O	8	NMOD
12	,	,	O	,	O	1	P
13	in	in	B-PP	IN	O	1	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	absence	absence	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	prior	prior	B-NP	JJ	O	18	NMOD
18	activation	activation	I-NP	NN	O	16	PMOD
19	,	,	O	,	O	1	P
20	induces	induce	B-VP	VBZ	O	0	ROOT
21	a	a	B-NP	DT	O	23	NMOD
22	weak	weak	I-NP	JJ	O	23	NMOD
23	up-regulation	up-regulation	I-NP	NN	O	20	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	VDR	VDR	B-NP	NN	B-protein	26	NMOD
26	expression	expression	I-NP	NN	O	24	PMOD
27	but	but	O	CC	O	20	VMOD
28	fails	fail	B-VP	VBZ	O	20	VMOD
29	to	to	I-VP	TO	O	30	VMOD
30	generate	generate	I-VP	VB	O	28	VMOD
31	vitamin	vitamin	B-NP	NN	B-protein	33	NMOD
32	D-responsive	D-responsive	I-NP	JJ	I-protein	31	AMOD
33	element	element	I-NP	NN	I-protein	35	AMOD
34	(	(	O	(	I-protein	35	AMOD
35	VDRE	VDRE	B-NP	NN	I-protein	40	NMOD
36	)	)	O	)	I-protein	35	AMOD
37	-reactive	-reactive	B-NP	JJ	I-protein	35	AMOD
38	nuclear	nuclear	I-NP	JJ	I-protein	40	NMOD
39	protein	protein	I-NP	NN	I-protein	40	NMOD
40	complexes	complex	I-NP	NNS	I-protein	30	OBJ
41	or	or	O	CC	O	30	VMOD
42	to	to	B-VP	TO	O	43	VMOD
43	initiate	initiate	I-VP	VB	O	30	VMOD
44	the	the	B-NP	DT	O	46	NMOD
45	genomic	genomic	I-NP	JJ	O	46	NMOD
46	transcription	transcription	I-NP	NN	O	43	OBJ
47	of	of	B-PP	IN	O	46	NMOD
48	25-hydroxyvitamin	25-hydroxyvitamin	B-NP	NN	B-protein	50	NMOD
49	D3	D3	I-NP	NN	I-protein	50	NMOD
50	24-hydroxylase	24-hydroxylase	I-NP	NN	I-protein	47	PMOD
51	.	.	O	.	O	20	P

1	However	However	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	this	this	B-NP	DT	O	5	NMOD
4	apparent	apparent	I-NP	JJ	O	5	NMOD
5	lack	lack	I-NP	NN	O	11	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	response	response	B-NP	NN	O	6	PMOD
8	to	to	B-PP	TO	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	secosterol	secosterol	I-NP	NN	O	8	PMOD
11	can	can	B-VP	MD	O	0	ROOT
12	be	be	I-VP	VB	O	11	VC
13	overcome	overcome	I-VP	VBN	O	12	VC
14	by	by	B-PP	IN	O	13	VMOD
15	stimulation	stimulation	B-NP	NN	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	B	B	B-NP	NN	B-cell_type	18	NMOD
18	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD
19	with	with	B-PP	IN	O	15	NMOD
20	a	a	B-NP	DT	O	21	NMOD
21	combination	combination	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	these	these	B-NP	DT	O	26	NMOD
24	cellular	cellular	I-NP	JJ	O	26	NMOD
25	activation	activation	I-NP	NN	O	26	NMOD
26	signals	signal	I-NP	NNS	O	22	PMOD
27	,	,	O	,	O	26	P
28	which	which	B-NP	WDT	O	26	NMOD
29	are	be	B-VP	VBP	O	28	SBAR
30	sufficient	sufficient	B-ADJP	JJ	O	29	PRD
31	to	to	B-VP	TO	O	32	VMOD
32	lead	lead	I-VP	VB	O	30	AMOD
33	to	to	B-PP	TO	O	32	VMOD
34	G1	G1	B-NP	NN	O	37	NMOD
35	cell	cell	I-NP	NN	O	37	NMOD
36	cycle	cycle	I-NP	NN	O	37	NMOD
37	progression	progression	I-NP	NN	O	33	PMOD
38	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	9	VMOD
2	A20	A20	B-NP	NN	B-cell_line	4	NMOD
3	B	B	I-NP	NN	I-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD
5	,	,	O	,	O	9	P
6	the	the	B-NP	DT	O	8	NMOD
7	TNF-alpha	TNF-alpha	I-NP	NN	B-DNA	8	NMOD
8	gene	gene	I-NP	NN	I-DNA	9	SUB
9	is	be	B-VP	VBZ	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	regulated	regulate	I-VP	VBN	O	9	VC
12	by	by	B-PP	IN	O	11	VMOD
13	NFATp	NFATp	B-NP	NN	B-protein	12	PMOD
14	bound	bind	B-VP	VBD	O	13	NMOD
15	to	to	B-PP	TO	O	14	VMOD
16	the	the	B-NP	DT	O	19	NMOD
17	kappa	kappa	I-NP	NN	B-DNA	19	NMOD
18	3	3	I-NP	CD	I-DNA	19	NMOD
19	element	element	I-NP	NN	I-DNA	15	PMOD
20	.	.	O	.	O	9	P

1	Changes	Change	B-NP	NNS	O	10	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	any	any	B-NP	DT	O	5	NMOD
4	cysteine	cysteine	I-NP	NN	O	5	NMOD
5	residue	residue	I-NP	NN	O	2	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	9	NMOD
8	hRAR	hRAR	I-NP	NN	B-protein	9	NMOD
9	alpha-LBD	alpha-LBD	I-NP	NN	I-protein	6	PMOD
10	had	have	B-VP	VBD	O	0	ROOT
11	no	no	B-NP	DT	O	13	NMOD
12	significant	significant	I-NP	JJ	O	13	NMOD
13	influence	influence	I-NP	NN	O	10	OBJ
14	on	on	B-PP	IN	O	10	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	binding	binding	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	all-trans	all-trans	B-NP	JJ	O	19	NMOD
19	RA	RA	I-NP	NN	O	22	NMOD
20	or	or	O	CC	O	22	NMOD
21	9-cis	9-cis	B-NP	JJ	O	22	NMOD
22	RA	RA	I-NP	NN	O	17	PMOD
23	.	.	O	.	O	10	P

1	For	For	B-PP	IN	O	11	VMOD
2	all	all	B-NP	DT	O	5	NMOD
3	other	other	I-NP	JJ	O	5	NMOD
4	arginine	arginine	I-NP	NN	O	5	NMOD
5	mutations	mutation	I-NP	NNS	O	1	PMOD
6	,	,	O	,	O	11	P
7	no	no	B-NP	DT	O	8	NMOD
8	differences	difference	I-NP	NNS	O	11	SUB
9	in	in	B-PP	IN	O	8	NMOD
10	affinity	affinity	B-NP	NN	O	9	PMOD
11	were	be	B-VP	VBD	O	0	ROOT
12	detectable	detectable	B-ADJP	JJ	O	11	PRD
13	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	3	NMOD
2	two	two	I-NP	CD	O	3	NMOD
3	mutations	mutation	I-NP	NNS	O	7	SUB
4	R217A	R217A	I-NP	NN	O	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	R294A	R294A	I-NP	NN	O	3	NMOD
7	caused	cause	B-VP	VBD	O	0	ROOT
8	an	an	B-NP	DT	O	11	NMOD
9	increased	increase	I-NP	VBN	O	11	NMOD
10	binding	binding	I-NP	NN	O	11	NMOD
11	efficiency	efficiency	I-NP	NN	O	16	NMOD
12	for	for	B-PP	IN	O	11	NMOD
13	antagonists	antagonist	B-NP	NNS	O	12	PMOD
14	but	but	O	CC	O	16	NMOD
15	no	no	B-NP	DT	O	16	NMOD
16	change	change	I-NP	NN	O	7	OBJ
17	in	in	B-PP	IN	O	16	NMOD
18	agonist	agonist	B-NP	NN	O	19	NMOD
19	binding	binding	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	2	NMOD
2	phosphorylation	phosphorylation	I-NP	NN	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	CREB	CREB	B-NP	NN	B-protein	3	PMOD
5	that	that	B-NP	WDT	O	2	NMOD
6	results	result	B-VP	VBZ	O	5	SBAR
7	in	in	B-PP	IN	O	6	VMOD
8	activation	activation	B-NP	NN	O	7	PMOD
9	is	be	B-VP	VBZ	O	0	ROOT
10	mediated	mediate	I-VP	VBN	O	9	VC
11	by	by	B-PP	IN	O	10	VMOD
12	protein	protein	B-NP	NN	B-protein	14	NMOD
13	kinase	kinase	I-NP	NN	I-protein	14	NMOD
14	C	C	I-NP	NN	I-protein	11	PMOD
15	rather	rather	B-CONJP	RB	O	14	NMOD
16	than	than	I-CONJP	IN	O	15	DEP
17	by	by	B-PP	IN	O	15	DEP
18	protein	protein	B-NP	NN	B-protein	20	NMOD
19	kinase	kinase	I-NP	NN	I-protein	20	NMOD
20	A	A	I-NP	NN	I-protein	17	PMOD
21	.	.	O	.	O	9	P

1	Importantly	Importantly	B-ADVP	RB	O	0	ROOT
2	,	,	O	,	O	1	P
3	culture	culture	B-NP	NN	O	2	ROOT
4	of	of	B-PP	IN	O	3	NMOD
5	MM	MM	B-NP	NN	B-cell_line	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_line	4	PMOD
7	with	with	B-PP	IN	O	3	NMOD
8	RB	RB	B-NP	NN	B-protein	14	AMOD
9	antisense	antisense	B-ADJP	JJ	O	8	AMOD
10	,	,	O	,	O	14	P
11	but	but	O	CC	O	14	AMOD
12	not	not	O	RB	O	11	DEP
13	RB	RB	B-NP	NN	B-protein	14	AMOD
14	sense	sense	I-NP	NN	O	20	SUB
15	,	,	O	,	O	20	P
16	oligonucleotide	oligonucleotide	B-NP	NN	O	20	SUB
17	(	(	O	(	O	19	DEP
18	ODN	ODN	B-NP	NN	O	19	DEP
19	)	)	O	)	O	16	NMOD
20	triggered	trigger	B-VP	VBD	O	7	SBAR
21	IL-6	IL-6	B-NP	NN	B-protein	24	NMOD
22	secretion	secretion	I-NP	NN	O	24	NMOD
23	and	and	I-NP	CC	O	24	NMOD
24	proliferation	proliferation	I-NP	NN	O	20	OBJ
25	in	in	B-PP	IN	O	20	VMOD
26	MM	MM	B-NP	NN	B-cell_line	27	NMOD
27	cells	cell	I-NP	NNS	I-cell_line	25	PMOD
28	;	;	O	:	O	3	P

1	Although	Although	B-SBAR	IN	O	30	VMOD
2	CD40	CD40	B-NP	NN	B-protein	3	NMOD
3	ligand	ligand	I-NP	NN	I-protein	7	SUB
4	(	(	O	(	O	6	DEP
5	CD40L	CD40L	B-NP	NN	B-protein	6	DEP
6	)	)	O	)	O	3	NMOD
7	triggers	trigger	B-VP	VBZ	O	1	SBAR
8	a	a	B-NP	DT	O	9	NMOD
9	shift	shift	I-NP	NN	O	14	NMOD
10	from	from	B-PP	IN	O	14	NMOD
11	dephosphorylated	dephosphorylate	B-VP	VBN	O	10	PMOD
12	to	to	B-PP	TO	O	14	NMOD
13	phosphorylated	phosphorylate	B-NP	VBN	O	12	PMOD
14	pRB	pRB	I-NP	NN	B-protein	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	proliferation	proliferation	I-NP	NN	O	7	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	B	B	B-NP	NN	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
20	,	,	O	,	O	30	P
21	the	the	B-NP	DT	O	22	NMOD
22	addition	addition	I-NP	NN	O	30	SUB
23	of	of	B-PP	IN	O	22	NMOD
24	exogenous	exogenous	B-NP	JJ	O	25	NMOD
25	IL-6	IL-6	I-NP	NN	B-protein	23	PMOD
26	to	to	B-PP	TO	O	22	NMOD
27	CD40L-treated	CD40L-treated	B-NP	JJ	B-cell_type	29	NMOD
28	B	B	I-NP	NN	I-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
30	does	do	B-VP	VBZ	O	0	ROOT
31	not	not	I-VP	RB	O	30	VMOD
32	alter	alter	I-VP	VB	O	30	VC
33	either	either	O	CC	O	36	NMOD
34	pRB	pRB	B-NP	NN	B-protein	36	NMOD
35	or	or	I-NP	CC	O	36	NMOD
36	proliferation	proliferation	I-NP	NN	O	32	OBJ
37	,	,	O	,	O	32	P
38	as	as	B-SBAR	IN	O	32	VMOD
39	observed	observe	B-VP	VBN	O	38	SBAR
40	in	in	B-PP	IN	O	39	VMOD
41	MM	MM	B-NP	NN	B-cell_line	42	NMOD
42	cells	cell	I-NP	NNS	I-cell_line	40	PMOD
43	.	.	O	.	O	30	P

1	The	The	B-NP	DT	O	2	NMOD
2	activation	activation	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	JNK	JNK	B-NP	NN	B-protein	3	PMOD
5	by	by	B-PP	IN	O	2	NMOD
6	classical	classical	B-NP	JJ	O	9	NMOD
7	T	T	I-NP	NN	O	9	NMOD
8	cell	cell	I-NP	NN	O	9	NMOD
9	stimuli	stimulus	I-NP	NNS	O	5	PMOD
10	was	be	B-VP	VBD	O	13	VMOD
11	transient	transient	B-ADJP	JJ	O	10	PRD
12	,	,	O	,	O	13	P
13	whereas	whereas	O	IN	O	0	ROOT
14	that	that	B-NP	DT	O	26	SUB
15	mediated	mediate	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	PDTC	PDTC	B-NP	NN	O	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	butylated	butylate	B-NP	VBN	O	20	NMOD
20	hydroxyanisole	hydroxyanisole	I-NP	NN	O	16	PMOD
21	(	(	O	(	O	25	DEP
22	but	but	B-NP	CC	O	24	NMOD
23	not	not	I-NP	RB	O	22	DEP
24	N-acetylcysteine	N-acetylcysteine	B-NP	NN	O	25	DEP
25	)	)	O	)	O	20	NMOD
26	was	be	B-VP	VBD	O	13	VMOD
27	sustained	sustained	B-ADJP	JJ	O	26	PRD
28	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	10	VMOD
2	addition	addition	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	JNK	JNK	B-NP	NN	B-protein	5	NMOD
5	activation	activation	I-NP	NN	O	10	SUB
6	by	by	B-PP	IN	O	5	NMOD
7	PMA	PMA	B-NP	NN	O	9	NMOD
8	plus	plus	O	CC	O	9	NMOD
9	ionophore	ionophore	B-NP	NN	O	6	PMOD
10	was	be	B-VP	VBD	O	0	ROOT
11	sensitive	sensitive	B-ADJP	JJ	O	10	PRD
12	to	to	B-PP	TO	O	11	AMOD
13	inhibitors	inhibitor	B-NP	NNS	O	12	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	signaling	signaling	B-NP	NN	O	16	NMOD
16	pathways	pathway	I-NP	NNS	O	14	PMOD
17	involving	involve	B-VP	VBG	O	16	NMOD
18	Ca2+	Ca2+	B-NP	NN	O	26	NMOD
19	,	,	O	,	O	26	P
20	protein	protein	B-NP	NN	B-protein	22	NMOD
21	kinase	kinase	I-NP	NN	I-protein	22	NMOD
22	C	C	I-NP	NN	I-protein	26	NMOD
23	,	,	O	,	O	26	P
24	and	and	O	CC	O	26	NMOD
25	tyrosine	tyrosine	B-NP	NN	O	26	NMOD
26	phosphorylation	phosphorylation	I-NP	NN	O	17	OBJ
27	,	,	O	,	O	26	P
28	which	which	B-NP	WDT	O	26	NMOD
29	failed	fail	B-VP	VBD	O	28	SBAR
30	to	to	I-VP	TO	O	31	VMOD
31	inhibit	inhibit	I-VP	VB	O	29	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	activation	activation	I-NP	NN	O	31	OBJ
34	mediated	mediate	B-VP	VBN	O	33	NMOD
35	by	by	B-PP	IN	O	34	VMOD
36	PDTC	PDTC	B-NP	NN	O	35	PMOD
37	.	.	O	.	O	10	P

1	Transfection	Transfection	B-NP	NN	O	33	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	trans-dominant	trans-dominant	B-NP	JJ	B-DNA	6	NMOD
4	negative	negative	I-NP	JJ	I-DNA	6	NMOD
5	expression	expression	I-NP	NN	I-DNA	6	NMOD
6	vectors	vector	I-NP	NNS	I-DNA	2	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	ras	ras	B-NP	NN	B-protein	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	raf	raf	I-NP	NN	B-protein	7	PMOD
11	,	,	O	,	O	1	P
12	together	together	B-ADVP	RB	O	13	PMOD
13	with	with	B-PP	IN	O	33	VMOD
14	AP-1-dependent	AP-1-dependent	B-NP	JJ	B-DNA	16	NMOD
15	reporter	reporter	I-NP	NN	I-DNA	16	NMOD
16	constructs	construct	I-NP	NNS	I-DNA	13	PMOD
17	,	,	O	,	O	33	P
18	as	as	B-CONJP	RB	O	23	NMOD
19	well	well	I-CONJP	RB	O	18	DEP
20	as	as	I-CONJP	IN	O	18	DEP
21	Western	Western	B-NP	JJ	O	23	NMOD
22	blot	blot	I-NP	NN	O	23	NMOD
23	analysis	analysis	I-NP	NN	O	33	SUB
24	using	use	B-VP	VBG	O	23	NMOD
25	anti-ERK	anti-ERK	O	JJ	B-protein	31	NMOD
26	(	(	O	(	I-protein	30	DEP
27	extracellular	extracellular	B-NP	JJ	I-protein	29	NMOD
28	signal-regulated	signal-regulated	I-NP	JJ	I-protein	29	NMOD
29	kinase	kinase	I-NP	NN	I-protein	30	DEP
30	)	)	O	)	I-protein	25	AMOD
31	antibodies	antibody	B-NP	NNS	I-protein	24	OBJ
32	,	,	O	,	O	23	P
33	indicated	indicate	B-VP	VBD	O	0	ROOT
34	that	that	B-SBAR	IN	O	33	VMOD
35	the	the	B-NP	DT	O	37	NMOD
36	Ras/Raf/ERK	Ras/Raf/ERK	I-NP	NN	O	37	NMOD
37	pathway	pathway	I-NP	NN	O	38	SUB
38	did	do	B-VP	VBD	O	34	SBAR
39	not	not	I-VP	RB	O	38	VMOD
40	appear	appear	I-VP	VB	O	38	VC
41	to	to	I-VP	TO	O	42	VMOD
42	mediate	mediate	I-VP	VB	O	40	VMOD
43	the	the	B-NP	DT	O	44	NMOD
44	effect	effect	I-NP	NN	O	42	OBJ
45	of	of	B-PP	IN	O	44	NMOD
46	the	the	B-NP	DT	O	47	NMOD
47	antioxidant	antioxidant	I-NP	NN	O	45	PMOD
48	.	.	O	.	O	33	P

1	E3	E3	B-NP	NN	B-protein	2	NMOD
2	transcripts	transcript	I-NP	NNS	I-protein	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	RA-inducible	RA-inducible	B-ADJP	JJ	O	3	PRD
5	in	in	B-PP	IN	O	3	VMOD
6	HL60	HL60	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
8	,	,	B-PP	,	O	5	P
9	but	but	I-PP	CC	O	5	PMOD
10	not	not	B-PP	RB	O	5	PMOD
11	in	in	I-PP	IN	O	5	PMOD
12	an	an	B-NP	DT	O	14	NMOD
13	RA-resistant	RA-resistant	I-NP	JJ	B-cell_line	14	NMOD
14	subclone	subclone	I-NP	NN	I-cell_line	16	NMOD
15	,	,	O	,	O	16	P
16	HL60R	HL60R	B-NP	NN	B-cell_line	11	PMOD
17	,	,	O	,	O	16	P
18	that	that	B-NP	WDT	O	16	NMOD
19	harbors	harbor	B-VP	VBZ	O	18	DEP
20	a	a	B-NP	DT	O	24	NMOD
21	mutated	mutate	I-NP	VBN	O	24	NMOD
22	RAR	RAR	I-NP	NN	B-DNA	24	NMOD
23	alpha	alpha	I-NP	NN	I-DNA	24	NMOD
24	gene	gene	I-NP	NN	I-DNA	19	OBJ
25	.	.	O	.	O	3	P

1	E3	E3	B-NP	NN	B-protein	2	NMOD
2	transcripts	transcript	I-NP	NNS	I-protein	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	present	present	B-ADJP	JJ	O	15	AMOD
5	in	in	B-PP	IN	O	4	AMOD
6	the	the	B-NP	DT	O	13	NMOD
7	myeloid	myeloid	I-NP	JJ	O	13	NMOD
8	,	,	I-NP	,	O	13	P
9	B-lymphoid	B-lymphoid	I-NP	JJ	O	13	NMOD
10	,	,	O	,	O	13	P
11	and	and	O	CC	O	13	NMOD
12	erythroid	erythroid	B-NP	JJ	B-cell_type	13	NMOD
13	lineages	lineage	I-NP	NNS	I-cell_type	5	PMOD
14	,	,	O	,	O	15	P
15	absent	absent	B-ADJP	JJ	O	3	PRD
16	in	in	B-PP	IN	O	15	AMOD
17	nonhematopoietic	nonhematopoietic	B-NP	JJ	B-cell_type	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
19	,	,	O	,	O	3	P
20	and	and	O	CC	O	3	VMOD
21	encode	encode	B-VP	VBP	O	3	VMOD
22	a	a	B-NP	DT	O	28	NMOD
23	highly	highly	I-NP	RB	O	24	AMOD
24	hydrophobic	hydrophobic	I-NP	JJ	O	27	AMOD
25	,	,	I-NP	,	O	27	P
26	potentially	potentially	I-NP	RB	O	27	AMOD
27	phosphorylated	phosphorylate	I-NP	VBN	O	28	NMOD
28	polypeptide	polypeptide	I-NP	NN	O	21	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	unknown	unknown	B-NP	JJ	O	31	NMOD
31	function	function	I-NP	NN	O	29	PMOD
32	with	with	B-PP	IN	O	28	NMOD
33	significant	significant	B-NP	JJ	O	34	NMOD
34	homology	homology	I-NP	NN	O	32	PMOD
35	to	to	B-PP	TO	O	34	NMOD
36	a	a	B-NP	DT	O	38	NMOD
37	putative	putative	I-NP	JJ	B-protein	38	NMOD
38	protein	protein	I-NP	NN	I-protein	35	PMOD
39	expressed	express	B-VP	VBN	O	38	NMOD
40	in	in	B-PP	IN	O	39	VMOD
41	myeloid	myeloid	B-NP	JJ	B-cell_type	42	NMOD
42	cells	cell	I-NP	NNS	I-cell_type	40	PMOD
43	.	.	O	.	O	3	P

1	To	To	B-VP	TO	O	3	VMOD
2	further	further	I-VP	RB	O	3	VMOD
3	reduce	reduce	I-VP	VB	O	12	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	size	size	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	10	NMOD
8	common	common	I-NP	JJ	O	10	NMOD
9	deleted	delete	I-NP	VBN	O	10	NMOD
10	region	region	I-NP	NN	O	6	PMOD
11	we	we	B-NP	PRP	O	12	SUB
12	have	have	B-VP	VBP	O	0	ROOT
13	searched	search	I-VP	VBN	O	12	VC
14	for	for	B-PP	IN	O	13	VMOD
15	small	small	B-NP	JJ	O	16	NMOD
16	deletions	deletion	I-NP	NNS	O	20	NMOD
17	or	or	O	CC	O	20	NMOD
18	mitotic	mitotic	B-NP	JJ	O	20	NMOD
19	recombination	recombination	I-NP	NN	O	20	NMOD
20	events	event	I-NP	NNS	O	14	PMOD
21	,	,	O	,	O	12	P
22	neither	neither	B-NP	DT	O	23	NMOD
23	of	of	B-PP	IN	O	12	VMOD
24	which	which	B-NP	WDT	O	23	PMOD
25	would	would	B-VP	MD	O	23	SBAR
26	be	be	I-VP	VB	O	25	VC
27	detected	detect	I-VP	VBN	O	26	VC
28	by	by	B-PP	IN	O	27	VMOD
29	conventional	conventional	B-NP	JJ	O	30	NMOD
30	cytogenetics	cytogenetic	I-NP	NNS	O	28	PMOD
31	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	7	VMOD
2	each	each	B-NP	DT	O	3	NMOD
3	case	case	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	7	P
5	cytogenetic	cytogenetic	B-NP	JJ	O	6	NMOD
6	analysis	analysis	I-NP	NN	O	7	SUB
7	had	have	B-VP	VBD	O	0	ROOT
8	either	either	I-VP	CC	O	7	VMOD
9	failed	fail	I-VP	VBD	O	7	VC
10	or	or	O	CC	O	7	VMOD
11	had	have	B-VP	VBD	O	7	VMOD
12	shown	show	I-VP	VBN	O	11	VC
13	no	no	B-NP	DT	O	14	NMOD
14	abnormalities	abnormality	I-NP	NNS	O	12	OBJ
15	of	of	B-PP	IN	O	14	NMOD
16	chromosome	chromosome	B-NP	NN	B-DNA	15	PMOD
17	20	20	I-NP	CD	I-DNA	16	NMOD
18	.	.	O	.	O	7	P

1	No	No	B-NP	DT	O	2	NMOD
2	instance	instance	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	microsatellite	microsatellite	B-NP	NN	O	5	NMOD
5	instability	instability	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	observed	observe	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	a	a	B-NP	DT	O	10	NMOD
10	total	total	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	880	880	B-NP	CD	O	13	NMOD
13	comparisons	comparison	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	granulocyte	granulocyte	B-NP	NN	B-DNA	18	NMOD
16	and	and	I-NP	CC	I-DNA	18	NMOD
17	T-cell	T-cell	I-NP	NN	I-DNA	18	NMOD
18	DNA	DNA	I-NP	NN	I-DNA	14	PMOD
19	.	.	O	.	O	6	P

1	Loss	Loss	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	heterozygosity	heterozygosity	B-NP	NN	O	2	PMOD
4	in	in	B-PP	IN	O	1	NMOD
5	PB	PB	B-NP	NN	B-cell_type	6	NMOD
6	granulocytes	granulocyte	I-NP	NNS	I-cell_type	4	PMOD
7	would	would	B-VP	MD	O	0	ROOT
8	be	be	I-VP	VB	O	7	VC
9	masked	mask	I-VP	VBN	O	8	VC
10	by	by	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	presence	presence	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	significant	significant	B-NP	JJ	O	15	NMOD
15	numbers	number	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	normal	normal	B-NP	JJ	B-cell_type	18	NMOD
18	granulocytes	granulocyte	I-NP	NNS	I-cell_type	16	PMOD
19	not	not	B-VP	RB	O	20	VMOD
20	derived	derive	I-VP	VBN	O	18	NMOD
21	from	from	B-PP	IN	O	20	VMOD
22	the	the	B-NP	DT	O	24	NMOD
23	malignant	malignant	I-NP	JJ	B-cell_line	24	NMOD
24	clone	clone	I-NP	NN	I-cell_line	21	PMOD
25	.	.	O	.	O	7	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	,	,	O	,	O	4	P
6	in	in	B-PP	IN	O	22	VMOD
7	the	the	B-NP	DT	O	9	NMOD
8	vast	vast	I-NP	JJ	O	9	NMOD
9	majority	majority	I-NP	NN	O	6	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	patients	patient	B-NP	NNS	O	10	PMOD
12	presented	present	B-VP	VBN	O	11	NMOD
13	here	here	B-ADVP	RB	O	12	VMOD
14	,	,	O	,	O	22	P
15	the	the	B-NP	DT	O	16	NMOD
16	failure	failure	I-NP	NN	O	22	SUB
17	to	to	B-VP	TO	O	18	VMOD
18	detect	detect	I-VP	VB	O	16	NMOD
19	loss	loss	B-NP	NN	O	18	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	heterozygosity	heterozygosity	B-NP	NN	O	20	PMOD
22	can	can	B-VP	MD	O	4	SBAR
23	not	not	I-VP	RB	O	22	VMOD
24	be	be	I-VP	VB	O	22	VC
25	attributed	attribute	I-VP	VBN	O	24	VC
26	to	to	B-PP	TO	O	25	VMOD
27	the	the	B-NP	DT	O	28	NMOD
28	presence	presence	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	normal	normal	B-NP	JJ	B-cell_type	32	NMOD
31	polyclonal	polyclonal	I-NP	JJ	I-cell_type	32	NMOD
32	granulocytes	granulocyte	I-NP	NNS	I-cell_type	29	PMOD
33	.	.	O	.	O	3	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	4	SUB
3	therefore	therefore	B-ADVP	RB	O	4	VMOD
4	show	show	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	24	DEP
6	allele	allele	B-NP	NN	O	7	NMOD
7	loss	loss	I-NP	NN	O	14	SUB
8	on	on	B-PP	IN	O	7	NMOD
9	chromosome	chromosome	B-NP	NN	B-DNA	10	NMOD
10	20q	20q	I-NP	NN	I-DNA	8	PMOD
11	in	in	B-PP	IN	O	7	NMOD
12	polycythemia	polycythemia	B-NP	NN	O	13	NMOD
13	vera	vera	I-NP	NN	O	11	PMOD
14	does	do	B-VP	VBZ	O	5	SBAR
15	not	not	I-VP	RB	O	14	VMOD
16	commonly	commonly	I-VP	RB	O	14	VMOD
17	involve	involve	I-VP	VB	O	14	VC
18	mitotic	mitotic	B-NP	JJ	O	19	NMOD
19	recombination	recombination	I-NP	NN	O	22	NMOD
20	or	or	I-NP	CC	O	22	NMOD
21	chromosome	chromosome	I-NP	NN	O	22	NMOD
22	loss	loss	I-NP	NN	O	17	OBJ
23	and	and	O	CC	O	24	DEP
24	that	that	B-SBAR	IN	O	4	VMOD
25	microsatellite	microsatellite	B-NP	NN	O	26	NMOD
26	instability	instability	I-NP	NN	O	27	SUB
27	is	be	B-VP	VBZ	O	24	SBAR
28	a	a	B-NP	DT	O	30	NMOD
29	rare	rare	I-NP	JJ	O	30	NMOD
30	event	event	I-NP	NN	O	27	PRD
31	in	in	B-PP	IN	O	27	VMOD
32	this	this	B-NP	DT	O	33	NMOD
33	disorder	disorder	I-NP	NN	O	31	PMOD
34	.	.	O	.	O	4	P

1	However	However	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	more	more	B-NP	RBR	O	4	AMOD
4	recent	recent	I-NP	JJ	O	5	NMOD
5	studies	study	I-NP	NNS	O	11	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	human	human	B-NP	JJ	B-cell_line	10	NMOD
8	T	T	I-NP	NN	I-cell_line	10	NMOD
9	cell	cell	I-NP	NN	I-cell_line	10	NMOD
10	lines	line	I-NP	NNS	I-cell_line	6	PMOD
11	have	have	B-VP	VBP	O	0	ROOT
12	suggested	suggest	I-VP	VBN	O	11	VC
13	that	that	B-SBAR	IN	O	24	DEP
14	the	the	B-NP	DT	O	16	NMOD
15	N-terminal	N-terminal	I-NP	JJ	B-protein	16	NMOD
16	domain	domain	I-NP	NN	I-protein	17	SUB
17	is	be	B-VP	VBZ	O	13	SBAR
18	not	not	O	RB	O	17	VMOD
19	necessary	necessary	B-ADJP	JJ	O	17	PRD
20	for	for	B-PP	IN	O	19	AMOD
21	steroid-regulated	steroid-regulated	B-NP	JJ	O	22	NMOD
22	apoptosis	apoptosis	I-NP	NN	O	20	PMOD
23	and	and	O	CC	O	24	DEP
24	that	that	B-SBAR	IN	O	12	VMOD
25	GR-mediated	GR-mediated	B-NP	JJ	O	26	NMOD
26	transrepression	transrepression	I-NP	NN	O	27	SUB
27	may	may	B-VP	MD	O	24	SBAR
28	be	be	I-VP	VB	O	27	VC
29	the	the	B-NP	DT	O	32	NMOD
30	more	more	I-NP	RBR	O	31	AMOD
31	critical	critical	I-NP	JJ	O	32	NMOD
32	mechanism	mechanism	I-NP	NN	O	28	PRD
33	.	.	O	.	O	11	P

1	To	To	B-VP	TO	O	3	VMOD
2	better	well	I-VP	RBR	O	3	VMOD
3	understand	understand	I-VP	VB	O	20	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	contribution	contribution	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	11	NMOD
8	GR	GR	I-NP	NN	B-protein	11	NMOD
9	N-terminal	N-terminal	I-NP	JJ	I-protein	11	NMOD
10	transactivation	transactivation	I-NP	NN	I-protein	11	NMOD
11	domain	domain	I-NP	NN	I-protein	6	PMOD
12	in	in	B-PP	IN	O	5	NMOD
13	mediating	mediate	B-VP	VBG	O	12	PMOD
14	murine	murine	B-NP	JJ	O	16	NMOD
15	thymocyte	thymocyte	I-NP	NN	O	16	NMOD
16	apoptosis	apoptosis	I-NP	NN	O	13	OBJ
17	,	,	O	,	O	20	P
18	we	we	B-NP	PRP	O	20	SUB
19	stably	stably	B-ADVP	RB	O	20	VMOD
20	transfected	transfecte	B-VP	VBD	O	0	ROOT
21	GR	GR	B-NP	NN	B-protein	29	NMOD
22	,	,	O	,	O	29	P
23	GR	GR	B-NP	NN	B-protein	24	NMOD
24	variants	variant	I-NP	NNS	I-protein	29	NMOD
25	,	,	O	,	O	29	P
26	and	and	O	CC	O	29	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	androgen	androgen	I-NP	NN	B-protein	29	NMOD
29	receptor	receptor	I-NP	NN	I-protein	20	OBJ
30	(	(	O	(	O	32	DEP
31	AR	AR	B-NP	NN	B-protein	32	DEP
32	)	)	O	)	O	29	NMOD
33	into	into	B-PP	IN	O	20	VMOD
34	receptor-negative	receptor-negative	B-NP	JJ	B-cell_line	38	NMOD
35	S49	S49	I-NP	NN	I-cell_line	38	NMOD
36	murine	murine	I-NP	JJ	I-cell_line	38	NMOD
37	thymoma	thymoma	I-NP	NN	I-cell_line	38	NMOD
38	cells	cell	I-NP	NNS	I-cell_line	33	PMOD
39	.	.	O	.	O	20	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	results	result	I-NP	NNS	O	6	SUB
6	support	support	B-VP	VBP	O	0	ROOT
7	our	our	B-NP	PRP$	O	8	NMOD
8	conclusion	conclusion	I-NP	NN	O	6	OBJ
9	that	that	B-SBAR	IN	O	8	NMOD
10	transcriptional	transcriptional	B-NP	JJ	O	11	NMOD
11	transactivation	transactivation	I-NP	NN	O	12	SUB
12	is	be	B-VP	VBZ	O	9	SBAR
13	a	a	B-NP	DT	O	16	NMOD
14	necessary	necessary	I-NP	JJ	O	16	NMOD
15	signaling	signaling	I-NP	NN	O	16	NMOD
16	component	component	I-NP	NN	O	12	PRD
17	of	of	B-PP	IN	O	16	NMOD
18	S49	S49	B-NP	NN	O	20	NMOD
19	cell	cell	I-NP	NN	O	20	NMOD
20	apoptosis	apoptosis	I-NP	NN	O	17	PMOD
21	,	,	O	,	O	6	P
22	although	although	B-SBAR	IN	O	6	VMOD
23	an	an	B-NP	DT	O	25	NMOD
24	additional	additional	I-NP	JJ	O	25	NMOD
25	role	role	I-NP	NN	O	29	SUB
26	for	for	B-PP	IN	O	25	NMOD
27	GR-mediated	GR-mediated	B-NP	JJ	O	28	NMOD
28	transrepression	transrepression	I-NP	NN	O	26	PMOD
29	can	can	B-VP	MD	O	22	SBAR
30	not	not	I-VP	RB	O	29	VMOD
31	be	be	I-VP	VB	O	29	VC
32	excluded	exclude	I-VP	VBN	O	31	VC
33	.	.	O	.	O	6	P

1	Suppression	Suppression	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	c-jun	c-jun	B-NP	NN	B-DNA	2	PMOD
4	by	by	B-PP	IN	O	1	NMOD
5	antisense	antisense	B-NP	JJ	O	6	NMOD
6	oligonucleotides	oligonucleotide	I-NP	NNS	O	4	PMOD
7	inhibits	inhibit	B-VP	VBZ	O	0	ROOT
8	cell	cell	B-NP	NN	O	9	NMOD
9	adhesion	adhesion	I-NP	NN	O	13	NMOD
10	but	but	B-CONJP	CC	O	13	NMOD
11	not	not	I-CONJP	RB	O	10	DEP
12	respiratory	respiratory	B-NP	JJ	O	13	NMOD
13	burst	burst	I-NP	NN	O	7	OBJ
14	during	during	B-PP	IN	O	7	VMOD
15	phorbol	phorbol	B-NP	NN	O	17	NMOD
16	ester-induced	ester-induced	I-NP	JJ	O	15	AMOD
17	differentiation	differentiation	I-NP	NN	O	14	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	U937	U937	B-NP	NN	B-cell_line	22	NMOD
20	human	human	I-NP	JJ	I-cell_line	22	NMOD
21	monoblastic	monoblastic	I-NP	JJ	I-cell_line	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_line	18	PMOD
23	.	.	O	.	O	7	P

1	the	the	B-NP	DT	O	4	NMOD
2	C-JUN	C-JUN	I-NP	NN	B-DNA	4	NMOD
3	AS	AS	I-NP	JJ	O	4	NMOD
4	oligonucleotides	oligonucleotide	I-NP	NNS	O	5	SUB
5	inhibited	inhibit	B-VP	VBD	O	9	VMOD
6	cell	cell	B-NP	NN	O	7	NMOD
7	adhesion	adhesion	I-NP	NN	O	5	OBJ
8	,	,	O	,	O	9	P
9	whereas	whereas	O	IN	O	0	ROOT
10	they	they	B-NP	PRP	O	11	SUB
11	did	do	B-VP	VBD	O	9	VMOD
12	not	not	I-VP	RB	O	11	VMOD
13	affect	affect	I-VP	VB	O	11	VC
14	another	another	B-NP	DT	O	15	NMOD
15	marker	marker	I-NP	NN	O	20	NMOD
16	of	of	B-PP	IN	O	15	NMOD
17	differentiation	differentiation	B-NP	NN	O	16	PMOD
18	,	,	O	,	O	20	P
19	respiratory	respiratory	B-NP	JJ	O	20	NMOD
20	burst	burst	I-NP	NN	O	13	OBJ
21	(	(	O	(	O	20	NMOD
22	measured	measure	B-VP	VBN	O	20	NMOD
23	by	by	B-PP	IN	O	22	VMOD
24	nitro	nitro	B-NP	NN	O	28	NMOD
25	blue	blue	I-NP	JJ	O	28	NMOD
26	tetrazolium	tetrazolium	I-NP	NN	O	28	NMOD
27	reduction	reduction	I-NP	NN	O	28	NMOD
28	assay	assay	I-NP	NN	O	23	PMOD
29	)	)	O	)	O	20	NMOD
30	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	6	NMOD
5	critical	critical	I-NP	JJ	O	6	NMOD
6	role	role	I-NP	NN	O	3	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	c-jun	c-jun	B-NP	NN	B-DNA	7	PMOD
9	in	in	B-PP	IN	O	6	NMOD
10	both	both	O	CC	O	16	NMOD
11	cell	cell	B-NP	NN	O	12	NMOD
12	proliferation	proliferation	I-NP	NN	O	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	PMA-induced	PMA-induced	B-NP	JJ	O	16	NMOD
15	cell	cell	I-NP	NN	O	16	NMOD
16	adhesion	adhesion	I-NP	NN	O	9	PMOD
17	but	but	B-PP	CC	O	9	PMOD
18	not	not	B-PP	RB	O	19	PMOD
19	in	in	I-PP	IN	O	9	PMOD
20	PMA-induced	PMA-induced	B-NP	JJ	O	22	NMOD
21	respiratory	respiratory	I-NP	JJ	O	22	NMOD
22	burst	burst	I-NP	NN	O	19	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	U937	U937	B-NP	NN	B-cell_line	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_line	23	PMOD
26	.	.	O	.	O	3	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	report	report	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	differentiated	differentiate	B-NP	VBN	B-cell_type	8	NMOD
7	B	B	I-NP	NN	I-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	9	SUB
9	contain	contain	B-VP	VBP	O	5	SBAR
10	a	a	B-NP	DT	O	13	NMOD
11	novel	novel	I-NP	JJ	O	13	NMOD
12	substoichiometric	substoichiometric	I-NP	JJ	O	13	NMOD
13	TAF	TAF	I-NP	NN	B-protein	9	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	105	105	B-NP	CD	O	16	NMOD
16	kDa	kDa	I-NP	NN	O	14	PMOD
17	not	not	B-VP	RB	O	18	VMOD
18	found	find	I-VP	VBN	O	13	NMOD
19	associated	associate	I-VP	VBN	O	18	VMOD
20	with	with	B-PP	IN	O	19	VMOD
21	TFIID	TFIID	B-NP	NN	B-protein	20	PMOD
22	isolated	isolate	B-VP	VBN	O	21	NMOD
23	from	from	B-PP	IN	O	22	VMOD
24	other	other	B-NP	JJ	O	26	NMOD
25	cell	cell	I-NP	NN	O	26	NMOD
26	types	type	I-NP	NNS	O	23	PMOD
27	.	.	O	.	O	4	P

1	No	No	B-NP	DT	O	4	NMOD
2	glucocorticoid	glucocorticoid	I-NP	NN	B-DNA	4	NMOD
3	recognition	recognition	I-NP	NN	I-DNA	4	NMOD
4	sequences	sequence	I-NP	NNS	I-DNA	5	SUB
5	are	be	B-VP	VBP	O	13	VMOD
6	present	present	B-ADJP	JJ	O	5	PRD
7	in	in	B-PP	IN	O	6	AMOD
8	this	this	B-NP	DT	O	10	NMOD
9	promoter	promoter	I-NP	NN	B-DNA	10	NMOD
10	region	region	I-NP	NN	I-DNA	7	PMOD
11	and	and	I-NP	CC	O	13	VMOD
12	dexamethasone	dexamethasone	I-NP	NN	O	13	SUB
13	is	be	B-VP	VBZ	O	0	ROOT
14	still	still	B-ADVP	RB	O	13	VMOD
15	able	able	B-ADJP	JJ	O	13	PRD
16	to	to	B-VP	TO	O	17	VMOD
17	repress	repress	I-VP	VB	O	15	AMOD
18	transcription	transcription	B-NP	NN	O	17	OBJ
19	when	when	B-ADVP	WRB	O	13	VMOD
20	the	the	B-NP	DT	O	24	NMOD
21	multimerized	multimerized	I-NP	JJ	B-DNA	24	NMOD
22	NF-kappa	NF-kappa	I-NP	NN	I-DNA	24	NMOD
23	B	B	I-NP	NN	I-DNA	24	NMOD
24	sequence	sequence	I-NP	NN	I-DNA	25	SUB
25	is	be	B-VP	VBZ	O	19	SBAR
26	transactivated	transactivate	I-VP	VBN	O	25	VC
27	by	by	B-PP	IN	O	26	VMOD
28	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	27	PMOD
29	upon	upon	B-PP	IN	O	26	VMOD
30	transfection	transfection	B-NP	NN	O	29	PMOD
31	in	in	B-PP	IN	O	30	NMOD
32	293	293	B-NP	CD	B-cell_line	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_line	31	PMOD
34	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	3	NMOD
2	proliferative	proliferative	I-NP	JJ	O	3	NMOD
3	responses	response	I-NP	NNS	O	11	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	purified	purify	B-NP	VBN	B-cell_type	10	NMOD
6	CD4+	CD4+	I-NP	JJ	I-cell_type	10	NMOD
7	or	or	I-NP	CC	I-cell_type	10	NMOD
8	CD8+	CD8+	I-NP	JJ	I-cell_type	10	NMOD
9	T	T	I-NP	NN	I-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
11	are	be	B-VP	VBP	O	0	ROOT
12	suppressed	suppress	I-VP	VBN	O	11	VC
13	more	more	B-ADVP	RBR	O	14	AMOD
14	strongly	strongly	I-ADVP	RB	O	12	VMOD
15	by	by	B-PP	IN	O	12	VMOD
16	TPCK	TPCK	B-NP	NN	O	15	PMOD
17	when	when	B-ADVP	WRB	O	12	VMOD
18	anti-CD28	anti-CD28	O	NN	B-protein	24	NMOD
19	rather	rather	B-CONJP	RB	O	24	NMOD
20	than	than	I-CONJP	IN	O	19	DEP
21	the	the	B-NP	DT	O	24	NMOD
22	phorbol	phorbol	I-NP	NN	O	24	NMOD
23	ester	ester	I-NP	NN	O	24	NMOD
24	PMA	PMA	I-NP	NN	O	25	SUB
25	is	be	B-VP	VBZ	O	17	SBAR
26	used	use	I-VP	VBN	O	25	VC
27	as	as	B-PP	IN	O	26	VMOD
28	the	the	B-NP	DT	O	30	NMOD
29	mitogenic	mitogenic	I-NP	JJ	B-protein	30	NMOD
30	coactivator	coactivator	I-NP	NN	I-protein	27	PMOD
31	.	.	O	.	O	11	P

1	Using	Use	B-VP	VBG	O	8	VMOD
2	electrophoretic	electrophoretic	B-NP	JJ	O	5	NMOD
3	mobility	mobility	I-NP	NN	O	5	NMOD
4	shift	shift	I-NP	NN	O	5	NMOD
5	assays	assay	I-NP	NNS	O	1	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	find	find	B-VP	VBP	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	TPCK	TPCK	B-NP	NN	O	12	SUB
11	virtually	virtually	B-ADVP	RB	O	12	VMOD
12	abolishes	abolish	B-VP	VBZ	O	9	SBAR
13	(	(	O	(	O	12	VMOD
14	to	to	B-PP	TO	O	12	VMOD
15	less	less	B-NP	JJR	O	16	AMOD
16	than	than	I-NP	IN	O	18	NMOD
17	1	1	I-NP	CD	O	16	AMOD
18	%	%	I-NP	NN	O	14	PMOD
19	)	)	O	)	O	12	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	levels	level	I-NP	NNS	O	12	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	NF	NF	B-NP	NN	B-protein	27	NMOD
24	(	(	O	(	I-protein	27	NMOD
25	kappa	kappa	B-NP	NN	I-protein	27	NMOD
26	)	)	O	)	I-protein	27	NMOD
27	B	B	B-NP	NN	I-protein	22	PMOD
28	(	(	O	(	O	32	DEP
29	but	but	O	CC	O	31	NMOD
30	not	not	O	RB	O	29	DEP
31	Oct-1	Oct-1	B-NP	NN	B-protein	32	DEP
32	)	)	O	)	O	27	NMOD
33	found	find	B-VP	VBN	O	27	NMOD
34	in	in	B-PP	IN	O	33	VMOD
35	nuclear	nuclear	B-NP	JJ	O	37	AMOD
36	and	and	I-NP	CC	O	37	AMOD
37	whole	whole	I-NP	JJ	O	39	NMOD
38	cell	cell	I-NP	NN	O	39	NMOD
39	extracts	extract	I-NP	NNS	O	34	PMOD
40	of	of	B-PP	IN	O	39	NMOD
41	activated	activate	B-NP	VBN	B-cell_type	43	NMOD
42	T	T	I-NP	NN	I-cell_type	43	NMOD
43	cells	cell	I-NP	NNS	I-cell_type	40	PMOD
44	.	.	O	.	O	8	P

1	NAC	NAC	B-NP	NN	O	4	SUB
2	not	not	B-CONJP	RB	O	4	VMOD
3	only	only	I-CONJP	RB	O	2	DEP
4	blocks	block	B-VP	VBZ	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	effect	effect	I-NP	NN	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	TPCK	TPCK	B-NP	NN	O	7	PMOD
9	but	but	O	CC	O	4	VMOD
10	enhances	enhance	B-VP	VBZ	O	4	VMOD
11	mitogenesis	mitogenesis	B-NP	NN	O	14	NMOD
12	and	and	O	CC	O	14	NMOD
13	cytokine	cytokine	B-NP	NN	B-protein	14	NMOD
14	production	production	I-NP	NN	O	10	OBJ
15	(	(	O	(	O	23	DEP
16	&	&	B-NP	CC	O	17	NMOD
17	gt	gt	I-NP	NN	O	23	DEP
18	;	;	O	:	O	17	P
19	2.5-fold	2.5-fold	B-ADVP	RB	O	20	PMOD
20	in	in	B-PP	IN	O	17	NMOD
21	some	some	B-NP	DT	O	22	NMOD
22	cases	case	I-NP	NNS	O	20	PMOD
23	)	)	O	)	O	10	VMOD
24	upon	upon	B-PP	IN	O	10	VMOD
25	activation	activation	B-NP	NN	O	24	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	unsuppressed	unsuppressed	B-NP	JJ	B-cell_type	29	NMOD
28	T	T	I-NP	NN	I-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
30	.	.	O	.	O	4	P

1	IL-12-induced	IL-12-induced	B-NP	JJ	O	2	NMOD
2	activation	activation	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NK	NK	B-NP	NN	B-cell_type	6	NMOD
5	and	and	O	CC	I-cell_type	6	NMOD
6	T	T	B-NP	NN	I-cell_type	7	NMOD
7	cells	cell	B-NP	NNS	I-cell_type	3	PMOD
8	occurs	occur	B-VP	VBZ	O	0	ROOT
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	absence	absence	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	immediate-early	immediate-early	B-NP	JJ	B-DNA	16	NMOD
14	activation	activation	I-NP	NN	I-DNA	16	NMOD
15	gene	gene	I-NP	NN	I-DNA	16	NMOD
16	expression	expression	I-NP	NN	O	12	PMOD
17	.	.	O	.	O	8	P

1	Using	Use	B-VP	VBG	O	8	VMOD
2	reverse-transcription	reverse-transcription	B-NP	NN	O	5	NMOD
3	PCR	PCR	I-NP	NN	O	5	NMOD
4	differential	differential	I-NP	JJ	O	5	NMOD
5	display	display	I-NP	NN	O	1	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	isolated	isolate	B-VP	VBD	O	0	ROOT
9	an	an	B-NP	DT	O	11	NMOD
10	mRNA	mRNA	I-NP	NN	B-RNA	11	NMOD
11	species	specie	I-NP	NNS	I-RNA	8	OBJ
12	expressed	express	B-VP	VBN	O	11	NMOD
13	in	in	B-PP	IN	O	12	VMOD
14	IL-2-	IL-2-	B-NP	NN	O	17	AMOD
15	but	but	B-CONJP	CC	O	17	AMOD
16	not	not	I-CONJP	RB	O	17	AMOD
17	IL-12-stimulated	IL-12-stimulated	B-NP	JJ	B-cell_line	19	NMOD
18	NK	NK	I-NP	NN	I-cell_line	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_line	13	PMOD
20	.	.	O	.	O	8	P

1	This	This	B-NP	DT	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	identified	identify	I-VP	VBN	O	2	VC
4	as	as	B-PP	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	mRNA	mRNA	I-NP	NN	B-RNA	4	PMOD
7	encoding	encode	B-VP	VBG	O	6	NMOD
8	the	the	B-NP	DT	O	11	NMOD
9	transcription	transcription	I-NP	NN	B-protein	11	NMOD
10	factor	factor	I-NP	NN	I-protein	11	NMOD
11	egr-1	egr-1	I-NP	NN	B-protein	7	OBJ
12	,	,	O	,	O	6	P
13	which	which	B-NP	WDT	O	6	NMOD
14	is	be	B-VP	VBZ	O	13	SBAR
15	expressed	express	I-VP	VBN	O	14	VC
16	with	with	B-PP	IN	O	15	VMOD
17	fast	fast	B-NP	JJ	O	18	NMOD
18	kinetics	kinetic	I-NP	NNS	O	16	PMOD
19	in	in	B-PP	IN	O	15	VMOD
20	T	T	B-NP	NN	B-cell_type	23	NMOD
21	and	and	I-NP	CC	I-cell_type	23	NMOD
22	NK	NK	I-NP	NN	I-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	19	PMOD
24	upon	upon	B-PP	IN	O	15	VMOD
25	IL-2	IL-2	B-NP	NN	B-protein	24	PMOD
26	,	,	O	,	O	24	P
27	but	but	O	CC	O	31	NMOD
28	not	not	O	RB	O	27	DEP
29	IL-12	IL-12	B-NP	NN	B-protein	31	NMOD
30	,	,	O	,	O	31	P
31	stimulation	stimulation	B-NP	NN	O	24	PMOD
32	.	.	O	.	O	2	P

1	Analysis	Analysis	B-NP	NN	O	14	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	accumulation	accumulation	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	mRNA-encoding	mRNA-encoding	B-NP	JJ	B-protein	7	NMOD
7	members	member	I-NP	NNS	I-protein	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	13	NMOD
10	AP-1	AP-1	I-NP	NN	B-protein	13	NMOD
11	transcription	transcription	I-NP	NN	I-protein	13	NMOD
12	factor	factor	I-NP	NN	I-protein	13	NMOD
13	family	family	I-NP	NN	I-protein	8	PMOD
14	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
15	that	that	B-SBAR	IN	O	14	VMOD
16	c-fos	c-fos	B-NP	NN	B-DNA	18	NMOD
17	and	and	O	CC	O	18	NMOD
18	junB	junB	B-NP	NN	B-DNA	19	SUB
19	are	be	B-VP	VBP	O	36	VMOD
20	also	also	I-VP	RB	O	19	VMOD
21	expressed	express	I-VP	VBN	O	19	VC
22	upon	upon	B-PP	IN	O	21	VMOD
23	stimulation	stimulation	B-NP	NN	O	22	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	NK	NK	B-NP	NN	B-cell_type	28	NMOD
26	and	and	O	CC	I-cell_type	28	NMOD
27	T	T	B-NP	NN	I-cell_type	28	NMOD
28	cells	cell	B-NP	NNS	I-cell_type	24	PMOD
29	with	with	B-PP	IN	O	23	NMOD
30	IL-2	IL-2	B-NP	NN	B-protein	34	NMOD
31	,	,	B-NP	,	O	34	P
32	but	but	I-NP	CC	O	34	NMOD
33	not	not	I-NP	RB	O	32	DEP
34	IL-12	IL-12	B-NP	NN	B-protein	29	PMOD
35	,	,	O	,	O	36	P
36	whereas	whereas	O	IN	O	15	SBAR
37	expression	expression	B-NP	NN	O	42	SUB
38	of	of	B-PP	IN	O	37	NMOD
39	c-jun	c-jun	B-NP	NN	B-DNA	41	NMOD
40	and	and	O	CC	O	41	NMOD
41	junD	junD	B-NP	NN	B-protein	38	PMOD
42	is	be	B-VP	VBZ	O	36	VMOD
43	not	not	I-VP	RB	O	42	VMOD
44	modified	modify	I-VP	VBN	O	42	VC
45	by	by	B-PP	IN	O	44	VMOD
46	either	either	B-NP	DT	O	47	NMOD
47	cytokine	cytokine	I-NP	NN	B-protein	45	PMOD
48	.	.	O	.	O	14	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	provide	provide	B-VP	VBP	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	first	first	I-NP	JJ	O	6	NMOD
6	demonstration	demonstration	I-NP	NN	O	3	OBJ
7	that	that	B-NP	IN	O	6	NMOD
8	IL-12-mediated	IL-12-mediated	B-NP	JJ	O	9	NMOD
9	activation	activation	I-NP	NN	O	15	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	T	T	B-NP	NN	B-cell_type	13	NMOD
12	and	and	I-NP	CC	I-cell_type	13	NMOD
13	NK	NK	I-NP	NN	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	10	PMOD
15	does	do	B-VP	VBZ	O	7	SBAR
16	not	not	I-VP	RB	O	15	VMOD
17	involve	involve	I-VP	VB	O	15	VC
18	expression	expression	B-NP	NN	O	42	NMOD
19	of	of	B-PP	IN	O	18	NMOD
20	members	member	B-NP	NNS	O	19	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	26	NMOD
23	immediate-early	immediate-early	I-NP	JJ	B-DNA	26	NMOD
24	activation	activation	I-NP	NN	I-DNA	26	NMOD
25	genes	gene	I-NP	NNS	I-DNA	26	NMOD
26	family	family	I-NP	NN	I-DNA	21	PMOD
27	(	(	O	(	O	34	DEP
28	egr-1	egr-1	B-NP	NN	B-DNA	33	NMOD
29	,	,	O	,	O	33	P
30	c-fos	c-fos	B-NP	NN	B-DNA	33	NMOD
31	,	,	O	,	O	33	P
32	and	and	O	CC	O	33	NMOD
33	junB	junB	B-NP	NN	B-DNA	34	DEP
34	)	)	O	)	O	26	NMOD
35	,	,	O	,	O	42	P
36	AP-1	AP-1	B-NP	NN	B-protein	38	NMOD
37	transcriptional	transcriptional	I-NP	JJ	O	38	NMOD
38	activity	activity	I-NP	NN	O	42	NMOD
39	,	,	O	,	O	42	P
40	or	or	O	CC	O	42	NMOD
41	bcl-2	bcl-2	B-NP	NN	B-protein	42	NMOD
42	expression	expression	I-NP	NN	O	17	OBJ
43	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	21	VMOD
2	,	,	O	,	O	21	P
3	in	in	B-PP	IN	O	21	VMOD
4	the	the	B-NP	DT	O	3	PMOD
5	absence	absence	I-NP	NN	O	3	PMOD
6	of	of	B-PP	IN	O	3	PMOD
7	exogenous	exogenous	B-NP	JJ	O	8	NMOD
8	HGFs	HGF	I-NP	NNS	B-protein	3	PMOD
9	,	,	O	,	O	21	P
10	FL	FL	B-NP	NN	B-cell_type	12	NMOD
11	monocytic	monocytic	I-NP	JJ	I-cell_type	12	NMOD
12	progenitors	progenitor	I-NP	NNS	I-cell_type	21	SUB
13	(	(	O	(	O	20	DEP
14	colony-forming	colony-forming	B-NP	JJ	B-cell_type	16	NMOD
15	unit	unit	I-NP	NN	I-cell_type	16	NMOD
16	monocyte	monocyte	I-NP	NN	I-cell_type	20	DEP
17	[	[	O	(	O	19	DEP
18	CFU-M	CFU-M	B-NP	NN	B-protein	19	DEP
19	]	]	O	)	O	16	NMOD
20	)	)	O	)	O	12	NMOD
21	generate	generate	B-VP	VBP	O	0	ROOT
22	large	large	B-NP	JJ	O	23	NMOD
23	colonies	colony	I-NP	NNS	O	21	OBJ
24	exclusively	exclusively	B-VP	RB	O	25	VMOD
25	composed	compose	I-VP	VBN	O	23	NMOD
26	of	of	B-PP	IN	O	25	VMOD
27	monocytes-macrophages	monocytes-macrophage	B-NP	NNS	B-cell_type	26	PMOD
28	;	;	O	:	O	21	P

1	these	these	B-NP	DT	O	2	NMOD
2	colonies	colony	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	absent	absent	B-ADJP	JJ	O	3	PRD
5	in	in	B-PP	IN	O	4	AMOD
6	FCS-	FCS-	B-NP	NN	B-cell_line	8	NMOD
7	clonogenic	clonogenic	I-NP	JJ	I-cell_line	8	NMOD
8	culture	culture	I-NP	NN	I-cell_line	5	PMOD
9	.	.	O	.	O	3	P

1	Studies	Study	B-NP	NNS	O	10	SUB
2	on	on	B-PP	IN	O	1	NMOD
3	unicellular	unicellular	B-NP	JJ	B-cell_line	5	AMOD
4	and	and	I-NP	CC	I-cell_line	5	AMOD
5	paired	paired	I-NP	JJ	I-cell_line	8	NMOD
6	daughter	daughter	I-NP	NN	I-cell_line	8	NMOD
7	cell	cell	I-NP	NN	I-cell_line	8	NMOD
8	culture	culture	I-NP	NN	I-cell_line	2	PMOD
9	unequivocally	unequivocally	B-ADVP	RB	O	10	VMOD
10	indicate	indicate	B-VP	VBP	O	0	ROOT
11	that	that	B-SBAR	IN	O	10	VMOD
12	the	the	B-NP	DT	O	13	NMOD
13	shift	shift	I-NP	NN	O	14	SUB
14	is	be	B-VP	VBZ	O	11	SBAR
15	mediated	mediate	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	modulation	modulation	B-NP	NN	O	31	NMOD
18	of	of	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	22	NMOD
20	HPC	HPC	I-NP	NN	B-cell_type	22	NMOD
21	differentiation	differentiation	I-NP	NN	O	22	NMOD
22	program	program	I-NP	NN	O	18	PMOD
23	to	to	B-PP	TO	O	17	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	granulopoietic	granulopoietic	I-NP	JJ	O	26	NMOD
26	pathway	pathway	I-NP	NN	O	23	PMOD
27	(	(	O	(	O	31	NMOD
28	rather	rather	B-PP	RB	O	31	NMOD
29	than	than	I-PP	IN	O	28	DEP
30	RA-induced	RA-induced	B-NP	JJ	O	31	NMOD
31	down-modulation	down-modulation	I-NP	NN	O	16	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	multipotent/erythroid/monocytic	multipotent/erythroid/monocytic	B-NP	JJ	O	35	NMOD
34	HPC	HPC	I-NP	NN	O	35	NMOD
35	growth	growth	I-NP	NN	O	32	PMOD
36	coupled	couple	B-VP	VBN	O	35	NMOD
37	with	with	B-PP	IN	O	36	VMOD
38	recruitment	recruitment	B-NP	NN	O	37	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	granulocytic	granulocytic	B-NP	JJ	B-cell_type	41	NMOD
41	HPCs	HPC	I-NP	NNS	I-cell_type	39	PMOD
42	)	)	O	)	O	31	NMOD
43	.	.	O	.	O	10	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	crucial	crucial	B-ADJP	JJ	O	2	PRD
4	that	that	B-SBAR	IN	O	2	VMOD
5	these	these	B-NP	DT	O	6	NMOD
6	results	result	I-NP	NNS	O	7	SUB
7	mirror	mirror	B-VP	VBP	O	4	SBAR
8	recent	recent	B-NP	JJ	O	9	NMOD
9	observations	observation	I-NP	NNS	O	7	OBJ
10	indicating	indicate	B-VP	VBG	O	9	NMOD
11	that	that	B-SBAR	IN	O	10	VMOD
12	murine	murine	B-NP	JJ	O	14	NMOD
13	adult	adult	I-NP	JJ	O	14	NMOD
14	HPCs	HPC	I-NP	NNS	B-cell_type	25	SUB
15	transduced	transduce	B-VP	VBN	O	14	NMOD
16	with	with	B-PP	IN	O	15	VMOD
17	dominant	dominant	B-NP	JJ	B-protein	20	NMOD
18	negative	negative	I-NP	JJ	I-protein	20	NMOD
19	ATRA	ATRA	I-NP	NN	I-protein	20	NMOD
20	receptor	receptor	I-NP	NN	I-protein	24	NMOD
21	(	(	O	(	O	23	DEP
22	RAR	RAR	B-NP	NN	B-protein	23	DEP
23	)	)	O	)	O	20	NMOD
24	gene	gene	B-NP	NN	O	16	PMOD
25	are	be	B-VP	VBP	O	11	SBAR
26	immortalized	immortalize	I-VP	VBN	O	25	PRD
27	and	and	O	CC	O	25	VMOD
28	show	show	B-VP	VBP	O	25	VMOD
29	a	a	B-NP	DT	O	31	NMOD
30	selective	selective	I-NP	JJ	O	31	NMOD
31	blockade	blockade	I-NP	NN	O	28	OBJ
32	of	of	B-PP	IN	O	31	NMOD
33	granulocytic	granulocytic	B-NP	JJ	O	34	NMOD
34	differentiation	differentiation	I-NP	NN	O	32	PMOD
35	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	15	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	15	P
4	neither	neither	O	CC	O	9	NMOD
5	the	the	B-NP	DT	O	9	NMOD
6	RA-stimulated	RA-stimulated	I-NP	JJ	O	8	AMOD
7	,	,	I-NP	,	O	8	P
8	RARE-mediated	RARE-mediated	I-NP	JJ	O	9	NMOD
9	transcription	transcription	I-NP	NN	O	14	NMOD
10	nor	nor	O	CC	O	14	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	induced	induce	I-NP	VBN	O	14	NMOD
13	RAR-beta	RAR-beta	I-NP	NN	B-protein	14	NMOD
14	expression	expression	I-NP	NN	O	15	SUB
15	was	be	B-VP	VBD	O	0	ROOT
16	suppressed	suppress	I-VP	VBN	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	VitD3	VitD3	B-NP	NN	O	17	PMOD
19	,	,	O	,	O	16	P
20	suggesting	suggest	B-VP	VBG	O	16	VMOD
21	that	that	B-SBAR	IN	O	20	VMOD
22	VitD3	VitD3	B-NP	NN	O	24	SUB
23	selectively	selectively	B-ADVP	RB	O	24	VMOD
24	inhibited	inhibit	B-VP	VBD	O	21	SBAR
25	the	the	B-NP	DT	O	28	NMOD
26	retinoid-induced	retinoid-induced	I-NP	JJ	O	28	NMOD
27	differentiation	differentiation	I-NP	NN	O	28	NMOD
28	program	program	I-NP	NN	O	33	NMOD
29	but	but	B-NP	CC	O	33	NMOD
30	not	not	I-NP	RB	O	29	DEP
31	the	the	B-NP	DT	O	33	NMOD
32	RARE-mediated	RARE-mediated	I-NP	JJ	O	33	NMOD
33	signal	signal	I-NP	NN	O	24	OBJ
34	.	.	O	.	O	15	P

1	Pb-induced	Pb-induced	B-NP	JJ	O	2	NMOD
2	activation	activation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappa	NF-kappa	B-NP	NN	B-protein	5	NMOD
5	B	B	I-NP	NN	I-protein	3	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	blocked	block	I-VP	VBN	O	6	VC
8	by	by	B-PP	IN	O	7	VMOD
9	antibodies	antibody	B-NP	NNS	B-protein	8	PMOD
10	for	for	B-PP	IN	O	9	NMOD
11	p65	p65	B-NP	NN	B-protein	13	NMOD
12	and	and	I-NP	CC	O	13	NMOD
13	p50	p50	I-NP	NN	B-protein	14	NMOD
14	subunits	subunit	I-NP	NNS	I-protein	17	NMOD
15	but	but	B-NP	CC	O	17	NMOD
16	not	not	I-NP	RB	O	15	DEP
17	cRel	cRel	B-NP	NN	B-protein	10	PMOD
18	,	,	O	,	O	7	P
19	indicating	indicate	B-VP	VBG	O	7	VMOD
20	that	that	B-SBAR	IN	O	19	VMOD
21	the	the	B-NP	DT	O	25	NMOD
22	p65	p65	I-NP	NN	B-protein	25	NMOD
23	:	:	O	:	I-protein	25	P
24	p50	p50	B-NP	NN	I-protein	25	NMOD
25	heterodimer	heterodimer	I-NP	NN	I-protein	30	SUB
26	(	(	O	(	O	29	DEP
27	NF-kappa	NF-kappa	B-NP	NN	B-protein	28	NMOD
28	B	B	I-NP	NN	I-protein	29	DEP
29	)	)	O	)	O	25	NMOD
30	is	be	B-VP	VBZ	O	20	SBAR
31	involved	involve	I-VP	VBN	O	30	VC
32	.	.	O	.	O	6	P

1	Pb	Pb	B-NP	NN	O	2	SUB
2	did	do	B-VP	VBD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	activate	activate	I-VP	VB	O	2	VC
5	NF-kappa	NF-kappa	B-NP	NN	B-protein	6	NMOD
6	B	B	I-NP	NN	I-protein	4	OBJ
7	in	in	B-PP	IN	O	4	VMOD
8	4	4	B-NP	CD	O	12	NMOD
9	different	different	I-NP	JJ	O	12	NMOD
10	T	T	I-NP	NN	B-cell_line	12	NMOD
11	cell	cell	I-NP	NN	I-cell_line	12	NMOD
12	lines	line	I-NP	NNS	I-cell_line	7	PMOD
13	,	,	O	,	O	4	P
14	suggesting	suggest	B-VP	VBG	O	4	VMOD
15	that	that	B-SBAR	IN	O	14	VMOD
16	lymphoid	lymphoid	B-NP	JJ	B-cell_line	18	NMOD
17	cell	cell	I-NP	NN	I-cell_line	18	NMOD
18	lines	line	I-NP	NNS	I-cell_line	19	SUB
19	may	may	B-VP	MD	O	15	SBAR
20	not	not	I-VP	RB	O	19	VMOD
21	be	be	I-VP	VB	O	19	VC
22	reliable	reliable	B-NP	JJ	O	23	NMOD
23	surrogates	surrogate	I-NP	NNS	O	21	PRD
24	for	for	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	study	study	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	transcriptional	transcriptional	B-NP	JJ	O	29	NMOD
29	activation	activation	I-NP	NN	O	27	PMOD
30	in	in	B-PP	IN	O	29	NMOD
31	human	human	B-NP	JJ	B-cell_type	33	NMOD
32	T	T	I-NP	NN	I-cell_type	33	NMOD
33	cells	cell	I-NP	NNS	I-cell_type	30	PMOD
34	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	p2l	p2l	B-NP	NN	B-protein	7	NMOD
6	(	(	O	(	I-protein	7	NMOD
7	ras	ras	B-NP	NN	I-protein	9	SUB
8	)	)	O	)	I-protein	7	NMOD
9	is	be	B-VP	VBZ	O	4	SBAR
10	an	an	B-NP	DT	O	12	NMOD
11	essential	essential	I-NP	JJ	O	12	NMOD
12	mediator	mediator	I-NP	NN	O	9	PRD
13	in	in	B-PP	IN	O	12	NMOD
14	generating	generate	B-VP	VBG	O	13	PMOD
15	not	not	B-CONJP	RB	O	14	VMOD
16	only	only	I-CONJP	RB	O	15	DEP
17	positive	positive	B-ADJP	JJ	O	22	NMOD
18	but	but	B-CONJP	CC	O	22	NMOD
19	also	also	I-CONJP	RB	O	18	DEP
20	negative	negative	B-NP	JJ	O	22	NMOD
21	modulatory	modulatory	I-NP	JJ	O	22	NMOD
22	mechanisms	mechanism	I-NP	NNS	O	15	PMOD
23	controlling	control	B-VP	VBG	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	competence	competence	I-NP	NN	O	23	OBJ
26	of	of	B-PP	IN	O	25	NMOD
27	T	T	B-NP	NN	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	in	in	B-PP	IN	O	23	VMOD
30	response	response	B-NP	NN	O	29	PMOD
31	to	to	B-PP	TO	O	29	PMOD
32	inductive	inductive	B-NP	JJ	O	33	NMOD
33	stimulations	stimulation	I-NP	NNS	O	29	PMOD
34	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	catalytic	catalytic	I-NP	JJ	B-protein	3	NMOD
3	domain	domain	I-NP	NN	I-protein	14	NMOD
4	of	of	B-PP	IN	O	3	NMOD
5	pp56	pp56	B-NP	NN	B-protein	7	NMOD
6	(	(	O	(	I-protein	7	NMOD
7	lck	lck	B-NP	NN	I-protein	4	PMOD
8	)	)	O	)	I-protein	7	NMOD
9	,	,	O	,	O	14	P
10	but	but	O	CC	O	14	NMOD
11	not	not	O	RB	O	10	DEP
12	its	its	B-NP	PRP$	O	14	NMOD
13	regulatory	regulatory	I-NP	JJ	B-protein	14	NMOD
14	domain	domain	I-NP	NN	I-protein	16	SUB
15	,	,	O	,	O	14	P
16	is	be	B-VP	VBZ	O	0	ROOT
17	sufficient	sufficient	B-ADJP	JJ	O	16	PRD
18	for	for	B-PP	IN	O	17	AMOD
19	inducing	induce	B-VP	VBG	O	18	PMOD
20	IL-2	IL-2	B-NP	NN	B-protein	21	NMOD
21	production	production	I-NP	NN	O	19	OBJ
22	.	.	O	.	O	16	P

1	Two	Two	B-NP	CD	O	6	NMOD
2	pp56	pp56	I-NP	NN	B-protein	6	NMOD
3	(	(	O	(	I-protein	6	NMOD
4	lck	lck	B-NP	NN	I-protein	6	NMOD
5	)	)	O	)	I-protein	6	NMOD
6	mutants	mutant	B-NP	NNS	I-protein	19	SUB
7	lacking	lack	B-VP	VBG	O	6	NMOD
8	either	either	O	CC	O	18	NMOD
9	the	the	B-NP	DT	O	12	NMOD
10	entire	entire	I-NP	JJ	O	12	NMOD
11	catalytic	catalytic	I-NP	JJ	B-protein	12	NMOD
12	domain	domain	I-NP	NN	I-protein	18	NMOD
13	or	or	O	CC	O	18	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	entire	entire	I-NP	JJ	O	18	NMOD
16	NH2	NH2	I-NP	NN	B-protein	18	NMOD
17	regulatory	regulatory	I-NP	JJ	B-protein	18	NMOD
18	domain	domain	I-NP	NN	I-protein	7	OBJ
19	were	be	B-VP	VBD	O	45	VMOD
20	generated	generate	I-VP	VBN	O	19	VC
21	,	,	O	,	O	45	P
22	and	and	O	CC	O	45	VMOD
23	their	their	B-NP	PRP$	O	24	NMOD
24	abilities	ability	I-NP	NNS	O	45	SUB
25	to	to	B-VP	TO	O	26	VMOD
26	trigger	trigger	I-VP	VB	O	24	NMOD
27	transactivation	transactivation	B-NP	NN	O	26	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	the	the	B-NP	DT	O	32	NMOD
30	TCR-regulated	TCR-regulated	I-NP	JJ	B-protein	32	NMOD
31	nuclear	nuclear	I-NP	JJ	I-protein	32	NMOD
32	factor	factor	I-NP	NN	I-protein	40	NMOD
33	of	of	B-PP	IN	O	32	NMOD
34	activated	activate	B-NP	VBN	O	36	NMOD
35	T	T	I-NP	NN	O	36	NMOD
36	cells	cell	I-NP	NNS	O	33	PMOD
37	(	(	O	(	O	39	DEP
38	NF-AT	NF-AT	B-NP	NN	B-protein	39	DEP
39	)	)	O	)	O	32	NMOD
40	region	region	B-NP	NN	O	28	PMOD
41	of	of	B-PP	IN	O	40	NMOD
42	the	the	B-NP	DT	O	44	NMOD
43	IL-2	IL-2	I-NP	NN	B-DNA	44	NMOD
44	promoter	promoter	I-NP	NN	I-DNA	41	PMOD
45	were	be	B-VP	VBD	O	0	ROOT
46	compared	compare	I-VP	VBN	O	45	VC
47	.	.	O	.	O	45	P

1	Only	Only	B-NP	RB	O	11	NMOD
2	the	the	I-NP	DT	O	3	NMOD
3	catalytic	catalytic	I-NP	JJ	O	8	NMOD
4	,	,	I-NP	,	O	8	P
5	but	but	I-NP	CC	O	8	NMOD
6	not	not	I-NP	RB	O	5	DEP
7	the	the	B-NP	DT	O	8	NMOD
8	NH2	NH2	I-NP	NN	B-protein	11	NMOD
9	regulatory	regulatory	B-ADJP	JJ	O	8	NMOD
10	,	,	O	,	O	11	P
11	domain	domain	B-NP	NN	O	17	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	pp56	pp56	B-NP	NN	B-protein	15	NMOD
14	(	(	O	(	I-protein	15	NMOD
15	lck	lck	B-NP	NN	I-protein	12	PMOD
16	)	)	O	)	I-protein	15	NMOD
17	was	be	B-VP	VBD	O	0	ROOT
18	able	able	B-ADJP	JJ	O	17	PRD
19	to	to	B-VP	TO	O	20	VMOD
20	induce	induce	I-VP	VB	O	18	AMOD
21	NF-AT	NF-AT	B-NP	NN	B-protein	23	NMOD
22	region	region	I-NP	NN	O	23	NMOD
23	transactivation	transactivation	I-NP	NN	O	20	OBJ
24	on	on	B-PP	IN	O	20	VMOD
25	its	its	B-NP	PRP$	O	26	NMOD
26	own	own	I-NP	JJ	O	24	PMOD
27	and	and	O	CC	O	20	VMOD
28	to	to	B-VP	TO	O	29	VMOD
29	cooperate	cooperate	I-VP	VB	O	20	VMOD
30	with	with	B-PP	IN	O	29	VMOD
31	other	other	B-NP	JJ	O	33	NMOD
32	intracellular	intracellular	I-NP	JJ	O	33	NMOD
33	signals	signal	I-NP	NNS	O	30	PMOD
34	to	to	B-VP	TO	O	35	VMOD
35	trigger	trigger	I-VP	VB	O	29	VMOD
36	this	this	B-NP	DT	O	37	NMOD
37	response	response	I-NP	NN	O	35	OBJ
38	.	.	O	.	O	17	P

1	Induction	Induction	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	fra-1	fra-1	B-NP	NN	B-DNA	2	PMOD
4	following	follow	B-PP	VBG	O	1	NMOD
5	engagement	engagement	B-NP	NN	O	4	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	CD40	CD40	B-NP	NN	B-protein	6	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	require	require	I-VP	VB	O	8	VC
11	protein	protein	B-NP	NN	O	12	NMOD
12	synthesis	synthesis	I-NP	NN	O	10	OBJ
13	,	,	O	,	O	10	P
14	suggesting	suggest	B-VP	VBG	O	10	VMOD
15	that	that	B-SBAR	IN	O	14	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	PKC-dependent	PKC-dependent	I-NP	JJ	O	18	NMOD
18	linkage	linkage	I-NP	NN	O	23	SUB
19	between	between	B-PP	IN	O	18	NMOD
20	CD40	CD40	B-NP	NN	B-protein	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	fra-1	fra-1	I-NP	NN	B-DNA	19	PMOD
23	is	be	B-VP	VBZ	O	15	SBAR
24	direct	direct	B-ADJP	JJ	O	23	PRD
25	.	.	O	.	O	8	P

1	Overexpression	Overexpression	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Bcl-2	Bcl-2	B-NP	NN	B-protein	2	PMOD
4	in	in	B-PP	IN	O	1	NMOD
5	tumor	tumor	B-NP	NN	B-cell_type	6	NMOD
6	cells	cell	I-NP	NNS	I-cell_type	4	PMOD
7	blocks	block	B-VP	VBZ	O	19	VMOD
8	apoptosis	apoptosis	B-NP	NN	O	7	OBJ
9	induced	induce	B-VP	VBN	O	8	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	many	many	B-NP	JJ	O	12	NMOD
12	stimuli	stimulus	I-NP	NNS	O	10	PMOD
13	,	,	O	,	O	19	P
14	but	but	O	CC	O	19	VMOD
15	inhibition	inhibition	B-NP	NN	O	19	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	Fas-mediated	Fas-mediated	B-NP	JJ	O	18	NMOD
18	killing	killing	I-NP	NN	O	16	PMOD
19	has	have	B-VP	VBZ	O	0	ROOT
20	not	not	I-VP	RB	O	19	VMOD
21	been	be	I-VP	VBN	O	19	VC
22	consistently	consistently	I-VP	RB	O	21	VMOD
23	observed	observe	I-VP	VBN	O	21	VC
24	.	.	O	.	O	19	P

1	Transient	Transient	B-NP	JJ	O	2	NMOD
2	overexpression	overexpression	I-NP	NN	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	Bcl-2	Bcl-2	B-NP	NN	B-protein	3	PMOD
5	in	in	B-PP	IN	O	2	NMOD
6	mouse	mouse	B-NP	NN	O	11	NMOD
7	and	and	O	CC	O	6	DEP
8	human	human	B-NP	JJ	B-cell_type	6	DEP
9	T	T	B-NP	NN	I-cell_type	11	NMOD
10	cell	cell	I-NP	NN	I-cell_type	11	NMOD
11	blasts	blast	I-NP	NNS	I-cell_type	5	PMOD
12	did	do	B-VP	VBD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	block	block	I-VP	VB	O	12	VC
15	Fas-mediated	Fas-mediated	B-NP	JJ	O	16	NMOD
16	apoptosis	apoptosis	I-NP	NN	O	14	OBJ
17	,	,	O	,	O	12	P
18	whereas	whereas	O	IN	O	12	VMOD
19	etoposide-	etoposide-	B-NP	NN	O	21	AMOD
20	and	and	O	CC	O	21	AMOD
21	glucocorticoid-induced	glucocorticoid-induced	B-NP	JJ	O	22	NMOD
22	cytotoxicity	cytotoxicity	I-NP	NN	O	23	SUB
23	was	be	B-VP	VBD	O	18	SBAR
24	potently	potently	I-VP	RB	O	23	VMOD
25	inhibited	inhibit	I-VP	VBN	O	23	VC
26	.	.	O	.	O	12	P

1	Expression	Expression	B-NP	NN	O	8	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	Bcl-xL	Bcl-xL	B-NP	NN	B-protein	7	NMOD
4	and	and	I-NP	CC	O	7	NMOD
5	adenovirus	adenovirus	I-NP	NN	B-protein	7	NMOD
6	E1B	E1B	I-NP	NN	I-protein	7	NMOD
7	19K	19K	I-NP	NN	I-protein	2	PMOD
8	did	do	B-VP	VBD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	interfere	interfere	I-VP	VB	O	8	VC
11	with	with	B-PP	IN	O	10	VMOD
12	anti-Fas	anti-Fas	B-NP	JJ	O	13	NMOD
13	killing	killing	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	5	NMOD
2	last	last	I-NP	JJ	B-protein	5	NMOD
3	13	13	I-NP	CD	I-protein	5	NMOD
4	amino	amino	I-NP	NN	I-protein	5	NMOD
5	acids	acid	I-NP	NNS	I-protein	10	SUB
6	containing	contain	B-VP	VBG	O	5	NMOD
7	a	a	B-NP	DT	O	9	NMOD
8	PXQXT/S	PXQXT/S	I-NP	NN	B-DNA	9	NMOD
9	sequence	sequence	I-NP	NN	I-DNA	6	OBJ
10	are	be	B-VP	VBP	O	0	ROOT
11	highly	highly	I-VP	RB	O	12	VMOD
12	conserved	conserve	I-VP	VBN	O	10	VC
13	in	in	B-PP	IN	O	12	VMOD
14	human	human	B-NP	JJ	O	16	AMOD
15	and	and	I-NP	CC	O	16	AMOD
16	simian	simian	I-NP	JJ	O	18	NMOD
17	EBV	EBV	I-NP	NN	O	18	NMOD
18	LMP1	LMP1	I-NP	NN	B-protein	13	PMOD
19	but	but	O	CC	O	10	VMOD
20	do	do	B-VP	VBP	O	10	VMOD
21	not	not	I-VP	RB	O	20	VMOD
22	bind	bind	I-VP	VB	O	20	VC
23	TRAF3	TRAF3	B-NP	NN	B-protein	22	OBJ
24	,	,	O	,	O	10	P
25	suggesting	suggest	B-VP	VBG	O	10	VMOD
26	a	a	B-NP	DT	O	28	NMOD
27	distinct	distinct	I-NP	JJ	O	28	NMOD
28	role	role	I-NP	NN	O	25	OBJ
29	for	for	B-PP	IN	O	28	NMOD
30	this	this	B-NP	DT	O	32	NMOD
31	conserved	conserve	I-NP	VBN	O	32	NMOD
32	region	region	I-NP	NN	O	29	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	LMP1	LMP1	B-NP	NN	B-protein	33	PMOD
35	.	.	O	.	O	10	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	report	report	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	sustained	sustained	B-NP	JJ	O	7	NMOD
6	high	high	I-NP	JJ	O	7	NMOD
7	concentrations	concentration	I-NP	NNS	O	14	NMOD
8	of	of	B-PP	IN	O	7	NMOD
9	Ca2+	Ca2+	B-NP	NN	O	8	PMOD
10	,	,	O	,	O	14	P
11	but	but	O	CC	O	14	NMOD
12	not	not	O	RB	O	11	DEP
13	transient	transient	B-NP	JJ	O	14	NMOD
14	pulses	pulse	I-NP	NNS	O	16	SUB
15	,	,	O	,	O	14	P
16	are	be	B-VP	VBP	O	4	SBAR
17	required	require	I-VP	VBN	O	16	VC
18	to	to	I-VP	TO	O	19	VMOD
19	maintain	maintain	I-VP	VB	O	17	VMOD
20	NF-AT	NF-AT	B-NP	NN	B-protein	22	NMOD
21	transcription	transcription	I-NP	NN	B-protein	22	NMOD
22	factors	factor	I-NP	NNS	I-protein	19	OBJ
23	in	in	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	25	NMOD
25	nucleus	nucleus	I-NP	NN	O	23	PMOD
26	,	,	O	,	O	25	P
27	where	where	B-ADVP	WRB	O	25	NMOD
28	they	they	B-NP	PRP	O	29	SUB
29	participate	participate	B-VP	VBP	O	27	SBAR
30	in	in	B-PP	IN	O	29	VMOD
31	Ca2+-dependent	Ca2+-dependent	B-NP	JJ	O	32	NMOD
32	induction	induction	I-NP	NN	O	30	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	genes	gene	B-NP	NNS	B-DNA	33	PMOD
35	required	require	B-VP	VBN	O	34	NMOD
36	for	for	B-PP	IN	O	35	VMOD
37	lymphocyte	lymphocyte	B-NP	NN	B-cell_type	36	PMOD
38	activation	activation	B-NP	NN	O	40	NMOD
39	and	and	O	CC	O	40	NMOD
40	proliferation	proliferation	B-NP	NN	O	37	NMOD
41	.	.	O	.	O	3	P

1	Furthermore	Furthermore	B-ADVP	RB	O	25	VMOD
2	,	,	O	,	O	25	P
3	overexpression	overexpression	B-NP	NN	O	7	NMOD
4	and	and	O	CC	O	7	NMOD
5	constitutive	constitutive	B-NP	JJ	O	7	NMOD
6	nuclear	nuclear	I-NP	JJ	O	7	NMOD
7	localization	localization	I-NP	NN	O	25	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	NF-AT	NF-AT	B-NP	NN	B-protein	23	NMOD
10	,	,	B-NP	,	O	23	P
11	but	but	I-NP	CC	O	23	NMOD
12	not	not	I-NP	RB	O	11	DEP
13	Jun	Jun	B-NP	NN	B-protein	23	NMOD
14	,	,	O	,	O	23	P
15	Fos	Fos	B-NP	NN	B-protein	23	NMOD
16	,	,	O	,	O	23	P
17	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	23	NMOD
18	,	,	O	,	O	23	P
19	Oct	Oct	B-NP	NN	B-protein	23	NMOD
20	or	or	O	CC	O	23	NMOD
21	Ets	Ets	B-NP	NN	B-protein	23	NMOD
22	family	family	I-NP	NN	I-protein	23	NMOD
23	members	member	I-NP	NNS	I-protein	8	PMOD
24	,	,	O	,	O	7	P
25	renders	render	B-VP	VBZ	O	0	ROOT
26	the	the	B-NP	DT	O	28	NMOD
27	interleukin-2	interleukin-2	I-NP	NN	B-DNA	28	NMOD
28	enhancer	enhancer	I-NP	NN	I-DNA	25	OBJ
29	in	in	B-PP	IN	O	28	NMOD
30	Jurkat	Jurkat	B-NP	NN	B-cell_line	32	NMOD
31	T	T	I-NP	NN	I-cell_line	32	NMOD
32	lymphocytes	lymphocyte	I-NP	NNS	I-cell_line	29	PMOD
33	resistant	resistant	B-ADJP	JJ	O	32	NMOD
34	to	to	B-PP	TO	O	33	AMOD
35	FK506	FK506	B-NP	NN	O	38	NMOD
36	and	and	O	CC	O	38	NMOD
37	cyclosporin	cyclosporin	B-NP	NN	O	38	NMOD
38	A	A	I-NP	NN	O	34	PMOD
39	.	.	O	.	O	25	P

1	However	However	B-ADVP	RB	O	7	VMOD
2	,	,	O	,	O	7	P
3	IFN	IFN	B-NP	NN	B-protein	5	NMOD
4	(	(	O	(	I-protein	5	NMOD
5	alpha	alpha	B-NP	NN	I-protein	7	SUB
6	)	)	O	)	I-protein	5	NMOD
7	does	do	B-VP	VBZ	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	have	have	I-VP	VB	O	7	VC
10	any	any	B-NP	DT	O	11	NMOD
11	effects	effect	I-NP	NNS	O	9	OBJ
12	on	on	B-PP	IN	O	9	VMOD
13	the	the	B-NP	DT	O	15	NMOD
14	retinoid-dependent	retinoid-dependent	I-NP	JJ	O	15	NMOD
15	regulation	regulation	I-NP	NN	O	12	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	the	the	B-NP	DT	O	20	NMOD
18	myeloid	myeloid	I-NP	JJ	B-protein	20	NMOD
19	surface	surface	I-NP	NN	I-protein	20	NMOD
20	markers	marker	I-NP	NNS	I-protein	16	PMOD
21	CD11b	CD11b	I-NP	NN	B-protein	23	NMOD
22	and	and	I-NP	CC	O	23	NMOD
23	CD33	CD33	I-NP	NN	B-protein	20	NMOD
24	.	.	O	.	O	7	P

1	The	The	B-NP	DT	O	3	NMOD
2	IFN-dependent	IFN-dependent	I-NP	JJ	O	3	NMOD
3	increase	increase	I-NP	NN	O	13	NMOD
4	in	in	B-PP	IN	O	3	NMOD
5	RAR	RAR	B-NP	NN	B-protein	7	NMOD
6	(	(	O	(	I-protein	7	NMOD
7	alpha	alpha	B-NP	NN	I-protein	9	NMOD
8	)	)	O	)	I-protein	7	NMOD
9	levels	level	B-NP	NNS	O	4	PMOD
10	and	and	O	CC	O	13	NMOD
11	the	the	B-NP	DT	O	13	NMOD
12	enhancing	enhancing	I-NP	NN	O	13	NMOD
13	effect	effect	I-NP	NN	O	22	SUB
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	16	NMOD
16	cytokine	cytokine	I-NP	NN	B-protein	14	PMOD
17	on	on	B-PP	IN	O	13	NMOD
18	retinoid-dependent	retinoid-dependent	B-NP	JJ	B-protein	21	NMOD
19	granulocytic	granulocytic	I-NP	JJ	I-protein	21	NMOD
20	markers	marker	I-NP	NNS	I-protein	21	NMOD
21	expression	expression	I-NP	NN	O	17	PMOD
22	may	may	B-VP	MD	O	0	ROOT
23	be	be	I-VP	VB	O	22	VC
24	a	a	B-NP	DT	O	25	NMOD
25	characteristic	characteristic	I-NP	NN	O	23	PRD
26	of	of	B-PP	IN	O	25	NMOD
27	PML-RAR	PML-RAR	B-NP	NN	B-cell_line	29	NMOD
28	positive	positive	I-NP	JJ	I-cell_line	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_line	26	PMOD
30	,	,	O	,	O	23	P
31	since	since	B-SBAR	IN	O	23	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	phenomena	phenomenon	I-NP	NNS	O	34	SUB
34	are	be	B-VP	VBP	O	31	SBAR
35	not	not	I-VP	RB	O	34	VMOD
36	observed	observe	I-VP	VBN	O	34	VC
37	in	in	B-PP	IN	O	36	VMOD
38	HL-60	HL-60	B-NP	NN	B-cell_line	39	NMOD
39	promyelocytes	promyelocyte	I-NP	NNS	I-cell_line	37	PMOD
40	.	.	O	.	O	22	P

1	Interferons	Interferon	B-NP	NNS	B-protein	5	NMOD
2	as	as	B-CONJP	RB	O	5	NMOD
3	well	well	I-CONJP	RB	O	2	DEP
4	as	as	I-CONJP	IN	O	2	DEP
5	retinoids	retinoid	B-NP	NNS	O	6	SUB
6	inhibit	inhibit	B-VP	VBP	O	0	ROOT
7	the	the	B-NP	DT	O	8	NMOD
8	growth	growth	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	NB4	NB4	B-NP	NN	B-cell_line	11	NMOD
11	cells	cell	I-NP	NNS	I-cell_line	9	PMOD
12	,	,	O	,	O	6	P
13	although	although	B-SBAR	IN	O	6	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	2	2	I-NP	CD	O	16	NMOD
16	classes	class	I-NP	NNS	O	19	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	compounds	compound	B-NP	NNS	O	17	PMOD
19	do	do	B-VP	VBP	O	13	SBAR
20	not	not	I-VP	RB	O	19	VMOD
21	significantly	significantly	I-VP	RB	O	19	VMOD
22	interact	interact	I-VP	VB	O	19	VC
23	in	in	B-PP	IN	O	22	VMOD
24	terms	term	B-NP	NNS	O	23	PMOD
25	of	of	B-PP	IN	O	24	NMOD
26	anti-proliferative	anti-proliferative	B-NP	JJ	O	27	NMOD
27	activity	activity	I-NP	NN	O	25	PMOD
28	.	.	O	.	O	6	P

1	We	We	B-NP	PRP	O	2	SUB
2	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	although	although	B-SBAR	IN	O	19	VMOD
5	the	the	B-NP	DT	O	7	NMOD
6	individual	individual	I-NP	JJ	O	7	NMOD
7	components	component	I-NP	NNS	O	11	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	this	this	B-NP	DT	O	10	NMOD
10	element	element	I-NP	NN	O	8	PMOD
11	do	do	B-VP	VBP	O	4	SBAR
12	not	not	I-VP	RB	O	11	VMOD
13	respond	respond	I-VP	VB	O	11	VC
14	to	to	B-PP	TO	O	13	VMOD
15	IL-2	IL-2	B-NP	NN	B-protein	14	PMOD
16	,	,	O	,	O	19	P
17	together	together	B-ADVP	RB	O	19	VMOD
18	they	they	B-NP	PRP	O	19	SUB
19	form	form	B-VP	VBP	O	3	SBAR
20	a	a	B-NP	DT	O	22	NMOD
21	composite	composite	I-NP	JJ	B-DNA	22	NMOD
22	element	element	I-NP	NN	I-DNA	19	OBJ
23	capable	capable	B-ADJP	JJ	O	22	NMOD
24	of	of	B-PP	IN	O	23	AMOD
25	conferring	confer	B-VP	VBG	O	24	PMOD
26	IL-2	IL-2	B-NP	NN	B-protein	27	NMOD
27	responsiveness	responsiveness	I-NP	NN	O	25	OBJ
28	to	to	B-PP	TO	O	27	NMOD
29	a	a	B-NP	DT	O	31	NMOD
30	heterologous	heterologous	I-NP	JJ	B-DNA	31	NMOD
31	promoter	promoter	I-NP	NN	I-DNA	28	PMOD
32	.	.	O	.	O	2	P

1	Thus	Thus	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	IL-2-induced	IL-2-induced	B-NP	JJ	O	7	NMOD
4	IL-2R	IL-2R	I-NP	NN	O	7	NMOD
5	alpha	alpha	I-NP	NN	O	7	NMOD
6	promoter	promoter	I-NP	NN	O	7	NMOD
7	activity	activity	I-NP	NN	O	8	SUB
8	requires	require	B-VP	VBZ	O	0	ROOT
9	a	a	B-NP	DT	O	12	NMOD
10	complex	complex	I-NP	JJ	B-DNA	12	NMOD
11	upstream	upstream	I-NP	JJ	I-DNA	12	NMOD
12	element	element	I-NP	NN	I-DNA	8	OBJ
13	,	,	O	,	O	12	P
14	which	which	B-NP	WDT	O	12	NMOD
15	appears	appear	B-VP	VBZ	O	14	SBAR
16	to	to	I-VP	TO	O	17	VMOD
17	contain	contain	I-VP	VB	O	15	VMOD
18	binding	bind	B-NP	VBG	B-DNA	19	NMOD
19	sites	site	I-NP	NNS	I-DNA	17	OBJ
20	for	for	B-PP	IN	O	19	NMOD
21	both	both	B-NP	CC	O	24	AMOD
22	positive	positive	I-NP	JJ	B-protein	24	AMOD
23	and	and	I-NP	CC	I-protein	24	AMOD
24	negative	negative	I-NP	JJ	I-protein	26	NMOD
25	regulatory	regulatory	I-NP	JJ	I-protein	26	NMOD
26	factors	factor	I-NP	NNS	I-protein	20	PMOD
27	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	2	NMOD
2	nature	nature	I-NP	NN	O	14	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	CD40-dependent	CD40-dependent	B-NP	JJ	O	5	NMOD
5	signals	signal	I-NP	NNS	O	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	proliferating	proliferate	B-VP	VBG	B-cell_type	13	NMOD
8	fresh	fresh	B-NP	JJ	I-cell_type	13	NMOD
9	human	human	I-NP	JJ	I-cell_type	13	NMOD
10	Epstein-Barr	Epstein-Barr	I-NP	JJ	I-cell_type	13	NMOD
11	virus-negative	virus-negative	I-NP	JJ	I-cell_type	13	NMOD
12	B	B	I-NP	NN	I-cell_type	13	NMOD
13	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	6	PMOD
14	is	be	B-VP	VBZ	O	0	ROOT
15	currently	currently	B-ADJP	RB	O	14	VMOD
16	unknown	unknown	I-ADJP	JJ	O	14	PRD
17	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	2	NMOD
2	use	use	I-NP	NN	O	16	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	14	NMOD
5	protein	protein	I-NP	NN	B-protein	7	NMOD
6	tyrosine	tyrosine	I-NP	NN	I-protein	7	NMOD
7	kinase	kinase	I-NP	NN	I-protein	11	AMOD
8	(	(	O	(	O	10	DEP
9	PTK	PTK	B-NP	NN	B-protein	10	DEP
10	)	)	O	)	O	7	NMOD
11	-specific	-specific	B-NP	JJ	O	14	NMOD
12	inhibitor	inhibitor	I-NP	NN	O	14	NMOD
13	herbimycin	herbimycin	I-NP	NN	O	14	NMOD
14	A	A	I-NP	NN	O	3	PMOD
15	dramatically	dramatically	B-ADVP	RB	O	16	VMOD
16	decreased	decrease	B-VP	VBD	O	0	ROOT
17	cellular	cellular	B-NP	JJ	O	18	NMOD
18	proliferation	proliferation	I-NP	NN	O	16	OBJ
19	without	without	B-PP	IN	O	16	VMOD
20	altering	alter	B-VP	VBG	O	19	PMOD
21	the	the	B-NP	DT	O	22	NMOD
22	activity	activity	I-NP	NN	O	20	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	30	NMOD
25	human	human	I-NP	JJ	B-DNA	30	NMOD
26	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	30	NMOD
27	virus-1	virus-1	I-NP	NN	I-DNA	30	NMOD
28	long	long	I-NP	JJ	I-DNA	30	NMOD
29	terminal	terminal	I-NP	JJ	I-DNA	30	NMOD
30	repeat	repeat	I-NP	NN	I-DNA	37	NMOD
31	(	(	O	(	O	34	DEP
32	HIV-1	HIV-1	B-NP	NN	B-DNA	33	NMOD
33	LTR	LTR	I-NP	NN	I-DNA	34	DEP
34	)	)	O	)	O	30	NMOD
35	,	,	O	,	O	37	P
36	a	a	B-NP	DT	O	37	NMOD
37	promoter	promoter	I-NP	NN	B-DNA	23	PMOD
38	largely	largely	B-ADJP	RB	O	39	AMOD
39	dependent	dependent	I-ADJP	JJ	O	37	NMOD
40	on	on	B-PP	IN	O	39	AMOD
41	the	the	B-NP	DT	O	42	NMOD
42	binding	binding	I-NP	NN	O	40	PMOD
43	of	of	B-PP	IN	O	42	NMOD
44	nuclear	nuclear	B-NP	JJ	B-protein	47	NMOD
45	factor	factor	I-NP	NN	I-protein	47	NMOD
46	kappa	kappa	I-NP	NN	I-protein	47	NMOD
47	B	B	I-NP	NN	I-protein	43	PMOD
48	(	(	O	(	O	51	DEP
49	NF-kappa	NF-kappa	B-NP	NN	B-protein	50	NMOD
50	B	B	I-NP	NN	I-protein	51	DEP
51	)	)	O	)	O	47	NMOD
52	.	.	O	.	O	16	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	the	the	B-NP	DT	O	10	NMOD
5	cAMP-dependent	cAMP-dependent	I-NP	JJ	B-protein	7	NMOD
6	protein	protein	I-NP	NN	I-protein	7	NMOD
7	kinase	kinase	I-NP	NN	I-protein	8	AMOD
8	specific	specific	I-NP	JJ	O	10	NMOD
9	inhibitor	inhibitor	I-NP	NN	O	10	NMOD
10	H-89	H-89	I-NP	NN	O	12	SUB
11	totally	totally	B-ADVP	RB	O	12	VMOD
12	inhibited	inhibit	B-VP	VBD	O	0	ROOT
13	HIV-1	HIV-1	B-NP	NN	B-DNA	15	NMOD
14	LTR	LTR	I-NP	NN	I-DNA	15	NMOD
15	activity	activity	I-NP	NN	O	12	OBJ
16	at	at	B-PP	IN	O	12	VMOD
17	a	a	B-NP	DT	O	18	NMOD
18	concentration	concentration	I-NP	NN	O	16	PMOD
19	as	as	B-ADJP	RB	O	21	AMOD
20	low	low	I-ADJP	JJ	O	21	AMOD
21	as	as	B-PP	IN	O	18	NMOD
22	100	100	B-NP	CD	O	21	AMOD
23	nM	nM	I-NP	NN	O	21	PMOD
24	without	without	B-PP	IN	O	12	VMOD
25	affecting	affect	B-VP	VBG	O	24	PMOD
26	cellular	cellular	B-NP	JJ	O	27	NMOD
27	proliferation	proliferation	I-NP	NN	O	25	OBJ
28	.	.	O	.	O	12	P

1	While	While	B-SBAR	IN	O	21	VMOD
2	PKC	PKC	B-NP	NN	B-protein	3	NMOD
3	depletion	depletion	I-NP	NN	O	4	SUB
4	did	do	B-VP	VBD	O	1	SBAR
5	not	not	I-VP	RB	O	4	VMOD
6	alter	alter	I-VP	VB	O	4	VC
7	the	the	B-NP	DT	O	10	NMOD
8	NF-kappa	NF-kappa	I-NP	NN	B-protein	10	NMOD
9	B	B	I-NP	NN	I-protein	10	NMOD
10	level	level	I-NP	NN	O	6	OBJ
11	,	,	O	,	O	21	P
12	treatment	treatment	B-NP	NN	O	21	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	B	B	B-NP	NN	B-cell_type	15	NMOD
15	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	13	PMOD
16	with	with	B-PP	IN	O	12	NMOD
17	H-89	H-89	B-NP	NN	B-protein	20	NMOD
18	or	or	I-NP	CC	O	20	NMOD
19	herbimycin	herbimycin	I-NP	NN	O	20	NMOD
20	A	A	I-NP	NN	O	16	PMOD
21	provoked	provoke	B-VP	VBD	O	0	ROOT
22	a	a	B-NP	DT	O	23	NMOD
23	decrease	decrease	I-NP	NN	O	21	OBJ
24	in	in	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	NF-kappa	NF-kappa	I-NP	NN	B-protein	28	NMOD
27	B	B	I-NP	NN	I-protein	28	NMOD
28	level	level	I-NP	NN	O	24	PMOD
29	.	.	O	.	O	21	P

1	Active	Active	B-NP	JJ	O	2	NMOD
2	suppression	suppression	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	9	NMOD
5	class	class	I-NP	NN	B-DNA	9	NMOD
6	II	II	I-NP	CD	I-DNA	9	NMOD
7	transactivator-encoding	transactivator-encoding	I-NP	JJ	I-DNA	9	NMOD
8	AIR-1	AIR-1	I-NP	NN	I-DNA	9	NMOD
9	locus	locus	I-NP	NN	I-DNA	3	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	responsible	responsible	B-ADJP	JJ	O	10	PRD
12	for	for	B-PP	IN	O	11	AMOD
13	the	the	B-NP	DT	O	14	NMOD
14	lack	lack	I-NP	NN	O	12	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	major	major	B-NP	JJ	B-DNA	21	NMOD
17	histocompatibility	histocompatibility	I-NP	NN	I-DNA	21	NMOD
18	complex	complex	I-NP	NN	I-DNA	21	NMOD
19	class	class	I-NP	NN	I-DNA	21	NMOD
20	II	II	I-NP	CD	I-DNA	21	NMOD
21	gene	gene	I-NP	NN	I-DNA	22	NMOD
22	expression	expression	I-NP	NN	O	15	PMOD
23	observed	observe	B-VP	VBN	O	22	NMOD
24	during	during	B-PP	IN	O	23	VMOD
25	differentiation	differentiation	B-NP	NN	O	24	PMOD
26	from	from	B-PP	IN	O	25	NMOD
27	B	B	B-NP	NN	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	to	to	B-PP	TO	O	25	NMOD
30	plasma	plasma	B-NP	NN	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	29	PMOD
32	.	.	O	.	O	10	P

1	Class	Class	B-NP	NN	B-protein	3	NMOD
2	II	II	B-NP	CD	I-protein	3	NMOD
3	molecules	molecule	I-NP	NNS	I-protein	4	SUB
4	are	be	B-VP	VBP	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	expressed	express	I-VP	VBN	O	4	VC
7	in	in	B-PP	IN	O	6	VMOD
8	plasma	plasma	B-NP	NN	B-cell_type	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_type	7	PMOD
10	because	because	B-PP	IN	O	6	VMOD
11	of	of	I-PP	IN	O	10	PMOD
12	an	an	B-NP	DT	O	14	NMOD
13	active	active	I-NP	JJ	O	14	NMOD
14	suppression	suppression	I-NP	NN	O	10	PMOD
15	resulting	result	B-VP	VBG	O	14	NMOD
16	in	in	B-PP	IN	O	15	VMOD
17	the	the	B-NP	DT	O	18	NMOD
18	abrogation	abrogation	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	class	class	B-NP	NN	B-DNA	23	NMOD
21	II	II	I-NP	CD	I-DNA	23	NMOD
22	gene	gene	I-NP	NN	I-DNA	23	NMOD
23	transcription	transcription	I-NP	NN	O	19	PMOD
24	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	show	show	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	2	VMOD
5	the	the	B-NP	DT	O	9	NMOD
6	plasma	plasma	I-NP	NN	B-protein	9	NMOD
7	cell-specific	cell-specific	I-NP	JJ	I-protein	6	AMOD
8	repressor	repressor	I-NP	NN	I-protein	9	NMOD
9	function	function	I-NP	NN	O	21	SUB
10	,	,	O	,	O	9	P
11	designated	designate	B-VP	VBN	O	9	NMOD
12	SIR	SIR	B-NP	NN	B-DNA	11	VMOD
13	(	(	O	(	O	19	DEP
14	suppressor	suppressor	B-NP	NN	O	19	DEP
15	of	of	B-PP	IN	O	14	NMOD
16	immune	immune	B-NP	JJ	B-DNA	18	NMOD
17	response	response	I-NP	NN	I-DNA	18	NMOD
18	genes	gene	I-NP	NNS	I-DNA	15	PMOD
19	)	)	O	)	O	12	NMOD
20	,	,	O	,	O	9	P
21	does	do	B-VP	VBZ	O	4	SBAR
22	not	not	I-VP	RB	O	21	VMOD
23	act	act	I-VP	VB	O	21	VC
24	directly	directly	B-ADVP	RB	O	23	VMOD
25	on	on	B-PP	IN	O	23	VMOD
26	the	the	B-NP	DT	O	27	NMOD
27	transcription	transcription	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	class	class	B-NP	NN	B-DNA	31	NMOD
30	II	II	I-NP	CD	I-DNA	31	NMOD
31	genes	gene	I-NP	NNS	I-DNA	28	PMOD
32	,	,	O	,	O	21	P
33	but	but	O	CC	O	21	VMOD
34	instead	instead	B-ADVP	RB	O	21	VMOD
35	on	on	B-PP	IN	O	34	AMOD
36	the	the	B-NP	DT	O	37	NMOD
37	transcription	transcription	I-NP	NN	O	35	PMOD
38	of	of	B-PP	IN	O	37	NMOD
39	the	the	B-NP	DT	O	41	NMOD
40	AIR-1	AIR-1	I-NP	NN	B-DNA	41	NMOD
41	gene	gene	I-NP	NN	I-DNA	44	NMOD
42	,	,	O	,	O	41	P
43	whose	whose	B-NP	WP$	O	44	NMOD
44	product	product	I-NP	NN	O	49	NMOD
45	,	,	O	,	O	49	P
46	the	the	B-NP	DT	O	49	NMOD
47	class	class	I-NP	NN	B-protein	49	NMOD
48	II	II	I-NP	CD	I-protein	49	NMOD
49	transactivator	transactivator	I-NP	NN	I-protein	38	PMOD
50	(	(	O	(	O	52	DEP
51	CIITA	CIITA	B-NP	NN	B-protein	52	DEP
52	)	)	O	)	O	49	NMOD
53	,	,	O	,	O	21	P
54	is	be	B-VP	VBZ	O	21	VMOD
55	fundamental	fundamental	B-ADJP	JJ	O	54	PRD
56	for	for	B-PP	IN	O	55	AMOD
57	the	the	B-NP	DT	O	58	NMOD
58	regulation	regulation	I-NP	NN	O	56	PMOD
59	of	of	B-PP	IN	O	58	NMOD
60	the	the	B-NP	DT	O	64	NMOD
61	constitutive	constitutive	I-NP	JJ	O	63	AMOD
62	and	and	I-NP	CC	O	63	AMOD
63	inducible	inducible	I-NP	JJ	O	64	NMOD
64	expression	expression	I-NP	NN	O	59	PMOD
65	of	of	B-PP	IN	O	64	NMOD
66	MHC	MHC	B-NP	NN	B-DNA	69	NMOD
67	class	class	I-NP	NN	I-DNA	69	NMOD
68	II	II	B-NP	CD	I-DNA	69	NMOD
69	genes	gene	I-NP	NNS	I-DNA	65	PMOD
70	.	.	O	.	O	2	P

1	This	This	B-NP	DT	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	unambiguously	unambiguously	I-VP	RB	O	2	VMOD
4	demonstrated	demonstrate	I-VP	VBN	O	2	VC
5	by	by	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	fact	fact	I-NP	NN	O	5	PMOD
8	that	that	B-SBAR	IN	O	7	NMOD
9	plasmacytoma	plasmacytoma	B-NP	NN	B-cell_line	13	NMOD
10	x	x	I-NP	NN	I-cell_line	13	NMOD
11	B	B	I-NP	NN	I-cell_line	13	NMOD
12	cell	cell	I-NP	NN	I-cell_line	13	NMOD
13	hybrids	hybrid	I-NP	NNS	I-cell_line	22	SUB
14	carrying	carry	B-VP	VBG	O	13	NMOD
15	an	an	B-NP	DT	O	17	NMOD
16	AIR-1	AIR-1	I-NP	NN	B-DNA	17	NMOD
17	locus	locus	I-NP	NN	I-DNA	14	OBJ
18	derived	derive	B-VP	VBN	O	17	NMOD
19	from	from	B-PP	IN	O	18	VMOD
20	CIITA-expressing	CIITA-expressing	B-NP	JJ	B-cell_line	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_line	19	PMOD
22	do	do	B-VP	VBP	O	8	SBAR
23	not	not	I-VP	RB	O	22	VMOD
24	express	express	I-VP	VB	O	22	VC
25	CIITA-specific	CIITA-specific	B-NP	JJ	B-RNA	26	NMOD
26	transcripts	transcript	I-NP	NNS	I-RNA	24	OBJ
27	.	.	O	.	O	2	P

1	Interestingly	Interestingly	B-ADVP	RB	O	16	VMOD
2	,	,	O	,	O	16	P
3	in	in	B-PP	IN	O	16	VMOD
4	CIITA-transfected	CIITA-transfected	B-NP	JJ	B-cell_line	6	NMOD
5	cell	cell	I-NP	NN	I-cell_line	6	NMOD
6	hybrids	hybrid	I-NP	NNS	I-cell_line	3	PMOD
7	,	,	O	,	O	16	P
8	cell	cell	B-NP	NN	O	10	NMOD
9	surface	surface	I-NP	NN	O	10	NMOD
10	expression	expression	I-NP	NN	O	16	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	human	human	I-NP	JJ	B-protein	15	NMOD
14	HLA-DQ	HLA-DQ	I-NP	NN	I-protein	15	NMOD
15	heterodimer	heterodimer	I-NP	NN	I-protein	11	PMOD
16	was	be	B-VP	VBD	O	0	ROOT
17	not	not	I-VP	RB	O	16	VMOD
18	observed	observe	I-VP	VBN	O	16	VC
19	.	.	O	.	O	16	P

1	This	This	B-NP	DT	O	2	NMOD
2	result	result	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	not	not	O	RB	O	3	VMOD
5	attributable	attributable	B-ADJP	JJ	O	3	PRD
6	to	to	B-PP	TO	O	5	AMOD
7	lack	lack	B-NP	NN	O	6	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	HLA-DQ	HLA-DQ	B-NP	NN	B-protein	10	NMOD
10	alpha	alpha	I-NP	NN	I-protein	13	NMOD
11	or	or	O	CC	O	13	NMOD
12	-DQ	-DQ	B-NP	NN	O	13	NMOD
13	beta	beta	I-NP	NN	O	14	NMOD
14	transcription	transcription	I-NP	NN	O	8	PMOD
15	,	,	O	,	O	3	P
16	because	because	B-SBAR	IN	O	3	VMOD
17	both	both	B-NP	DT	O	18	NMOD
18	transcripts	transcript	I-NP	NNS	O	19	SUB
19	were	be	B-VP	VBD	O	16	SBAR
20	present	present	B-ADJP	JJ	O	19	PRD
21	in	in	B-PP	IN	O	20	AMOD
22	the	the	B-NP	DT	O	24	NMOD
23	CIITA-transfected	CIITA-transfected	I-NP	JJ	B-cell_line	24	NMOD
24	hybrids	hybrid	I-NP	NNS	I-cell_line	21	PMOD
25	,	,	O	,	O	19	P
26	although	although	B-SBAR	IN	O	19	VMOD
27	at	at	B-PP	IN	O	26	DEP
28	reduced	reduce	B-NP	VBN	O	29	NMOD
29	levels	level	I-NP	NNS	O	27	PMOD
30	.	.	O	.	O	3	P

1	Lobular	Lobular	B-NP	JJ	O	3	AMOD
2	or	or	I-NP	CC	O	3	AMOD
3	mucinous	mucinous	I-NP	JJ	O	4	NMOD
4	samples	sample	I-NP	NNS	O	5	SUB
5	showed	show	B-VP	VBD	O	11	VMOD
6	few	few	B-ADJP	JJ	O	9	NMOD
7	or	or	O	CC	O	6	AMOD
8	no	no	B-NP	DT	O	6	AMOD
9	alterations	alteration	I-NP	NNS	O	5	OBJ
10	,	,	O	,	O	11	P
11	whereas	whereas	O	IN	O	0	ROOT
12	most	most	B-NP	JJS	O	14	NMOD
13	ductal	ductal	I-NP	JJ	O	14	NMOD
14	samples	sample	I-NP	NNS	O	15	SUB
15	had	have	B-VP	VBD	O	11	VMOD
16	high	high	B-NP	JJ	O	19	NMOD
17	chromosome	chromosome	I-NP	NN	B-DNA	19	NMOD
18	1	1	I-NP	CD	I-DNA	19	NMOD
19	polysomy	polysomy	I-NP	NN	O	15	OBJ
20	with	with	B-PP	IN	O	19	NMOD
21	under-representation	under-representation	B-NP	NN	O	20	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	1p36	1p36	B-NP	NN	B-DNA	22	PMOD
24	.	.	O	.	O	11	P

1	No	No	B-NP	DT	O	2	NMOD
2	correlation	correlation	I-NP	NN	O	28	SUB
3	between	between	B-PP	IN	O	2	NMOD
4	chromosome	chromosome	B-NP	NN	B-DNA	6	NMOD
5	1	1	I-NP	CD	I-DNA	6	NMOD
6	alterations	alteration	I-NP	NNS	O	27	NMOD
7	and	and	O	CC	O	13	NMOD
8	nuclear	nuclear	B-NP	JJ	O	13	NMOD
9	grade	grade	I-NP	NN	O	13	NMOD
10	,	,	O	,	O	13	P
11	age	age	B-NP	NN	O	13	NMOD
12	,	,	O	,	O	13	P
13	size	size	B-NP	NN	O	6	NMOD
14	,	,	O	,	O	27	P
15	lymph-node	lymph-node	B-NP	JJ	O	16	NMOD
16	involvement	involvement	I-NP	NN	O	27	NMOD
17	,	,	O	,	O	27	P
18	hormonal	hormonal	B-NP	JJ	O	20	NMOD
19	receptor	receptor	I-NP	NN	O	20	NMOD
20	presence	presence	I-NP	NN	O	27	NMOD
21	,	,	O	,	O	27	P
22	proliferation	proliferation	B-NP	NN	O	23	NMOD
23	activity	activity	I-NP	NN	O	27	NMOD
24	or	or	O	CC	O	27	NMOD
25	p53	p53	B-NP	NN	B-protein	27	NMOD
26	protein	protein	I-NP	NN	O	27	NMOD
27	expression	expression	I-NP	NN	O	3	PMOD
28	was	be	B-VP	VBD	O	0	ROOT
29	detected	detect	I-VP	VBN	O	28	VC
30	.	.	O	.	O	28	P

1	Silencing	Silencing	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	human	human	B-NP	JJ	B-protein	6	NMOD
4	fetal	fetal	I-NP	JJ	I-protein	6	NMOD
5	globin	globin	I-NP	NN	I-protein	6	NMOD
6	expression	expression	I-NP	NN	O	2	PMOD
7	is	be	B-VP	VBZ	O	0	ROOT
8	impaired	impaired	B-ADJP	JJ	O	7	PRD
9	in	in	B-PP	IN	O	8	AMOD
10	the	the	B-NP	DT	O	11	NMOD
11	absence	absence	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	19	NMOD
14	adult	adult	I-NP	JJ	B-protein	19	NMOD
15	beta-globin	beta-globin	I-NP	NN	I-protein	19	NMOD
16	gene	gene	I-NP	NN	I-protein	19	NMOD
17	activator	activator	I-NP	NN	I-protein	19	NMOD
18	protein	protein	I-NP	NN	I-protein	19	NMOD
19	EKLF	EKLF	I-NP	NN	B-protein	12	PMOD
20	.	.	O	.	O	7	P

1	We	We	B-NP	PRP	O	2	SUB
2	find	find	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	in	in	B-PP	IN	O	20	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	absence	absence	I-NP	NN	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	EKLF	EKLF	B-NP	NN	B-protein	7	PMOD
9	,	,	O	,	O	20	P
10	while	while	B-SBAR	IN	O	20	VMOD
11	human	human	B-NP	JJ	B-protein	13	NMOD
12	beta-globin	beta-globin	I-NP	NN	I-protein	13	NMOD
13	expression	expression	I-NP	NN	O	14	SUB
14	is	be	B-VP	VBZ	O	10	SBAR
15	dramatically	dramatically	I-VP	RB	O	14	VMOD
16	reduced	reduce	I-VP	VBN	O	14	VC
17	,	,	O	,	O	20	P
18	gamma-globin	gamma-globin	B-NP	NN	B-RNA	19	NMOD
19	transcripts	transcript	I-NP	NNS	I-RNA	20	SUB
20	are	be	B-VP	VBP	O	3	SBAR
21	elevated	elevate	I-VP	VBN	O	20	VC
22	approximately	approximately	B-ADVP	RB	O	21	VMOD
23	5-fold	5-fold	I-ADVP	RB	O	22	AMOD
24	.	.	O	.	O	2	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	are	be	B-VP	VBP	O	0	ROOT
4	compatible	compatible	B-ADJP	JJ	O	3	PRD
5	with	with	B-PP	IN	O	4	AMOD
6	a	a	B-NP	DT	O	8	NMOD
7	competitive	competitive	I-NP	JJ	O	8	NMOD
8	model	model	I-NP	NN	O	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	switching	switching	B-NP	NN	O	9	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	which	which	B-NP	WDT	O	11	PMOD
13	EKLF	EKLF	B-NP	NN	B-protein	11	PMOD
14	mediates	mediate	B-VP	VBZ	O	3	VMOD
15	an	an	B-NP	DT	O	18	NMOD
16	adult	adult	I-NP	JJ	O	18	NMOD
17	stage-specific	stage-specific	I-NP	JJ	O	18	NMOD
18	interaction	interaction	I-NP	NN	O	14	OBJ
19	between	between	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	beta-globin	beta-globin	I-NP	NN	B-DNA	23	NMOD
22	gene	gene	I-NP	NN	I-DNA	23	NMOD
23	promoter	promoter	I-NP	NN	I-DNA	28	NMOD
24	and	and	O	CC	O	28	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	locus	locus	I-NP	NN	B-DNA	28	NMOD
27	control	control	I-NP	NN	I-DNA	28	NMOD
28	region	region	I-NP	NN	I-DNA	19	PMOD
29	that	that	B-NP	WDT	O	28	NMOD
30	excludes	exclude	B-VP	VBZ	O	29	SBAR
31	the	the	B-NP	DT	O	33	NMOD
32	gamma-globin	gamma-globin	I-NP	NN	B-DNA	33	NMOD
33	gene	gene	I-NP	NN	I-DNA	30	OBJ
34	.	.	O	.	O	3	P

1	it	it	B-NP	PRP	O	2	SUB
2	had	have	B-VP	VBD	O	0	ROOT
3	no	no	B-NP	DT	O	4	NMOD
4	effect	effect	I-NP	NN	O	2	OBJ
5	on	on	B-PP	IN	O	2	VMOD
6	IL-10	IL-10	B-NP	NN	B-protein	7	NMOD
7	secretion	secretion	I-NP	NN	O	5	PMOD
8	.	.	O	.	O	2	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	stress	stress	B-NP	NN	O	4	SUB
4	may	may	B-VP	MD	O	0	ROOT
5	cause	cause	I-VP	VB	O	4	VC
6	a	a	B-NP	DT	O	8	NMOD
7	selective	selective	I-NP	JJ	O	8	NMOD
8	suppression	suppression	I-NP	NN	O	14	NMOD
9	of	of	B-PP	IN	O	8	NMOD
10	TH1	TH1	B-NP	NN	O	11	NMOD
11	functions	function	I-NP	NNS	O	9	PMOD
12	and	and	O	CC	O	14	NMOD
13	a	a	B-NP	DT	O	14	NMOD
14	shift	shift	I-NP	NN	O	5	OBJ
15	toward	toward	B-PP	IN	O	14	NMOD
16	a	a	B-NP	DT	O	19	NMOD
17	TH2	TH2	I-NP	NN	B-protein	19	NMOD
18	cytokine	cytokine	I-NP	NN	I-protein	19	NMOD
19	pattern	pattern	I-NP	NN	O	24	NMOD
20	rather	rather	B-CONJP	RB	O	24	NMOD
21	than	than	I-CONJP	IN	O	20	DEP
22	generalized	generalize	B-NP	VBN	O	24	NMOD
23	TH	TH	I-NP	NN	O	24	NMOD
24	suppression	suppression	I-NP	NN	O	15	PMOD
25	.	.	O	.	O	4	P

1	RT-PCR	RT-PCR	B-NP	NN	O	2	SUB
2	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	NL	NL	B-NP	NNP	B-cell_type	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	both	both	B-NP	DT	O	7	NMOD
7	subtypes	subtype	I-NP	NNS	O	5	PMOD
8	expressed	express	B-VP	VBD	O	3	SBAR
9	EBNAI	EBNAI	B-NP	NN	B-protein	8	OBJ
10	of	of	B-PP	IN	O	9	NMOD
11	the	the	B-NP	DT	O	14	NMOD
12	QUK	QUK	I-NP	NN	O	14	NMOD
13	splice	splice	I-NP	NN	O	14	NMOD
14	pattern	pattern	I-NP	NN	O	10	PMOD
15	,	,	O	,	O	2	P
16	the	the	B-NP	DT	O	19	NMOD
17	latent	latent	I-NP	JJ	B-protein	19	NMOD
18	membrane	membrane	I-NP	NN	I-protein	19	NMOD
19	proteins	protein	I-NP	NNS	I-protein	23	NMOD
20	,	,	O	,	O	23	P
21	LMP1	LMP1	B-NP	NN	B-protein	23	NMOD
22	and	and	O	CC	I-protein	23	NMOD
23	2	2	B-NP	CD	I-protein	29	NMOD
24	and	and	O	CC	O	29	NMOD
25	the	the	B-NP	DT	O	29	NMOD
26	BamHI	BamHI	I-NP	NN	B-RNA	29	NMOD
27	A	A	I-NP	NN	I-RNA	29	NMOD
28	rightward	rightward	I-NP	JJ	I-RNA	29	NMOD
29	transcripts	transcript	I-NP	NNS	I-RNA	2	VMOD
30	in	in	B-PP	IN	O	29	NMOD
31	the	the	B-NP	DT	O	32	NMOD
32	absence	absence	I-NP	NN	O	30	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	EBNA2	EBNA2	B-NP	NN	B-RNA	35	NMOD
35	mRNAs	mRNA	I-NP	NNS	I-RNA	33	PMOD
36	,	,	O	,	O	29	P
37	compatible	compatible	B-ADJP	JJ	O	29	NMOD
38	with	with	B-PP	IN	O	37	AMOD
39	the	the	B-NP	DT	O	43	NMOD
40	latency	latency	I-NP	NN	O	43	NMOD
41	type	type	I-NP	NN	O	43	NMOD
42	II	II	I-NP	CD	O	43	NMOD
43	pattern	pattern	I-NP	NN	O	38	PMOD
44	.	.	O	.	O	2	P

1	Although	Although	B-SBAR	IN	O	30	VMOD
2	2	2	B-NP	CD	B-RNA	5	NMOD
3	early	early	I-NP	JJ	I-RNA	5	NMOD
4	lytic	lytic	I-NP	JJ	I-RNA	5	NMOD
5	transcripts	transcript	I-NP	NNS	I-RNA	9	NMOD
6	,	,	O	,	O	9	P
7	BZLF1	BZLF1	B-NP	NN	B-protein	9	NMOD
8	and	and	O	CC	O	9	NMOD
9	BHRF1	BHRF1	B-NP	NN	B-protein	11	SUB
10	,	,	O	,	O	9	P
11	were	be	B-VP	VBD	O	1	SBAR
12	also	also	I-VP	RB	O	11	VMOD
13	detected	detect	I-VP	VBN	O	11	VC
14	in	in	B-PP	IN	O	13	VMOD
15	13	13	B-NP	CD	O	17	AMOD
16	and	and	I-NP	CC	O	17	AMOD
17	10	10	I-NP	CD	O	18	NMOD
18	cases	case	I-NP	NNS	O	14	PMOD
19	,	,	O	,	O	11	P
20	respectively	respectively	B-ADVP	RB	O	11	VMOD
21	,	,	O	,	O	30	P
22	the	the	B-NP	DT	O	23	NMOD
23	lack	lack	I-NP	NN	O	30	SUB
24	of	of	B-PP	IN	O	23	NMOD
25	ZEBRA	ZEBRA	B-NP	NN	B-protein	26	NMOD
26	staining	staining	I-NP	NN	O	24	PMOD
27	in	in	B-PP	IN	O	23	NMOD
28	any	any	B-NP	DT	O	29	NMOD
29	case	case	I-NP	NN	O	27	PMOD
30	indicates	indicate	B-VP	VBZ	O	0	ROOT
31	that	that	B-SBAR	IN	O	30	VMOD
32	these	these	B-NP	DT	O	34	NMOD
33	lytic	lytic	I-NP	JJ	B-RNA	34	NMOD
34	transcripts	transcript	I-NP	NNS	I-RNA	35	SUB
35	are	be	B-VP	VBP	O	31	SBAR
36	most	most	I-VP	RBS	O	37	AMOD
37	likely	likely	I-VP	RB	O	38	VMOD
38	expressed	express	I-VP	VBN	O	35	VC
39	by	by	B-PP	IN	O	38	VMOD
40	rare	rare	B-NP	JJ	B-cell_type	41	NMOD
41	cells	cell	I-NP	NNS	I-cell_type	39	PMOD
42	in	in	B-PP	IN	O	41	NMOD
43	the	the	B-NP	DT	O	44	NMOD
44	biopsies	biopsy	I-NP	NNS	O	42	PMOD
45	entering	enter	B-VP	VBG	O	44	NMOD
46	lytic	lytic	B-NP	JJ	O	47	NMOD
47	cycle	cycle	I-NP	NN	O	45	OBJ
48	.	.	O	.	O	30	P

1	Lack	Lack	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	IL-12	IL-12	B-NP	NN	B-protein	4	NMOD
4	signaling	signaling	I-NP	NN	O	2	PMOD
5	in	in	B-PP	IN	O	1	NMOD
6	human	human	B-NP	JJ	B-cell_line	9	NMOD
7	allergen-specific	allergen-specific	I-NP	JJ	I-cell_line	9	NMOD
8	Th2	Th2	I-NP	NN	I-cell_line	9	NMOD
9	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
10	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	2	NMOD
2	majority	majority	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	these	these	B-NP	DT	O	5	NMOD
5	TCC	TCC	I-NP	NN	B-cell_line	3	PMOD
6	exhibited	exhibit	B-VP	VBD	O	19	VMOD
7	a	a	B-NP	DT	O	12	NMOD
8	strongly	strongly	I-NP	RB	O	9	AMOD
9	polarized	polarize	I-NP	VBN	O	12	NMOD
10	Th2	Th2	I-NP	NN	O	12	NMOD
11	cytokine	cytokine	I-NP	NN	B-protein	12	NMOD
12	profile	profile	I-NP	NN	O	6	OBJ
13	,	,	O	,	O	19	P
14	and	and	O	CC	O	19	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	production	production	I-NP	NN	O	19	SUB
17	of	of	B-PP	IN	O	16	NMOD
18	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	17	PMOD
19	could	could	B-VP	MD	O	0	ROOT
20	not	not	I-VP	RB	O	19	VMOD
21	be	be	I-VP	VB	O	19	VC
22	induced	induce	I-VP	VBN	O	21	VC
23	by	by	B-PP	IN	O	22	VMOD
24	exogenous	exogenous	B-NP	JJ	O	25	NMOD
25	IL-12	IL-12	I-NP	NN	B-protein	23	PMOD
26	.	.	O	.	O	19	P

1	Only	Only	B-NP	RB	O	3	NMOD
2	those	those	I-NP	DT	O	3	NMOD
3	TCC	TCC	I-NP	NN	B-cell_line	13	SUB
4	with	with	B-PP	IN	O	3	NMOD
5	low	low	B-NP	JJ	O	7	NMOD
6	IFN-gamma	IFN-gamma	I-NP	NN	B-protein	7	NMOD
7	levels	level	I-NP	NNS	O	4	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	absence	absence	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	IL-12	IL-12	B-NP	NN	B-protein	11	PMOD
13	responded	respond	B-VP	VBD	O	0	ROOT
14	to	to	B-PP	TO	O	13	VMOD
15	IL-12	IL-12	B-NP	NN	B-protein	14	PMOD
16	by	by	B-PP	IN	O	13	VMOD
17	additional	additional	B-NP	JJ	O	18	NMOD
18	enhancement	enhancement	I-NP	NN	O	16	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	21	NMOD
21	production	production	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	3	NMOD
2	IL-12	IL-12	I-NP	NN	B-protein	3	NMOD
3	nonresponsiveness	nonresponsiveness	I-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	Th2	Th2	I-NP	NN	B-cell_line	7	NMOD
7	clones	clone	I-NP	NNS	I-cell_line	4	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	further	further	B-ADJP	RBR	O	10	AMOD
10	evident	evident	I-ADJP	JJ	O	8	PRD
11	by	by	B-PP	IN	O	8	VMOD
12	the	the	B-NP	DT	O	14	NMOD
13	total	total	I-NP	JJ	O	14	NMOD
14	lack	lack	I-NP	NN	O	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	IL-12-induced	IL-12-induced	B-NP	JJ	O	17	NMOD
17	phosphorylation	phosphorylation	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	STAT4	STAT4	B-NP	NN	B-protein	31	NMOD
20	(	(	O	(	O	27	DEP
21	signal	signal	B-NP	NN	B-protein	27	DEP
22	transducer	transducer	I-NP	NN	I-protein	24	NMOD
23	and	and	O	CC	I-protein	24	NMOD
24	activator	activator	B-NP	NN	I-protein	21	NMOD
25	of	of	B-PP	IN	I-protein	21	NMOD
26	transcription-4	transcription-4	B-NP	NN	I-protein	25	PMOD
27	)	)	O	)	O	19	NMOD
28	,	,	O	,	O	31	P
29	a	a	B-NP	DT	O	31	NMOD
30	transcription	transcription	I-NP	NN	B-protein	31	NMOD
31	factor	factor	I-NP	NN	I-protein	18	PMOD
32	that	that	B-NP	WDT	O	31	NMOD
33	is	be	B-VP	VBZ	O	32	SBAR
34	typically	typically	I-VP	RB	O	33	VMOD
35	involved	involve	I-VP	VBN	O	33	VC
36	in	in	B-PP	IN	O	35	VMOD
37	IL-12	IL-12	B-NP	NN	B-protein	38	NMOD
38	signaling	signaling	I-NP	NN	O	36	PMOD
39	.	.	O	.	O	8	P

1	Consequently	Consequently	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	IL-12	IL-12	B-NP	NN	B-protein	5	SUB
4	also	also	B-ADVP	RB	O	5	VMOD
5	failed	fail	B-VP	VBD	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	induce	induce	I-VP	VB	O	5	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	DNA-binding	DNA-binding	I-NP	JJ	O	10	NMOD
10	activity	activity	I-NP	NN	O	7	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	STAT4-containing	STAT4-containing	B-NP	JJ	B-protein	13	NMOD
13	complexes	complex	I-NP	NNS	I-protein	11	PMOD
14	in	in	B-PP	IN	O	7	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	nuclei	nucleus	I-NP	NNS	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	these	these	B-NP	DT	O	20	NMOD
19	Th2	Th2	I-NP	NN	B-cell_line	20	NMOD
20	clones	clone	I-NP	NNS	I-cell_line	17	PMOD
21	.	.	O	.	O	5	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	human	human	B-NP	JJ	B-cell_line	8	NMOD
6	allergen-specific	allergen-specific	I-NP	JJ	I-cell_line	8	NMOD
7	Th	Th	I-NP	NN	I-cell_line	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_line	15	SUB
9	with	with	B-PP	IN	O	8	NMOD
10	strongly	strongly	B-NP	RB	O	11	AMOD
11	polarized	polarize	I-NP	VBN	O	14	NMOD
12	Th2	Th2	I-NP	NN	O	14	NMOD
13	cytokine	cytokine	I-NP	NN	B-protein	14	NMOD
14	profiles	profile	I-NP	NNS	O	9	PMOD
15	do	do	B-VP	VBP	O	4	SBAR
16	not	not	I-VP	RB	O	15	VMOD
17	respond	respond	I-VP	VB	O	15	VC
18	to	to	B-PP	TO	O	17	VMOD
19	IL-12	IL-12	B-NP	NN	B-protein	18	PMOD
20	and	and	O	CC	O	15	VMOD
21	,	,	O	,	O	15	P
22	therefore	therefore	B-ADVP	RB	O	15	VMOD
23	,	,	O	,	O	15	P
24	can	can	B-VP	MD	O	15	VMOD
25	not	not	I-VP	RB	O	24	VMOD
26	be	be	I-VP	VB	O	24	VC
27	induced	induce	I-VP	VBN	O	26	VC
28	to	to	B-VP	TO	O	29	VMOD
29	produce	produce	I-VP	VB	O	27	VMOD
30	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	29	OBJ
31	.	.	O	.	O	3	P

1	Using	Use	B-VP	VBG	O	24	VMOD
2	a	a	B-NP	DT	O	5	NMOD
3	structure-function	structure-function	I-NP	JJ	O	5	NMOD
4	mutagenesis	mutagenesis	I-NP	NN	O	5	NMOD
5	approach	approach	I-NP	NN	O	1	OBJ
6	,	,	O	,	O	24	P
7	two	two	B-NP	CD	O	9	NMOD
8	tyrosine	tyrosine	I-NP	NN	O	9	NMOD
9	residues	residue	I-NP	NNS	O	24	SUB
10	(	(	O	(	O	14	DEP
11	Tyr427	Tyr427	B-NP	NN	O	13	NMOD
12	and	and	O	CC	O	13	NMOD
13	Tyr477	Tyr477	B-NP	NN	O	14	DEP
14	)	)	O	)	O	9	NMOD
15	in	in	B-PP	IN	O	9	NMOD
16	the	the	B-NP	DT	O	18	NMOD
17	intracellular	intracellular	I-NP	JJ	B-protein	18	NMOD
18	domain	domain	I-NP	NN	I-protein	15	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	murine	murine	I-NP	JJ	B-protein	23	NMOD
22	IL-10	IL-10	I-NP	NN	I-protein	23	NMOD
23	receptor	receptor	I-NP	NN	I-protein	19	PMOD
24	were	be	B-VP	VBD	O	0	ROOT
25	found	find	I-VP	VBN	O	24	VC
26	to	to	I-VP	TO	O	27	VMOD
27	be	be	I-VP	VB	O	25	VMOD
28	redundantly	redundantly	I-VP	RB	O	29	VMOD
29	required	require	I-VP	VBN	O	27	VC
30	for	for	B-PP	IN	O	29	VMOD
31	receptor	receptor	B-NP	NN	O	32	NMOD
32	function	function	I-NP	NN	O	30	PMOD
33	and	and	B-PP	CC	O	30	PMOD
34	for	for	B-PP	IN	O	30	PMOD
35	activation	activation	B-NP	NN	O	34	PMOD
36	of	of	B-PP	IN	O	35	NMOD
37	Stat3	Stat3	B-NP	NN	B-protein	36	PMOD
38	but	but	B-PP	CC	O	36	PMOD
39	not	not	B-PP	RB	O	40	PMOD
40	for	for	I-PP	IN	O	36	PMOD
41	Stat1	Stat1	B-NP	NN	B-protein	43	NMOD
42	or	or	I-NP	CC	O	43	NMOD
43	Stat5	Stat5	I-NP	NN	B-protein	40	PMOD
44	.	.	O	.	O	24	P

1	Twelve	Twelve	B-NP	CD	O	4	NMOD
2	amino	amino	I-NP	NN	O	4	NMOD
3	acid	acid	I-NP	NN	O	4	NMOD
4	peptides	peptide	I-NP	NNS	O	15	SUB
5	encompassing	encompass	B-VP	VBG	O	4	NMOD
6	either	either	B-NP	DT	O	5	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	these	these	B-NP	DT	O	11	NMOD
9	two	two	I-NP	CD	O	11	NMOD
10	tyrosine	tyrosine	I-NP	NN	O	11	NMOD
11	residues	residue	I-NP	NNS	O	7	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	phosphorylated	phosphorylated	B-NP	JJ	B-protein	14	NMOD
14	form	form	I-NP	NN	I-protein	12	PMOD
15	coprecipitated	coprecipitate	B-VP	VBD	O	0	ROOT
16	Stat3	Stat3	B-NP	NN	B-protein	19	NMOD
17	but	but	B-NP	CC	O	19	NMOD
18	not	not	I-NP	RB	O	17	DEP
19	Stat1	Stat1	B-NP	NN	B-protein	15	OBJ
20	and	and	O	CC	O	15	VMOD
21	blocked	block	B-VP	VBD	O	15	VMOD
22	IL-10-induced	IL-10-induced	B-NP	JJ	O	24	NMOD
23	Stat3	Stat3	I-NP	NN	B-protein	24	NMOD
24	phosphorylation	phosphorylation	I-NP	NN	O	21	OBJ
25	in	in	B-PP	IN	O	21	VMOD
26	a	a	B-NP	DT	O	28	NMOD
27	cell-free	cell-free	I-NP	JJ	O	28	NMOD
28	system	system	I-NP	NN	O	25	PMOD
29	.	.	O	.	O	15	P

1	In	In	B-PP	IN	O	10	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	10	P
4	tyrosine-phosphorylated	tyrosine-phosphorylated	B-NP	JJ	O	5	NMOD
5	peptides	peptide	I-NP	NNS	O	10	SUB
6	containing	contain	B-VP	VBG	O	5	NMOD
7	Tyr374	Tyr374	B-NP	NN	O	9	NMOD
8	or	or	I-NP	CC	O	9	NMOD
9	Tyr396	Tyr396	I-NP	NN	O	6	OBJ
10	did	do	B-VP	VBD	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	interact	interact	I-VP	VB	O	10	VC
13	with	with	B-PP	IN	O	12	VMOD
14	Stat3	Stat3	B-NP	NN	B-protein	18	NMOD
15	or	or	I-NP	CC	O	18	NMOD
16	block	block	I-NP	NN	O	18	NMOD
17	Stat3	Stat3	I-NP	NN	B-protein	18	NMOD
18	activation	activation	I-NP	NN	O	13	PMOD
19	.	.	O	.	O	10	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Stat3	Stat3	B-NP	NN	B-protein	10	NMOD
6	but	but	B-NP	CC	O	7	NMOD
7	not	not	I-NP	RB	O	10	NMOD
8	Stat1	Stat1	B-NP	NN	B-protein	10	NMOD
9	or	or	O	CC	O	10	NMOD
10	Stat5	Stat5	B-NP	NN	B-protein	11	SUB
11	is	be	B-VP	VBZ	O	4	SBAR
12	directly	directly	I-VP	RB	O	11	VMOD
13	recruited	recruit	I-VP	VBN	O	11	VC
14	to	to	B-PP	TO	O	13	VMOD
15	the	the	B-NP	DT	O	18	NMOD
16	ligand-activated	ligand-activated	I-NP	JJ	B-protein	18	NMOD
17	IL-10	IL-10	I-NP	NN	I-protein	18	NMOD
18	receptor	receptor	I-NP	NN	I-protein	14	PMOD
19	by	by	B-PP	IN	O	13	VMOD
20	binding	bind	B-VP	VBG	O	19	PMOD
21	to	to	B-PP	TO	O	20	VMOD
22	specific	specific	B-NP	JJ	O	24	AMOD
23	but	but	I-NP	CC	O	24	AMOD
24	redundant	redundant	I-NP	JJ	O	28	NMOD
25	receptor	receptor	I-NP	NN	O	28	NMOD
26	intracellular	intracellular	I-NP	JJ	O	28	NMOD
27	domain	domain	I-NP	NN	O	28	NMOD
28	sequences	sequence	I-NP	NNS	O	21	PMOD
29	containing	contain	B-VP	VBG	O	28	NMOD
30	phosphotyrosine	phosphotyrosine	B-NP	NN	O	29	OBJ
31	.	.	O	.	O	3	P

1	High	High	B-NP	JJ	O	2	NMOD
2	levels	level	I-NP	NNS	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	Sp140	Sp140	B-NP	NN	B-RNA	5	NMOD
5	mRNA	mRNA	I-NP	NN	I-RNA	3	PMOD
6	were	be	B-VP	VBD	O	0	ROOT
7	detected	detect	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	human	human	B-NP	JJ	O	14	NMOD
10	spleen	spleen	I-NP	NN	O	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD
13	blood	blood	I-NP	NN	I-cell_type	14	NMOD
14	leukocytes	leukocyte	I-NP	NNS	I-cell_type	8	PMOD
15	,	,	O	,	O	7	P
16	but	but	O	CC	O	7	VMOD
17	not	not	O	RB	O	7	VMOD
18	other	other	B-NP	JJ	O	20	NMOD
19	human	human	I-NP	JJ	O	20	NMOD
20	tissues	tissue	I-NP	NNS	O	7	VMOD
21	.	.	O	.	O	6	P

1	however	however	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	has	have	B-VP	VBZ	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	been	be	I-VP	VBN	O	4	VC
7	established	establish	I-VP	VBN	O	6	VC
8	whether	whether	B-SBAR	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	expression	expression	I-NP	NN	O	11	SUB
11	has	have	B-VP	VBZ	O	8	SBAR
12	a	a	B-NP	DT	O	14	NMOD
13	causal	causal	I-NP	JJ	O	14	NMOD
14	role	role	I-NP	NN	O	11	OBJ
15	in	in	B-PP	IN	O	11	VMOD
16	oncogenesis	oncogenesis	B-NP	NN	O	15	PMOD
17	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	4	NMOD
2	magnitude	magnitude	I-NP	NN	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	kinetics	kinetic	I-NP	NNS	O	8	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	intracellular	intracellular	B-NP	JJ	O	7	NMOD
7	ROI	ROI	I-NP	NN	O	5	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	similar	similar	B-ADJP	JJ	O	8	PRD
10	,	,	O	,	O	8	P
11	suggesting	suggest	B-VP	VBG	O	8	VMOD
12	that	that	B-SBAR	IN	O	11	VMOD
13	there	there	B-NP	EX	O	14	SUB
14	were	be	B-VP	VBD	O	12	SBAR
15	no	no	B-NP	DT	O	16	NMOD
16	differences	difference	I-NP	NNS	O	14	PRD
17	in	in	B-PP	IN	O	14	VMOD
18	ROI-forming	ROI-forming	B-NP	JJ	O	19	NMOD
19	mechanisms	mechanism	I-NP	NNS	O	22	NMOD
20	or	or	O	CC	O	22	NMOD
21	antioxidative	antioxidative	B-NP	JJ	O	22	NMOD
22	capacities	capacity	I-NP	NNS	O	17	PMOD
23	.	.	O	.	O	8	P

1	Moreover	Moreover	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	ZK161422	ZK161422	B-NP	NN	O	7	NMOD
4	,	,	O	,	O	7	P
5	but	but	O	CC	O	7	NMOD
6	not	not	O	RB	O	5	DEP
7	ZK157202	ZK157202	B-NP	NN	O	9	SUB
8	,	,	O	,	O	7	P
9	showed	show	B-VP	VBD	O	0	ROOT
10	preference	preference	B-NP	NN	O	9	OBJ
11	for	for	B-PP	IN	O	10	NMOD
12	gene	gene	B-NP	NN	O	13	NMOD
13	activation	activation	I-NP	NN	O	11	PMOD
14	from	from	B-PP	IN	O	13	NMOD
15	a	a	B-NP	DT	O	16	NMOD
16	promoter	promoter	I-NP	NN	B-DNA	14	PMOD
17	carrying	carry	B-VP	VBG	O	16	NMOD
18	a	a	B-NP	DT	O	21	NMOD
19	VD	VD	I-NP	NN	B-DNA	21	NMOD
20	response	response	I-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	17	OBJ
22	with	with	B-PP	IN	O	21	NMOD
23	a	a	B-NP	DT	O	25	NMOD
24	palindromic	palindromic	I-NP	JJ	O	25	NMOD
25	arrangement	arrangement	I-NP	NN	O	22	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	two	two	B-NP	CD	O	31	NMOD
28	hexameric	hexameric	I-NP	JJ	B-DNA	31	NMOD
29	receptor	receptor	I-NP	NN	I-DNA	31	NMOD
30	binding	binding	I-NP	NN	I-DNA	31	NMOD
31	sites	site	I-NP	NNS	I-DNA	26	PMOD
32	spaced	space	B-VP	VBN	O	31	NMOD
33	by	by	B-PP	IN	O	32	VMOD
34	9	9	B-NP	CD	O	35	NMOD
35	nucleotides	nucleotide	B-NP	NNS	O	33	PMOD
36	(	(	O	(	O	38	DEP
37	IP9	IP9	B-NP	NN	B-protein	38	DEP
38	)	)	O	)	O	35	NMOD
39	rather	rather	B-PP	RB	O	11	PMOD
40	than	than	I-PP	IN	O	39	DEP
41	for	for	B-PP	IN	O	11	PMOD
42	activation	activation	B-NP	NN	O	41	PMOD
43	from	from	B-PP	IN	O	42	NMOD
44	a	a	B-NP	DT	O	46	NMOD
45	response	response	I-NP	NN	O	46	NMOD
46	element	element	I-NP	NN	O	43	PMOD
47	formed	form	B-VP	VBN	O	46	NMOD
48	by	by	B-PP	IN	O	47	VMOD
49	a	a	B-NP	DT	O	51	NMOD
50	direct	direct	I-NP	JJ	O	51	NMOD
51	repeat	repeat	I-NP	NN	O	48	PMOD
52	spaced	space	B-VP	VBN	O	51	NMOD
53	by	by	B-PP	IN	O	52	VMOD
54	3	3	B-NP	CD	O	55	NMOD
55	nucleotides	nucleotide	B-NP	NNS	O	53	PMOD
56	(	(	O	(	O	58	DEP
57	DR3	DR3	B-NP	NN	B-protein	58	DEP
58	)	)	O	)	O	55	NMOD
59	.	.	O	.	O	9	P

1	We	We	B-NP	PRP	O	2	SUB
2	report	report	B-VP	VBP	O	0	ROOT
3	here	here	B-ADVP	RB	O	2	VMOD
4	that	that	B-SBAR	IN	O	97	DEP
5	PML	PML	B-NP	NN	B-protein	6	SUB
6	is	be	B-VP	VBZ	O	4	SBAR
7	expressed	express	I-VP	VBN	O	6	VC
8	at	at	B-PP	IN	O	7	VMOD
9	low	low	B-NP	JJ	O	10	NMOD
10	levels	level	I-NP	NNS	O	8	PMOD
11	or	or	O	CC	O	7	VMOD
12	not	not	B-VP	RB	O	13	VMOD
13	expressed	express	I-VP	VBN	O	7	VMOD
14	in	in	B-PP	IN	O	13	VMOD
15	normal	normal	B-NP	JJ	O	17	NMOD
16	circulating	circulate	I-NP	VBG	O	17	NMOD
17	human	human	I-NP	JJ	B-cell_type	24	NMOD
18	monocytes	monocyte	I-NP	NNS	I-cell_type	24	NMOD
19	,	,	O	,	O	24	P
20	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	24	NMOD
21	,	,	O	,	O	24	P
22	and	and	O	CC	O	24	NMOD
23	polymorphonucleate	polymorphonucleate	B-NP	JJ	B-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	14	PMOD
25	,	,	O	,	O	6	P
26	but	but	O	CC	O	6	VMOD
27	is	be	B-VP	VBZ	O	6	VMOD
28	markedly	markedly	I-VP	RB	O	27	VMOD
29	induced	induce	I-VP	VBN	O	27	VC
30	by	by	B-PP	IN	O	29	VMOD
31	interferon	interferon	B-NP	NN	B-protein	30	PMOD
32	;	;	O	:	O	97	P
33	that	that	B-NP	IN	O	97	DEP
34	PML	PML	B-NP	NN	B-protein	37	NMOD
35	and	and	I-NP	CC	O	37	NMOD
36	PML/RAR	PML/RAR	I-NP	NN	B-protein	37	NMOD
37	alpha	alpha	I-NP	NN	I-protein	38	NMOD
38	expression	expression	I-NP	NN	O	39	SUB
39	is	be	B-VP	VBZ	O	33	SBAR
40	augmented	augment	I-VP	VBN	O	39	VC
41	by	by	B-PP	IN	O	40	VMOD
42	interferon	interferon	B-NP	NN	B-protein	41	PMOD
43	in	in	B-PP	IN	O	40	VMOD
44	the	the	B-NP	DT	O	48	NMOD
45	NB4	NB4	I-NP	NN	B-cell_line	48	NMOD
46	APL	APL	I-NP	NN	I-cell_line	48	NMOD
47	cell	cell	I-NP	NN	I-cell_line	48	NMOD
48	line	line	I-NP	NN	I-cell_line	43	PMOD
49	,	,	O	,	O	48	P
50	which	which	B-NP	WDT	O	48	NMOD
51	carries	carry	B-VP	VBZ	O	50	SBAR
52	the	the	B-NP	DT	O	51	OBJ
53	t	t	I-NP	NN	B-DNA	52	PMOD
54	(	(	O	(	I-DNA	58	DEP
55	15	15	B-NP	CD	I-DNA	57	NMOD
56	;	;	O	:	I-DNA	57	P
57	17	17	B-NP	CD	I-DNA	58	DEP
58	)	)	O	)	I-DNA	53	NMOD
59	,	,	O	,	O	53	P
60	and	and	O	CC	O	53	NMOD
61	in	in	B-PP	IN	O	60	DEP
62	APL	APL	B-NP	NN	B-cell_type	63	NMOD
63	blasts	blast	I-NP	NNS	I-cell_type	61	PMOD
64	from	from	B-PP	IN	O	63	NMOD
65	patients	patient	B-NP	NNS	O	64	PMOD
66	;	;	O	:	O	97	P
67	that	that	B-SBAR	IN	O	97	DEP
68	interferon	interferon	B-NP	NN	B-protein	69	SUB
69	inhibits	inhibit	B-VP	VBZ	O	67	SBAR
70	growth	growth	B-NP	NN	O	72	NMOD
71	and	and	I-NP	CC	O	72	NMOD
72	survival	survival	I-NP	NN	O	69	OBJ
73	of	of	B-PP	IN	O	72	NMOD
74	NB4	NB4	B-NP	NN	B-cell_line	76	NMOD
75	APL	APL	I-NP	NN	I-cell_line	76	NMOD
76	cells	cell	I-NP	NNS	I-cell_line	73	PMOD
77	in	in	B-PP	IN	O	69	VMOD
78	cooperation	cooperation	B-NP	NN	O	77	PMOD
79	with	with	B-PP	IN	O	78	NMOD
80	RA	RA	B-NP	NN	O	79	PMOD
81	;	;	O	:	O	97	P
82	that	that	B-SBAR	IN	O	97	DEP
83	interferons	interferon	B-NP	NNS	B-protein	85	SUB
84	alone	alone	B-ADVP	RB	O	83	NMOD
85	have	have	B-VP	VBP	O	82	SBAR
86	minimal	minimal	B-NP	JJ	O	88	NMOD
87	maturation	maturation	I-NP	NN	O	88	NMOD
88	effect	effect	I-NP	NN	O	85	OBJ
89	on	on	B-PP	IN	O	85	VMOD
90	NB4	NB4	B-NP	NN	B-cell_line	91	NMOD
91	cells	cell	I-NP	NNS	I-cell_line	89	PMOD
92	;	;	O	:	O	97	P
93	and	and	O	CC	O	97	DEP
94	,	,	O	,	O	97	P
95	finally	finally	B-ADVP	RB	O	97	DEP
96	,	,	O	,	O	97	P
97	that	that	B-SBAR	IN	O	2	VMOD
98	interferon	interferon	B-NP	NN	B-protein	99	NMOD
99	gamma	gamma	I-NP	NN	I-protein	105	NMOD
100	,	,	O	,	O	105	P
101	but	but	O	CC	O	105	NMOD
102	not	not	O	RB	O	101	DEP
103	alpha	alpha	B-NP	NN	O	105	NMOD
104	or	or	O	CC	O	105	NMOD
105	beta	beta	B-NP	NN	O	107	SUB
106	,	,	O	,	O	105	P
107	induces	induce	B-VP	VBZ	O	97	SBAR
108	maturation	maturation	B-NP	NN	O	111	NMOD
109	and	and	I-NP	CC	O	111	NMOD
110	growth	growth	I-NP	NN	O	111	NMOD
111	suppression	suppression	I-NP	NN	O	107	OBJ
112	of	of	B-PP	IN	O	111	NMOD
113	NB4	NB4	B-NP	NN	B-cell_line	114	NMOD
114	cells	cell	I-NP	NNS	I-cell_line	112	PMOD
115	with	with	B-PP	IN	O	107	VMOD
116	de	de	B-NP	FW	O	117	AMOD
117	novo	novo	I-NP	FW	O	119	NMOD
118	retinoid	retinoid	I-NP	NN	O	119	NMOD
119	resistance	resistance	I-NP	NN	O	115	PMOD
120	,	,	O	,	O	107	P
121	and	and	O	CC	O	107	VMOD
122	partially	partially	B-VP	RB	O	123	VMOD
123	restores	restore	I-VP	VBZ	O	107	VMOD
124	RA	RA	B-NP	NN	O	125	NMOD
125	response	response	I-NP	NN	O	123	OBJ
126	.	.	O	.	O	2	P

1	However	However	B-ADVP	RB	O	14	VMOD
2	,	,	O	,	O	14	P
3	in	in	B-ADVP	FW	O	14	VMOD
4	vivo	vivo	I-ADVP	FW	O	3	AMOD
5	,	,	O	,	O	14	P
6	not	not	B-CONJP	RB	O	13	NMOD
7	only	only	I-CONJP	RB	O	6	DEP
8	CSF	CSF	B-NP	NN	B-protein	13	NMOD
9	but	but	B-CONJP	CC	O	13	NMOD
10	also	also	I-CONJP	RB	O	9	DEP
11	many	many	B-NP	JJ	O	13	NMOD
12	other	other	I-NP	JJ	O	13	NMOD
13	cytokines	cytokine	I-NP	NNS	B-protein	14	SUB
14	are	be	B-VP	VBP	O	0	ROOT
15	produced	produce	I-VP	VBN	O	14	VC
16	under	under	B-PP	IN	O	15	VMOD
17	various	various	B-NP	JJ	O	18	NMOD
18	conditions	condition	I-NP	NNS	O	16	PMOD
19	.	.	O	.	O	14	P

1	However	However	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	monocyte-derived	monocyte-derived	I-NP	JJ	B-cell_line	5	NMOD
5	DC	DC	I-NP	NN	I-cell_line	6	SUB
6	were	be	B-VP	VBD	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	terminally	terminally	I-VP	RB	B-cell_type	9	AMOD
9	differentiated	differentiate	I-VP	VBN	I-cell_type	10	NMOD
10	cells	cell	B-NP	NNS	I-cell_type	6	VMOD
11	;	;	O	:	O	6	P

1	In	In	B-PP	IN	O	0	ROOT
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	2	NMOD
4	IL-4	IL-4	B-NP	NN	B-protein	10	SUB
5	,	,	O	,	O	10	P
6	interferon-gamma	interferon-gamma	B-NP	NN	B-protein	10	SUB
7	(	(	O	(	O	9	DEP
8	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	9	DEP
9	)	)	O	)	O	6	NMOD
10	had	have	B-VP	VBD	O	3	SBAR
11	no	no	B-NP	DT	O	13	NMOD
12	demonstrable	demonstrable	I-NP	JJ	O	13	NMOD
13	effect	effect	I-NP	NN	O	10	OBJ
14	on	on	B-PP	IN	O	10	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	differentiation	differentiation	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	monocytes	monocyte	B-NP	NNS	B-cell_type	17	PMOD
19	.	.	O	.	O	1	P

1	Taken	Take	B-VP	VBN	O	6	VMOD
2	together	together	B-ADVP	RB	O	1	VMOD
3	,	,	O	,	O	6	P
4	these	these	B-NP	DT	O	5	NMOD
5	results	result	I-NP	NNS	O	6	SUB
6	provide	provide	B-VP	VBP	O	0	ROOT
7	a	a	B-NP	DT	O	9	NMOD
8	new	new	I-NP	JJ	O	9	NMOD
9	aspect	aspect	I-NP	NN	O	6	OBJ
10	to	to	B-PP	TO	O	6	VMOD
11	our	our	B-NP	PRP$	O	12	NMOD
12	knowledge	knowledge	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	monocyte	monocyte	B-NP	NN	B-cell_type	15	NMOD
15	differentiation	differentiation	I-NP	NN	O	13	PMOD
16	and	and	O	CC	O	6	VMOD
17	provide	provide	B-VP	VBP	O	6	VMOD
18	evidence	evidence	B-NP	NN	O	17	OBJ
19	that	that	B-SBAR	IN	O	18	NMOD
20	human	human	B-NP	JJ	B-cell_type	21	NMOD
21	monocytes	monocyte	I-NP	NNS	I-cell_type	22	SUB
22	are	be	B-VP	VBP	O	19	SBAR
23	flexible	flexible	B-ADJP	JJ	O	22	PRD
24	in	in	B-PP	IN	O	22	VMOD
25	their	their	B-NP	PRP$	O	27	NMOD
26	differentiation	differentiation	I-NP	NN	O	27	NMOD
27	potential	potential	I-NP	NN	O	24	PMOD
28	and	and	O	CC	O	22	VMOD
29	are	be	B-VP	VBP	O	22	VMOD
30	precursors	precursor	B-NP	NNS	O	29	PRD
31	not	not	B-CONJP	RB	O	30	NMOD
32	only	only	I-CONJP	RB	O	31	DEP
33	of	of	B-PP	IN	O	31	PMOD
34	macrophages	macrophage	B-NP	NNS	B-cell_type	33	PMOD
35	but	but	B-CONJP	CC	O	31	PMOD
36	also	also	I-CONJP	RB	O	35	DEP
37	of	of	B-PP	IN	O	31	PMOD
38	CD1+relB+DC	CD1+relB+DC	B-NP	NN	B-cell_type	41	NMOD
39	and	and	O	CC	O	41	NMOD
40	TRAP-positive	TRAP-positive	B-NP	JJ	B-cell_type	41	NMOD
41	MGC	MGC	I-NP	NN	I-cell_type	37	PMOD
42	.	.	O	.	O	6	P

1	Implication	Implication	B-NP	NN	O	15	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	viruses	virus	B-NP	NNS	O	2	PMOD
4	such	such	B-PP	JJ	O	5	PMOD
5	as	as	I-PP	IN	O	3	NMOD
6	Epstein-Barr	Epstein-Barr	B-NP	JJ	O	7	NMOD
7	virus	virus	I-NP	NN	O	5	PMOD
8	(	(	O	(	O	10	DEP
9	EBV	EBV	B-NP	NN	O	10	DEP
10	)	)	O	)	O	7	NMOD
11	in	in	B-PP	IN	O	1	NMOD
12	rheumatoid	rheumatoid	B-NP	JJ	O	14	NMOD
13	arthritis	arthritis	I-NP	NN	O	14	NMOD
14	pathogenesis	pathogenesis	I-NP	NN	O	11	PMOD
15	has	have	B-VP	VBZ	O	38	VMOD
16	been	be	I-VP	VBN	O	15	VC
17	suspected	suspect	I-VP	VBN	O	16	VC
18	on	on	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	18	PMOD
20	basis	basis	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	18	PMOD
22	several	several	B-NP	JJ	O	24	NMOD
23	indirect	indirect	I-NP	JJ	O	24	NMOD
24	observations	observation	I-NP	NNS	O	18	PMOD
25	,	,	O	,	O	38	P
26	but	but	O	CC	O	38	VMOD
27	thus	thus	B-ADVP	RB	O	38	VMOD
28	far	far	I-ADVP	RB	O	27	AMOD
29	,	,	O	,	O	38	P
30	a	a	B-NP	DT	O	32	NMOD
31	direct	direct	I-NP	JJ	O	32	NMOD
32	link	link	I-NP	NN	O	38	SUB
33	between	between	B-PP	IN	O	32	NMOD
34	EBV	EBV	B-NP	NN	O	37	NMOD
35	and	and	O	CC	O	37	NMOD
36	rheumatoid	rheumatoid	B-NP	JJ	O	37	NMOD
37	arthritis	arthritis	I-NP	NN	O	33	PMOD
38	has	have	B-VP	VBZ	O	0	ROOT
39	not	not	I-VP	RB	O	38	VMOD
40	been	be	I-VP	VBN	O	38	VC
41	provided	provide	I-VP	VBN	O	40	VC
42	.	.	O	.	O	38	P

1	Recently	Recently	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	has	have	B-VP	VBZ	O	0	ROOT
5	been	be	I-VP	VBN	O	4	VC
6	shown	show	I-VP	VBN	O	5	VC
7	that	that	B-SBAR	IN	O	6	VMOD
8	RelB	RelB	B-NP	NN	B-protein	10	NMOD
9	knockout	knockout	I-NP	NN	O	10	NMOD
10	mice	mouse	I-NP	NNS	O	11	SUB
11	have	have	B-VP	VBP	O	7	SBAR
12	no	no	B-NP	DT	O	14	NMOD
13	dendritic	dendritic	I-NP	JJ	B-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	11	OBJ
15	(	(	O	(	O	17	DEP
16	DC	DC	B-NP	NN	B-cell_type	17	DEP
17	)	)	O	)	O	14	NMOD
18	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	12	VMOD
2	germinal	germinal	B-NP	JJ	O	4	NMOD
3	centers	center	I-NP	NNS	O	4	NMOD
4	GC	GC	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	12	P
6	p50	p50	B-NP	NN	B-protein	11	NMOD
7	,	,	O	,	O	11	P
8	p52	p52	B-NP	NN	B-protein	11	NMOD
9	,	,	O	,	O	11	P
10	and	and	O	CC	O	11	NMOD
11	RelB	RelB	B-NP	NN	B-protein	12	SUB
12	were	be	B-VP	VBD	O	0	ROOT
13	found	find	I-VP	VBN	O	12	VC
14	in	in	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	nuclei	nucleus	I-NP	NNS	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	FDC	FDC	B-NP	NN	B-cell_type	17	PMOD
19	only	only	B-ADVP	RB	O	16	NMOD
20	and	and	O	CC	O	12	VMOD
21	were	be	B-VP	VBD	O	12	VMOD
22	not	not	I-VP	RB	O	21	VMOD
23	detected	detect	I-VP	VBN	O	21	VC
24	in	in	B-PP	IN	O	23	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	nuclei	nucleus	I-NP	NNS	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	CD68+	CD68+	B-NP	JJ	B-cell_type	29	NMOD
29	cells	cell	I-NP	NNS	I-cell_type	27	PMOD
30	.	.	O	.	O	12	P

1	Cells	Cell	B-NP	NNS	O	5	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	nuclear	nuclear	B-NP	JJ	O	4	NMOD
4	p50	p50	I-NP	NN	B-protein	2	PMOD
5	were	be	B-VP	VBD	O	0	ROOT
6	negative	negative	B-ADJP	JJ	O	5	PRD
7	for	for	B-PP	IN	O	6	AMOD
8	the	the	B-NP	DT	O	14	NMOD
9	CD38	CD38	I-NP	NN	B-protein	14	NMOD
10	,	,	I-NP	,	O	14	P
11	CD20	CD20	I-NP	NN	B-protein	14	NMOD
12	and	and	I-NP	CC	O	14	NMOD
13	CD2	CD2	I-NP	NN	B-protein	14	NMOD
14	markers	marker	I-NP	NNS	I-protein	7	PMOD
15	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	86	DEP
5	,	,	O	,	O	4	P
6	physiologically	physiologically	B-ADVP	RB	O	18	VMOD
7	,	,	O	,	O	18	P
8	high	high	B-NP	JJ	O	9	NMOD
9	levels	level	I-NP	NNS	O	18	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	nuclear	nuclear	B-NP	JJ	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	p50	p50	B-NP	NN	B-protein	17	NMOD
14	,	,	O	,	O	17	P
15	p52	p52	B-NP	NN	B-protein	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	RelB	RelB	B-NP	NN	B-protein	12	PMOD
18	are	be	B-VP	VBP	O	4	SBAR
19	restricted	restricted	B-ADJP	JJ	O	18	PRD
20	to	to	B-PP	TO	O	37	VMOD
21	accessory	accessory	B-NP	JJ	B-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	the	the	B-NP	DT	O	26	NMOD
25	immune	immune	I-NP	JJ	O	26	NMOD
26	system	system	I-NP	NN	O	23	PMOD
27	,	,	O	,	O	22	P
28	which	which	B-NP	WDT	O	22	NMOD
29	include	include	B-VP	VBP	O	28	SBAR
30	FDC	FDC	B-NP	NN	B-cell_type	29	OBJ
31	in	in	B-PP	IN	O	30	NMOD
32	GC	GC	B-NP	NN	O	31	PMOD
33	,	,	O	,	O	37	P
34	and	and	O	CC	O	37	NMOD
35	DC	DC	B-NP	NN	B-cell_type	37	NMOD
36	and	and	O	CC	O	37	NMOD
37	macrophages	macrophage	B-NP	NNS	B-cell_type	19	SUB
38	in	in	B-PP	IN	O	37	NMOD
39	the	the	B-NP	DT	O	42	NMOD
40	T	T	I-NP	NN	O	42	NMOD
41	cell	cell	I-NP	NN	O	42	NMOD
42	zone	zone	I-NP	NN	O	38	PMOD
43	,	,	O	,	O	86	P
44	that	that	B-NP	WDT	O	86	DEP
45	specialized	specialize	B-VP	VBD	O	47	NMOD
46	scavenger	scavenger	B-NP	NN	B-cell_type	47	NMOD
47	macrophages	macrophage	I-NP	NNS	I-cell_type	50	SUB
48	from	from	B-PP	IN	O	47	NMOD
49	GC	GC	B-NP	NN	B-cell_type	48	PMOD
50	do	do	B-VP	VBP	O	60	VMOD
51	not	not	I-VP	RB	O	50	VMOD
52	have	have	I-VP	VB	O	50	VC
53	detectable	detectable	B-NP	JJ	O	54	NMOD
54	levels	level	I-NP	NNS	O	52	OBJ
55	of	of	B-PP	IN	O	54	NMOD
56	p52	p52	B-NP	NN	B-protein	58	NMOD
57	and	and	I-NP	CC	O	58	NMOD
58	RelB	RelB	I-NP	NN	B-protein	55	PMOD
59	,	,	O	,	O	60	P
60	whereas	whereas	O	IN	O	44	SBAR
61	macrophages	macrophage	B-NP	NNS	B-cell_type	77	SUB
62	from	from	B-PP	IN	O	61	NMOD
63	the	the	B-NP	DT	O	66	NMOD
64	T	T	I-NP	NN	O	66	NMOD
65	cell	cell	I-NP	NN	O	66	NMOD
66	area	area	I-NP	NN	O	62	PMOD
67	,	,	O	,	O	61	P
68	known	know	B-VP	VBN	O	61	NMOD
69	to	to	B-VP	TO	O	70	VMOD
70	present	present	I-VP	VB	O	68	VMOD
71	the	the	B-NP	DT	O	72	NMOD
72	antigen	antigen	I-NP	NN	O	70	OBJ
73	to	to	B-PP	TO	O	70	VMOD
74	T	T	B-NP	NN	B-cell_type	75	NMOD
75	cells	cell	I-NP	NNS	I-cell_type	73	PMOD
76	,	,	O	,	O	61	P
77	do	do	B-VP	VBP	O	60	VMOD
78	have	have	I-VP	VB	O	77	VC
79	both	both	B-NP	CC	O	80	NMOD
80	nuclear	nuclear	I-NP	JJ	O	78	OBJ
81	p52	p52	I-NP	NN	B-protein	83	NMOD
82	and	and	I-NP	CC	O	83	NMOD
83	RelB	RelB	I-NP	NN	B-protein	80	NMOD
84	,	,	O	,	O	86	P
85	and	and	O	CC	O	86	DEP
86	that	that	B-SBAR	IN	O	3	VMOD
87	in	in	B-PP	IN	O	96	VMOD
88	the	the	B-NP	DT	O	91	NMOD
89	T	T	I-NP	NN	O	91	NMOD
90	cell	cell	I-NP	NN	O	91	NMOD
91	zone	zone	I-NP	NN	O	87	PMOD
92	,	,	O	,	O	96	P
93	p52	p52	B-NP	NN	B-protein	95	NMOD
94	and	and	I-NP	CC	O	95	NMOD
95	RelB	RelB	I-NP	NN	B-protein	96	SUB
96	are	be	B-VP	VBP	O	111	VMOD
97	located	located	B-ADJP	JJ	O	96	PRD
98	in	in	B-PP	IN	O	97	AMOD
99	nuclei	nucleus	B-NP	NNS	O	98	PMOD
100	of	of	B-PP	IN	O	99	NMOD
101	both	both	O	CC	O	106	AMOD
102	CD1a+	CD1a+	B-NP	JJ	B-cell_line	106	AMOD
103	,	,	O	,	O	106	P
104	CD68+	CD68+	B-VP	JJ	O	106	AMOD
105	or	or	O	CC	O	106	AMOD
106	both	both	O	DT	O	109	NMOD
107	,	,	O	,	O	106	P
108	cells	cell	B-NP	NNS	O	109	NMOD
109	APC	APC	I-NP	NN	B-cell_type	100	PMOD
110	,	,	O	,	O	111	P
111	whereas	whereas	O	IN	O	86	SBAR
112	p50	p50	B-NP	NN	B-protein	113	SUB
113	is	be	B-VP	VBZ	O	111	VMOD
114	restricted	restricted	B-ADJP	JJ	O	113	PRD
115	to	to	B-PP	TO	O	114	AMOD
116	CD1a-	CD1a-	B-NP	NN	B-protein	118	AMOD
117	and	and	O	CC	O	118	AMOD
118	CD68-	CD68-	B-NP	JJ	B-cell_type	119	NMOD
119	APC	APC	I-NP	NN	I-cell_type	115	PMOD
120	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	protein	protein	I-NP	NN	O	7	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	E.	E.	B-NP	FW	O	5	NMOD
5	coli	coli	I-NP	FW	O	3	PMOD
6	specifically	specifically	B-ADVP	RB	O	7	VMOD
7	converted	convert	B-VP	VBD	O	0	ROOT
8	dUTP	dUTP	B-NP	NN	O	7	OBJ
9	to	to	B-PP	TO	O	7	VMOD
10	dUMP	dUMP	B-NP	NN	O	9	PMOD
11	and	and	O	CC	O	7	VMOD
12	did	do	B-VP	VBD	O	7	VMOD
13	not	not	I-VP	RB	O	12	VMOD
14	react	react	I-VP	VB	O	12	VC
15	with	with	B-PP	IN	O	14	VMOD
16	other	other	B-NP	JJ	O	15	PMOD
17	dNTPs	dNTP	I-NP	NNS	O	19	NMOD
18	or	or	I-NP	CC	O	19	NMOD
19	NTPs	NTP	I-NP	NNS	B-protein	16	NMOD
20	.	.	O	.	O	7	P

1	While	While	B-SBAR	IN	O	0	ROOT
2	the	the	B-NP	DT	O	3	NMOD
3	sera	serum	I-NP	NNS	O	16	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	EBV-negative	EBV-negative	B-NP	JJ	O	6	NMOD
6	individuals	individual	I-NP	NNS	O	12	NMOD
7	(	(	O	(	O	9	DEP
8	0/3	0/3	B-NP	CD	O	9	DEP
9	)	)	O	)	O	6	NMOD
10	or	or	O	CC	O	12	NMOD
11	healthy	healthy	B-NP	JJ	O	12	NMOD
12	carriers	carrier	I-NP	NNS	O	4	PMOD
13	(	(	O	(	O	15	DEP
14	0/33	0/33	B-NP	CD	O	15	DEP
15	)	)	O	)	O	12	NMOD
16	did	do	B-VP	VBD	O	1	SBAR
17	not	not	I-VP	RB	O	16	VMOD
18	contain	contain	I-VP	VB	O	16	VC
19	detectable	detectable	B-NP	JJ	O	20	NMOD
20	levels	level	I-NP	NNS	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	antibodies	antibody	B-NP	NNS	B-protein	51	SUB
23	,	,	O	,	O	51	P
24	patients	patient	B-NP	NNS	O	51	SUB
25	with	with	B-PP	IN	O	24	NMOD
26	mononucleosis	mononucleosis	B-NP	NN	O	47	NMOD
27	(	(	O	(	O	29	DEP
28	5/18	5/18	B-NP	CD	O	29	DEP
29	)	)	O	)	O	26	NMOD
30	,	,	O	,	O	47	P
31	chronic	chronic	B-NP	JJ	O	33	NMOD
32	EBV	EBV	I-NP	NN	O	33	NMOD
33	infection	infection	I-NP	NN	O	47	NMOD
34	(	(	O	(	O	36	DEP
35	2/7	2/7	B-NP	CD	O	36	DEP
36	)	)	O	)	O	33	NMOD
37	,	,	O	,	O	47	P
38	EBV	EBV	B-NP	NN	O	39	NMOD
39	reactivation	reactivation	I-NP	NN	O	47	NMOD
40	(	(	O	(	O	42	DEP
41	7/20	7/20	B-NP	CD	O	42	DEP
42	)	)	O	)	O	39	NMOD
43	and	and	O	CC	O	47	NMOD
44	human	human	B-NP	JJ	O	47	NMOD
45	immunodeficiency	immunodeficiency	I-NP	NN	O	47	NMOD
46	virus	virus	I-NP	NN	O	47	NMOD
47	infection	infection	I-NP	NN	O	25	PMOD
48	(	(	O	(	O	50	DEP
49	5/24	5/24	B-NP	CD	O	50	DEP
50	)	)	O	)	O	47	NMOD
51	showed	show	B-VP	VBD	O	21	SBAR
52	elevated	elevated	B-NP	JJ	O	54	NMOD
53	antibody	antibody	I-NP	NN	O	54	NMOD
54	titres	titre	I-NP	NNS	O	51	OBJ
55	against	against	B-PP	IN	O	54	NMOD
56	the	the	B-NP	DT	O	57	NMOD
57	enzyme	enzyme	I-NP	NN	B-protein	55	PMOD
58	.	.	O	.	O	1	P

1	Using	Use	B-VP	VBG	O	8	VMOD
2	electrophoretic	electrophoretic	B-NP	JJ	O	5	NMOD
3	mobility	mobility	I-NP	NN	O	5	NMOD
4	shift	shift	I-NP	NN	O	5	NMOD
5	assay	assay	I-NP	NN	O	1	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	a	a	B-NP	DT	O	12	NMOD
11	short	short	I-NP	JJ	O	12	NMOD
12	treatment	treatment	I-NP	NN	O	19	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	human	human	B-NP	JJ	B-cell_type	16	NMOD
15	T	T	I-NP	NN	I-cell_type	16	NMOD
16	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	13	PMOD
17	with	with	B-PP	IN	O	12	NMOD
18	PGE2	PGE2	B-NP	NN	B-protein	17	PMOD
19	induces	induce	B-VP	VBZ	O	9	SBAR
20	specific	specific	B-NP	JJ	O	22	NMOD
21	binding	binding	I-NP	NN	O	22	NMOD
22	activity	activity	I-NP	NN	O	19	OBJ
23	to	to	B-PP	TO	O	22	NMOD
24	CRE	CRE	B-NP	NN	B-DNA	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	AP-2	AP-2	I-NP	NN	B-protein	30	NMOD
27	,	,	B-NP	,	O	30	P
28	but	but	I-NP	CC	O	30	NMOD
29	not	not	I-NP	RB	O	28	DEP
30	AP-1	AP-1	B-NP	NN	B-protein	33	NMOD
31	,	,	O	,	O	30	P
32	DNA	DNA	B-NP	NN	O	33	NMOD
33	elements	element	I-NP	NNS	O	23	PMOD
34	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	4	NMOD
2	Oct-2	Oct-2	I-NP	NN	B-protein	4	NMOD
3	transcription	transcription	I-NP	NN	I-protein	4	NMOD
4	factor	factor	I-NP	NN	I-protein	5	SUB
5	is	be	B-VP	VBZ	O	0	ROOT
6	a	a	B-NP	DT	O	7	NMOD
7	member	member	I-NP	NN	O	5	PRD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	14	NMOD
10	POU	POU	I-NP	NN	B-protein	14	NMOD
11	(	(	O	(	I-protein	14	NMOD
12	Pit-Oct-Unc	Pit-Oct-Unc	B-NP	NN	I-protein	14	NMOD
13	)	)	O	)	I-protein	14	NMOD
14	family	family	B-NP	NN	I-protein	8	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	transcription	transcription	B-NP	NN	B-protein	17	NMOD
17	factors	factor	I-NP	NNS	I-protein	15	PMOD
18	and	and	O	CC	O	5	VMOD
19	is	be	B-VP	VBZ	O	5	VMOD
20	expressed	express	I-VP	VBN	O	19	VC
21	only	only	B-ADVP	RB	O	22	PMOD
22	in	in	B-PP	IN	O	20	VMOD
23	B	B	B-NP	NN	B-cell_type	24	NMOD
24	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	22	PMOD
25	and	and	B-PP	CC	O	22	PMOD
26	in	in	B-PP	IN	O	22	PMOD
27	neuronal	neuronal	B-NP	JJ	B-cell_type	28	NMOD
28	cells	cell	I-NP	NNS	I-cell_type	26	PMOD
29	but	but	B-PP	CC	O	22	PMOD
30	not	not	B-PP	RB	O	31	PMOD
31	in	in	I-PP	IN	O	22	PMOD
32	other	other	B-NP	JJ	O	34	NMOD
33	cell	cell	I-NP	NN	O	34	NMOD
34	types	type	I-NP	NNS	O	31	PMOD
35	.	.	O	.	O	5	P

1	Visceral	Visceral	B-NP	JJ	O	3	NMOD
2	TSC2	TSC2	I-NP	NN	B-DNA	3	NMOD
3	expression	expression	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	comparable	comparable	B-ADJP	JJ	O	4	PRD
6	in	in	B-PP	IN	O	5	AMOD
7	autopsy	autopsy	B-NP	NN	O	8	NMOD
8	tissues	tissue	I-NP	NNS	O	6	PMOD
9	from	from	B-PP	IN	O	8	NMOD
10	patients	patient	B-NP	NNS	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	and	and	B-PP	CC	O	11	PMOD
13	without	without	B-PP	IN	O	11	PMOD
14	TSC	TSC	B-NP	NN	O	11	PMOD
15	;	;	O	:	O	4	P

1	In	In	B-PP	IN	O	17	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	erythroleukemia	erythroleukemia	I-NP	NN	B-cell_line	6	NMOD
4	cell	cell	I-NP	NN	I-cell_line	6	NMOD
5	line	line	I-NP	NN	I-cell_line	6	NMOD
6	K562	K562	I-NP	NN	I-cell_line	1	PMOD
7	,	,	O	,	O	17	P
8	due	due	B-PP	IN	O	17	VMOD
9	to	to	B-PP	TO	O	8	PMOD
10	the	the	B-NP	DT	O	11	NMOD
11	absence	absence	I-NP	NN	O	8	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	Spi-B	Spi-B	B-NP	NN	B-protein	12	PMOD
14	,	,	O	,	O	17	P
15	only	only	B-NP	RB	O	16	NMOD
16	PU.1	PU.1	I-NP	NN	B-protein	17	SUB
17	bound	bind	B-VP	VBD	O	0	ROOT
18	to	to	B-PP	TO	O	17	VMOD
19	the	the	B-NP	DT	O	21	NMOD
20	Btk	Btk	I-NP	NN	B-DNA	21	NMOD
21	promoter	promoter	I-NP	NN	I-DNA	18	PMOD
22	.	.	O	.	O	17	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	mutation	mutation	B-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	PU	PU	I-NP	NN	B-DNA	7	NMOD
7	box	box	I-NP	NN	I-DNA	4	PMOD
8	had	have	B-VP	VBD	O	0	ROOT
9	no	no	B-NP	DT	O	10	NMOD
10	effect	effect	I-NP	NN	O	8	OBJ
11	in	in	B-PP	IN	O	8	VMOD
12	the	the	B-NP	DT	O	15	NMOD
13	T-cell	T-cell	I-NP	NN	B-cell_line	15	NMOD
14	line	line	I-NP	NN	I-cell_line	15	NMOD
15	Jurkat	Jurkat	I-NP	NN	I-cell_line	11	PMOD
16	,	,	O	,	O	15	P
17	where	where	B-ADVP	WRB	O	15	NMOD
18	none	none	B-NP	NN	O	24	SUB
19	of	of	B-PP	IN	O	18	NMOD
20	the	the	B-NP	DT	O	23	NMOD
21	Spi-1	Spi-1	I-NP	NN	B-protein	23	NMOD
22	family	family	I-NP	NN	I-protein	23	NMOD
23	members	member	I-NP	NNS	I-protein	19	PMOD
24	is	be	B-VP	VBZ	O	17	SBAR
25	expressed	express	I-VP	VBN	O	24	VC
26	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	18	VMOD
2	fetal	fetal	B-NP	JJ	O	3	NMOD
3	liver	liver	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	PU.1-/-	PU.1-/-	B-NP	JJ	O	6	NMOD
6	mice	mouse	I-NP	NNS	O	4	PMOD
7	,	,	O	,	O	6	P
8	which	which	B-NP	WDT	O	6	NMOD
9	lack	lack	B-VP	VBP	O	8	SBAR
10	lymphoid	lymphoid	B-NP	JJ	B-cell_type	12	AMOD
11	and	and	I-NP	CC	I-cell_type	12	AMOD
12	myeloid	myeloid	I-NP	JJ	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	9	OBJ
14	,	,	O	,	O	18	P
15	expression	expression	B-NP	NN	O	18	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	Btk	Btk	B-NP	NN	B-protein	16	PMOD
18	was	be	B-VP	VBD	O	0	ROOT
19	reduced	reduce	I-VP	VBN	O	18	VC
20	two-	two-	B-NP	CD	O	19	VMOD
21	to	to	B-VP	TO	O	20	AMOD
22	threefold	threefold	I-VP	RB	O	20	AMOD
23	but	but	I-VP	CC	O	19	VMOD
24	not	not	I-VP	RB	O	25	VMOD
25	abolished	abolish	I-VP	VBN	O	19	VMOD
26	.	.	O	.	O	18	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	none	none	B-NP	NN	O	8	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	these	these	B-NP	DT	O	7	NMOD
6	proximal	proximal	I-NP	JJ	B-DNA	7	NMOD
7	regions	region	I-NP	NNS	I-DNA	4	PMOD
8	account	account	B-VP	VBP	O	0	ROOT
9	for	for	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	induction	induction	I-NP	NN	O	9	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	IL-2R	IL-2R	B-NP	NN	B-protein	15	NMOD
14	alpha	alpha	I-NP	NN	I-protein	15	NMOD
15	transcription	transcription	I-NP	NN	O	12	PMOD
16	by	by	B-PP	IN	O	11	NMOD
17	IL-2	IL-2	B-NP	NN	B-protein	16	PMOD
18	.	.	O	.	O	8	P

1	The	The	B-NP	DT	O	3	NMOD
2	negative	negative	I-NP	JJ	O	3	NMOD
3	effects	effect	I-NP	NNS	O	24	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	point	point	B-NP	NN	O	6	NMOD
6	mutations	mutation	I-NP	NNS	O	4	PMOD
7	in	in	B-PP	IN	O	3	NMOD
8	the	the	B-NP	DT	O	16	NMOD
9	LMP1	LMP1	I-NP	NN	B-DNA	16	NMOD
10	(	(	O	(	I-DNA	16	NMOD
11	1-231	1-231	B-NP	CD	I-DNA	16	NMOD
12	)	)	O	)	I-DNA	16	NMOD
13	core	core	B-NP	NN	I-DNA	16	NMOD
14	TRAF	TRAF	I-NP	NN	I-DNA	16	NMOD
15	binding	binding	I-NP	NN	I-DNA	16	NMOD
16	motif	motif	I-NP	NN	I-DNA	7	PMOD
17	on	on	B-PP	IN	O	3	NMOD
18	TRAF	TRAF	B-NP	NN	B-protein	19	NMOD
19	binding	binding	I-NP	NN	O	22	NMOD
20	and	and	O	CC	O	22	NMOD
21	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	22	NMOD
22	activation	activation	I-NP	NN	O	17	PMOD
23	genetically	genetically	B-ADVP	RB	O	24	VMOD
24	link	link	B-VP	VBP	O	0	ROOT
25	the	the	B-NP	DT	O	26	NMOD
26	TRAFs	TRAF	I-NP	NNS	B-protein	24	OBJ
27	to	to	B-PP	TO	O	24	VMOD
28	LMP1	LMP1	B-NP	NN	B-protein	34	NMOD
29	(	(	O	(	O	34	NMOD
30	1-231	1-231	B-NP	CD	O	34	NMOD
31	)	)	O	)	O	34	NMOD
32	-mediated	-mediated	B-NP	JJ	O	34	NMOD
33	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	34	NMOD
34	activation	activation	I-NP	NN	O	27	PMOD
35	.	.	O	.	O	24	P

1	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	2	NMOD
2	activation	activation	I-NP	NN	O	8	SUB
3	by	by	B-PP	IN	O	2	NMOD
4	LMP1	LMP1	B-NP	NN	B-protein	3	PMOD
5	(	(	O	(	O	7	DEP
6	1-231	1-231	B-NP	NN	O	7	DEP
7	)	)	O	)	O	4	NMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	likely	likely	B-ADJP	JJ	O	8	PRD
10	to	to	B-VP	TO	O	11	VMOD
11	be	be	I-VP	VB	O	9	AMOD
12	mediated	mediate	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	TRAF1/TRAF2	TRAF1/TRAF2	B-NP	NN	O	15	NMOD
15	heteroaggregates	heteroaggregate	I-NP	NNS	O	13	PMOD
16	since	since	B-SBAR	IN	O	12	VMOD
17	TRAF1	TRAF1	B-NP	NN	B-protein	18	SUB
18	is	be	B-VP	VBZ	O	16	SBAR
19	unique	unique	B-ADJP	JJ	O	18	PRD
20	among	among	B-PP	IN	O	18	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	TRAFs	TRAF	I-NP	NNS	B-protein	20	PMOD
23	in	in	B-PP	IN	O	18	VMOD
24	coactivating	coactivate	B-VP	VBG	O	23	PMOD
25	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	24	OBJ
26	with	with	B-PP	IN	O	24	VMOD
27	LMP1	LMP1	B-NP	NN	B-protein	35	NMOD
28	(	(	O	(	O	30	DEP
29	1-231	1-231	B-NP	CD	O	30	DEP
30	)	)	O	)	O	27	NMOD
31	,	,	O	,	O	35	P
32	a	a	B-NP	DT	O	35	NMOD
33	TRAF2	TRAF2	I-NP	NN	B-protein	35	NMOD
34	dominant-negative	dominant-negative	I-NP	JJ	O	35	NMOD
35	mutant	mutant	I-NP	NN	O	26	PMOD
36	can	can	B-VP	MD	O	8	VMOD
37	block	block	I-VP	VB	O	36	VC
38	LMP1	LMP1	B-NP	NN	B-protein	44	NMOD
39	(	(	O	(	O	44	NMOD
40	1-231	1-231	B-NP	CD	O	44	NMOD
41	)	)	O	)	O	44	NMOD
42	-mediated	-mediated	B-NP	JJ	O	44	NMOD
43	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	44	NMOD
44	activation	activation	I-NP	NN	O	37	OBJ
45	as	as	B-CONJP	RB	O	56	VMOD
46	well	well	I-CONJP	RB	O	45	DEP
47	as	as	I-CONJP	IN	O	45	DEP
48	TRAF1	TRAF1	B-NP	NN	B-protein	49	NMOD
49	coactivation	coactivation	I-NP	NN	O	56	SUB
50	,	,	O	,	O	56	P
51	and	and	O	CC	O	56	VMOD
52	30	30	B-NP	CD	O	53	NMOD
53	%	%	I-NP	NN	O	56	SUB
54	of	of	B-PP	IN	O	53	NMOD
55	TRAF2	TRAF2	B-NP	NN	B-protein	54	PMOD
56	is	be	B-VP	VBZ	O	37	VMOD
57	associated	associate	I-VP	VBN	O	56	VC
58	with	with	B-PP	IN	O	57	VMOD
59	TRAF1	TRAF1	B-NP	NN	B-protein	58	PMOD
60	in	in	B-PP	IN	O	57	VMOD
61	EBV-transformed	EBV-transformed	B-NP	JJ	B-cell_line	63	NMOD
62	B	B	I-NP	NN	I-cell_line	63	NMOD
63	cells	cell	I-NP	NNS	I-cell_line	60	PMOD
64	.	.	O	.	O	8	P

1	TRAF3	TRAF3	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	negative	negative	I-NP	JJ	O	5	NMOD
5	modulator	modulator	I-NP	NN	O	2	PRD
6	of	of	B-PP	IN	O	5	NMOD
7	LMP1	LMP1	B-NP	NN	B-protein	13	NMOD
8	(	(	O	(	O	13	NMOD
9	1-231	1-231	B-NP	CD	O	13	NMOD
10	)	)	O	)	O	13	NMOD
11	-mediated	-mediated	B-NP	JJ	O	13	NMOD
12	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	13	NMOD
13	activation	activation	I-NP	NN	O	6	PMOD
14	.	.	O	.	O	2	P

1	Surprisingly	Surprisingly	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	TRAF1	TRAF1	B-NP	NN	B-protein	8	NMOD
4	,	,	O	,	O	8	P
5	-2	-2	B-NP	CD	O	8	NMOD
6	,	,	O	,	O	8	P
7	or	or	O	CC	O	8	NMOD
8	-3	-3	B-NP	CD	O	9	SUB
9	does	do	B-VP	VBZ	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	interact	interact	I-VP	VB	O	9	VC
12	with	with	B-PP	IN	O	11	VMOD
13	the	the	B-NP	DT	O	17	NMOD
14	terminal	terminal	I-NP	JJ	B-protein	17	NMOD
15	LMP1	LMP1	I-NP	NN	I-protein	17	NMOD
16	CT	CT	I-NP	NN	I-protein	17	NMOD
17	aa	aa	I-NP	NNS	O	12	PMOD
18	333	333	B-NP	CD	O	20	NMOD
19	to	to	B-PP	TO	O	20	NMOD
20	386	386	B-NP	CD	O	17	NMOD
21	which	which	B-NP	WDT	O	17	NMOD
22	can	can	B-VP	MD	O	21	SBAR
23	independently	independently	I-VP	RB	O	22	VMOD
24	mediate	mediate	I-VP	VB	O	22	VC
25	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	26	NMOD
26	activation	activation	I-NP	NN	O	24	OBJ
27	.	.	O	.	O	9	P

1	CD40	CD40	B-NP	NN	B-protein	14	SUB
2	,	,	O	,	O	14	P
3	but	but	O	CC	O	14	VMOD
4	not	not	O	RB	O	3	DEP
5	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	anti-IgM	anti-IgM	B-NP	JJ	B-protein	8	NMOD
8	stimulation	stimulation	I-NP	NN	O	14	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	primary	primary	B-NP	JJ	B-cell_type	12	NMOD
11	B	B	I-NP	NN	I-cell_type	12	NMOD
12	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD
13	,	,	O	,	O	8	P
14	leads	lead	B-VP	VBZ	O	0	ROOT
15	to	to	B-PP	TO	O	14	VMOD
16	a	a	B-NP	DT	O	19	NMOD
17	persistent	persistent	I-NP	JJ	O	19	NMOD
18	nuclear	nuclear	I-NP	JJ	O	19	NMOD
19	accumulation	accumulation	I-NP	NN	O	15	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	RelB	RelB	B-NP	NN	B-protein	20	PMOD
22	.	.	O	.	O	14	P

1	LPS	LPS	B-NP	NN	O	2	NMOD
2	stimulation	stimulation	I-NP	NN	O	3	SUB
3	did	do	B-VP	VBD	O	17	VMOD
4	not	not	I-VP	RB	O	3	VMOD
5	give	give	I-VP	VB	O	3	VC
6	rise	rise	B-NP	NN	O	5	OBJ
7	to	to	B-PP	TO	O	5	VMOD
8	a	a	B-NP	DT	O	11	NMOD
9	persistent	persistent	I-NP	JJ	O	11	NMOD
10	nuclear	nuclear	I-NP	JJ	O	11	NMOD
11	accumulation	accumulation	I-NP	NN	O	7	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	RelB	RelB	B-NP	NN	B-protein	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	c-Rel	c-Rel	I-NP	NN	B-protein	12	PMOD
16	,	,	O	,	O	17	P
17	whereas	whereas	O	IN	O	0	ROOT
18	nuclear	nuclear	B-NP	JJ	O	23	NMOD
19	c-Rel	c-Rel	I-NP	NN	B-protein	23	NMOD
20	,	,	O	,	O	23	P
21	but	but	O	CC	O	23	NMOD
22	not	not	O	RB	O	21	DEP
23	RelB	RelB	B-NP	NN	B-protein	25	SUB
24	,	,	O	,	O	23	P
25	accumulated	accumulate	B-VP	VBN	O	17	VMOD
26	after	after	B-PP	IN	O	25	VMOD
27	B	B	B-NP	NN	B-protein	30	NMOD
28	cell	cell	I-NP	NN	I-protein	30	NMOD
29	receptor	receptor	I-NP	NN	I-protein	30	NMOD
30	stimulation	stimulation	I-NP	NN	O	26	PMOD
31	.	.	O	.	O	17	P

1	CD40	CD40	B-NP	NN	B-protein	2	SUB
2	induced	induce	B-VP	VBD	O	0	ROOT
3	not	not	B-CONJP	RB	O	11	NMOD
4	only	only	I-CONJP	RB	O	3	DEP
5	nuclear	nuclear	B-NP	JJ	O	6	NMOD
6	translocation	translocation	I-NP	NN	O	11	NMOD
7	but	but	O	CC	O	11	NMOD
8	also	also	B-NP	RB	O	7	DEP
9	de	de	I-NP	FW	O	10	AMOD
10	novo	novo	I-NP	FW	O	11	NMOD
11	synthesis	synthesis	I-NP	NN	O	2	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	RelB	RelB	B-NP	NN	B-RNA	16	NMOD
14	RNA	RNA	I-NP	NN	I-RNA	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	protein	protein	I-NP	NN	O	12	PMOD
17	.	.	O	.	O	2	P

1	S107	S107	B-NP	NN	B-cell_line	3	NMOD
2	plasmacytoma	plasmacytoma	I-NP	NN	I-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	18	SUB
4	,	,	O	,	O	3	P
5	which	which	B-NP	WDT	O	3	NMOD
6	express	express	B-VP	VBP	O	5	SBAR
7	CD40	CD40	B-NP	NN	B-protein	6	OBJ
8	but	but	O	CC	O	6	VMOD
9	are	be	B-VP	VBP	O	6	VMOD
10	defective	defective	B-ADJP	JJ	O	9	PRD
11	for	for	B-PP	IN	O	10	AMOD
12	the	the	B-NP	DT	O	14	NMOD
13	nuclear	nuclear	I-NP	JJ	O	14	NMOD
14	appearance	appearance	I-NP	NN	O	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	p50/p65-NF-kappaB	p50/p65-NF-kappaB	B-NP	NN	B-protein	15	PMOD
17	,	,	O	,	O	3	P
18	do	do	B-VP	VBP	O	0	ROOT
19	not	not	I-VP	RB	O	18	VMOD
20	express	express	I-VP	VB	O	18	VC
21	RelB	RelB	B-NP	NN	B-protein	20	OBJ
22	after	after	B-PP	IN	O	20	VMOD
23	CD40	CD40	B-NP	NN	B-protein	24	NMOD
24	stimulation	stimulation	I-NP	NN	O	22	PMOD
25	.	.	O	.	O	18	P

1	Since	Since	B-SBAR	IN	O	12	VMOD
2	LPS	LPS	B-NP	NN	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	anti-IgM	anti-IgM	I-NP	NN	B-protein	5	SUB
5	were	be	B-VP	VBD	O	1	SBAR
6	unable	unable	B-ADJP	JJ	O	5	PRD
7	to	to	B-VP	TO	O	8	VMOD
8	activate	activate	I-VP	VB	O	6	AMOD
9	RelB	RelB	B-NP	NN	B-protein	8	OBJ
10	,	,	O	,	O	12	P
11	CD40	CD40	B-NP	NN	B-protein	12	SUB
12	appears	appear	B-VP	VBZ	O	0	ROOT
13	to	to	I-VP	TO	O	14	VMOD
14	trigger	trigger	I-VP	VB	O	12	VMOD
15	a	a	B-NP	DT	O	17	NMOD
16	special	special	I-NP	JJ	O	17	NMOD
17	program	program	I-NP	NN	O	14	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	gene	gene	B-NP	NN	O	20	NMOD
20	expression	expression	I-NP	NN	O	18	PMOD
21	involved	involve	B-VP	VBN	O	20	NMOD
22	in	in	B-PP	IN	O	21	VMOD
23	the	the	B-NP	DT	O	26	NMOD
24	proliferation	proliferation	I-NP	NN	O	26	NMOD
25	and/or	and/or	O	CC	O	26	NMOD
26	differentiation	differentiation	B-NP	NN	O	22	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	B	B	B-NP	NN	B-cell_type	29	NMOD
29	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	27	PMOD
30	.	.	O	.	O	12	P

1	Consequently	Consequently	B-ADVP	RB	O	6	VMOD
2	,	,	O	,	O	6	P
3	the	the	B-NP	DT	O	5	NMOD
4	present	present	I-NP	JJ	O	5	NMOD
5	study	study	I-NP	NN	O	6	SUB
6	was	be	B-VP	VBD	O	0	ROOT
7	addressed	address	I-VP	VBN	O	6	VC
8	to	to	B-VP	TO	O	9	VMOD
9	understand	understand	I-VP	VB	O	7	VMOD
10	this	this	B-NP	DT	O	11	NMOD
11	phenomenon	phenomenon	I-NP	NN	O	9	OBJ
12	and	and	O	CC	O	6	VMOD
13	revealed	reveal	B-VP	VBD	O	6	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	existence	existence	I-NP	NN	O	38	NMOD
16	of	of	B-PP	IN	O	15	NMOD
17	a	a	B-NP	DT	O	22	NMOD
18	unique	unique	I-NP	JJ	B-protein	22	NMOD
19	47	47	I-NP	CD	I-protein	20	AMOD
20	kDa	kDa	I-NP	NN	I-protein	22	NMOD
21	protein	protein	I-NP	NN	I-protein	22	NMOD
22	factor	factor	I-NP	NN	I-protein	16	PMOD
23	having	have	B-VP	VBG	O	22	NMOD
24	affinity	affinity	B-NP	NN	O	23	OBJ
25	for	for	B-PP	IN	O	24	NMOD
26	this	this	B-NP	DT	O	28	NMOD
27	SRE	SRE	I-NP	NN	B-DNA	28	NMOD
28	sequence	sequence	I-NP	NN	I-DNA	25	PMOD
29	in	in	B-PP	IN	O	15	NMOD
30	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	29	PMOD
31	from	from	B-PP	IN	O	30	NMOD
32	normal	normal	B-NP	JJ	O	33	NMOD
33	subjects	subject	I-NP	NNS	O	31	PMOD
34	as	as	B-CONJP	RB	O	38	NMOD
35	well	well	I-CONJP	RB	O	34	DEP
36	as	as	I-CONJP	IN	O	34	DEP
37	its	its	B-NP	PRP$	O	38	NMOD
38	absence	absence	I-NP	NN	O	13	OBJ
39	in	in	B-PP	IN	O	38	NMOD
40	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	39	PMOD
41	from	from	B-PP	IN	O	40	NMOD
42	untreated	untreated	B-NP	JJ	O	44	NMOD
43	CML	CML	I-NP	NN	O	44	NMOD
44	patients	patient	I-NP	NNS	O	41	PMOD
45	.	.	O	.	O	6	P

1	Ara-C	Ara-C	B-NP	NN	O	2	SUB
2	activated	activate	B-VP	VBD	O	0	ROOT
3	SMase	SMase	B-NP	NN	B-protein	2	OBJ
4	with	with	B-PP	IN	O	2	VMOD
5	10	10	B-NP	CD	O	6	NMOD
6	minutes	minute	I-NP	NNS	O	4	PMOD
7	in	in	B-PP	IN	O	6	NMOD
8	both	both	O	CC	O	12	NMOD
9	Jurkat	Jurkat	B-NP	NN	B-cell_line	12	NMOD
10	and	and	O	CC	O	12	NMOD
11	EL4	EL4	B-NP	NN	B-cell_line	12	NMOD
12	cells	cell	I-NP	NNS	I-cell_line	7	PMOD
13	,	,	O	,	O	2	P
14	while	while	B-SBAR	IN	O	2	VMOD
15	phorbol	phorbol	B-NP	NN	O	16	NMOD
16	ester	ester	I-NP	NN	O	20	SUB
17	(	(	O	(	O	19	DEP
18	PMA	PMA	B-NP	NN	O	19	DEP
19	)	)	O	)	O	16	NMOD
20	had	have	B-VP	VBD	O	14	SBAR
21	no	no	B-NP	DT	O	22	NMOD
22	effect	effect	I-NP	NN	O	20	OBJ
23	.	.	O	.	O	2	P

1	PMA	PMA	B-NP	NN	O	7	NMOD
2	,	,	O	,	O	7	P
3	but	but	O	CC	O	7	NMOD
4	not	not	O	RB	O	3	DEP
5	Ara-C	Ara-C	B-NP	NN	O	7	NMOD
6	or	or	I-NP	CC	O	7	NMOD
7	ceramides	ceramide	I-NP	NNS	O	9	SUB
8	,	,	O	,	O	7	P
9	activated	activate	B-NP	VBN	O	0	ROOT
10	ERK	ERK	I-NP	NN	B-protein	11	NMOD
11	MAPKS	MAPKS	I-NP	NN	I-protein	9	OBJ
12	,	,	O	,	O	9	P
13	in	in	B-PP	IN	O	9	VMOD
14	Jurkat	Jurkat	B-NP	NN	B-cell_line	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	EL4	EL4	I-NP	NN	B-cell_line	13	PMOD
17	.	.	O	.	O	9	P

1	Thus	Thus	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	ceramide	ceramide	B-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	not	not	O	RB	O	4	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	positive	positive	I-NP	JJ	O	8	NMOD
8	signal	signal	I-NP	NN	O	4	PRD
9	for	for	B-PP	IN	O	8	NMOD
10	ERK	ERK	B-NP	NN	B-protein	11	NMOD
11	activation	activation	I-NP	NN	O	9	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	T-cell	T-cell	B-NP	NN	B-cell_line	14	NMOD
14	lines	line	I-NP	NNS	I-cell_line	12	PMOD
15	.	.	O	.	O	4	P

1	In	In	B-PP	IN	O	5	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	paper	paper	I-NP	NN	O	1	PMOD
4	we	we	B-NP	PRP	O	5	SUB
5	have	have	B-VP	VBP	O	0	ROOT
6	investigated	investigate	I-VP	VBN	O	5	VC
7	the	the	B-NP	DT	O	8	NMOD
8	role	role	I-NP	NN	O	6	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	Egr-1	Egr-1	B-NP	NN	B-protein	9	PMOD
11	in	in	B-PP	IN	O	8	NMOD
12	B	B	B-NP	NN	O	15	NMOD
13	cell	cell	I-NP	NN	O	15	NMOD
14	growth	growth	I-NP	NN	O	15	NMOD
15	regulation	regulation	I-NP	NN	O	11	PMOD
16	by	by	B-PP	IN	O	6	VMOD
17	examining	examine	B-VP	VBG	O	16	PMOD
18	the	the	B-NP	DT	O	20	NMOD
19	gene	gene	I-NP	NN	O	20	NMOD
20	expression	expression	I-NP	NN	O	17	OBJ
21	in	in	B-PP	IN	O	20	NMOD
22	a	a	B-NP	DT	O	23	NMOD
23	panel	panel	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	B	B	B-NP	NN	B-cell_line	27	NMOD
26	cell	cell	I-NP	NN	I-cell_line	27	NMOD
27	lines	line	I-NP	NNS	I-cell_line	24	PMOD
28	,	,	O	,	O	27	P
29	including	include	B-PP	VBG	O	27	NMOD
30	both	both	O	CC	O	35	AMOD
31	EBV	EBV	B-NP	NN	B-DNA	32	NMOD
32	genome	genome	I-NP	NN	I-DNA	33	AMOD
33	negative	negative	B-ADJP	JJ	O	35	AMOD
34	and	and	O	CC	O	35	AMOD
35	EBV	EBV	B-NP	NN	B-cell_line	38	NMOD
36	carrying	carry	B-VP	VBG	I-cell_line	35	AMOD
37	cell	cell	B-NP	NN	I-cell_line	38	NMOD
38	lines	line	I-NP	NNS	I-cell_line	29	PMOD
39	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	3	NMOD
2	CpG	CpG	I-NP	NN	O	3	NMOD
3	dinucleotide	dinucleotide	I-NP	NN	O	7	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	this	this	B-NP	DT	O	6	NMOD
6	element	element	I-NP	NN	B-DNA	4	PMOD
7	is	be	B-VP	VBZ	O	26	VMOD
8	selectively	selectively	I-VP	RB	O	7	VMOD
9	methylated	methylate	I-VP	VBN	O	7	VC
10	in	in	B-PP	IN	O	9	VMOD
11	Th2	Th2	B-NP	NN	B-cell_type	13	NMOD
12	T	T	I-NP	NN	I-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	16	NMOD
14	and	and	O	CC	O	16	NMOD
15	other	other	B-NP	JJ	O	16	NMOD
16	cells	cell	I-NP	NNS	O	10	PMOD
17	that	that	B-NP	WDT	O	16	NMOD
18	do	do	B-VP	VBP	O	17	SBAR
19	not	not	I-VP	RB	O	18	VMOD
20	express	express	I-VP	VB	O	18	VC
21	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	20	OBJ
22	,	,	O	,	O	26	P
23	and	and	O	CC	O	26	VMOD
24	methylation	methylation	B-NP	NN	O	26	SUB
25	markedly	markedly	B-ADVP	RB	O	26	VMOD
26	reduces	reduce	B-VP	VBZ	O	0	ROOT
27	transcription	transcription	B-NP	NN	B-protein	29	NMOD
28	factor	factor	I-NP	NN	I-protein	29	NMOD
29	binding	binding	I-NP	NN	O	26	OBJ
30	.	.	O	.	O	26	P

1	Contrary	Contrary	B-ADVP	JJ	O	2	PMOD
2	to	to	B-PP	TO	O	21	VMOD
3	the	the	B-NP	DT	O	4	NMOD
4	idea	idea	I-NP	NN	O	2	PMOD
5	that	that	B-SBAR	IN	O	4	NMOD
6	protein	protein	B-NP	NN	B-protein	8	NMOD
7	kinase	kinase	I-NP	NN	I-protein	8	NMOD
8	C	C	I-NP	NN	I-protein	9	SUB
9	is	be	B-VP	VBZ	O	5	SBAR
10	involved	involve	I-VP	VBN	O	9	VC
11	in	in	B-PP	IN	O	10	VMOD
12	TCR-mediated	TCR-mediated	B-NP	JJ	O	13	NMOD
13	activation	activation	I-NP	NN	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	14	PMOD
16	,	,	O	,	O	21	P
17	high	high	B-NP	JJ	O	18	NMOD
18	doses	dose	I-NP	NNS	O	21	SUB
19	of	of	B-PP	IN	O	18	NMOD
20	staurosporine	staurosporine	B-NP	NN	O	19	PMOD
21	did	do	B-VP	VBD	O	0	ROOT
22	not	not	I-VP	RB	O	21	VMOD
23	interfere	interfere	I-VP	VB	O	21	VC
24	with	with	B-PP	IN	O	23	VMOD
25	activation	activation	B-NP	NN	O	24	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	26	PMOD
28	by	by	B-PP	IN	O	25	NMOD
29	PHA	PHA	B-NP	NN	B-protein	28	PMOD
30	,	,	O	,	O	23	P
31	while	while	B-SBAR	IN	O	23	VMOD
32	the	the	B-NP	DT	O	34	NMOD
33	same	same	I-NP	JJ	O	34	NMOD
34	dose	dose	I-NP	NN	O	38	SUB
35	of	of	B-PP	IN	O	34	NMOD
36	staurosporine	staurosporine	B-NP	NN	O	35	PMOD
37	completely	completely	B-ADVP	RB	O	38	VMOD
38	blocked	block	B-VP	VBD	O	31	SBAR
39	activation	activation	B-NP	NN	O	38	OBJ
40	by	by	B-PP	IN	O	38	VMOD
41	PMA	PMA	B-NP	NN	O	40	PMOD
42	.	.	O	.	O	21	P

1	PHA-induced	PHA-induced	B-NP	JJ	O	4	NMOD
2	kappaB-dependent	kappaB-dependent	I-NP	JJ	O	4	NMOD
3	reporter	reporter	I-NP	NN	O	4	NMOD
4	activity	activity	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	,	,	O	,	O	5	P
7	however	however	B-ADVP	RB	O	5	VMOD
8	,	,	O	,	O	5	P
9	effectively	effectively	B-VP	RB	O	10	VMOD
10	blocked	block	I-VP	VBN	O	5	VC
11	by	by	B-PP	IN	O	10	VMOD
12	a	a	B-NP	DT	O	15	NMOD
13	dominant	dominant	I-NP	JJ	O	15	NMOD
14	negative	negative	I-NP	JJ	O	15	NMOD
15	form	form	I-NP	NN	O	11	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	Raf-1	Raf-1	B-NP	NN	B-protein	16	PMOD
18	,	,	O	,	O	10	P
19	suggesting	suggest	B-VP	VBG	O	10	VMOD
20	a	a	B-NP	DT	O	22	NMOD
21	critical	critical	I-NP	JJ	O	22	NMOD
22	role	role	I-NP	NN	O	19	OBJ
23	for	for	B-PP	IN	O	22	NMOD
24	a	a	B-NP	DT	O	26	NMOD
25	Raf	Raf	I-NP	NN	B-protein	26	NMOD
26	kinase	kinase	I-NP	NN	I-protein	23	PMOD
27	.	.	O	.	O	5	P

1	To	To	B-VP	TO	O	2	VMOD
2	help	help	I-VP	VB	O	16	VMOD
3	elucidate	elucidate	I-VP	VB	O	2	VMOD
4	further	further	B-ADVP	RBR	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	mechanism	mechanism	I-NP	NN	O	3	OBJ
7	by	by	B-PP	IN	O	6	NMOD
8	which	which	B-NP	WDT	O	7	PMOD
9	ZAP-70	ZAP-70	B-NP	NN	B-protein	10	SUB
10	regulates	regulate	B-VP	VBZ	O	7	SBAR
11	these	these	B-NP	DT	O	13	NMOD
12	initial	initial	I-NP	JJ	O	13	NMOD
13	events	event	I-NP	NNS	O	10	OBJ
14	,	,	O	,	O	16	P
15	we	we	B-NP	PRP	O	16	SUB
16	used	use	B-VP	VBD	O	0	ROOT
17	a	a	B-NP	DT	O	20	NMOD
18	dominant-negative	dominant-negative	I-NP	JJ	O	20	NMOD
19	mutant	mutant	I-NP	JJ	O	20	NMOD
20	approach	approach	I-NP	NN	O	16	OBJ
21	.	.	O	.	O	16	P

1	This	This	B-NP	DT	O	2	NMOD
2	result	result	I-NP	NN	O	3	SUB
3	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	Tyr-492	Tyr-492	B-NP	NN	O	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	Tyr-493	Tyr-493	I-NP	NN	O	8	SUB
8	are	be	B-VP	VBP	O	4	SBAR
9	not	not	O	RB	O	8	VMOD
10	responsible	responsible	B-ADJP	JJ	O	8	PRD
11	for	for	B-PP	IN	O	10	AMOD
12	the	the	B-NP	DT	O	17	NMOD
13	Src	Src	I-NP	NN	B-protein	15	AMOD
14	homology	homology	I-NP	NN	I-protein	15	AMOD
15	domain	domain	I-NP	NN	I-protein	17	NMOD
16	2-mediated	2-mediated	I-NP	JJ	O	15	AMOD
17	association	association	I-NP	NN	O	11	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	p56	p56	B-NP	NN	B-protein	21	NMOD
20	(	(	O	(	I-protein	21	NMOD
21	lck	lck	B-NP	NN	I-protein	18	PMOD
22	)	)	O	)	I-protein	21	NMOD
23	with	with	B-PP	IN	O	17	NMOD
24	ZAP-70	ZAP-70	B-NP	NN	B-protein	23	PMOD
25	.	.	O	.	O	3	P

1	Lymphocytes	Lymphocyte	B-NP	NNS	B-cell_type	5	SUB
2	from	from	B-PP	IN	O	1	NMOD
3	CML	CML	B-NP	NN	O	4	NMOD
4	patients	patient	I-NP	NNS	O	2	PMOD
5	lack	lack	B-VP	VBP	O	0	ROOT
6	a	a	B-NP	DT	O	9	NMOD
7	47	47	I-NP	CD	B-protein	8	AMOD
8	kDa	kDa	I-NP	NN	I-protein	9	NMOD
9	factor	factor	I-NP	NN	I-protein	5	OBJ
10	having	have	B-VP	VBG	O	9	NMOD
11	affinity	affinity	B-NP	NN	O	10	OBJ
12	for	for	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	17	NMOD
14	genomic	genomic	I-NP	JJ	B-DNA	17	NMOD
15	sterol	sterol	I-NP	NN	I-DNA	17	NMOD
16	regulatory	regulatory	I-NP	JJ	I-DNA	17	NMOD
17	sequence	sequence	I-NP	NN	I-DNA	12	PMOD
18	.	.	O	.	O	5	P

1	Since	Since	B-SBAR	IN	O	27	VMOD
2	the	the	B-NP	DT	O	7	NMOD
3	human	human	I-NP	JJ	B-DNA	7	NMOD
4	genomic	genomic	I-NP	JJ	I-DNA	7	NMOD
5	sterol	sterol	I-NP	NN	I-DNA	7	NMOD
6	regulatory	regulatory	I-NP	JJ	I-DNA	7	NMOD
7	element	element	I-NP	NN	I-DNA	11	SUB
8	(	(	O	(	O	10	DEP
9	SRE	SRE	B-NP	NN	B-DNA	10	DEP
10	)	)	O	)	O	7	NMOD
11	has	have	B-VP	VBZ	O	1	SBAR
12	been	be	I-VP	VBN	O	11	VC
13	shown	show	I-VP	VBN	O	12	VC
14	to	to	I-VP	TO	O	15	VMOD
15	regulate	regulate	I-VP	VB	O	13	VMOD
16	various	various	B-NP	JJ	O	18	NMOD
17	key	key	I-NP	JJ	O	18	NMOD
18	genes	gene	I-NP	NNS	O	15	OBJ
19	involved	involve	B-VP	VBN	O	18	NMOD
20	in	in	B-PP	IN	O	19	VMOD
21	this	this	B-NP	DT	O	22	NMOD
22	phenomenon	phenomenon	I-NP	NN	O	20	PMOD
23	,	,	O	,	O	27	P
24	the	the	B-NP	DT	O	26	NMOD
25	present	present	I-NP	JJ	O	26	NMOD
26	study	study	I-NP	NN	O	27	SUB
27	revealed	reveal	B-VP	VBD	O	0	ROOT
28	the	the	B-NP	DT	O	29	NMOD
29	existence	existence	I-NP	NN	O	53	NMOD
30	of	of	B-PP	IN	O	29	NMOD
31	a	a	B-NP	DT	O	36	NMOD
32	unique	unique	I-NP	JJ	B-protein	36	NMOD
33	47	47	I-NP	CD	I-protein	34	AMOD
34	kDa	kDa	I-NP	NN	I-protein	36	NMOD
35	protein	protein	I-NP	NN	I-protein	36	NMOD
36	factor	factor	I-NP	NN	I-protein	30	PMOD
37	having	have	B-VP	VBG	O	36	NMOD
38	affinity	affinity	B-NP	NN	O	37	OBJ
39	for	for	B-PP	IN	O	38	NMOD
40	this	this	B-NP	DT	O	42	NMOD
41	SRE	SRE	I-NP	NN	B-DNA	42	NMOD
42	sequence	sequence	I-NP	NN	I-DNA	39	PMOD
43	in	in	B-PP	IN	O	29	NMOD
44	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	43	PMOD
45	from	from	B-PP	IN	O	44	NMOD
46	normal	normal	B-NP	JJ	O	47	NMOD
47	subjects	subject	I-NP	NNS	O	45	PMOD
48	,	,	O	,	O	53	P
49	as	as	B-CONJP	RB	O	53	NMOD
50	well	well	I-CONJP	RB	O	49	DEP
51	as	as	I-CONJP	IN	O	49	DEP
52	its	its	B-NP	PRP$	O	53	NMOD
53	absence	absence	I-NP	NN	O	27	OBJ
54	in	in	B-PP	IN	O	53	NMOD
55	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	54	PMOD
56	from	from	B-PP	IN	O	55	NMOD
57	untreated	untreated	B-NP	JJ	O	59	NMOD
58	CML	CML	I-NP	NN	O	59	NMOD
59	patients	patient	I-NP	NNS	O	56	PMOD
60	.	.	O	.	O	27	P

1	The	The	B-NP	DT	O	4	NMOD
2	SCMV	SCMV	I-NP	NN	B-DNA	4	NMOD
3	SNE	SNE	I-NP	NN	I-DNA	4	NMOD
4	sites	site	I-NP	NNS	I-DNA	5	SUB
5	contain	contain	B-VP	VBP	O	0	ROOT
6	potential	potential	B-NP	JJ	O	11	NMOD
7	overlapping	overlap	I-NP	VBG	O	11	NMOD
8	core	core	I-NP	NN	O	11	NMOD
9	recognition	recognition	I-NP	NN	O	11	NMOD
10	binding	binding	I-NP	NN	O	11	NMOD
11	motifs	motif	I-NP	NNS	O	5	OBJ
12	for	for	B-PP	IN	O	11	NMOD
13	SRF	SRF	B-NP	NN	B-protein	23	NMOD
14	,	,	O	,	O	23	P
15	Rel/NFkappaB	Rel/NFkappaB	B-NP	NN	B-protein	23	NMOD
16	,	,	O	,	O	23	P
17	ETS	ETS	B-NP	NN	B-protein	23	NMOD
18	,	,	O	,	O	23	P
19	and	and	O	CC	O	23	NMOD
20	YY1	YY1	B-NP	NN	B-protein	23	NMOD
21	class	class	I-NP	NN	I-protein	23	NMOD
22	transcription	transcription	I-NP	NN	I-protein	23	NMOD
23	factors	factor	I-NP	NNS	I-protein	12	PMOD
24	but	but	O	CC	O	5	VMOD
25	fail	fail	B-VP	VBP	O	5	VMOD
26	to	to	I-VP	TO	O	27	VMOD
27	respond	respond	I-VP	VB	O	25	VMOD
28	to	to	B-PP	TO	O	27	VMOD
29	either	either	O	CC	O	35	NMOD
30	serum	serum	B-NP	NN	O	35	NMOD
31	or	or	O	CC	O	35	NMOD
32	tumor	tumor	B-NP	NN	B-protein	35	NMOD
33	necrosis	necrosis	I-NP	NN	I-protein	35	NMOD
34	factor	factor	I-NP	NN	I-protein	35	NMOD
35	alpha	alpha	I-NP	NN	I-protein	28	PMOD
36	.	.	O	.	O	5	P

1	Unlike	Unlike	B-PP	IN	O	13	VMOD
2	classical	classical	B-NP	JJ	O	4	NMOD
3	NFkappaB	NFkappaB	I-NP	NN	B-DNA	4	NMOD
4	sites	site	I-NP	NNS	I-DNA	1	PMOD
5	,	,	O	,	O	13	P
6	neither	neither	O	CC	O	12	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	SNE	SNE	I-NP	NN	B-DNA	12	NMOD
9	nor	nor	O	CC	O	12	NMOD
10	the	the	B-NP	DT	O	12	NMOD
11	SEE	SEE	I-NP	NN	B-DNA	12	NMOD
12	motif	motif	I-NP	NN	I-DNA	13	SUB
13	responded	respond	B-VP	VBD	O	0	ROOT
14	to	to	B-PP	TO	O	13	VMOD
15	phosphatase	phosphatase	B-NP	NN	B-protein	16	NMOD
16	inhibition	inhibition	I-NP	NN	O	14	PMOD
17	by	by	B-PP	IN	O	16	NMOD
18	okadaic	okadaic	B-NP	JJ	O	19	NMOD
19	acid	acid	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	13	P

1	A	A	B-NP	DT	O	3	NMOD
2	40-fold	40-fold	I-NP	JJ	O	3	NMOD
3	stimulation	stimulation	I-NP	NN	O	16	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	chloramphenicol	chloramphenicol	B-NP	NN	B-protein	7	NMOD
6	acetyltransferase	acetyltransferase	I-NP	NN	I-protein	7	NMOD
7	activity	activity	I-NP	NN	O	4	PMOD
8	mediated	mediate	B-VP	VBN	O	3	NMOD
9	by	by	B-PP	IN	O	8	VMOD
10	four	four	B-NP	CD	O	12	NMOD
11	tandem	tandem	I-NP	JJ	B-DNA	12	NMOD
12	repeats	repeat	I-NP	NNS	I-DNA	9	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	SNE	SNE	I-NP	NN	B-DNA	13	PMOD
16	could	could	B-VP	MD	O	0	ROOT
17	be	be	I-VP	VB	O	16	VC
18	induced	induce	I-VP	VBN	O	17	VC
19	within	within	B-PP	IN	O	18	VMOD
20	2	2	B-NP	CD	O	21	NMOD
21	h	h	I-NP	NN	O	19	PMOD
22	(	(	O	(	O	18	VMOD
23	and	and	O	CC	O	18	VMOD
24	up	up	B-ADVP	RB	O	18	VMOD
25	to	to	B-PP	TO	O	24	AMOD
26	250-fold	250-fold	B-NP	JJ	O	24	AMOD
27	within	within	B-PP	IN	O	24	VMOD
28	6	6	B-NP	CD	O	29	NMOD
29	h	h	I-NP	NN	O	27	PMOD
30	)	)	O	)	O	18	VMOD
31	after	after	B-PP	IN	O	18	VMOD
32	addition	addition	B-NP	NN	O	31	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	TPA	TPA	B-NP	NN	O	33	PMOD
35	in	in	B-PP	IN	O	32	NMOD
36	DNA-transfected	DNA-transfected	B-NP	JJ	B-cell_line	38	NMOD
37	U-937	U-937	I-NP	NN	I-cell_line	38	NMOD
38	cells	cell	I-NP	NNS	I-cell_line	35	PMOD
39	,	,	O	,	O	18	P
40	indicating	indicate	B-VP	VBG	O	18	VMOD
41	that	that	B-SBAR	IN	O	40	VMOD
42	the	the	B-NP	DT	O	43	NMOD
43	stimulation	stimulation	I-NP	NN	O	44	SUB
44	appeared	appear	B-VP	VBD	O	41	SBAR
45	likely	likely	B-ADJP	JJ	O	44	PRD
46	to	to	B-VP	TO	O	47	VMOD
47	be	be	I-VP	VB	O	45	AMOD
48	a	a	B-NP	DT	O	55	NMOD
49	true	true	I-NP	JJ	O	51	AMOD
50	protein	protein	I-NP	NN	O	51	AMOD
51	kinase	kinase	I-NP	NN	O	55	NMOD
52	C-mediated	C-mediated	I-NP	JJ	O	51	AMOD
53	signal	signal	I-NP	NN	O	55	NMOD
54	transduction	transduction	I-NP	NN	O	55	NMOD
55	event	event	I-NP	NN	O	60	NMOD
56	rather	rather	B-CONJP	RB	O	60	NMOD
57	than	than	I-CONJP	IN	O	56	DEP
58	a	a	B-NP	DT	O	60	NMOD
59	differentiation	differentiation	I-NP	NN	O	60	NMOD
60	response	response	I-NP	NN	O	47	PRD
61	.	.	O	.	O	16	P

1	We	We	B-NP	PRP	O	2	SUB
2	find	find	B-VP	VBP	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	,	,	O	,	O	3	P
5	although	although	B-SBAR	IN	O	40	VMOD
6	the	the	B-NP	DT	O	9	NMOD
7	variant	variant	I-NP	JJ	O	9	NMOD
8	octamer	octamer	I-NP	NN	B-DNA	9	NMOD
9	motif	motif	I-NP	NN	I-DNA	10	SUB
10	binds	bind	B-VP	VBZ	O	5	SBAR
11	Oct-1	Oct-1	B-NP	NN	B-protein	13	NMOD
12	and	and	I-NP	CC	O	13	NMOD
13	Oct-2	Oct-2	I-NP	NN	B-protein	10	OBJ
14	in	in	B-ADVP	FW	O	10	VMOD
15	vitro	vitro	I-ADVP	FW	O	14	AMOD
16	with	with	B-PP	IN	O	10	VMOD
17	5-fold	5-fold	B-NP	RB	O	19	NMOD
18	lower	low	I-NP	JJR	O	17	AMOD
19	affinity	affinity	I-NP	NN	O	16	PMOD
20	than	than	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	24	NMOD
22	consensus	consensus	I-NP	NN	B-DNA	24	NMOD
23	octamer	octamer	I-NP	NN	I-DNA	24	NMOD
24	motif	motif	I-NP	NN	I-DNA	20	PMOD
25	,	,	O	,	O	40	P
26	mutation	mutation	B-NP	NN	O	40	SUB
27	of	of	B-PP	IN	O	26	NMOD
28	the	the	B-NP	DT	O	31	NMOD
29	variant	variant	I-NP	JJ	O	31	NMOD
30	octamer	octamer	I-NP	NN	B-DNA	31	NMOD
31	motif	motif	I-NP	NN	I-DNA	27	PMOD
32	to	to	B-PP	TO	O	26	NMOD
33	either	either	O	CC	O	39	NMOD
34	a	a	B-NP	DT	O	36	NMOD
35	consensus	consensus	I-NP	NN	B-DNA	36	NMOD
36	octamer	octamer	I-NP	NN	I-DNA	39	NMOD
37	or	or	O	CC	O	39	NMOD
38	non-octamer	non-octamer	B-NP	JJ	B-DNA	39	NMOD
39	motif	motif	I-NP	NN	I-DNA	32	PMOD
40	has	have	B-VP	VBZ	O	3	SBAR
41	no	no	B-NP	DT	O	42	NMOD
42	effect	effect	I-NP	NN	O	40	OBJ
43	on	on	B-PP	IN	O	40	VMOD
44	transcriptional	transcriptional	B-NP	JJ	O	45	NMOD
45	activation	activation	I-NP	NN	O	43	PMOD
46	from	from	B-PP	IN	O	45	NMOD
47	the	the	B-NP	DT	O	49	NMOD
48	germline	germline	I-NP	NN	B-DNA	49	NMOD
49	promoter	promoter	I-NP	NN	I-DNA	46	PMOD
50	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	promoter	promoter	I-NP	NN	B-DNA	3	NMOD
3	region	region	I-NP	NN	I-DNA	4	SUB
4	lacked	lack	B-VP	VBD	O	0	ROOT
5	a	a	B-NP	DT	O	7	NMOD
6	TATA	TATA	I-NP	NN	B-DNA	7	NMOD
7	box	box	I-NP	NN	I-DNA	4	OBJ
8	but	but	O	CC	O	4	VMOD
9	contained	contain	B-VP	VBD	O	4	VMOD
10	potential	potential	B-NP	JJ	O	12	NMOD
11	binding	bind	I-NP	VBG	O	12	NMOD
12	sites	site	I-NP	NNS	O	9	OBJ
13	for	for	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	transcriptional	transcriptional	I-NP	JJ	B-protein	16	NMOD
16	factors	factor	I-NP	NNS	I-protein	13	PMOD
17	including	include	B-PP	VBG	O	16	NMOD
18	two	two	B-NP	CD	O	19	NMOD
19	Sp1	Sp1	I-NP	NN	B-protein	25	NMOD
20	,	,	O	,	O	25	P
21	CRE	CRE	B-NP	NN	B-DNA	25	NMOD
22	,	,	O	,	O	25	P
23	Myb	Myb	B-NP	NN	B-protein	25	NMOD
24	and	and	I-NP	CC	O	25	NMOD
25	NFkB	NFkB	I-NP	NN	B-protein	17	PMOD
26	located	located	B-ADJP	JJ	O	40	AMOD
27	at	at	B-PP	IN	O	40	AMOD
28	positions	position	B-NP	NNS	O	27	PMOD
29	-153	-153	B-NP	CD	O	38	NMOD
30	,	,	I-NP	,	O	38	P
31	-178	-178	I-NP	CD	O	38	NMOD
32	,	,	I-NP	,	O	38	P
33	-286	-286	I-NP	CD	O	38	NMOD
34	,	,	I-NP	,	O	38	P
35	-875	-875	I-NP	CD	O	38	NMOD
36	,	,	O	,	O	38	P
37	and	and	O	CC	O	38	NMOD
38	-1011	-1011	B-NP	CD	O	28	NMOD
39	,	,	O	,	O	40	P
40	respectively	respectively	B-ADVP	RB	O	12	NMOD
41	.	.	O	.	O	4	P

1	Inhibition	Inhibition	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	RANTES	RANTES	B-NP	NN	B-protein	4	NMOD
4	expression	expression	I-NP	NN	O	2	PMOD
5	did	do	B-VP	VBD	O	0	ROOT
6	not	not	I-VP	RB	O	5	VMOD
7	appear	appear	I-VP	VB	O	5	VC
8	to	to	I-VP	TO	O	9	VMOD
9	be	be	I-VP	VB	O	7	VMOD
10	secondary	secondary	B-ADJP	JJ	O	9	PRD
11	to	to	B-PP	TO	O	10	AMOD
12	IL-2	IL-2	B-NP	NN	B-protein	13	NMOD
13	inhibition	inhibition	I-NP	NN	O	11	PMOD
14	and	and	O	CC	O	5	VMOD
15	required	require	B-VP	VBD	O	5	VMOD
16	binding	binding	B-NP	NN	O	15	OBJ
17	to	to	B-PP	TO	O	16	NMOD
18	the	the	B-NP	DT	O	21	NMOD
19	intracellular	intracellular	I-NP	JJ	O	21	NMOD
20	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	21	NMOD
21	receptor	receptor	I-NP	NN	I-protein	17	PMOD
22	.	.	O	.	O	5	P

1	Although	Although	B-SBAR	IN	O	18	VMOD
2	inhibition	inhibition	B-NP	NN	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	IL-4-driven	IL-4-driven	B-NP	JJ	B-cell_line	8	NMOD
5	germline	germline	I-NP	NN	I-cell_line	8	NMOD
6	C	C	I-NP	NN	I-cell_line	8	NMOD
7	epsilon	epsilon	I-NP	NN	I-cell_line	8	NMOD
8	transcription	transcription	I-NP	NN	O	3	PMOD
9	by	by	B-PP	IN	O	2	NMOD
10	NAC	NAC	B-NP	NN	O	9	PMOD
11	was	be	B-VP	VBD	O	1	SBAR
12	not	not	O	RB	O	11	VMOD
13	sufficient	sufficient	B-ADJP	JJ	O	11	PRD
14	,	,	O	,	O	18	P
15	the	the	B-NP	DT	O	16	NMOD
16	agent	agent	I-NP	NN	O	18	SUB
17	remarkably	remarkably	B-ADVP	RB	O	18	VMOD
18	diminished	diminish	B-VP	VBD	O	0	ROOT
19	anti-CD40	anti-CD40	B-NP	JJ	B-protein	20	AMOD
20	mAb-mediated	mAb-mediated	I-NP	JJ	O	21	NMOD
21	up-regulation	up-regulation	I-NP	NN	O	18	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	germline	germline	B-NP	NN	B-DNA	26	NMOD
24	C	C	I-NP	NN	O	26	NMOD
25	epsilon	epsilon	I-NP	NN	O	26	NMOD
26	transcription	transcription	I-NP	NN	O	22	PMOD
27	.	.	O	.	O	18	P

1	However	However	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	NAC	NAC	B-NP	NN	O	4	SUB
4	did	do	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	significantly	significantly	I-VP	RB	O	4	VMOD
7	affect	affect	I-VP	VB	O	4	VC
8	the	the	B-NP	DT	O	10	NMOD
9	spontaneous	spontaneous	I-NP	JJ	O	10	NMOD
10	production	production	I-NP	NN	O	7	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	IgE	IgE	B-NP	NN	B-protein	11	PMOD
13	by	by	B-PP	IN	O	10	NMOD
14	atopic	atopic	B-NP	JJ	B-cell_type	16	NMOD
15	B	B	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
17	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	purpose	purpose	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	5	NMOD
5	review	review	I-NP	NN	O	3	PMOD
6	is	be	B-VP	VBZ	O	0	ROOT
7	to	to	B-VP	TO	O	8	VMOD
8	show	show	I-VP	VB	O	6	PRD
9	how	how	B-ADVP	WRB	O	8	VMOD
10	the	the	B-NP	DT	O	11	NMOD
11	accumulation	accumulation	I-NP	NN	O	19	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	various	various	B-NP	JJ	O	15	NMOD
14	biochemical	biochemical	I-NP	JJ	O	15	NMOD
15	lesions	lesion	I-NP	NNS	O	12	PMOD
16	with	with	B-PP	IN	O	11	NMOD
17	advancing	advance	B-VP	VBG	O	18	NMOD
18	age	age	B-NP	NN	O	16	PMOD
19	leads	lead	B-VP	VBZ	O	9	SBAR
20	to	to	B-PP	TO	O	19	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	failure	failure	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	a	a	B-NP	DT	O	27	NMOD
25	critical	critical	I-NP	JJ	O	27	NMOD
26	cell	cell	I-NP	NN	O	27	NMOD
27	function	function	I-NP	NN	O	23	PMOD
28	,	,	O	,	O	8	P
29	namely	namely	B-ADVP	RB	O	8	VMOD
30	the	the	B-NP	DT	O	33	NMOD
31	activation-induced	activation-induced	I-NP	JJ	O	33	NMOD
32	lymphocyte	lymphocyte	I-NP	NN	O	33	NMOD
33	proliferation	proliferation	I-NP	NN	O	8	VMOD
34	.	.	O	.	O	6	P

1	They	They	B-NP	PRP	O	2	SUB
2	fail	fail	B-VP	VBP	O	0	ROOT
3	to	to	I-VP	TO	O	4	VMOD
4	induce	induce	I-VP	VB	O	2	VMOD
5	mRNA	mRNA	B-NP	NN	B-RNA	4	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	6	PMOD
8	after	after	B-PP	IN	O	4	VMOD
9	3	3	B-NP	CD	O	10	NMOD
10	h	h	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	culture	culture	B-NP	NN	O	11	PMOD
13	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	kinetics	kinetic	I-NP	NNS	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	expression	expression	B-NP	NN	O	3	PMOD
5	suggest	suggest	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	10	NMOD
8	high	high	I-NP	JJ	O	10	NMOD
9	initial	initial	I-NP	JJ	O	10	NMOD
10	levels	level	I-NP	NNS	O	11	SUB
11	are	be	B-VP	VBP	O	6	SBAR
12	caused	cause	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	isolation	isolation	I-NP	NN	O	16	NMOD
16	procedure	procedure	I-NP	NN	O	13	PMOD
17	,	,	O	,	O	5	P
18	and	and	O	CC	O	5	VMOD
19	do	do	B-VP	VBP	O	5	VMOD
20	not	not	I-VP	RB	O	19	VMOD
21	reflect	reflect	I-VP	VB	O	19	VC
22	constitutive	constitutive	B-NP	JJ	O	23	NMOD
23	expression	expression	I-NP	NN	O	21	OBJ
24	.	.	O	.	O	5	P

1	Although	Although	B-SBAR	IN	O	23	VMOD
2	JAK3	JAK3	B-NP	NN	B-protein	3	SUB
3	is	be	B-VP	VBZ	O	1	SBAR
4	required	require	I-VP	VBN	O	3	VC
5	for	for	B-PP	IN	O	4	VMOD
6	proper	proper	B-NP	JJ	O	8	NMOD
7	lymphoid	lymphoid	I-NP	JJ	O	8	NMOD
8	development	development	I-NP	NN	O	5	PMOD
9	,	,	O	,	O	23	P
10	the	the	B-NP	DT	O	12	NMOD
11	precise	precise	I-NP	JJ	O	12	NMOD
12	roles	role	I-NP	NNS	O	23	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	this	this	B-NP	DT	O	15	NMOD
15	kinase	kinase	I-NP	NN	B-protein	13	PMOD
16	in	in	B-PP	IN	O	12	NMOD
17	IL-2	IL-2	B-NP	NN	B-protein	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	IL-4	IL-4	I-NP	NN	B-protein	20	NMOD
20	signaling	signaling	I-NP	NN	O	16	PMOD
21	in	in	B-PP	IN	O	12	NMOD
22	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	21	PMOD
23	have	have	B-VP	VBP	O	0	ROOT
24	not	not	I-VP	RB	O	23	VMOD
25	been	be	I-VP	VBN	O	23	VC
26	defined	define	I-VP	VBN	O	25	VC
27	.	.	O	.	O	23	P

1	Here	Here	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	have	have	B-VP	VBP	O	0	ROOT
5	studied	study	I-VP	VBN	O	4	VC
6	IL-2	IL-2	B-NP	NN	B-protein	9	NMOD
7	and	and	O	CC	O	9	NMOD
8	IL-4	IL-4	B-NP	NN	B-protein	9	NMOD
9	signaling	signaling	I-NP	NN	O	5	OBJ
10	in	in	B-PP	IN	O	9	NMOD
11	B	B	B-NP	NN	B-cell_line	13	NMOD
12	cell	cell	I-NP	NN	I-cell_line	13	NMOD
13	lines	line	I-NP	NNS	I-cell_line	10	PMOD
14	lacking	lack	B-VP	VBG	O	13	NMOD
15	JAK3	JAK3	B-NP	NN	B-protein	14	OBJ
16	.	.	O	.	O	4	P

1	Although	Although	B-SBAR	IN	O	33	VMOD
2	IL-2-induced	IL-2-induced	B-NP	JJ	O	3	NMOD
3	phosphorylation	phosphorylation	I-NP	NN	O	13	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	IL-2R	IL-2R	B-NP	NN	B-protein	6	NMOD
6	beta	beta	I-NP	NN	I-protein	11	NMOD
7	,	,	O	,	O	11	P
8	JAK1	JAK1	B-NP	NN	B-protein	11	NMOD
9	,	,	O	,	O	11	P
10	and	and	O	CC	O	11	NMOD
11	STAT5	STAT5	B-NP	NN	B-protein	4	PMOD
12	all	all	O	DT	O	3	NMOD
13	required	require	B-VP	VBD	O	1	SBAR
14	the	the	B-NP	DT	O	15	NMOD
15	presence	presence	I-NP	NN	O	13	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	JAK3	JAK3	B-NP	NN	B-protein	16	PMOD
18	,	,	O	,	O	33	P
19	IL-4-mediated	IL-4-mediated	B-NP	JJ	O	20	NMOD
20	phosphorylation	phosphorylation	I-NP	NN	O	33	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	JAK1	JAK1	B-NP	NN	B-protein	29	NMOD
23	,	,	O	,	O	29	P
24	STAT6	STAT6	B-NP	NN	B-protein	29	NMOD
25	,	,	O	,	O	29	P
26	and	and	O	CC	O	29	NMOD
27	insulin	insulin	B-NP	NN	B-protein	29	NMOD
28	receptor	receptor	I-NP	NN	I-protein	29	NMOD
29	substrates	substrate	I-NP	NNS	I-protein	21	PMOD
30	1	1	B-NP	CD	I-protein	32	NMOD
31	and	and	I-NP	CC	I-protein	32	NMOD
32	2	2	I-NP	CD	I-protein	29	NMOD
33	did	do	B-VP	VBD	O	0	ROOT
34	not	not	O	RB	O	33	VMOD
35	.	.	O	.	O	33	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	IL-4	IL-4	B-NP	NN	B-protein	6	NMOD
6	signaling	signaling	I-NP	NN	O	7	SUB
7	occurs	occur	B-VP	VBZ	O	4	SBAR
8	in	in	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	absence	absence	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	of	of	B-PP	IN	O	11	PMOD
13	JAK3	JAK3	B-NP	NN	B-protein	12	PMOD
14	,	,	O	,	O	7	P
15	but	but	O	CC	O	7	VMOD
16	is	be	B-VP	VBZ	O	7	VMOD
17	comparatively	comparatively	B-ADJP	RB	O	18	AMOD
18	inefficient	inefficient	I-ADJP	JJ	O	16	PRD
19	.	.	O	.	O	3	P

1	Transfection	Transfection	B-NP	NN	O	13	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	an	an	B-NP	DT	O	5	NMOD
4	expression	expression	I-NP	NN	O	5	NMOD
5	vector	vector	I-NP	NN	O	2	PMOD
6	containing	contain	B-VP	VBG	O	5	NMOD
7	ORF2	ORF2	B-NP	NN	B-DNA	12	NMOD
8	but	but	B-CONJP	CC	O	12	NMOD
9	not	not	I-CONJP	RB	O	8	DEP
10	full	full	B-NP	JJ	B-DNA	12	NMOD
11	length	length	I-NP	NN	I-DNA	12	NMOD
12	cDNA	cDNA	I-NP	NN	I-DNA	6	OBJ
13	was	be	B-VP	VBD	O	0	ROOT
14	able	able	B-ADJP	JJ	O	13	PRD
15	to	to	B-VP	TO	O	16	VMOD
16	transform	transform	I-VP	VB	O	14	AMOD
17	NIH3T3	NIH3T3	B-NP	NN	B-cell_line	18	NMOD
18	cells	cell	I-NP	NNS	I-cell_line	16	OBJ
19	and	and	O	CC	O	16	VMOD
20	induce	induce	B-VP	VB	O	16	VMOD
21	tumors	tumor	B-NP	NNS	O	20	OBJ
22	in	in	B-PP	IN	O	20	VMOD
23	nude	nude	B-NP	JJ	O	24	NMOD
24	mice	mouse	I-NP	NNS	O	22	PMOD
25	.	.	O	.	O	13	P

1	Within	Within	B-PP	IN	O	8	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	PBL	PBL	I-NP	NN	B-cell_type	1	PMOD
4	,	,	O	,	O	8	P
5	Bcd	Bcd	B-NP	NN	B-DNA	7	NMOD
6	gene	gene	I-NP	NN	O	7	NMOD
7	expression	expression	I-NP	NN	O	8	SUB
8	was	be	B-VP	VBD	O	0	ROOT
9	restricted	restricted	B-ADJP	JJ	O	14	AMOD
10	to	to	B-PP	TO	O	9	AMOD
11	CD19+	CD19+	B-NP	JJ	B-cell_type	12	NMOD
12	B-cells	B-cell	I-NP	NNS	I-cell_type	10	PMOD
13	and	and	O	CC	O	14	AMOD
14	absent	absent	B-ADJP	JJ	O	8	PRD
15	from	from	B-PP	IN	O	14	AMOD
16	CD14+	CD14+	B-NP	JJ	B-cell_type	17	NMOD
17	monocytes	monocyte	I-NP	NNS	I-cell_type	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	T-cells	T-cell	I-NP	NNS	B-cell_type	15	PMOD
20	.	.	O	.	O	8	P

1	Bcd	Bcd	B-NP	NN	B-RNA	2	NMOD
2	transcripts	transcript	I-NP	NNS	I-RNA	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	detected	detect	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	all	all	B-NP	DT	O	9	NMOD
7	normal	normal	I-NP	JJ	O	9	NMOD
8	PBL	PBL	I-NP	NN	B-cell_type	9	NMOD
9	samples	sample	I-NP	NNS	O	5	PMOD
10	tested	test	B-VP	VBN	O	9	NMOD
11	but	but	B-PP	CC	O	5	PMOD
12	not	not	B-PP	RB	O	13	PMOD
13	in	in	I-PP	IN	O	5	PMOD
14	several	several	B-NP	JJ	O	18	NMOD
15	malignant	malignant	I-NP	JJ	B-cell_line	18	NMOD
16	human	human	I-NP	JJ	I-cell_line	18	NMOD
17	B-cell	B-cell	I-NP	NN	I-cell_line	18	NMOD
18	lines	line	I-NP	NNS	I-cell_line	13	PMOD
19	and	and	O	CC	O	5	PMOD
20	not	not	B-PP	RB	O	21	PMOD
21	in	in	I-PP	IN	O	5	PMOD
22	50	50	B-NP	CD	O	23	NMOD
23	%	%	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	B-cells	B-cell	B-NP	NNS	B-cell_type	24	PMOD
26	from	from	B-PP	IN	O	25	NMOD
27	B-CLL	B-CLL	B-NP	NN	O	28	NMOD
28	patients	patient	I-NP	NNS	O	26	PMOD
29	.	.	O	.	O	3	P

1	Its	Its	B-NP	PRP$	O	3	NMOD
2	immunosuppressive	immunosuppressive	I-NP	JJ	O	3	NMOD
3	property	property	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	distinct	distinct	B-ADJP	JJ	O	4	PRD
6	from	from	B-PP	IN	O	5	AMOD
7	cyclosporin	cyclosporin	B-NP	NN	O	6	PMOD
8	because	because	B-SBAR	IN	O	4	VMOD
9	only	only	B-NP	RB	O	10	NMOD
10	tepoxalin	tepoxalin	I-NP	NN	O	14	NMOD
11	,	,	O	,	O	14	P
12	but	but	O	CC	O	14	NMOD
13	not	not	O	RB	O	12	DEP
14	cyclosporin	cyclosporin	B-NP	NN	O	16	SUB
15	,	,	O	,	O	14	P
16	suppresses	suppress	B-VP	VBZ	O	8	SBAR
17	NF-kappa	NF-kappa	B-NP	NN	B-protein	18	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	activation	activation	I-NP	NN	O	16	OBJ
20	.	.	O	.	O	4	P

1	No	No	B-NP	DT	O	2	NMOD
2	difference	difference	I-NP	NN	O	6	SUB
3	in	in	B-PP	IN	O	2	NMOD
4	plasma	plasma	B-NP	NN	O	5	NMOD
5	cortisol	cortisol	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	found	find	I-VP	VBN	O	6	VC
8	between	between	B-PP	IN	O	7	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	patients	patient	I-NP	NNS	O	14	NMOD
11	and	and	O	CC	O	14	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	healthy	healthy	I-NP	JJ	O	14	NMOD
14	subjects	subject	I-NP	NNS	O	8	PMOD
15	(	(	O	(	O	21	DEP
16	P	P	B-NP	NN	O	18	NMOD
17	&	&	I-NP	CC	O	18	NMOD
18	gt	gt	I-NP	NN	O	20	SUB
19	;	;	O	:	O	20	P
20	0.05	0.05	B-NP	CD	O	21	DEP
21	)	)	O	)	O	14	NMOD
22	.	.	O	.	O	6	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	function	function	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	adrenal	adrenal	B-NP	JJ	O	9	NMOD
9	cortex	cortex	I-NP	NN	O	7	PMOD
10	may	may	B-VP	MD	O	26	VMOD
11	be	be	I-VP	VB	O	10	VC
12	improved	improve	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	compensation	compensation	I-NP	NN	O	16	NMOD
16	mechanism	mechanism	I-NP	NN	O	13	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	patients	patient	I-NP	NNS	O	17	PMOD
20	,	,	O	,	O	26	P
21	but	but	O	CC	O	26	VMOD
22	the	the	B-NP	DT	O	25	NMOD
23	lower	low	I-NP	JJR	O	25	NMOD
24	GCR	GCR	I-NP	NN	B-protein	25	NMOD
25	number	number	I-NP	NN	O	26	SUB
26	was	be	B-VP	VBD	O	4	SBAR
27	the	the	B-NP	DT	O	28	NMOD
28	result	result	I-NP	NN	O	26	PRD
29	of	of	B-PP	IN	O	28	NMOD
30	lacking	lacking	B-NP	NN	O	29	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	oxygen	oxygen	B-NP	NN	O	31	PMOD
33	in	in	B-PP	IN	O	30	NMOD
34	the	the	B-NP	DT	O	35	NMOD
35	patients	patient	I-NP	NNS	O	33	PMOD
36	.	.	O	.	O	3	P

1	However	However	B-ADVP	RB	O	12	VMOD
2	,	,	O	,	O	12	P
3	the	the	B-NP	DT	O	4	NMOD
4	nature	nature	I-NP	NN	O	12	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	subunit	subunit	I-NP	NN	O	5	PMOD
8	involved	involve	B-VP	VBN	O	7	NMOD
9	in	in	B-PP	IN	O	8	VMOD
10	this	this	B-NP	DT	O	11	NMOD
11	mechanism	mechanism	I-NP	NN	O	9	PMOD
12	has	have	B-VP	VBZ	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	been	be	I-VP	VBN	O	12	VC
15	defined	define	I-VP	VBN	O	14	VC
16	.	.	O	.	O	12	P

1	High	High	B-NP	JJ	O	2	NMOD
2	doses	dose	I-NP	NNS	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	sodium	sodium	B-NP	NN	O	5	NMOD
5	salicylate	salicylate	I-NP	NN	O	3	PMOD
6	suppressed	suppress	B-VP	VBD	O	25	VMOD
7	NF-kappa	NF-kappa	B-NP	NN	B-protein	10	NMOD
8	B	B	I-NP	NN	I-protein	10	NMOD
9	p65	p65	I-NP	NN	B-RNA	10	NMOD
10	mRNA	mRNA	I-NP	NN	I-RNA	11	NMOD
11	accumulation	accumulation	I-NP	NN	O	6	OBJ
12	,	,	O	,	O	6	P
13	resulting	result	B-VP	VBG	O	6	VMOD
14	in	in	B-PP	IN	O	13	VMOD
15	suppression	suppression	B-NP	NN	O	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	total	total	B-NP	JJ	O	19	NMOD
18	NF-kappa	NF-kappa	I-NP	NN	B-protein	19	NMOD
19	B	B	I-NP	NN	I-protein	16	PMOD
20	,	,	O	,	O	25	P
21	p50	p50	B-NP	NN	B-protein	25	SUB
22	on	on	B-PP	IN	O	21	NMOD
23	tissue	tissue	B-NP	NN	O	24	NMOD
24	oligonucleotide	oligonucleotide	I-NP	NN	O	22	PMOD
25	had	have	B-VP	VBD	O	0	ROOT
26	no	no	B-NP	DT	O	27	NMOD
27	effects	effect	I-NP	NNS	O	25	OBJ
28	on	on	B-PP	IN	O	25	VMOD
29	lipopolysaccharide-induced	lipopolysaccharide-induced	B-NP	JJ	O	32	NMOD
30	NF-kappa	NF-kappa	I-NP	NN	B-protein	32	NMOD
31	B	B	I-NP	NN	I-protein	32	NMOD
32	activation	activation	I-NP	NN	O	28	PMOD
33	.	.	O	.	O	25	P

1	Lack	Lack	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	T-cell-mediated	T-cell-mediated	B-NP	JJ	O	4	NMOD
4	recognition	recognition	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	fusion	fusion	I-NP	NN	B-protein	8	NMOD
8	region	region	I-NP	NN	I-protein	5	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	pml/RAR-alpha	pml/RAR-alpha	I-NP	NN	B-protein	13	NMOD
12	hybrid	hybrid	I-NP	NN	I-protein	13	NMOD
13	protein	protein	I-NP	NN	I-protein	9	PMOD
14	by	by	B-PP	IN	O	1	NMOD
15	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	14	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	acute	acute	B-NP	JJ	O	20	NMOD
18	promyelocytic	promyelocytic	I-NP	JJ	O	20	NMOD
19	leukemia	leukemia	I-NP	NN	O	20	NMOD
20	patients	patient	I-NP	NNS	O	16	PMOD
21	.	.	O	.	O	1	P

1	The	The	B-NP	DT	O	4	NMOD
2	in	in	I-NP	FW	O	3	AMOD
3	vitro	vitro	I-NP	FW	O	4	NMOD
4	immunization	immunization	I-NP	NN	O	31	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	peripheral	peripheral	B-NP	JJ	B-cell_type	8	NMOD
7	blood	blood	I-NP	NN	I-cell_type	8	NMOD
8	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	5	PMOD
9	from	from	B-PP	IN	O	8	NMOD
10	four	four	B-NP	CD	O	11	NMOD
11	patients	patient	I-NP	NNS	O	9	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	remission	remission	B-NP	NN	O	12	PMOD
14	(	(	O	(	O	23	DEP
15	S.R.	S.R.	B-NP	NNP	O	22	NMOD
16	,	,	O	,	O	22	P
17	F.R.	F.R.	B-NP	NNP	O	22	NMOD
18	,	,	O	,	O	22	P
19	M.M.	M.M.	B-NP	NNP	O	22	NMOD
20	,	,	O	,	O	22	P
21	P.	P.	B-NP	NNP	O	22	NMOD
22	G.	G.	I-NP	NNP	O	23	DEP
23	)	)	O	)	O	4	NMOD
24	with	with	B-PP	IN	O	4	NMOD
25	BCR1/25	BCR1/25	B-NP	NN	O	29	NMOD
26	,	,	O	,	O	29	P
27	a	a	B-NP	DT	O	29	NMOD
28	25-mer	25-mer	I-NP	NN	B-protein	29	NMOD
29	pml/RAR-alpha	pml/RAR-alpha	I-NP	NN	I-protein	24	PMOD
30	,	,	O	,	O	4	P
31	did	do	B-VP	VBD	O	0	ROOT
32	not	not	I-VP	RB	O	31	VMOD
33	elicit	elicit	I-VP	VB	O	31	VC
34	either	either	O	CC	O	41	NMOD
35	a	a	B-NP	DT	O	36	NMOD
36	polyclonal	polyclonal	I-NP	JJ	O	41	NMOD
37	or	or	O	CC	O	41	NMOD
38	a	a	B-NP	DT	O	41	NMOD
39	clonal	clonal	I-NP	JJ	O	41	NMOD
40	immune	immune	I-NP	JJ	O	41	NMOD
41	response	response	I-NP	NN	O	33	OBJ
42	specific	specific	B-ADJP	JJ	O	41	NMOD
43	to	to	B-PP	TO	O	42	AMOD
44	the	the	B-NP	DT	O	45	NMOD
45	peptide	peptide	I-NP	NN	O	43	PMOD
46	.	.	O	.	O	31	P

1	APL	APL	B-NP	NN	B-cell_type	2	NMOD
2	blasts	blast	I-NP	NNS	I-cell_type	12	SUB
3	,	,	O	,	O	2	P
4	available	available	B-ADJP	JJ	O	2	NMOD
5	only	only	B-ADVP	RB	O	6	PMOD
6	from	from	B-PP	IN	O	4	AMOD
7	patients	patient	B-NP	NNS	O	10	NMOD
8	F.R.	F.R.	I-NP	NNP	O	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	P.G.	P.G.	I-NP	NNP	O	6	PMOD
11	,	,	O	,	O	2	P
12	were	be	B-VP	VBD	O	0	ROOT
13	not	not	I-VP	RB	O	12	VMOD
14	lysed	lyse	I-VP	VBN	O	12	VC
15	by	by	B-PP	IN	O	14	VMOD
16	C3/5	C3/5	B-NP	NN	B-protein	15	PMOD
17	and	and	O	CC	O	12	VMOD
18	were	be	B-VP	VBD	O	12	VMOD
19	unable	unable	B-ADJP	JJ	O	18	PRD
20	to	to	B-VP	TO	O	21	VMOD
21	present	present	I-VP	VB	O	19	AMOD
22	peptide	peptide	B-NP	NN	O	23	NMOD
23	BCR1/25	BCR1/25	I-NP	NN	O	21	OBJ
24	.	.	O	.	O	12	P

1	Incubation	Incubation	B-NP	NN	O	7	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	APL	APL	B-NP	NN	B-cell_line	4	NMOD
4	cells	cell	I-NP	NNS	I-cell_line	2	PMOD
5	with	with	B-PP	IN	O	1	NMOD
6	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	5	PMOD
7	failed	fail	B-VP	VBD	O	0	ROOT
8	to	to	I-VP	TO	O	9	VMOD
9	induce	induce	I-VP	VB	O	7	VMOD
10	HLA	HLA	B-NP	NN	B-protein	13	NMOD
11	class	class	I-NP	NN	I-protein	13	NMOD
12	II	II	B-NP	CD	I-protein	13	NMOD
13	molecules	molecule	I-NP	NNS	I-protein	15	NMOD
14	and	and	O	CC	O	15	NMOD
15	recognition	recognition	B-NP	NN	O	9	OBJ
16	by	by	B-PP	IN	O	9	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	C3/5	C3/5	I-NP	NN	B-cell_line	19	NMOD
19	clone	clone	I-NP	NN	I-cell_line	16	PMOD
20	.	.	O	.	O	7	P

1	Since	Since	B-SBAR	IN	O	13	VMOD
2	APL	APL	B-NP	NN	B-cell_line	3	NMOD
3	cells	cell	I-NP	NNS	I-cell_line	4	SUB
4	do	do	B-VP	VBP	O	1	SBAR
5	not	not	I-VP	RB	O	4	VMOD
6	express	express	I-VP	VB	O	4	VC
7	HLA	HLA	B-NP	NN	B-protein	10	NMOD
8	class	class	I-NP	NN	I-protein	10	NMOD
9	II	II	B-NP	CD	I-protein	10	NMOD
10	molecules	molecule	I-NP	NNS	I-protein	6	OBJ
11	,	,	O	,	O	13	P
12	we	we	B-NP	PRP	O	13	SUB
13	tested	test	B-VP	VBD	O	0	ROOT
14	in	in	B-PP	IN	O	13	VMOD
15	two	two	B-NP	CD	O	16	NMOD
16	donors	donor	I-NP	NNS	O	14	PMOD
17	(	(	O	(	O	21	DEP
18	D.E.	D.E.	B-NP	NNP	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	C.H.R.	C.H.R.	I-NP	NNP	O	21	DEP
21	)	)	O	)	O	13	VMOD
22	and	and	O	CC	O	25	VMOD
23	in	in	B-PP	IN	O	25	VMOD
24	patients	patient	B-NP	NNS	O	23	PMOD
25	S.R.and	S.R.and	B-VP	VBP	O	13	VMOD
26	P.G.whether	P.G.whether	B-PP	IN	O	25	VMOD
27	the	the	B-NP	DT	O	28	NMOD
28	use	use	I-NP	NN	O	26	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	9-mer	9-mer	B-NP	NN	O	31	NMOD
31	peptides	peptide	I-NP	NNS	O	29	PMOD
32	(	(	O	(	O	34	DEP
33	BCR1/9	BCR1/9	B-NP	NN	O	34	DEP
34	)	)	O	)	O	31	NMOD
35	would	would	B-VP	MD	O	25	VMOD
36	generate	generate	I-VP	VB	O	35	VC
37	a	a	B-NP	DT	O	41	NMOD
38	CD8/HLA	CD8/HLA	I-NP	NN	O	41	NMOD
39	class	class	I-NP	NN	O	41	NMOD
40	I-restricted	I-restricted	I-NP	JJ	O	41	NMOD
41	response	response	I-NP	NN	O	36	OBJ
42	.	.	O	.	O	13	P

1	No	No	B-NP	DT	O	6	NMOD
2	peptide-specific	peptide-specific	I-NP	JJ	B-cell_line	4	NMOD
3	T-cell	T-cell	I-NP	NN	I-cell_line	4	NMOD
4	line	line	I-NP	NN	I-cell_line	6	NMOD
5	or	or	O	CC	O	6	NMOD
6	clone	clone	B-NP	NN	O	7	SUB
7	could	could	B-VP	MD	O	0	ROOT
8	be	be	I-VP	VB	O	7	VC
9	generated	generate	I-VP	VBN	O	8	VC
10	from	from	B-PP	IN	O	9	VMOD
11	both	both	O	CC	O	14	NMOD
12	donors	donor	B-NP	NNS	O	14	NMOD
13	and	and	O	CC	O	14	NMOD
14	patients	patient	B-NP	NNS	O	10	PMOD
15	.	.	O	.	O	7	P

1	5-LOX	5-LOX	B-NP	NN	B-protein	5	NMOD
2	and	and	I-NP	CC	O	5	NMOD
3	5-LOX	5-LOX	I-NP	NN	B-protein	5	NMOD
4	activating	activating	I-NP	NN	I-protein	5	NMOD
5	protein	protein	I-NP	NN	I-protein	9	SUB
6	(	(	O	(	O	8	DEP
7	FLAP	FLAP	B-NP	NN	B-protein	8	DEP
8	)	)	O	)	O	5	NMOD
9	are	be	B-VP	VBP	O	0	ROOT
10	coexpressed	coexpresse	I-VP	VBN	O	9	VC
11	in	in	B-PP	IN	O	10	VMOD
12	lymphoid	lymphoid	B-NP	JJ	B-cell_type	13	NMOD
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
14	but	but	B-PP	CC	O	11	PMOD
15	not	not	B-PP	RB	O	16	PMOD
16	in	in	I-PP	IN	O	11	PMOD
17	monocytic	monocytic	B-NP	JJ	B-cell_type	20	NMOD
18	or	or	I-NP	CC	I-cell_type	20	NMOD
19	epithelial	epithelial	I-NP	JJ	I-cell_type	20	NMOD
20	cells	cell	I-NP	NNS	I-cell_type	16	PMOD
21	.	.	O	.	O	9	P

1	IL-1beta	IL-1beta	B-NP	NN	B-protein	2	NMOD
2	stimulation	stimulation	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	epithelial	epithelial	B-NP	JJ	B-cell_type	5	NMOD
5	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
6	did	do	B-VP	VBD	O	14	VMOD
7	not	not	I-VP	RB	O	6	VMOD
8	generate	generate	I-VP	VB	O	6	VC
9	any	any	B-NP	DT	O	10	NMOD
10	ROIs	ROI	I-NP	NNS	O	8	OBJ
11	and	and	I-NP	CC	O	14	VMOD
12	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	13	NMOD
13	induction	induction	I-NP	NN	O	14	SUB
14	was	be	B-VP	VBD	O	0	ROOT
15	not	not	I-VP	RB	O	14	VMOD
16	influenced	influence	I-VP	VBN	O	14	VC
17	by	by	B-PP	IN	O	16	VMOD
18	5-LOX	5-LOX	B-NP	NN	B-protein	19	NMOD
19	inhibitors	inhibitor	I-NP	NNS	O	17	PMOD
20	.	.	O	.	O	14	P

1	This	This	B-NP	DT	O	2	NMOD
2	pathway	pathway	I-NP	NN	O	3	SUB
3	involves	involve	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	8	NMOD
5	Rac1	Rac1	I-NP	NN	B-protein	8	NMOD
6	and	and	I-NP	CC	O	8	NMOD
7	Cdc42	Cdc42	I-NP	NN	B-protein	8	NMOD
8	GTPases	GTPas	I-NP	NNS	I-protein	11	NMOD
9	,	,	O	,	O	11	P
10	two	two	B-NP	CD	O	11	NMOD
11	enzymes	enzyme	I-NP	NNS	B-protein	3	OBJ
12	which	which	B-NP	WDT	O	11	NMOD
13	are	be	B-VP	VBP	O	12	SBAR
14	not	not	I-VP	RB	O	13	VMOD
15	required	require	I-VP	VBN	O	13	VC
16	for	for	B-PP	IN	O	15	VMOD
17	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	18	NMOD
18	activation	activation	I-NP	NN	O	16	PMOD
19	by	by	B-PP	IN	O	18	NMOD
20	IL-1beta	IL-1beta	B-NP	NN	B-protein	19	PMOD
21	in	in	B-PP	IN	O	18	NMOD
22	epithelial	epithelial	B-NP	JJ	B-cell_type	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_type	21	PMOD
24	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	first	first	I-NP	JJ	B-DNA	3	NMOD
3	intron	intron	I-NP	NN	I-DNA	4	SUB
4	acted	act	B-VP	VBD	O	0	ROOT
5	as	as	B-PP	IN	O	4	VMOD
6	a	a	B-NP	DT	O	9	NMOD
7	strong	strong	I-NP	JJ	O	9	NMOD
8	transcriptional	transcriptional	I-NP	JJ	O	9	NMOD
9	activator	activator	I-NP	NN	O	5	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	a	a	B-NP	DT	O	13	NMOD
12	position-dependent	position-dependent	I-NP	JJ	O	13	NMOD
13	manner	manner	I-NP	NN	O	10	PMOD
14	and	and	B-PP	CC	O	5	PMOD
15	with	with	B-PP	IN	O	5	PMOD
16	no	no	B-NP	DT	O	18	NMOD
17	cell-type	cell-type	I-NP	JJ	O	18	NMOD
18	specificity	specificity	I-NP	NN	O	15	PMOD
19	.	.	O	.	O	4	P

1	Patients	Patient	B-NP	NNS	O	5	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	diabetic	diabetic	B-NP	JJ	O	4	NMOD
4	nephropathy	nephropathy	I-NP	NN	O	2	PMOD
5	showed	show	B-VP	VBD	O	0	ROOT
6	higher	high	B-NP	JJR	O	9	NMOD
7	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	9	NMOD
8	binding	binding	I-NP	NN	O	9	NMOD
9	activity	activity	I-NP	NN	O	18	NMOD
10	in	in	B-PP	IN	O	9	NMOD
11	Electrophoretic	Electrophoretic	B-NP	JJ	O	14	NMOD
12	Mobility	Mobility	I-NP	NN	O	14	NMOD
13	Shift	Shift	I-NP	NN	O	14	NMOD
14	Assays	Assay	I-NP	NNS	O	10	PMOD
15	and	and	O	CC	O	18	NMOD
16	stronger	strong	B-NP	JJR	O	18	NMOD
17	immunohistological	immunohistological	I-NP	JJ	O	18	NMOD
18	staining	staining	I-NP	NN	O	5	OBJ
19	for	for	B-PP	IN	O	18	NMOD
20	activated	activate	B-NP	VBN	O	21	NMOD
21	NF-kappaBp65	NF-kappaBp65	I-NP	NN	B-protein	19	PMOD
22	than	than	B-PP	IN	O	18	NMOD
23	patients	patient	B-NP	NNS	O	22	PMOD
24	without	without	B-PP	IN	O	23	NMOD
25	renal	renal	B-NP	JJ	O	26	NMOD
26	complications	complication	I-NP	NNS	O	24	PMOD
27	.	.	O	.	O	5	P

1	When	When	B-ADVP	WRB	O	26	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	analyzed	analyze	B-VP	VBD	O	1	SBAR
4	the	the	B-NP	DT	O	5	NMOD
5	nature	nature	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	STAT	STAT	B-NP	NN	B-protein	8	NMOD
8	proteins	protein	I-NP	NNS	I-protein	6	PMOD
9	capable	capable	B-ADJP	JJ	O	8	NMOD
10	of	of	B-PP	IN	O	9	AMOD
11	binding	bind	B-VP	VBG	O	10	PMOD
12	to	to	B-PP	TO	O	11	VMOD
13	IL-2Ralpha	IL-2Ralpha	B-NP	NN	B-protein	20	NMOD
14	,	,	O	,	O	20	P
15	pim-1	pim-1	B-NP	NN	B-DNA	20	NMOD
16	,	,	O	,	O	20	P
17	and	and	O	CC	O	20	NMOD
18	IRF-1	IRF-1	B-NP	NN	B-DNA	20	NMOD
19	GAS	GAS	I-NP	NN	I-DNA	20	NMOD
20	elements	element	I-NP	NNS	I-DNA	12	PMOD
21	after	after	B-PP	IN	O	11	VMOD
22	cytokine	cytokine	B-NP	NN	B-protein	23	NMOD
23	stimulation	stimulation	I-NP	NN	O	21	PMOD
24	,	,	O	,	O	26	P
25	we	we	B-NP	PRP	O	26	SUB
26	observed	observe	B-VP	VBD	O	0	ROOT
27	IFN-alpha-induced	IFN-alpha-induced	B-NP	JJ	O	28	NMOD
28	binding	binding	I-NP	NN	O	26	OBJ
29	of	of	B-PP	IN	O	28	NMOD
30	STAT1	STAT1	B-NP	NN	B-protein	39	NMOD
31	,	,	O	,	O	39	P
32	STAT3	STAT3	B-NP	NN	B-protein	39	NMOD
33	,	,	O	,	O	39	P
34	and	and	O	CC	O	39	NMOD
35	STAT4	STAT4	B-NP	NN	B-protein	39	NMOD
36	,	,	O	,	O	39	P
37	but	but	O	CC	O	39	NMOD
38	not	not	O	RB	O	37	DEP
39	STAT5	STAT5	B-NP	NN	B-protein	29	PMOD
40	to	to	B-PP	TO	O	28	NMOD
41	all	all	B-NP	DT	O	40	PMOD
42	of	of	B-PP	IN	O	41	NMOD
43	these	these	B-NP	DT	O	44	NMOD
44	elements	element	I-NP	NNS	O	42	PMOD
45	.	.	O	.	O	26	P

1	Tumor	Tumor	B-NP	NN	B-protein	3	NMOD
2	necrosis	necrosis	I-NP	NN	I-protein	3	NMOD
3	factor	factor	I-NP	NN	I-protein	9	NMOD
4	(	(	O	(	O	6	DEP
5	TNF	TNF	B-NP	NN	B-protein	6	DEP
6	)	)	O	)	O	3	NMOD
7	-alpha-induced	-alpha-induced	B-NP	JJ	O	9	NMOD
8	HIV-1	HIV-1	I-NP	NN	O	9	NMOD
9	replication	replication	I-NP	NN	O	15	SUB
10	in	in	B-PP	IN	O	9	NMOD
11	OM10.1	OM10.1	B-NP	NN	B-cell_line	14	NMOD
12	or	or	I-NP	CC	O	14	NMOD
13	Ach2	Ach2	I-NP	NN	B-cell_line	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_line	10	PMOD
15	was	be	B-VP	VBD	O	0	ROOT
16	significantly	significantly	I-VP	RB	O	15	VMOD
17	inhibited	inhibit	I-VP	VBN	O	15	VC
18	by	by	B-PP	IN	O	17	VMOD
19	non-cytotoxic	non-cytotoxic	B-NP	JJ	O	20	NMOD
20	doses	dose	I-NP	NNS	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	AuTG	AuTG	B-NP	NN	O	37	NMOD
23	(	(	O	(	O	37	NMOD
24	&	&	B-NP	CC	O	37	NMOD
25	gt	gt	I-NP	NN	O	37	NMOD
26	;	;	O	:	O	37	P
27	10	10	B-NP	CD	O	28	NMOD
28	microM	microM	I-NP	NN	O	34	NMOD
29	in	in	B-PP	IN	O	28	NMOD
30	OM10.1	OM10.1	B-NP	NN	B-cell_line	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_line	29	PMOD
32	and	and	O	CC	O	34	NMOD
33	&	&	B-NP	CC	O	34	NMOD
34	gt	gt	I-NP	NN	O	37	NMOD
35	;	;	O	:	O	37	P
36	25	25	B-NP	CD	O	37	NMOD
37	F.M	F.M	I-NP	NN	O	21	PMOD
38	in	in	B-PP	IN	O	17	VMOD
39	Ach2	Ach2	B-NP	NN	B-cell_line	40	NMOD
40	cells	cell	I-NP	NNS	I-cell_line	38	PMOD
41	)	)	O	)	O	17	VMOD
42	,	,	O	,	O	15	P
43	while	while	B-SBAR	IN	O	15	VMOD
44	25	25	B-NP	CD	O	45	NMOD
45	microM	microM	I-NP	NN	O	63	SUB
46	of	of	B-PP	IN	O	45	NMOD
47	the	the	B-NP	DT	O	49	NMOD
48	counter-anion	counter-anion	I-NP	NN	B-protein	49	NMOD
49	thioglucose	thioglucose	I-NP	NN	I-protein	55	NMOD
50	(	(	O	(	O	52	DEP
51	TG	TG	B-NP	NN	B-protein	52	DEP
52	)	)	O	)	O	49	NMOD
53	or	or	O	CC	O	55	NMOD
54	gold	gold	B-NP	NN	O	55	NMOD
55	compound	compound	I-NP	NN	O	61	NMOD
56	containing	contain	B-VP	VBG	O	55	NMOD
57	divalent	divalent	B-NP	JJ	O	59	NMOD
58	gold	gold	I-NP	NN	O	59	NMOD
59	ion	ion	I-NP	NN	O	56	OBJ
60	,	,	O	,	O	61	P
61	HAuCl3	HAuCl3	B-NP	NN	O	46	PMOD
62	,	,	O	,	O	61	P
63	had	have	B-VP	VBD	O	43	SBAR
64	no	no	B-NP	DT	O	65	NMOD
65	effect	effect	I-NP	NN	O	63	OBJ
66	.	.	O	.	O	15	P

1	The	The	B-NP	DT	O	3	NMOD
2	molecular	molecular	I-NP	JJ	O	3	NMOD
3	basis	basis	I-NP	NN	O	11	SUB
4	for	for	B-PP	IN	O	3	NMOD
5	increased	increase	B-NP	VBN	O	8	NMOD
6	IL-4	IL-4	I-NP	NN	B-protein	8	NMOD
7	gene	gene	I-NP	NN	O	8	NMOD
8	expression	expression	I-NP	NN	O	4	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	atopy	atopy	B-NP	NN	O	9	PMOD
11	is	be	B-VP	VBZ	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	fully	fully	I-VP	RB	O	11	VMOD
14	understood	understand	I-VP	VBN	O	11	VC
15	.	.	O	.	O	11	P

1	At	At	B-PP	IN	O	13	VMOD
2	the	the	B-NP	DT	O	6	NMOD
3	most	most	I-NP	RBS	O	4	AMOD
4	proximal	proximal	I-NP	JJ	B-DNA	6	NMOD
5	P0	P0	I-NP	NN	I-DNA	6	NMOD
6	site	site	I-NP	NN	I-DNA	1	PMOD
7	,	,	O	,	O	13	P
8	NFAT-containing	NFAT-containing	B-NP	JJ	B-protein	9	NMOD
9	complexes	complex	I-NP	NNS	I-protein	13	SUB
10	devoid	devoid	B-ADJP	JJ	O	9	NMOD
11	of	of	B-PP	IN	O	10	AMOD
12	NFAT2	NFAT2	B-NP	NN	B-protein	11	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	readily	readily	B-ADJP	RB	O	15	AMOD
15	inducible	inducible	I-ADJP	JJ	O	13	PRD
16	in	in	B-PP	IN	O	13	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	Th1	Th1	I-NP	NN	B-cell_line	19	NMOD
19	clones	clone	I-NP	NNS	I-cell_line	16	PMOD
20	,	,	O	,	O	13	VMOD
21	but	but	O	CC	O	20	VMOD
22	hardly	hardly	B-ADVP	RB	O	21	DEP
23	or	or	O	CC	O	22	AMOD
24	not	not	O	RB	O	22	AMOD
25	in	in	B-PP	IN	O	22	PMOD
26	the	the	B-NP	DT	O	28	NMOD
27	Th2	Th2	I-NP	NN	B-cell_line	28	NMOD
28	clones	clone	I-NP	NNS	I-cell_line	25	PMOD
29	.	.	O	.	O	13	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	12	P
4	both	both	B-PP	CC	O	5	PMOD
5	in	in	I-PP	IN	O	12	VMOD
6	Th1	Th1	B-NP	NN	B-cell_line	9	NMOD
7	and	and	I-NP	CC	I-cell_line	9	NMOD
8	Th2	Th2	I-NP	NN	I-cell_line	9	NMOD
9	clones	clone	I-NP	NNS	I-cell_line	5	PMOD
10	NFAT-containing	NFAT-containing	B-NP	JJ	B-protein	11	NMOD
11	complexes	complex	I-NP	NNS	I-protein	12	SUB
12	were	be	B-VP	VBD	O	0	ROOT
13	strongly	strongly	B-ADJP	RB	O	14	AMOD
14	inducible	inducible	I-ADJP	JJ	O	12	PRD
15	at	at	B-PP	IN	O	12	VMOD
16	the	the	B-NP	DT	O	18	NMOD
17	P1	P1	I-NP	NN	B-DNA	18	NMOD
18	site	site	I-NP	NN	I-DNA	15	PMOD
19	,	,	O	,	O	12	P
20	consisting	consist	B-VP	VBG	O	12	VMOD
21	of	of	B-PP	IN	O	20	VMOD
22	NFAT2	NFAT2	B-NP	NN	B-protein	27	NMOD
23	and	and	O	CC	O	27	NMOD
24	a	a	B-NP	DT	O	27	NMOD
25	P0-compatible	P0-compatible	I-NP	JJ	O	27	NMOD
26	NFAT	NFAT	I-NP	NN	B-protein	27	NMOD
27	activity	activity	I-NP	NN	O	21	PMOD
28	,	,	O	,	O	12	P
29	without	without	B-PP	IN	O	12	VMOD
30	apparent	apparent	B-NP	JJ	O	31	NMOD
31	differences	difference	I-NP	NNS	O	29	PMOD
32	between	between	B-PP	IN	O	31	NMOD
33	Th1	Th1	B-NP	NN	B-cell_line	36	NMOD
34	and	and	I-NP	CC	I-cell_line	36	NMOD
35	Th2	Th2	I-NP	NN	I-cell_line	36	NMOD
36	clones	clone	I-NP	NNS	I-cell_line	32	PMOD
37	.	.	O	.	O	12	P

1	Like	Like	B-PP	IN	O	10	VMOD
2	in	in	B-PP	IN	O	1	PMOD
3	Th2	Th2	B-NP	NN	B-cell_line	4	NMOD
4	clones	clone	I-NP	NNS	I-cell_line	2	PMOD
5	,	,	O	,	O	10	P
6	suppressed	suppress	B-VP	VBD	O	9	NMOD
7	NFAT-P0	NFAT-P0	B-NP	NN	B-protein	9	NMOD
8	complex	complex	I-NP	NN	I-protein	9	NMOD
9	formation	formation	I-NP	NN	O	10	SUB
10	was	be	B-VP	VBD	O	0	ROOT
11	observed	observe	I-VP	VBN	O	10	VC
12	also	also	B-ADVP	RB	O	11	VMOD
13	at	at	B-PP	IN	O	11	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	polyclonal	polyclonal	I-NP	JJ	O	16	NMOD
16	level	level	I-NP	NN	O	13	PMOD
17	in	in	B-PP	IN	O	11	VMOD
18	peripheral	peripheral	B-NP	JJ	B-cell_type	21	NMOD
19	blood	blood	I-NP	NN	I-cell_type	21	NMOD
20	mononuclear	mononuclear	I-NP	JJ	I-cell_type	21	NMOD
21	cells	cell	I-NP	NNS	I-cell_type	17	PMOD
22	(	(	O	(	O	24	DEP
23	PBMC	PBMC	B-NP	NN	B-cell_type	24	DEP
24	)	)	O	)	O	21	NMOD
25	of	of	B-PP	IN	O	21	NMOD
26	three	three	B-NP	CD	O	27	AMOD
27	of	of	I-NP	IN	O	32	NMOD
28	five	five	I-NP	CD	O	27	AMOD
29	severe	severe	I-NP	JJ	O	32	NMOD
30	atopic	atopic	I-NP	JJ	O	32	NMOD
31	dermatitis	dermatitis	I-NP	NN	O	32	NMOD
32	patients	patient	I-NP	NNS	O	25	PMOD
33	with	with	B-PP	IN	O	32	NMOD
34	strongly	strongly	B-NP	RB	O	35	AMOD
35	elevated	elevated	I-NP	JJ	O	38	NMOD
36	serum	serum	I-NP	NN	O	38	NMOD
37	IgE	IgE	I-NP	NN	B-protein	38	NMOD
38	levels	level	I-NP	NNS	O	33	PMOD
39	,	,	B-PP	,	O	17	P
40	but	but	I-PP	CC	O	17	PMOD
41	not	not	B-PP	RB	O	42	PMOD
42	in	in	I-PP	IN	O	17	PMOD
43	control	control	B-NP	NN	O	44	NMOD
44	PBMC	PBMC	I-NP	NN	B-cell_type	42	PMOD
45	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	inhibitory	inhibitory	I-NP	JJ	O	3	NMOD
3	effects	effect	I-NP	NNS	O	6	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	NAC	NAC	B-NP	NN	O	4	PMOD
6	were	be	B-VP	VBD	O	0	ROOT
7	not	not	O	RB	O	6	VMOD
8	due	due	B-ADJP	JJ	O	9	PMOD
9	to	to	B-PP	TO	O	6	PRD
10	nonspecific	nonspecific	B-NP	JJ	O	11	NMOD
11	toxicity	toxicity	I-NP	NN	O	9	PMOD
12	as	as	B-PP	IN	O	6	VMOD
13	neither	neither	O	CC	O	22	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	viability	viability	I-NP	NN	O	22	NMOD
16	of	of	B-PP	IN	O	15	NMOD
17	DC	DC	B-NP	NN	B-cell_type	16	PMOD
18	nor	nor	O	CC	O	22	NMOD
19	their	their	B-NP	PRP$	O	22	NMOD
20	mannose	mannose	I-NP	NN	O	22	NMOD
21	receptor-mediated	receptor-mediated	I-NP	JJ	O	20	AMOD
22	endocytosis	endocytosis	I-NP	NN	O	23	SUB
23	were	be	B-VP	VBD	O	12	SBAR
24	modified	modify	I-VP	VBN	O	23	VC
25	by	by	B-PP	IN	O	24	VMOD
26	NAC	NAC	B-NP	NN	O	25	PMOD
27	.	.	O	.	O	6	P

1	Finally	Finally	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	we	we	B-NP	PRP	O	4	SUB
4	found	find	B-VP	VBD	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	the	the	B-NP	DT	O	7	NMOD
7	addition	addition	I-NP	NN	O	19	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	NAC	NAC	B-NP	NN	O	8	PMOD
10	to	to	B-PP	TO	O	7	NMOD
11	MLR	MLR	B-NP	NN	B-protein	10	PMOD
12	between	between	B-PP	IN	O	11	NMOD
13	naive	naive	B-NP	JJ	B-cell_type	15	NMOD
14	T	T	I-NP	NN	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	18	NMOD
16	and	and	O	CC	O	18	NMOD
17	allogeneic	allogeneic	B-NP	JJ	O	18	NMOD
18	DC	DC	I-NP	NN	B-cell_type	12	PMOD
19	resulted	result	B-VP	VBD	O	5	SBAR
20	in	in	B-PP	IN	O	19	VMOD
21	a	a	B-NP	DT	O	23	NMOD
22	profound	profound	I-NP	JJ	O	23	NMOD
23	inhibition	inhibition	I-NP	NN	O	20	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	alloreactive	alloreactive	B-NP	JJ	O	26	NMOD
26	responses	response	I-NP	NNS	O	24	PMOD
27	,	,	O	,	O	23	P
28	which	which	B-NP	WDT	O	23	NMOD
29	could	could	B-VP	MD	O	28	SBAR
30	be	be	I-VP	VB	O	29	VC
31	attributed	attribute	I-VP	VBN	O	30	VC
32	to	to	B-PP	TO	O	31	VMOD
33	a	a	B-NP	DT	O	34	NMOD
34	defect	defect	I-NP	NN	O	32	PMOD
35	of	of	B-PP	IN	O	34	NMOD
36	DC	DC	B-NP	NN	B-cell_type	35	PMOD
37	as	as	B-PP	IN	O	19	VMOD
38	APC-independent	APC-independent	B-NP	JJ	O	41	NMOD
39	T	T	I-NP	NN	O	41	NMOD
40	cell	cell	I-NP	NN	O	41	NMOD
41	responses	response	I-NP	NNS	O	42	SUB
42	were	be	B-VP	VBD	O	37	SBAR
43	not	not	I-VP	RB	O	42	VMOD
44	inhibited	inhibit	I-VP	VBN	O	42	VC
45	by	by	B-PP	IN	O	44	VMOD
46	NAC	NAC	B-NP	NN	O	45	PMOD
47	.	.	O	.	O	4	P

1	Bacterial	Bacterial	B-NP	JJ	O	2	NMOD
2	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	6	AMOD
3	(	(	O	(	O	5	DEP
4	LPS	LPS	B-NP	NN	O	5	DEP
5	)	)	O	)	O	2	NMOD
6	-mediated	-mediated	B-NP	JJ	O	8	NMOD
7	immune	immune	I-NP	JJ	O	8	NMOD
8	responses	response	I-NP	NNS	O	21	SUB
9	,	,	O	,	O	8	P
10	including	include	B-PP	VBG	O	8	NMOD
11	activation	activation	B-NP	NN	O	10	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	monocytes	monocyte	B-NP	NNS	B-cell_type	19	NMOD
14	,	,	O	,	O	19	P
15	macrophages	macrophage	B-NP	NNS	B-cell_type	19	NMOD
16	,	,	O	,	O	19	P
17	and	and	O	CC	O	19	NMOD
18	endothelial	endothelial	B-NP	JJ	B-cell_type	19	NMOD
19	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
20	,	,	O	,	O	8	P
21	play	play	B-VP	VBP	O	0	ROOT
22	an	an	B-NP	DT	O	24	NMOD
23	important	important	I-NP	JJ	O	24	NMOD
24	role	role	I-NP	NN	O	21	OBJ
25	in	in	B-PP	IN	O	21	VMOD
26	the	the	B-NP	DT	O	27	NMOD
27	pathogenesis	pathogenesis	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	Gram-negative	Gram-negative	B-NP	JJ	O	32	NMOD
30	bacteria-induced	bacteria-induced	I-NP	JJ	O	32	NMOD
31	sepsis	sepsis	I-NP	NN	O	32	NMOD
32	syndrome	syndrome	I-NP	NN	O	28	PMOD
33	.	.	O	.	O	21	P

1	In	In	B-PP	IN	O	24	VMOD
2	transient	transient	B-NP	JJ	O	4	NMOD
3	cotransfection	cotransfection	I-NP	NN	O	4	NMOD
4	experiments	experiment	I-NP	NNS	O	1	PMOD
5	,	,	O	,	O	24	P
6	dominant	dominant	B-NP	JJ	B-protein	8	NMOD
7	negative	negative	I-NP	JJ	I-protein	8	NMOD
8	mutants	mutant	I-NP	NNS	I-protein	24	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	IL-1	IL-1	I-NP	NN	B-protein	13	NMOD
12	signaling	signaling	I-NP	NN	O	13	NMOD
13	pathway	pathway	I-NP	NN	O	9	PMOD
14	,	,	O	,	O	8	P
15	including	include	B-PP	VBG	O	8	NMOD
16	MyD88	MyD88	B-NP	NN	B-protein	23	NMOD
17	,	,	O	,	O	23	P
18	IRAK	IRAK	B-NP	NN	B-protein	23	NMOD
19	,	,	O	,	O	23	P
20	IRAK2	IRAK2	B-NP	NN	B-protein	23	NMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	NMOD
23	TRAF6	TRAF6	B-NP	NN	B-protein	15	PMOD
24	inhibited	inhibit	B-VP	VBD	O	0	ROOT
25	both	both	O	CC	O	28	AMOD
26	IL-1-	IL-1-	B-NP	NN	B-protein	28	AMOD
27	and	and	O	CC	O	28	AMOD
28	LPS-induced	LPS-induced	B-NP	JJ	O	30	NMOD
29	NF-kappaB-luciferase	NF-kappaB-luciferase	I-NP	NN	B-protein	30	NMOD
30	activity	activity	I-NP	NN	O	24	OBJ
31	.	.	O	.	O	24	P

1	LPS-induced	LPS-induced	B-NP	JJ	O	3	NMOD
2	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	3	NMOD
3	activation	activation	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	not	not	I-VP	RB	O	4	VMOD
6	inhibited	inhibit	I-VP	VBN	O	4	VC
7	by	by	B-PP	IN	O	6	VMOD
8	a	a	B-NP	DT	O	11	NMOD
9	dominant	dominant	I-NP	JJ	B-protein	11	NMOD
10	negative	negative	I-NP	JJ	I-protein	11	NMOD
11	mutant	mutant	I-NP	NN	I-protein	7	PMOD
12	of	of	B-PP	IN	O	11	NMOD
13	TRAF2	TRAF2	B-NP	NN	B-protein	12	PMOD
14	that	that	B-NP	WDT	O	11	NMOD
15	is	be	B-VP	VBZ	O	14	SBAR
16	involved	involve	I-VP	VBN	O	15	VC
17	in	in	B-PP	IN	O	16	VMOD
18	TNF	TNF	B-NP	NN	B-protein	19	NMOD
19	signaling	signaling	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	4	P

1	LPS-induced	LPS-induced	B-NP	JJ	O	2	NMOD
2	activation	activation	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	NF-kappaB-responsive	NF-kappaB-responsive	B-NP	JJ	B-DNA	6	NMOD
5	reporter	reporter	I-NP	NN	I-DNA	6	NMOD
6	gene	gene	I-NP	NN	I-DNA	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	not	not	I-VP	RB	O	7	VMOD
9	inhibited	inhibit	I-VP	VBN	O	7	VC
10	by	by	B-PP	IN	O	9	VMOD
11	IL-1	IL-1	B-NP	NN	B-protein	13	NMOD
12	receptor	receptor	I-NP	NN	O	13	NMOD
13	antagonist	antagonist	I-NP	NN	O	10	PMOD
14	.	.	O	.	O	7	P

1	However	However	B-ADVP	RB	O	11	VMOD
2	,	,	O	,	O	11	P
3	the	the	B-NP	DT	O	4	NMOD
4	mechanism	mechanism	I-NP	NN	O	11	SUB
5	by	by	B-PP	IN	O	4	NMOD
6	which	which	B-NP	WDT	O	5	PMOD
7	IFNs	IFN	B-NP	NNS	B-protein	8	SUB
8	mediate	mediate	B-VP	VBP	O	5	SBAR
9	this	this	B-NP	DT	O	10	NMOD
10	inhibition	inhibition	I-NP	NN	O	8	OBJ
11	has	have	B-VP	VBZ	O	0	ROOT
12	not	not	I-VP	RB	O	11	VMOD
13	been	be	I-VP	VBN	O	11	VC
14	defined	define	I-VP	VBN	O	13	VC
15	.	.	O	.	O	11	P

1	The	The	B-NP	DT	O	2	NMOD
2	ability	ability	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	type	type	B-NP	NN	B-protein	9	NMOD
5	I	I	I-NP	CD	I-protein	4	NMOD
6	and	and	I-NP	CC	I-protein	9	NMOD
7	type	type	I-NP	NN	I-protein	9	NMOD
8	II	II	I-NP	CD	I-protein	9	NMOD
9	IFNs	IFN	I-NP	NNS	I-protein	3	PMOD
10	to	to	B-VP	TO	O	11	VMOD
11	inhibit	inhibit	I-VP	VB	O	2	NMOD
12	IL-4/IL-13-induced	IL-4/IL-13-induced	B-NP	JJ	O	14	NMOD
13	STAT6	STAT6	I-NP	NN	B-protein	14	NMOD
14	activity	activity	I-NP	NN	O	11	OBJ
15	is	be	B-VP	VBZ	O	0	ROOT
16	dose-	dose-	B-ADJP	NN	O	18	AMOD
17	and	and	I-ADJP	CC	O	18	AMOD
18	time-dependent	time-dependent	I-ADJP	JJ	O	15	PRD
19	,	,	O	,	O	15	P
20	and	and	O	CC	O	15	VMOD
21	is	be	B-VP	VBZ	O	15	VMOD
22	not	not	O	RB	O	21	VMOD
23	unique	unique	B-ADJP	JJ	O	21	PRD
24	to	to	B-PP	TO	O	23	AMOD
25	monocytes	monocyte	B-NP	NNS	B-cell_type	24	PMOD
26	because	because	B-SBAR	IN	O	15	VMOD
27	IFNs	IFN	B-NP	NNS	B-protein	28	SUB
28	induce	induce	B-VP	VBP	O	26	SBAR
29	the	the	B-NP	DT	O	31	NMOD
30	same	same	I-NP	JJ	O	31	NMOD
31	effects	effect	I-NP	NNS	O	28	OBJ
32	in	in	B-PP	IN	O	28	VMOD
33	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	32	PMOD
34	.	.	O	.	O	15	P

1	Inhibition	Inhibition	B-NP	NN	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	STAT6	STAT6	B-NP	NN	B-protein	4	NMOD
4	activity	activity	I-NP	NN	O	2	PMOD
5	is	be	B-VP	VBZ	O	0	ROOT
6	not	not	O	RB	O	5	VMOD
7	evident	evident	B-ADJP	JJ	O	5	PRD
8	unless	unless	B-SBAR	IN	O	5	VMOD
9	cells	cell	B-NP	NNS	O	10	SUB
10	are	be	B-VP	VBP	O	8	SBAR
11	preincubated	preincubate	I-VP	VBN	O	10	VC
12	with	with	B-PP	IN	O	11	VMOD
13	IFN	IFN	B-NP	NN	B-protein	12	PMOD
14	for	for	B-PP	IN	O	11	VMOD
15	at	at	B-NP	IN	O	18	NMOD
16	least	least	I-NP	JJS	O	15	AMOD
17	1	1	I-NP	CD	O	15	AMOD
18	h	h	I-NP	NN	O	14	PMOD
19	before	before	B-PP	IN	O	11	VMOD
20	IL-4	IL-4	B-NP	NN	B-protein	21	NMOD
21	stimulation	stimulation	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	supershift	supershift	B-NP	NN	O	5	NMOD
5	analysis	analysis	I-NP	NN	O	3	PMOD
6	using	use	B-VP	VBG	O	5	NMOD
7	specific	specific	B-NP	JJ	B-protein	8	NMOD
8	antibodies	antibody	I-NP	NNS	I-protein	6	OBJ
9	against	against	B-PP	IN	O	8	NMOD
10	transcription	transcription	B-NP	NN	B-protein	11	NMOD
11	factors	factor	I-NP	NNS	I-protein	9	PMOD
12	suggested	suggest	B-VP	VBD	O	0	ROOT
13	that	that	B-SBAR	IN	O	12	VMOD
14	both	both	O	CC	O	16	NMOD
15	binding	binding	B-NP	NN	O	16	NMOD
16	complexes	complex	I-NP	NNS	O	17	SUB
17	contained	contain	B-VP	VBD	O	13	SBAR
18	the	the	B-NP	DT	O	20	NMOD
19	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	20	NMOD
20	components	component	I-NP	NNS	O	17	OBJ
21	p50	p50	I-NP	NN	B-protein	23	NMOD
22	and	and	I-NP	CC	O	23	NMOD
23	p65	p65	I-NP	NN	B-protein	20	NMOD
24	,	,	O	,	O	17	P
25	and	and	O	CC	O	17	VMOD
26	did	do	B-VP	VBD	O	17	VMOD
27	not	not	I-VP	RB	O	26	VMOD
28	contain	contain	I-VP	VB	O	26	VC
29	other	other	B-NP	JJ	O	31	NMOD
30	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	31	NMOD
31	proteins	protein	I-NP	NNS	I-protein	51	NMOD
32	(	(	O	(	O	39	DEP
33	p52	p52	B-NP	NN	B-protein	38	NMOD
34	,	,	O	,	O	38	P
35	c-Rel	c-Rel	B-NP	NN	B-protein	38	NMOD
36	,	,	O	,	O	38	P
37	Rel	Rel	B-NP	NN	B-protein	38	NMOD
38	B	B	I-NP	NN	I-protein	39	DEP
39	)	)	O	)	O	31	NMOD
40	,	,	O	,	O	51	P
41	AP-1	AP-1	B-NP	NN	B-protein	42	NMOD
42	proteins	protein	I-NP	NNS	I-protein	51	NMOD
43	(	(	O	(	O	47	DEP
44	c-Fos	c-Fos	B-NP	NN	B-protein	46	NMOD
45	,	,	I-NP	,	O	46	P
46	C-Jun	C-Jun	I-NP	NN	B-protein	47	DEP
47	)	)	O	)	O	42	NMOD
48	,	,	O	,	O	51	P
49	CREB	CREB	B-NP	NN	B-protein	51	NMOD
50	or	or	O	CC	O	51	NMOD
51	C/EBPbeta	C/EBPbeta	B-NP	NN	B-protein	28	OBJ
52	(	(	O	(	O	54	DEP
53	NF-IL6	NF-IL6	B-NP	NN	B-protein	54	DEP
54	)	)	O	)	O	51	NMOD
55	.	.	O	.	O	12	P

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	CoCl2	CoCl2	B-NP	NN	O	5	SUB
4	also	also	B-ADVP	RB	O	5	VMOD
5	caused	cause	B-VP	VBD	O	0	ROOT
6	time-dependent	time-dependent	B-NP	JJ	O	8	NMOD
7	tyrosine	tyrosine	I-NP	NN	O	8	NMOD
8	phosphorylation	phosphorylation	I-NP	NN	O	5	OBJ
9	of	of	B-PP	IN	O	8	NMOD
10	mitogen-activated	mitogen-activated	B-NP	JJ	B-protein	17	NMOD
11	protein	protein	I-NP	NN	I-protein	17	NMOD
12	(	(	O	(	I-protein	17	NMOD
13	MAP	MAP	B-NP	NN	I-protein	17	NMOD
14	)	)	O	)	I-protein	17	NMOD
15	kinase	kinase	B-NP	NN	I-protein	17	NMOD
16	isoform	isoform	I-NP	NN	O	17	NMOD
17	ERK2	ERK2	I-NP	NN	B-protein	9	PMOD
18	without	without	B-PP	IN	O	5	VMOD
19	significantly	significantly	B-VP	RB	O	20	VMOD
20	affecting	affect	I-VP	VBG	O	18	PMOD
21	ERK1	ERK1	B-NP	NN	B-protein	20	OBJ
22	,	,	O	,	O	5	P
23	indicating	indicate	B-VP	VBG	O	5	VMOD
24	ERK2	ERK2	B-NP	NN	B-protein	25	SUB
25	is	be	B-VP	VBZ	O	23	VMOD
26	the	the	B-NP	DT	O	28	NMOD
27	preferred	prefer	I-NP	VBN	O	28	NMOD
28	substrate	substrate	I-NP	NN	O	25	PRD
29	for	for	B-PP	IN	O	28	NMOD
30	upstream	upstream	B-NP	JJ	B-protein	31	NMOD
31	kinase	kinase	I-NP	NN	I-protein	29	PMOD
32	of	of	B-PP	IN	O	31	NMOD
33	the	the	B-NP	DT	O	35	NMOD
34	MAPK	MAPK	I-NP	NN	B-protein	35	NMOD
35	pathway	pathway	I-NP	NN	O	32	PMOD
36	.	.	O	.	O	5	P

1	Treatment	Treatment	B-NP	NN	O	27	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	human	human	B-NP	JJ	B-cell_line	11	NMOD
4	umbilical	umbilical	I-NP	JJ	I-cell_line	11	NMOD
5	vein	vein	I-NP	NN	I-cell_line	11	NMOD
6	endothelial	endothelial	I-NP	JJ	I-cell_line	11	NMOD
7	cell	cell	I-NP	NN	I-cell_line	11	NMOD
8	(	(	O	(	O	11	NMOD
9	HUVEC	HUVEC	B-NP	NN	B-cell_line	11	NMOD
10	)	)	O	)	O	11	NMOD
11	monolayers	monolayer	B-NP	NNS	O	2	PMOD
12	for	for	B-PP	IN	O	1	NMOD
13	6	6	B-NP	CD	O	14	NMOD
14	hours	hour	I-NP	NNS	O	12	PMOD
15	with	with	B-PP	IN	O	1	NMOD
16	0.2	0.2	B-NP	CD	O	17	AMOD
17	mmol/L	mmol/L	I-NP	NN	O	18	NMOD
18	diamide	diamide	I-NP	NN	O	23	NMOD
19	and	and	O	CC	O	23	NMOD
20	1	1	B-NP	CD	O	21	AMOD
21	mmol/L	mmol/L	I-NP	NN	O	23	NMOD
22	buthionine	buthionine	I-NP	NN	O	23	NMOD
23	sulfoximine	sulfoximine	I-NP	NN	O	15	PMOD
24	(	(	O	(	O	26	DEP
25	BSO	BSO	B-NP	NN	O	26	DEP
26	)	)	O	)	O	23	NMOD
27	decreased	decrease	B-VP	VBD	O	0	ROOT
28	GSH	GSH	B-NP	NN	O	29	NMOD
29	levels	level	I-NP	NNS	O	27	OBJ
30	and	and	O	CC	O	27	VMOD
31	increased	increase	B-VP	VBD	O	27	VMOD
32	the	the	B-NP	DT	O	33	NMOD
33	ratio	ratio	I-NP	NN	O	31	OBJ
34	of	of	B-PP	IN	O	33	NMOD
35	GSSG	GSSG	B-NP	NN	O	34	PMOD
36	to	to	B-PP	TO	O	33	NMOD
37	GSH	GSH	B-NP	NN	O	36	PMOD
38	without	without	B-PP	IN	O	31	VMOD
39	cell	cell	B-NP	NN	O	40	NMOD
40	toxicity	toxicity	I-NP	NN	O	38	PMOD
41	.	.	O	.	O	27	P

1	Interestingly	Interestingly	B-ADVP	RB	O	19	VMOD
2	,	,	O	,	O	19	P
3	phase	phase	B-NP	NN	O	5	NMOD
4	1	1	I-NP	CD	O	5	NMOD
5	adhesion	adhesion	I-NP	NN	O	6	SUB
6	was	be	B-VP	VBD	O	19	VMOD
7	inversely	inversely	I-VP	RB	O	8	VMOD
8	correlated	correlate	I-VP	VBN	O	6	VC
9	with	with	B-PP	IN	O	8	VMOD
10	GSH	GSH	B-NP	NN	O	11	NMOD
11	levels	level	I-NP	NNS	O	9	PMOD
12	but	but	B-PP	CC	O	9	PMOD
13	not	not	B-PP	RB	O	14	PMOD
14	with	with	I-PP	IN	O	9	PMOD
15	the	the	B-NP	DT	O	17	NMOD
16	GSSG/GSH	GSSG/GSH	I-NP	NN	O	17	NMOD
17	ratio	ratio	I-NP	NN	O	14	PMOD
18	,	,	O	,	O	19	P
19	whereas	whereas	O	IN	O	0	ROOT
20	phase	phase	B-NP	NN	O	23	NMOD
21	2	2	I-NP	CD	O	23	NMOD
22	neutrophil	neutrophil	I-NP	NN	B-cell_type	23	NMOD
23	adhesion	adhesion	I-NP	NN	O	24	SUB
24	was	be	B-VP	VBD	O	19	VMOD
25	positively	positively	I-VP	RB	O	24	VMOD
26	correlated	correlate	I-VP	VBN	O	24	VC
27	with	with	B-PP	IN	O	26	VMOD
28	GSSG/GSH	GSSG/GSH	B-NP	NN	O	29	NMOD
29	ratio	ratio	I-NP	NN	O	27	PMOD
30	but	but	B-PP	CC	O	27	PMOD
31	not	not	B-PP	RB	O	32	PMOD
32	with	with	I-PP	IN	O	27	PMOD
33	GSH	GSH	B-NP	NN	O	34	NMOD
34	levels	level	I-NP	NNS	O	32	PMOD
35	.	.	O	.	O	19	P

1	Examination	Examination	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	activation-induced	activation-induced	B-NP	JJ	O	2	PMOD
4	phosphorylation	phosphorylation	I-NP	NN	O	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	ubiquitination	ubiquitination	I-NP	NN	O	3	NMOD
7	of	of	B-PP	IN	O	3	NMOD
8	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	7	PMOD
9	did	do	B-VP	VBD	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	demonstrate	demonstrate	I-VP	VB	O	9	VC
12	any	any	B-NP	DT	O	15	NMOD
13	significant	significant	I-NP	JJ	O	15	NMOD
14	age-related	age-related	I-NP	JJ	O	15	NMOD
15	alterations	alteration	I-NP	NNS	O	11	OBJ
16	.	.	O	.	O	9	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	a	a	B-NP	DT	O	6	NMOD
6	decline	decline	I-NP	NN	O	10	SUB
7	in	in	B-PP	IN	O	6	NMOD
8	proteasome	proteasome	B-NP	NN	B-protein	9	NMOD
9	activity	activity	I-NP	NN	O	7	PMOD
10	results	result	B-VP	VBZ	O	4	SBAR
11	in	in	B-PP	IN	O	10	VMOD
12	a	a	B-NP	DT	O	13	NMOD
13	failure	failure	I-NP	NN	O	11	PMOD
14	to	to	B-VP	TO	O	16	VMOD
15	fully	fully	I-VP	RB	O	16	VMOD
16	degrade	degrade	I-VP	VB	O	13	NMOD
17	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	16	OBJ
18	in	in	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	elderly	elderly	I-NP	JJ	O	18	PMOD
21	.	.	O	.	O	3	P

1	This	This	B-NP	DT	O	2	NMOD
2	failure	failure	I-NP	NN	O	6	SUB
3	to	to	B-VP	TO	O	4	VMOD
4	degrade	degrade	I-VP	VB	O	2	NMOD
5	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	4	OBJ
6	may	may	B-VP	MD	O	0	ROOT
7	underlie	underlie	I-VP	VB	O	6	VC
8	both	both	O	CC	O	19	NMOD
9	the	the	B-NP	DT	O	11	NMOD
10	observed	observe	I-NP	VBN	O	11	NMOD
11	decrease	decrease	I-NP	NN	O	19	NMOD
12	in	in	B-PP	IN	O	11	NMOD
13	NFkappaB	NFkappaB	B-NP	NN	B-protein	14	NMOD
14	induction	induction	I-NP	NN	O	12	PMOD
15	and	and	O	CC	O	19	NMOD
16	the	the	B-NP	DT	O	19	NMOD
17	IL-2	IL-2	I-NP	NN	B-protein	19	NMOD
18	receptor	receptor	I-NP	NN	I-protein	19	NMOD
19	expression	expression	I-NP	NN	O	7	OBJ
20	in	in	B-PP	IN	O	19	NMOD
21	TNF-treated	TNF-treated	B-NP	JJ	B-cell_line	23	NMOD
22	T	T	I-NP	NN	I-cell_line	23	NMOD
23	cells	cell	I-NP	NNS	I-cell_line	20	PMOD
24	during	during	B-PP	IN	O	19	NMOD
25	aging	aging	B-NP	NN	O	24	PMOD
26	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	11	VMOD
2	CAT	CAT	B-NP	NN	B-DNA	4	NMOD
3	reporter	reporter	I-NP	NN	I-DNA	4	NMOD
4	constructions	construction	I-NP	NNS	I-DNA	1	PMOD
5	no	no	B-NP	DT	O	7	NMOD
6	appreciable	appreciable	I-NP	JJ	O	7	NMOD
7	level	level	I-NP	NN	O	11	SUB
8	of	of	B-PP	IN	O	7	NMOD
9	CAT	CAT	B-NP	NN	B-protein	10	NMOD
10	activity	activity	I-NP	NN	O	8	PMOD
11	was	be	B-VP	VBD	O	23	VMOD
12	supported	support	I-VP	VBN	O	11	VC
13	by	by	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	17	NMOD
15	beta	beta	I-NP	NN	B-DNA	17	NMOD
16	globin	globin	I-NP	NN	I-DNA	17	NMOD
17	promoter	promoter	I-NP	NN	I-DNA	13	PMOD
18	,	,	O	,	O	23	P
19	and	and	O	CC	O	23	NMOD
20	only	only	B-NP	RB	O	23	NMOD
21	low	low	I-NP	JJ	O	23	NMOD
22	level	level	I-NP	NN	O	23	NMOD
23	activity	activity	I-NP	NN	O	0	ROOT
24	by	by	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	delta	delta	I-NP	NN	B-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	24	PMOD
28	.	.	O	.	O	23	P

1	Coupling	Coupling	B-NP	NN	O	20	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	7	NMOD
4	upstream	upstream	I-NP	JJ	B-DNA	7	NMOD
5	beta	beta	I-NP	NN	I-DNA	7	NMOD
6	globin	globin	I-NP	NN	I-DNA	7	NMOD
7	sequence	sequence	I-NP	NN	I-DNA	2	PMOD
8	from	from	B-PP	IN	O	7	NMOD
9	approximately	approximately	B-NP	RB	O	8	AMOD
10	-500	-500	I-NP	CD	B-DNA	8	AMOD
11	to	to	I-NP	TO	I-DNA	8	AMOD
12	-250	-250	I-NP	CD	I-DNA	8	AMOD
13	bp	bp	I-NP	NN	I-DNA	8	PMOD
14	to	to	B-PP	TO	O	1	NMOD
15	the	the	B-NP	DT	O	19	NMOD
16	truncated	truncate	I-NP	VBN	O	19	NMOD
17	delta	delta	I-NP	NN	B-DNA	19	NMOD
18	promoter	promoter	I-NP	NN	I-DNA	19	NMOD
19	fragment	fragment	I-NP	NN	I-DNA	14	PMOD
20	led	lead	B-VP	VBD	O	0	ROOT
21	to	to	I-VP	TO	O	20	VMOD
22	complete	complete	I-VP	VB	O	23	NMOD
23	extinction	extinction	B-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	transcription	transcription	B-NP	NN	O	26	NMOD
26	activity	activity	I-NP	NN	O	24	PMOD
27	,	,	O	,	O	20	P
28	consistent	consistent	B-ADJP	JJ	O	20	VMOD
29	with	with	B-PP	IN	O	28	AMOD
30	a	a	B-NP	DT	O	33	NMOD
31	negative	negative	I-NP	JJ	O	33	NMOD
32	regulatory	regulatory	I-NP	JJ	O	33	NMOD
33	effect	effect	I-NP	NN	O	29	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	the	the	B-NP	DT	O	42	NMOD
36	beta	beta	I-NP	NN	B-DNA	42	NMOD
37	globin	globin	I-NP	NN	I-DNA	42	NMOD
38	gene	gene	I-NP	NN	I-DNA	42	NMOD
39	upstream	upstream	I-NP	JJ	I-DNA	42	NMOD
40	element	element	I-NP	NN	I-DNA	42	NMOD
41	(	(	I-NP	(	O	42	NMOD
42	s	s	I-NP	NNS	O	34	PMOD
43	)	)	O	)	O	42	NMOD
44	.	.	O	.	O	20	P

1	The	The	B-NP	DT	O	3	NMOD
2	signal	signal	I-NP	NN	O	3	NMOD
3	cascade	cascade	I-NP	NN	O	7	SUB
4	transducing	transduce	B-VP	VBG	O	3	NMOD
5	this	this	B-NP	DT	O	6	NMOD
6	effect	effect	I-NP	NN	O	4	OBJ
7	is	be	B-VP	VBZ	O	0	ROOT
8	not	not	O	RB	O	7	VMOD
9	yet	yet	B-ADJP	RB	O	7	VMOD
10	clear	clear	I-ADJP	JJ	O	7	PRD
11	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	5	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	5	P
4	gp41	gp41	B-NP	NN	B-protein	5	SUB
5	failed	fail	B-VP	VBD	O	0	ROOT
6	to	to	I-VP	TO	O	7	VMOD
7	stimulate	stimulate	I-VP	VB	O	5	VMOD
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	10	NMOD
9	binding	binding	I-NP	NN	O	10	NMOD
10	activity	activity	I-NP	NN	O	7	OBJ
11	in	in	B-PP	IN	O	14	DEP
12	as	as	B-NP	RB	O	14	DEP
13	much	much	I-NP	JJ	O	14	DEP
14	as	as	B-PP	IN	O	7	VMOD
15	no	no	B-NP	DT	O	16	NMOD
16	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	17	SUB
17	bound	bind	B-VP	VBD	O	14	SBAR
18	to	to	B-PP	TO	O	17	VMOD
19	the	the	B-NP	DT	O	22	NMOD
20	main	main	I-NP	JJ	B-DNA	22	NMOD
21	NF-kappaB-binding	NF-kappaB-binding	I-NP	JJ	I-DNA	22	NMOD
22	site	site	I-NP	NN	I-DNA	18	PMOD
23	2	2	I-NP	CD	O	22	NMOD
24	of	of	B-PP	IN	O	22	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	IL-10	IL-10	I-NP	NN	B-DNA	27	NMOD
27	promoter	promoter	I-NP	NN	I-DNA	24	PMOD
28	after	after	B-PP	IN	O	17	VMOD
29	addition	addition	B-NP	NN	O	28	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	gp41	gp41	B-NP	NN	B-protein	30	PMOD
32	.	.	O	.	O	5	P

1	Specific	Specific	B-NP	JJ	O	2	NMOD
2	inhibitors	inhibitor	I-NP	NNS	O	15	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	p70	p70	B-NP	NN	B-protein	8	NMOD
5	(	(	O	(	I-protein	8	NMOD
6	S6	S6	B-NP	NN	I-protein	8	NMOD
7	)	)	O	)	I-protein	8	NMOD
8	-kinase	-kinase	B-NP	NN	I-protein	3	PMOD
9	(	(	O	(	O	11	DEP
10	rapamycin	rapamycin	B-NP	NN	O	11	DEP
11	)	)	O	)	O	8	NMOD
12	,	,	O	,	O	15	P
13	and	and	O	CC	O	15	NMOD
14	Gi	Gi	B-NP	NN	B-protein	15	NMOD
15	protein	protein	I-NP	NN	I-protein	21	SUB
16	(	(	O	(	O	19	DEP
17	pertussis	pertussis	B-NP	NN	B-protein	18	NMOD
18	toxin	toxin	I-NP	NN	I-protein	19	DEP
19	)	)	O	)	O	15	NMOD
20	,	,	O	,	O	15	P
21	prevented	prevent	B-VP	VBD	O	0	ROOT
22	induction	induction	B-NP	NN	O	21	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	IL-10	IL-10	B-NP	NN	B-protein	25	NMOD
25	production	production	I-NP	NN	O	23	PMOD
26	by	by	B-PP	IN	O	22	NMOD
27	gp41	gp41	B-NP	NN	B-protein	26	PMOD
28	in	in	B-PP	IN	O	22	NMOD
29	monocytes	monocyte	B-NP	NNS	B-cell_type	28	PMOD
30	,	,	O	,	O	21	P
31	while	while	B-SBAR	IN	O	21	VMOD
32	inhibitors	inhibitor	B-NP	NNS	O	56	SUB
33	of	of	B-PP	IN	O	32	NMOD
34	the	the	B-NP	DT	O	36	NMOD
35	phosphatidylinositol	phosphatidylinositol	I-NP	NN	B-protein	36	NMOD
36	3-kinase	3-kinase	I-NP	NN	I-protein	51	NMOD
37	(	(	O	(	O	40	DEP
38	PI	PI	B-NP	NN	B-protein	39	NMOD
39	3-kinase	3-kinase	I-NP	NN	I-protein	40	DEP
40	)	)	O	)	O	36	NMOD
41	(	(	O	(	O	43	DEP
42	wortmannin	wortmannin	B-NP	NN	O	43	DEP
43	)	)	O	)	O	36	NMOD
44	and	and	O	CC	O	51	NMOD
45	mitogen-activated	mitogen-activated	B-NP	JJ	B-protein	47	NMOD
46	protein	protein	I-NP	NN	I-protein	47	NMOD
47	kinase	kinase	I-NP	NN	I-protein	51	NMOD
48	(	(	O	(	O	50	DEP
49	MAPK	MAPK	B-NP	NN	B-protein	50	DEP
50	)	)	O	)	O	47	NMOD
51	pathway	pathway	B-NP	NN	O	33	PMOD
52	(	(	O	(	O	55	DEP
53	PD	PD	B-NP	NN	O	55	DEP
54	98059	98059	I-NP	CD	O	53	NMOD
55	)	)	O	)	O	51	NMOD
56	did	do	B-VP	VBD	O	31	SBAR
57	not	not	O	RB	O	56	VMOD
58	.	.	O	.	O	21	P

1	Thus	Thus	B-NP	RB	O	8	VMOD
2	HIV-1	HIV-1	I-NP	NN	O	5	NMOD
3	gp41-induced	gp41-induced	I-NP	JJ	O	5	NMOD
4	IL-10	IL-10	I-NP	NN	B-protein	5	NMOD
5	up-regulation	up-regulation	I-NP	NN	O	8	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	monocytes	monocyte	B-NP	NNS	B-cell_type	6	PMOD
8	may	may	B-VP	MD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	involve	involve	I-VP	VB	O	8	VC
11	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	18	NMOD
12	,	,	O	,	O	18	P
13	MAPK	MAPK	B-NP	NN	B-protein	18	NMOD
14	,	,	O	,	O	18	P
15	or	or	O	CC	O	18	NMOD
16	PI	PI	B-NP	NN	B-protein	17	NMOD
17	3-kinase	3-kinase	I-NP	NN	I-protein	18	NMOD
18	activation	activation	I-NP	NN	O	10	OBJ
19	,	,	O	,	O	8	P
20	but	but	O	CC	O	8	VMOD
21	rather	rather	B-VP	RB	O	20	DEP
22	may	may	I-VP	MD	O	8	VMOD
23	operate	operate	I-VP	VB	O	22	VC
24	through	through	B-PP	IN	O	23	VMOD
25	activation	activation	B-NP	NN	O	24	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	adenylate	adenylate	B-NP	NN	B-protein	28	NMOD
28	cyclase	cyclase	I-NP	NN	I-protein	32	NMOD
29	and	and	O	CC	O	32	NMOD
30	pertussis-toxin-sensitive	pertussis-toxin-sensitive	B-NP	JJ	B-protein	32	NMOD
31	Gi/Go	Gi/Go	I-NP	NN	I-protein	32	NMOD
32	protein	protein	I-NP	NN	I-protein	26	PMOD
33	to	to	B-PP	TO	O	23	VMOD
34	effect	effect	B-NP	NN	O	39	NMOD
35	p70	p70	I-NP	NN	B-protein	39	NMOD
36	(	(	O	(	I-protein	39	NMOD
37	S6	S6	B-NP	NN	I-protein	39	NMOD
38	)	)	O	)	I-protein	39	NMOD
39	-kinase	-kinase	B-NP	NN	I-protein	40	NMOD
40	activation	activation	I-NP	NN	O	33	PMOD
41	.	.	O	.	O	8	P

1	However	However	B-ADVP	RB	O	10	VMOD
2	,	,	O	,	O	10	P
3	the	the	B-NP	DT	O	4	NMOD
4	sensitivity	sensitivity	I-NP	NN	O	10	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	cells	cell	B-NP	NNS	O	5	PMOD
7	to	to	B-PP	TO	O	4	NMOD
8	these	these	B-NP	DT	O	9	NMOD
9	agents	agent	I-NP	NNS	O	7	PMOD
10	is	be	B-VP	VBZ	O	0	ROOT
11	not	not	I-VP	RB	O	10	VMOD
12	merely	merely	I-VP	RB	O	10	VMOD
13	governed	govern	I-VP	VBN	O	10	VC
14	by	by	B-PP	IN	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	expression	expression	I-NP	NN	O	22	NMOD
17	of	of	B-PP	IN	O	16	NMOD
18	their	their	B-NP	PRP$	O	19	NMOD
19	receptors	receptor	I-NP	NNS	O	17	PMOD
20	and	and	O	CC	O	22	NMOD
21	the	the	B-NP	DT	O	22	NMOD
22	availability	availability	I-NP	NN	O	14	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	ligand	ligand	B-NP	NN	O	23	PMOD
25	to	to	B-VP	TO	O	26	VMOD
26	bind	bind	I-VP	VB	O	22	NMOD
27	them	them	B-NP	PRP	O	26	OBJ
28	.	.	O	.	O	10	P

1	Neither	Neither	B-NP	DT	O	3	NMOD
2	cell	cell	I-NP	NN	O	3	NMOD
3	population	population	I-NP	NN	O	4	SUB
4	generated	generate	B-VP	VBD	O	0	ROOT
5	significant	significant	B-NP	JJ	O	6	NMOD
6	amounts	amount	I-NP	NNS	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	E2	E2	B-NP	NN	B-protein	7	PMOD
9	from	from	B-PP	IN	O	6	NMOD
10	E1	E1	B-NP	NN	B-protein	9	PMOD
11	.	.	O	.	O	4	P

1	However	However	B-ADVP	RB	O	8	VMOD
2	,	,	O	,	O	8	P
3	the	the	B-NP	DT	O	5	NMOD
4	HTLV-I	HTLV-I	I-NP	NN	B-DNA	5	NMOD
5	genes	gene	I-NP	NNS	I-DNA	8	SUB
6	including	include	B-PP	VBG	O	5	NMOD
7	Tax	Tax	B-NP	NN	B-protein	6	PMOD
8	are	be	B-VP	VBP	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	expressed	express	I-VP	VBN	O	8	VC
11	significantly	significantly	B-ADVP	RB	O	10	VMOD
12	in	in	B-PP	IN	O	10	VMOD
13	primary	primary	B-NP	JJ	B-cell_type	15	NMOD
14	leukemic	leukemic	I-NP	JJ	I-cell_type	15	NMOD
15	cells	cell	I-NP	NNS	I-cell_type	12	PMOD
16	from	from	B-PP	IN	O	15	NMOD
17	ATL	ATL	B-NP	NN	O	18	NMOD
18	patients	patient	I-NP	NNS	O	16	PMOD
19	.	.	O	.	O	8	P

1	One	One	B-NP	CD	O	3	NMOD
2	T-cell	T-cell	I-NP	NN	B-cell_line	3	NMOD
3	line	line	I-NP	NN	I-cell_line	10	NMOD
4	derived	derive	B-VP	VBN	O	3	NMOD
5	from	from	B-PP	IN	O	4	VMOD
6	ATL	ATL	B-NP	NN	O	8	NMOD
7	leukemic	leukemic	I-NP	JJ	B-cell_type	8	NMOD
8	cells	cell	I-NP	NNS	I-cell_type	5	PMOD
9	,	,	O	,	O	10	P
10	TL-Om1	TL-Om1	B-NP	NN	O	12	SUB
11	,	,	O	,	O	10	P
12	displayed	display	B-VP	VBD	O	0	ROOT
13	constitutive	constitutive	B-NP	JJ	O	15	NMOD
14	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	15	NMOD
15	activity	activity	I-NP	NN	O	21	NMOD
16	,	,	O	,	O	21	P
17	as	as	B-CONJP	RB	O	21	NMOD
18	well	well	I-CONJP	RB	O	17	DEP
19	as	as	I-CONJP	IN	O	17	DEP
20	enhanced	enhance	B-NP	VBN	O	21	NMOD
21	degradation	degradation	I-NP	NN	O	12	OBJ
22	of	of	B-PP	IN	O	21	NMOD
23	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	22	PMOD
24	,	,	O	,	O	12	P
25	despite	despite	B-PP	IN	O	12	VMOD
26	the	the	B-NP	DT	O	27	NMOD
27	lack	lack	I-NP	NN	O	25	PMOD
28	of	of	B-PP	IN	O	27	NMOD
29	detectable	detectable	B-NP	JJ	O	31	NMOD
30	Tax	Tax	I-NP	NN	B-protein	31	NMOD
31	expression	expression	I-NP	NN	O	28	PMOD
32	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	6	NMOD
2	CD34+	CD34+	I-NP	JJ	B-cell_line	6	NMOD
3	myelomonocytic	myelomonocytic	I-NP	JJ	I-cell_line	6	NMOD
4	cell	cell	I-NP	NN	I-cell_line	6	NMOD
5	line	line	I-NP	NN	I-cell_line	6	NMOD
6	KG1	KG1	I-NP	NN	B-cell_line	7	SUB
7	differentiates	differentiate	B-VP	VBZ	O	0	ROOT
8	into	into	B-PP	IN	O	7	VMOD
9	dendritic-like	dendritic-like	B-NP	JJ	B-cell_type	10	NMOD
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD
11	in	in	B-PP	IN	O	7	VMOD
12	response	response	B-NP	NN	O	11	PMOD
13	to	to	B-PP	TO	O	12	NMOD
14	granulocyte-macrophage	granulocyte-macrophage	B-NP	JJ	B-protein	15	NMOD
15	CSF	CSF	I-NP	NN	I-protein	17	NMOD
16	plus	plus	I-NP	CC	O	17	NMOD
17	TNF-alpha	TNF-alpha	I-NP	NN	B-protein	13	PMOD
18	,	,	O	,	O	7	VMOD
19	or	or	O	CC	O	20	NMOD
20	PMA	PMA	B-NP	NN	O	18	SUB
21	(	(	O	(	O	20	NMOD
22	with	with	B-PP	IN	O	20	NMOD
23	or	or	I-PP	CC	O	22	PMOD
24	without	without	I-PP	IN	O	22	PMOD
25	the	the	B-NP	DT	O	28	NMOD
26	calcium	calcium	I-NP	NN	O	28	NMOD
27	ionophore	ionophore	I-NP	NN	O	28	NMOD
28	ionomycin	ionomycin	I-NP	NN	O	31	NMOD
29	,	,	O	,	O	31	P
30	or	or	O	CC	O	31	NMOD
31	TNF-alpha	TNF-alpha	B-NP	NN	B-protein	22	PMOD
32	)	)	O	)	O	20	NMOD
33	,	,	O	,	O	20	P
34	with	with	B-PP	IN	O	20	NMOD
35	different	different	B-NP	JJ	O	36	NMOD
36	stimuli	stimulus	I-NP	NNS	O	37	SUB
37	mediating	mediate	B-VP	VBG	O	34	PMOD
38	different	different	B-NP	JJ	O	39	NMOD
39	aspects	aspect	I-NP	NNS	O	37	OBJ
40	of	of	B-PP	IN	O	39	NMOD
41	the	the	B-NP	DT	O	42	NMOD
42	process	process	I-NP	NN	O	40	PMOD
43	.	.	O	.	O	7	P

1	IL-2-mediated	IL-2-mediated	B-NP	JJ	O	4	NMOD
2	cell	cell	I-NP	NN	O	4	NMOD
3	cycle	cycle	I-NP	NN	O	4	NMOD
4	progression	progression	I-NP	NN	O	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	inhibition	inhibition	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	apoptosis	apoptosis	B-NP	NN	O	7	PMOD
9	does	do	B-VP	VBZ	O	0	ROOT
10	not	not	I-VP	RB	O	9	VMOD
11	require	require	I-VP	VB	O	9	VC
12	NF-kappa	NF-kappa	B-NP	NN	B-protein	13	NMOD
13	B	B	I-NP	NN	I-protein	11	OBJ
14	or	or	O	CC	O	11	VMOD
15	activating	activate	B-VP	VBG	B-protein	17	NMOD
16	protein-1	protein-1	B-NP	NN	I-protein	17	NMOD
17	activation	activation	I-NP	NN	O	11	OBJ
18	in	in	B-PP	IN	O	17	NMOD
19	primary	primary	B-NP	JJ	B-cell_type	22	NMOD
20	human	human	I-NP	JJ	I-cell_type	22	NMOD
21	T	T	I-NP	NN	I-cell_type	22	NMOD
22	cells	cell	I-NP	NNS	I-cell_type	18	PMOD
23	.	.	O	.	O	9	P

1	IL-2	IL-2	B-NP	NN	B-protein	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	required	require	I-VP	VBN	O	2	VC
4	not	not	B-CONJP	RB	O	3	VMOD
5	only	only	I-CONJP	RB	O	4	DEP
6	for	for	B-PP	IN	O	4	DEP
7	cell	cell	B-NP	NN	O	9	NMOD
8	cycle	cycle	I-NP	NN	O	9	NMOD
9	progression	progression	I-NP	NN	O	6	PMOD
10	but	but	B-CONJP	CC	O	4	DEP
11	also	also	I-CONJP	RB	O	10	DEP
12	to	to	B-VP	TO	O	13	VMOD
13	protect	protect	I-VP	VB	O	4	DEP
14	Ag-activated	Ag-activated	B-NP	JJ	B-cell_type	16	NMOD
15	T	T	I-NP	NN	I-cell_type	16	NMOD
16	cells	cell	I-NP	NNS	I-cell_type	13	OBJ
17	from	from	B-PP	IN	O	13	VMOD
18	programmed	program	B-NP	VBN	O	20	NMOD
19	cell	cell	I-NP	NN	O	20	NMOD
20	death	death	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	3	NMOD
2	current	current	I-NP	JJ	O	3	NMOD
3	study	study	I-NP	NN	O	5	SUB
4	clearly	clearly	B-ADVP	RB	O	5	VMOD
5	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	IL-2	IL-2	B-NP	NN	B-protein	8	SUB
8	does	do	B-VP	VBZ	O	6	SBAR
9	not	not	I-VP	RB	O	8	VMOD
10	induce	induce	I-VP	VB	O	8	VC
11	I	I	B-NP	NN	B-protein	14	NMOD
12	kappa	kappa	I-NP	NN	I-protein	14	NMOD
13	B	B	I-NP	NN	I-protein	14	NMOD
14	alpha	alpha	I-NP	NN	I-protein	15	NMOD
15	degradation	degradation	I-NP	NN	O	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	NF-kappa	NF-kappa	B-NP	NN	B-protein	18	NMOD
18	B	B	I-NP	NN	I-protein	19	NMOD
19	activation	activation	I-NP	NN	O	10	OBJ
20	in	in	B-PP	IN	O	19	NMOD
21	primary	primary	B-NP	JJ	B-cell_type	24	NMOD
22	human	human	I-NP	JJ	I-cell_type	24	NMOD
23	T	T	I-NP	NN	I-cell_type	24	NMOD
24	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
25	that	that	B-NP	WDT	O	24	NMOD
26	respond	respond	B-VP	VBP	O	25	SBAR
27	to	to	B-PP	TO	O	26	VMOD
28	IL-2	IL-2	B-NP	NN	B-protein	27	PMOD
29	by	by	B-PP	IN	O	26	VMOD
30	entering	enter	B-VP	VBG	O	29	PMOD
31	the	the	B-NP	DT	O	33	NMOD
32	cell	cell	I-NP	NN	O	33	NMOD
33	cycle	cycle	I-NP	NN	O	30	OBJ
34	and	and	O	CC	O	30	VMOD
35	avoiding	avoid	B-VP	VBG	O	30	VMOD
36	apoptosis	apoptosis	B-NP	NN	O	35	OBJ
37	.	.	O	.	O	5	P

1	Similarly	Similarly	B-ADVP	RB	O	5	VMOD
2	,	,	O	,	O	5	P
3	IL-2	IL-2	B-NP	NN	B-protein	5	SUB
4	neither	neither	O	CC	O	5	VMOD
5	activates	activate	B-VP	VBZ	O	0	ROOT
6	JNK	JNK	B-NP	NN	B-protein	5	OBJ
7	nor	nor	O	CC	O	5	VMOD
8	increases	increase	B-VP	VBZ	O	5	VMOD
9	AP-1	AP-1	B-NP	NN	B-protein	11	NMOD
10	binding	binding	I-NP	NN	O	11	NMOD
11	activity	activity	I-NP	NN	O	8	OBJ
12	to	to	B-PP	TO	O	11	NMOD
13	a	a	B-NP	DT	O	21	NMOD
14	consensus	consensus	I-NP	NN	B-DNA	21	NMOD
15	o-tetradecanoylphorbol	o-tetradecanoylphorbol	I-NP	NN	I-DNA	21	NMOD
16	13-acetate	13-acetate	I-NP	NN	I-DNA	21	NMOD
17	(	(	O	(	I-DNA	21	NMOD
18	TPA	TPA	B-NP	NN	I-DNA	21	NMOD
19	)	)	O	)	I-DNA	21	NMOD
20	response	response	B-NP	NN	I-DNA	21	NMOD
21	element	element	I-NP	NN	I-DNA	12	PMOD
22	.	.	O	.	O	5	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	neither	neither	O	CC	O	10	NMOD
6	NF-kappa	NF-kappa	B-NP	NN	B-protein	7	NMOD
7	B	B	I-NP	NN	I-protein	10	NMOD
8	nor	nor	O	CC	O	10	NMOD
9	AP-1	AP-1	B-NP	NN	B-protein	10	NMOD
10	activation	activation	I-NP	NN	O	11	SUB
11	is	be	B-VP	VBZ	O	4	SBAR
12	required	require	I-VP	VBN	O	11	VC
13	for	for	B-PP	IN	O	12	VMOD
14	IL-2-mediated	IL-2-mediated	B-NP	JJ	O	15	NMOD
15	survival	survival	I-NP	NN	O	19	NMOD
16	or	or	O	CC	O	19	NMOD
17	cell	cell	B-NP	NN	O	19	NMOD
18	cycle	cycle	I-NP	NN	O	19	NMOD
19	progression	progression	I-NP	NN	O	13	PMOD
20	in	in	B-PP	IN	O	19	NMOD
21	activated	activate	B-NP	VBN	B-cell_type	25	NMOD
22	primary	primary	I-NP	JJ	I-cell_type	25	NMOD
23	human	human	I-NP	JJ	I-cell_type	25	NMOD
24	T	T	I-NP	NN	I-cell_type	25	NMOD
25	cells	cell	I-NP	NNS	I-cell_type	20	PMOD
26	.	.	O	.	O	3	P

1	Fetal	Fetal	B-NP	JJ	B-cell_type	2	NMOD
2	thymocytes	thymocyte	I-NP	NNS	I-cell_type	10	SUB
3	infected	infect	B-VP	VBN	O	2	NMOD
4	with	with	B-PP	IN	O	3	VMOD
5	adenovirus	adenovirus	B-NP	NN	O	4	PMOD
6	containing	contain	B-VP	VBG	O	5	NMOD
7	mut-I	mut-I	B-NP	NN	B-protein	9	NMOD
8	kappa	kappa	I-NP	NN	I-protein	9	NMOD
9	B	B	I-NP	NN	I-protein	6	OBJ
10	were	be	B-VP	VBD	O	0	ROOT
11	found	find	I-VP	VBN	O	10	VC
12	to	to	I-VP	TO	O	13	VMOD
13	develop	develop	I-VP	VB	O	11	VMOD
14	normally	normally	B-ADVP	RB	O	13	VMOD
15	until	until	B-SBAR	IN	O	13	VMOD
16	the	the	B-NP	DT	O	21	NMOD
17	CD44-CD25+	CD44-CD25+	I-NP	JJ	O	20	AMOD
18	,	,	I-NP	,	O	20	P
19	CD4-CD8-	CD4-CD8-	I-NP	JJ	O	20	AMOD
20	double-negative	double-negative	I-NP	JJ	O	21	NMOD
21	stage	stage	I-NP	NN	O	15	PMOD
22	,	,	O	,	O	10	P
23	while	while	B-SBAR	IN	O	10	VMOD
24	production	production	B-NP	NN	O	32	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	more	more	B-NP	RBR	O	27	AMOD
27	mature	mature	I-NP	JJ	O	31	NMOD
28	double-positive	double-positive	I-NP	JJ	O	30	AMOD
29	and	and	I-NP	CC	O	30	AMOD
30	single-positive	single-positive	I-NP	JJ	O	31	NMOD
31	populations	population	I-NP	NNS	O	25	PMOD
32	was	be	B-VP	VBD	O	23	SBAR
33	strongly	strongly	I-VP	RB	O	32	VMOD
34	decreased	decrease	I-VP	VBN	O	32	VC
35	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	24	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	24	P
4	treatment	treatment	B-NP	NN	O	24	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	HL-60	HL-60	B-NP	NN	B-cell_line	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_line	5	PMOD
8	with	with	B-PP	IN	O	4	NMOD
9	retinoic	retinoic	B-NP	JJ	O	10	NMOD
10	acid	acid	I-NP	NN	O	12	NMOD
11	or	or	O	CC	O	12	NMOD
12	DMSO	DMSO	B-NP	NN	O	8	PMOD
13	,	,	O	,	O	12	P
14	which	which	B-NP	WDT	O	12	NMOD
15	results	result	B-VP	VBZ	O	14	SBAR
16	in	in	B-PP	IN	O	15	VMOD
17	a	a	B-NP	DT	O	19	NMOD
18	granulocytic	granulocytic	I-NP	JJ	O	19	NMOD
19	differentiation	differentiation	I-NP	NN	O	16	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	these	these	B-NP	DT	O	22	NMOD
22	cells	cell	I-NP	NNS	O	20	PMOD
23	,	,	O	,	O	4	P
24	decreases	decrease	B-VP	VBZ	O	0	ROOT
25	4E-BP1	4E-BP1	B-NP	NN	B-protein	26	NMOD
26	amount	amount	I-NP	NN	O	24	OBJ
27	without	without	B-PP	IN	O	24	VMOD
28	affecting	affect	B-VP	VBG	O	27	PMOD
29	its	its	B-NP	PRP$	O	30	NMOD
30	phosphorylation	phosphorylation	I-NP	NN	O	28	OBJ
31	and	and	O	CC	O	24	VMOD
32	strongly	strongly	B-VP	RB	O	33	VMOD
33	increases	increase	I-VP	VBZ	O	24	VMOD
34	4E-BP2	4E-BP2	B-NP	NN	B-protein	35	NMOD
35	amount	amount	I-NP	NN	O	33	OBJ
36	.	.	O	.	O	24	P

1	CD40	CD40	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	19	VMOD
4	confirmed	confirm	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	7	7	B-NP	CD	O	10	NMOD
7	human	human	I-NP	JJ	B-cell_line	10	NMOD
8	MM	MM	I-NP	NN	I-cell_line	10	NMOD
9	cell	cell	I-NP	NN	I-cell_line	10	NMOD
10	lines	line	I-NP	NNS	I-cell_line	5	PMOD
11	established	establish	B-VP	VBN	O	10	NMOD
12	from	from	B-PP	IN	O	11	VMOD
13	immunogenic	immunogenic	B-NP	JJ	O	15	NMOD
14	primary	primary	I-NP	JJ	O	15	NMOD
15	tumors	tumor	I-NP	NNS	O	17	NMOD
16	or	or	I-NP	CC	O	17	NMOD
17	metastases	metastasis	I-NP	NNS	O	12	PMOD
18	,	,	O	,	O	19	P
19	whereas	whereas	O	IN	O	0	ROOT
20	11	11	B-NP	CD	O	22	NMOD
21	cell	cell	I-NP	NN	B-cell_line	22	NMOD
22	lines	line	I-NP	NNS	I-cell_line	27	SUB
23	established	establish	B-VP	VBN	O	22	NMOD
24	from	from	B-PP	IN	O	23	VMOD
25	advanced	advance	B-NP	VBN	O	26	NMOD
26	stages	stage	I-NP	NNS	O	24	PMOD
27	were	be	B-VP	VBD	O	19	VMOD
28	CD40	CD40	B-ADJP	NN	B-protein	27	PRD
29	negative	negative	I-ADJP	JJ	O	28	AMOD
30	.	.	O	.	O	19	P

1	CD40	CD40	B-NP	NN	B-protein	2	NMOD
2	expression	expression	I-NP	NN	O	3	SUB
3	could	could	B-VP	MD	O	0	ROOT
4	be	be	I-VP	VB	O	3	VC
5	enhanced	enhance	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	CD40-positive	CD40-positive	B-NP	JJ	O	8	NMOD
8	MM	MM	I-NP	NN	O	6	PMOD
9	by	by	B-PP	IN	O	5	VMOD
10	stimulation	stimulation	B-NP	NN	O	9	PMOD
11	with	with	B-PP	IN	O	10	NMOD
12	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	16	NMOD
13	and	and	O	CC	O	16	NMOD
14	tumor	tumor	B-NP	NN	B-protein	16	NMOD
15	necrosis	necrosis	I-NP	NN	I-protein	16	NMOD
16	factor-alpha	factor-alpha	I-NP	NN	I-protein	11	PMOD
17	but	but	B-PP	CC	O	11	PMOD
18	not	not	B-PP	RB	O	19	PMOD
19	by	by	I-PP	IN	O	11	PMOD
20	interleukin	interleukin	B-NP	NN	B-protein	27	NMOD
21	(	(	O	(	I-protein	27	NMOD
22	IL	IL	B-NP	NN	I-protein	27	NMOD
23	)	)	O	)	I-protein	27	NMOD
24	-1beta	-1beta	B-NP	NN	I-protein	27	NMOD
25	or	or	O	CC	O	27	NMOD
26	CD40	CD40	B-NP	NN	B-protein	27	NMOD
27	triggering	triggering	I-NP	NN	O	19	PMOD
28	.	.	O	.	O	3	P

1	When	When	B-ADVP	WRB	O	37	VMOD
2	two	two	B-NP	CD	O	5	NMOD
3	4-trifluoromethyl	4-trifluoromethyl	I-NP	NN	O	5	NMOD
4	salicylate	salicylate	I-NP	NN	O	5	NMOD
5	derivatives	derivative	I-NP	NNS	O	22	SUB
6	[	[	O	(	O	21	DEP
7	2-acetoxy-4-trifluoromethyl-benzoic	2-acetoxy-4-trifluoromethyl-benzoic	B-NP	JJ	O	8	NMOD
8	acid	acid	I-NP	NN	O	17	NMOD
9	(	(	O	(	O	11	DEP
10	triflusal	triflusal	B-NP	NN	O	11	DEP
11	)	)	O	)	O	8	NMOD
12	and	and	O	CC	O	17	NMOD
13	its	its	B-NP	PRP$	O	17	NMOD
14	deacetylated	deacetylate	I-NP	VBN	O	17	NMOD
15	metabolite	metabolite	I-NP	NN	O	17	NMOD
16	2-hydroxy-4-trifluoromethylbenzoic	2-hydroxy-4-trifluoromethylbenzoic	I-NP	JJ	O	17	NMOD
17	acid	acid	I-NP	NN	O	21	DEP
18	(	(	O	(	O	20	DEP
19	HTB	HTB	B-NP	NN	O	20	DEP
20	)	)	O	)	O	17	NMOD
21	]	]	O	)	O	5	NMOD
22	were	be	B-VP	VBD	O	1	SBAR
23	compared	compare	I-VP	VBN	O	22	VC
24	with	with	B-PP	IN	O	23	VMOD
25	aspirin	aspirin	B-NP	NN	O	28	NMOD
26	and	and	I-NP	CC	O	28	NMOD
27	sodium	sodium	I-NP	NN	O	28	NMOD
28	salicylate	salicylate	I-NP	NN	O	24	PMOD
29	as	as	B-PP	IN	O	23	VMOD
30	cyclooxygenase-2	cyclooxygenase-2	B-NP	NN	B-protein	34	NMOD
31	(	(	O	(	O	33	DEP
32	COX-2	COX-2	B-NP	NN	B-protein	33	DEP
33	)	)	O	)	O	30	NMOD
34	inhibitors	inhibitor	B-NP	NNS	O	29	PMOD
35	,	,	O	,	O	37	P
36	we	we	B-NP	PRP	O	37	SUB
37	observed	observe	B-VP	VBD	O	0	ROOT
38	that	that	B-SBAR	IN	O	37	VMOD
39	in	in	B-PP	IN	O	57	VMOD
40	bacterial	bacterial	B-NP	JJ	O	41	AMOD
41	lipopolysaccharide-activated	lipopolysaccharide-activated	I-NP	JJ	O	43	NMOD
42	human	human	I-NP	JJ	O	43	NMOD
43	blood	blood	I-NP	NN	O	39	PMOD
44	,	,	O	,	O	57	P
45	triflusal	triflusal	B-NP	NN	O	55	NMOD
46	,	,	O	,	O	55	P
47	aspirin	aspirin	B-NP	NN	O	55	NMOD
48	,	,	O	,	O	55	P
49	and	and	O	CC	O	55	NMOD
50	HTB	HTB	B-NP	NN	B-protein	55	NMOD
51	,	,	O	,	O	55	P
52	but	but	O	CC	O	55	NMOD
53	not	not	O	RB	O	52	DEP
54	sodium	sodium	B-NP	NN	O	55	NMOD
55	salicylate	salicylate	I-NP	NN	O	57	SUB
56	,	,	O	,	O	55	P
57	inhibited	inhibit	B-VP	VBD	O	38	SBAR
58	COX-2-mediated	COX-2-mediated	B-NP	JJ	O	60	NMOD
59	prostaglandin	prostaglandin	I-NP	NN	O	60	NMOD
60	E2	E2	I-NP	NN	O	64	NMOD
61	(	(	O	(	O	63	DEP
62	PGE2	PGE2	B-NP	NN	O	63	DEP
63	)	)	O	)	O	60	NMOD
64	production	production	B-NP	NN	O	57	OBJ
65	(	(	O	(	O	82	DEP
66	IC50	IC50	B-NP	NN	O	79	NMOD
67	=	=	B-VP	SYM	O	66	NMOD
68	0.16	0.16	B-NP	CD	O	76	NMOD
69	,	,	O	,	O	76	P
70	0.18	0.18	B-NP	CD	O	76	NMOD
71	,	,	I-NP	,	O	76	P
72	0.39	0.39	I-NP	CD	O	76	NMOD
73	,	,	O	,	O	76	P
74	and	and	O	CC	O	76	NMOD
75	&	&	B-NP	CC	O	76	NMOD
76	gt	gt	I-NP	NN	O	67	AMOD
77	;	;	O	:	O	79	P
78	10	10	B-NP	CD	O	79	NMOD
79	mM	mM	I-NP	NN	O	82	DEP
80	,	,	O	,	O	79	P
81	respectively	respectively	B-ADVP	RB	O	79	VMOD
82	)	)	O	)	O	57	VMOD
83	.	.	O	.	O	37	P

1	To	To	B-VP	TO	O	2	VMOD
2	test	test	I-VP	VB	O	8	VMOD
3	this	this	B-NP	DT	O	5	NMOD
4	apparent	apparent	I-NP	JJ	O	5	NMOD
5	discrepancy	discrepancy	I-NP	NN	O	2	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	realized	realize	B-VP	VBD	O	0	ROOT
9	that	that	B-SBAR	IN	O	8	VMOD
10	HTB	HTB	B-NP	NN	B-protein	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	triflusal	triflusal	I-NP	NN	O	20	SUB
13	(	(	O	(	O	19	DEP
14	but	but	O	CC	O	19	DEP
15	neither	neither	O	CC	O	18	NMOD
16	aspirin	aspirin	B-NP	NN	O	18	NMOD
17	nor	nor	O	CC	O	18	NMOD
18	salicylate	salicylate	B-NP	NN	O	19	DEP
19	)	)	O	)	O	12	NMOD
20	produced	produce	B-VP	VBD	O	9	SBAR
21	a	a	B-NP	DT	O	23	NMOD
22	concentration-dependent	concentration-dependent	I-NP	JJ	O	23	NMOD
23	inhibition	inhibition	I-NP	NN	O	20	OBJ
24	of	of	B-PP	IN	O	23	NMOD
25	COX-2	COX-2	B-NP	NN	B-protein	27	NMOD
26	protein	protein	I-NP	NN	O	27	NMOD
27	expression	expression	I-NP	NN	O	24	PMOD
28	in	in	B-PP	IN	O	23	NMOD
29	peripheral	peripheral	B-NP	JJ	B-cell_type	32	NMOD
30	human	human	I-NP	JJ	I-cell_type	32	NMOD
31	mononuclear	mononuclear	I-NP	JJ	I-cell_type	32	NMOD
32	cells	cell	I-NP	NNS	I-cell_type	28	PMOD
33	.	.	O	.	O	8	P

1	Unexpectedly	Unexpectedly	B-ADVP	RB	O	15	VMOD
2	,	,	O	,	O	15	P
3	the	the	B-NP	DT	O	4	NMOD
4	presence	presence	I-NP	NN	O	15	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	nuclear	nuclear	B-NP	JJ	O	13	NMOD
7	I	I	I-NP	NN	B-protein	13	NMOD
8	(	(	O	(	I-protein	13	NMOD
9	kappa	kappa	B-NP	NN	I-protein	13	NMOD
10	)	)	O	)	I-protein	13	NMOD
11	B	B	B-NP	NN	I-protein	13	NMOD
12	(	(	O	(	I-protein	13	NMOD
13	alpha	alpha	B-NP	NN	I-protein	5	PMOD
14	)	)	O	)	I-protein	13	NMOD
15	did	do	B-VP	VBD	O	25	VMOD
16	not	not	I-VP	RB	O	15	VMOD
17	inhibit	inhibit	I-VP	VB	O	15	VC
18	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	19	NMOD
19	binding	binding	I-NP	NN	O	17	OBJ
20	to	to	B-PP	TO	O	19	NMOD
21	DNA	DNA	B-NP	NN	O	20	PMOD
22	and	and	O	CC	O	25	VMOD
23	this	this	B-NP	DT	O	24	NMOD
24	phenomenon	phenomenon	I-NP	NN	O	25	SUB
25	was	be	B-VP	VBD	O	0	ROOT
26	not	not	O	RB	O	25	VMOD
27	due	due	B-ADJP	JJ	O	28	PMOD
28	to	to	B-PP	TO	O	25	PRD
29	the	the	B-NP	DT	O	30	NMOD
30	presence	presence	I-NP	NN	O	28	PMOD
31	of	of	B-PP	IN	O	30	NMOD
32	IkappaBbeta	IkappaBbeta	B-NP	NN	B-protein	31	PMOD
33	at	at	B-PP	IN	O	30	NMOD
34	the	the	B-NP	DT	O	36	NMOD
35	nuclear	nuclear	I-NP	JJ	O	36	NMOD
36	level	level	I-NP	NN	O	33	PMOD
37	.	.	O	.	O	25	P

1	Immunoprecipitation	Immunoprecipitation	B-NP	NN	O	2	NMOD
2	experiments	experiment	I-NP	NNS	O	3	SUB
3	failed	fail	B-VP	VBD	O	0	ROOT
4	to	to	I-VP	TO	O	5	VMOD
5	demonstrate	demonstrate	I-VP	VB	O	3	VMOD
6	an	an	B-NP	DT	O	7	NMOD
7	association	association	I-NP	NN	O	5	OBJ
8	between	between	B-PP	IN	O	7	NMOD
9	nuclear	nuclear	B-NP	JJ	O	16	NMOD
10	I	I	I-NP	NN	B-protein	16	NMOD
11	(	(	O	(	I-protein	16	NMOD
12	kappa	kappa	B-NP	NN	I-protein	16	NMOD
13	)	)	O	)	I-protein	16	NMOD
14	B	B	B-NP	NN	I-protein	16	NMOD
15	(	(	O	(	I-protein	16	NMOD
16	alpha	alpha	B-NP	NN	I-protein	20	NMOD
17	)	)	O	)	I-protein	16	NMOD
18	and	and	O	CC	O	20	NMOD
19	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	20	NMOD
20	proteins	protein	I-NP	NNS	I-protein	8	PMOD
21	.	.	O	.	O	3	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	in	in	B-PP	IN	O	20	VMOD
6	resting	rest	B-NP	VBG	O	8	AMOD
7	and	and	I-NP	CC	O	8	AMOD
8	PMA-activated	PMA-activated	I-NP	JJ	B-cell_type	10	NMOD
9	human	human	I-NP	JJ	I-cell_type	10	NMOD
10	PBL	PBL	I-NP	NN	I-cell_type	5	PMOD
11	,	,	O	,	O	20	P
12	I	I	B-NP	NN	B-protein	18	NMOD
13	(	(	O	(	I-protein	18	NMOD
14	kappa	kappa	B-NP	NN	I-protein	18	NMOD
15	)	)	O	)	I-protein	18	NMOD
16	B	B	B-NP	NN	I-protein	18	NMOD
17	(	(	O	(	I-protein	18	NMOD
18	alpha	alpha	B-NP	NN	I-protein	20	SUB
19	)	)	O	)	I-protein	18	NMOD
20	is	be	B-VP	VBZ	O	4	SBAR
21	present	present	B-ADJP	JJ	O	20	PRD
22	in	in	B-PP	IN	O	21	AMOD
23	the	the	B-NP	DT	O	24	NMOD
24	nucleus	nucleus	I-NP	NN	O	22	PMOD
25	in	in	B-PP	IN	O	21	AMOD
26	an	an	B-NP	DT	O	29	NMOD
27	apparently	apparently	I-NP	RB	O	28	AMOD
28	inactive	inactive	I-NP	JJ	O	29	NMOD
29	form	form	I-NP	NN	O	25	PMOD
30	unable	unable	B-ADJP	JJ	O	29	NMOD
31	to	to	B-VP	TO	O	32	VMOD
32	disrupt	disrupt	I-VP	VB	O	30	AMOD
33	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	34	NMOD
34	binding	binding	I-NP	NN	O	32	OBJ
35	from	from	B-PP	IN	O	34	NMOD
36	DNA	DNA	B-NP	NN	O	35	PMOD
37	.	.	O	.	O	3	P

1	No	No	B-NP	DT	O	2	NMOD
2	evidence	evidence	I-NP	NN	O	7	SUB
3	for	for	B-PP	IN	O	2	NMOD
4	inflammatory	inflammatory	B-NP	JJ	B-protein	6	NMOD
5	cytokine	cytokine	I-NP	NN	I-protein	6	NMOD
6	production	production	I-NP	NN	O	3	PMOD
7	was	be	B-VP	VBD	O	0	ROOT
8	obtained	obtain	I-VP	VBN	O	7	VC
9	under	under	B-PP	IN	O	8	VMOD
10	these	these	B-NP	DT	O	11	NMOD
11	conditions	condition	I-NP	NNS	O	9	PMOD
12	.	.	O	.	O	7	P

